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Editorial on the Research Topic
Peripheral Nerve Regeneration
The Research Topic entitled “Peripheral Nerve Regeneration” is focused on strategies to promote
and improve the same. Injuries to peripheral nerves have variable causation such as metabolic or
hereditary poly-neuropathies, nerve sheath tumors, or nerve trauma resulting from occupational or
car accidents or combat activities. Although knowledge on the processes allowing peripheral nerve
regeneration after degeneration or injury has been significantly increased over the last decades,
and although (micro-)surgical methods have been refined considerably, more research is still
needed to minimize consequences for patients and society. Treatment of acutely or chronically
injured peripheral nerves is far from being optimal. Patients suffer from severe impairment of
their quality of life due to continuous disabilities and their treatment is still affiliated with high
socio-economic costs.
We are very grateful to the 123 authors from 14 different countries and five continents that
contributed to the current Research Topic with seven review articles and 12 original research
articles. These publications look from different angles into the current challenges for the field. For
more than 100 years investigative surgeons and basic researchers have revealed solid knowledge on
(1) key events orchestrating the process of peripheral nerve regeneration, and (2) basic mechanisms
and pathways that need to be activated or blocked for axonal regeneration and correct reinnervation
of peripheral target tissue. They have also discovered (3) cellular key players and how lineage
reprogramming is generating them, and, not to forget, (4) surgical approaches and biomaterials
supporting successful recovery.
This collection of articles adds insights to the aforementioned knowledge and also provides
technical information worth considering in future research. In the following we first give
an overview about the included review articles before shortly reporting on the original
research articles.
Ronchi et al. analyzed the potential applications, advantages and limitations of the rat median
nerve injury and repair model in pre-clinical research. They provide a synthetic overview of a
variety of methods that can be applied in this model for assessing functional nerve regeneration
and present informative tables about the research that has made use of this model. Also the
article of Lovati et al. considers pre-clinical work performed in rat models. They performed a
systematic review of the literature (from January 2007 to October 2017) regarding the different
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decellularization protocols used and aimed, through assessment
of the results from histological and functional read-outs, to
compare the effectiveness of the different nerve grafts. Boecker
et al. reviewed the clinical relevance of chitosan derived nerve
guides for short gap repair in human patients. They give an
overview on the physiologic properties of chitosan in comparison
to other nerve guide materials and discuss actual and future
translation of chitosan into clinical practice.
In their article Duraikannu et al. review the regenerative
capacity of adult neurons and novel intrinsic pathways that
have impact on axonal regrowth, downstream from growth
factor receptors. They thereby describe a novel approach
to enhance the intrinsic growth of adult neurons, targeting
neuronal inhibitors of regeneration, like tumor suppressor
molecules, by means of non-viral siRNA. Orchestration of
proteases and secretases during Wallerian degeneration and
setting-up of a pro-regenerative environment is the focus of the
article contributed by Pellegatta and Taveggia. They describe
the role of different proteases and secretases in controlling,
on a post-translational level, the activity of transmembrane
proteins involved in peripheral nerve regeneration, among which
the neurotrophin receptor p75NTR, the receptor Notch, the
growth factor Neuregulin-1, and how this creates a permissive
environment to allow successful regeneration of injured axons.
Jessen and Mirsky review the remarkable plasticity of Schwann
cells and the characteristics of the denervated repair Schwann
cell population. Knowledge about their distinct properties
and cell-type specific control mechanisms can potentially be
used to foster the development of effective treatments, further
increasing regenerative potential andmaintaining repair capacity
for the extended periods that are required for substantial
nerve regeneration.
Neurotrophic factors and especially brain derived
neurotrophic factor (BDNF) are known to modulate axonal
regeneration. McGregor and English put a particular focus on
discussing the role of BDNF in activity-dependent treatments to
enhance regeneration such as electrical stimulation, exercise, and
optogenetic stimulation. The authors further discuss the impact
of a common single nucleotide polymorphism in the human
bdfn gene, Val66Met, on the effectiveness of these treatments and
emphasize the need for personalized regenerative medicine.
The original research articles included into this Research
Topic, again, cover versatile aspects of peripheral nerve
regeneration research.
The characteristic properties of the graft material will have an
important impact on the outcome of functional recovery after
nerve gap repair. This is not only true for bioartificial grafts, but
also for autografts that are commonly harvested from sensory
nerves and implanted into motor (mixed) nerves. In this context
Hercher et al. evaluated regeneration-associated gene expression
in homotopic or heterotopic 6mm rat femoral nerve grafts. They
describe evident spatiotemporal differences in the expression of
some trophic factors and cell adhesion molecules between grafts
from sensory and motor branches. Although differences in the
capabilities of these grafts to sustain motor regeneration in their
short gap repair model were minor, the paper contributes to
the debate about the concerns of using sensory donor nerves
as the gold standard to repair especially long nerve defects.
The paper of Wilcox et al. considers a technical issue for going
beyond rodent models in peripheral nerve research. For ethical
and practical reasons, research of nerve injury and repair is
focused to rodent models. Nevertheless, during reconstructive
nerve repair it is sometimes possible to obtain human nerve
samples. These samples are, however, exposed to the complex
surgical environment, bringing them in contact with chemical
and physical factors which are not present when sampling animal
tissues in a research laboratory. With the aim of optimizing
protocols for the efficient extraction of RNA for quantitative
analysis, the authors characterized the effect of time delays before
cryopreservation and the effect of contact with antiseptic surgical
reagents on the quantity and quality of RNA isolated from human
samples in comparison to rat nerve samples.
The efficacy of two novel bioartificial nerve grafts has been
investigated by other groups in two different models, the 10mm
rat median nerve and the 10mm rat sciatic nerve model.
Dietzmeyer et al. report their analysis of a more bendable 2-
chambered chitosan nerve guide. Bendability was increased by
a corrugated outer wall and the chambers were formed by
longitudinally introducing a perforated chitosan film to assist
axonal outgrowth. The authors evaluated functional regeneration
with three methods in the advanced rat median nerve model
and demonstrate that the device represents a promising and
innovative alternative for nerve repair in mobile body parts
such as digits. Chato-Astrain et al. describe their attempt to
produce a tissue engineered nerve graft from mesenchymal
stem cells integrated into a nanostructured hydrogel. They
evaluated their graft alone or introduced into clinically approved
collagen type I nerve guides in the rat sciatic nerve model.
The results presented suggest that the novel nanostructured
fibrin-agarose bio-artificial nerve substitutes support nerve tissue
regeneration and functional recovery to an extent similar to the
autograft control.
As also discussed in the review by McGregor and English,
already mentioned above, physical exercise has been shown to
add positive effects on motor recovery after nerve transection
and repair. In this context Arbat-Plana et al. investigated how
physical exercise can modulate the synaptic stripping and other
spinal changes that spinal motoneurons undergo after axotomy
in a rat model of end-to-end sciatic nerve repair. They describe
that in addition to the activity-dependent modulation of the
BDNF system, noradrenergic projections of the locus coerules
are important for some but not all the effects that exercise
induces on the spinal cord after peripheral nerve injury. Besides
physical exercise, also supplementation of specific nutrients is
frequently discussed to support peripheral nerve regeneration.
The paper of Li et al. investigated the effects of ascorbic acid
(vitamin C), an essential micronutrient, on nerve regeneration
in vivo in mice and in vitro. The study showed that ascorbic
acid improved regeneration and functional recovery following
sciatic nerve crush, promoted neurite outgrowth in dorsal
root ganglion (DRG) neuron cultures, enhanced proliferation
and migration behavior in primary Schwann cell cultures, and
positively modulated the polarization of primary macrophages in
culture toward the pro-regenerative phenotype.
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Since sufficient peripheral nerve regeneration obviously
depends on axonal outgrowth and its support by Schwann cells,
we have included into this special issue also basic research papers
reporting novel knowledge about these topics. The critical role
of micro domains in cell membranes, specifically cholesterol-rich
lipid rafts which cluster proteins and other molecules together,
is explored by Roselló-Busquets et al. using a series of in vitro
and mouse in vivo models. This study showed that cholesterol
depletion disrupted lipid rafts, altered growth cone morphology,
and resulted in increased axonal growth during development and
after axotomy, with implications for both peripheral and central
nervous system research.
It is widely accepted that the neurotrophin receptor p75NTR
is a central component in nerve regeneration, but since it is
expressed in both neurons and glia and has been associated with
a wide range of cellular behaviors its specific role remains elusive.
Gonçalves et al. generated a conditional knockout mouse model
to silence expression of p75NTR specifically in Schwann cells,
subsequently showing that Schwann cell p75NTR is not critical
for axonal regrowth or remyelination following crush injury,
although its absence did reduce nerve conduction velocity.
Following injury, the axons and their terminals release
mitochondrial DNA (mtDNA) fragments and proteins known
as “mitochondrial damage-associated molecular patterns”
(mtDAMPs). In their paper, Korimová et al. hypothesized that
mtDAMPs might stimulate Schwann cells to put out cytoplasmic
processes through the action of the corresponding receptors and
tested their hypothesis in vitro in RT4-D6P2T schwannoma cells.
Schwann cell proliferation is an important component of the
peripheral nerve injury response and Tan et al. explored the
effect of inhibiting RhoA-subfamily GTPases with C3 transferase
on this process, since RhoA inhibition is an established target
used for improving neural regeneration. Using an in vitro
model they showed that the C3 transferase CT04 suppressed
primary Schwann cell proliferation, but that this was likely to
be independent of the ROCK pathway and instead involved
inactivation of the AKT pathway. Also related to the topic
of Schwann cell proliferation, Gordon et al. analyzed the
proliferative capacity of rat Schwann cells obtained from distal
nerve stumps subjected to acute denervation of 7 days or
chronic denervation of either 7 weeks or 17 months, showing in
vitro that these cells retained their capacity to myelinate DRG
neurites, although with a reduced capacity. They hypothesized
that, although these Schwann cells retain their ability to respond
to axonal signals and to elaborate myelin, their low numbers
and their reduced capacity to proliferate might account, at least
in part, for the poor functional recovery observed after delayed
surgical repair of injured peripheral nerves.
The last, but not least, publication included into this Research
Topic, is a contribution of Stratton et al. who elucidated the
role of the microenvironment to sustain/suppress malignant
peripheral nerve sheath tumors (MPNST) that usually lead
to aggressive nerve resections. Therefore, strategies aimed to
suppress proliferation of these tumors would limit the functional
loss derived from these malignancies. The authors present a
novel in vitromodel for studying MPNST by using isolated adult
rodent Schwann cells and their results strengthen the finding
that balanced properties of the tissue environment are crucial for
tumor-suppression and point out to the high importance of the
endoneurial tissue in this context.
We, the guest editors, thank all authors onemore time for their
valuable contributions and hope that the readers of this Research
Topic will, as much as we did, enjoy learning the expert opinions
and excellent research results presented.
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Background: Deciphering avenues to adequately control malignancies in the peripheral
nerve will reduce the need for current, largely-ineffective, standards of care which
includes the use of invasive, nerve-damaging, resection surgery. By avoiding the
need for en bloc resection surgery, the likelihood of retained function or efficient
nerve regeneration following the control of tumor growth is greater, which has several
implications for long-term health and well-being of cancer survivors. Nerve tumors can
arise as malignant peripheral nerve sheath tumors (MPNST) that result in a highly-
aggressive form of soft tissue sarcoma. Although the precise cause of MPNST remains
unknown, studies suggest that dysregulation of Schwann cells, mediated by the
microenvironment, plays a key role in tumor progression. This study aimed to further
characterize the role of local microenvironment on tumor progression, with an emphasis
on identifying factors within tumor suppressive environments that have potential for
therapeutic application.
Methods: We created GFP-tagged adult induced tumorigenic Schwann cell lines
(iSCs) and transplanted them into various in vivo microenvironments. We used
immunohistochemistry to document the response of iSCs and performed proteomics
analysis to identify local factors that might modulate divergent iSC behaviors.
Results: Following transplant into the skin, spinal cord or epineurial compartment of the
nerve, iSCs formed tumors closely resembling MPNST. In contrast, transplantation into
the endoneurial compartment of the nerve significantly suppressed iSC proliferation.
Proteomics analysis revealed a battery of factors enriched within the endoneurial
compartment, of which one growth factor of interest, ciliary neurotrophic factor (CNTF)
was capable of preventing iSCs proliferation in vitro.
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Conclusions: This dataset describes a novel approach for identifying biologically
relevant therapeutic targets, such as CNTF, and highlights the complex relationship
that tumor cells have with their local microenvironment. This study has significant
implications for the development of future therapeutic strategies to fight MPNSTs, and,
consequently, improve peripheral nerve regeneration and nerve function.
Keywords: peripheral nerve, sarcoma, Schwann cell, MPNST, CNTF, endoneurium, epineurium, microenvironment
IMPORTANCE OF STUDY
These studies provide several major findings. First, we develop
a reproducible in vitro model to study MPNST from isolated
adult rodent Schwann cells (termed iSCs) that following
transplantation, share striking phenotypic resemblance to human
MPNST tumors. Second, our results underscore the importance
of tissue microenvironment in promoting tumorigenic growth
and identify the endoneurial compartment within the peripheral
nerve as a unique microenvironment enriched in tumor
suppressive factors. Third, by probing uniquely expressed
proteins within the endoneurial compartment, we demonstrated
an autonomous role for CNTF to block proliferation of iSCs
mimicking the inhibition observed when grafted iSCs are
contained within the endoneurial compartment in vivo. Together,
these experiments provide evidence for a tumor suppressive
endoneurial niche that functions to repress proliferation and
identifies CNTF signaling as a potential therapeutic avenue for
MPNST.
INTRODUCTION
Malignancies within the peripheral nerve usually arise from
aberrant Schwann cell proliferation (Miller et al., 2006; Chen
et al., 2014) giving rise to malignant peripheral nerve sheath
tumors (MPNST), a highly aggressive and largely untreatable
form of soft tissue sarcoma, often culminating in patient death
within ten years(LaFemina et al., 2013). MPNSTs occur in
association with inherited syndromes, such as Neurofibromatosis
Type 1 (NF1) but can also occur sporadically (46–48% of
cases) (LaFemina et al., 2013). Although numerous treatment
modalities have been assessed for treating MPNSTs (i.e., radiation
therapy, surgical resection) they show moderate to poor results
long term (LaFemina et al., 2013).
Deciphering avenues to adequately control malignancies in
the peripheral nerve will potentially improve the current standard
of care. More effective adjunctive drug therapy may allow
modification of en block procedures, toward a nerve-sparing
approach, to permit function to be retained.
There is strong evidence to suggest that distinct locations
within the peripheral nervous system are prone to tumor
formation and progression. For example, several studies have
reported the capacity of nerve sheath tumors to form, with
increased tumor burden, within the proximal nerves and
plexus compared to the distal nerves (Plotkin et al., 2012)
and are increasingly metastatic in the intrathoracic and dorsal
root ganglion (DRG) regions compared to subdiaphragmatic
regions (Kourea et al., 1998). One potential difference between
these anatomical regions is the presence of distinct local
microenvironments unique to each location (Le et al., 2010;
Lavasani et al., 2013). Moreover, transplanting NF1-mutant cells
into several distinct locations within healthy rodents revealed that
aberrant cell growth was especially pronounced when introduced
into distinct regions (Le et al., 2010). The factors responsible for
these divergent effects remain to be elucidated.
In line with this, others have observed similar phenomena
following injury (Ribeiro et al., 2013; Schulz et al., 2016).
Recently, Ribeiro and his colleagues found that when NF1
mutation was induced in adult Schwann cells, tumors formed
in the nerve, but intriguingly only post-injury, and were
restricted only to the injury site. In this context, the authors
concluded that tumor formation must involve an interplay
between Schwann cell-associated NF1 mutation and injury
environments. They suggested that although the nerve is
generally a “tumor suppressive environment,” an insult can
locally alter the composition and concentration of factors
present at the injury site, consequently allowing unregulated
cell growth. Indeed, cytokine-releasing mast cells at the
injury site have been shown to play a role in nerve tumor
progression by introducing factors that are not typically present
within the intact nerve (Yang et al., 2008). Importantly, the
authors also noted that tumors did not form distal to the
injury site – an area of the nerve that undergoes Wallerian
degeneration post-injury. Since this area is subjected to similar
injury cues, including the presence of mast cells (Gaudet
et al., 2011), such findings suggest that injury-associated
factors are not the sole mediators of tumorigenicity in this
context.
Another plausible explanation for the formation of tumors
at the injury site is the breakdown of connective tissue barriers
as a result of the mechanical force exerted at the injury site
itself (Olsson and Kristensson, 1973). The perineurial barrier, a
thin layer of perineurial cells and collagen (Riccardi, 2007), acts
as a specialized blood-nerve barrier in health (similar to that
of the central nervous systems blood-brain barrier) (Allt and
Lawrenson, 2000), but becomes compromised at sites of nerve
injury (Haftek and Thomas, 1968). In homeostatic conditions,
this specialized perineurial barrier with tight junctions prevents
components from the endoneurium, where axons and Schwann
cells reside, to diffuse freely into the epineurium, where large
amounts of connective tissue resides (Olsson and Kristensson,
1973), as well as vice versa. Importantly, long term compromised
perineurial barrier function post-injury is spatially confined only
to the site of injury and does not extend distally (Olsson and
Kristensson, 1973).
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The potential contribution of a compromised barrier function
to tumor progression becomes especially plausible when the types
of cells and factors present within each defined compartment
are considered. The epineurium harbors fibroblasts, adipocytes,
endothelial cells, blood vessels, mast cells and large amounts
of collagen (Norris et al., 1985; Verheijen et al., 2003). On
the other hand, the endoneurial compartment mainly harbors
Schwann cells (90%) and axons as well as a small number of
neural-crest derived fibroblasts, endothelial cells, immune cells
and small amounts of collagen (Sunderland, 1945; Riccardi, 2007;
Weiss et al., 2016). Interestingly, several studies have shown
that factors/cells known to be present within the epineurium
enhance tumor progression (Fang et al., 2014; Kuzet and
Gaggioli, 2016; McDonald et al., 2016), while several factors
known to be present within the endoneurial compartment
suppress Schwann cell proliferation (Parrinello et al., 2008).
As such, one might hypothesize that Schwann cell-derived
tumorigenesis is a consequence of perineurium breakdown
and consequent exposure of latent tumorigenic cells to factors
previously restricted to the epineurial compartment competing
with suppressive factors within the endoneurium.
To elucidate the role of microenvironment on tumor
progression, we subjected healthy adult Schwann cells to a
mutagenic environment in vitro following which they were
transplanted into various in vivo anatomical microenvironments.
Following transplantation, mutagenic Schwann cells share
striking phenotypic resemblance to human MPNST tumors.
Intriguingly, when these same mutagenic induced tumor
Schwann cells (iSCs) are injected and contained within the
endoneurial compartment, they exit cell cycle and down-regulate
tumor markers. Using quantitative proteomics to screen for
factors that were uniquely present within the endoneurial
compartment, we identified ciliary neurotrophic factor (CNTF), a
growth factor known for promoting Schwann cell differentiation
(Reynolds and Woolf, 1993), as a factor that was not only
enriched within the endoneurium, but exhibited an autonomous
capacity to inhibit proliferation of mutagenic Schwann cells.
Uncovering the signals in the endoneurial niche that bias
Schwann cells against hyperproliferation can safeguard against
nerve malignancies and pave the path for regeneration and return
of nerve function for cancer survivors.
MATERIALS AND METHODS
In vitro Induction of Tumor-Forming
Adult Schwann Cells (iSCs)
Sciatic nerves were collected from three adult Sprague Dawley
rats, then Schwann cells were isolated using a modified protocol
from previously described methods (Mirfeizi et al., 2017). Briefly,
nerves were dissected and minced, and subsequently incubated
in collagenase Type IV (Worthington) at 37◦C for 40 min.
Samples were then centrifuged (1000 rpm for 5 min), then
re-suspended in Schwann cell media containing DMEM and
F12 (3:1), neuregulin-1 type III (50 ng/ml), forskolin (5 µM),
B27 supplement (1%), and penicillin (100 µg/ml)/streptomycin
(100 units/ml). Cells were plated on poly-D-Lysine (20 µg/ml)
and laminin (4 µg/ml) coated surfaces (BD Bioscience) and
cultured at 37◦C in a 5% CO2 incubator. Cultures were
also supplemented with plasmocin (25 µg/mL, Invitrogen)
and fungizone (40 ng/ml, Invitrogen) for the first month of
culturing to prevent mycoplasma and fungal growth. Triple-
filtered fetal bovine serum (1–5% FBS; Hyclone) was added for
the first 5 days of culturing. Cells were maintained in vitro for
3–4 months. For passaging, media was removed and TrypLE-
express (Invitrogen) was added to cultures and incubated at 37◦C
for 5 min. All detached cells were collected and plated at a density
of 50,000 cells/ml for further maintenance. Tumor-forming
characteristics of adult Schwann cells were induced by extended
growth and repeated passage in vitro as previously described
(Funk et al., 2007). Spherical colony formation (loss of contact
mediated growth inhibition) and growth factor independence
was observed by 3 months in culture. Cells were fed every 4th
day and treated identically.
Lenti-Viral Labeling
To track cells following in vivo transplantation, cells were
transduced with a GFP-expressing lenti-viral vector as previously
described (Mirfeizi et al., 2017). All lentivirus work was
undertaken in a biohazard level 2+ laboratory using previously
established protocols. Cells (70% confluence) were incubated
overnight in DMEM containing GFP-expressing lentiviral
particles and polybrene (8 µg/ml). The next day, fresh media was
applied and cells were left to grow to 100% confluence. Cells were
then dissociated and FACs sorted (BD FACS Aria III) to further
purify the GFP+ cell fraction.
Karyotyping
To assess chromosomal integrity, karyotyping was performed
on iSCs using previously described methods (Fan et al.,
2014). Cultures (70% confluence) were treated with KaryoMAX
Colcemid solution (30 ng/mL, Gibco) for 4 h at 37◦C. Schwann
cells were then detached from dishes, centrifuged, then re-
suspended in cell hypotonic solution (CHS; 40 mM Kcl, 20 mM
HEPES, 0.5 mM EGTA and 9 mM NaOH) and incubated for 1 h
at 37◦C. After 1 h, the mix was fixed with acetic acid/methanol
(1:3) and G-banding analysis was performed in the Clinical
Genetics Facility at the Alberta Children’s Hospital.
In vitro Treatments,
Immunocytochemistry and Imaging
To assess the response of iSCs to different environmental stimuli,
iSCs were plated onto 96-well plates at 10,000 cells/mL. Cells
were treated with base media in the presence of neuregulin
(100 ng/ml, R&D), CNTF (0–100 ng/ml, Peprotech), or media
pre-conditioned with epineurial tissue, endoneurial tissue or
spinal cord tissue. To prepare media for conditioned media
experiments, equal wet weights of healthy epineurial tissue or
endoneurial tissue from sciatic nerves, or white matter from
thoracic spinal cords was dissected from C57BL/6 mice (n = 8–
10), then maintained in DMEM and F12 (3:1), B27 supplement
(1%), penicillin (100 µg/ml)/streptomycin (100 units/ml) and
10% FBS for 4–6 days before filtering (0.4 µm), and snap
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freezing at −80◦C until iSCs 96-well experiments were ready.
Depleted media alone controls were treated identically except
no explants were added. Three days post-treatment, cells were
washed with sterile PBS and then fixed in 4% paraformaldehyde
(PFA) for 5–10 min. For immunocytochemistry, cells were
permeabilized using 0.5% triton X-100 and 5% BSA for 1–
2 h at room temperature. Primary antibodies (rat anti-Ki67
(clone SolA15, 14569882, eBiosciences), mouse anti-nestin
(SC23927, Santa Cruz) were incubated overnight (1:200) at
room temperature. Unbound primary antibodies were washed
and cells were subsequently incubated with Alexa-conjugated
secondary antibodies (1:200, Invitrogen) at room temperature
for 1–2 h, washed, and nuclei were counterstained with Hoechst
(1:1000, Sigma) and imaged using ImageXpress (Molecular
Devices). The sum of cells (Ki67+ NES+ Hoechst+ versus
NES+ Hoechst+) in 12 images (20×) per well was obtained,
then normalized to obtain a percentage value for each well.
This value was subsequently averaged across three replicates
per condition. Experiments were replicated on 3 independent
days.
Animal Care and Surgery
Animal procedures were approved by the University of Calgary
and University of British Columbia Animal Care Committees
in compliance with the Guidelines of the Canadian Council of
Animal Care. To assess the impact of in vivo microenvironments
on the capacity of iSCs to form tumors, adult 8–12 weeks
immune-deficient Foxn1nu, NOD/CB17-Prkdcscid/NcrCrl mice
(for nerve and skin injections), or Sprague Dawley rats (for
spinal cord injections) were used [Charles River Laboratories
(Senneville, QC, Canada)]. Rats were treated with Cyclosporin A
and GM1 natural killer cell antibodies for immunosuppression.
Rodents were maintained on a 12-h light cycle in a temperature-
controlled environment with unlimited food and water. For
cell transplants, rodents were anesthetized using isofluorane
(5% induction and 2% maintenance) and given subcutaneous
injections of 0.1 mL (0.03 mg/mL) buprenorphine for pain relief.
For nerve and spinal cord transplants, an injury was first induced
prior to transplants in order to create an environment permissive
for tumor formation (Ribeiro et al., 2013). Surgery sites were
sterilized and then the sciatic nerve (including endoneurial and
epineurial compartments) or spinal cords were exposed and
crush injured using #5 forceps (nerve) or an Infinite Horizon
Impactor, 200 KD (spinal cord). Immediately after (nerve) or
2 weeks after (spinal cord) injury, each distal nerve received
a 2 µl volume injection (100,000 cells) and each spinal cord
received a 5 µl volume injection (500,000 cells) of GFP+ve
nerve or skin-derived iSCs (n = 3–4 rodent per donor, 2–3
donors) using a 33-gauge Hamilton syringe. iSCs were suspended
in neuregulin (500 ng/ml) and fast green (1%) in DMEM
at a density of 50,000 cells/µl. Importantly, this injection
strategy resulted in the presence of iSCs in the endoneurial
(tibial fascicles) and epineurial (surrounding the fascicles)
compartments. For skin transplants, GFP transduced iSCs
were injected intradermally into the back skin of NOD/CB17-
Prkdcscid/NcrCrl mice. In all cases, tissue was collect within
2–4 months of surgeries.
Tissue Processing,
Immunohistochemistry and Imaging
Briefly, nerve, skin, and spinal cord tissue was harvested at 2–
4 months post-transplant, then fixed overnight with 4% PFA.
For spinal cords, 4% PFA cardiac perfusion was also performed.
Tissue was then left in 30% sucrose overnight, then frozen in OCT
(VWR International) and stored at −80◦C. For comparisons
to MPNST, archived human and rodent samples were fixed
overnight in 10% neutral buffered formalin, processed through
graded ethanol’s and xylene, and embedded in paraffin. Sections
were cut at 4 µm thickness and stained with hematoxylin
and eosin (H&E). For IHC, heat-induced antigen retrieval was
performed in 10 mM sodium citrate for 25 min in microwave
prior to staining with the following primary antibodies: S100
(DAKO) rabbit polyclonal 1:3,000 dilution and Desmin (DAKO)
mouse monoclonal D33 1:400 dilution. Detection of staining was
performed using Envision+DAB kit (DAKO) per manufacturer’s
protocol with hematoxylin as a counterstain. Archival material
from MPNST surgical samples were obtained from the Clark
Smith Tumor Bank at the University of Calgary (in collaboration
with Calgary Laboratory Services) with ethics approval from the
Health Research Ethics Board of Alberta – Cancer Committee.
For immmunohistochemitry for PFA fixed tissue, sections were
cut using a Leica cryotome at 10–20 µm. Sections were
then permeabilized with 0.5% triton-X 100 and blocked with
5% BSA or 10% NDS. Primary antibodies were incubated
overnight (rabbit anti-Ncad, AB12221 Abcam; rat anti-Ki67,
14569882, eBiosciences; goat anti-CNTF, AB557 R&D; sheep
anti-ErbB3, AF4518 R&D), washed with PBS, and then Alexa-
conjugated secondary antibodies (1:200, Invitrogen) were applied
for 2 h at room temperature. Hoechst was used to stain nuclei
(1:1000, Sigma) and mounted with Permafluor (Thermo Fisher
Scientific). Image collection and quantification was done using
a Leica SP8 confocal microscope. Two images per condition
at 4 mm distal to the injury site was collected using a
63× objective lens and Z-stack (eight planes) features. Images
(maximum projection) were analyzed using ImageJ (NIH). These
counts were then expressed as a ratio (i.e., GFP+ve Ki67+ve
cells/GFP+ve cells) and averaged within each animal (n = 5
animals/group).
Proteomics
In order to assess the protein composition of the fascicular
portion of the nerve, sciatic nerves were firstly extracted
from healthy adult C57BL/6 mice (n = 8). Using fine forceps
the outer sheaths (ie. epineurium and perineurium) of the
sciatic nerves were carefully removed. At this stage the
contents of the endoneurium (individual myelinated axons) were
clearly distinguishable, and were minced and incubated before
processing for protein collection. Equal wets weights of the
dorsal column from the same mice were also collected as a
comparison. Protein was extracted with SDS gel sample buffer
[0.2 M Tris, 5 mM EDTA, 1 M Sucrose, SDS and dithiothreitol
(DTT)]. Protein was then run on 10% acrylamide gel containing
SDS to separate out proteins that were most likely of interest
(10–60 kDa).
Frontiers in Cellular Neuroscience | www.frontiersin.org 4 October 2018 | Volume 12 | Article 35611
fncel-12-00356 October 10, 2018 Time: 16:48 # 5
Stratton et al. MPNST and Microenvironment
Gel plugs were washed in 50 mM ammonium
bicarbonate/acetonitrile (50:50, v/v) then incubated in 100%
acetonitrile. After being air dried, proteins were reduced with
DTT (10 mM) at 56◦C and alkylated with iodoacetamide
(50 mM) at 24◦C. Gel plugs were washed then rehydrated with
a trypsin solution (Promega; 0.02 µg/ul, 10% acetonitrile) for
2 h at 0◦C then placed in buffer for 16 h at 37◦C. Supernatant
(tryptic peptides) was transferred to acidifying solution
[acetonitrile/water/10% trifluoroacetic acid (60:30:10, v/v)].
Gel plugs were washed with the same acidifying solution and
combined. Samples were then lyophilized and resuspended in
1% formic acid. The tryptic peptides were analyzed by liquid
chromatography (LC; Agilent 1260 Infinity chip cube interface)
tandem mass spectrometry (MS/MS) on an Agilent 6550 iFunnel
quadrupole (Q)- time-of-flight (TOF) mass spectrometer.
The LC and the Q-TOF were both controlled by MassHunter
(B.05.00). The capillary pump used: A1 (97% water, 2.9%
acetonitrile, 0.1% formic acid) and B1 (90% acetonitrile, 9.9%
water; 0.1% formic acid) solutions; and, the nanopump used: A1
(97% water, 2.9% acetonitrile, 0.1% formic acid) and B1 (97%
acetonitrile, 2.9% water; 0.1% formic acid) solutions. Tryptic
peptides (1 µl) were loaded onto a C18 trap column of an Agilent
chip operating in enrichment mode using the capillarity pump of
the LC system at a flow rate of 2.5 µl/min. Elution of the peptides
was performed using a 25 min linear gradient from 3% to 50% B1
generated by the nanopump operated at 0.3 µl/min. The peptides
were electrosprayed into the Q-TOF using an ionization voltage
of 1950V and a 275◦C heated drying gas at a flow of 13 l/min.
The Q-TOF was operated in positive auto MS/MS mode. The
precursor ions with a m/z comprised between 275 and 1700 were
acquired at a scan rate of 250 ms/spectrum and the 10 most
abundant precursors for each cycle having a charge higher than 1,
an intensity of at least 1000 counts and a peptidic isotopic model
were fragmented by collision induced dissociation. Fragment
ions having a m/z comprised between 50 and 1700 were acquired
at a scan rate of 333.3 ms/spectrum. The collision energy was
calculated for each precursor based on its charge and its mass. An
active exclusion which was released after 1 spectrum and 0.2 min
was applied to avoid re-acquiring the same precursor.
For data extraction, a peptidic isotopic model with a
maximum charge state of 6 was used. The peak filtering for
MS/MS data was set up at an absolute height of at least 10
counts and relative height of the most abundant peak of at least
0.1%. Using Mascot algorithm (2.4), NCBI database search was
performed. Parameters included: trypsin as enzyme, maximum
number of missed cleavage of 1, a peptide charge of 2+, 3+,
and 4+, cysteine carbamidomethylation as fixed modification,
methionine oxidation as variable modification and a mass error
tolerance of 20 ppm. A mass error tolerance of 0.2 Da was
selected for the fragment ions. Only peptides identified with a
score having a confidence higher than 95% were kept for further
analysis.
Statistical Analysis
All statistical analysis was performed using GraphPad Prism
(v5.0). Statistical comparisons were performed using a
two-tailed unpaired Student’s t-test or One-way ANOVA
followed by Tukey’s posthoc test. A p-value of <0.05 was
considered statistically significant. All graphs are presented as
mean± standard error of mean (SEM).
RESULTS
The Development of a Model for MPNST
To develop an MPNST model, we isolated primary Schwann
cells from adult uninjured nerves (n = 3) and subjected these
cells to identical mutagenic in vitro conditions as described by
Funk and colleagues rodent experiments (Funk et al., 2007).
Following 3–4 months of in vitro processing, adult Schwann cells
consistently demonstrated features typical to tumor cell lines,
including growth factor independent growth, loss of contact-
mediated growth suppression, and abnormal chromosomes
(Figure 1). Immunocytochemical assessment of proliferation
kinetics indicated that iSCs were capable of proliferating at
similar rates even in the absence of growth factors (neuregulin
and forskolin; Figures 1A,B); indicating a loss of growth factor-
dependent growth (Funk et al., 2007). Subsequent quantification
revealed that the percentage of Ki67+ iSCs did not statistically
differ between iSCs cultured in the presence or absence of growth
factors critical to SC survival (Student’s t-test, n = 4, p = 0.3).
Also, iSCs formed non-adherent spherical colonies indicating
a loss of contact-mediated cell cycle arrest—another common
feature of uncontrolled proliferation (Figure 1C). Finally,
we also demonstrated that there were several chromosomal
abnormalities, including polyploidy and monosomy present
within all iSC cultures (Figure 1D). Together, such findings
indicate that Schwann cells exposed to extended in vitro cell
culture exhibit reproducible transformation of otherwise healthy
Schwann cells.
In order to determine the subtype of tumors generated by
iSCs, we assessed several in vivo features of iSC-generated
tumors following transplantation into the skin and compared
these to human MPNST tumor biopsies collected at the Clark
Smith Tumor Bank at the University of Calgary. Following
subcutaneous injection of iSCs, 10/12 (83%) of cases showed
a dermal growth at the injection site (Figure 1E). Consistent
with MPNST (Figure 1F–I), iSC-generated tumors consisted
of solid sheets and fascicles comprising elongated spindled
cells with enlarged atypical oval and tapered nuclei, and
moderate amounts of cytoplasm (Figures 1J,K). Tumor cells were
mitotically active and displayed foci of intratumoral necrosis.
Immunohistochemical staining showed that the tumor cells
were focally immunoreactive for S100 (Figure 1L) and were
negative for desmin (Figure 1M). Together, the histologic
and immunophenotypic findings of iSC-generated tumors
recapitulate those of human MPNST.
Endoneurial Microenvironment
Suppresses Tumorigenesis of MPNST
To assess the effect of distinct nerve microenvironments on iSC
tumor progression, GFP-labeled iSCs were injected into specific
compartments (eg. endoneurium and epineurium) within the
sciatic nerves of immune deficient rodents. Within 2 months
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FIGURE 1 | The development of a malignant peripheral nerve sheath tumors (MPNST) model. (A) Representative immunocytochemical images of induced tumor
Schwann cells (iSCs) either deprived of growth factors (–NRG) or treated with neuregulin and forskolin (+NRG, 50 ng/ml neuregulin, 5 mM Forskolin). Note the similar
numbers of Nestin+ (green, NES), Hoechst+ (blue) iSCs that express Ki67 (red) across both conditions. (B) Quantification of percentage of Ki67+ cells revealed no
difference between groups (Student’s t-test, n = 4, P = 0.3). (C) Note the presence of sphere formation when iSCs are grown in growth factor deprived conditions.
(D) Karyotyping analysis indicates multiple chromosomal abnormalities, including polyploidy and monosomy cells. (E) Intradermal iSC injections into back skin
resulted in the development of tumors within 16 weeks. (F–M) Representative histological images of H&E (F,G,J,K), s100 (H,L) and Desmin (I,M) from a biopsied
sample of human MPNSTs (F–I) and from a sample from iSCs (J–M). Note the presence of necrosis, mitosis and spindle-shaped cells in both samples (F,G and
J,K). Also note the presence of S100 (H,L) immunoreactivity, as well as the lack of Desmin immunoreactivity (I,M) in both samples. Scale bars = A (50 µm), C
(200 µm), G–I (20 µm).
post-transplant, in 88% of cases (8/9 animals), we observed
the formation of tumors (Figure 2A). Importantly, there was
a robust presence of Ki67+ GFP+ iSCs (Watanabe et al.,
2001) and their location was strictly confined to the epineurial
compartment (Figure 2B). Quantification of the percentage
of Ki67+ GFP+ iSCs demonstrated a fourfold decrease in
proliferation in the endoneurial compartment compared to the
epineurial compartment (One-way ANOVA with Tukey’s posthoc
test, n = 6, p < 0.001, Figure 2E). We also noted reduced
expression of other cancer-associated proteins in iSCs within
the endoneurial compartment compared to those within the
epineurial compartment, including ErbB3 (Stonecypher et al.,
2005) and N-cadherin (Flaiz et al., 2008), both associated
with dysregulated growth factor signaling in tumor growth
(Aplin et al., 1998; Hanahan and Weinberg, 2000) (Figure 3).
We also performed identical injections of iSCs into the spinal
cord. Similar to the epineurial compartment, highly proliferative
and invasive iSC tumors formed in 88% of cases (9/10)
(Figures 2C–E).
Finally, we asked whether secreted factors may be responsible
for this context-dependent growth inhibition. To do this,
we exposed iSCs to conditioned media from microdissected
adult nerve endoneurium, epineurium or spinal cord tissues.
Intriguingly, there was a ∼40% reduction in the percentage
of proliferative iSCs when subjected to conditioned media
from endoneurial tissue compared to media conditioned with
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FIGURE 2 | The endoneurial microenvironment suppresses tumorigenesis of MPNST. (A) Intraneural iSC injections into the sciatic nerve resulted in the development
of tumors within 2 months. (B) Representative immunohistochemical images of the endoneurial and epineurial compartments. Note the presence of widespread
Ki67+ (red), Hoechst+ (blue) proliferative iSC (green) in the epineurial compartment compared to the endoneurial compartment. See inset (ˆˆ) for high-resolution
example of localization (arrowheads). (C) iSCs injected into the dorsal column of the spinal cord formed tumors within 2 months. (D) Representative
immunohistochemical images of the spinal cord. Note the presence of widespread Ki67+ (red), Hoechst+ (blue) proliferative iSC (green) in the spinal cord. See inset
(∗∗) for high-resolution example of localization (arrowheads). (E) Quantification of the percentage of Ki67+ iSCs in the endoneurial compartment, epineurial
compartment and spinal cord demonstrated a significant decrease in endoneurial compartment compared to other regions (One-way ANOVA, Tukey’s posthoc test,
n = 6–8, ∗p < 0.01, ∗∗p < 0.001). (F) Representative immunocytochemical images of iSCs treated with conditioned media (CM). Note there are less Ki67+ (red)
Hoechst+ (blue) iSCs in the cultures treated with endoneurial CM compared to epineurial, spinal cord or base media. (G) Quantification of the percentage of Ki67+
iSCs demonstrated a significant decrease in the percentage of Ki67+ iSCs under endoneurial CM conditions compared to all other groups (One-way ANOVA,
Tukey’s posthoc test, n = 3, ∗∗∗∗p < 0.0001, ∗∗∗p < 0.001, ∗∗p < 0.01). Scale bars = B (50 µm), E (20 µm), F (50 µm).
epineurium or spinal cord tissue homogenates (One-way
ANOVA, Tukey’s posthoc test, n = 3, endoneurium vs; depleted,
p < 0.0001; spinal cord, p < 0.001; epineurium, p < 0.01,
Figures 2F,G). Taken together, these findings suggest that
endoneurial microenvironments are uniquely suppressive for
Schwann cells predisposed for oncogenic growth.
The Identification of Suppressive Factors
in the Endoneurial Compartment
To identify potential repressive signaling proteins (10–60 kDa)
enriched in endoneurial tissue of the adult mouse sciatic nerve
we employed tandem mass spectrometry to perform unbiased
proteomic analysis. We found that CNTF—a growth factor
known for promoting Schwann cell differentiation (Reynolds
and Woolf, 1993), was 5.5-fold enriched in endoneurial tissue
compared to spinal cord tissue (Figure 4A). We validated CNTF
expression with immunohistochemistry on mouse and human
adult uninjured nerves and found CNTF immunoreactivity
restricted to cytoplasmic-rich regions of myelinating Schwann
cells – most obviously at the perinuclear area (Figure 4B).
Most importantly, we found that application of CNTF alone
on iSCs in vitro caused a striking dose-dependent reduction in
proliferation (Figure 4C). Quantification of this effect revealed
up to a sixfold reduction in the percentage of Ki67+ iSCs when
treated with 100ng/ml CNTF (One-way ANOVA, Tukey’s posthoc
test, n = 3, ∗∗p < 0.05) (Figure 4D). Taken together, CNTF
appears to be an important regulator of oncogenic Schwann cells
and this data suggests that CNTF or small molecules targeting
its downstream targets, may offer some therapeutic value toward
controlling aberrant Schwann cells and MPNSTs.
DISCUSSION
These studies provide several major findings that has implications
for MPNST and consequently peripheral nerve regeneration.
First, we developed a reproducible in vitro model to study
MPNST from isolated adult Schwann cells (termed iSCs) that
following transplantation, share striking phenotypic resemblance
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FIGURE 3 | The fascicular microenvironment suppresses tumor-associated protein expression in MPNST. (A) Representative immunohistochemical images of the
endoneurial and epineurial compartments. Note the presence of widespread Ncad+ (red), Hoechst+ (blue) iSC (green) in the epineurial compartment (inset)
compared to the endoneurial compartment (arrow). See inset for high-resolution example of colocalization of proteins. (B) Quantification of the percentage of Ncad+
iSCs in endoneurial and epineurial compartments demonstrated a significant decrease in endoneurial compartment (Student’s t-test, n = 4, ∗∗∗p < 0.0008).
(C) Representative immunohistochemical images of the endoneurial and epineurial compartment. Note the presence of widespread ErbB3+ (red), Hoechst+ (blue)
iSC (green) in the epineurium (insert) compared to the endoneurium (arrows). See inset for high-resolution example of colocalization of proteins. Scale bars = A
(20 µm), C (10 µm), Insets (10 µm, A; 5 µm, C).
to primary human MPNST tumors. Second, our results
underscore the importance of regional microenvironments in
promoting tumorigenic growth and identify the endoneurial
compartment within the peripheral nerve as a unique
microenvironment enriched in tumor suppressive factors.
Third, by probing uniquely expressed proteins within the
endoneurial compartment, we demonstrated an autonomous
role for CNTF to block proliferation of iSCs mimicking the
inhibition observed when grafted iSCs are contained within the
endoneurial compartment in vivo. Together, these experiments
underscore the plasticity of iSC, highlights their sensitivity to
microenvironment, and identifies CNTF signaling as a potential
therapeutic avenue for MPNST.
Therapeutic approaches that take advantage of the
responsiveness of tumor forming cells to CNTF offers a
promising approach to treat MPNST. First, tumor-forming cells
remain responsive to this growth factor—which is already a
potentially valuable finding given the large amount of pathogenic
pathways present within cancer cells (Birindelli et al., 2001).
Moreover, given the well-described role of CNTF-induced
differentiation in healthy cells (Rathje et al., 2011; Johnson et al.,
2014), we suspect that CNTF-induced cell cycle arrest in iSCs
likely takes advantage of differentiation-induced cell cycle arrest,
which has for a long time been a promising avenue to treat
cancer (Nguyen et al., 2016). Like in MPNST, in normal health
following nerve injury, proliferation of Schwann cells also occurs.
But in contrast to the uncontrollable Schwann cell proliferation
that occurs in MPNST, in normal health, these Schwann cells
have the capacity to transition back into a mature differentiated
myelinating state and contribute to regeneration. It is possible
that CNTF-induced cell cycle arrest of iSCs piggy-backs on
similar molecular pathways as regenerative-induced cell cycle
arrest in normal health, but further study is needed.
Malignant peripheral nerve sheath tumors are mostly resistant
to current standards of treatment (Ferner and Gutmann, 2002;
Zehou et al., 2013), and surgical removal is often inadequate
and debilitating as major nerves are sacrificed, given that the
MPNST is often in close proximity to or in association with
major nerves (Plotkin et al., 2013). At present, there are few
early-stage diagnostic features that can adequately predict the
risk of MPNST. In recent years, there have been several attempts
to better understand the genetic bases of MPNST with the
hope that this knowledge could be used for early detection,
better predictions, and the discovery of new therapeutic targets.
Recently, Rahrmann et al. (2013) used an animal model approach
to investigate several likely genetic links (NF1, Pten, and EGFR)
for PNSTs, finding that a subset of genes were key players in the
formation of high-grade PNSTs (otherwise known as MPNST).
Unfortunately, identified genes only partially accounted for
the progression of benign tumors toward high-grade PNST
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FIGURE 4 | The identification of suppressive factors in the endoneurial compartment. (A) Fold change in candidate proteins (10–60 kDa) enriched in the
endoneurium compared to spinal cord tissue. Ciliary neurotrophic factor (CNTF, red box), a growth factor known for its role in promoting differentiation of Schwann
cells, was found at levels 5.5-fold higher in endoneurium tissue compared to spinal cord tissue. (B) Representative immunohistochemical images of uninjured mouse
and human sciatic nerves demonstrating the presence of CNTF (red) in the cytoplasm of Schwann cells (blue). Note the presence of CNTF around the peri-nuclear
area adjacent to nuclei (blue)—a cytoplasmic rich region of the myelinating Schwann cell. (C) Representative immunocytochemical images of iSCs (blue) treated with
0 ng/ml and 100 ng/ml CNTF. Note the reduction in Ki67+ (red) cells in CNTF treated conditions. (D) Quantification of the percentage of Ki67+ cells treated with 0,
10, or 100 ng/ml CNTF revealed a reduction in ki67+ cells at 100 ng/ml compared to 0 ng/ml (One-way ANOVA, Tukey’s posthoc test, n = 3, ∗∗p < 0.05). Scale
bars = B (25 µm), C (50 µm).
formation and in most cases only when there was a combination
of forced genetic mutations. Rodents generally formed either
benign PNSTs, such as neurofibromas, or no tumors at all. Taken
together, such findings suggest that, although there may be some
genetic characteristics of MPNST, these characteristics do not
autonomously dictate outcome. Rather, additional contributors,
such as, epigenetic and environmental factors, must also play a
role in MPNST development.
Our results support the notion that the cellular
microenvironment plays a key role in predictability of tumor
formation. When Ribiero and colleagues first made the seminal
discovery that NF1-mutant Schwann cells only formed tumors
post-injury, a logical conclusion for this phenomenon was
an environmental cue associated with the injury must also
play a role. Indeed there are several factors associated with
injury (Gaudet et al., 2011) as well as associated with tumor
progression (Brossier and Carroll, 2012) that overlap. Most
researched, in relation to PNST, is the mast cell (Yang et al.,
2008). But, in addition to mast cells, there are many other
injury-associated factors that influence cancer cells. Regulatory
T-cells thrive in the cancerous microenvironment, producing
excess TGFβ1, preventing the proliferation of other immune
cells reducing immune responses to tumors, as well as enhancing
tumor cell proliferation (Franco et al., 2016). In addition,
cancer associated fibroblasts (CAFs) have the ability to regulate
malignant growth (Erez et al., 2010; Xing et al., 2010). Finally,
another influencing factor for tumor progression is low pH
(Jahde et al., 1982)— also known to be regulated in injury
(Lengheden and Jansson, 1995). The fact that there is so much
overlap with injury-associated factors and factors known to
promote tumorigenesis, presupposes relationships between
these factors and tumor progression (Brossier and Carroll,
2012). Interestingly, though Ribeiro et al. (2013) found that
tumors did not form distal to the injury site – an area of
the nerve that undergoes Wallerian degeneration post-injury
and is, therefore, subject to similar injury cues, including
the presence of mast cells and much of the factors described
above (Gaudet et al., 2011). Such findings suggest that injury-
associated factors are not the only mechanism at play in
injury-associated Schwann cell-derived nerve sheath tumor
progression. Consistent with Ribeiro et al. (2013), our results
demonstrate that iSCs injected into the endoneurium of the
distal stump, where injury cues are widespread, does not result in
tumor formation. Together, such findings suggest that exposure
to other factors at the injury site may be triggering malignant
growth.
The fact that the perineurium is compromised when nerve
injury occurs, resulting in long term dysfunction of the
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perineurium, including a chronic increase in permeability, but
only at the injury site and not distally (Haftek and Thomas,
1968; Olsson and Kristensson, 1973) makes it plausible that
a compromised nerve-barrier might contribute to Schwann
cell-derived tumor formation and progression. Usually this
specialized perineurial barrier prevents fibroblast-derived and
adipocyte-derived factors, as well as large amounts of collagen
in the epineurium (Sunderland, 1945; Riccardi, 2007; Weiss
et al., 2016) to diffuse freely within the endoneurium where
widespread Schwann cells are present (Norris et al., 1985;
Verheijen et al., 2003). Given that several papers have shown
that factors within the epineurial compartment can lead to
tumor progression (Fang et al., 2014; Kuzet and Gaggioli,
2016; McDonald et al., 2016); and that factors within the
endoneurial compartment reduce Schwann cell proliferation
(Parrinello et al., 2008), including CNTF, it is not surprising
that we have found that iSCs are highly tumorigenic in
the epineurial compartment compared to the endoneurial
compartment. Taken together, this dataset suggests that in order
for tumor progression to occur, the growth-promoting factors
within the epineurium override suppressive factors within the
endoneurium, ultimately driving tumor formation in peripheral
nerves.
Finally, our data offers a cautionary note regarding the
use of adult Schwann cells for stem cell transplant-based
therapies to treat nervous system injury and disease. Our
work demonstrates that these cells can exhibit genomic
instability and readily acquire aberrations following repeated
in vitro expansion resulting in uncontrolled growth. As such,
we strongly believe that adult Schwann cells, isolated from
patients for subsequent autologous nervous system transplants,
should undergo minimal in vitro processing, and be subjected
to rigorous genetic screening before re-introduction into
patients.
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Peripheral nerve regeneration after severe traumatic nerve injury is a relevant clinical
problem. Several different strategies have been investigated to solve the problem
of bridging the nerve gap. Among these, the use of decellularized nerve grafts has
been proposed as an alternative to auto/isografts, which represent the current gold
standard in the treatment of severe nerve injury. This study reports the results of a
systematic review of the literature published between January 2007 and October 2017.
The aim was to quantitatively analyze the effectiveness of decellularized nerve grafts
in rat experimental models. The review included 33 studies in which eight different
decellularization protocols were described. The decellularized nerve grafts were reported
to be immunologically safe and able to support both functional and morphological
regeneration after nerve injury. Chemical protocols were found to be superior to physical
protocols. However, further research is needed to optimize preparation protocols,
including recellularization, improve their effectiveness, and substitute the current gold
standard, especially in the repair of long nerve defects.
Keywords: nerve injury, nerve regeneration, allograft, decellularized nerve graft, rat model
INTRODUCTION
Traumatic injury of peripheral nerves is of considerable clinical importance due to its high
incidence. The estimated incidence is upward of 300,000 cases per year in Europe (Kingham and
Terenghi, 2006) and more than one million per year worldwide (Daly et al., 2012). Peripheral
nerve lesions are five times more frequent than spinal cord lesions and results in decreased or
complete loss of sensitivity and/or motor activity. The ability of peripheral nerves to regenerate
has been recognized for more than a century; however, clinical and experimental evidence shows
that regeneration is often unsatisfactory, especially following severe injury (Navarro et al., 2007; Sun
et al., 2009; Pfister et al., 2011). For treating mild injury, direct suturing is the most common surgical
technique. For nerve substance loss, nerve autograft (transplantation of an autologous nerve)
Abbreviations: AG, autograft/isograft; AP, authors’ (in-house) protocol; AP-T, authors’ protocol using triton-X; AP-TPA,
authors’ protocol using triton-X and peracetic acid; AP-TS, authors’ protocol using triton-X and SDS; AP-W, authors’
protocol using Wallerian degeneration; CMAP, compound muscle action potential; CV, conduction velocity; FTP, freeze and
thaw protocol; HP, Hudson’s protocol; NP, Neubauer’s protocol; PBS, phosphate-buffered saline; SDS, sodium dodecyl sulfate;
SFI, Sciatic Functional Index; SP, Sondell’s protocol.
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is currently the gold standard (Battiston et al., 2009) despite
its limitations (e.g., additional surgery, scarring, and donor-site
morbidity, limited source of donor nerves) (Hoben et al., 2018).
There is a strong need to find innovative therapies.
Recent research has focused on the use of biological and
synthetic conduits. Progress in materials sciences, with the
availability of new biomaterials and innovative manufacturing
procedures (Siemionow et al., 2013) has led to the development
of innovative artificial conduits. However, as the translation of
synthetic nerve grafts from bench to bedside is still limited,
biological tubulization remains the mainstay approach. Albert
(1885) first used a nerve graft from a donor (allograft) to
reconstruct a damaged nerve after resection of a sarcoma.
Although devoid of the drawbacks of autografts, allografts can
be rejected by the recipient body and therefore require systemic
immunosuppressive therapy. Advances in tissue engineering in
the last decade have led to the realization of decellularized
nerve allografts (Hundepool et al., 2017; Philips et al., 2018).
Unlike conventional allografts, they are cleaned of their antigenic
component yet retain their 3D structure which serves as scaffolds
for axonal growth. Decellularized nerve allografts could thus
represent a potentially ideal alternative.
The aim of this review was to quantitatively analyze the
relevant scientific literature for comparative assessment of the
effectiveness of nerve allografts in relation to decellularized grafts.
METHODS
The PubMed database was searched for articles published
in English between January 2007 and October 2017. The
search terms were “decellularization, decellularized, decellular,
acellularization, acellular, acellularized” combined with the
keyword “nerve.” The present study was focused on the
integration of decellularized nerve grafts and tissue repair
in rat models of peripheral nerve defects. Rat and mouse
models are often the first choice for nerve regeneration studies.
For this study we focused on the rat model because there
is a marked predominance of rat use in nerve regeneration
studies. Also, because rat nerves are larger and more resilient
than the corresponding mouse nerves, standardized functional
tests can be performed and the anatomy of rat nerves is
better known (Greene, 1935; Tos et al., 2008). A total of
185 studies were retrieved, of which 149 full-text articles were
excluded: 25 review articles; 30 articles because they concerned
decellularization of tissue or matrices other than nerves; 12
studies on engineered nerve tissue with different cell sources
unrelated to any decellularization protocol; 12 studies on the
repair of spinal cord injuries but not peripheral nerve lesions;
23 studies on the clinical use of commercial products for
which decellularization techniques are not described; 9 studies
described only in vitro approaches and investigations; 7 were
unrelated to nerve regeneration and/or integration; 8 involved
animal species other than rats; 26 lacked specific control groups,
such as the absence of autograft or pure decellularized nerve
graft implantation, making it impossible to verify the efficacy of
the decellularization protocols compared to the selected studies.
Ultimately, a total of 33 studies performed in rat models met our
inclusion criteria for this review of the literature (Figure 1 and
Table 1).
RESULTS AND DISCUSSION
Decellularization Protocols
Several studies described the attempt to repair severe nerve
damage by means of biologically derived scaffolds, such as
decellularized nerve grafts. There are three main decellularization
protocols for the creation of a functional graft: the one described
by Sondell et al. (1998) and Hudson et al. (2004), and the
combined Hudson protocol added with chondroitinase ABC by
Krekoski et al. (2001). SP was used in 33% of the studies (Jia
et al., 2012, 2017; Wang et al., 2012; Zhang et al., 2014; Zheng
et al., 2014; Zhou et al., 2014; Zhu and Weihua, 2014; Huang
et al., 2015; Garcia-Pérez et al., 2017; Zhu et al., 2015, 2017);
HP was used in 24% (Saheb-Al-Zamani et al., 2013; Gao et al.,
2014a; Hoben et al., 2015; Marquardt et al., 2015; Kim et al., 2016;
Tajdaran et al., 2016; Yan et al., 2016; Cai et al., 2017), and a
combined HP was used in 12% (Whitlock et al., 2009; Vasudevan
et al., 2014; Wood et al., 2014; Jiang et al., 2016). Other studies
(6%) used a FTP with or without the addition of chondroitinase
ABC as introduced by Krekoski et al. (2001; Godinho et al., 2013;
Wang H. et al., 2016). Moreover, others still (21%) developed an
in-house decellularization protocol and tested its efficacy against
autografts (Liu et al., 2011; Zhang and Lv, 2013; Wakimura et al.,
2015; Kusaba et al., 2016; Wang W. et al., 2016; Wang et al.,
2017b; Xiang et al., 2017). One study (3%) compared the efficacy
of Hudson’s, Sondell’s, and the FTP in the same experimental
setup (Nagao et al., 2011).
The most widely used protocol was developed by Sondell et al.
(1998) (SP), who demonstrated in vitro good removal of the
myelin sheath and cells, along with satisfying nerve regeneration
in the absence of inflammatory response in vivo. This method is
based on two sequential steps with a 3% Triton X-100 solution
followed by a 4% sodium deoxycholate solution, in which the
combination of a non-ionic surfactant with an anionic detergent
is considered efficient to chemically lyse cells.
Several years later, Hudson et al. (2004) proposed a milder
chemical treatment to better preserve the structure of the
extracellular matrix (ECM). HP requires several steps repeated
twice. In particular, an amphoteric detergent consisting of
125 mM sulfobetaine-10 (SB-10) solution is followed by
an anionic detergent solution of 0.14% Triton X-200 and
0.6 mM sulfobetaine-16 (SB-16). The use of detergents with
a demonstrated mild toxicity at low concentrations allowed
Hudson and co-workers to efficiently disrupt the cell membranes
while maintaining the ECM intact.
In order to eliminate chondroitin sulfate proteoglycans, which
are known to inhibit axonal growth and the growth-promoting
cues derived from the ECM components, Krekoski et al. (2001)
introduced a step of proteoglycan degradation by means of
the chondroitinase ABC enzyme, thus developing the so-called
NP. By adopting this improvement, many authors were able
to optimize their protocols by adding this degradation step
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FIGURE 1 | Research strategy. Flow chart of the selection process.
at the end of the decellularization process, especially after HP
and the FTP. The original NP started the process with thermal
decellularization, which is one of the most common methods to
produce biological acellular grafts. In this process, tissues usually
undergo three to five repeated freeze–thaw cycles.
In the various in-house protocols (Author’s protocol, AP),
three chemicals are employed to obtain nerve decellularization:
Triton-X100 or 200 (Liu et al., 2011; Zhang and Lv, 2013; Kim
et al., 2016; Wang et al., 2017b; Xiang et al., 2017) (AP-T; 50% of
all AP), its combination with SDS (Wakimura et al., 2015; Kusaba
et al., 2016; Wang H. et al., 2016) (AP-TS, 30% of AP) or with
peracetic acid (Cai et al., 2017) (AP-TPA, 10% of AP). Moreover,
Vasudevan et al. (2014) cultured explanted nerves in vitro with
normal culture media to initiate the Wallerian degeneration and
then in PBS to decellularize them and abruptly remove nutrient
supply (AP-W, 10% of AP). SDS is an anionic surfactant with
amphiphilic properties that lyses cells and denatures proteins.
Peracetic acid is a potent oxidizing agent used to sterilize collagen
tissues (Kemp, 1994; Gilbert et al., 2006). In decellularization,
it acts by enhancing tissue permeability, allowing detergent
penetration and subsequent cell colonization (Bottagisio et al.,
2016).
The first parameter in the choice of a decellularization
protocol is its duration. Duration is important for the time
needed to obtain the results, for the structural maintenance
of the biological scaffolds, and for the cost of the procedure.
In fact, the reduction of the entire process diminishes or
eventually avoids the need for sterilization techniques, such
as gamma irradiation, which has a controversial effect on
decellularized matrix integrity (Boriani et al., 2017). Another
issue is the use of numerous chemical detergents with reduced
incubation times during the decellularization protocol. Indeed,
the combination of different chemicals augments the deprivation
of ECM components (Alhamdani et al., 2010) but also permits
use of lower doses of detergents and shortens the incubation
time, thus facilitating the complete removal of detergents, which
results in a more suitable graft for cell repopulation (Rieder et al.,
2004; Serghei et al., 2010; Crapo et al., 2011) and makes the
procedure less time-consuming. In our analysis of the original
version of the protocols considered here, the FTP was found to
be the quickest and least laborious: it consists of three to five
brief freeze and thaw cycles and takes a few minutes to complete
without the need for chemical detergents and devoid of chemical
remains with toxic side effects (Serghei et al., 2010; Crapo et al.,
2011). All the other protocols take considerably longer: the HP
needs almost 69.5 h and the SP 86 h to complete. Besides its
shorter duration, the HP requires a lower percentage of chemical
detergents, making their elimination more easy. The NP entails
the chondroitinase ABC incubation step, which lasts 16 h, so the
total duration of decellularization before this step is increased by
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TABLE 1 | In vivo studies of nerve tissue decellularization and graft implantation.
Decellularization
protocol
Implantation
time (week)
Graft length
(mm)
Investigations Results Reference
SP; HP; FTP 52 15 Sciatic functional index AG = HP HP > FTP
and SP
Nagao et al., 2011
SP 8 10 Conduction velocity, latency period, wave
amplitude, muscle wet weight ratio, myelinated
fiber density, axon diameter, myelin sheath
thickness
AG > SP Jia et al., 2012
SP 2,12 20 Muscle wet weight and tension ratio,
myelinated fiber number, myelin sheath
thickness, Von Frey hair sensitivity test
AG > SP Wang et al., 2012
SP 1,2,4,8,12 15 Sciatic functional index, conduction velocity,
myelinated fiber density, myelinated fiber
number, myelin sheath thickness,
immunostaining
AG > SP Zhou et al., 2014
SP 8 10 Sciatic functional index, conduction velocity,
latency period, wave amplitude, muscle wet
weight ratio, myelinated fiber number, myelin
sheath thickness
AG > SP Zhang et al., 2014
SP 12 15 Sciatic functional index, conduction velocity,
muscle wet weight and tension ratio,
myelinated fiber density, axon diameter, myelin
sheath thickness, immunostaining, gene
expression (nerve growth factor, glial-derived
neurotrophic factor, growth-associated protein
43, neurofilament heavy)
AG > SP, AG = SP in
the first 6 weeks for
sciatic functional index.
Expression of all genes:
AG > SP
Zheng et al., 2014
SP 20 6 Latency period, wave amplitude, myelinated
fiber density, axon diameter, myelin sheath
thickness
SP = AG Zhu and Weihua,
2014
SP 1,2,4 15 Myelinated fiber density, axon diameter, myelin
sheath thickness Immunostaining Gene
expression (angiogenesis-related genes)
AG > SP Expression of
angiogenesis-related
genes: AG > SP
Zhu et al., 2015
SP 12 10 Conduction velocity Myelinated fiber density,
myelinated fiber number, axon diameter, myelin
sheath thickness Immunostaining
AG > SP, AG = SP
myelinated fiber
number Number of
Schwann cells:
AG > SP
Huang et al., 2015
SP 15 15 Sciatic functional index Immunostaining AG = SP Presence of
myelin in AG but not in
SP
Garcia-Pérez et al.,
2017
SP 8 10 Latency period, conduction velocity, wave
amplitude Muscle wet weight ratio Myelinated
fiber density, axon diameter, myelin sheath
thickness
AG > SP Presence of
laminin and myelin in
AG, in SP only laminin
Jia et al., 2017
SP 1,2,3,4 10 Immunostaining AG > SP Zhu et al., 2017
HP + NP 6,12,22 14,28 Sciatic functional index Muscle wet weight ratio
Myelinated fiber number, axon diameter
14-mm graft:
AG = HP + NP,
AG > HP + NP for
myelinated fiber
number at 6 weeks.
AG = HP + NP at
12 weeks 28-mm graft:
AG > HP + NP at 6
and 22 weeks
HP + NP resulted
non-immunogenic and
maintained laminin
structure
Whitlock et al.,
2009
HP 10,20 20,40,60 Muscle wet weight and tension ratio Myelinated
fiber number, axon diameter Immunostaining
Gene expression (senescence markers)
AG > HP Senescence:
AG < HP
Saheb-Al-Zamani
et al., 2013
(Continued)
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TABLE 1 | Continued
Decellularization
protocol
Implantation
time (week)
Graft length
(mm)
Investigations Results Reference
HP 6,12 10 Sciatic functional index Conduction velocity
Muscle wet weight ratio Axon diameter, myelin
sheath thickness
AG > HP Gao et al., 2014a
HP + NP; AP-W 12 35 Muscle wet weight and tension ratio Myelinated
fiber number, myelin sheath thickness
AG > HP + NP and AP-W,
HP + NP = AP-W
Vasudevan et al.,
2014
HP + NP 12 14 Myelinated fiber number, axon diameter, myelin
sheath thickness Retrograde nerve tracking
AG > HP + NP,
AG = HP + NP for
myelinated fiber number
Regenerating nerves:
AG = HP + NP,
allograft > xenograft
Wood et al., 2014
HP 10 20 Myelinated fiber density, myelinated fiber
number, axon diameter
AG > HP Hoben et al., 2015
HP 8 30 Muscle wet weight ratio Myelinated fiber
density, myelinated fiber number
AG > HP Marquardt et al.,
2015
HP 8 20 Muscle wet weight and tension ratio Myelinated
fiber number Gene expression (Glial-derived
neurotrophic factor)
AG > HP, AG = HP for
muscle tension ratio
Glial-derived neurotrophic
factor expression: AG > HP
Yan et al., 2016
HP 8 10 Myelinated fiber number, axon diameter, myelin
sheath thickness Retrograde nerve tracking
AG = HP, AG > SP for
myelinated fiber number
Regenerating neurons:
AG > HP
Tajdaran et al.,
2016
HP; HP + NP 12 15 Conduction velocity Muscle wet weight ratio
Myelinated fiber density, myelin sheath
thickness
AG > HP and HP + NP,
HP + NP > HP,
HP + NP = HP for myelin
sheath thickness
Jiang et al., 2016
HP; AP-T 12 15 Muscle wet weight ratio Myelinated fiber
density, myelin sheath thickness
AG > HP and AP-T,
AP-T > HP
Kim et al., 2016
HP; AP-TPA
Triton-X200 in
sulfobetaine 10 +
sulfobetaine 16 +
4% sodium
deoxycholate +
0.1% peracetic
acid
1,8 15 Muscle wet weight ratio Myelinated fiber
number, axon diameter, myelin sheath thickness
Thermosensitivity Immunological response
AG = AP-TPA, AG and
AP-TPA > HP,
AP-TPA = HP for
myelinated fiber number
In vivo host immune
response: AP-TPA < HP
Cai et al., 2017
NP 8,12 20 Sciatic functional index Muscle wet weight and
tension ratio Myelinated fiber number, axon
diameter, myelin sheath thickness ELISA
(collagen I and III)
AG = NP Collagen III
expression: AG = NP
Collagen I: AG < NP
Wang H. et al.,
2016
FTP (5 cycles) 10 10 Myelinated fiber number
Unmyelinated/myelinated axons ratio, area of
individual myelinated axon, number of axons in
unmyelinated bundle
AG = FTP Godinho et al.,
2013
AP-T 3 days,12 15 Sciatic functional index Conduction velocity,
latency period, wave amplitude Myelinated fiber
number, axon diameter, myelin sheath
thickness Immunostaining
AG > AP-T Liu et al., 2011
AP-T 12 15 Conduction velocity Muscle wet weight ratio
Immunostaining
AG > AP-T Presence of
acetyl
cholinesterase-positive
nerve fibers in motor
endplates in AG and AP-T
Zhang and Lv,
2013
AP-TS 4,24 10,15 Latency period, wave amplitude Myelinated
fiber density, myelin sheath thickness, axon
diameter Immunostaining Von Frey’s hair
sensitivity test, toe spread factor
AG = AP-TS Basal lamina
preserved in AG and AP-TS
Limited presence of
macrophage in both AG
and AP-TS
Wakimura et al.,
2015
(Continued)
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TABLE 1 | Continued
Decellularization
protocol
Implantation
time (week)
Graft length
(mm)
Investigations Results Reference
AP-TS 4,24 10,15 Latency period, wave amplitude Myelinated
fiber density, axon diameter, myelin sheath
thickness Immunostaining Von Frey’s hair
sensitivity test, toe spread factor
AG = AP-TS Basal
lamina preserved in AG
and AP-TS Limited
presence of
macrophage in both
AG and AP-TS
Wang W. et al.,
2016
AP-TS 25 15 Latency period, wave amplitude Myelinated
fiber density, axon diameter Von Frey’s hair
sensitivity test, toe spread factor
AG = AP-TS Basal
lamina preserved in AG
and AP-TS
Kusaba et al., 2016
AP-T 11 10 Muscle wet weight and tension ratio Axon
diameter, myelin sheath thickness
AG > AP-T, AG < AP-T
for axon diameter
Wang et al., 2017b
AP-T 2,12 15 Sciatic functional index Conduction velocity,
latency period Muscle wet weight ratio
Retrograde nerve tracking
AG > AP-T, AG = AP-T
for sciatic functional
index at 2 weeks
Cellularity and
regenerating fibers:
AG > AP-T
Xiang et al., 2017
AG, Autograft or isograft; HP, Hudson Protocol; NP, Neubauer Protocol; SP, Sondell Protocol; FTP, Freeze/Thaw Protocol; AP-T, Authors’ Protocol using Triton X; AP-TS,
Authors’ Protocol using Triton X + SDS; AP-TPA, Authors’ Protocol using Triton X + Peracetic Acid; AP-W, Authors’ Protocol using Wallerian degeneration.
16 h. In the group of AP, the AP-TPA was the quickest protocol,
taking 84.5 h, similar to the SP. The AP-T protocols varied in the
amount of time required for decellularization: from 70 h in the
protocol developed by Xiang et al. (2017) to 200 h in the protocol
by Wang et al. (2017b), with an average duration of 128 h. The
longest protocol was based on Wallerian degeneration developed
by Vasudevan et al. (2014) which required 2 weeks of culture in
complete culture medium and then another week of incubation
in PBS in order to deprive cells of nutrients.
Evaluation of Parameters to Measure
and Compare Nerve Decellularization
Protocols After in vivo Implantation
The efficacy of nerve regeneration with decellularized
nerve grafts was evaluated using quantitative analyses and
standardized parameters to compare study outcomes after
in vivo transplantation in rat models. We examined the SFI,
the von Frey hair sensitivity test, and the toe spread factor
which, altogether, indicate functional recovery after nerve
grafting. The SFI comprises values between -100 (complete loss
of functionality) to 0 (normal functionality). The von Frey hair
sensitivity test entails stimulation of the animal’s paw by means
of increasingly stiff nylon monofilaments; paw withdrawal and
flinch are considered positive responses and the test results
are presented as a correlation between stimulus intensity and
type of response (Chaplan et al., 1994). The toe spread factor is
calculated on the basis of the distance from the first to the fifth
toe (Geuna et al., 2009).
Among the various electrophysiological tests that evaluate
ex vivo recovery of the graft‘s electrical functionality after
implantation, conduction velocity (CV, m/s) through the graft
and compound muscle action potential (CMAP, mV), and two
features derived from CMAP, i.e., latency period (µsec) and wave
amplitude (mV), were analyzed. CMAP records the summation
of all muscle fiber action potentials derived from the activation
of a group of motor neurons within a nerve bundle by means of a
brief electrical stimulation. The latency period is the time between
the application of an electrical stimulus to a nerve and muscle
contraction. The wave amplitude represents the maximum value
measured from baseline in the CMAP-resulting curve.
To assess muscle atrophy and functional recovery of the
muscles most commonly analyzed (gastrocnemius, triceps surae,
extensor digitorum, and tibialis anterior), muscle wet weight and
maximum contraction tension were considered. Both parameters
were analyzed by the studies ex vivo and mainly expressed as
the ratio between the operated and the uninjured side. Moreover,
since functional recovery is based on restoration of physiological
neuronal morphology (Geuna et al., 2009), histomorphometric
parameters were examined, including myelinated axon number,
density (number of fibers/mm2), total fiber number, axon
diameter (µm), and myelin sheath thickness (µm).
Morphological and Functional
Comparison of Autografts and Sham
Control of Nerve Gap Reconstruction in
Rat Models
For a quantitative assessment of the functional and
morphological recovery of the nerve graft, all manuscripts
published in the literature and reporting numerical values for
nerve recovery in terms of functionality and morphology over
time were analyzed. Specifically, three different time points
were considered: 2–5, 6–9, and 10–15 weeks after implantation.
Comparable results from week 2 after graft implantation –
the time in which nerve regeneration begins - until week 15
after surgery were evaluated. After surgical grafting, 3–6 weeks
are necessary for Schwann cells and macrophages to arrive
at the injury site and clear it of cellular and myelin debris
(Geuna et al., 2009). The Schwann cells then start to proliferate,
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organizing themselves in columns to permit the association of
the regenerating axons. The choice of 15 weeks as the last time
point was based on the study by Waitayawinyu et al. (2007),
who reported that analyzing the outcomes of nerve recovery
beyond 15 weeks may lead to misleading interpretations because
differences between the experimental groups might be lost, also
given the high regenerative capacity of the rodent model.
Most studies (Liu et al., 2011; Wang et al., 2012; Zhang and
Lv, 2013; Gao et al., 2014a; Vasudevan et al., 2014; Wood et al.,
2014; Zheng et al., 2014; Zhou et al., 2014; Huang et al., 2015;
Jiang et al., 2016; Kim et al., 2016; Wang H. et al., 2016; Xiang
et al., 2017) (39% of the studies included) set week 12 as the last
endpoint and a few went beyond the 15th week. For instance,
Zhou et al. (2014) and Saheb-Al-Zamani et al. (2013) evaluated
the regenerative process until week 20, Whitlock et al. (2009)
until week 22, Wakimura et al. (2015), Kusaba et al. (2016), and
Wang W. et al. (2016) until week 24, and Nagao et al. (2011) until
week 52.
As autografting represents the gold standard procedure for
peripheral nerve reconstruction, we first analyzed its outcomes
and then compared them with those obtained from sham
procedures on healthy nerves. Only five studies included a sham
control (Nagao et al., 2011; Tajdaran et al., 2016; Wang H.
et al., 2016; Wang et al., 2017b; Garcia-Pérez et al., 2017), in
which a slight decrease in nerve functionality after sham surgery
(sham control) was found compared to that of the native nerves.
This small number of studies could constitute a limitation of
the present literature review and preclude comparison of the
parameters analyzed. Taking into account that evaluation based
on the SFI could vary widely depending on artifacts and operator
ability (Varejao et al., 2001; Nichols et al., 2005; Monte-Raso et al.,
2008; Fricker et al., 2016), the mean SFI of the sham controls
was −8.16 at week 15 (Nagao et al., 2011; Wang H. et al., 2016;
Wang et al., 2017a; Garcia-Pérez et al., 2017). Only one study
reported a SFI of −2, which approached the normal value at
52 weeks after surgery (Nagao et al., 2011). The SFI of autografts
was expected to be lower than the sham surgery. The average SFI
values were, in fact, significantly lower for the autografts than
the sham controls at all time points. These data indicate that
also sham surgery affects nerve functionality, albeit to a lesser
extent. Differently, although autografting compromised nerve
functionality initially, there was a predictable improvement in the
SFI over time, indicating that nerve regeneration and recovery
processes had begun.
The electrophysiological parameters (CV, WA, and LP)
reported in Figure 2 were compared among studies, obtaining
data for the sham controls and AG 2–5 weeks from one study
(Wang H. et al., 2016), for AG 6–9 weeks from four studies (Jia
et al., 2012; Zhang et al., 2014; Wang H. et al., 2016; Jia et al.,
2017), and for AG 10–15 weeks from six studies (Liu et al., 2011;
Zhang and Lv, 2013; Zheng et al., 2014; Huang et al., 2015; Jiang
et al., 2015; Wang H. et al., 2016). The low amount of recorded
data did not permit to statistically analyze the differences in the
results. However, the trend of the electrophysiological parameters
(Figure 2) showed higher CV and wave amplitude values for
the sham control, while the latency period in the autografts was
longer during the first 5 weeks after surgery and almost the same
FIGURE 2 | Average values of electrophysiological parameters indicating the
electrical functionality of nerves. The Conduction Velocity (CV; m/s), Wave
Amplitude (WA; mV) and Latency Period (LP; ms) are compared between
sham control and autografts (AG) at different time points. Data are reported as
mean ± SD.
for the two groups at the later time points. At 6–9 weeks, this
parameter was even lower for the autografts, probably because
only one study reported data for the sham control (Wang H. et al.,
2016). The three parameters showed improvement over time,
with an increase in CV and wave amplitude at the last time point,
reaching half that of the sham control values. Otherwise, the
latency period shortened over time, similar to the sham control
value.
Muscle functionality, reported as the muscle wet weight and
tension ratio, was greater in the sham control compared to
autografts at all time points. The average muscle wet weight ratio
in the sham control was 82% of that of the native limb (Wang
H. et al., 2016), while the ratio obtained with the autografts was
increased over time, from a mean of 46.3–51.6% from weeks 6–9
to 10–15, though none of the studies analyzed this parameter
during the first 5 weeks (Whitlock et al., 2009; Liu et al., 2011;
Jia et al., 2012, 2017; Wang et al., 2012, 2017a; Zhang and Lv,
2013; Vasudevan et al., 2014; Zheng et al., 2014; Marquardt et al.,
2015; Jiang et al., 2016; Kim et al., 2016; Wang H. et al., 2016;
Yan et al., 2016; Cai et al., 2017). The average muscle tension was
75% for the sham control and 54.7% for the autografts at the last
time point; no analyses were performed at earlier time points.
These results demonstrated that the autografts supported and
strengthened reinnervation along the graft over time, resulting
in a decrease in muscle atrophy and reinforcement of the tension
that the muscles were able to elicit.
In the case of histomorphometric analyses, several authors
reported evaluable data to be analyzed through non-parametric
statistical tests, as reported in Figure 3. Indeed, for the sham
controls, five authors reported quantitative parameters (Jia et al.,
2012, 2017; Zhang et al., 2014; Wang H. et al., 2016; Wang et al.,
2017b). For AG at 6–9 weeks, seven records indicated values for
myelin and axon morphology (Whitlock et al., 2009; Jia et al.,
2012; Zhang et al., 2014; Marquardt et al., 2015; Tajdaran et al.,
2016; Cai et al., 2017; Jia et al., 2017), as well as, fourteen records
detailed values for AG at 10–15 weeks (Whitlock et al., 2009;
Liu et al., 2011; Wang et al., 2012, 2017b; Godinho et al., 2013;
Vasudevan et al., 2014; Wood et al., 2014; Zheng et al., 2014;
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FIGURE 3 | Quantitative analysis of the neuronal morphology based on different parameters emerging from the histomorphometric evaluations. The myelinated fiber
density (number of axons per mm2), myelinated fiber number, axon diameter (µm) and myelin sheath thickness (µm) are compared between sham control and
autografts (AG) at different time points. One way ANOVA for nonparametric data and Dunns’ post hoc correction was performed. Data are reported as mean ± SD,
∗∗p < 0.01.
Zhou et al., 2014; Hoben et al., 2015; Huang et al., 2015; Jiang
et al., 2015; Kim et al., 2016; Wang H. et al., 2016).
As expected, myelinated fiber density and number were
lower in the sham control than with the autograft at 6–9
and 10–15 weeks (Figure 3). The axon diameter in the sham
controls showed a normal opposite trend, with a significant
difference compared to the autografts at 10–15 weeks (p < 0.01).
Unexpectedly, myelin sheath thickness was comparable between
the sham controls and autografts and over time was decreased for
the autografts. These data are far higher than normal estimated
for a regenerating nerve, in which myelin sheath thickness
is expected to be lower than in sham controls and directly
proportional to the regenerating axon diameter, especially during
the first weeks of regeneration.
There was a fluctuating trend for myelinated fiber density
in the autografts owing to the study by Zhou et al. (2014)
who reported a value of 53876 at weeks 2–5 (data not
shown). Moreover, the myelinated fiber density in the autografts
continued to increase, reaching 29000 myelinated fibers/mm2
at 24 weeks, as reported by Wakimura et al. (2015) and Wang
W. et al. (2016). These authors also reported an average myelin
sheath thickness of 1 µm at 24 weeks after surgery (Wakimura
et al., 2015; Wang W. et al., 2016). In addition, the axon diameter
increased, reaching 5.6 µm (Wakimura et al., 2015; Kusaba et al.,
2016; Wang W. et al., 2016). The data reported in Figure 3 do not
include the results reported by Godinho et al. (2013) because they
seem to differ greatly (23000 myelinated fiber number) from the
physiological parameters of a healthy nerve.
Interestingly, Godinho et al. (2013) evaluated three more
parameters that could be useful for gaining a broader perspective
on nerve function recovery at 8 weeks after surgery. The first
parameter was the unmyelinated and myelinated axon ratio,
which was 6 in the sham control and 3 in the autograft.
The second was the average number of axons in unmyelinated
bundles, which was 3.5 in both groups. Moreover, in the same
study, the sectional area of the myelinated axons was greater in
the sham control than in the autograft group (9.5 vs. 3.6 µm2).
Overall, most of the studies reported consistent and
comparable results for SFI, muscle wet weight ratio, and wave
amplitude. Only a few reported values that substantially differed
from the mean. In the autograft group, Wang et al. (2017b)
reported a SFI markedly lower than average at all three time
points, with a value of −48 at weeks 2–5, −45 at weeks 6–9, and
−40 at weeks 10–15. Zhang et al. (2014) reported a much higher
SFI and muscle wet weight ratio, with an increase from –32.3
after 2 weeks to –18.7 after 8 weeks and a muscle weight ratio of
89.5% at 8 weeks after surgery. Also, Xiang et al. (2017) reported
a SFI value higher (−17) compared to the autograft average at
12 weeks. Liu et al. (2011) found a wave amplitude of 29.5 mV
at 12 weeks after autografting, which was twice the mean value
obtained for the sham control.
As expected, the overall values for the autografts were lower
than the sham controls. In the majority of the parameters,
there was a positive trend for the autografts over time,
indicating a progressive recovery in nerve functionality and
morphology. This recovery is due to the autografts providing
viable Schwann cells and neurotrophic factors that support nerve
axon regeneration (Flores et al., 2000; Siemionow and Brzezicki,
2009). Autografts are, in fact, effective and employed in the
treatment of severe nerve injury in clinical practice (Rinker and
Vyas, 2014). Based on this premise, the outcomes with autografts
were compared with the results obtained with the different
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decellularization protocols and were considered as benchmark
values for evaluating the recovery of graft functionality and
morphology.
Morphological and Functional Outcomes
of Nerve Grafts Obtained With
Decellularization Protocols
In order to evaluate the functional and morphological efficacy of
decellularized nerve grafts at the three time points (2–5, 6–9, and
10–15 weeks after implantation), these parameters were analyzed
and compared with respect to the decellularization protocols and
to autografts or isografts used as the gold standard.
Also, the implanted graft length was considered. The success
of regeneration has been shown to be proportional to the
extent of the interstump zone and of the advancing sprouting
cell protrusions. Nerve regeneration takes place through the
extension of Schwann cell protrusions rather than axonal growth;
Schwann cells guide and support the regenerating axons and
regulate the rate of the recovery process (Son and Thompson,
1995). Lundborg et al. (1982) experimentally fixed at 10 mm
the length beyond which the nerve injury is considered a
critical defect in the rat model. This limit was corroborated
by Saheb-Al-Zamani et al. (2013) who found it difficult to
regenerate with the use of decellularized grafts longer than
20 mm and reported no regeneration in grafts in 60 mm
long. Therefore, graft length is a crucial feature, as are its
functional and morphological recovery properties, for developing
a suitable alternative to autografts. Moreover, as stated by Hare
et al. (1992) and demonstrated by Whitlock et al. (2009),
the use of a very long nerve graft (28 mm) could produce
misleading results in the evaluation of nerve functionality due
to the poor reinnervation process along the distal edges of the
grafts.
In the studies that used the classic decellularization protocols
(SP, HP, NP, and FTP), the majority (75.8%) used grafts ranging
in length from 10 to 15 mm (Whitlock et al., 2009; Liu et al.,
2011; Nagao et al., 2011; Jia et al., 2012, 2017; Godinho et al.,
2013; Zhang and Lv, 2013; Gao et al., 2014a; Wood et al.,
2014; Zhang et al., 2014; Zheng et al., 2014; Zhou et al., 2014;
Huang et al., 2015; Wakimura et al., 2015; Zhu et al., 2015;
Jiang et al., 2016; Kim et al., 2016; Kusaba et al., 2016; Tajdaran
et al., 2016; Wang W. et al., 2016; Wang et al., 2017b; Cai
et al., 2017; Garcia-Pérez et al., 2017; Xiang et al., 2017). Among
the others, only Zhu and Weihua (2014) used a shorter graft
(6 mm), while others still used longer grafts: a 20-mm graft in
five studies (Wang et al., 2012; Saheb-Al-Zamani et al., 2013;
Hoben et al., 2015; Yan et al., 2016; Wang H. et al., 2016); a
30-mm graft in two (Whitlock et al., 2009; Marquardt et al.,
2015); a 35–40 mm graft in two (Saheb-Al-Zamani et al., 2013;
Vasudevan et al., 2014), and a 60- mm graft in one study (Saheb-
Al-Zamani et al., 2013). The mean graft length used with the
SP was 12.6 mm, 16.7 mm with the HP, 21 mm with the NP,
and 12.5 mm with the FTP. Regarding the various in-house
protocols, the average graft length was 14.3 mm (range, from
10 to 15 mm), except for the 35-mm-long graft developed by
Vasudevan et al. (2014). The average length of the AP-T grafts
was 14 mm and that of the AP-TS and AP-TPA grafts was 15 mm.
In general, the average length of the autografts and isografts was
14.8 mm.
Sciatic Functional Index
Like the autografts, all the decellularized grafts, except for those
produced using the NP, showed an improvement in the SFI
(Table 2). In particular, the results of the grafts produced using
the SP seemed to be closer to those obtained with the autografts.
It has to be taken into account, however, that the average SP
graft length was 4 mm shorter than that of the autografts or the
HP grafts and 9 mm shorter than the NP grafts. This difference
could influence the SFI, although no studies examined whether
length difference had an impact on the SFI. Zhang et al. (2014)
reported a value of −33.39 for SP grafts at 8 weeks after surgery,
a value much higher than the SP or the autograft average. Only
two studies calculated the SFI of the NP grafts (Whitlock et al.,
2009; Wang H. et al., 2016a). Wang H. et al. (2016) reported
higher positive values than Whitlock et al. (2009) which could
explain the opposite trend observed in this protocol. Only Nagao
et al. (2011) calculated the SFI in HP and FTP grafts, while
only Liu et al. (2011) evaluated it in AP-T grafts. This lack of
relevant data precluded analysis of this parameter. Therefore,
our analysis focused on the study by Nagao et al. (2011) who
evaluated and compared the SFI for the SP, HP, and FTP grafts
in the same experimental procedure. They found that the grafts
reached a plateau in the recovery of SFI at 12 weeks, and that from
week 12 until week 52 the SFI for the HP grafts was statistically
superior compared to the SP and FTP grafts. In brief, a more rapid
recovery during the first weeks after surgery was noted for the HP
grafts, which then maintained a higher SFI over time.
Extensively employed in nerve injury and recovery studies,
this parameter is generally considered to be highly accurate and
reliable in describing sciatic nerve function (Varejao et al., 2001;
Nichols et al., 2005). Nonetheless, SFI has certain disadvantages:
frequent footprint artifacts and distortions produced by smearing
of the ink when applied to the rats’ paws (Fricker et al., 2016);
the footprint key points have to be adequately recognized and
analyzed, which are operator dependent (Monte-Raso et al.,
2008). For these reasons, together with the lack of data, this
parameter was insufficient to describe functional recovery, but it
was used to complete the evaluation of functional restoration in
association with other parameters.
Electrophysiology
In our analysis of the electrophysiological features of
decellularized nerve grafts, sufficient data for a comparison
were available only for CV at 10–15 weeks (Table 3).
Electrophysiological measurement allows for a meaningful
evaluation of the effective re-innervation of the graft over time.
For instance, latency period and CV are correlated with the
myelination rate and the size of the regenerating axons (Geuna
et al., 2009). The CV can be subject to high variability during
recording, however (Geuna et al., 2009). Nonetheless, it is a
reliable factor for the evaluation of nerve regeneration (Booth
and Gollnick, 1983). The CV in nerve grafts obtained with NP,
HP, and AP was nearly half that of the SP grafts, which showed
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CV values slightly below those of the autografts. CV in the HP
and NP grafts was measured only in one study (Jiang et al., 2016).
The wave amplitude is correlated with the number and size of
effectively regenerated axons, in which electrical impulses can be
propagated. Also, CV is influenced by the graft distance (Geuna
et al., 2009). The best results were obtained with the AP-T grafts,
with higher values than those of the autografts. The amplitude of
the SP grafts was half that measured for the autografts, although
evaluated at the previous time point (data not shown). Given
the longer average length of the AP-T grafts, this outcome was
remarkable, notwithstanding its being calculated only by Liu
et al. (2011). In contrast, the latency period was shorter in the
SP than the AP-T grafts, indicating greater fiber maturation in
the SP than in the AP-T grafts (Wang W. et al., 2016) (data not
shown).
All the studies on AP-TS grafts evaluated the wave amplitude
and latency period at 25 weeks after surgery. The results were
expressed in percentage (43.2 and 46.9%, respectively) with
respect to the contralateral non-operated limb, precluding their
comparison with the other groups (Wakimura et al., 2015;
Kusaba et al., 2016; Wang W. et al., 2016).
Due to the variability in the CV recordings and the
absence of data for wave amplitude and latency period, the
electrophysiological parameters need to be correlated with other
functional and morphological data in order to evaluate the whole
regeneration process.
Muscle Functionality
Evaluation of muscle functionality is the key to assessment of
the progress of nerve regeneration. The muscle wet weight ratio
is related to muscle atrophy: without physiological innervations,
muscles would undergo atrophy and loss of functionality and
lose weight. Therefore, an increase in muscle weight and tension
reflects the effective reinnervation of a graft able to conduct
and deliver electrical stimuli to the target effector muscle (Zhao
et al., 2014; Wang et al., 2015). The peripheral nervous system
is capable of a certain degree of self-regeneration (Cerri et al.,
2014). But when nerve continuity is interrupted, and particularly
when the gap defect is large, complete reinnervation will be
difficult. For this reason, we considered the muscle functionality
parameter as being highly relevant for predicting effective
functional recovery. Restoration of muscle function implies that
the regenerating nerve fibers have effectively crossed the graft
and reached the target muscle. In the present analysis, the best
result was obtained with AP-TPA grafts, which showed the best
muscle mass recovery similar to that of autografts (Table 4).
This represents a remarkable result because it was evaluated at
8 weeks after surgery with a 15-mm-long graft (Cai et al., 2017).
Unfortunately, no data on muscle tension were reported for AP-
TPA grafts. Among the other protocols, the HP grafts came the
closest to the autografts at the last time point, with increasing
improvement over time and good recovery from muscle atrophy.
The NP grafts started at a value similar to the HP grafts at weeks
6–9 but the rate of improvement fell behind that of the HP grafts
over the following weeks, probably due to the higher average
length of the grafts. In contrast, no increase was observed for
the SP grafts. Moreover, Zhu and Weihua (2014) found some
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motoneuron endplate activity in the SP grafts also on the operated
side, but Zheng et al. (2014) reported that these motor endplates
were scarce and characterized by serious atrophy. Vasudevan et al.
(2014) calculated the muscle wet weight ratio for AP-W grafts
and reported the lowest outcomes of all the decellularization
protocols.
The muscle tension ratio was evaluated only for the SP, NP, and
AP-T grafts at weeks 10–15 (Table 5). It reflected the same trend
of the previous parameter, in which the muscle tension ratio for
the AP-T grafts was slightly higher than that of the NP grafts,
which was greater than that of the SP grafts, albeit to a lesser
extent. This parameter was calculated only by one author for both
NP (Wang H. et al., 2016) and AP-T grafts (Wang et al., 2017b).
Further evidence of recovery of muscle functionality
was presented by Zhang and Lv (2013) and Zhu and
Weihua (2014) who demonstrated, in SP and AP-T grafts,
respectively, the presence of fibers positive to acetylcholinesterase
immunostaining in some motoneuron endplates.
Morphology
Quantitative histomorphology is an essential method to
investigate nerve regeneration, as numerous morphological
parameters can be associated with functional outcomes (Geuna
et al., 2004; Vleggeert-Lankamp, 2007). Table 6 presents the
morphological data, in which only values at 10–15 weeks are
included since the results at this time point were richer. AP-TPA
is an exception because it had better and promising outcomes
than the other decellularization protocols. It has been included
in the table even if it was evaluated at 6–9 weeks.
Myelinated fiber density
The number of myelinated neurons in a regenerating nerve
reflects the rate of functional recovery (Geuna et al., 2009).
Regenerating nerves are initially characterized by a shortage
of myelin, but, thanks to the action of Schwann cells, the
fibers will be surrounded in a myelin layer (Flores et al.,
2000). Myelinated fiber density is also related to a nerve’s
electrophysiological characteristics and provides a meaningful
measure of the recovery process (Russell et al., 1996).
The highest myelinated fiber density, comparable to autograft
values, was measured in FTP grafts, and it was evaluated only
in one study (Godinho et al., 2013). Comparable results were
obtained with SP and HP grafts, in which the fiber density was
almost half that of the autografts. Some studies published very
variable values for myelinated fiber density. Zhu et al. (2015)
and Zhou et al. (2014) reported unexpectedly higher density
values for SP grafts with respect to autografts at 2–5 (48231) and
10–15 (40523) weeks, while Zhu and Weihua (2014) reported a
lower density of 2090 at week 20. The average density of the NP
grafts, calculated only at 10–15 weeks, was the lowest among the
decellularized grafts.
Among the grafts produced with an in-house protocol, the AP-
T grafts had an intermediate value between the SP/HP and the
NP grafts. For the same group (AP-T), Liu et al. (2011) reported
only 0.03 myelinated fibers per mm2 at week 12, considerably
lower than those reported by other studies. The myelinated fiber
density of AP-W grafts, reported only by Vasudevan et al. (2014),
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was out of range since it was almost twice that of the autografts.
However, the same study reported a density value out of range
also for the NP grafts (75000), which was greater than that of the
AP-W grafts. The AP-TS grafts had a higher density (17050) than
the HP grafts, though this difference might have resulted from
the late time point considered in these studies (Wakimura et al.,
2015; Kusaba et al., 2016; Wang W. et al., 2016).
Myelinated fiber number
Since some studies evaluated either myelinated fiber density or
myelinated fiber number, we examined both these parameters
even if their functional significance is identical. Unlike
myelinated fiber density, myelinated fiber number was similar in
NP grafts and autografts. As seen for other parameters, already
at weeks 6–9, the fiber number in the AP-TPA grafts was higher
than in those produced with other decellularization protocols
and was only slightly lower than the autografts (5743 at week
6–9). The grafts with the lowest number of myelinated fibers
were produced with AP-T (Kim et al., 2016) and SP (Huang et al.,
2015), though only one study evaluated both types of grafts.
Axon diameter
The average axon diameter in a regenerating nerve is an
important parameter; it is the determining factor that influences
CV and defines the capacity of nerves to transmit electrical
stimuli (Hoffman, 1995; Assaf et al., 2008). During the
regeneration phase in the first weeks after injury, the axon
diameter increases. Evaluation of this parameter during the very
early phases may be challenging, however, because it is difficult to
discern between small successfully regenerated fibers from small
atrophic or dying fibers (Ikeda and Oka, 2012). For this reason,
we compared the results measured at the last time point. Axon
diameter in AP-TS grafts was the largest (5.4 µm) since it was
evaluated at week 25. Once again, AP-TPA had the best outcome
among the other protocols, although evaluated only at 8 weeks
after surgery. This value was even slightly greater than that for
autografts measured at the same time point (3.8 µm), meaning
that this graft type probably also had a high CV, which was not
experimentally measured, however. The NP grafts had the largest
diameter, reflecting the outcome derived from CV recording. HP
grafts were evaluated only by one study (Hoben et al., 2015),
which found an intermediate value, confirming the graft’s average
velocity in the conduction of electrical stimuli. The SP grafts were
re-innervated by axons with a diameter among the lowest, higher
only than that of the AP-T grafts. In addition, Zhu and Weihua
(2014) demonstrated that axon diameter was increased slightly
in the SP grafts, reaching 2.5 µm at week 20. A discrepancy was
noted in the comparison with the CV recorded for SP grafts: while
these grafts had the fastest CV, their axon diameter was among the
lowest. This cannot be elucidated by the reported data, since the
parameters were evaluated by different studies and were nearly
comparable, albeit with low variance. Finally, in line with CV
outcomes, the axons in the AP-T grafts had the smallest diameter.
Myelin sheath thickness
Myelin sheath thickness has been shown to correlate with
the functional recovery of regenerating nerves (Kanaya et al.,
1996). During the early period after injury, the axon diameter
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decreases and then later increases over time (Sanders, 1948).
The decrease in axon diameter is associated with a mild increase
in myelin sheath thickness, maintaining the size of the entire
fiber steady. The axons then start to increase their diameter,
causing the surrounding myelin sheath to decrease in thickness
(Sanders, 1948). The correlation between these two parameters is
useful for interpreting the results. For instance, in the AP-TPA
grafts, despite measurement at an earlier time point, myelin
sheath thickness and axon diameter were nearly comparable
to those of the autografts, meaning that these two types of
grafts were probably almost at the same regeneration phase.
This comparison was not possible with NP grafts, as myelin
sheath thickness was evaluated only at the last time point. Its low
value, together with the increased axon diameter, suggested that
the grafts were further along in the regeneration process than
the HP grafts. In fact, axon diameter was smaller, while myelin
sheath thickness remained substantially unchanged, indicating
that the HP grafts were probably still in an intermediate phase
of regeneration. Kim et al. (2016) reported a myelin sheath
thickness of 4 µm in HP grafts at 12 weeks after the graft
procedure, which was much higher and out of the range, even
when compared with autografts. Differently, a slight increase in
axon diameter and a slight decrease in myelin sheath thickness
was observed in SP grafts, suggesting that they were probably at
the beginning of the second phase of regeneration. The AP-TS
grafts were re-innervated by large axons (5.4 µm in diameter)
and had a lower myelin sheath thickness (0.8 µm), indicating
good progress in the regeneration process, as expected, given
the time point at which they were evaluated. Conversely, the
myelin sheath was thickest in the AP-T grafts, in which the
axon diameter was among the smallest. In this case, the myelin
sheath thickness reported for this graft type appeared to be
outside the expected physiological range, as mentioned in Section
“Morphological and Functional Comparison of Autografts and
Sham Control of Nerve Gap Reconstruction in Rat Models.”
Unfortunately, some of the studies (Liu et al., 2011; Kim
et al., 2016) reported unforeseen and off-the-scale values due
to possible methodological sampling errors or, more commonly,
insufficient methodological information to obtain significant
results, as demonstrated elsewhere (Geuna et al., 2004; Geuna and
Herrera-Rincon, 2015).
Other histomorphological parameters
The unmyelinated/myelinated axon ratio, the number of axons
in the unmyelinated bundle, and the sectional area of single
myelinated axons were evaluated by Godinho et al. (2013) in
FTP grafts at weeks 10–15. The unmyelinated/myelinated axon
ratio was also evaluated in AP-TS grafts (Wang W. et al., 2016).
Unmyelinated axons are physiologically present in the peripheral
nervous system and can result locally abundant, accounting for
about 75% of axons in the cutaneous nerves of mammals (Geuna
et al., 2009). They are usually small; given the lack of a myelin
sheath, they do not permit saltatory conduction, resulting in a
lower CV. Both FTP (with an unmyelinated/myelinated axon
ratio of 4) and especially AP-TS grafts (with a ratio of 5.3) seemed
to be re-innervated by a higher number of unmyelinated neurons
compared with autografts, in which the ratio was 3.5. This implies
that the CV was slower in these grafts, though evidence for this
parameter was not directly evaluated.
Godinho et al. (2013) observed a difference in axon sectional
area between FTP grafts and autografts (2.1 µm2 vs. 3.6 µm2),
supporting the hypothesis that CV in FTP grafts is slower. In
addition, the two parameters correlating with functional recovery
were evaluated in AP-TS grafts (Wakimura et al., 2015; Kusaba
et al., 2016; Wang W. et al., 2016): the von Frey hair sensitivity
test and the toe spread factor, both as compared to the healthy
limb and expressed as a percentage. The mean von Frey hair
sensitivity value was 13.8% and the toe spread factor ratio was
46.3%, consistent with the values for autografts measured in other
studies (Wang et al., 2012; Wakimura et al., 2015; Kusaba et al.,
2016; Wang W. et al., 2016), indicating comparable functional
recovery for AP-TS grafts and autografts at week 20.
Vascularization and Inflammation
Nerve grafts obtained with decellularization protocols often
proved inadequate for clinical application, and this inadequacy
was noted to increase linearly with graft length (He et al., 2012,
2014; Hayashida et al., 2015). A chief reason is that, ischemia,
degeneration, and necrosis can occur in the non-vascularized
parts of long, decellularized nerve grafts, associated with
slow regeneration and risk of graft failure (Hayashida et al.,
2015; Rbia and Shin, 2017). In conventional approaches with
autografts or isografts, revascularization is simpler and more
direct, based on reconnection with the existing vasculature
(Best et al., 1999). Differently, the native cells in decellularized
grafts, including endothelial cells, are removed, thus impeding
adequate and rapid support to the decellularized nerve scaffold.
Given the importance of this issue, and in order to better
understand the process of vascularization in decellularized
grafts, we analyzed two studies. Zhu et al. (2017) evaluated
patterns of microangiogenesis in decellularized grafts, while
Farber et al. (2016) completed the study by Saheb-Al-Zamani
et al. (2013) investigating the difference in vascularization
between long auto/isografts and decellularized grafts. Zhu
et al. (2017) studied short grafts (10 mm in length) and
demonstrated that nutrient supply relies on fluid permeation
from the surrounding tissues during the early stages after
the graft procedure. Microvessels started to grow at the graft
extremities and then penetrated into the decellularized nerve
matrix along the long axis. Moreover, they calculated that
the microvessels grew more rapidly in the autografts than
in the decellularized nerves. After 14 days, newly formed
microvessels were anastomosed at the midgraft in the autografts
AG, whereas the decellularized grafts needed 21 days for this
process.
Farber et al. (2016) demonstrated that long nerve grafts
(60 mm) need different times for complete vascularization,
depending on the approach used. Auto/isografts take about
5 days before the first signs of vascularization in the midgraft
appear, whereas decellularized nerves need about 20 days, as
shown in Zhu et al.’s (2017) study. The longer time to obtain
adequate vascularization might be the cause of cell damage and
senescence, oxidative stress, and other numerous pathological
processes. Hence, one of the main reasons why better outcomes
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are achieved with auto/isografts is this faster and higher
microvascularization capability of autografts. Angiogenesis and
the formation of new vascularization within the nerve graft are
two processes necessary for successful nerve regeneration and
must be taken into account in the development of functional
nerve grafts.
Another fundamental issue in decellularization is graft
biocompatibility, i.e., the risk of eliciting an inflammatory
response or immunological rejection of the transplanted nerve
matrix. During the decellularization process, a great quantity
of cells, myelin sheath, and ECM debris is generated, which
is theoretically able to activate inflammatory and macrophage
response that could damage the basement membrane and thus
delay regeneration (Gao et al., 2014b). Moreover, some of
these fragments might result immunogenic and able to activate
lymphocyte T cells, promoting their migration within the graft
and leading to its destruction. Therefore, it is important to
consider the pro-inflammatory and immunologic potential of
decellularized nerves used as a graft. In the present review,
six studies described immunological response to decellualarized
grafts (Jia et al., 2011; Godinho et al., 2013; Fan et al., 2014;
Jiang et al., 2015; Wakimura et al., 2015; Poppler et al., 2016;
Wang W. et al., 2016; Cai et al., 2017; Kaizawa et al., 2017). All
six studies used immunostaining to detect T lymphocyte (CD3,
CD4, CD8) and macrophage (CD68) activity. The majority of
the studies showed a slight increase in these cells as compared
with autografts within and in the immediate proximity of the
graft, especially during the first days after grafting, though
there was no statistical difference between these values. Only
Cai et al. (2017) reported a significant difference between
autografts and decellularized nerve grafts. Jiang et al. (2015)
quantified the serum concentration of inflammatory cytokines
(IL-2, TNF-α, and IFN-γ) after a grafting procedure but found
no significant increase in inflammatory cytokines in animals
grafted with a decellularized nerve graft and those that received
an autograft. These outcomes indicated no apparent graft
rejection during the early recovery period but only a restrained
inflammatory response. This means that decellularized nerves
are not subject to the cytotoxic effect of T lymphocytes and
macrophage degradation, making them fairly safe for in vivo
use.
CONCLUSION
With this literature review, we wanted to quantitatively analyze
the effectiveness of decellularized nerve grafts as possible
substitutes for auto/isografts, which currently represent the
current gold standard procedure in the treatment of severe nerve
injury. We evaluated functional and morphological parameters
that reflect the progressive recovery of nerve function. The
parameters were selected because they are the ones most
commonly used in the studies and the most representative
of the regeneration process. Among these parameters, muscle
functionality and histomorphometric analysis (axon diameter
and myelin sheath thickness) best predicted effective recovery
of nerve function. Restoration of muscle weight and tension
entails effective crossing of the nerve gap to reach the target
muscle. The histomorphometric evaluations not only highlighted
the graft’s morphological features but also its functional and
electrophysiological characteristics. Overall, histomorphometric
evaluations are subject to methodological sampling errors,
which may induce bias in the interpretation of the results.
We noted, for example, that myelin sheath thickness was
frequently overrated, supporting the hypothesis of common
errors in the evaluation of histomorphometric parameters, as
pointed out in our previously studies (Geuna et al., 2004; Geuna
and Herrera-Rincon, 2015). In contrast, SFI evaluation and
electrophysiological measurements are useful in the assessment
of nerve regeneration, though they, too, may be subject to error
and high variability (Monte-Raso et al., 2008; Geuna et al., 2009;
Fricker et al., 2016).
The main limitation of the present study was the lack of data
for numerous investigations: not all parameters were evaluated
for all decellularization protocols at all time points. Moreover,
only one evaluation reported by a single study was available
in many cases, making complete and exhaustive comparison
between the protocols not always possible.
Overall, although reported in only one study (Cai et al.,
2017), the most promising outcomes were obtained with the
grafts produced with the AP-TPA protocol. This protocol had
the best data for muscle wet weight ratio, myelinated fiber
number, axon diameter, and myelin sheath thickness, with all
values comparable to those of autografts evaluated at 8 weeks
after surgery. Moreover, the effectiveness of this protocol was
notable also for the length of the graft (15 mm, longer than
the critical size) and the time needed for decellularization
(the quickest among the in-house protocols and similar to
that of SP). Based on the promising results of AP-TPA,
further investigations should be carried out to confirm these
outcomes.
Among the well-established protocols, NP, especially when
performed after HP, seemed to be the most effective. In fact, it
resulted in grafts with sufficient muscle weight and tension ratio,
axon diameter, myelin sheath thickness, myelinated fiber number,
CV, and SFI (until week 9). Given that the NP grafts were the
longest on average (21 mm), the outcomes appeared even more
remarkable. This protocol is, in fact, used in the manufacture
of Avance R© processed nerve grafts (AxoGen, Inc., Alachua, FL,
United States), which is a decellularized nerve graft currently
employed in clinical practice. The protocol was developed with
the idea to improve on the effectiveness of the previously
developed, well-established protocols (SP and HP) by removing
chondroitin sulfate proteoglycans, which were demonstrated to
inhibit axonal growth (Krekoski et al., 2001; Jiang et al., 2016);
this improvement was confirmed in our analysis. The HP and the
SP showed similar results; however, based on specific parameters,
mainly muscle functionality, outcomes with the HP grafts were
slightly superior. This observation was confirmed by Nagao
et al. (2011) who compared SP, HP, and FTP grafts in the
same experimental procedure and reported a significantly better
improvement in SFI with use of HP grafts as compared to those
obtained with the other two protocols. Moreover, HP takes less
time to complete than SP. This can be explained by the fact
Frontiers in Cellular Neuroscience | www.frontiersin.org 16 November 2018 | Volume 12 | Article 42734
fncel-12-00427 November 19, 2018 Time: 12:12 # 17
Lovati et al. Decellularized Nerve Grafts
that SP was the first decellularization protocol to be developed,
while HP is a later improvement with better preservation of
the ECM structure and an easier detergent removal step using
lower doses of chemicals (Hudson et al., 2004; Rieder et al., 2004;
Alhamdani et al., 2010; Serghei et al., 2010; Crapo et al., 2011).
Evaluation of FTP grafts was scarce, since it was evaluated only by
two studies (Nagao et al., 2011; Godinho et al., 2013) that reported
the lowest values for SFI, statistically lower than the HP grafts
(Nagao et al., 2011). Moreover, in the same experimental design,
the myelinated fiber density was lower in the FTP than in the
NP grafts (Godinho et al., 2013). Three major advantages of FTP
are that it is the quickest decellularization protocol, it requires
no chemicals, and the effect of decellularization is uniform on the
entire tissue, without depending on diffusion or perfusion (Crapo
et al., 2011). Nonetheless, the protocol has many limitations,
which explains the worse outcomes obtained. First the technique
causes rapid tissue expansion and contraction that can damage
basal lamina continuity, making axonal regeneration difficult.
Moreover, FTP kills cells in the tissue. Since it does not have a
washing step, the debris is not eliminated (Gulati and Cole, 1994;
Sondell et al., 1998; Szynkaruk et al., 2013), which might activate
inflammatory or immunological response (Gao et al., 2014b).
Concerning the other in-house protocols, the AP-T protocol
employed a longer time for decellularization and the outcomes
were generally slightly worse than with HP, particularly for
morphology. Finally, the AP-W protocol ranked last; its long
duration (2 weeks) makes it less attractive and effective than the
other protocols.
Table 7 summarizes the advantages and disadvantages of
the different techniques used to decellularize nerve grafts for
potential clinical use.
In conclusion, decellularized nerve grafts are a promising,
alternative to auto/isografts for the treatment of nerve injury,
even in the repair of defects with large gaps. They are
immunologically safe and some more than others support the
functional and morphological recovery of the injured nerve.
Although the use of peracetic acid showed very promising
outcomes, it needs to be further analyzed. The use of
chondroitinase ABC, introduced with NP, seems to effectively
improve the outcomes obtained with SP and HP. The use of
triton-X alone or in association with SDS did not seem to improve
the outcomes with the HP or the SP grafts. The worst results
were obtained with physical techniques (freeze/thaw or Wallerian
degeneration protocol); therefore, chemicals and washing steps
TABLE 7 | Advantages and disadvantages of the various protocols to decellularize nerve grafts.
Decellularization protocol Advantages Disadvantages
Sondell (SP) • SFI similar to autograft
• CV similar to autograft
• Motor endplates seriously atrophied and low recovery of
muscle functionality
• Very few regenerated myelinated nerve fibers
Hudson (HP) • Low percentage of chemical detergents
• Good muscle wet weight ratio at 10–15 weeks
• Axon diameter and myelinated sheath thickness
comparable to autografts at 10–15 weeks
• Low CV values 10–15 weeks after repair
Neubauer (NP) • Satisfying SFI
• Satisfying muscle weight and tension ratio
• Satisfying quantitative histomorphological
parameters (myelinated fiber number, axon diameter,
myelin sheath thickness)
• CV values halved of that registered in autografts
• Low myelinated fiber density
Freeze-and-thaw (FTP) • Quickest and less laborious protocol, no chemicals
are needed
• Low values of SFI
• Low myelinated fiber density
• Cell debris are not eliminated
• Damaged basal lamina and difficult axonal regeneration
Triton-X (AP-T) • Remarkable electrophysiological outcome
(considering the higher average graft length)
• Muscle tension ratio recovery similar to autografts
• Long time to the decellularization process
• Low values of SFI recovery
Triton-X + SDS (AP-TS) • Good progress in nerve regeneration (large axons at
25 weeks)
• Basal lamina preserved
• Few data comparable to the other protocols
Triton-X + peracetic acid (AP-TPA) • Quickest protocol between in-house protocols
• Muscle mass recovery (muscle wet weight ratio) at
8 weeks similar to autografts
• Quantitative histomorphological parameters
(myelinated fiber number, axon diameter, myelin
sheath thickness) at 8 weeks comparable with those
of the autograft at 10–15 weeks
• Only one paper describing this protocol
Wallerian degeneration (AP-W) • Myelin thickness of regenerating fibers similar to
autografts
• Longest protocol
• Muscle wet weight ratio recovery half than autografts
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are needed to obtain an effective decellularized nerve graft.
Finally, in order to further improve process performance,
a recellularization step could be introduced to produce a
graft that is able to substitute the current gold standard of
auto/isografts.
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Inhibiting RhoA-subfamily GTPases by C3 transferase is widely recognized as
a prospective strategy to enhance axonal regeneration. When C3 transferase is
administered for treating the injured peripheral nerves, Schwann cells (SCs, important
glial cells in peripheral nerve) are inevitably impacted and therefore SC bioeffects on
nerve regeneration might be influenced. However, the potential role of C3 transferase
on SCs remains elusive. Assessed by cell counting, EdU and water-soluble tetrazolium
salt-1 (WST-1) assays as well as western blotting with PCNA antibody, herein we first
found that CT04 (a cell permeable C3 transferase) treatment could significantly suppress
SC proliferation. Unexpectedly, using Y27632 to inhibit ROCK (the well-accepted
downstream signal molecule of RhoA subfamily) did not impact SC proliferation. Further
studies indicated that CT04 could inactivate AKT pathway by altering the expression
levels of phosphorylated AKT (p-AKT), PI3K and PTEN, while activating AKT pathway by
IGF-1 or SC79 could reverse the inhibitory effect of CT04 on SC proliferation. Based on
present data, we concluded that inhibition of RhoA-subfamily GTPases could suppress
SC proliferation, and this effect is independent of conventional ROCK pathway but
involves inactivation of AKT pathway.
Keywords: Schwann cell, proliferation, RhoA-subfamily GTPase, C3 transferase, AKT, ROCK
INTRODUCTION
Rho family small guanosine triphosphatases (Rho-GTPases) are essential in the regulation of diverse
cellular functions such as regulation of actin cytoskeleton, vesicular trafficking and transcriptome
dynamics (Hu and Selzer, 2017; Nomikou et al., 2017). Rho-GTPases cycle between an active
GTP-bound and an inactive GDP-bound form, regulated by the opposing actions of guanine
nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs; Bai et al., 2015). The
best characterized members of Rho family are classified into three subgroups, the RhoA (RhoA,
B, C), Cdc42 (Cdc42, Tc10 and TcL) and Rac (Rac1, 2, 3 and RhoG) subfamilies, respectively
(Erschbamer et al., 2005). RhoA subfamily is widely recognized as a crucial molecular switch to
initiate growth cone collapse and inhibit axonal regrowth in the nervous system (Antoine-Bertrand
et al., 2011; Matsukawa et al., 2018).
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Peripheral nerve injury (PNI) is a common global clinical
problem which involves approximate 2.8% clinic trauma
patients, and it significantly affects the life quality of patients
and arouses an enormous socioeconomic burden (Wang et al.,
2017). Recently, inhibiting RhoA subfamily has been accepted as
a prospective strategy to facilitate axonal regrowth and functional
recovery after PNI (Hiraga et al., 2006; Auer et al., 2012; Hynds,
2015; Joshi et al., 2015). Due to C3 transferase is able to selectively
inactivate RhoA-subfamily GTPases, it is widely used to promote
neural regeneration (Auer et al., 2012, 2013; Zhou et al., 2012;
Forgione and Fehlings, 2014; Gutekunst et al., 2016).
Peripheral nerves are composed not only of axons but also
of Schwann cells (SCs), which wrap around the axons and
form myelin sheath (Tricaud, 2017). SCs are the first cells
activated following PNI and play vital roles in nerve regeneration
through dedifferentiation and proliferation (Pan et al., 2017).
The proliferated SCs can organize the clearance of broken
axons and myelin debris by promoting macrophage recruitment
or via phagocytosis by themselves, secrete neurotrophins to
facilitate the axonal regrowth, form bands of Bunger in the
distal stump to provide a permissive microenvironment for
axon regeneration and ensuing remyelination (Monk et al.,
2015; Jessen and Mirsky, 2016; Wong et al., 2017). Thus, SC
proliferation is regarded as a crucial part of the nerve injury
and regeneration (Jessen et al., 2015). When C3 transferase
is administered to promote the axonal regeneration in the
injured peripheral nerves, SCs are inevitably impacted and their
bioeffects on nerve regeneration might be influenced. However,
the potential roles of C3 transferase on SCs remain elusive. To
figure out this issue, the present project was firstly designed to
reveal the effect of CT04 (a cell permeable C3 transferase) on
SC proliferation and then the underlying mechanisms were also
studied.
MATERIALS AND METHODS
Primary Cultures of Schwann Cells
The procedures of this study were performed in accordance
with National Institutes of Health (NIH) guidelines for the
care and use of laboratory animals (NIH Publications) and
approved by the Animal Experimental Ethics Committee of
the Southern Medical University (SMU), Guangdong Province,
China. All efforts were made to minimize animal suffering
and usage. Primary rat SCs were isolated and cultured
according to our previous reports (Wen et al., 2017a,b). Briefly,
spinal and sciatic nerves were aseptically isolated from 3-
day to 5-day postnatal Sprague-Dawley (SD) rats (provided
by the Experimental Animal Center of SMU). The collected
nerves were dissociated by 0.25% Trypsin-EDTA (Gibco) at
37◦C for 30 min and single cells were obtained by gentle
pipetting. Following digestion and dissociation, the cells were
centrifuged for 10 min at 1,000 rpm and re-suspended in
DMEM/F12 (Corning) containing 10% fetal bovine serum (FBS,
Corning). Then cells were plated onto poly-L-lysine (PLL,
Sigma-Aldrich)-coated petri dish (Jet Biofil). The next day,
10 µM of cytosine arabinoside (Sigma-Aldrich) was added
into the medium and incubated with the cells to eliminate
fibroblasts. Forty-eight hours later, the medium was replaced
by SC medium (DMEM/F12) containing 3% FBS, 3 µM
forskolin (Sigma-Aldrich), 10 ng/ml heregulin (PeproTech)
and 100 mg/ml penicillin-streptomycin (Gibco) to expand the
cells. And all experiments of the present study were routinely
performed using SCs collected at passages 3–5th. In designed
experiments, 2µg/ml CT04 (RhoA-subfamily GTPases inhibitor,
Cytoskeleton), 50 µM Y27632 (ROCK inhibitor, Selleck),
150 ng/ml IGF-1 (AKT activator, PeproTech) or 20 µM SC79
(AKT activator, Selleck) was added into the culture medium and
maintained for 24 h.
Immunofluorescence Staining
To characterize the primary isolated cells, the cultured cells
of passage 3 were fixed by 4% (w/v) paraformaldehyde for
20 min and washed three times with 0.01 M PBS. The fixed
cells were permeabilized by 0.5% Triton X-100 (Sigma) for
30 min and then blocked with 5% bovine serum albumin
(BSA, GBCBIO Technologies) in PBS for 1 h at room
temperature, followed by the incubation with primary antibodies
diluted in 1% BSA overnight at 4◦C. The dilutions of the
primary antibodies are as follows: rabbit anti-GFAP (1:400,
Sigma-Aldrich); mouse anti-S100 (1:200, Millipore); and mouse
anti-P75 (1:400, Millipore). Alexa 488 fluorescent conjugated
secondary antibodies (1:400, Molecular Probes) were applied for
2 h at room temperature, and the nuclei were counterstained
by 1 µg/ml 4′,6-diamidino-2-phenylindole (DAPI, Sigma) for
2 min. After immunofluorescence staining, the cultures were
mounted using the anti-fading mounting medium (Vector) and
images were captured with a fluorescent microscope (Leica).
Schwann Cell Proliferation Assays
EdU Incorporation Assay
The EdU incorporation assay was conducted according to the
manufacturer’s instructions (RiboBio). In brief, the cells were
seeded at 1 × 104/well in 96-well plates and incubated overnight
to allow cell adherence. Cells were exposed to various drug
treatments as designed for 24 h and then incubated with
50 µM EdU labeling reagent for 3 h prior to fixation. Following
permeabilization in 0.5% Triton X-100, the cells underwent
EdU staining. The cell nuclei were counterstained with DAPI.
EdU-positive nuclei were determined under a fluorescence
microscope (Leica). Five images were captured at the center and
four quadrants in each plate using a fluorescent microscope. The
EdU positive ratio was calculated as the number of EdU-positive
cells divided by the number of total cells (positive for DAPI).
Meanwhile, the cell density of each group was calculated
and defined as the number of cells (positive for DAPI) in
each captured image. The number of cells was counted using
Image-Pro Plus software (Media Cybernetics).
WST-1 Assay
The cell proliferation was also evaluated by the water-soluble
tetrazolium salt-1 (WST-1) assay using a Quick Cell Proliferation
Assay Kit II (Abcam). SCs were prepared as described above
(EdU incorporation assay). According to the manufacturer’s
instructions, 10 µl of the WST reagent was added to each
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well of the 96-well plates for 3 h at 37◦C. The absorbance
was measured at 450 nm by using a microplate reader
(BioTek). Abackground is the absorbance of culture medium plus
WST in the absence of cells. The actual absorbance of the
control cells (Acontrol) is the absorbance of Acontrol minus the
absorbance of Abackground. The actual absorbance of the treated
cells (Aexperimental) is the absorbance of Aexperimental minus the
absorbance of Abackground.
Western Blotting
For western blotting, SCs were treated with various drugs
as designed for 24 h. The subjected cells were washed
twice with ice-cold PBS, scraped and lysed in RIPA buffer
(GBCBIO) containing protease inhibitor cocktail (1:100, Cell
Signaling). Lysates were incubated on ice for 30 min and
centrifuged (14,000 rpm, 20 min, 4◦C) in order to collect
the supernatant. Extracts were combined with SDS-PAGE
sample buffer (400 mM Tris/HCl, pH 6.8, 10% SDS, 50%
glycerol, 500 mM DTT, 2 µg/ml bromophenol blue) and
denatured by boiling for 10 min. Equal protein samples were
loaded and resolved by 10% SDS-PAGE gels and transferred
to polyvinylidene difluoride (PVDF) membrane (Bio-Rad) by
liquid transfer. Membranes were blocked with 5% BSA for 1 h
at room temperature and incubated with primary antibodies
overnight at 4◦C. The following primary antibodies were
used in western blotting: rabbit anti-GAPDH (1:3,000, Multi
Science); rabbit anti-PCNA (1:500, Cell Signaling Technology);
rabbit anti-PTEN (1:1,000, Cell Signaling Technology); rabbit
anti-PI3K (1:1,000, Cell Signaling Technology); rabbit anti-
phospho-AKT (1:1,000, Cell Signaling Technology); rabbit
anti-AKT (1:1,000, Cell Signaling Technology). After washed
three times with Tris-buffered saline containing 0.05%
Tween-20, the membranes were incubated with respective
HRP-conjugated secondary antibodies (1:2,000, Cell Signaling
Technology) for 2 h at room temperature. Immunoreactive
proteins bands were detected and imaged by enhanced
chemiluminescence (ECL, Millipore) using Lumazone system
(Roper). After exposure, membranes were washed by stripping
buffer (Thermo) for further incubation of another antibody
if needed. Integrated optical density (IOD) of each lane was
quantified with Image-Pro Plus software and the expression
levels of targeted proteins were normalized by the IOD of
GAPDH.
Cytotoxicity Assay by Live/Dead Cell
Staining
In order to assess whether the effect of CT04 on cell proliferation
is attributed to the cytotoxicity of CT04, an assay with Live/Dead
cell staining kit (BestBio) was conducted according to the
manufacturer’s instructions. In brief, the cells were seeded at
1 × 104/well in 96-well plates and incubated overnight to allow
cell adherence. The culture media were supplemented with
2 µg/ml CT04 or 30% DMSO for 24 h and then incubated
for 30 min with the Live/Dead cell staining solution which was
prepared with the reagents A, B and C of the kit. After that, the
cultures were observed with a fluorescence microscope to detect
the live cells (stained by Calcein-AM with green fluorescence)
and dead cells (stained by PI with red fluorescence). Five
images were captured at the center and four quadrants in each
culture. Then the live cell ratio was calculated as the number of
Calcein-AM positive cells divided by the number of total cells
(Calcein-AM-positive cells plus PI-positive cells).
Statistical Analysis
All statistical analyses and calculations were carried out using
SPSS 20.0 software (IBM, Armonk, NY, USA). Statistics for
FIGURE 1 | Characterization and identification of primary cultured Schwann cells (SCs). (A,A′) Primary cultured SCs showed a bipolar spindle shape under phase
contrast microscope. More than 95% of the cells were positive for the SC specific markers, including GFAP (B,B′), S100 (C,C′) and P75 (D,D′).
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multiple comparisons were generated using one-way ANOVA
followed by Bonferroni post hoc tests. Independent samples
t-test was used to analyze values between two groups. All
statistical graphs were plotted with the Graph Pad Prism 6.0
(Graph Pad software), and quantitative data were presented as
mean ± standard deviation (SD). Differences were considered
statistically significant with P-value< 0.05.
RESULTS
CT04 Suppresses Schwann Cell
Proliferation
As shown in Figure 1, primary cultured SCs exhibited a
bipolar spindle shape (Figures 1A,A′) and were positive
for SC-specific markers, including GFAP, S100 and P75
(Figures 1B–D,B′–D′). To illustrate the effect of CT04 on
SC proliferation, SCs were treated by CT04 for 24 h.
Then, the EdU and WST-1 measurements were conducted.
The EdU assay displayed that the ratio of EdU positive
cells was significantly reduced in the presence of CT04
(Figures 2A–G). Furthermore, the statistical analysis of cell
density indicated that the number of total cells was also decreased
by CT04 treatment (Figure 2H). The WST-1 results revealed
that CT04 markedly decreased the absorbance value compared
to the control group (Figure 2I). Meanwhile, the level of
PCNA, determined using western blotting, was remarkably
down-regulated by CT04 treatment (Figures 2J,K). Taken
together, all these results confirm that CT04 can suppress SC
proliferation.
Further experiment with Live/Dead cell staining assay was
designed to test the potential cytotoxicity of CT04 in the SC
cultures. In order to confirm the efficiency and reliability of
this assay, we set up a positive control (30% DMSO treatment)
and a negative control (no drug treatment) to do the parallel
experiment with the CT04 treatment. The results illustrated that
the overwhelmingmajority of cells in both of the negative control
group and CT04 group were live cells, only very few of cells in
these two groups were dead cells (Figures 3A–F,J). However,
almost all cells in the positive control group were dead cells
(Figures 3G–J). These results demonstrate that the effect of
CT04 on SC proliferation is not caused by cytotoxicity.
Inhibition of ROCK Does Not Affect
Schwann Cell Proliferation
To identify whether CT04 modulates SC proliferation through
ROCK which is the most well-known downstream effector of
RhoA-subfamily GTPases, the SCs were treated with Y27632 (a
widely used specific ROCK inhibitor) for 24 h. Unexpectedly,
FIGURE 2 | CT04 suppresses SC proliferation. (A–G) EdU staining showed that EdU positive ratio was suppressed by CT04 treatment (n = 15, ∗P < 0.05).
(H) Statistical graph of cell density indicated that the number of total cells (positive for 4′,6-diamidino-2-phenylindole (DAPI)) was decreased in the presence of CT04
(n = 15, ∗P < 0.05). (I) Water-soluble tetrazolium salt-1 (WST-1) measurement revealed that CT04 markedly decreased the absorbance value compared to the
control group (n = 4, ∗P < 0.05). (J,K) Western blotting displayed that the expression of PCNA was remarkably down-regulated in the CT04 treated cells (n = 6,
∗P < 0.05). The blots were cropped from different parts of the same gel. The expression level of PCNA in the control group was normalized to 1.
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FIGURE 3 | CT04 does not induce toxic effect on SC. The cytotoxicity of CT04 was evaluated using Live/Dead cell staining. (A–J) The Live/Dead cell staining and
statistical diagrams suggested that addition of CT04 did not induce cell death in the SCs cultures (n = 20, ∗P < 0.05). N.S. as non-significance.
Y27632 did not result in the same effect on SC proliferation
as CT04. As shown in Figure 4, the EdU assay indicated that
the ratio of EdU positive cells as well as the cell density was
not affected in the presence of Y27632 (Figures 4A–G,H).
Meanwhile, WST-1 assay showed no difference in absorbance
value between Y27632 and control groups (Figure 4I). In
addition, the expression level of PCNA was similar between two
groups (Figures 4J,K). These data strongly implicate that ROCK
is not involved in the regulation of SC proliferation.
CT04 Inactivates AKT Signaling Pathway
According to previous reports (He et al., 2011; Chen et al.,
2016; Wu et al., 2016), AKT pathway is one of the most
important pathways involved in regulating SC proliferation. To
determine whether this pathway is responsible for mediating
the CT04-induced suppression on SC proliferation, the total
AKT, phosphorylated AKT (p-AKT) as well as AKT’s critical
upstream regulator—PI3K (Gaesser and Fyffe-Maricich, 2016)
and its crucial inhibitor—PTEN (Liu et al., 2017) were detected.
Western blotting verified that the p-AKT was significantly
decreased in CT04 group, while the total AKT was unaffected
(Figures 5A,B). Furthermore, the expression of PI3K was
down-regulated in the presence of CT04 (Figures 5C,D), while
the expression of PTEN was up-regulated (Figures 5E,F).
These data drew us to hypothesize that AKT pathway
might be involved in the inhibitory effect of CT04 on SC
proliferation.
Activation of AKT Reverses the Inhibitory
Effect of CT04 on SC Proliferation
To ascertain the potential role of AKT pathway on
CT04-mediated inhibition of SC proliferation, we treated
the SCs with CT04 in the presence or absence of AKT activators
(IGF-1 (Jo et al., 2012; Sabater et al., 2017) or SC79 (Wu
et al., 2017; Yang et al., 2018; Zhou et al., 2018)), respectively.
Western blotting indicated that IGF-1 dramatically increased
the level of p-AKT while the level of total AKT was not affected
(Figures 6A,B). Subsequently, the EdU assay showed that
CT04-induced suppression of EdU positive ratio of SCs and the
cell density were obviously restored by IGF-1 (Figures 6C–L,M).
The effect of IGF-1 on SC proliferation was also verified by the
change in absorbance value detected by WST-1 measurement
(Figure 6N). What’s more, the down-regulation of PCNA
expression caused by CT04 treatment was also significantly
alleviated by IGF-1 as shown in western blots (Figures 6O,P).
Similar findings were observed when SCs were treated with
CT04 in the presence of SC79, another specific activator of AKT.
The results of cell density, EdU, WST-1 and western blotting
assays also revealed that the addition of SC79 partly reversed
CT04-mediated suppression of SC proliferation (Figure 7).
DISCUSSION
Collectively, overall data of the present study demonstrate
that: (1) data got from the assessments of cell density, EdU,
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FIGURE 4 | Inhibition of ROCK does not affect SC proliferation. (A–G) EdU assay showed that EdU positive ratio was not affected by Y27632 treatment (n = 15). (H)
Statistical diagram of cell density suggested that the number of total cells was not altered in the presence of Y27632 (n = 15). (I) WST-1 measurement revealed that
there was no significant difference in the absorbance value between the control group and Y27632 group (n = 4). (J,K) Western blotting indicated that the expression
of PCNA was unaffected in the Y27632 treated cells (n = 6). The blots were cropped from different parts of the same gel. The expression level of PCNA in the control
group was normalized to 1. N.S. as non-significance.
WST-1 and PCNA expression indicate that the inhibition
of RhoA-subfamily GTPases by C3 transferase (CT04) can
suppress the SC proliferation; (2) Live/Dead cell staining assay
indicates CT04 does not induce cell death in the SCs cultures,
which means the effect of CT04 on SC proliferation was not
related to the cytotoxicity; (3) Y27632 (a widely used specific
ROCK inhibitor) does not affect the SC proliferation. By which
excludes the possibility of RhoA-subfamily GTPases regulating
SC proliferation via ROCK pathway; (4) the level of p-AKT
is significantly decreased in the CT04 treated SCs, while the
total AKT is unaffected. Since AKT activation (phosphorylation)
is involved in regulating the proliferation of many kinds of
cells including SCs, these results suggest AKT inactivation
might play a role in CT04 negative effects on SC proliferation;
(5) CT04 treatment results in down-regulation of PI3K and
up-regulation of PTEN, which can confirm and verify the results
of CT04 suppressing the AKT activation; and (6) reversing the
AKT activation by IGF-1 or SC79 (two kinds of widely used
AKT activators) can significantly alleviate the inhibitory effect of
CT04 on SC proliferation. These data confirm that AKT pathway
is involved in the mechanisms of CT04-induced suppression on
SC proliferation.
Since SCs are important glial cells in peripheral nerve and they
have attractive application prospects in cell transplantation for
the therapy of nervous system injury, the biology and application
of SCs have been attracting a great deal of attention (Belin
et al., 2017). Recent decades, lots of publications focused on
the study of SC proliferation (Atanasoski et al., 2004; Deng
et al., 2017; Pan et al., 2017; Piñero et al., 2017). As molecular
switches that control the organization and dynamics of the actin
cytoskeleton, Rho GTPases are considered to be key regulators
of proliferation of various cells (Hu et al., 2014; Wang et al.,
2014). Our previous study indicated that lentivirus-mediated
RhoA knocking down to reduce the total protein level of RhoA
could significantly slack the proliferation of SCs (Wen et al.,
2017a). In this study, we aimed to reveal whether inhibiting
the activation of RhoA-subfamily GTPases can impact the SC
proliferation. CT04 is able to specifically and irreversibly inhibit
activation of RhoA-subfamily GTPases by ADP ribosylation,
our recent study proved CT04 treatment could reduce the level
of activated GTP-RhoA in cultured SCs (Wen et al., 2018).
Combined with the present data of cell density, EdU assay,
WST-1 assessment and western blotting of PCNA, we can safely
draw the conclusion that inhibition of RhoA-subfamily GTPases
by CT04 can significantly slow down the SC proliferation.
Up to now, the most well-known downstream effector of
RhoA-subfamily GTPases is ROCK. In existing reports, RhoA
subfamily plays roles in various biologic effects including
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FIGURE 5 | CT04 regulates the AKT signaling pathway. (A,B) The western blots indicated that the phosphorylation of AKT was markedly decreased in the presence
of CT04 (n = 12, ∗P < 0.05). (C–F) Immunoblot assays and statistical diagrams also revealed that addition of CT04 resulted in down-regulation of PI3K and
up-regulation of PTEN (n = 4, ∗P < 0.05). The blots were cropped from different parts of the same gel. The expression levels of target proteins in the control group
were normalized to 1.
FIGURE 6 | Activation of AKT by IGF-1 reverses the inhibitory effect of CT04 on SC proliferation. The SCs were treated with CT04 in the presence or absence of
IGF-1 for 24 h. (A,B) Western blotting was performed to confirm the effect of IGF-1 on activation of AKT. GAPDH was used as the loading control (n = 4, ∗P < 0.05).
(C-L) Analysis of EdU incorporation indicated that IGF-1 partly restored the declined EdU positive ratio in CT04 treated cells (n = 15, ∗P < 0.05). (M) Statistics of cell
density displayed that CT04-mediated inhibition of SC density was reversed by IGF-1 (n = 15, ∗P < 0.05). (N) WST-1 assay revealed that IGF-1 treatment partly
restored the change in absorbance value caused by CT04 (n = 4, ∗P < 0.05). (O) Western blots showed that application of IGF-1 up-regulated the expression of
PCNA in the CT04 treated cells. The blots were cropped from different parts of the same gel. (P) Statistical diagram of relative protein expression of PCNA (n = 4,
∗P < 0.05). The expression levels of target proteins in the control group were normalized to 1.
cell proliferation always by regulating actin dynamics via
ROCK pathway. Thus, we naturally consider CT04 may also
influence SC proliferation through ROCK pathway. However,
the treatment of Y27632, a widely used inhibitor of ROCK,
has no significant impact on the parameters of SC proliferation
including cell density, EdU, WST-1 and western blotting of
PCNA. Therefore, ROCK is impossible taking part in the
regulation of RhoA subfamily on SC proliferation.
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FIGURE 7 | Activation of AKT by SC79 counteracts the inhibitory effect of CT04 on SC proliferation. SCs were treated with DMSO as vehicle control. The SCs were
treated with CT04 with or without SC79 for 24 h. (A,B) Western blotting was performed to confirm the effect of SC79 on activation of AKT (n = 4, ∗P < 0.05).
(C-L) The EdU incorporation assay suggested that application of SC79 increased the EdU positive ratio in CT04 treated cells (n = 15, ∗P < 0.05). (M) The statistics
showed that CT04-mediated suppression of SC density was partly restored by SC79 (n = 15, ∗P < 0.05). (N) Assessment of cell proliferation by WST-1 assay
displayed that SC79 counteracted the inhibitory effect of CT04 on SC proliferation (n = 4, ∗P < 0.05). (O,P) Western blots and statistical data indicated that the
addition of SC79 increased the expression of PCNA in the CT04 treated cells (n = 4, ∗P < 0.05). The blots were cropped from different parts of the same gel. The
expression levels of target proteins in the control group were normalized to 1.
AKT pathway is demonstrated as an important signaling
pathway in the regulation of cell proliferation, including SCs
(Wu et al., 2016; Liu et al., 2017; Zhao et al., 2017). This
drew us to think whether CT04 treatment modulated SC
proliferation via AKT pathway. In order to test this hypothesis,
the phosphorylation of AKT was firstly evaluated. The results
demonstrated that CT04 treatment significantly reduced the level
of p-AKT. Moreover, the expression level of PI3K, which is
the crucial positive upstream molecule of AKT, was markedly
decreased. It has been shown in several researches that in the
PTEN/PI3K/AKT signaling pathway, PI3K can catalyze 3,4,5-
phosphatidylinositol trisphosphate phosphorylation and then
activate AKT to promote the proliferation of cells (Zhang
et al., 2015). In addition, we found that the expression of
PTEN was dramatically up-regulated. PTEN is an important
negative regulator of AKT pathway, it can antagonize PI3K
and then weaken the activation of AKT (Zhang et al., 2015;
Ahmed et al., 2016). Therefore, the up-regulation of PTEN
and down-regulation of PI3K further confirmed that AKT
pathway could be inactivated by CT04. To further validate
whether the inactivation of AKT pathway was responsible
for CT04-mediated suppression of SC proliferation, two kinds
of activators of AKT pathway (IGF-1 and SC79) were used
to do the rescue experiments. As expected, both IGF-1 and
SC79 could reverse the AKT inactivation by CT04 and
significantly alleviate the inhibitory effect of CT04 on SC
proliferation.
Taken together, we can conclude that: (1) C3 transferase
(CT04) treatment can significantly suppress the SC proliferation.
Considering SCs are important glial cells in peripheral nerves
and C3 transferase is widely used to promote axonal regeneration
in the injured peripheral nerve, the present study indicates
further studies are needed to explore new strategies to avoid
this side-effect when using this drug to treat the injured nerve;
and (2) the effect of CT04 on SC proliferation involves the
AKT pathway. While ROCK, the most well-known downstream
molecule of Rho subfamily, is independent of the effect of
CT04 on the SC proliferation. Considering the complicate
signaling networks of Rho GTPases in most kinds of cells, and
combining with present data, we believe that AKT is not the only
downstream of RhoA subfamily on SC proliferation. The clear
mechanism needs further studies in the future.
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Activated Schwann cells put out cytoplasmic processes that play a significant role
in cell migration and axon regeneration. Following nerve injury, axonal mitochondria
release mitochondrial damage-associated molecular patterns (mtDAMPs), including
formylated peptides and mitochondrial DNA (mtDNA). We hypothesize that mtDAMPs
released from disintegrated axonal mitochondria may stimulate Schwann cells to put
out cytoplasmic processes. We investigated RT4-D6P2T schwannoma cells (RT4)
in vitro treated with N-formyl-L-methionyl-L-leucyl-phenylalanine (fMLP) or cytosine-
phospho-guanine oligodeoxynucleotide (CpG ODN) for 1, 6 and 24 h. We also
used immunohistochemical detection to monitor the expression of formylpeptide
receptor 2 (FPR2) and toll-like receptor 9 (TLR9), the canonical receptors for
formylated peptides and mtDNA, in RT4 cells and Schwann cells distal to nerve
injury. RT4 cells treated with fMLP put out a significantly higher number of cytoplasmic
processes compared to control cells. Preincubation with PBP10, a selective inhibitor
of FPR2 resulted in a significant reduction of cytoplasmic process outgrowth. A
significantly higher number of cytoplasmic processes was also found after treatment
with CpG ODN compared to control cells. Pretreatment with inhibitory ODN (INH
ODN) resulted in a reduced number of cytoplasmic processes after subsequent
treatment with CpG ODN only at 6 h, but 1 and 24 h treatment with CpG ODN
demonstrated an additive effect of INH ODN on the development of cytoplasmic
processes. Immunohistochemistry and western blot detected increased levels of
tyrosine-phosphorylated paxillin in RT4 cells associated with cytoplasmic process
outgrowth after fMLP or CpG ODN treatment. We found increased immunofluorescence
of FPR2 and TLR9 in RT4 cells treated with fMLP or CpG ODN as well as in
activated Schwann cells distal to the nerve injury. In addition, activated Schwann
cells displayed FPR2 and TLR9 immunostaining close to GAP43-immunopositive
regenerated axons and their growth cones after nerve crush. Increased FPR2 and
TLR9 immunoreaction was associated with activation of p38 and NFkB, respectively.
Surprisingly, the growth cones displayed also FPR2 and TLR9 immunostaining.
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These results present the first evidence that potential mtDAMPs may play a key role in the
induction of Schwann cell processes. This reaction of Schwann cells can be mediated
via FPR2 and TLR9 that are canonical receptors for formylated peptides and mtDNA.
The possible role for FPR2 and TLR9 in growth cones is also discussed.
Keywords: RT4-D6P2T schwannoma cells, in vitro, fMLP, CpG ODN, FPR2, TLR9, growth conus, nerve injury
INTRODUCTION
Wallerian degeneration (WD) is the highly orchestrated cascade
of cellular and molecular events distal to injury of nerve fibers,
and is considered to be a kind of innate immune reaction or
sterile inflammation (Stoll et al., 2002; Gaudet et al., 2011). These
events comprise, among others, invasion of macrophages and
other immune cells, axon fragmentation, as well as activation
and inflammatory profiling of Schwann cells (Stoll et al., 2002;
Dubový et al., 2013). Schwann cells of the injured nerve
and the so-called terminal Schwann cells overlying denervated
neuromuscular junctions elaborate processes that guide the
sprouts of regenerated axons (Son and Thompson, 1995a,b;
Gomez-Sanchez et al., 2017). Thus, cytoplasmic extensions
of Schwann cells are crucial for axon regeneration in the
peripheral nervous system. However, the stimuli that trigger
the elaboration of Schwann cells processes have still not been
precisely characterized.
Degeneration of a distal nerve stump is the source of a broad
spectrum of damage-associated molecular patterns (DAMPs)
produced by the digestion of the endoneurial extracellular matrix
as well as fragmentation of axons and their myelin sheaths
(Karanth et al., 2006; Boivin et al., 2007; Kato and Svensson,
2015). These DAMPs are ligands for pattern recognition
receptors such as the toll-like receptors (TLRs) that regulate WD
and Schwann cell inflammatory profiling (Boivin et al., 2007;
Goethals et al., 2010; Boerboom et al., 2016; Dubový, 2017).
The axons and their terminals contain abundant
mitochondria which are disintegrated distal to a peripheral
nerve lesion. The disintegrated mitochondria release specific
mitochondrial DNA (mtDNA) fragments and proteins like
formyl peptides generally termed mitochondrial damage-
associated molecular patterns (mtDAMPs; Krysko et al., 2011).
Formylated peptides are ligands for the formylpeptide receptor
2 (FPR2; Le et al., 2002) while mtDNA activates the toll-like
receptor 9 (TLR9; Zhang et al., 2010).
We hypothesize that mtDAMPs of disintegrated axonal
mitochondria in the immediate aftermath of WD can
stimulate Schwann cells to put out cytoplasmic processes
through the action of the corresponding receptors. In the
experiments presented here, we used the rat RT4-D6P2T
schwannoma cell line as a model for studying the elaboration
of cytoplasmic processes induced by the potential mtDAMPs,
formyl-methionyl-leucyl-phenylalanine (fMLP) and cytosine-
phospho-guanine oligodeoxynucleotide (CpG ODN) known to
be the prototypical ligands of FPR2 and TLR9, respectively (Le
et al., 2002; Chen et al., 2011). In addition, we detected FPR2 and
TLR9 in activated Schwann cells distal to the nerve injury but
close to regenerated axons.
MATERIALS AND METHODS
Cell Culture and Treatment
Rat RT4-D6P2T schwannoma cell line (RT4) was provided by
ATCC. RT4 cells were cultivated in Dulbecco’s Modified Eagle’s
Medium/Nutrient F-12 Ham (DMEM/F12) at 37◦C in a 5%
CO2 atmosphere. The medium was supplemented with 10%
Fetal Bovine Serum (FBS), 2 mM L-glutamine and antibiotics
(100 U/ml penicillin and 100 µg/ml streptomycin; all obtained
from Sigma Aldrich). At approximately 90% confluency, cells
were seeded at a density of 1 × 104 cells/cm2 and harvested in
serum-free medium before treatment.
To determine changes in cytoplasmic process extension,
RT4 cells were stimulated with the appropriate mtDAMPs. fMLP
(Sigma-Aldrich) dissolved in dimethyl sulfoxide (DMSO) as a
100 mM stock solution and maintained at −20◦C was used in
100 nM, 10 µM and 50 µM concentration for 1, 6 and 24 h
and equivalent volumes of DMSO (0.02%, 0.2% and 1%) were
used in controls. To test if the fMLP effect is mediated by FPR2,
a set of cells was preincubated with 1 µM PBP10 (Tocris), a
selective inhibitor of FPR2 (Forsman et al., 2012), for 20 min
before treatment with 50 µM fMLP.
RT4 cells were treated for the same durations, with
immunostimulatory 1 µM CpG ODN (ODN D-SL03, a C class
CpG ODN, 5′-tcg cgaacgttcgccgcgttcgaacgcgg-3′, Invivogen)
directly or following a pretreatment with 1- or 10-fold amounts
of inhibitory ODN (INH ODN) (1 or 10 µM, ODN 4084-F,
5′-cctggatgggaa-3′, Invivogen) for 30 min. Oligonucleotides
tested for absence of bacterial contamination were separately
resuspended in endotoxin-free water to 500 µM stock solution
according to the manufacturer’s instructions, aliquoted and
stored at−20◦C until used.
Immunofluorescent Staining and
Quantitative Analysis of Cytoplasmic
Processes
At the end of the treatments described, cells cultured on slides
in 12-well plates were fixed with 4% paraformaldehyde in
phosphate-buffered saline (PBS) for 5 min, washed three time
with PBS, and permeabilized with cold methanol:acetone (1:1).
The cells were then immunostained with rabbit monoclonal anti-
β-actin (1:200; Cell Signaling) overnight and FITC-conjugated
donkey anti-rabbit affinity-purified secondary antibody (1:100;
Millipore) for 90 min at room temperature. The slides with
cells were washed extensively in PBS and mounted with the
anti-fading mediumMowiol.
To detect FPR2, TLR9 or paxillin expression, portions
of the RT4 cells were immunostained overnight with rabbit
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polyclonal anti-FPR2 (1:100; Novusbio), anti-TLR9 antibody
(1:500; Acris) or a mouse monoclonal antibody recognizing
tyrosine-phosphorylated paxillin (1:1,000; Chemicon). The
immunohistochemical reaction was visualized using TRITC-
conjugated donkey anti-rabbit or anti-mouse affinity-purified
secondary antibodies (1:100; Millipore) for 90 min at room
temperature. Control cells for immunohistochemical staining
were incubated without primary antibody or by substituting
the primary antibodies with the donkey IgG isotype. Cell
nuclei were stained with Hoechst 33342, and the slides were
mounted in aqueous mounting medium (Vectashield; Vector
Laboratories, Burlingame, CA, USA). The stained RT4 cells
were analyzed, and pictures captured using an epifluorescence
microscope (Nikon Eclipse NI-E Motorized Microscope System)
equipped with a Nikon DS-Ri1 camera (Nikon, Prague,
Czechia).
Actin immunostained RT4 cells were used for quantitative
analysis of cytoplasmic processes in response to stimuli. At
least 50 cells were randomly chosen for each experimental
group and the number of cytoplasmic processes per cell was
manually counted using the Count and Taxonomy module
of NIS- Elements software (Nikon, Prague, Czechia) following
curve fitting detection of cell body boundaries. The number of
cytoplasmic processes was measured by a person blind to the
experimental conditions.
Dimethyl sulfoxide was used as a solvent and vehicle for
fMLP. Because it was demonstrated that medium supplemented
with DMSO was enough to induce changes in cell surface area
(Lemieux et al., 2011), we compared number of cell processes
after fMLP treatment to those of cells cultivated in medium
supplemented with DMSO of a corresponding concentration
used for dissolution of fMLP and for the appropriate durations.
Western Blot Analysis
As activated paxillin is involved in the initiation of cytoplasmic
processes outgrowth in the cell (López-Colomé et al., 2017),
we quantified the level of paxillin phosphorylated in tyrosine
positions by western blot analysis in RT4 cells after potential
mtDAMP action. After cultivation in the presence or absence
of stimulants or inhibitors, RT4 cells were washed twice with
ice-cold PBS, mechanically harvested from the culture dishes
and sonicated for 30 s. The samples were centrifuged at
2,000 rpm for 5 min and lysed at 4◦C in buffer containing
80 mM HEPES, pH 7.5; 2.5 M urea, 1 mM EDTA, 0.5%
Triton X-100 and 20 mM β-mercaptoethanol as well as cocktails
of protease and phosphatase inhibitors (Roche, Germany).
Equal amounts of proteins from cell lysates (50 µg/lane)
were separated by SDS-polyacrylamide gel electrophoresis and
transferred to a nitrocellulose membrane (Bio-Rad). After
blocking of nonspecific binding sites with 5% bovine serum
albumin (BSA) in TRIS-buffered saline (pH 7.2) for 2 h,
membranes were incubated with mouse monoclonal anti-
tyrosine-phosphorylated paxillin (1:1,000; Chemicon) at 4◦C
overnight, followed by peroxidase-conjugated anti-mouse IgG
(1:1,000; Sigma, Ronkonkoma, NY, USA) at room temperature
for 1 h. Protein bands were visualized using the ECL detection
kit (Bio-Rad) on a PXi chemiluminometer reader and analyzed
using the GeneTools densitometry software (Syngene). All
analyzed proteins were normalized to β-actin.
Animals and Surgical Treatment
The in vivo experiments were performed in 15 adult male
rats (Wistar, 250–280 g, Anlab, Brno, Czechia) housed on
12 h light/dark cycles at a temperature of 22–24◦C under
specific pathogen-free conditions in the animal housing
facility of Masaryk University. Sterilized standard rodent
food and water were available ad libitum. Animals for
surgical treatments were anesthetized using a mixture of
ketamine (40 mg/ml) and xylazine (4 mg/ml) administered
intraperitoneally (0.2 ml/100 g body weight). All surgical
procedures were carried out under sterile conditions by the
same person according to protocols approved by the Animal
Investigation Committee of the Faculty of Medicine, Brno,
Czechia.
The right ulnar nerve of three rats was exposed in mid-thigh,
ligated with two ligatures and cut. The proximal nerve stump
was buried and fixed in muscles to protect the distal stump
from reinnervation. The right ulnar nerve of three other rats
was exposed for a short segment and crushed with clamp of
a defined force of 1.9 N twice for 1 min (Ronchi et al., 2010)
under a stereological microscope. The distal margin of the crush
injury was indicated with Indian ink and the skin wound was
closed with 5/0 sutures. The ulnar nerve of sham-operated rats
(n = 3) was carefully exposed without any lesion. To demonstrate
a role of p38 and NFkB in downstream signaling pathways of
FPR2 and TLR9, the right ulnar nerve of four rats was crushed
as described above and 10 µl of PBP10 (1 µM; Tocris) or
chloroquine (50µM; InvivoGen) was injected via a micro syringe
into the subarachnoid space of the cisterna magna (Dubový et al.,
2018). The inhibitor of FPR2 (PBP10) or TLR9 (chloroquine)
was dissolved in artificial cerebrospinal fluid (ACSF; Hylden
and Wilcox, 1980). Ten microliter of ACSF was injected in two
control rats. All operated rats were left to survive for 3 days.
Immunofluorescence Staining of Activated
Schwann Cells Distal to Nerve Injury
After the period of survival, the animals were deeply anesthetized
with a lethal dose of sodium pentobarbital (70 mg/kg body
weight, i.p.) and perfused transcardially with 500 ml PBS
(10 mM sodium phosphate buffer, pH 7.4, containing 0.15 M
NaCl) followed by 500 ml of Zamboni’s fixative (Zamboni
and Demartin, 1967). The right ulnar nerves of sham-operated
rats, distal stumps of transected and crushed ulnar nerves were
removed and immersed in Zamboni’s fixative overnight. After
washing with 10% sucrose in PBS, longitudinal cryostat sections
of 10 µm thickness were cut.
The sections were washed with PBS containing 0.05% Tween
20 (PBS-T) and 1% BSA for 10 min, treated with 5% normal
donkey serum in PBS-T for 30 min and immunostained.
The longitudinal sections prepared from nerve segments of
sham-operated animals and nerve segments distal to nerve
transection were incubated under the same conditions with
rabbit polyclonal anti-FPR2 (1:100; Novusbio) or anti-TLR9
(1:500; Acris) primary antibodies and TRITC-conjugated
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 November 2018 | Volume 12 | Article 45751
Korimová et al. Mitochondrial DAMPs and Schwann Cells
and affinity-purified donkey anti-rabbit secondary antibody
(1:100; Millipore). One portion of the sections was double
immunostained for GFAP and FPR2 or TLR9 to detect these
receptor proteins in activated Schwann cells. Briefly, the sections
were incubated with rabbit polyclonal anti-FPR2 or anti-TLR9
antibodies and then with chicken polyclonal anti-GFAP antibody
(1:500; Abcam), in each primary antibody overnight. To visualize
the immunoreaction, the sections were incubated with TRITC-
conjugated and affinity-purified donkey anti-rabbit secondary
antibody, while FITC-conjugated donkey anti-chicken secondary
antibody (both 1:100; Millipore) was used for development of
GFAP immunostaining. Control sections were incubated
without primary antibodies as well as with rabbit or chicken
polyclonal antibodies and treated with FITC-conjugated donkey
anti-chicken or TRITC-conjugated donkey anti-rabbit secondary
antibodies, respectively. No immunofluorescence staining was
observed in the control sections (data not shown).
To visualize activated Schwann cells close to growing axons,
the longitudinal sections distal to ulnar nerve crush were
double immunostained with mouse monoclonal anti-GAP43
(1:500; Sigma) and chicken polyclonal anti-GFAP antibodies.
The immunostaining was visualized with FITC-conjugated
donkey anti-mouse and TRITC-conjugated donkey anti-chicken
secondary antibodies.
For evidence of FPR2 or TLR9 immunopositivity in
cells close to growing axons, the sections were incubated
with mouse monoclonal anti-GAP43 (1:500; Sigma) and
rabbit polyclonal anti-FPR2 (1:100; Novusbio) or anti-TLR9
(1:500; Acris) antibodies. Moreover, double immunostaining
with rabbit polyclonal anti-FPR2 and mouse monoclonal
anti-phosphorylated p38 MAPK (1:100; Santa Cruz) antibodies
as well as mouse monoclonal anti-TLR9 (1:100; Novusbio)
and rabbit monoclonal anti-pNFkB(p65) (1:100; Cell Signaling)
antibodies was used to determine downstream signaling
pathways of FPR2 and TLR9. The nerve sections of ACSF- and
PGP10- or chloroquine-treated rats were double immunostained
under the same conditions. Double immunofluorescence was
developed with corresponding FITC- and TRITC-conjugated
affinity-purified donkey anti-mouse and anti-rabbit secondary
antibodies (1:100; Millipore). Control sections were incubated
without primary antibody.
All sections were stained with Hoechst 33342 to detect cell
nuclei, mounted in aqueous mounting medium (Vectashield;
Vector Laboratories, Burlingame, CA, USA) and analyzed using
an epifluorescence microscope (Nikon Eclipse NI-E Motorized
Microscope System) equipped with a Nikon DS-Ri1 camera
(Nikon, Prague, Czechia).
RESULTS
Quantitative Analysis of Cytoplasmic
Processes in RT4 Cells Induced by fMLP or
CpG
To investigate whether the potential mtDAMPs fMLP or CpG
can induce outgrowth of Schwann cells processes, RT4 cells
were cultured in vitro with 100 nM, 10 µM and 50 µM
concentrations of fMLP or 1 µM CpG ODN for 1, 6 and
24 h. Representative pictures illustrating changes of cytoplasmic
processes in RT4 cells after treatment with fMLP and CpG
in comparison to controls as well as following pretreatment
with the FPR2 inhibitor PBP10 or INH ODN are shown in
Figure 1.
Because fMLP was dissolved in DMSO, it was necessary to
compare values of cytoplasmic processes measured in RT4 cells
after fMLP treatment to control values obtained in RT4 cells
cultivated with the corresponding concentration of DMSO used
to dissolve fMLP. fMLP influenced the formation of RT4 cell
processes very differently under different concentrations and
treatment durations (Figure 1G). No effect on the number
of cell processes was demonstrated in low concentrations of
fMLP (100 nM and 10 µM) after 1 h and 6 h, whereas a
higher concentration of fMLP (50 µM) for the same duration
resulted in a significant increase in the number of cytoplasmic
processes per cell (1 h: 6.2 ± 1.7 vs. 7.4 ± 1.8, p < 0.05;
6 h: 6.7 ± 2.7 vs. 10.0 ± 2.2, p < 0.001). Nevertheless, after
24 h, 100 nM fMLP resulted in a significantly increased number
of cytoplasmic processes per cell (6.7 ± 2.4 vs. 8.4 ± 2.6,
p < 0.05), but higher concentrations (10 µM and 50 µM)
reduced the number of the processes when compared to
controls (Figure 1G). Because the greatest increase in the
number of cytoplasmic processes was induced by 50 µM
fMLP treatment for 6 h, these conditions were used to test
the effect of FPR2 inhibition. A 20 min preincubation with
1 µM PBP10 as an FPR2 inhibitor before 50 µM fMLP
treatment resulted in a significant reduction of cytoplasmic
process outgrowth when compared with the standard treatment
for 6 h (6.9 ± 2.3 vs. 10.0 ± 2.2, p < 0.001; see also
Figure 1C).
CpG ODN treatment for 6 and 24 h induced a significantly
increased number of cytoplasmic processes compared to control
cells (6 h: 7.8± 2.5 vs. 6.1± 1.5, p< 0.05; 8.8± 2.7 vs. 6.9± 2.0,
p < 0.001). However, CpG ODN treatment for 1 h did
not significantly affect the number of cytoplasmic processes
(Figure 1H). A pre-treatment with 1 or 10 µM INH ODN
before 1 or 24 h CpG ODN stimulation unexpectedly resulted
in significantly increased outgrowth of cytoplasmic processes
when compared to control cells or cells treated only with CpG
ODN (Figures 1F,H). In contrast, pre-treatment with 1 or 10µM
INH ODN and subsequent stimulation with CpG ODN for 6 h
caused the expected inhibitory effect and the mean number of
cell processes was reduced when compared with only CpG ODN
treatment (Figure 1H).
Immunohistochemical Detection of FPR2,
TLR9 and Analysis of Activated Paxillin in
RT4 Cells
To prove that fMLP and CpG can induce changes of cytoplasmic
processes in RT4 cells via the corresponding receptors, we
detected FPR2 and TLR9 expression in control and treated
cells. RT4 cells cultured in medium with fMLP (50 µM) for
6 h displayed increased intensity of FPR2 immunofluorescence
in contrast to control cells cultivated in medium only with
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FIGURE 1 | Representative pictures of RT4-D6P2T cells cultivated in control medium (A,D) and medium with 50 µM formyl-L-methionyl-L-leucyl-phenylalanine
(fMLP) (B) for 6 h or 1 µM cytosine-phospho-guanine oligodeoxynucleotide (CpG ODN) (E) for 24 h showing an increased number of cytoplasmic processes.
Preincubation of RT4 cells with the formylpeptide receptor 2 (FPR2) inhibitor PBP10 (1 µM) resulted in a noticeable reduction of cytoplasmic processes in
comparison to only fMLP treatment (C). An additive effect of 10 µM of inhibitory ODN (INH ODN) pre-treatment for 30 min before 1 µM CpG ODN for 24 h on the
development of cytoplasmic processes is shown in (F). After in vitro cultivation and treatment, the cells were fixed and immunostained with rabbit monoclonal
anti-β-actin antibody and FITC-conjugated donkey anti-rabbit secondary antibody. Cell nuclei were stained with Hoechst 33342. Scale bars = 50 µm. (G) The graph
illustrates mean number of cytoplasmic processes per cell of the RT4-D6P2T cell line cultivated for different time periods (1, 6 and 24 h) with fMLP at 100 nM, 10 µM
and 50 µM concentrations and controls (CTR) containing the appropriate volume of dissolved in dimethyl sulfoxide (DMSO). ∗p < 0.05 when compared with DMSO
control, ∗∗p < 0.001 when compared with DMSO control. (H) The graph illustrates mean number of cytoplasmic processes per cell of the RT4-D6P2T cell line
cultivated for different time periods (1, 6 and 24 h) with control medium (CTR), 1 µM CpG ODN (CpG) and cells pre-treated with 1 µM or 10 µM of INH ODN (INH) for
30 min before treating with CpG ODN. ∗p < 0.05 compared with control, ∗∗p < 0.001 compared with control, †p < 0.05 INH ODN pre-treatment compared with
CpG ODN, ††p < 0.001 INH ODN pre-treatment compared with CpG ODN.
the corresponding concentration of DMSO (Figures 2A,B).
Similarly, untreated control RT4 cells displayed a weak
TLR9 immunofluorescence whereas those cultivated in
medium with CpG (1 µM) for 24 h showed a more intense
immunofluorescence (Figures 2C,D).
We also detected phosphorylated paxillin in RT4 cells.
Dot-like immunofluorescence was observed in both control and
treated cells with a marked increase of immunofluorescence
in RT4 cells treated with 50 µM fMLP for 6 h (Figures 3A,B)
or with 1 µM CpG for 6 h (Figures 3C,D). Increased levels
of phosphorylated paxillin in RT4 cells after treatment
with 50 µM fMLP or 1 µM CpG for 6 h as well as
decreased levels after FPR2 inhibition by PBP10 or
inhibitory effect of INH ODN were demonstrated by
western blot analysis (Figure 3E). These altered levels of
phosphorylated paxillin corresponded to changes in numbers
of cytoplasmic processes analyzed at the same conditions
(Figures 1G,H).
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FIGURE 2 | Representative pictures illustrating FPR2 or toll-like receptor 9
(TLR9) immunostaining in RT4-D6P2T cells cultivated in control medium
(A,C, respectively) and increased immunofluorescence intensity after
treatment with 50 µM fMLP for 6 h (B) or 1 µM CpG ODN for 24 h (D). Both
control and treated cells were immunostained under the same conditions with
rabbit polyclonal anti-FPR2 or anti-TLR9 antibody and TRITC-conjugated
donkey anti-rabbit secondary antibody. Cell nuclei were stained with Hoechst
33342. Scale bars = 50 µm.
FPR2 and TLR9 Immunostaining Distal to
Nerve Injury
Longitudinal cryostat sections through the ulnar nerves
from sham-operated rats displayed very low intensity of
FPR2 and TLR9 immunofluorescence (Figures 4A,B). In
contrast, increased intensity of TLR9 and FPR2 immunostaining
was detected in sections cut distal to the nerve transection
(Figures 4C,F). FPR2 or TLR9 immunopositivity was present
in spindle-shaped cells and their processes that also displayed
GFAP immunostaining indicating their Schwann cell origin
(Figures 4D,E,G,H). Double immunodetection showed
p-p38 MAPK immunostaining in FPR2 immunopositive
Schwann-like cells distal to the ulnar nerve crush and
intrathecal administration of ACSF. In contrast, intrathecal
application of PBP10, an inhibitor of FPR2, reduced
markedly immunofluorescence for both FPR2 and p-p38
MAPK (Figures 5A–F). Double immunostaining also
revealed perinuclear pNFkB(p65) immunofluorescence
in TLR9 immunopositive Schwann-like cells after ACSF
administration, while the nerve sections from rats treated with
chloroquine displayed significantly decreased intensity of both
TLR9 and NFkB immunofluorescence (Figures 5G–L).
Activated GFAP-immunopositive Schwann cells were
found close to regenerated axons and their growth cones
distal to ulnar nerve crush (Figures 6A–C). Moreover,
Schwann-like cells with FPR2 or TLR9 immunopositivity
were frequently observed near the regenerated axons and
their growth cones as visualized by GAP43 immunostaining.
Primarily, we could demonstrate increased FPR2 and
TLR9 expression in activated Schwann cells and their
cytoplasmic process close to regenerated axons. Surprisingly,
FIGURE 3 | Representative pictures of RT4-D6P2T cells cultivated in control
medium displayed low immunofluorescence intensity for phosphorylated
paxillin (A,C) in comparison to increased immunofluorescence intensity after
treatment with 50 µM fMLP (B) for 6 h or 1 µM CpG ODN for 6 h (D). The
cells were immunostained with mouse monoclonal antibody recognizing
paxillin phosphorylated in tyrosine positions and TRITC-conjugated donkey
anti-mouse secondary antibody. Cell nuclei were stained with Hoechst 33342.
Scale bars = 50 µm. (E) Upper panel shows a representative western blot of
phosphorylated paxillin (p-paxillin) protein analyzed in RT4-D6P2T cells
cultivated in control medium (−) and the cells after treatment with fMLP
(100 nM, 10 µM and 50 µM) for 6 h or with 1 µM PBP10 preincubation and
treatment with 50 µM fMLP for 6 h. Right-sided set shows a representative
western blot of phosphorylated paxillin (p-paxillin) protein in RT4-D6P2T cells
cultivated in control medium (−) and after 1 µM CpG ODN (+) treatment for
6 h or pre-treatment with INH ODN (1 µM, 10 µM). The graph below illustrates
mean values ± SD of p-paxillin protein density relative to values of untreated
cells from three independent experiments. ∗p < 0.05 when compared to fMLP
or CpG ODN stimulation control, †p < 0.05 when compared to fMLP or CpG
treatment.
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FIGURE 4 | Representative longitudinal sections of the ulnar nerve removed from sham-operated rats (A,B) and distal to the ulnar nerve 3 days after transection
(C–H). The sections were immunostained with rabbit polyclonal anti-FPR2 (A) or anti-TLR9 (B) antibodies as well as double immunostained for FPR2 (C) or TLR9 (F)
and then with chicken polyclonal anti-GFAP antibody (D,G). Immunostaining was visualized with TRITC-conjugated donkey anti-rabbit (A,B,C,F) and
FITC-conjugated anti-chicken secondary antibodies (D,G). Merged pictures showed that GFAP+ activated Schwann cells and their cytoplasmic processes
(arrowheads) displayed immunostaining for FPR2 (E) or TLR9 (H). Cell nuclei were stained with Hoechst 33342. Scale bars = 40 µm.
FIGURE 5 | Representative longitudinal sections of the ulnar nerve distal to nerve crush after 3 days and intrathecal injection of artificial cerebrospinal fluid (ACSF;
A–C, G–I), 1 µM PBP10 (D–F) or 50 µM chloroquine (J–L). The sections were double immunostained for FPR2 (A,D) and p-p38 (B,E) or TLR9 (G,J) and pNFkB
(H,K) under the same condition. Merged pictures revealed co-localization of p-p38 immunostaining in FPR2 immunopositive (C) and pNFkB immunofluorescence in
TLR9 immunopositive (I) Schwann-like cells of rats with ACSF administration (arrowheads). Intrathecal injection of PBP10 or chloroquine significantly reduced
FPR2/p-p38 (D–F) and TLR9/pNFkB (J–L) double immunostaining, respectively. Cell nuclei were stained with Hoechst 33342. Scale bars = 40 µm.
FPR2 or TLR9 immunostaining was also found in regenerated
axons and mainly in their growth cones including filopodia
(Figures 6D–I).
DISCUSSION
Schwann cells play a critical role in axon regeneration following
peripheral nerve injury. Nerve injury-induced activation of
Schwann cells is associated with extension of their cytoplasmic
processes that promote axon growth and guidance of regenerated
axons (Son and Thompson, 1995b; Gomez-Sanchez et al., 2017).
Moreover, elaboration of cytoplasmic processes by Schwann cells
is the main prerequisite for their migration to form a bridge
spanning the gap between the distal and proximal stumps of
severed nerves (Deumens et al., 2010) or other types of peripheral
nerve lesions that then leads to nerve regeneration (Dubový and
Svízenská, 1994; Liu et al., 2016).
Efficient axonal degeneration is essential for subsequent
regeneration and functional recovery after nerve damage (Scheib
and Höeke, 2013). Axonal degeneration of injured peripheral
nerves involves granular degeneration of most axonal structures
including mitochondria (Coleman, 2005; Park et al., 2013).
Peripheral nerve axons contain a huge number of mitochondria
which are a potent source of mtDAMPs as a result of their
disintegration (Krysko et al., 2011). These include formylated
peptides and mtDNA that can induce innate and inflammatory
reactions after tissue damage (Zhang et al., 2010; Monlun et al.,
2017).
fMLP and CpG were chosen as prototypic mtDAMPs for
analyzing their effect on cytoplasmic process formation in
RT4 schwannoma cells cultivated in vitro. Treatment with fMLP
or CpG induced quantitative changes in cytoplasmic process
extension in RT4 cells. The results indicated that formylated
peptides and mtDNA released from mitochondria are involved,
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FIGURE 6 | Representative longitudinal sections of the ulnar nerve distal to nerve crush after 3 days. Longitudinal section of the distal ulnar segment was double
immunostained with chicken polyclonal anti-GFAP (A) and mouse monoclonal anti-GAP43 (B) antibodies. Immunoreaction was visualized with TRITC-conjugated
anti-chicken (A) and FITC-conjugated anti-mouse secondary antibodies (B). Cell nuclei were stained with Hoechst 33342. GFAP immunostained Schwann cells and
their cytoplasmic processes (arrowheads) (A,C) were located close to the GAP43 immunopositive growth cone (arrow) (B,C). Other longitudinal sections were
double immunostained with rabbit polyclonal anti-FPR2 (D) or anti-TLR9 (G) antibodies and mouse monoclonal anti-GAP43 antibody (E,H). Immunoreaction
visualized with TRITC-conjugated donkey anti-rabbit (D,G) and FITC-conjugated donkey anti-mouse (E,H) secondary antibodies revealed that both FPR2 and
TLR9 are present not only in cells close to (arrowheads) but also in growth cones and their processes (arrows) as shown in merged pictures (F,I). Cell nuclei were
stained with Hoechst 33342. Scale bars = 40 µm.
at the very least, in the initiation of cytoplasmic process extension
by Schwann cells distal to nerve injury. This is in line with
published evidence that mtDNA released by degenerating motor
terminals can activate terminal Schwann cells and stimulate
reinnervation of the neuromuscular junction through the MAPK
pathway (Duregotti et al., 2015). In addition to mtDNA, terminal
Schwann cells of degenerated motor terminals can be also
activated by H2O2 triggering specific RNAs (Negro et al.,
2018).
Our in vitro results revealed differences in the elaboration of
cytoplasmic processes by various concentrations and durations
of fMLP treatment. A higher concentration of fMLP (50µM)was
required to increase the number of cytoplasmic processes with a
1 and 6 h treatment, while a lower concentration (100 nM) was
enough with longer exposure (24 h). In contrast, extended (24 h)
exposure to high concentrations of fMLP (10 µM and 50 µM)
had an inhibitory effect on elaboration of RT4 cell processes.
These results suggest that a higher concentration of formylated
peptides is needed for early initiation of cytoplasmic processes,
but low concentration is enough to stimulate the formation of
Schwann cell processes during prolonged exposure. The sort
of fMLP dynamics revealed in vitro affecting the formation of
cytoplasmic processes, may be close to the in vivo situation
during activation of Schwann cells by formylated peptides
during WD.
In contrast to fMLP, 1 µM CpG ODN induced a greater
elaboration of cytoplasmic processes after 6 and 24 h treatment,
while a shorter exposure for 1 h had no effect on the
outgrowth of cytoplasmic processes in RT4 cells. Surprisingly, the
inhibitory effect of INHODNpre-treatment was found only after
subsequent exposure with CpG ODN for 6 h, but 1 h and 24 h
CpG ODN treatment following INH ODN pre-treatment had a
synergistic effect on the formation of cytoplasmic extensions of
RT4 cells. This synergistic effect of INH ODN pre-treatment on
cytoplasmic extensions cannot yet be fully explained and further
experiments are indicated.
Paxillin is an approximately 68 kDa cytoskeletal adaptor
protein required for cell adhesion and outgrowth of cytoplasmic
processes related to cell migration (Vindis et al., 2004; Achuthan
et al., 2006; Romanova and Mushinski, 2011; López-Colomé
et al., 2017). We detected significantly increased levels of
phosphorylated paxillin in RT4 cells after treatment with 50 µM
fMLP and 1 µM CpG ODN for 6 h compared to control cells.
In addition, phosphorylated paxillin protein levels were reduced
by preincubation of RT4 cells with PBP10 or INH ODN in
experimental sets for 6 h corresponding with inhibitory effects on
cytoplasmic process development. Our immunohistochemistry
and western blot results revealed that both fMLP and CpG
treatments for 6 h lead to increased phosphorylated paxillin
levels concomitantly with increased formation of cytoplasmic
processes. This is in agreement with enhanced phosphorylation
of paxillin associated with cytoplasmic processes induced by
fMLP or CpG in other cell types (Leventhal et al., 1997;
Weiner et al., 2001; VanCompernolle et al., 2003; Vindis
et al., 2004; Achuthan et al., 2006; Miyamoto et al., 2012).
Moreover, fMLP is a known chemoattractant stimulating
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cell movement involving cytoplasmic processes (Xu et al.,
2003).
Mitochondrial DAMPs produced by disintegrated
mitochondria can be recognized by pattern-recognition
receptors (PRRs) that include TLRs, FPR2, NOD-like receptors
(NLRs), RIG-I-like receptors (RLRs) and purinergic receptors
(Walsh et al., 2013; Wenceslau et al., 2013). Our results show
that increased immunostaining for FPR2 and TLR9 was induced
in RT4 cells treated with fMLP or CpG as prototypical ligands of
these receptors, respectively. In addition, activated Schwann cells
and their processes distal to nerve injury also displayed increased
levels of both FPR2 and TLR9 indicating that these peripheral
glial cells can react to mtDAMPs such as formylated peptides and
mtDNA released from disintegrated axonal mitochondria during
WD. Schwann cells and their processes positive for FPR2 and
TLR9 immunostaining were frequently found close to growth
cones of regenerated axons after nerve crush. Surprisingly, a
distinct immunoreaction for these receptors was also observed
in the growth cones indicating that these critical structures of
regenerated axons can also react to formylated peptides and
mtDNA present distal to nerve injury. The immunodetection
of FPR2 and TLR9 in RT4 cells, activated Schwann cells
and axonal growth cones indicates the involvement of both
mtDAMP receptors in the overall mechanism of cell process
formation.
It was demonstrated that FPR2 and TLR9 signaling pathway
in glial cells contains activation of p38 MAPK and NFkB,
respectively (Cattaneo et al., 2010; Lacagnina et al., 2018).
To determine signaling events associated with FPR2 and
TLR9 expression in activated Schwann cells after nerve injury,
we used double immunostaining of these receptors with
p-p38 MAPK and pNFkB(p65) in nerve segment distal to
nerve crush after intrathecal administration of vehiculum
(ACSF) in comparison to PBP10 or chloroquine as FPR2 and
TLR9 inhibitors, respectively (Takeshita et al., 2004; Ho et al.,
2018).
Our first observation of FPR2 localization in growth
cones—thus, suggesting involvement of FPR2 signaling in
axonal growth following nerve injury—is confirmed by the
reduction of axon and dendrite outgrowth in developing
hippocampal neurons after in vitro FPR2 inhibition (Ho et al.,
2018). Moreover, FPR2 activation can promote axonal growth
through F-actin polymerization—an important component
of growth cones (Pacheco and Gallo, 2016; Wang et al.,
2016). Besides formylated peptides, activation of FPR2 in
growth cones may also be mediated by lipoxin A4 (LXA4)
produced by myelin degradation during WD (Edström
et al., 1996; De et al., 2003). For example, LXA4 binding
to FPR2 can induce axonal or dendritic outgrowth as was
revealed by treating primary hippocampal neurons with
the FPR2 inhibitor PBP10, resulting in reduced axon and
dendrite lengths (Ho et al., 2018). A role for TLR9 activation
in the regenerating axon is suggested by a significant
increase in both mRNA and protein levels of TLR9 in the
developing mouse brain (Kaul et al., 2012). In contrast to
FPR2, direct evidence for this TLR9 function is not yet
available.
The in vitro results revealed a potentiated effect of INH
ODN pre-treatment on the increased outgrowth of cytoplasmic
processes of RT4 cells mainly following a 24 h CpG ODN
treatment. Surprisingly, an inhibitory effect of INH ODN
pre-treatment was observed on the extension of cytoplasmic
processes at both concentrations used (1 µM, 10 µM), but
only after CpG ODN stimulation of RT4 cells for 6 h. INH
ODNs (e.g., TCCTGGCGGGGAAGT) selectively interfere with
TLR9-mediated immunoactivation by competing with CpG
ODN for binding to the C-terminal region of TLR9 (Avalos
and Ploegh, 2011). Our results of the different efficacy of
INH ODN pre-treatment on the induction of cytoplasmic
processes in RT4 cells following various CpG ODN treatment
times may reflect varying competition between INH ODN
and CpG ODN.
CONCLUSION
We proved that fMLP and CpG ODN act as prototypic
mtDAMPs andmodulate the outgrowth of cytoplasmic processes
of RT4 schwannoma cells in association with increased levels
of phosphorylated paxillin. fMLP and CpG ODN affected
formation of RT4 cell cytoplasmic processes in a dose-
and time-dependent fashion. RT4 cells displayed increased
immunostaining for FPR2 and TLR9 following treatments with
fMLP or CpG, the ligands of these receptors, respectively.
FPR2 and TLR9 immunofluorescence staining was also found
in Schwann cells and their processes distal to nerve injury
and close to growth cones suggesting a possible activation of
the glial cells by mtDAMPs released after nerve injury. In
addition to Schwann cells, both FPR2 and TLR9 were observed
also in growth cones suggesting their involvement in axon
regeneration. The results indicate the involvement of both
FPR2 and TLR9 activation in the general mechanisms of cell
process formation.
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The regenerative capability of peripheral nerves is very limited, and several strategies
have been proposed to increase nerve regeneration. In the present work, we have
analyzed the in vivo usefulness of a novel nanostructured fibrin-agarose bio-artificial
nerve substitute (Nano) used alone or in combination with NeuraGen R© collagen type
I conduits (Coll-Nano) in laboratory rats with a 10-mm sciatic nerve defect. Control
animals were subjected to the gold-standard autograft technique (Auto). Results first
demonstrated that the percentage of self-amputations was lower in Nano and Coll-Nano
groups as compared to the Auto group. Neurotrophic ulcers were more abundant in the
Auto group (60%, with 66.6% of them being >2-mm) than Nano and Coll-Nano groups
(0%) at 4 weeks, although Nano showed more ulcers after 12 weeks. Foot length was
significantly altered in Auto animals due to neurogenic retraction, but not in Nano and
Coll-Nano groups after 12 weeks. At the functional level, all animals showed a partial
sensory recovery as determined by the pinch test, especially in Nano and Auto groups,
but did not reach the levels of native animals. Toe-spread test revealed a partial motor
function recovery only in Nano animals at 4 weeks and Auto and Nano at 12 weeks.
Electromyography showed clear denervation signs in all experimental groups, with few
differences between Auto and Nano animals. After 12 weeks, an important denervation
decrease and an increase of the reinnervation process was found in Auto and Nano
groups, with no differences between these groups. Histological analyses demonstrated
an active peripheral nerve regeneration process with newly formed peripheral nerve
fascicles showing S-100, GAP-43 and myelin in all experimental groups. The peripheral
nerve regeneration process was more abundant in Auto group, followed by Nano
group, and both were better than Coll-Nano group. Muscle histology confirmed the
electromyography results and showed some atrophy and fibrosis signs and an important
weight and volume loss in all groups, especially in the Coll-Nano group (56.8% weight
and 60.4% volume loss). All these results suggest that the novel Nano substitutes used
in in vivo were able to contribute to bridge a 10-mm peripheral nerve defect in rats.
Keywords: peripheral nerve repair, neural tissue engineering, fibrin-agarose hydrogels, in vivo, histology,
mesenchymal stem cells
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INTRODUCTION
Peripheral nerves (PNs) are delicate organs which form a highly
complex network throughout the body connecting the central
nervous system with distal target organs (Topp and Boyd, 2006;
Carriel et al., 2014a). Histologically, PNs are composed by the
nerve tissue or parenchyma and three specialized connective
tissue layers or stroma (Geuna et al., 2009; Carriel et al.,
2014a). The parenchyma is organized in conductive units called
peripheral nerve fibers (PNFs) internally formed by neuronal
axons surrounded by Schwann cells (SCs) and a thin external
basal lamina. PNFs can be myelinated (in which SCs form a
lipid-rich multilayered myelin sheath) or unmyelinated (Carriel
et al., 2017a). About the stroma, PNs are externally covered
by a collagen-rich and vascularized connective tissue layer, the
epineurium. Internally, the parenchyma is organized forming
fascicles which are surrounded by the perineurium. Finally, at
the intrafascicular level, each PNF is surrounded by a loose
connective tissue, the endoneurium (Topp and Boyd, 2006;
Geuna et al., 2009; Carriel et al., 2014a, 2017a).
The structure and function of PNs can be affected by
several pathological conditions, neoplasm and traumatic injuries
(Dahlin, 2008; Moore et al., 2009; Carriel et al., 2014a). Following
structural damage, PNs have a limited capability to regenerate
their components to reestablish the motor, sensory and vegetative
functions. Neoplasm removal and traumatic injuries could
severely affect the PNs structure and function with a negative
impact in the quality of life of patients worldwide. Incomplete
or complete transections of PNs, without loss of substance, are
directly repaired by neurorrhaphy in order to re-establish the
nerve trunk and fascicles continuity with acceptable functional
recovery (Dahlin, 2008; Carriel et al., 2014a). To repair nerve
injuries with loss of substance, the use of nerve grafts (autograft
or allograft) is needed (Campbell, 2008; Dahlin, 2008; Kehoe
et al., 2012; Carriel et al., 2014a,b). Currently, the nerve autograft
is the gold standard treatment to repair critical nerve gaps
(>3-cm of length). This method provides an adequate ECM,
functional SCs and growth factors which promote an efficient PN
regeneration in approximately 50% of these cases (Pabari et al.,
2010; Daly W. et al., 2012; Carriel et al., 2014a). However, the
nerve autograft and especially the nerve allograft, have several
well-known disadvantages (e.g., donor site morbidity, lack of
graft material, possibility of painful neuroma, scarring, sensory
loss, etc.) and their use should be limited to repair nerve gaps
of approximately 5-cm length (Kehoe et al., 2012; Carriel et al.,
2014a).
In this context, the tubulization technique emerged as a
potential alternative for PN repair. The first generations of hollow
nerve conduits, composed by natural or synthetic biomaterials,
showed promising experimental results (Daly W. et al., 2012;
Kehoe et al., 2012; Carriel et al., 2014a). However, once they
started to be used to treat critical nerve gaps in human, failure
results started to be published (Moore et al., 2009; Liodaki et al.,
2013; Carriel et al., 2014a). Tubulization failure can be related
to several factors, but in critical nerve defects, a reduction of
growth factors diffusion occurs with the consequent failure of the
regeneration process (Webber and Zochodne, 2010; Carriel et al.,
2014a). Currently, tubulization is considered a safe treatment in
the repair of non-critical (<3-cm) sensory nerve gaps (Moore
et al., 2009; Wangensteen and Kalliainen, 2010; Boeckstyns
et al., 2013; Carriel et al., 2014a). Due to the limitations and
unsatisfactory results obtained with the nerve grafts and conduits,
current research is focused on the generation of novel tissue
engineering (TE) strategies for PN repair.
Tissue engineering combines cells with biomaterials and
specific growth factors to elaborate tissue-like substitutes for the
replacement or repair of damaged tissues or organs (Sanchez-
Quevedo et al., 2007; Carriel et al., 2014a). In the case
of the peripheral nerve TE (PNTE), the aim is to develop
biological substitutes to promote and/or accelerate the intrinsic
regeneration capability of damaged PNs (Geuna et al., 2010; Daly
W. et al., 2012; Carriel et al., 2014a). Over the recent years, a
wide range of promising TE strategies have been described (see
reviews, Daly W. et al., 2012; Carriel et al., 2014a; Wieringa et al.,
2018). From a physical and structural point of view, important
advances were obtained by the incorporation of aligned
biomaterials or nanofibers to the regenerative microenvironment
(Gu et al., 2014; Pedrosa et al., 2017). From the biological
perspective, authors demonstrated a significant increase of PNs
regeneration through the use of functionalized and biologically
active biomaterials, the incorporation of growth factors and
gene-based therapies and, especially, by the incorporation of
biomaterials containing different cells sources (Zheng and Cui,
2010; Ladak et al., 2011; Lopatina et al., 2011; McGrath et al.,
2012; Carriel et al., 2013, 2017c; Georgiou et al., 2015). These
advances suggest that the closer we get to the biomimetic
regenerative microenvironment and structure, the better results
we obtain (Carriel et al., 2014a; Wieringa et al., 2018).
In the field of TE, our research group developed a natural
and biodegradable hybrid hydrogel composed by human fibrin
and agarose type VII (Alaminos et al., 2006). This fibrin-
agarose hydrogel (FAH) was successfully used to develop
bioengineered cornea (Alaminos et al., 2006), oral mucosa
(Sanchez-Quevedo et al., 2007), skin (Carriel et al., 2012),
cartilage (Garcia-Martinez et al., 2017), PNs substitutes (Carriel
et al., 2013, 2017c) and other tissue-like structures (Campos
et al., 2016, 2017). Regarding the use of FAH in PNTE, these
biomaterials were used alone and in combination with adipose-
derived mesenchymal stem cells (ADMSCs) as intraluminal
fillers of biodegradable NeuraGen R© conduits to repair 10-mm
nerve gap in rats (Carriel et al., 2013, 2017c). These studies
demonstrated that the incorporation of acellular FAH hydrogels
and, especially, FAH containing ADMSCs, provided a suitable
regenerative microenvironment which resulted in a significant
improvement of the clinical, functional, electromyographic and
histological profiles (Carriel et al., 2013, 2017c). These studies
suggest that NeuraGen R© conduits and cellular FAH contributed
synergistically to the PN regeneration process and reinnervation
of distal target organs. Despite these positive results, FAH does
not have the adequate biomechanical properties to be directly
used in PN reconstruction. In this context, it was recently
demonstrated that the biomechanical and structural properties
of FAH can be significantly improved in a controlled manner
with the nanostructuration technique (Campos et al., 2016, 2017).
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This methodology promotes nanoscale molecular interactions
among the biomaterial fibers, and it was recently applied to
generate novel nanostructured fibrin-agarose bio-artificial nerve
substitutes (NFABNS) (Carriel et al., 2017d). This fabrication
process allowed to successfully recreate the size and shape of PNs
with promising structural and biomechanical properties (Carriel
et al., 2017d). In addition, ex vivo characterization demonstrated
that NFABNS were cytocompatible, supporting human ADMSCs
viability, proliferation and function over the time (Carriel et al.,
2017d). However, the potential clinical usefulness of NFABNS has
not been studied yet.
Due to the promising structural and biological properties
offered by novel NFABNS for PN reconstruction, and in view of
the putative synergetic effects of FAH and NeuraGen R© collagen
conduits, we have carried out an in vivo study to determine the
usefulness of these devices in PN repair. For these reasons, the
aim of this study was to evaluate the possibility to bridge 10-mm
nerve gaps in rats by using NFABNS and NFABNS as intraluminal
fillers of NeuraGen R© conduits. Furthermore, the PN regeneration
profile was determined through the use of clinical, functional,
electromyography, histological, and ultrastructural studies.
MATERIALS AND METHODS
Laboratory Animals
In this study, 20 male 13-week-old Wistar rats weighing
250–300 g (at the beginning) were obtained from JANVIER
LABS R© and kept under veterinary and technical supervision
in the animal facility of the University Hospital Virgen de las
Nieves, Granada, Spain. Animals were housed in a light and
temperature-controlled room (∼21◦C and 12 h light/dark) with
ad libitum access to standard rat chow and tap water. In this
study, 15 animals were subjected to surgical procedures using
general anesthesia by intraperitoneal injection of a mixture of
acepromazine -Calmo-Neosan R© 0.001 mg per g of weight of the
animal-, ketamine -Imalgene 1000 R© 0.15 mg per g of weight-
and atropine −0.05 µg of per g of weight-. At the beginning
of the study, we harvested a small biopsy (∼1-cm3) from the
inguinal pad fat for isolation of autologous ADMSCs. Once
enough amounts of ADMSCs were obtained, PNs substitutes
were generated. In addition, five healthy animals were used as
control native (CTR-Native). At the end of this study, all animals
were euthanatized by overdose of anesthesia. All procedures
were performed according to the European Union and Spanish
Government guidelines for the ethical care of animals (EU
Directive No. 63/2010, RD 53/2013) and the research projects
were approved by the ethical and experimentation committee of
Granada (FIS PI14/01343 and FIS PI17/0393).
Adipose-Derived Mesenchymal Stem
Cells Isolation and Culture
The autologous ADMSCs were isolated and cultured following
previously described protocols (Carriel et al., 2013, 2017d).
Concisely, adipose tissue biopsies were mechanically fragmented
into small pieces and digested with 0.3% type I collagenase
solution (Gibco BRL Life Technologies) for 8 h at 37◦C. Once
the ECM was digested, the cells were isolated by centrifugation
and then cultured in basal medium [Dulbecco’s modified
Eagle’s medium (DMEM)] supplemented with 10% fetal bovine
serum (FBS; Sigma-Aldrich) and antibiotic-antimycotics cocktail
solution (100 U/ml penicillin G, 100 µg/ml streptomycin,
and 0.25 µg/ml amphotericin B, Sigma-Aldrich, Steinheim,
Germany). Cells were kept under standard culture conditions
(37◦C and 5% CO2), the culture media was renewed every 3 days
and cells expanded until passage 4.
The stemness profile of the rat ADMSCs used was determined
by flow cytometry and immunofluorescence as previously
reported (Sun et al., 2011; Lotfy et al., 2014). Flow cytometry
was performed using a NovoCyte R© 1000 Flow Cytometer (ACEA,
Biosciences Inc., United States) and cells demonstrated to be
positive for CD 90 (99.43%) and CD 29 (99.67%) and negative
for CD 45 (0.07%) markers. Immunofluorescence representative
images and the technical information of the antibodies used can
be found in Figure 1 and Table 1, respectively.
Fabrication of NFABNS
First, FAHs containing ADMSCs were elaborated following
previously described protocols (Carriel et al., 2013, 2017d).
Briefly, to prepare 10 ml of FAH a mixture composed by
7.6 ml human plasma, 0.15 ml tranexamic acid (Amchafibrin,
Fides-Ecofarma, Valencia, Spain) and 1.25 ml of basal medium
containing ADMSCs (5 × 104 cells/ml) was prepared. This
solution was mixed and 1 ml of 2% CaCl2 and 0.5 ml of melted
2% type VII agarose were added, carefully mixed, placed in
60-mm petri dishes and kept under standard culture condition
until complete gelation (∼1 h). This procedure resulted in the
generation of 10 ml of uniform FAH containing ADMSCs with
specific dimensions (5-mm of thickness and 6-mm of diameter).
After gelation, 5 ml of basal medium was added to each construct
and they were kept in culture for 24 h and then used for the
fabrication of NFABNS.
To generate the NFABNS, we followed a well-described
protocol, which allowed us to produce customized substitutes
with specific biomechanical properties and dimensions ensuring
the cellular viability and functionality (Carriel et al., 2017d).
Briefly, to fabricate these NFABNS, FAHs were carefully
harvested from the petri dishes and then nanostructured.
Hydrogels were cut symmetrically (3-cm × 3-cm × 3-cm)
and then placed between a couple of nylon filters membranes
(0.22 µm) and Whatman 3-mm absorbent papers below a
flat glass surface. Immediately, a uniform and homogeneously
distributed mechanical pressure (500 g) was applied for 2.5 min
obtaining a highly dense nanostructured FAH (NFAH) of
50–60 µm thickness (Scionti et al., 2014; Carriel et al., 2017d)
(Figure 1). At this point, it was possible to fabricate NFABNS
with specific dimensions (length and/or diameter) or number
of fascicles (uni-fascicular or multi-fascicular) (see examples
of each in Figure 1). Here, unifascicular NFABNS composed
by multilayered NFAH of 1-cm long and ∼1.5-mm or 1-mm
diameter were generated based on the dimensions of the adult rat
sciatic nerve, and according to the length of the nerve gap created
(10-mm).
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FIGURE 1 | ADMSCs characterization and NFABNS generation. (A) Shows representative images of the immunostaining pattern of stemness markers of the rat
ADMSCs. (B) Shows how from a square uncompressed FAH it is possible to fabricate a cylindrical multilayered NFABNS of desire dimensions. (C) Exhibit the
histological pattern of NFABNS, ADMSCs distribution with HE and the presence and percentages of proliferating cells (cell proliferation index) detected by
immunohistochemistry for PCNA and Ki-67 markers, respectively. (D) Shows the macroscopic and scanning electron microscopy aspect of the NFABNS used to
repair the nerve defect in this study. In (E) scanning electron microscopy images show examples of multifasciculated NFABNS that can be generated with this
methodology if needed.
This methodology allowed us to generate NFABNS with
0.30 ± 0.04 MPa of Young’s Modulus, 0.42 ± 0.03 MPa
of stress at fracture and 169.6 ± 9.85% strain at fracture
(deformation) mean values, as previously characterized (Carriel
et al., 2017d). Furthermore, to ensure the viability of the
ADMSCs contained in the NFABNS, cell proliferation was
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TABLE 1 | Antibodies used for flow cytometry and immunostaining.
Antibody Dilution Pretreatment Application Cat. No.
FITC/Mouse monoclonal anti-CD90 1:300 – FC BioLegend, San Diego, CA, United States
(Clone OX-7) 1:200 IF cat. no. 202503
PerCP/Cy5.5/Hamster 1:75 – FC BioLegend, San Diego, CA, United States
anti-CD-29 1:50 IF cat. no. 102227
PE/Mouse monoclonal anti-CD-45 1:100 – FC/IF BioLegend, San Diego, CA, United States cat.
no. 202207
Mouse monoclonal anti-PCNA (clone
PC10)
1:1000 Citrate buffer, pH 6, 95◦C for 25 min IHC Sigma-Aldrich, Steinheim, Germany cat. no.
P8825
Rabbit monoclonal anti-Ki67 – EDTA buffer pH 9, 95◦C for 25 min IHC Master Diagnostica, Granada, Spain cat. no.
MAD-000310QD
Rabbit polyclonal anti-S100 1:400 Citrate buffer, pH 6, 95◦C for 25 min IHC Dako Cytomation, Glostrup, Denmark cat. no.
Z0311
Rabbit polyclonal anti-GAP-43 (ab-41) 1:50 EDTA buffer, pH 9, 95◦C for 25 min IHC Sigma-Aldrich, Steinheim, Germany cat. no.
Sab4300525
Horse anti-mouse/rabbit IgG
(peroxidase)
– – IHC Vector Laboratories, CA, United States cat. no.
MP-7500
FC, flow cytometry; IF, immunofluorescence; IHC, immunohistochemistry.
determined by immunohistochemistry for PCNA and Ki-67 after
48 h of culture (Figure 1) as described previously (Carriel
et al., 2017d). In this sense, the cell proliferation index of the
ADMSCs was 71.72% for PCNA and 76.32% for Ki-67. The
technical information of the antibodies used is summarized in the
Table 1.
Surgical Procedures and Experimental
Study Groups
Initially, 15 animals were subjected to general anesthesia (as
described above) and then a segment of 10-mm was removed
from the left sciatic nerve. The right hind leg was used as non-
operated control in all cases (CTR). Animals were then randomly
assigned to the following experimental groups (n = 5 in each):
- Autograft control group (Auto), where the removed
fragment of the nerve was rotated 180◦ and used to bridge
the nerve gap.
- Nano group (Nano), in which the nerve gap was
microsurgically bridged by using 10-mm NFABNS of
∼1.5-mm diameter.
- Collagen Nano group (Coll-Nano), where the nerve
defects were repaired with NeuraGen R© collagen type I
conduits (Integra R© Life Sciences Corp., Plainsboro, NJ,
United States) filled with an NFABNS of 10-mm of∼1-mm
diameter.
- Control native (CTR-Native), where healthy animals were
used for comparisons.
For all surgical procedures 7/0 Prolene (polypropylene,
blue monofilament) suture material was used. After the nerve
microsurgical repair and wound closure, all animals were housed
as mentioned above and each one received analgesic treatment
(metamizole) in the drinking water for 48 h. In this study,
animals were subjected to a two-time clinical assessment and
electromyography (EMG) at 4 and 12 weeks after surgery,
respectively. The analyses at 4 weeks were performed to confirm
the clinical and functional impact of nerve injury, whereas the
aim of the 12 weeks evaluation was to accurately determine
differences among groups during an active regeneration and
partial functional recovery, as recommended in the literature
(Geuna, 2015). Following the second EMG, animals were housed
for other 14 days and then euthanized. This period was used
to favor muscle healing (hemorrhage and inflammation due to
the EMG) for further morphometric and histological analyses.
Therefore, all histological analyses were performed at 14 weeks
after surgery.
The NeuraGen R© conduits were chosen due to their well-
known positive impact on PNs regeneration when combined with
FAH and ADMSCs (Carriel et al., 2013, 2017c). Furthermore,
these conduits are FDA approved and they are currently
one of the most frequently used nerve guides in the clinical
practice (Wangensteen and Kalliainen, 2010; Krarup et al.,
2017).
Clinical Assessment
In order to determine the sensory and motor function profile
after PN repair, animals were subjected to a series of well-
known tests at 4 and 12 weeks after surgery (Vleggeert-
Lankamp, 2007; Siemionow et al., 2011; Carriel et al., 2013). In
this regard, the following analyses were performed: evaluation
of toes self-amputations in the operated leg; the percentage
and size of plantar neurotrophic ulcers (≤2-mm/>2-mm);
the foot length (in mm), as indicator of the neurogenic
retraction of the muscles innervated by the sciatic nerve;
the pinch test of sensory recovery; and the toe-spread
test.
For the pinch test, a mild pinching stimulus was applied to
the skin of the operated leg from the toe to the knee joint, until
a withdrawal reaction was observed. This reaction was graded
on a four-point scale as follows: 0 = no withdrawal response,
1 = response to stimulus above the ankle, 2 = response to
distal stimulation to the ankle in the heel/plantar region and
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3 = response to stimulation in the metatarsal region as previously
described (Siemionow et al., 2011; Carriel et al., 2013).
The toe-spread test consisted in the evaluation of the extension
and abduction reaction of the toes during tail-suspension. These
results were graded on a four-point scale as follows: 0 = no toe
movement, 1 = some sign of toe movement, 2 = toe abduction,
and 3 = toe abduction with extension (Vleggeert-Lankamp, 2007;
Siemionow et al., 2011; Carriel et al., 2013).
For foot length, the rat’s hind feet were dipped in a blue
ink, and the animals were permitted to walk down the walking
pathway on a Plexiglas R© device (1-m length, 10-cm width
and 15-cm height) covered with white paper, leaving its hind
footprints on the paper. The foot length was measured as the
distance from the heel to the third toe.
Electromyography
All animals were subjected to EMG tests 4 and 12 weeks
after the surgical procedure as previously described (Carriel
et al., 2013). Briefly, animals were mildly anesthetized (1/10
of the doses used for general anesthesia) with ketamine and
acepromazine to study the muscle function at rest. Furthermore,
the spontaneous electrical activity of the gastrocnemius (lateral
and medial) and tibialis anterior muscles was determined.
These muscles were analyzed using concentric-needles and
a Topas 4-channel electromyograph (Schwarzer GmbH R,
Munich, Germany) with band-pass filter settings of 5–5,000 Hz.
Each muscle was subjected to three measurements in three
different areas. Denervation and reinnervation results were
scored using a four-point scale as follows: 0 = absent
(no signs in any of the three muscle areas); 1 = mild
(signs in one of the three areas); 2 = moderate (signs
in two areas), or 3 = severe (signs in all three areas).
These analyses were carried out and interpreted by three
independent experts (EM, SGG, JAS) blinded to the experimental
groups. The percentage of animals with specific denervation
or reinnervation degrees was calculated for each study group.
The right leg of each operated animal (CTR) and both legs
of independent unoperated animals (CTR-Native) were also
analyzed as controls.
Muscle Morphometric Evaluation
In order to assess the degree of atrophy of the muscles
innervated by the operated left sciatic nerve, the weight
(w) and volume (v) of the whole lower leg was measured
at 14 weeks after surgery. Lower legs were harvested after
the intracardiac perfusion (see details below). The lower legs
[which contain several muscles exclusively innervated by the
sciatic nerve trunk (Greene, 1968)] were exposed and then
disjointed from the knee and ankle. For the w assessment,
the dissected legs were removed from the fixative, dried in
absorbent paper and weighed in a digital weighing machine
(Sartorius BP 121S, precision: 0.1 mg, Sigma–Aldrich). For
the v assessment, dissected legs were immersed in test tube
(50 ml) containing 30 ml of PBS and the increase of this
volume represented the lower legs volume. In this study, the
percentage of w and v loss was calculated between the operated
and the contralateral-side leg from each animal, including healthy
animals (CTR-Native), and these values were used for statistical
comparisons.
Macroscopy, Histological, and
Ultrastructural Analyses
First, animals under general anesthesia received an
intraperitoneal heparin injection and then were euthanized
by anesthesia overdose. After that, animals were perfused with
500 ml of saline solution followed by 500 ml of 4% neutral
buffered paraformaldehyde. Perfused animals were used to
evaluate the macroscopic aspect of the repaired nerves and then
nerves, implants and muscle were harvested for histology.
Macroscopic analysis was aimed to evaluate nerve continuity,
uniformity, adherences, or inflammatory reactions. For the
histological analyses, healthy PNs and implants were carefully
harvested, sectioned transversally and the central portion was
obtained for light and transmission electron microscopy (TEM)
analyses. For light microscopy, samples were immersed in
fixative for another 24 h. In the case of muscles, following the
morphometric evaluation (described above), the tibialis anterior
and gastrocnemius muscles were dissected from both legs.
Muscles were immersed in fixative for 24 h, sectioned transversely
and then fixed for another 24 h (a total of 48 h of chemical
fixation). All fixed tissues were placed in histological cassettes
embedded in paraffin and sectioned at 5 µm of thickness (Carriel
et al., 2017a,b).
In this study, all sections were stained with Hematoxylin
and eosin (HE) for general histology. In addition, the MCOLL
histochemical method was used to evaluate the general histology
during the remyelination and collagen fibers reorganization
processes in PNs and implants as described previously (Carriel
V. et al., 2011; Carriel et al., 2013, 2014b, 2017a). The presence
of SCs and newly formed axonal sprouts were evaluated by
indirect immunohistochemistry for S-100 protein and GAP-43,
respectively, as previously described (Carriel et al., 2013, 2014b,
2017c).
In order to determine the degree of muscle atrophy and
fibrotic stromal reaction due to PN repair, the transversal sections
of the tibialis anterior and gastrocnemius muscles were stained
with picrosirius (PS) and Masson trichrome (MST) methods
(Carriel V.S. et al., 2011; Philips et al., 2018b). Furthermore,
histological sections from healthy muscles were used as native
control.
For TEM analysis small tissue samples were obtained
immediately after intracardiac perfusion and postfixed with
2.5% neutral buffered glutaraldehyde followed by 2% osmium
tetroxide (Carriel et al., 2017d). Fixed samples were dehydrated,
embedded in epoxy resin. Ultrathin sections were stained with
uracil acetate and lead citrate, transferred to mesh grids and
analyzed in a JEOL JEM 1200 EX II or a Carl Zeiss SMT LIBRA R©
120 PLUS transmission electron microscopes.
Statistical Analyses
All quantitative data obtained from clinical assessments and
muscle morphometry were analyzed using the Shapiro–Wilk
test of normality. All non-normally distributed variables
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(toe spread, pinch test, volume loss, weight loss, electromyogram
results) were compared with the Mann–Whitney non-parametric
test. In the case of ulcers and amputations, variables which
were expressed in percentage, the Fisher exact test was used
for statistical comparisons. In all cases, p < 0.05 values were
considered statistically significant in two-tailed tests. All data
and statistical comparisons were calculated with the SPSS 16.0
software.
RESULTS
Implantation and Macroscopic
Postsurgical Aspect
In this study, one of the aims was to determine if, from the
structural and surgical perspective, the NFABNS (Nano) and
the NFABNS used as intraluminal fillers of collagen conduits
(Coll-Nano) were suitable alternatives to bridge a 10-mm sciatic
nerve gap in rats. The methodology used allowed to generate
NFABNS with comparable size (length and diameter), shape
and consistency than the target nerves. From the surgical point
of view, NFABNS were easy to handle during implantation
process and allowed us to repair the nerve gaps in a comparable
time and technique than nerve autograft (Figure 2). Regarding
the Coll-Nano group, the NFABNS were easily incorporated as
intraluminal fillers of collagen conduits during surgery, and the
defects were repaired by using the conventional tubulization
technique without any technical inconvenience. After 14 weeks
of in vivo implantation the Auto group showed a complete
repair of the defects without any sign of structural damage,
although a loose connective tissue was observed covering the
repaired area (Figure 2). In the case of the Nano group, the
macroscopic analysis revealed that NFABNS allowed to bridge
the nerve defects successfully without signs of adherences or
local adenopathies (Figure 2). Similarly, the postsurgical analysis
confirmed that collagen conduits with NFABNS were able to
successfully bridge the gap and the collagen conduits remained
in the surface without any adherence, compression or conduit
deformation (Figure 2).
Clinical Results
In this study, clinical and functional parameters were evaluated at
4 and 12 weeks after PN repair, and results are shown in Table 2.
The percentages of self-amputations at 4 weeks were higher in
Auto group (80%) as compared to Nano and Coll-Nano groups
(20% each). However, differences were not statistically significant
between experimental groups, except for the comparison between
Auto vs. CTR-native group (p < 0.05, Table 2). Interestingly,
the percentage of self-amputations increased in the Nano and
Coll-Nano groups (reaching to 60% and 40%, respectively),
and differences were only significant for comparisons between
CTR-Native group vs. Auto and Nano groups (p < 0.05,
Table 2).
Assessment of plantar neurotrophic ulcers after 4 weeks
revealed that only animals from Auto groups developed these
injuries (60% of animals), being these values significantly higher
(p < 0.05) than Nano and Coll-Nano groups, where these
injuries did not occur. In addition, the 66.6% of these ulcers
FIGURE 2 | Implantation and postoperative aspect of repaired sciatic nerves. These images show the macroscopic aspect of repaired nerves and the postoperative
results for autografts (Auto), NFABNS (Nano) and collagen conduits filled with one NFABNS (Coll-Nano). In all cases the nerve gap was successfully bridged after 14
weeks. In Coll-Nano group, the collagen conduits were first sutured in one of the nerve stump, filled with one 1-mm diameter NFABNS (arrow) and then the opposite
nerve stump was inserted and sutured into the conduits. Please note that all images at 14 weeks were taken after perfusion.
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TABLE 2 | Quantitative clinical and functional recovery results.
Groups
n = 5 each
% Self-amputations % Neurotrophic
ulcers
% Neurotrophic ulcers
(>2 mm)
Foot length (mm) Pinch test Toe spread test
4 weeks postsurgical analyses
CTR-native 0.00 0.00 0.00 – 3.00 ± 0.00 3.00 ± 0.00
Auto 80.00a 60.00a,b,d,e 66.67a,b,d,e – 1.60 ± 0.55a,e 0.00 ± 0.00a
Nano 20.00e 0.00b,e 0.00b – 2.00 ± 0.71a,c,e 0.40 ± 0.55a
Coll-Nano 20.00e 0.00d 0.00d – 0.80 ± 0.84a,c 0.00 ± 0.00a
12 weeks postsurgical analyses
CTR-native 0.00 0.00 0.00 39.17 ± 2.04 3.00 ± 0.00 3.00 ± 0.00
Auto 80.00a 20.00e 100.00a,b,d,e 34.01 ± 2.47a,d 1.00 ± 0.71a,e 0.20 ± 0.45a
Nano 60.00a,e 40.00e 50.00b,e 37.39 ± 2.57 1.6 ± 0.55a,e 1.00 ± 0.71a,c
Coll-Nano 40.00e 0.00 0.00d 40.04 ± 1.67d 1.40 ± 0.55a 0.00 ± 0.00a,c
The table shows all quantitative results conducted at 4 and 12 weeks followed peripheral nerve repair. Self-amputations and neurotrophic ulcers results are expressed
in percentage, while the foot length, pinch and toe spread tests results are shown as mean ± standard deviation values. In this study, p < 0.05 values were considered
statistically significant in two tailed tests. Significant differences are indicated as follows: aSignificant differences with CTR group. bSignificant differences between Auto
vs. Nano group. cSignificant differences between Nano vs. Coll-Nano group. dSignificant differences between Auto vs Coll-Nano group. eSignificant differences between
4 weeks vs 12 weeks for each condition.
(Auto group) were higher than 2-mm (Table 2). The analysis
after 12 weeks showed a decrease of the presence of ulcers
in the Auto group (from 60 to 20%) and an increase in the
Nano group (from 0 to 40%), while in Coll-Nano group values
were not altered (0%). However, differences among groups
were not statistically significant (Table 2). Curiously, 100%
of ulcers of Auto group and the 50% of Nano group were
higher than 2-mm, being the differences between Auto vs.
Nano and Coll-Nano groups statistically significant (p < 0.05,
Table 2).
Evaluation of neurogenic retraction of the muscles innervated
by the sciatic nerve was evaluated through the measurement
of foot length at 12 weeks. This analysis revealed lower foot
length values, meaning neurogenic retraction, in Auto group
(34.01-mm), followed by the Nano Group (37.39-mm) and
then the Coll-Nano group (40-mm). Differences were only
significant for comparisons between CTR-Native group vs.
Auto group and for Auto vs. Coll-Nano group (p < 0.05,
Table 2).
The pinch test of sensory recovery after 4 weeks showed
higher values, better sensory recovery, in Nano group (2/3),
than the Auto (1.6/3) and Coll-Nano (0.8/3) groups. Although
signs of sensory recovery were observed, especially in Nano
group, these values were significantly lower (p < 0.05) than
the sensory reaction observed in healthy animals (CTR-Native
group) (3/3). In addition, when we compared these values
between experimental groups differences between Auto vs. Nano
group were not significant (p > 0.05), but differences were
statistically significant when we compared Nano vs. Coll-Nano
groups values (p < 0.05, Table 2). The pinch test of sensory
recovery after 12 weeks showed a slight decreased of these values
in the Auto (from 1.6/3 to 1/3) and Nano (from 2/3 to 1.6/3)
groups and a slight increase in Coll-Nano group (from 0.8/3
to 1.4). Differences among these groups were not statistically
significant (p > 0.05, Table 2), and all operated animals showed
significantly lower values than the CTR-native group (p < 0.05,
Table 2).
Finally, assessment of the motor function of digital
muscle with the toe spread test revealed that all operated
animals were far to be comparable to the motor response
of healthy animals at 4 and 12 weeks, and differences were
statistically significant (p < 0.05, Table 2). Interestingly, after
4 weeks slight signs of motor function were only observed in
Nano group (0.4/3), but these values were not significantly
higher (p > 0.05) than the values observed in Auto and
Coll-Nano groups (Table 2). When motor function was
evaluated after 12 weeks these values were increased in
the Nano group (from 0.4/3 to 1/3) and slight increase in
the Auto group (from 0/3 to 0.2/3), but no signs of motor
function recovery were observed in Coll-Nano group (0/3),
which was significantly lower than Nano group (p < 0.05,
Table 2).
Electromyography Results
First, the analysis of the right leg of each operated animal (CTR)
and both legs of independent animals not subjected to surgery
(CTR-Native group) revealed a normal recruitment pattern with
normal motor unit potentials and no spontaneous activity at
rest. In contrast, the EMG analysis of the experimental groups
showed a wide variation of denervation and reinnervation signs
(Table 3).
At a follow-up period of 4 weeks, most experimental
groups showed clear signs of denervation (Table 3). The
percentage of muscle denervation (gastrocnemius and tibialis
anterior) was more severe in the Coll-Nano group (100% of
tibialis anterior and gastrocnemius medial muscles were severely
denervated) followed by Nano and Auto group, respectively
(Table 3). Differences were statistically significant for the
comparison of Coll-Nano group vs. Auto group for all analyzed
muscles (p < 0.05) and for the gastrocnemius muscle for the
comparison of Nano vs. Auto groups (p < 0.05). Curiously,
some signs of reinnervation in the gastrocnemius and tibialis
anterior muscles were observed in Auto group at this stage
(Table 3).
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TABLE 3 | Electromyography profile of muscles innervated by repaired sciatic nerves.
Groups n = 5 each Muscles % Denervation % Reinnervation
0 1 2 3 0 1 2 3
Electromyography after 4 weeks of peripheral nerve repair
Auto Gastrocnemius lateral 40 40 20 0 0 67 33 0
Gastrocnemius medialc 0 80 20 0 0 100 0 0
Tibialis anteriorc 0 20 80 0 0 100 0 0
Nano Gastrocnemius laterala,f 0 20 40 40 100 0 0 0
Gastrocnemius mediald,f 20 0 40 40 100 0 0 0
Tibialis anteriord,f 0 20 0 80 100 0 0 0
Coll-Nano Gastrocnemius laterala 0 0 20 80 100 0 0 0
Gastrocnemius mediala,c,d 0 0 0 100 100 0 0 0
Tibialis anteriora,c,d 0 0 0 100 100 0 0 0
Electromyography after 12 weeks of peripheral nerve repair
Auto Gastrocnemius lateral 100 0 0 0 0 60 40 0
Gastrocnemius medialc 0 100 0 0 20 40 40 0
Tibialis anteriorc 100 0 0 0 20 60 20 0
Nano Gastrocnemius laterala,b,f 0 60 40 0 0 60 40 0
Gastrocnemius medialb,f 20 40 40 0 0 80 20 0
Tibialis anteriora,f 0 20 80 0 0 80 20 0
Coll-Nano Gastrocnemius laterala,b,d 0 0 60 40 60 40 0 0
Gastrocnemius mediala,b,c 0 20 20 60 80 20 0 0
Tibialis anteriora,c 0 20 60 20 60 40 0 0
Results are shown as the percentage of animals of each experimental group with specific denervation or reinnervation signs in the gastrocnemius (lateral and medial)
and tibialis anterior muscles at 4 and 12 weeks after surgery. Each muscle was subjected to three measurements in three different areas, and the results were scored as
follows: 0 = absent (no signs in any of the three muscle areas); 1 = mild (signs in one of the three areas); 2 = moderate (signs in two areas), or 3 = severe (signs in all three
areas). In this study, p < 0.05 values were considered statistically significant in two-tailed tests. Significant differences are indicated as follows: aSignificant differences in
denervation results with Auto group for each time. bSignificant differences in denervation between Nano group vs. Coll-Nano group for each time. cSignificant differences
in denervation between 4 weeks vs. 12 weeks for each group. dSignificant differences in reinnervation results with Auto group for each time. eSignificant differences in
reinnervation between Nano group vs. Coll-Nano group for each time. fSignificant differences in reinnervation between 4 weeks vs. 12 weeks for each group.
Analysis of animals after 12 weeks after the surgical procedure
revealed significant changes in the percentage of denervation and,
specially, in the reinnervation profile of all experimental groups
(Table 3). In the Auto group, a significant decrease of the muscle
denervation percentage was observed for all muscles, and none
of the animals showed denervation signs for the gastrocnemius
medial and tibialis anterior muscles at this time. These values
were accompanied by a slight, but not statistically significant
(p > 0.05, Table 3), increase of the reinnervation profile in this
Auto group. The EMG profile of the Nano group revealed a
slight non-significant decrease of the denervation profile, with
none of the muscles being severely denervated after 12 weeks.
In this group of animals, we found a significant improvement
(p < 0.05) of the reinnervation profile of all muscles at 12 weeks
of follow-up, and the reinnervation profile of the gastrocnemius
lateral muscle was comparable to the Auto group at this time
(Table 3). Although differences were non-significant (p > 0.05),
the reinnervation profiles of gastrocnemius medial and tibialis
anterior were slightly superior in Nano group as compared to
the Auto group (Table 3). Finally, the analysis of the Coll-
Nano animals at 12 weeks demonstrated a slight non-significant
improvement (p > 0.05) of the denervation profile found after
4 weeks. However, none of the muscles showed reinnervation
signs and did not differ from results found at the previous stage
(Table 3).
Peripheral Nerve Regeneration Histology
and Ultrastructure
The histological analysis carried out with HE staining at 14
weeks of the middle portion of repaired nerves confirmed an
active regeneration process in all experimental groups. In the
case of nerve gaps repaired with autograft technique (Auto
group), the regeneration process was observed mainly at the
intrafascicular level, but also in the epineural connective tissue
of the graft. In this group, the process was characterized by
the presence of relatively small newly formed nerve fascicles
containing PNFs. Furthermore, no sign of inflammatory reaction
was find in any animals (Figures 3A,B). Interestingly, it was often
observed a variable number of regenerating fascicles between
the surrounding rhabdomyocytes confirming some degree of
dispersion of the PN regeneration process (Figure 3B, inset). The
HE analysis of the implanted NFABNS (Nano group) confirmed
that these novel substitutes supported an active an abundant PNs
regeneration process (Figures 3A,B). Regeneration took place
through the connective tissue covering the implanted substitutes
with a similar histological pattern than the observed in the auto
group, meaning the presence of newly formed nerve fascicles
and PNFs. In addition, like in Auto group, some degree of PN
regeneration was also observed associated to the surrounding
muscle tissues (Figure 3B, inset). Concerning the implanted
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FIGURE 3 | Microscopic results of peripheral nerve regeneration and biomaterials biodegradation. Figures show HE cross-section staining at low (A) and middle
magnifications (B,C) from the central portion of repaired nerves by autografts (Auto), NFABNS (Nano) and collagen conduits filled with NFABNS (Coll-Nano). In
addition, a representative transversal histological section of a healthy nerve (CTR) was included. In (A) a general overview of the regeneration process is provided,
where nerve regeneration is indicated as (nr) in all groups. In Nano and Coll-Nano groups the active biodegradation of FAH is indicated with (biod.) whereas the
collagen conduit in Coll-Nano with (cc). Images in (B) show with moderate magnification the histological pattern of peripheral nerve regeneration in each group and
also the native control. In Auto and Nano groups some disperse regenerating nerve fascicles were found associated to the surrounding skeletal muscle (insets).
Figures in (C) show representative images of the biodegradation of the FAH [in Nano (left) and Coll-Nano (right) groups] and collagen conduit (Coll-Nano group) by
host macrophages (black arrows). In association to the macrophages, it was also observed a variable amount of mononuclear cells (red arrows). In right image
corresponding to Coll-Nano group the three well differentiated zones are indicated, the biodegradation of FAH (biod.), peripheral nerve regeneration zone (nr) and the
biodegradation of the collagen conduit (cc). TEM images in (D) confirmed the presence of active macrophages in Nano (left) and Coll-Nano (middle and right)
groups, where large phagosomes are indicated by red asterisks. Scale bar = 500 µm in (A), 100 µm and 50 µm (insets) in (B), 50 µm (left) and 100 µm (right) in (C)
and 1 µm in (D).
substitutes, they were mostly biodegraded after 14 weeks. The
biodegradation process was restricted to the biomaterial surface
and composed by a well delimited inflammatory reaction
composed by well-organized mononuclear macrophages and
some perivascular white blood cells (Figures 3A,C). In the
case of PNs defects repaired by collagen conduits filled with
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NFABNS (Coll-Nano group), histology revealed a less abundant
regenerating nerve tissue than in Auto and Nano groups. In this
group, the regeneration was restricted to the ECM area between
the collagen conduit wall and the internal biodegradation
process of the NFABNS. The regenerating tissue was composed
by poorly organized newly formed fascicles. Concerning the
biomaterials, the collagen conduits were well-preserved with an
associated biodegradation process by giant multinuclear cells
and some mononuclear infiltration. The intraluminal NFABNS
showed the same biodegradation process than the one observed
in Nano groups, although the structure was more preserved
(Figures 3A,C). Finally, TEM analysis confirmed that the
NFABNS in Nano and Coll-Nano groups was actively degraded
by mononuclear macrophages (Figure 3D).
The analyses of myelin and collagen fibers content carried
out with MCOLL histochemical method demonstrated that the
PN regeneration process was accompanied by certain degree
of myelination and collagen extracellular matrix reorganization
(Figure 4A). The analysis of Auto group revealed a high
amount of myelinated newly formed PNFs immersed in a loose
collagen extracellular matrix (Figure 4A). Similarly, in Nano
group abundant myelinated newly formed PNFs were observed
in the regenerating tissue, but the ECM collagen resulted to
be more abundant, especially around the newly formed nerve
fascicles (Figure 4A). In the case of Coll-Nano group, evident
histochemical reaction for myelin was not observed, although
an important amount of collagen was detected accompanying
the PN regeneration process (Figure 4A). Finally, TEM analysis
confirmed the presence of newly formed PNFs with a well-
formed myelin sheath as well as unmyelinated ones in both
Auto and Nano groups. Interestingly, TEM analysis confirmed
the presence of unmyelinated and myelinated PNFs in the Coll-
Nano group, but the myelin sheath was considerably thinner
and less organized than the myelin sheath observed in the
other experimental groups (Figure 4B). Despite the high degree
of myelination observed in Auto and Nano groups, light and
electron microscopy findings were not comparable to the PNFs
thickness and regularity observed in the control (Figures 4A,B).
In order to confirm the PN regeneration process, the SCs and
newly formed axons were immunohistochemically identify by
using antibodies against S-100 and GAP-43 proteins, respectively
(Figure 5). The immunohistochemical analysis of Auto group
FIGURE 4 | Histochemical and ultrastructural analysis of peripheral nerve regeneration and myelination. Figures in (A) shows the peripheral nerve regeneration
pattern, degree of myelination (blue histochemical reaction) and collagen reorganization (red) with MCOLL histochemical staining at moderate and higher
magnification in each experimental condition (Auto, Nano, and Coll-Nano) and native control (CTR). TEM images in (B) confirm the presence of myelinated peripheral
nerve fibers in all experimental groups and CTR. Scale bar = 100 µm (upper images) and 50 µm (lower images) in (A) and 2 µm in (B).
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FIGURE 5 | Immunohistochemical evaluation of Schwann cells and regenerating axons. The immunohistochemical staining (brown reaction) of S-100 was used to
reveal the presence and distribution of Sch whereas Gap-43 was used as a marker of newly formed regenerating axons. Both immunostaining were performed in
each experimental group (Auto, Nano, and Coll-Nano) and native control (CTR). Scale bar = 100 µm in lower magnifications and 50 µm higher magnification images.
revealed an abundant and consistent immunoreaction for S-100
and GAP-43 at the intrafascicular and interfascicular levels,
confirming the presence of an active PN regeneration process
as previously observed by the histological, histochemical and
ultrastructural analyses (Figure 5). In the Nano group, an
abundant immunoreaction for S-100 and GAP-43 was found
associated with the regenerating tissue with a similar pattern
than the one observed in the Auto group (Figure 5). The
immunohistochemical study of Coll-Nano group confirmed the
presence of an active PN regeneration process, but it was not
comparable to the pattern and amount observed in Nano and
Auto groups (Figure 5).
Results of Muscle Morphometry and
Histology
Muscle atrophy is a well-known consequence that takes place
after PN damage, and this process is an acceptable and
informative indicator of the degree of muscle reinnervation
following PN repair and regeneration (Vleggeert-Lankamp, 2007;
Siemionow et al., 2011). The quantitative analysis of lower leg
muscles innervated by the repaired sciatic nerves after 14 weeks
revealed an important w and v loss as compared to right control
legs in each group (Figure 6). In general, healthy legs weight
ranged between 7.8 and 7.1 g (mean 7.5 ± 0.2 g) and the
volume from 8 to 6.6 ml (mean 7.1 ± 0.5 ml), while operated
legs ranged from 3.3 to 4.7 g (mean 3.8 ± 0.6 g) and 2.7 to
4.6 ml (mean 3.5 ± 0.8 ml) (Figure 6). When comparing the
percentage of weight and volume loss a slight difference in in
the CTR-Native group was found (0.94% and 3.1%, respectively).
Concerning the operated animals, the lower percentage loss
was found in Auto group, where animals loss 32.67% of the
weight and 29.6% of the volume (Figure 6). When animals were
repaired with bio-artificial nerve substitutes the percentages of
weight and volume loss were significantly higher in Nano (54.4%
of weight and 54.5% of volume) and especially in Coll-Nano
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FIGURE 6 | Quantitative results of muscle’s weight and volume loss. Graphics (A,B) show the muscle weight and volume quantitative results of the injured (gray) and
right leg control (black) of the operated animals of each experimental condition (Auto, Nano, and Coll-Nano) and native control (CTR). Table in (C) shows the weight
and volume mean ± standard deviation values in grams (g) and milliliters (ml), respectively. Furthermore, the muscle atrophy is indicated by the % of loss between
the CTR and injured leg of each animal. In this study, significant differences are indicated as follows: aSignificant differences with CTR group. bSignificant differences
between Auto vs. Nano group. cSignificant differences between Nano vs. Coll-Nano group. dSignificant differences between Auto vs. Coll-Nano group. p < 0.05
values were considered statistically significant in two-tailed tests.
(56.8% of weight and 60.4% of volume) groups as compared to
animals from CTR-Native and Auto group (Figure 6). Although
the percentage of loss was higher in animals from Coll-Nano
group than Nano group, these differences were not statistically
significant (p = 0.251 for weight and p = 0.281 for volume).
The histochemical analyses of the transversal sections of the
tibialis anterior and gastrocnemius muscles confirmed the EMG
findings and especially the different degree of atrophy observed
by the morphometric evaluation among the experimental groups
(Figure 7). In Auto group, histology revealed slight signs of
atrophy in both muscles analyzed. The histological pattern was
characterized by the presence of randomly distributed well-
delimited rhabdomyocytes with certain signs of atrophy, such
as nuclear internalization and cell size reduction. In addition,
we did not observe signs of fibrosis or adipose tissue infiltration
with PS and MST methods (Figure 7). In general, muscles in
this group showed a similar histological pattern than healthy
muscles used as controls (Figure 7). In the Nano group, the
degree of atrophy in both muscles was more evident than in
Auto group. In this case, a grouped atrophy was observed, which
was characterized by the presence of groups of small and angular
rhabdomyocytes. Concerning the ECM, histochemistry revealed
a slight increase of the collagen content as well as the presence
of some adipocytes (Figure 7). The degree of atrophy observed
in Coll-Nano group was considerably higher than in Auto and
Nano groups. In this group, both muscles were mostly atrophic,
composed by small muscle fascicles containing moderately to
severely atrophied rhabdomyocytes. Furthermore, a considerable
increase of collagen fibers and some occasional adipocytes were
observed (Figure 7). Muscle histological analyses confirmed the
morphometric and EMG results.
DISCUSSION
Here, we report an in vivo preclinical evaluation of two novel
tissue engineering approaches for the repair of a 10-mm nerve
gap in the sciatic nerve of rats: a multilayered NFABNS and the
NFABNS used as intraluminal fillers of NeuraGen R© conduits. The
PNs regeneration process and functional recovery were assessed
by using clinical, functional and histological analyses.
In PNTE, bioartificial substitutes must have adequate
structural, physical and biological properties to successfully
repair nerve defects supporting, and ideally increasing, the
regeneration process and functional recovery (Daly W. et al.,
2012; Carriel et al., 2014a; Wieringa et al., 2018). From the
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FIGURE 7 | Histological profile of muscles innervated by repaired peripheral nerves. Figures show the histological pattern of the tibialis anterior and the
gastrocnemius muscles stained with picrosirius (upper images for each) and Masson trichrome (lower images for each) methods of each experimental condition
(Auto, Nano, and Coll-Nano) and native control (CTR). Observe that the histological pattern of Auto groups was comparable to the native control whereas different
degrees of atrophy and even fibrosis can be observed in Nano and especially Coll-Nano groups. Scale bar = 100 µm in each.
surgical perspective, it is important that nerve substitutes
may respond to specific anatomical requirements (e.g., length,
diameter, number of fascicles), should be easy to handle
and to suture to ensure an adequate tension-free PN repair,
and should be available for use in a reasonable period
of time (Carriel et al., 2014a; Gu et al., 2014; Pedrosa
et al., 2017). In this regard, the current gold standard
technique, the nerve autografts, effectively provides adequate
biological and physical properties with an acceptable functional
recovery. However, the use of sensory donor nerves to
repair motor ones rarely respond to the anatomical needs
(Brenner et al., 2006) and the well-known limitations of
nerve autograft, and specially allografts, urge researchers
to find more efficient alternatives (Daly W. et al., 2012;
Carriel et al., 2014a). Although promising, most currently
available PNTE strategies cannot be manufactured in an
opportune range of time or, as it is the case of FDA-approved
commercial devices, they are available with a pre-established
range of dimensions and may hardly fulfill the anatomical
demands.
In this study, we show the suitability of two natural
biomaterial-based TE strategies for PN repair, which were
generated following a previously described controlled and highly
reproducible procedure (Carriel et al., 2017d). On the one
hand, with our NFABNS, it was possible to successfully recreate
the shape, diameter and length of the PNs to be repaired,
thus demonstrating that the NFABNS can respond to specific
anatomical needs. On the other hand, the NFABNS demonstrated
to be suitable for use as intraluminal filler of NeuraGen R©
conduits. Concerning the design of the NFABNS, they were
generated by rolling thin layers of NFAH to generate consistent
multilayered rods containing viable, proliferating (positive for Ki-
67 and PCNA) and functional ADMSCs (Carriel et al., 2017d).
In addition, this simple, fast and economic procedure has the
advantage that it could be programmed some hours before
the surgery, which may fulfill the time requirements for an
opportune PN repair (Pedrosa et al., 2017; Zhang and Rosen,
2018). Moreover, the NFABNS has been demonstrated to be
surgically easy to handle with adequate mechanical stability and
flexibility, which allowed a tension-free repair just like nerve
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autografts. Interestingly, despite these advantages, tensile test
demonstrated that our NFABNS were not fully comparable to
the biomechanical response of native rat sciatic nerves (e.g.,
0.30 ± 0.04 MPa vs. 8.5 ± 2.48 MPa Young’s Modulus mean
values, respectively) (Carriel et al., 2017d; Philips et al., 2018a,b).
Nonetheless, here we demonstrated that, independently of these
biomechanical differences, our NFABNS were consistent enough
to successfully repair all defects ensuring the nerve continuity
after 14 weeks. The potential suitability of the use of NFABNS
in PN repair is supported by previous studies, in which natural
biomaterial-based substitutes with comparable multilayered 3D
design were successfully used in vivo. In this context, plastic
compressed, multilayered, and even multifasciculated, collagen-
based rods containing different cell sources were previously used
to bridge 8-mm (Schuh et al., 2018) and 1.5-mm defects in
rat sciatic nerves (Georgiou et al., 2013, 2015). Similarly, the
use of multilayered acellular small intestinal submucosa coated
with SC supported tissue regeneration in a 7-mm sciatic nerve
defect in rats (Hadlock et al., 2001). Unfortunately, none of these
reports provided information concerning the biomechanical
properties of these promising engineered substitutes, and
therefore these aspects as compared to our NFABNS remain
unknown.
Concerning the use of NeuraGen R© conduits filled with
NFABNS in PN repair, this strategy allowed us to efficiently
repair all nerve defects after 14 weeks without macroscopic
complications. Technically, this strategy was considerably faster
and easier than the use of NFABNS alone or nerve autografts
because repair was done following the conventional tubulization
technique. Regarding the suitability of this combined strategy
in PNs repair, it is well-accepted that the use of conduits
containing intraluminal fillers, especially those containing cells,
is able to enrich the regenerative microenvironment with the
consequent enhance of PN regeneration and functional recovery
(Pedrosa et al., 2017; Gonzalez-Perez et al., 2018; Ronchi et al.,
2018; Tajdaran et al., 2018; Wieringa et al., 2018). In this
study, the incorporation of NFABNS into NeuraGen R© conduits
prevented the deformation or compression of these commercial
devices during the period analyzed. Deformation, compression
and early reabsorption of some hollow conduits has been
described associated to this technique or to the use of vein grafts
in PNs reconstruction (Moore et al., 2009; Hernandez-Cortes
et al., 2010; Wangensteen and Kalliainen, 2010; Daly W. et al.,
2012; Liodaki et al., 2013; Papalia et al., 2013; Carriel et al.,
2014a; Krarup et al., 2017). In this regard, engineered neural
tissue-like substitutes based on cellular self-aligned and plastic
compressed collagen hydrogels were covered by NeuraWrapTM
(Integra, United States) devices and successfully used to repair
a critical nerve gap of 15-mm in rats (Georgiou et al., 2013).
Furthermore, the use of NFABNS to fill NeuraGen R© conduits
is especially supported by our previous studies in which these
conduits filled with uncompressed FAH containing ADMSCs
successfully repaired 10-mm nerve gaps in rats, supporting tissue
regeneration and functional recovery after 12 weeks (Carriel
et al., 2013, 2017c). Finally, all these previous studies support the
potential surgical usefulness of the use of NFABNS alone or as
intraluminal filler of nerve conduits in PNs repair.
Clinical and functional assessments are needed to determine
the degree of functional recovery following PN repair (Vleggeert-
Lankamp, 2007; Siemionow et al., 2011; Carriel et al., 2014b;
Navarro, 2016). This time-course study demonstrated that the
created injury severely compromised clinical and functional
parameters of all animals after 4 weeks, followed by a partial
recovery after 12 weeks. Clinically, all operated animals had self-
amputations over the time, but they were consistently higher in
the autograft group, although differences were not statistically
significant. Concerning the presence of neurotrophic ulcers,
which are associated to an impairment of the sensitive and motor
functions (den Dunnen and Meek, 2001; Vleggeert-Lankamp,
2007; Carriel et al., 2013), they were surprisingly absent in
animals treated with NeuraGen R© conduits filled with NFABNS
over the time. However, ulcers were found in animals that
received autograft (20%) and NFABNS (40%), without significant
differences after 12 weeks, being these findings in agreement
with previous studies (Meek et al., 1999; den Dunnen and Meek,
2001). In addition to these parameters, experimentally induced
sciatic nerve injuries are associated to muscle dysfunction and
neurogenic muscle retraction, which can be reflected by foot
length alterations (Kim et al., 2007; Carriel et al., 2013; Kappos
et al., 2015). In this study, a higher degree of neurogenic
muscle retraction was observed in animals treated with autograft,
while engineered strategies (NFABNS and filled conduits) were
associated to better results. The development of these injuries
at the foot level can be explained by a partial recovery of
the sensitive and motor functions assessed by pinch and toe-
spread tests. Our results were especially favorable with the use
of NFABNS as compared to the autograft, being less favorable
when nerves were repaired with filled conduits. However, these
results were not comparable to the normal function observed in
healthy animals. These results are in line with previous studies.
For example, the use of fibrin conduits containing different kinds
of ADMSCs demonstrated comparable functional recovery than
autografts in the repair of 10-mm gaps in rats after 12 weeks
(Kappos et al., 2015). In addition, a recent study demonstrated
successful functional recovery through the use of chitosan
conduits filled with cellular self-aligned collagen hydrogels in the
repair of a critical size defect of 15-mm in rats (Gonzalez-Perez
et al., 2018).
In order to accurately determine the degree of muscle
denervation and reinnervation, EMG studies of gastrocnemius
and tibialis anterior muscles were conducted as previously
recommended (Vleggeert-Lankamp, 2007; Carriel et al., 2013,
2014b; Navarro, 2016). These analyses confirmed a high degree
of muscle denervation at 4 weeks in all animals, as expected.
Interestingly, after 12 weeks, a decrease of muscle denervation
and an increase of muscle reinnervation were demonstrated in
animals treated with NFABNS and autografts. However, certain
degree of denervation was still present in the NFABNS group,
especially when filled conduits were used. Interestingly, the
EMG profile of animals treated with NFABNS resulted to be
more favorable than the results previously obtained with the
use of NeuraGen R© conduits filled with cellular and acellular
uncompressed FAH in the same animal model and period of
analysis (Carriel et al., 2013). Furthermore, our EMG results are
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in accordance with the percentage of w and v loss results. In
fact, higher percentages of w and v loss were obtained with the
use of filled conduits, followed by the use of NFABNS, being
these results significantly higher than the obtained with autograft
technique. These findings were later confirmed by the muscle
histochemical analyses which clearly revealed slight, moderate
and severe rhabdomyocytes atrophy in autograft, NFABNS and
filled conduits groups, respectively. Finally, our results suggest
that the use of NFABNS in PN repair promote an acceptable, and
in some aspect equivalent clinical and functional recovery profile
than the use autograft technique in the repair of 10-mm nerve
gap in rats, being these results supported by comparable studies
and engineered models (Georgiou et al., 2013, 2015; Jesuraj et al.,
2014; Kappos et al., 2015; Pedrosa et al., 2017; Schuh et al., 2018;
Wang and Sakiyama-Elbert, 2018).
Histological analyses are useful tools in PN regeneration
research being an essential complement to the clinical, functional
and electrophysiological investigation techniques (Vleggeert-
Lankamp, 2007; Carriel et al., 2014b; Geuna, 2015). In this
study, light microscopy and TEM histology were crucial to
demonstrate an active PN regeneration process at the middle
portion of all substitutes. However, differences in the amount,
regenerative tissue distribution pattern and host tissue response
to the implanted grafts were detected. Autograft group histology
confirmed the presence of newly formed PN fascicles with
moderate myelination (MCOLL and TEM results) along the
connective tissue layers and especially, at the intrafascicular level.
A comparable regeneration process was observed in NFABNS
groups, although it was restricted to the connective tissue
covering the implanted substitutes and not through the substitute
layers. Surprisingly, tissue regeneration in filled conduits was
considerably less abundant and poorly myelinated than the
in autograft and NFABNS groups. In fact, the nerve tissue
regeneration was restricted to the intraluminal area just around
the intraluminal surface of the NFABNS. In summary, histology
demonstrated that NFABNS – used alone or as intraluminal
filler – did not promote nerve tissue regeneration through its
biomaterials layers. Nevertheless, the direct use of NFABNS in PN
repair resulted to be an efficient physical platform to keep both
nerve stumps connected, supporting and guiding nerve tissue
regeneration through its surrounding connective tissue, thus
reaffirming the clinical, functional and EMG results. Therefore,
our histological findings are in accordance with the active nerve
tissue regeneration obtained by the use of comparable strategies
(Hadlock et al., 2001; Georgiou et al., 2013, 2015; Ronchi et al.,
2018; Schuh et al., 2018). In relation to the less favorable
results obtained with filled NeuraGen R© conduits, our histological
analyses suggest that this finding could be related to physical
factors (Daly W. et al., 2012; Carriel et al., 2014a). It is well
accepted that nerve conduits provide a close and controlled
protective microenvironment that guide and support nerve tissue
regeneration in non-critical nerve gaps (Daly W. et al., 2012;
Carriel et al., 2013, 2014a; Krarup et al., 2017; Pedrosa et al.,
2017; Ronchi et al., 2018). In this regard, we hypothesize that
the combined use of an external conduit filled with a highly
dense NFABNS may reduce the area needed for an optimal
tissue regeneration, and this would explain the poor functional
and electrophysiological recovery observed with this strategy.
In fact, it was experimentally demonstrated that low-density
intraluminal fillers enhance regeneration process and functional
recovery (Daly W. et al., 2012; Daly W.T. et al., 2012; Lee
et al., 2012; Carriel et al., 2013, 2014a, 2017c; Gu et al., 2014;
Wieringa et al., 2018). On the other hand, highly dense and
slowly degrading intraluminal fillers can reduce the area available
for tissue regeneration, thus delaying or even inhibiting tissue
regeneration (Labrador et al., 1998; Yao et al., 2010; Daly W. et al.,
2012; Daly W.T. et al., 2012; Carriel et al., 2014a).
In relation to the host response to our biomaterials,
histological analyses confirmed that NFABNS, used alone or as
intraluminal fillers, were progressively biodegraded by a local
inflammatory host response mainly consisting of macrophages.
These findings are in agreement with previous studies where
FAH-based substitutes were reabsorbed by a comparable
biodegradation process in some weeks (Carriel et al., 2012,
2013; Fernandez-Valades-Gamez et al., 2016; Martin-Piedra
et al., 2017). Besides, histology also confirmed that NeuraGen R©
conduits protect the intraluminal NFABNS from host tissue
biodegradation. This could reduce the intraluminal area needed
for an optimal tissue regeneration and would reaffirm the
hypothesis discussed above.
Finally, the use of cellular systems in PN repair demonstrated
to be an efficient alternative to increase regeneration and
functional recovery (Carriel et al., 2013, 2014a, 2017c; Kappos
et al., 2015; Gonzalez-Perez et al., 2018; Zhang and Rosen, 2018).
In this study, autologous undifferentiated ADMSCs were used
to functionalize the NFABNS due to their well-demonstrated
positive impact on PN repair (Kalbermatten et al., 2008; Lopatina
et al., 2011; Gu et al., 2014; Faroni et al., 2016; Carriel et al.,
2017b). In this study, acceptable PN regeneration and functional
recovery profiles were obtained with the direct use of NFABNS
in PN repair. However, due to technical reasons, it was not
possible to identify the cells implanted within the NFABNS.
Therefore, we cannot directly attribute to the cells the positive
effect on PN regeneration obtained with our NFABNS. Therefore,
the fate and potential role of these cells following in vivo
implantation remains unknown and should be determined in
future studies. In this regard, previous studies suggested that
ADMSCs could contribute to the regeneration process through
their differentiation to a SCs-like phenotype, releasing essential
neurotrophic factors and collaborating with the synthesis of an
essential ECM (Salgado et al., 2010; Tomita et al., 2012; Carriel
et al., 2013; Kappos et al., 2015; Faroni et al., 2016; Zhang and
Rosen, 2018).
CONCLUSION
In conclusion, the present study suggests that NFABNS support
a closely comparable functional recovery and tissue regeneration
than autograft technique. Overall results suggest that NFABNS
may have potential clinical usefulness in future clinical trials in
humans. However, further research should confirm their positive
impact on the reconstruction of critical nerve defects and should
improve the properties of these bioartificial tissue substitutes.
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Functional recovery is poor after peripheral nerve injury and delayed surgical repair
or when nerves must regenerate over long distances to reinnervate distant targets. A
reduced capacity of Schwann cells (SCs) in chronically denervated distal nerve stumps
to support and interact with regenerating axons may account for the poor outcome. In
an in vitro system, we examined the capacity of adult, long-term denervated rat SCs
to proliferate and to myelinate neurites in co-cultures with fetal dorsal root ganglion
(DRG) neurons. Non-neuronal cells were counted immediately after their isolation from
the distal sciatic nerve stumps that were subjected to acute denervation of 7 days
or chronic denervation of either 7 weeks or 17 months. Thereafter, equal numbers
of the non-neural cells were co-cultured with purified dissociated DRG neurons for
5 days. The co-cultures were then treated with 3H-Thymidine for 24 h to quantitate
SC proliferation with S100 immunostaining and autoradiography. After a 24-day period
of co-culture, Sudan Black staining was used to visualize and count myelin segments
that were elaborated around DRG neurites by the SCs. Isolated non-neural cells from
7-week chronically denervated nerve stumps increased 2.5-fold in number compared
to ∼2 million in 7 day acutely denervated stumps. There were only <0.2 million cells in
the 17-week chronically denervated stumps. Nonetheless, these chronically denervated
SCs maintained their proliferative capacity although the capacity was reduced to 30%
in the 17-month chronically denervated distal nerve stumps. Moreover, the chronically
denervated SCs retained their capacity to myelinate DRG neurites: there was extensive
myelination of the neurites by the acutely and chronically denervated SCs after 24 days
co-culture. There were no significant differences in the extent of myelination. We
conclude that the low numbers of surviving SCs in chronically denervated distal nerve
stumps retain their ability to respond to axonal signals to divide and to elaborate myelin.
However, their low numbers consequent to their poor survival and their reduced capacity
to proliferate account, at least in part, for the poor functional recovery after delayed
surgical repair of injured nerve and/or the repair of injured nerves far from their target
organs.
Keywords: Schwann cells, nerve transection, myelination, SC proliferation, neurites, nerve injury
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INTRODUCTION
The Schwann cells (SCs) in the peripheral nervous system
support nerve regeneration after nerve injury in contrast
to the oligodendrocytes in the central nervous system that
do not (Cajal, 1928; Bunge, 1994; Fenrich and Gordon,
2004; Toy and Namgung, 2013). Yet, functional recovery is
suboptimal after peripheral nerve injuries in patients who have
sustained injury to large nerve trunks such as the brachial
plexus (Sunderland, 1978; Kline and Hudson, 1995). The
prevailing view is that this failure in recovery is due to the
irreversible degeneration of chronically denervated muscles
and their replacement with fat during nerve regeneration
(Sunderland, 1978; Kline and Hudson, 1995). This is despite
the early conclusions by Holmes and Young (1942) that
there are ‘‘various factors, in addition to atrophy of the
end-organs, which are likely to reduce the effectiveness of
recovery when suture is made after a long delay’’ and the later
conclusion that ‘‘Most likely, multiple mechanisms contribute
to this phenomenon’’ (of diminished recovery of muscle
mass and integrated motor function), ‘‘which is sometimes
referred to as ‘irreversible denervation atrophy’’’ (Kobayashi
et al., 1997). Peripheral nerves regenerate at 1–3 mm/day,
resulting in delays of months and, in humans, even years
before regenerating nerves reach their denervated targets (Fu
and Gordon, 1997). Gutmann and Young (1944) reported
that denervated rat neuromuscular junctions progressively
deteriorate after delayed nerve surgery. The authors attributed
poor functional recovery after such a delay to an irreversible
inability of regenerating nerves to reinnervate chronically
denervated neuromuscular junctions. However, more recent
studies have demonstrated that the progressive failure of even
freshly injured (axotomized) neurons to successfully regenerate
their axons through chronically denervated distal nerve stumps
is the major factor accounting for progressive decline in
functional recovery (Fu and Gordon, 1995a; Vuorinen et al.,
1995; Sulaiman and Gordon, 2000; Gordon et al., 2003, 2011)
and the recovery of denervated muscle mass (Kobayashi et al.,
1997). Chronically denervated muscles do accept reinnervation
despite their declining satellite population and the consequent
incomplete recovery of reinnervatedmuscle fiber size andmuscle
wet weight (Fu and Gordon, 1995a; Kobayashi et al., 1997;
Sulaiman and Gordon, 2000; Jejurikar et al., 2002; Gordon
et al., 2011). Hence, changes in the microenvironment of
the chronically denervated nerve stumps provide, at least in
part, the explanation for the progressive failure of axonal
regeneration through the nerve stumps and to the denervated
muscles.
The specific changes in the microenvironment of the
denervated distal nerve stump accounting for poor axonal
regeneration, are not understood. Regeneration is fostered in
acutely injured peripheral nerves by the functional, structural,
and molecular changes occurring in the denervated SCs in
the distal stumps. Denervated SCs take an active role in
the phagocytosis of myelin, a role that is taken over by
macrophages that infiltrate the denervated nerve stump after
3 days (Gibson, 1979; Avellino et al., 1995; reviewed by Gordon,
2015). The SCs proliferate and extend long processes across
the injury site within the first 10 days after injury (Salonen
et al., 1988; Son and Thompson, 1995; Witzel et al., 2005).
They also participate in the development of reversible and
organized endoneurial structures that include the synthesis and
positioning of collagen fibrils close to the laminin-containing
basal lamina of the SCs and the formation of fascicle-like
structures by the endoneurial cells (Salonen et al., 1987a,b,
1988).
The early changes in the denervated SCs include the switch
in their phenotype from myelinating to a growth supportive
one, the SCs downregulating genes that transcribe myelin
associated proteins and glycoproteins and upregulating hundreds
of growth-supportive genes reciprocally (De Leon et al., 1991;
El Soury et al., 2018). The latter include genes that are responsible
for ribonuclear RNA metabolic processes which contribute to
the synthesis and production of new proteins and molecules
required for Wallerian degeneration and nerve regeneration
(El Soury et al., 2018). The many growth associated genes
include those that transcribe transcription factors, c-jun and
Notch, neurotrophic factors (reviewed by Jessen and Mirsky,
2016; Gordon and Borschel, 2017), soluble neuregulin 1 (NRG1)
type I and type II isoforms, the NRG1 receptor ErbB2/3
(Carroll et al., 1997; Audisio et al., 2008; Gambarotta et al.,
2013; Ronchi et al., 2016), and Erbin, an ErB2 interacting
protein required for remyelination (Liang et al., 2012). The
neurotrophic factors include nerve growth factor (NGF), brain-
and glial-derived neurotrophic factors, and pleiotrophin and
the receptors include p75 and truncated trk receptors for the
neurotrophic factors (Meyer et al., 1992; Funakoshi et al., 1993;
Naveilhan et al., 1997; Hoke et al., 2002, 2006; Mi et al., 2007;
Brushart et al., 2013). These early changes in the denervated
SC phenotype are important in promoting axonal regeneration
(Fu and Gordon, 1997; Boyd and Gordon, 2003; El Soury et al.,
2018).
The decline in the capacity of chronically denervated
SCs to support nerve regeneration is, at least in part,
explained by the transient nature of neurotrophic factor and
receptor upregulation (Boyd and Gordon, 2003; Gordon, 2015).
Their upregulated gene expression declines within a month
of denervation (Fu and Gordon, 1997; You et al., 1997;
Hoke et al., 2002, 2006; Brushart et al., 2013), as does
the upregulation of the erbB2/3 receptors (Li et al., 1997;
Hall, 1999) required for the proliferation of denervated SCs
(Carroll et al., 1997; Gambarotta et al., 2013). Importantly, the
chronically denervated SCs atrophy and decline in numbers:
progressive SC atrophy and loss with disruption of their
basement membranes and shrinkage of their columns, have
been reported in rat and rabbit hindlimb nerves over periods
of 1 to 26 months (Weinberg and Spencer, 1978; Salonen
et al., 1987a,b; Röyttä and Salonen, 1988; You et al., 1997;
Bradley et al., 1998). SC numbers identified with S-100
immunoreactivity, declined from a peak of ∼3.5 times that
of normal nerves at 4 weeks to the relatively low levels seen
in intact nerves by 30 and 50 weeks after chronic sciatic
nerve stump denervation in adult Wistar rats (Salonen et al.,
1988).
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In the present study, we evaluated the long-term survival of
chronically denervated SCs and their capacities for proliferation
and for myelination in response to contact with neurites. We
provide the first quantitative evaluation of survival of very
long-term (17 months) survival of chronically denervated SCs
and demonstrate their sustained capacity to proliferate and to
myelinate axons.
MATERIALS AND METHODS
Ethical Approval
All surgical procedures and perioperative care measures were
performed with strict accordance with the National Institutes
of Health guidelines. All the procedures were reviewed and
approved by the University of Alberta animal care committee
following the Canadian Council of Animal Care (CCAC)
guidelines. Rat embryos from pregnant females were removed
on the 15th day of gestation for dissection of dorsal root
ganglia (DRGs) for isolation of the DRG sensory neurons. All
the procedures of removal and isolation of DRG neurons were
carried out in Miami and were reviewed and approved by the
Miami Animal Care and Use Committee.
Animals
Adult female Sprague-Dawley rats (180–200 g body weight,
n = 20) were used in the experiments in which hindlimb nerves
were transected and ligated in vivo prior to removal of the
denervated distal nerve stumps. Pregnant rats (n = 2) were used
to remove 8–14 embryos each on the 15th day of gestation.
Materials
Cell culture reagents were purchased: Dulbecco’s Modified Eagle
Medium (DMEM) and Neurobasal medium and B27 supplement
fromGibco, 0.05% collagenase fromWorthington, 0.25% dispase
from Boehringer-Mannheim, fetal bovine serum (FBS) from
Hyclone, partially purified NGF from ProspectBio, trypsin
from Worthington, TRL3, NTB2 emulsion from Kodak, mouse
laminin from Collaborative Research, Inc., and rabbit anti-S100
antibody from Dako Corporation.
Anesthetic Protocols, Nerve Surgeries and
Monitoring
All surgical procedures of sciatic nerve transection and ligation
and the dissection of DRGs were made under anesthesia and
using sterile surgical technique. Surgical anesthesia of the rats was
induced with an intraperoneal injection of sodium pentobarbital
(30 mg/kg).
In vivo Sciatic Nerve Transection of the Sciatic
Nerves and Ligation of the Nerve Stumps
The left hindlimb was shaved and a lateral skin incision was
made. The intermuscular septum between the biceps femoris and
the vastus lateralis muscles was divided and the sciatic nerve
identified. The sciatic nerve was freed using blunt dissection
in order to cut the nerve sharply with scissors. The proximal
and distal nerve stumps were ligated with 4.0 silk and sutured
FIGURE 1 | In vivo sciatic nerve transection and ligation to denervate
Schwann cells (SCs) in the distal nerve stump. (A) Under surgical anesthesia
and using aseptic precautions, the left sciatic nerve was exposed, cut, and the
proximal and distal nerve stumps ligated and sutured to nearby innervated
muscles to prevent axonal regeneration and reconnection for 7 weeks or for
17 months, the experimental groups of chronic distal nerve denervation in the
left hindlimb. (B) In a second aseptic surgery, 7 weeks or 17 months later, the
rats were again anesthetized and the right sciatic nerve was cut and ligated
and again, the nerve stumps were sutured to innervated muscle in order to
prevent regeneration for 7 days.
to nearby innervated muscles in order to prevent reconnection
and subsequent axonal regeneration (Figure 1), as previously
described (Fu and Gordon, 1995a,b; Sulaiman and Gordon, 2000;
Gordon et al., 2011). The overlying muscle was closed and the
skin incision on the thigh was closed in layers. The rats were
placed under heat lamps and their recovery monitored.
In a second aseptic surgery, 7 weeks or 17 months later, the
rats were again anesthetized, and the contralateral right sciatic
nerve was cut and ligated. Again, the nerve stumps were sutured
to innervated muscle in order to prevent regeneration for 7 days
(Figure 1B).
Monitoring for Evidence of Nerve Regeneration
In a third aseptic surgical procedure, the skin was shaved on
both hindlimbs and then opened to expose, bilaterally, the sciatic
nerve and it’s tibial (TIB), common peroneal (CP) and sural
nerve branches. An aseptic bipolar electrode attached to a Grass
stimulator was used to deliver supramaximal stimuli at 10 Hz
to the proximal sciatic nerve stump, followed by the distal
stumps of the sciatic nerve and its branches to ensure that nerve
regeneration had not occurred. No muscle contractions were
observed in any of the rats confirming that the distal nerve
stumps of the sciatic nerves were acutely denervated for 7 days
and chronically denervated for 7 weeks and 17 months.
Surgical Removal of Sciatic, TIB, CP, and Sural Distal
Nerve Stumps
In the same third surgical procedure, the chronically denervated
(experimental) and the contralateral acutely denervated (control)
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distal stumps of the sciatic nerve and its branches in the left
and right hindlimbs, respectively, were removed and placed
in Belzer’s solution at 4◦C for shipment to Miami for nerve
dissociation, isolation of SCs, and preparation of co-cultures with
DRG neurons.
Dissection of Dorsal Root Ganglia (DRGs) From Rat
Embryos
Pregnant rats were deeply anesthetized with ether to allow
surgery to remove embryos on the 15th day of gestation as
previously described in detail (Kleitman et al., 1988). The DRGs
from each of the 8–14 embryos were carefully dissected free and
dissociated to establishDRG sensory neuron cultures (see below).
The mothers were euthanized by exsanguination.
In vitro Cellular Dissociations and
Co-culture
Non-neuronal Cells From Denervated Nerve Stumps
Using sterile procedure, the epineurium was removed from
the dissected distal nerve stumps of the sciatic nerve and
the CP, TIB and sural nerve branches which had been
chronically denervated for 7 weeks and 17 months (in the
left experimental hindlimb or acutely denervated in the
right control hindlimb for 7 days. Because the chronically
denervated nerves were shrunken, especially those after the
lengthy 17-month period of chronic denervation, the nerves
for each of the three periods of nerve stump denervation
were pooled for dissociation of their denervated non-neuronal
cells, i.e., 10 nerves each were pooled after 7 weeks and
17 months of chronic distal nerve stump denervation and
20 nerves were pooled after 7 days of acute distal nerve stump
denervation.
The nerves were incubated in culture medium containing
0.05% collagenase, 0.25% dispase solution in DMEM, and
10% FBS (Medium 1), for 18 h at 35–37◦C. The fascicles
were rinsed free of collagenase/dispase with DMEM +
10% FBS. They were then dissociated into a single cell
suspension by gentle trituration, using a glass micropipette
with a tip diameter of 0.3–0.5 mm. The non-neuronal cells
were harvested and re-suspended in Neurobasal medium
with 2% B27 supplement and partially purified NGF at
50 units/ml (hereafter referred to as Medium 2). The
cells were then counted and thereafter, their capacities to
proliferate and to myelinate isolated DRG neurons were
determined.
DRG Neurons From Rat Embryos
DRGs dissected from rat embryos on the 15th day of gestation
were sequentially: (1) incubated with 0.25% trypsin in calcium
andmagnesium—freeHank’s Balanced Salt Solution (Medium 3)
for 1 h at 35–37◦C on a slowly rotating shaker; (2) rinsed free of
trypsin with L-15 medium containing 10% heat-inactivated FBS;
and (3) dissociated by gentle trituration using a glass pipette with
a tip diameter of 0.3–0.5 mm. The dissociated DRG cells were
then harvested and re-suspended in Medium 2. The DRG cell
suspension was plated at a density of 20,000 cells in a volume
of two drops onto collagen-coated clear coverslips, 22 mm in
diameter (Kleitman et al., 1988) and placed into 25 mm clear
mini-dishes that were incubated in a 5% CO2 atmosphere at
37◦C.
A day after plating, the DRG neuron cultures were flooded
with 10 drops of the Medium 2 that was supplemented with
fluorodeoxyuridine (FdU) and uridine, both at a concentration of
10 µM (antimitotic Medium 2). This antimitotic treatment was
repeated on days 8 and 15 of culture. Thereafter, the antimitotic
agents were excluded from the culture medium (Medium 2),
the Medium 2 (without FdU and uridine) being used to wash
out the antimitotic agents (on days 19, 21, 26, 28, and 33, and
42). This washing ensured the depletion of antimitotic agents
from the culture environment of the DRG neurons prior to their
co-culture with non-neural cells from the acutely and chronically
denervated distal nerve stumps.
Co-culture of DRG Neurons and Non-neuronal Cells
From Denervated Nerve Stumps
The DRG neurons in each mini-dish were plated with 100,000
non-neuronal cells on the same day as the dissociation of the
non-neuronal cells from the chronically (7 weeks and 17months)
and acutely (7 days) denervated distal nerve stumps.
Experiments
Cellular Counts
Small aliquots of non-neuronal cell suspensions, prepared in
Medium 2 of each of the 7-week and 17-month chronically
denervated nerve stumps and from the 7-day acutely denervated
distal nerve stumps, were fixed in 4% paraformaldehyde in
0.05 M sodium phosphate buffer, pH 7.4 for 15 min at room
temperature and stained with Hoechst 33342 dye (10 µM). The
cells were visualized by fluorescence microscopy, counted in
a hemocytometer, and the total cell numbers calculated. The
resulting bright staining of cell nuclei allowed the unambiguous
recognition of the cells even when the suspensions were heavily
laden with myelin debris.
Cellular Proliferation Assay
The non-neuronal cell suspensions were diluted with Medium 2
to 100,000 cells/ml and plated onto cultures of isolated DRG
neurons at 1.0 ml per culture. Control neuronal cultures received
1.0 ml of Medium 2 without suspended cells. For maintenance,
the co-cultures were re-fed three times eachweek withMedium 2.
After 5 days of co-culture, the non-neuronal cells in each of
four cultures from the 7-day acutely denervated control group
and the 7-week and 17-month chronic denervation experimental
groups were labeled for 24 h with 3H-thymidine (0.5 µCi/ ml)
in Medium 2. The cultures were then rinsed and fixed with 4%
paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4 for
10 min at room temperature, permeabilized with 0.2% Triton
X-100 in the fixative for another 10 min at room temperature,
and prepared for immunostaining by blocking (30 s at room
temperature) in a solution of 50% heat-inactivated goat serum in
L-15 medium. The co-cultures were treated with rabbit anti-S100
antibody at 1:100 dilution in L-15/10% heat-inactivated goat
serum for 30 min at room temperature, rinsed, and treated
with fluorescein-conjugated goat anti-rabbit secondary antibody
at 1:100 dilution in L-15/10% heat-inactivated goat serum
for an additional 30 min at room temperature. The cultures
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were rinsed with buffer, distilled water and ethanol, dried and
mounted on glass slides, cell side up, with DPX mountant.
The slides were dipped in NTB2 emulsion and processed for
autoradiography (Wood and Bunge, 1975). The counts of the
S-100 positive cells were made directly under microscopic view
and not made on photographic images with their possible
distortions. A proliferation index was defined as the number
of the S-100 positive SCs that were labeled with 3H-thymidine
expressed as a percentage of the total number of S-100
positive SCs.
Myelination Assay
Six co-cultures per group of DRG neurons and non-neuronal
cells isolated from the chronically denervated sciatic, TIB,
CP, and sural nerve stumps, were maintained for 24 days in
Medium 2 that was supplemented with 10 ng/ml of mouse
laminin. Control cultures of DRG neurons without added
non-neuronal cells were kept in parallel. All cultures were fixed
overnight in FIX at 4◦C, osmicated for 1 h in 0.1% osmium
tetroxide in 0.1 M sodium phosphate buffer, pH 7.4, dehydrated
to 70% ethanol in water and stained for 1 h in 0.7% Sudan Black
in 70% ethanol in water (Kleitman et al., 1988). The cultures
were rehydrated and mounted in glycerin jelly on glass slides.
A quantitative measurement of myelination in each culture was
made by counting the number of myelin segments crossing the
equator of the cultures, using an eyepiece containing a single line
horizontally bisecting the field of view at 200×magnification.
Statistics
Statistical analysis was conducted using an ANOVA with the
Tukey’s post hoc test (confidence interval = 95%). Comparisons
were made between the experimental chronically denervated
(7 weeks and 17months) distal nerve stump of the cut and ligated
left sciatic nerve and the control acutely denervated (7 day) distal
nerve stump of the cut and ligated right sciatic nerve (Figure 1).
RESULTS
The Number of Non-neuronal Cells in
Peripheral Nerve Stumps Decline With
Time After Chronic Denervation
The nuclei of the non-neuronal cells in suspension were
unambiguously identified with Hoechst stain and their numbers
counted in a hemocytometer to calculate their total cell numbers.
The bright staining of cell nuclei allowed the unambiguous
recognition of cells even when the suspensions were heavily laden
with myelin debris.
The total numbers of non-neuronal cells from the
experimental 7-week denervated distal nerve stump from
the left hindlimb were >4 × 106 cells as compared to <2 × 106
cells in the acutely 7 day denervated distal stump from the right
hindlimb in each rat (Figure 2). This increase was not sustained,
the numbers after 17 months chronic nerve stump denervation
falling to ∼10% of those numbers enumerated in the control
7-day acutely denervated distal nerve stumps. The increase
of non-neuronal cells after chronic denervation at 7 weeks as
compared to the numbers after acute denervation at 7 days, likely
FIGURE 2 | Decline in the number of non-neuronal cells and the proliferative
capacity of S-100 positive SCs with chronic denervation. (A) Non-neuronal
cells isolated from acutely (7 days) and chronically (7 weeks and 17 months)
denervated distal nerve stumps of the sciatic nerve and its tibial (TIB),
common peroneal (CP), and sural nerve branches, namely control acute and
experimental chronically denervated distal nerve stump form the right and left
hindlimbs, respectively. The cells were counted in small aliquots of single cell
suspensions. (B) The mean (± SE) of the proliferation index. The index is the
number of S-100 positive SCs that, in co-cultures with isolated dorsal root
ganglion (DRG) neurons for 5 days, were labeled with 3H-thymidine and hence
were dividing, expressed as a percentage of the total number of S-100
positive SCs. The proliferation indices at 7 days, 7 weeks and 17 months were
significantly different from one another as indicated by *’s (p < 0.025).
include fibroblast-like and mast cells that also accumulate in the
denervated nerve stump (Salonen et al., 1988; Ronchi et al., 2017)
in addition to proliferating SCs in the nerve stumps during the
Wallerian degeneration period of∼4 weeks (Salonen et al., 1988;
You et al., 1997). The chronic denervation of the distal nerve
stumps was controlled for the age and weight of the rats because
the acutely and chronically denervated non-neuronal cells were
dissociated from left and right hindlimbs, respectively, from the
same rats.
Chronically Denervated Schwann Cells
Retain Their Capacity to Proliferate, Albeit
at a Reduced Rate
It is known that denervated SCs proliferate a second time when
regenerating axons make contact with the SCs in the denervated
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distal nerve stump (Pellegrino and Spencer, 1985). Five days
after co-culture of denervated SCs with isolated DRG neurons
and a 24-h exposure to 3H-thymidine, most of the 7-day acutely
denervated S-100 positive SCs were labeled with 3H-thymidine
and hence, had entered into the cell cycle (Figures 3A,D). Some
of these SCs are identified in the phase-contrast autoradiograph
with an arrowhead (Figure 3A) whilst those that were not
dividing are identified by an arrow (Figure 3D). The proportion
of mitotic SCs in the co-cultures of DRG neurons and SCs
from the acutely denervated nerves was high, the ratio of the
numbers of 3H-thymidine labeled and unlabeled SCs, expressed
as a percentage, the proliferative index in Figure 2B, being∼75%.
The chronically denervated SCs from the left experimental
hindlimb were also found to proliferate as shown in
Figures 3B–F and quantitated in Figure 2B. However, the
numbers of these 3H-thymidine positive SCs undergoing
proliferation in the co-culture with DRG neurons declined
significantly after chronic denervation (Figures 3B–F) with
∼50% and ∼30% of the SCs proliferating in the 7-week
and 17-month chronically denervated nerves, respectively,
the indices declining significantly with chronic denervation
FIGURE 3 | Many SCs in the nerve stump distal to the site of sciatic nerve
transection and ligation are in an active proliferative state after acute as well as
after chronic denervation, at least for up to 7 weeks. Phase-contrast
autoradiographs of isolated acutely (A,D: 7 days) and chronically (B,E:
7 weeks and C,F: 17 months) denervated SCs from right and left hindlimbs,
respectively. (A–C) Phase-contrast of the SCs that were exposed to
3H-thymidine for 24 h to identify dividing cells, 5 days after co-culture with
DRG neurons. Many of the SCs incorporated 3H-thymidine (arrowhead)
demonstrating SCs in an active proliferative state in the acute phase of
denervation (A) and up to 7 weeks (B). There are visibly more 3H-Thymidine
positive SCs than those that were not dividing (3H-Thymidine—negative cells
shown by arrows) after 7 weeks (B) as compared to 7 days (A). (C,D)
Immunostaining of SCs with S-100 identifies the dividing SCs (3H-thymidine
positive SCs—arrows) and those that do not (3H-thymidine—negative cells
shown by arrowheads). The proliferating S-100 positive SCs (arrows) are in
close contact with the neurites of the DRG neurons. Scale bars = 30 µm.
(p < 0.05; Figure 2B). The differences in proliferative indices
for the SCs from the control 1 week and experimental 7 weeks
and 17 months were all significant (p < 0.05). Note that the
S-100 immunostaining of the SCs in Figure 3 revealed that the
SCs were closely associated with and aligned along the neurites
of the DRG neurons, irrespective of the duration of prior SC
denervation in vivo.
Chronically Denervated Schwann Cells
Retain Their Capacity to Myelinate Axons
DRG neurons (without non-neuronal cells) were cultured for
24 days with and without non-neuronal cells that were freshly
isolated from denervated nerve stumps of the sciatic nerve and its
branches after acute (7 days) and chronic (7 weeks, 17 months)
denervation in the right and left hindlimbs, respectively. In
the absence of added non-neuronal cells, the DRG neurons
exhibited extensive axon bundles that were not stained with
Sudan Black (Figures 4A,B), a lipid stain widely used for
detecting and distinguishing lipid-rich myelin sheaths in tissue
culture (Eldridge et al., 1987). This result clearly indicates that
myelin was not formed by any residual SCs that might not have
been detected in the pure neuron cultures (Figures 4A,B). In
contrast, in the cultures of DRG neurons to which non-neuronal
cells (isolated from acute or chronically denervated sciatic
nerve stumps) were added, many elongated Sudan black-positive
FIGURE 4 | Neurites extended from DRG sensory neurons in vitro become
myelinated in co-cultures with chronically denervated SCs. Myelination of the
axons is not evident in the absence of SCs but it proceeds normally in
SC-DRG sensory neuronal co-cultures, even after chronic SC denervation.
(A,B) DRG neurons (∗) maintained in culture for 24 days without SCs, were not
myelinated as indicated by the arrows and seen by absence of Sudan Black
staining in the unmyelinated axon bundles. Magnification was 20× (A) and
40× (B). (C–E) DRG axons were myelinated when DRG neurons were
co-cultured with SCs whether or not the SCs were acutely denervated
(C: 7 days) or chronically for 7 weeks (D,E) or 17 months by transecting and
ligating the sciatic nerve in vivo in the right and left hindlimbs, respectively,
prior to co-culture. Scale bar = 30 µm.
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profiles were observed (Figures 4C–E). These profiles exhibited
the well characterized structure of myelin sheathes. These
findings demonstrate that the SCs that remain in chronically
denervated nerve stumps retain their capacity to form myelin
sheaths around neurites.
Neurite myelination was quantitated by counting the myelin
segments formed at 24 days after the co-culture of DRG neurons
with the acutely and chronically denervated non-neuronal
cells (see ‘‘Materials and Methods’’ section). In the assay,
the non-neuronal cells that were isolated from chronically
denervated sciatic nerve stumps from the left hindlimbs (i.e., the
7-week and 17-month groups) and co-cultured with DRG
neurons, elaborated as many myelin segments as was elaborated
by those cells isolated from the 7-day (acutely denervated)
nerves from the right hindlimbs. The mean values (± standard
deviations) were not significantly different (p > 0.05; Figure 5).
DISCUSSION
This study demonstrated that first, SCs do survive in hindlimb
nerve stumps that were chronically denervated for periods of up
to 17 months. However, their numbers diminish dramatically.
Second, the chronically denervated and atrophic SCs retain their
abilities to associate with and to proliferate in response to contact
with the neurites that extend from co-cultured DRG neurons.
However, the rate at which the SCs re-enter the cell cycle is
lower after a long period of denervation. Third, the chronically
denervated SCs also sustain their capacity to myelinate the
neurites extended in co-cultures of the cells with DRG neurons.
Chronically Denervated SCs Atrophy and
Many Die
Regeneration of injured peripheral nerves requires the presence
of viable SCs in the denervated nerve stump (Hall, 1986).
FIGURE 5 | DRG sensory neurites in vitro become myelinated irrespective of
the duration of SC denervation in vivo. The mean (± standard deviation)
counts of myelin segments in SC-DRG co-cultures. There was no statistical
difference in the counts when the co-cultures were performed with SCs that
were acutely (7 days) or chronically denervated (7 weeks and 17 months) in
the right and left hindlimbs, respectively (p > 0.05).
Orphaned SCs normally proliferate in response to the mitogenic
factor(s) provided by ingrowing axons (Wood and Bunge, 1975;
Salzer and Bunge, 1980; Salzer et al., 1980a,b; Sabue et al., 1984;
Pellegrino and Spencer, 1985; Stewart et al., 1991; Morrissey
et al., 1995). When SCs are chronically denervated for extended
periods of time, the SCs undergo atrophy and decline in number
(Weinberg and Spencer, 1978; Röyttä and Salonen, 1988; Salonen
et al., 1988; You et al., 1997; Bradley et al., 1998; Dedkov
et al., 2002; Jonsson et al., 2013; Kumar et al., 2016). There is
a concomitant decline in the capacity of injured neurons, both
motor and sensory, to regenerate their axons (Fu and Gordon,
1995a; Gordon et al., 2011; Jonsson et al., 2013), and in the
numbers of regenerated nerve fibers (Jonsson et al., 2013). In
our present study, the numbers of non-neuronal cells doubled
7 weeks after chronic distal nerve stump denervation in the
experimental left hindlimb as compared to the number in the
control right hindlimb (Figure 2A) but the cells likely included
mast cells and fibroblasts that accumulate in the denervated
stump (Salonen et al., 1988; Ronchi et al., 2017) which, in turn,
complete their phagocytic activities within 6–8 weeks prior to
withdrawing their processes (Röyttä and Salonen, 1988). SC
nuclei in the distal nerve stump increase ∼8-fold 25 days after
a crush injury (Abercrombie and Johnson, 1946; Abercrombie
and Santler, 1957) and to decline thereafter (Bradley and Asbury,
1970). Four weeks after chronic denervation, Salonen et al. (1988)
reported an increase of 3.5-fold in SC number, suggesting that
the number of proliferating SCs had already declined by 7 weeks.
The macrophages that enter into distal nerve stumps within
3 days of denervation decline to low levels within a month
(Gibson, 1979; Avellino et al., 1995) and therefore, are not likely
to contribute to the non-neuronal cells that were enumerated
after chronic denervation in the experimental nerves in the left
hindlimbs (Figure 2A) nerve stumps in this study. That several
non-neuronal cells enumerated after chronic denervation were
likely to be SCs is supported by their S100 immunostaining
(Figures 3D–F) after their co-culture with DRG neurons and
hence, their exposure to endogenous mitogens on the surface of
their neurites (Wood and Bunge, 1975; Salzer and Bunge, 1980;
Salzer et al., 1980a,b; Sabue et al., 1984). These SCs demonstrated
processes that were closely associated with and aligned along the
neurites of the DRG neurons, irrespective of the duration of prior
SC denervation in vivo.
The apparent discrepancy between the elevated non-neuronal
cell numbers, of which most are likely to be SCs, and the reduced
neuronal regenerative capacity at 7 weeks (Fu and Gordon,
1995a; Gordon et al., 2011) is likely due to the regression of
the SCs to a non-supportive phenotype in which upregulated
neurotrophic factors, including brain derived neurotrophic
and glial derived neurotrophic factors, their p75 and GFRα-
1 and GFRα-2 receptors, respectively, and soluble neuregulin 1
(Type I/II) and its Erb3/4 receptors, have declined back to low
baseline values (Hoke et al., 2002, 2006; Boyd and Gordon, 2003;
Gordon, 2015; Ronchi et al., 2017).
The non-neural cell numbers of >5 million at 7 days of
acute nerve stump denervation in the right control hindlimb
is dramatically lower, <2 million, in the right experimental
hindlimb after 17 months of chronic stump denervation
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(Figure 2A), consistent with the progressive decline in numbers
of viable SCs that were counted in rat hindlimb nerves after
3 and 6 months chronic denervation followed by 13 weeks nerve
regeneration (Jonsson et al., 2013) and with the observed decline
with light and electron microscopy, in 1–26-month chronically
denervated rabbit nerves (Bradley et al., 1998), and 3–58-week
chronically denervated rat nerves (Weinberg and Spencer, 1978).
Microscopic observations demonstrated progressive Wallerian
degeneration over the course of 7 weeks of chronic nerve stump
denervation (You et al., 1997) with progressive disappearance
of lipid-laden cells and residual myelin debris with cells of
perineurial type (not fibroblasts) encircling small groups of
denervated SC columns and progressive increase in the mass
of collagen and elastin (Weinberg and Spencer, 1978; Bradley
et al., 1998; see also Holmes and Young, 1942; Salonen et al.,
1987a,b). The SC basement membranes progressively fragment,
the shorter fragments dispersing throughout the endoneurium
(Giannini and Dyck, 1990). It is likely that death of non-neuronal
cells within chronically denervated nerve stumps explains the
dramatic decline in their numbers. The nature of the death
pathway is currently unknown and remains to be addressed.
Chronically Denervated SCs Proliferate but
Less so Than Acutely Denervated SCs
Despite high number of non-neuronal cells in the 7-week
chronically denervated distal nerve stumps in the experimental
left hindlimb, the S-100 positive SCs were less able than acutely
denervated SCs in the control right hindlimb to proliferate in
response to endogenous mitogens released by 5-day co-cultured
DRG neurons (Figure 2B). Reduced capacity of p75-positive
SCs to proliferate was reported by Kumar et al. (2016). At
1 week, ∼75% of the acutely denervated SCs proliferated
(Figure 2B), after which the proliferative capacity fell to ∼50%
and ∼30% 7 weeks and 17 months after chronic denervation,
respectively.
These findings of reduced proliferative capacity of chronically
denervated SCs in the left hindlimbs contrast with earlier
findings that SC proliferation was not altered by prior chronic
denervation when the proliferation was evaluated in reinnervated
nerve stumps, 13 weeks after surgical repair of 1–6-month
chronically injured sciatic nerve stumps via an autograft (Jonsson
et al., 2013). It must be recognized though, that, once the
epineurium was removed from the excised distal nerve stump
in that study, the ∼1 mm cut nerve pieces were incubated
in a SC growth medium for 2 weeks and that the medium
was supplemented by the exogenous mitogens of forskolin
and neuregulin NRG1 prior to the isolation and incubation
of the SCs for 7 days (see also Kumar et al., 2016). That
the proliferative capacity of the SCs within the 13-week
reinnervated nerve stumps was the same after this procedure,
irrespective of the period of acute or chronic SC denervation
that preceded the 13 weeks of nerve regeneration (Jonsson et al.,
2013), likely reflected a renewed capacity of the SCs contained
within the distal stump to proliferate normally in response to
regenerating axons. The demonstration by Casella et al. (1996)
of significantly enhanced proliferation of isolated human SCs
after their exposure to the same mitogens immediately after
their isolation, as compared to that of the SCs isolated from
untreated control nerves, provides further evidence that the
proliferative properties of isolated SCs are altered after isolation
and culture in media containing exogenous mitogens. In our
experiments, proliferation of the SCs was analyzed only after the
cells were exposed to the specific SC mitogens that are present
on the surface of DRG neurites in the 5-day SC-DRG co-cultures
(Wood and Bunge, 1975; Salzer and Bunge, 1980; Salzer et al.,
1980a,b).
In the proliferation assay that we used, the isolated
non-neuronal cells were labeled for 24 h with 3H-thymidine after
SC-DRG co-culture for 5 days. The cells were then fixed and
the dividing SCs identified as p75 immunoreactive (Figure 3).
Therefore, the proliferation index measures the occurrence of
new DNA synthesis and thereby, determines the capacity of
the denervated SCs to enter into the cell cycle in response to
the endogenous mitogens on the DRG neurons. SCs, whether
immediately reinnervated or after a delay of 1–6 months,
require time to re-enter the G1 phase of proliferation because
significantlymore reinnervated SCs proliferated at 5 as compared
to 3 days after a 2-week period of incubation (Jonsson et al.,
2013). Nonetheless, the reduced proliferation of chronically
denervated SCs during the early phase of proliferation argue that
the slower rate is unlikely to account for the findings.
The vigorous proliferation that we observed in acutely
denervated SCs from the control right hindlimbs (Figure 2B)
is consistent with the spontaneous upregulation of their erbB
receptors following nerve transection (Carroll et al., 1997; Fricker
and Bennett, 2011; Fricker et al., 2011; Chang et al., 2013) whilst
their reduced proliferation with chronic denervation is likely
linked to their downregulation of erbB2/erbB3 receptors (Li et al.,
1997; Hall, 1999; Jonsson et al., 2013; Ronchi et al., 2017). The
retained, albeit reduced, capacity of chronically denervated SCs
to proliferate in vitro (Figure 2B) and for 5%–10% of freshly
injured neurons to regenerate their axons through chronically
denervated nerve stumps (Fu and Gordon, 1995a; Sulaiman and
Gordon, 2000; Gordon et al., 2011), elaborate normal myelin
sheaths, and to recover their normal size once target contacts
are remade (Sulaiman and Gordon, 2000), demonstrate that the
proliferative quiescence of the chronically denervated SCs from
the experimental left hindlimbs is reversible: the dormant SCs
re-enter the cell cycle and proliferate (Figures 2B, 3), albeit at
a more sluggish initial rate.
Chronically Denervated SCs Remyelinate
Neurites
Sudan Black staining of the SCs isolated from chronically
denervated distal nerve stumps of the experimental left
hindlimbs and co-cultured with DRG neurons for 24 days,
demonstrated normal capacity to remyelinate the neurites
elaborated by the neurons (Figures 4, 5). Sudan Black staining
of the lipid-rich membranes of compacted myelin sheaths
was chosen to demonstrate remyelination of neurites rather
than immunostaining because SC immunostaining without
Sudan Black staining reveals SCs that are making myelin
proteins but are not necessarily making myelin sheathes. SC
immunostaining thereby, could give the erroneous impression
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that the SCs were making myelin sheaths when they were not.
The in vitro findings of neurite myelination reported here,
corroborate our in vivo findings of the remyelination of the
low numbers of axons that injured neurons regenerate into
chronically denervated nerve stumps (Sulaiman and Gordon,
2000). There were no significant differences in the extent of
myelination by acutely or chronically denervated SCs derived
from the right and left hindlimbs, respectively, whether the
duration of chronic denervation was 7 weeks or 17 months
(Figure 5). 1% to 5% of the DRG neurites were well myelinated,
irrespective of the duration of the SC denervation in vivo prior
to their co-culture, the remaining neurites being <1 µm in
diameter and hence, unmyelinated. This ‘‘normal’’ myelinating
capacity of chronically denervated SCs contrasts with the ‘‘severe
impairment’’ of the myelination of the neurites of DRG neurons
by 56-day denervated SCs after the non-neural passaging in
the presence of mitogens and subsequent cell sorting (Kumar
et al., 2016). This reported ‘‘severe impairment’’ however, does
not correspond with the capacity of chronically denervated
SCs to myelinate regenerated axons with restoration of the
normal proportional relationship between myelin thickness and
the size of the myelinated nerves (Sulaiman and Gordon,
2000).
Summary
The survival and sustained capacity of chronically denervated
SCs to re-enter the cell cycle together with the sustained capacity
for these SCs to form myelin around neurites in vitro and
regenerating axons in vivo indicates that surviving SCs may
be stimulated to divide and support axon regeneration and
re-myelination after chronic nerve injuries. Overall our results
suggest that failure of axons to regenerate into long denervated
nerve trunks is not due to lack of ability of the SCs to interact
or respond to the axons. Rather, it is more likely to result
from the reduced numbers of chronically injured neurons to
regenerate their axons (Fu andGordon, 1995b) and the extremely
small number of SCs available to support and remyelinate the
few regenerating axons in chronically denervated nerve stumps
that and support nerve regeneration (Fu and Gordon, 1995a;
Sulaiman and Gordon, 2000; Gordon et al., 2011). As such,
cellular therapy may be a clinically viable option for patients who
have sustained injuries to large nerve trunks.
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The Role of BDNF in Peripheral Nerve
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Treatments and Val66Met
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Despite the ability of peripheral nerves to spontaneously regenerate after injury, recovery
is generally very poor. The neurotrophins have emerged as an important modulator of
axon regeneration, particularly brain derived neurotrophic factor (BDNF). BDNF regulation
and signaling, as well as its role in activity-dependent treatments including electrical
stimulation, exercise, and optogenetic stimulation are discussed here. The importance
of a single nucleotide polymorphism in the BDNF gene, Val66Met, which is present
in 30% of the human population and may hinder the efficacy of these treatments
in enhancing regeneration after injury is considered. Preliminary data are presented
on the effectiveness of one such activity-dependent treatment, electrical stimulation,
in enhancing axon regeneration in mice expressing the met allele of the Val66Met
polymorphism.
Keywords: peripheral nerve injury, BDNF, Val66Met, trkB, electrical stimulation, exercise, optogenetics
PERIPHERAL NERVE INJURY
Despite the ability of axons in peripheral nerves to regenerate, recovery is generally very poor
(Portincasa et al., 2007; Scholz et al., 2009). The cellular changes that occur after an injury
often cannot sustain axon regeneration for the duration required to reinnervate target organs
(Fu and Gordon, 1995a,b). The neurotrophins have emerged as an important modulator of axon
regeneration, particularly brain derived neurotrophic factor (BDNF). Here, we will review BDNF
and its role in activity-dependent treatments to enhance regeneration. Then we will discuss a single
nucleotide polymorphism in the bdnf gene, Val66Met, which is present in 30% of the human
population and may hinder the efficacy of these treatments (Egan et al., 2003; Shimizu et al.,
2004). Finally, we will present preliminary data on the effectiveness of one such activity-dependent
treatment, electrical stimulation (ES), in enhancing axon regeneration in mice expressing the met
allele of the Val66Met polymorphism.
BRAIN DERIVED NEUROTROPHIC FACTOR
BDNF is a member of the neurotrophin family, which also includes nerve growth factor
(NGF), neurotrophin 3 (NT3), and neurotrophin 4/5 (NT4/5). BDNF is required for normal
development—BDNF knockout (KO) is embryonic lethal (Jones et al., 1994; Schwartz et al., 1997).
In adulthood, BDNF is involved in synaptic plasticity, long term potentiation (LTP), learning and
memory as well as hippocampal neurogenesis and regeneration after injury (Lindsay, 1988; Lewin
and Barde, 1996; Lu et al., 2014; Richner et al., 2014). In the subsequent paragraphs, we review
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how BDNF is regulated at the level of mRNA transcripts, protein
trafficking, and receptor binding, following with its role in
peripheral nerve regeneration.
Regulation of BDNF Transcripts
The human BDNF gene resides on the short arm of the
11th chromosome (Maisonpierre et al., 1991). It consists
of 9 exons—eight 5′ untranslated exons and one protein
coding 3′ exon (Figure 1) (Liu et al., 2006; Aid et al., 2007;
Pruunsild et al., 2007). Through alternative splicing, 17 distinct
mRNA transcripts for BDNF have been identified in humans
and 11 in rodents (Pruunsild et al., 2007). Additionally,
the 3′UTR of the gene contains two polyadenylation sites,
resulting in both a long 3′UTR and a short 3′UTR, doubling
the possible splice variants. The entire protein-coding
region resides on exon IX, so the mature BDNF protein
synthesized is identical regardless of mRNA splicing. Splice
variants allow for spatial and temporal control of the BDNF
transcript.
Spatial control of the 5′UTRs can be seen in exon expression
throughout the body. BDNF transcripts containing exons I,
II, and III are found exclusively in the brain, and transcripts
containing exon IV are predominantly found peripherally in the
lung and heart, but can also be found in brain tissue (Timmusk
et al., 1993). Even within brain tissue, different promoters can be
found in different cell types. For example, exon IV transcripts
are required for proper GABAergic interneuron function in the
prefrontal cortex (Sakata et al., 2009).
Many different stimuli exert temporal control over BDNF
transcription. In cultured cortical neurons, Ca2+ influx results
predominantly in transcription of exon IV-containing mRNA
(Tao et al., 1998). This promoter contains a cAMP/Ca2+-
response element-like element (CaRE3/CRE) that is required
for activity-dependent transcription (Tao et al., 1998; Hong
et al., 2008). The transcription factor CREB binds this element,
is phosphorylated by calcium-regulated kinase cascades, and
recruits transcriptional machinery resulting in Ca2+ dependent
transcription of exon IV-containing BDNF mRNA (West et al.,
2001; Lonze and Ginty, 2002). Other stimuli have been identified
in modulating BDNF expression. In motoneurons, exon VI
FIGURE 1 | Structure of BDNF gene and location of Val66Met SNP in the coding exon IX. The G to A substitution in the prodomain results in a valine to methionine
substitution and decreased Ca2+-dependent release of BDNF.
transcripts are androgen sensitive, despite no known androgen
response element on the bdnf gene (Ottem et al., 2010; Sabatier
and English, 2015). There is, however, an estrogen response
element (Sohrabji et al., 1995). SRY-box containing gene 11
(Sox11), a transcription factor involved in neuronal survival,
axon growth, and regeneration after injury, increases exon I
containing BDNF mRNA transcripts specifically in peripheral
DRG neurons, but not in CNS neurons (Jankowski et al., 2006;
Salerno et al., 2012; Struebing et al., 2017). Exons II and VI are
sensitive to tricyclic and atypical antidepressants (Vaghi et al.,
2014).
A further role for 5′ promoter exons regulating BDNF mRNA
may lie in mRNA trafficking. In both cortical and hippocampal
neurons, BDNFmRNA is found in dendrites and activity induces
trafficking of BDNF mRNA to distal dendrites (Tongiorgi et al.,
1997; Capsoni et al., 1999; Chiaruttini et al., 2008, 2009).
Interestingly, only certain splice variants are found in dendrites—
those containing exons IIB, IIC, and VI (Pattabiraman et al.,
2005; Chiaruttini et al., 2008). Transcripts containing exons I, III,
and IV are restricted to the cell body.
Further spatial and temporal translational control of BDNF
mRNA may come via the 3′UTR. The bdnf 3′ UTR contains two
polyadenylation sites. This allows for both a long 3′UTR and a
short 3′UTR to be transcribed (Timmusk et al., 1993; Aid et al.,
2007; Pruunsild et al., 2007). These different 3′UTRs are thought
to determine mRNA trafficking within the cell. Both the long
and short 3′UTR transcripts can be found in the dendrites under
different conditions (Vicario et al., 2015). However, in general,
the long 3′UTR transcripts are trafficked to the dendrites, where
local BDNF synthesis can regulate pruning and enlargement
of synapses, whereas the short 3′UTR transcripts stay in the
cell body (An et al., 2008). Both depolarization of the neuron
as well as BDNF itself increase the number of BDNF mRNA
transcripts targeted to the dendrites (Tongiorgi et al., 1997;
Righi et al., 2000). Remarkably, the short 3′UTR transcripts
account for the majority of BDNF translation, whereas the long
3′UTR transcripts are translationally repressed by RNA binding
proteins which stabilize the mRNA until neural activity elicits
rapid local translation (Lau et al., 2010; Allen et al., 2013; Vaghi
et al., 2014). Calcium influx associated with neuronal activity
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 January 2019 | Volume 12 | Article 52291
McGregor and English BDNF and Peripheral Nerve Regeneration
also results in increased stabilization of BDNF mRNA (Fukuchi
and Tsuda, 2010). Conversely, the 3′UTR also contains regions
which interact with microRNAs, which are short, non-coding
RNA strands that complement mRNA transcripts and result
in transcript degradation (Bartel, 2004). Numerous microRNAs
have been identified as regulators of BDNF, andmicroRNA access
to binding sites depends on the presence of the long or short
3′UTR (Mellios et al., 2008; Varendi et al., 2014).
BDNF Trafficking and Secretion
BDNF, like the other neurotrophins, is synthesized as a pre-
proprotein. The pre-domain functions as a signaling peptide that
directs synthesis to the endoplasmic reticulum (ER) for future
packaging as a secretory protein. It is immediately cleaved to
form proBDNF upon sequestration in the ER (Lessmann et al.,
2003). Within the ER, proBDNF forms homodimers (Kolbeck
et al., 1994). Both proBDNF and a further cleaved form, mature
BDNF, can be packaged into vesicles and secreted. ProBDNF
is approximately 29 kDa, and once cleaved, mature BDNF is
approximately 14 kDa (Seidah et al., 1996a). Intracellularly,
cleavage can occur within the trans-Golgi network or secretory
vesicles by furin, a protease, and proprotein convertases PCSK6
and PC5-6b. Extracellularly, cleavage is executed by tissue
plasminogen activator or matrix metalloproteinases, which are
secreted in an activity-dependent manner (Krystosek and Seeds,
1981; Gualandris et al., 1996; Seidah et al., 1996a,b; Lee et al.,
2001; Mowla et al., 2001; Hwang et al., 2005; Keifer et al., 2009;
Nagappan et al., 2009; Yang et al., 2009). Once cleaved, the
prodomain is not immediately degraded, and can be secreted
with mature BDNF (Anastasia et al., 2013).
From the trans-Golgi network, BDNF is directed to two
different secretory pathways: a constitutive pathway and a
regulated, Ca2+ dependent pathway (Mowla et al., 1999;
Lessmann et al., 2003; Kuczewski et al., 2009). The constitutive
pathway consists of small granules (50–100 nm diameter) that
fuse with the cell membrane near the neuronal somata and
proximal processes. The regulated secretory pathway consists of
larger granules (300 nm diameter) that fuse in distal processes
and axon terminals (Conner et al., 1997; Kohara et al., 2001;
Brigadski et al., 2005; Dieni et al., 2012). The dual pathway
for release is distinctive of BDNF. The other neurotrophins are
preferentially secreted through a constitutive pathway. Under
normal conditions, most neuronal BDNF is packaged into the
regulated pathway (Lu et al., 2014).
Two important interactions have been identified in the
sorting of BDNF into the regulatory pathway. The first to be
discovered was the interaction between the sorting receptor
carboxipeptidase E (CPE) and a three-dimensional motif on
the mature domain of BDNF (Lou et al., 2005). Knocking out
CPE in cortical neurons blocks activity-dependent release of
BDNF and increases constitutive release. Similarly, adding this
motif to NGF redirected its release to the regulated secretory
pathway (Lou et al., 2005). The second interaction is between the
prodomain and the protein sortilin (Chen et al., 2005). Sortilin
is localized predominantly to the Golgi apparatus and interacts
with the BDNF prodomain to direct it to the regulated secretory
pathway (Nielsen et al., 2001; Chen et al., 2005). When sortilin
is unable to interact with the prodomain of BDNF, regulated
release is decreased, but there is no compensatory increase in
constitutive release (Chen et al., 2005; Lu et al., 2005). This has
led to the hypothesis that the interaction between sortilin and
the prodomain of BDNF is necessary for proper protein folding,
which allows CPE to interact with the mature domain and sort
BDNF into one of the two pathways (Lu et al., 2005). When
NT-4/5, which is secreted constitutively, is modified to contain
the BDNF prodomain, it is trafficked to the regulated secretory
pathway (Brigadski et al., 2005). Similarly, blocking the cleavage
of the prodomain of NGF, which is also released constitutively,
results in its sorting into regulated secretory pathways (Mowla
et al., 1999).
BDNF Receptors
Once secreted, BDNF can bind to one of two receptors—
tropomyosin receptor kinase B (trkB) or the common
neurotrophin receptor, p75NTR. Mature BDNF preferentially
binds trkB, resulting in pro-growth signaling, whereas proBDNF
(as well as the other proneurotrophins) preferentially binds
p75NTR, resulting in antigrowth signaling (Lee et al., 2001).
BDNF is primarily secreted as proBDNF (Mowla et al., 1999,
2001; Chen et al., 2004). Thus the availability of proteins that
cleave the prodomain may regulate which receptor is activated
by BDNF release, providing another mechanism for control of
BDNF signaling.
The trkB receptor is a typical tyrosine kinase. When ligand
is bound, it dimerizes and autophosphorylates. In addition
to BDNF, trkB can also bind NT-4/5. Several isoforms of
trkB have been discovered, including isoforms that change its
sensitivity to NT-4/5, as well as a truncated form that lacks an
intracellular kinase domain (Eide et al., 1996). The truncated
form acts as a dominant negative receptor, forming heterodimers
with full length trkB receptors and blocking neurotrophin
signaling (Eide et al., 1996; Fryer et al., 1997). Another possible
role for truncated trkB on astrocytes and Schwann cells may
be to act to control the pool of available neurotrophins,
preventing them from degrading or signaling until released
into the extracellular space (Alderson et al., 2000). In its full-
length form, trkB has several intracellular tyrosine residues that
can be phosphorylated (Huang and Reichardt, 2003). Three
possible signaling cascades are then activated: phospholipase
C gamma (PLCG); phosphotidyl-inositol-3 kinase (PI3K); and
mitogen activated protein kinase/extracellular receptor kinase
(MAPK/ERK) (Reichardt, 2006).
The phosphorylation of residue Y490 creates a binding site
for adaptor protein Shc (Patapoutian and Reichardt, 2001). Shc
binding trkB allows for activation of Ras and further activation
of the MAPK/ERK pathway. Downstream of this pathway is
mechanistic target of rapamycin (mTOR). Shc binding residue
Y490 also results in the recruitment of PI3K and activation of
protein kinase B (Akt) (Reichardt, 2006). The phosphorylation
of residue Y785 creates a binding site for PLCG, which is
then phosphorylated by trkB (Patapoutian and Reichardt, 2001).
This phosphorylation activates PLCG, which then hydrolizes
phosphotidylinositides to generate diacylglyerol (DAG), which
activates protein kinase C (PKC), and inositol 1,4,5 triphosphate
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(IP3), which results in an influx of intracellular Ca2+ stores from
the ER. These signaling cascades all converge at the level of the
nucleus, where transcription is affected through CREB and other
transcription factors (Minichiello, 2009).
Once bound to ligand, trkB is endocytosed to form a signaling
endosome (Delcroix et al., 2003; Reichardt, 2006). Both ligand
and receptor are contained within the endosome, allowing trkB to
continue signaling as it is trafficked through the cell. In this way,
trkB can be moved closer to the nucleus, where it can affect gene
transcription, as well as brought into closer proximity to signaling
effectors (Delcroix et al., 2003). However, not all actions of trkB
happen at the level of the soma—BDNF-trkB activation has been
shown to affect local protein synthesis in the growth cone as well
(Yao et al., 2006).
The second receptor for BDNF is the pan-neurotrophin
receptor, p75NTR (Rodríguez-Tébar et al., 1992). Generally
thought of as a pro-death receptor, p75NTR is a member of
the tumor necrosis factor receptor super family and contains
a cytosolic death domain (Liepinsh et al., 1997; Locksley et al.,
2001). It is expressed primarily during development, but sensory
neurons and spinal motoneurons maintain low expression
through adulthood (Ernfors et al., 1989; Heuer et al., 1990; Wyatt
et al., 1990; Ibáñez and Simi, 2012). Its cytosolic domain is non-
enzymatic, so its actions depend entirely on associations with
cytoplasmic proteins (Nagata, 1997). Despite its canonical role,
p75NTR can mediate both pro-death and pro-survival signals
depending on its cytosolic partners. For example, p75NTR is
required during development for normal neuron growth and
ramification (Yamashita et al., 1999). Multiple adaptor complexes
interact with its cytosolic domain to mediate downstream effects
(Dechant and Barde, 2002).
Additionally, p75NTR has multiple membrane-bound and
extracellular binding partners which can alter whether its
signaling is pro-survival or pro-death. Through extracellular
pairing with sortilin, p75NTR is able to bind the proneurotrophins
(Nykjaer et al., 2004; Teng et al., 2005), resulting in pro-death
or anti-growth signaling through downstream JNK activation
or caspase activation (Reichardt, 2006). However, neurotrophin
binding to p75NTR can also result in NFκB activity, which is
a pro-survival signal (Carter et al., 1996; Hamanoue et al.,
1999; Middleton et al., 2000). One key protein regulated by
p75NTR is RhoA, a small GTPase that regulates the actin
cytoskeleton and inhibits axon elongation (Walsh et al., 1999;
Schmidt and Hall, 2002). Through such interactions with the so-
called death domain of p75NTR, neurotrophin binding inhibits
Rho (Yamashita et al., 1999; Roux and Barker, 2002). Through
forming a receptor complex with the Nogo receptor, NgR1,
p75NTR can act as a receptor for myelin-associated glycoprotein
(MAG) (Wang et al., 2002), which enhances Rho activation and
results in neurite collapse (Mi et al., 2004). Curiously, p75NTR
can act as a binding partner for the trks, including trkB, and
increases affinity and selectivity of binding and thus enhancing
trk signaling (Bibel et al., 1999).
Like trkB, truncated forms of p75NTR have been identified.
One short p75NTR isoform lacks an extracellular ligand binding
domain, but contains its intracellular machinery (Roux and
Barker, 2002). This form is unable to bind the neurotrophins
(Dechant and Barde, 1997). The extracellular domain of p75NTR
can also be cleaved by extracellular metalloproteinases (Roux
and Barker, 2002). These isoforms could act as modulators of
neurotrophin signaling.
The two receptors for BDNF are generally thought to
have opposing roles and may mediate a balance between
growth and death. trkB has a higher affinity for mBDNF,
but as levels of neurotrophin increase, p75NTR will also
bind mBDNF and activate signals in direct opposition to
trkB. Because of the different affinities for pro- and mature
BDNF, cleavage of BDNF becomes another mechanism to
control its downstream signaling effects (Lee et al., 2001).
Depolarization of a neuron, which results in secretion of BDNF,
also results in secretion of tissue plasminogen activator which
cleaves proBDNF to create mature BDNF (Gualandris et al.,
1996). BDNF-trkB signaling increases expression of matrix
metalloproteinase 9, which also cleaves BDNF (Kuzniewska et al.,
2013).
ROLE OF BDNF IN PERIPHERAL NERVE
INJURY
In peripheral nerves, BDNF is synthesized by motoneurons, a
subset of DRG neurons, and Schwann cells (Apfel et al., 1996;
Cho et al., 1997; Michael et al., 1997). After nerve crush or
complete transection, BDNF mRNA increases in all three cell
types, including in trkB- and trkC-expressing DRG neurons not
found previously to express BDNF (Meyer et al., 1992; Funakoshi
et al., 1993; Kobayashi et al., 1996; Michael et al., 1999; Al Majed
et al., 2000a; English et al., 2007). BDNF mRNA can be found in
low levels in the sciatic nerve, and after injury, that expression
is upregulated. This upregulation is sustained over the course of
weeks and can be attributed to both neuronal and non-neuronal
sources (Meyer et al., 1992; Funakoshi et al., 1993). In facial
nerve injury, upregulation of BDNF is correlated with enhanced
functional outcome (Grosheva et al., 2016).
Following sciatic nerve injury, a transient increase in both
BDNF and full length trkB mRNA is found in motoneurons
(Kobayashi et al., 1996; Al Majed et al., 2000a). Unlike sensory
neurons, NGF and trkA are not expressed by motoneurons,
nor are they upregulated after injury (Funakoshi et al., 1993;
Escandon et al., 1994). There is a small and short-lived
upregulation of NT3 and NT4/5 in motoneurons (Funakoshi
et al., 1993). TrkC is expressed by adult motoneurons, but it
is not upregulated after injury (Johnson et al., 1999). Thus, the
rapid upregulation of BDNF and trkB make it likely that BDNF
is the main neurotrophin mediating early motoneuron response
to nerve injury (Boyd and Gordon, 2003).
Schwann cells express only the truncated form of trkB, which
has the potential to act as a dominant negative receptor for BDNF
and NT4/5. Schwann cell truncated trkB mRNA levels decrease
significantly after sciatic nerve injury (Frisén et al., 1993). This
could be viewed as pro-regenerative, enabling available BDNF
to bind to trkB receptors on regenerating neurites and enhance
their growth. Conversely, after injury, Schwann cells upregulate
p75NTR, which has been suggested to result in sequestration of
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neurotrophins and inhibit regeneration (Taniuchi et al., 1986;
Bibel et al., 1999; Scott and Ramer, 2010).
trkB in Peripheral Nerve Injury
Axons regenerate through the formation of growth cones, which
need cytoskeletal proteins, such as actin and tubulin, to extend
and stabilize the new growth. Beta actin mRNA is localized
to peripheral axons, and peripheral nerve injury triggers actin
mRNA to be transported down the axon for local protein
synthesis (Koenig et al., 2000; Sotelo-Silveira et al., 2008; Willis
et al., 2011). BDNF/trkB signaling triggers local translation of
transported mRNAs through a Ca2+-dependent mechanism,
and this is required for bidirectional turning toward BDNF
(Yao et al., 2006). BDNF application to injured axons increases
the number of actin waves (transport of actin filaments and
associated proteins toward the growth cone) per hour (Difato
et al., 2011; Inagaki and Katsuno, 2017). Neurotrophins also
stimulate growth cone sprouting and actin accumulation in the
sprouts (Gallo and Letourneau, 1998). Both of these processes
aremediated through the PIP3/PI3K signaling pathway described
above (Asano et al., 2008). When an actin wave reaches the
growth cone, the growth cone enlarges, branches, and undergoes
forward expansion (Flynn et al., 2009). Application of BDNF
to growth cones results in microtubule reorganization to form
lamellipodial as well as filopodial elongation (Gibney and Zheng,
2003).
In addition to local protein synthesis, trkB signaling has
effects on cyclic AMP (cAMP) production, which may be
important for the initial extension of growth cones across
the site of injury. The MAPK/ERK pathway of BDNF/trkB
signaling results in inhibition of phosphodiesterases (PDE) which
normally degrade cAMP (Gao et al., 2003). As such, BDNF/trkB
signaling results in increased levels of cAMP (Souness et al.,
2000; Gao et al., 2003). This pathway has been shown to
be necessary to overcome inhibition by MAG, and therefore
PDE inhibition has been most thoroughly studied in models
of spinal cord injury, where MAG inhibition of axon growth
creates a substantial barrier to regeneration (Cai et al., 1999;
Gao et al., 2003; Batty et al., 2017). Although injured peripheral
nerves do not suffer inhibition by MAG to the same extent
as that seen in the central nervous system, early in the
regeneration process, inhibitory proteoglycans and myelin debris
form an impermissible environment for axon regeneration
(shen et al., 1998). Increasing cAMP through PDE inhibition
enhances peripheral regeneration after injury, and it is likely
that trkB activation contributes to this cAMP-mediated effect on
regeneration (Gordon et al., 2009; Udina et al., 2010).
The different neurotrophin signaling pathways activated
through trk receptors converge at the level of transcription
in the nucleus. CREB, resulting from trkB-generated PI3K-
Akt activation, increases sensory neurite outgrowth (White
et al., 2000). Inhibiting phosphatase and tensin homolog
(PTEN), an endogenous inhibitor of the PI3K pathway, through
genetic knock out or pharmacology, enhances peripheral nerve
regeneration in vivo and neurite outgrowth in vitro (Park et al.,
2008; Christie et al., 2010). Numerous other transcription factors
downstream of MAPK/ERK signaling, such as c-jun, STAT3, and
ATF-3, have all been associated with changes in gene expression
after injury that enhance survival and regeneration (Makwana
and Raivich, 2005). mTOR, also downstream of MAPK/ERK
signaling and repressed by PTEN, regulates protein synthesis and
is also beneficial for DRG regeneration after injury (Park et al.,
2008; Abe et al., 2010).
p75NTR in Peripheral Nerve Injury
Because of its roles in both pro-death and pro-survival signaling,
it is not surprising that the role of p75NTR in regeneration after
injury has been controversial. Although generally considered an
anti-growth signal, its role is far more complex as evidenced by
conflicting results using p75NTR knock-out mice.
Although expression is high during development, mature
Schwann cells do not express p75NTR. Schwann cell expression
of p75NTR increases after injury (Taniuchi et al., 1986; Heumann
et al., 1987a,b). Deletion of p75NTR in Schwann cells mediates
improved regeneration inDRGneurons (Scott and Ramer, 2010).
Conversely, for motoneurons, Schwann cell p75NTR deletion
results in diminished functional recovery and axonal growth
(Tomita et al., 2007). Expression of p75NTR is thought to
mediate remyelination through a BDNF-dependent mechanism.
Disruption of endogenous BDNF signaling impairs myelination
(Cosgaya et al., 2002; Zhang et al., 2008), as does p75NTR
knockout from Schwann cells (Cosgaya et al., 2002; Song et al.,
2006; Tomita et al., 2007).
In motoneurons, p75NTR levels rise dramatically after injury,
returning to baseline levels by 30 days (Raivich and Kreutzberg,
1987; Yan and Johnson, 1988; Ernfors et al., 1989; Koliatsos
et al., 1991; Saika et al., 1991; Rende et al., 1995; Gschwendtner
et al., 2003). This upregulation in p75NTR does not result in
motoneuron cell death, however (Bueker and Meyers, 1951;
Kuzis et al., 1999). Treating injured motoneurons with low-
levels of recombinant human BDNF enhances their regeneration.
Higher doses, however, result in failure to regenerate, which
can be reversed by p75NTR blockade (Boyd and Gordon, 2002).
There is currently no motoneuron-specific p75NTR knockout
model, but conflicting results have been found with regard
to motoneuron regeneration in p75NTR pan-knockout mice.
Boyd and Gordon found improved motor axon regeneration
in knockout mice after peroneal nerve transection (Boyd and
Gordon, 2001). Gschwendtner et al. found no effect of knocking
out p75NTR on facial nerve axon regeneration (Gschwendtner
et al., 2003). Ferri et al. found worse axon regeneration but
improved functional recovery after facial nerve crush (Ferri et al.,
1998). Song et al. found fewer regenerating axons in p75NTR
knockout mice using both sciatic nerve and facial nerve crush
injuries (Song et al., 2009). Most recently, Zhang et al. found
worse axonal regeneration among p75NTR knockout mice using
a facial nerve crush model (Zhang et al., 2010). Using cell-type
specific knockout of p75NTR or targeting the binding partners of
p75NTR that result in different signaling could provide clarity to
these conflicting results in how p75NTR is affecting motoneuron
regeneration.
Sensory neurons decrease expression of p75NTR after injury
(Zhou et al., 1996). Unlike adult motoneurons, there is significant
cell death of DRG neurons after an injury, but this is restricted
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to small-diameter, mainly cutaneous afferent neurons (Welin
et al., 2008; Wiberg et al., 2018). Cell death in these smaller
DRG neurons can be blocked by application of NGF (Rich
et al., 1987; Ljungberg et al., 1999). Likewise, in injured DRG
neurons, BDNF acts in an autocrine loop to prevent cell death,
and disruption in BDNF expression increases cell death (Acheson
et al., 1995). A decrease in expression of p75NTR could act as a
survival signal, such that the endogenous increased neurotrophin
secretion would be more likely to bind trk receptors and result in
pro-survival signaling. In support of this hypothesis, in cultures
of DRG neurons in which p75NTR has been rendered inactive,
cell survival is higher, and increased neurotrophin concentration
does not result in increased cell death (Zhou et al., 2005).
Similarly, disrupting the NT binding domain of p75NTR results
in increased sprouting after injury in DRG neurons (Scott et al.,
2005).
Despite the upregulation of BDNF and its receptors after
injury, neither BDNF nor the other neurotrophins (NGF,
NT3, and NT4/5), is required for spontaneous regeneration of
peripheral neurons (Diamond et al., 1987, 1992; Streppel et al.,
2002; Wilhelm et al., 2012). However, application of exogenous
BDNF enhances axonal regeneration, functional recovery and
decreases synaptic stripping (Lewin et al., 1997; Boyd and
Gordon, 2002, 2003; Davis-Lopez de Carrizosa et al., 2009).
Recently, small molecule trkB agonists have been developed, and
these also enhance regeneration after injury (English et al., 2013).
ACTIVITY DEPENDENT TREATMENTS
ENHANCE REGENERATION
The first published report using activity-dependent treatments
to enhance peripheral nerve regeneration was from Hines in
1942. He tested both electrical stimulation (ES) and different
exercise paradigms in enhancing functional outcome in rats
with tibial nerve transections (Hines, 1942). Since then, there
has been great interest in treatments which activate injured
neurons, collectively known as activity-dependent treatments,
to enhance nerve regeneration (Udina et al., 2011a). These
treatments include ES (Table 1), exercise (Tables 2–4), and
more recently, optogenetic stimulation (Table 5). One benefit
of activity-dependent treatments is the potential for easy
translation from bench to bedside—using ES and exercise in
human patients would require meeting far fewer regulatory
requirements than the use of an experimental drug. Moreover,
for nerve injuries that require surgical intervention, ES could
be performed easily at the time of surgical repair of the
nerve, as has already begun with clinical trials for patients
undergoing surgery for carpal tunnel release and complete
digital nerve transection (Gordon et al., 2010; Wong et al.,
2015). Exercise has the advantage of being low cost and
allowing patients to take control of their recovery. However,
in the case of extensive injuries, exercise may not be an
option for a recovering patient. For this reason, finding
treatments that mimic the effects of exercise, such as optogenetic
stimulation, may be advantageous in treating patients. To
accomplish such a goal, an understanding of the biological
basis for the enhancement seen with these treatments is
necessary.
Electrical Stimulation
Immediately after a peripheral nerve injury, a calcium wave
propagates along the cut axons toward their cell bodies. Blocking
this calcium wave through inhibition of voltage gated calcium
channels or inhibition of calcium release from the neuronal
endoplasmic reticulum blocks regeneration (Ghosh-Roy et al.,
2010). It has been proposed that ES mimics the retrograde
calcium wave that propagates at the time of injury in order
to elicit cell-autonomous mechanisms that initiate regeneration
(Mar et al., 2014). This hypothesis is supported by evidence that
ES enhances early regeneration by accelerating the process of
axons crossing the site of injury to enter endoneurial tubes in the
segment of the nerve distal to the injury (Brushart et al., 2002).
ES results in a doubling of the number of motoneurons crossing
the site of injury into the distal nerve at 1 week after nerve injury
(Brushart et al., 2002). Without treatment, axons can take as long
as 4 weeks to cross the site of injury, but by 3 weeks after injury,
Al Majed et al. found all electrically stimulated motoneurons had
already regenerated to their target muscle compared to 8 weeks
for untreated controls (Al Majed et al., 2000b; Brushart et al.,
2002).
The first applications of ES focused on the functional recovery
of the affected muscles. In 1983; Nix and Hopf described that
as early as 2 weeks after injury, treatment with 4Hz stimulation
24 h daily increased twitch force, tetanic tension, and muscle
action potentials (Nix and Hopf, 1983). In 1985; Pockett and
Gavin found earlier return of the plantar extensor reflex with
just 15–60min of 20Hz stimulation (Pockett and Gavin, 1985).
Al Majed et al. chose their 20Hz regimen based on the mean
physiological frequency of motoneuron discharge and tried
numerous stimulation regimens, stimulating continuously for
1 h, 1 day, 1 week, and 2 weeks. They were the first to examine
the effect of ES on the regenerating axons (Loeb et al., 1987; Al
Majed et al., 2000b). Just 1 h of 20Hz stimulation resulted in long-
lasting enhancement of peripheral nerve regeneration. Following
publication of this paper, 20Hz stimulation became the standard
for studying ES (Table 1).
Without treatment, axon regeneration into motor or sensory
pathways in the distal segment of a cut nerve is random
for the first 2 weeks following injury (Brushart, 1993).
Motoneurons whose axons have entered only sensory pathways
(endoneurial tubes previously occupied by cutaneous axons)
remain permanentlymistargeted (Brushart, 1993). Enhancing the
speed of regeneration but increasing mistargeting could result
in poorer functional recovery. However, ES has been shown
to increase the sensorimotor specificity of regenerating axons
after peripheral nerve injury. More motoneurons regenerate
exclusively into motor pathways in rats treated with ES
(Al Majed et al., 2000b). Fewer than 40% of injured DRG
neurons reinnervated sensory pathways in controls compared
to 75% in ES-treated animals (Brushart et al., 2005). However,
innervating a motor endoneurial tube does not necessitate
reaching the appropriate muscle target. Indeed, topographic
analysis of motoneuron regeneration after ES revealed increased
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TABLE 1 | Effect of electrical stimulation on peripheral nerve regeneration.
Regimen Model Result References
Unspecified 3 min/day Rat tibial nerve crush Functional recovery Hines, 1942
4Hz 24 h/4 weeks Rabbit soleus nerve crush Functional recovery Nix and Hopf, 1983
20 hz 15–60min Rat sciatic nerve crush Functional recovery Pockett and Gavin, 1985
20Hz 60min, 24 h, 1
week, 2 weeks
Rat femoral nerve transection Axonal growth Al Majed et al., 2000b
20Hz 8 h/day/4 weeks Rat sciatic nerve avulsion Functional Recovery Tam et al., 2001
100 hz 10 pulses/2min Cultured rat retinal ganglion cell Neurite outgrowth Goldberg et al., 2002
20Hz 1 h Rat femoral nerve transection Axonal growth Brushart et al., 2002
20Hz 1 h Rat femoral nerve transection Axonal growth Brushart et al., 2005
20Hz 1 h Thy1-H-YFP mouse fibular nerve
transection
Axonal growth English et al., 2007
20Hz 1 h, 3 h, 24 h, 1
week, 2 weeks
Rat femoral nerve transection 1hr-Axonal growth Others—no
change
Geremia et al., 2007
20Hz 1 h Mouse femoral nerve transection Functional recovery Ahlborn et al., 2007
? 30 min/day until
recovery
Rat facial nerve transection Functional recovery Lal et al., 2008
20Hz 1 h Rat sciatic nerve transection Functional Recovery Axonal
growth
Vivo et al., 2008
20 hz 1 h Human carpal tunnel syndrome
release surgery
Functional recovery Gordon et al., 2010
20Hz 3 days Rat adult cultured DRG neurons Neurite outgrowth Enes et al., 2010
20Hz 1 h Rat sciatic nerve crush Myelination and myelin thickness Wan et al., 2010
20Hz 1 h Thy1-H-YFP mouse sciatic nerve
transection
Axonal growth Singh et al., 2012
20Hz 1 h Rat cultured DRG neurons Neurite outgrowth Singh et al., 2012
20Hz 30 min/day
1–7days
Rat facial nerve crush Functional recovery Foecking et al., 2012
20Hz 20min Rat sciatic nerve
Delayed repair 2 h−24 weeks
Axonal growth Functional
recovery
Huang et al., 2013
20Hz 1 h Human digital nerve transection Functional sensory recovery Wong et al., 2015
20Hz 1 h Rat common peroneal nerve
transection
Delayed repair 3 months
Axonal growth Elzinga et al., 2015
Regimen specifies stimulation paradigm. Model specifies which animal and injury model was used. Result specifies what outcome measure was analyzed. Denotes improvement in
outcome measured, denotes worse outcome.
misdirection of regenerating motor axons to functionally
inappropriate targets by over 500% (English, 2005). This
misdirection resulted in motoneurons previously innervating
extensor muscles reinnervating antagonistic flexor muscles.
Appropriate pathway innervation may rely on Schwann cells
secreting specific growth factors for motor and sensory tubes.
Schwann cells in the cutaneous nerves express high levels of
NGF after injury, whereas Schwann cells in ventral roots express
high levels of glial cell line-derived neurotrophic factor (GDNF)
(Hoke et al., 2006; Brushart et al., 2013). This difference in
growth factor expression has been proposed to be the mechanism
through which preferential motor reinnervation occurs, with
DRG neurons choosing paths with high NGF, and motoneurons
entering paths with high GDNF. With no treatment, in rodents,
neurotrophin expression peaks 15 days after injury and declines
back to baseline by day 30. The day 15 peak coincides with the
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TABLE 2 | Effects of treadmill training on peripheral nerve regeneration.
Regimen Duration Delay Model Result References
6.5–27 m/min
10–40 min/day
1-2/day 2-3 weeks Rat sciatic nerve crush ♀ Functional recovery Herbison et al., 1980a
27 m/min
1–2/day
5 days/week
3–4 weeks 2–3 weeks Rat sciatic nerve crush ♀ No change Herbison et al., 1980b
1 h/day
26.8 m/min
10 weeks Prior to injury Rat L4 root transection ♀ Increased sprouting Gardiner et al., 1984
10 m/min
30 min/twice/day
21 days None Rat sciatic nerve crush ♂ Functional recovery van Meeteren et al., 1998
10 m/min
1.5 h/twice/day
5 days/week
10 weeks 1 week Rat peroneal nerve transection ♀ Functional recovery Marqueste et al., 2004
18 m/min
30 min/twice/day
2 weeks 12 h Rat sciatic nerve crush ♂ Axonal growth Seo et al., 2006
10 m/min*1 h/day
20 m/min
Or
2 min*4/day
5 days/week
2 weeks 3 days Thy1-H-YFP mouse sciatic nerve
transection
Axonal growth Sabatier et al., 2008
8 m/min
30 min/twice/day
2 weeks 12 h Rat sciatic nerve crush ♂ DRG
culture ♂
Axonal growth
Neurite length
Seo et al., 2009
10 m/min*1 h/day
20 m/min
2 min*4/day
5 days/week
2 weeks 3 days Mouse sciatic nerve transection Axonal growth English et al., 2009
20Hz 1 h ES + 5
m/min
2h/day
4 weeks 5 days Rat sciatic nerve transection ♀ Axonal growth Asensio-Pinilla et al., 2009
20 cm/s-54 cm/s
60 min/day
5 days/week
5 or 52 days 3 days Mouse sciatic nerve chronic
constriction injury ♂
Functional recovery Cobianchi et al., 2010
4.6 m/min
30min/twice/day
4 weeks 5 days Rat sciatic nerve transection ♀ Functional Recovery
Axonal growth
Udina et al., 2011b
1.8–3 m/min
20 min/day
3 weeks 7 days Rat ulnar nerve crush ♂ Functional recovery Pagnussat et al., 2012
10 m/min
1 h/5 days/week
2 weeks 3 days Rat sciatic nerve transection ♀ Functional recovery Boeltz et al., 2013
10 m/min
1 h/5 days/week
2 weeks 3 days Mouse sciatic nerve transection ♀ ♂ Synaptic stripping Liu et al., 2014
10 m/min
1 h/5 days/week
6 weeks 3 days Mouse median nerve transection ♂ Functional recovery Park and Höke, 2014
20 m/min
2 min*4/day
5 days/week
2 weeks 3 days SLICK::BDNFf/f mouse sciatic
nerve transection ♀
Synaptic stripping Krakowiak et al., 2015
Regimen is the speed of running and for how long each day. Duration is how many days TT was performed. Delay refers to how long after injury before exercise was performed. Model
specifies what type of injury and in what animal. Sex of animals is specified by ♀ or ♂. If this is not listed, it was not specified. Result specifies what outcome measure was analyzed.
Denotes improvement in outcome measured, denotes worse outcome. No arrow denotes no effect.
onset of pathway preference for regenerating axons (Gordon,
2015). ES, however, dramatically increases NGF secretion from
Schwann cells for 3 days following stimulation (Koppes et al.,
2014), possibly providing an earlier signal to regenerating sensory
axons as to which pathways to take, and thus improving pathway
targeting.
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TABLE 3 | Effect of swimming exercise on peripheral nerve regeneration.
Regimen Delay Model Result References
1 h/day Unspecified Rat tibial nerve transection Functional recovery Hines, 1942
10 min/day
10 days
4, 11, 18 days Rabbit sciatic nerve crush Myelination Sarikcioglu and Oguz, 2001
30 min/day
2 weeks
None
2 weeks
Rat sciatic nerve crush ♂ Decreased sprouting Teodori et al., 2011
10–30 min/day
3 days/week
3 weeks
7 days Rat sciatic nerve transection No change Liao et al., 2017
Regimen specifies how long swimming exercise lasted each day and how many days swimming was performed. Delay refers to how long after injury before exercise was performed.
Model specifies what type of injury and in what animal. Sex of animals is specified by ♀ or ♂. If this is not listed, it was not specified. Result specifies what outcome measure was
analyzed. Denotes improvement in outcome measured, denotes worse outcome. No arrow denotes no effect.
Exercise Treatment
For years, the evidence for exercise enhancing regeneration
was not as clear as the evidence for ES. Many different types
of exercise with varying intensities applied at different times
prior to or after injury have resulted in conflicting results.
It was hypothesized that increased neuronal activity through
exercise would enhance regeneration as early as 1979, but early
studies utilizing treadmill training, voluntary wheel running,
and swimming found unfavorable results (Hoffer et al., 1979;
Herbison et al., 1980a; Gardiner et al., 1984; Badke et al., 1989;
van Meeteren et al., 1998; Tam et al., 2001). These experiments
largely focused on the effect of exercise onmuscle fiber alterations
and muscle function, and did not probe the effect of exercise on
axon regeneration.
The change in emphasis from the effect of exercise on
denervated muscle to the effect of exercise on injured spinal
motoneurons and DRG neurons encouraged scientists to
continue researching exercise, despite previous underwhelming
results. In 2008, English and colleagues tested the efficacy of
interval training (short high-speed sprints followed by periods of
rest) in enhancing regeneration as a model that resembles how
mice voluntarily run (De Bono et al., 2006; Sabatier et al., 2008).
They found the surprising result that this regimen was effective
only in femalemice, and in fact themore commonly used training
regimen of slow continuous treadmill walking was effective only
in males (Wood et al., 2012). This previously unknown sex
difference could have affected outcomes in numerous exercise
experiments. For example, Seo et al. treated intact male rats with
either high or low intensity treadmill training before culturing
their DRGs and found only low intensity treadmill training
increased neurite outgrowth (Seo et al., 2009). Their treadmill
training regimen was very similar to the one used by Wood et al.
that proved effective only in male mice, and the results of this
experiment could have been different had females been included.
Many of the prior experiments mentioned used animals of only
one sex, and this could explain some of the variability in the
effects of exercise (Tables 2–4).
There are a few advantages to exercise over ES. For
example, while ES may increase misdirection of motoneurons
reaching targetmuscles, treadmill training enhancesmotoneuron
regeneration without decreasing topographic specificity (English
et al., 2009). The mechanism of ES is to accelerate crossing the
site of injury by regenerative sprouts; exercise does the same
but also sustains pro-growth signaling throughout the process of
regeneration (Gordon and English, 2016). There is also evidence
that the enhancing effects of 2 weeks of exercise are more robust
than that of a single bout of ES (Sabatier et al., 2008; Wood
et al., 2012; Gordon and English, 2016). In 2009; Asensio-Pinilla
et al. combined treadmill training with a single bout of ES
given at the time of injury, and found greater enhancement
of muscle reinnervation in the initial phase of recovery
compared to either treatment alone (Asensio-Pinilla et al.,
2009). Thus, after inauspicious beginnings, exercise has shown
great promise as a treatment in the field of peripheral nerve
regeneration.
Optogenetic Stimulation
The advent of optogenetics enabled cell-specific neuronal
activation with the use of the light-sensitive cation channel,
Channelrhodopsin (ChR2) (Krook-Magnuson et al., 2014).
Whereas ES stimulates all cells within the nerve (including
Schwann cells and various immune cells) and exercise likely
affects cells throughout the entire body, specific neuronal
activation can be achieved using optogenetics by expressing
ChR2 only in neurons. Park et al. were the first to demonstrate
the efficacy of light stimulation in enhancing regeneration by
replicating the common ES protocol using light stimulation of
20Hz for 1 h on explanted neonatal DRGs (Park et al., 2015).
Although they tested a number of different stimulation regimens,
the 1 h of 20Hz stimulation provided the largest effect on neurite
outgrowth. Ward et al. recapitulated this in vivo, finding that 1 h
of 20Hz light stimulation of light-sensitive neurons enhanced
axon regeneration only in the light-sensitive cells (Ward et al.,
2016, 2018).
MECHANISMS
Neurotrophins
Activity-dependent treatments require neuronal neurotrophin
production. ES increases neurotrophin expression in Schwann
cells, DRG neurons, and motoneurons (Al Majed et al., 2000a;
English et al., 2007; Wan et al., 2010; Koppes et al., 2014).
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TABLE 4 | Effect of other exercise paradigms on peripheral nerve regeneration.
Exercise Regimen Delay Model Result References
Forced Wheel Running 2 h/day Unspecified Rat tibial nerve transection Functional Recovery Hines, 1942
Overwork Chronic None Rat sciatic nerve crush ♀ Functional recovery Herbison et al., 1973
Voluntary wheel running 4 weeks None Mouse tibial nerve transection Functional recovery
Axonal growth
Badke et al., 1989
Axonal growth
Stretch Training 24 days None Rat sciatic nerve crush ♀ Functional recovery van Meeteren et al., 1997
Voluntary wheel running 8 h/day None L4 and L5 avulsion ♀ Axonal growth
Functional Recovery
Tam et al., 2001
Functional Recovery
Voluntary wheel running 3 or 7 days Prior to injury Rat DRG culture Rat sciatic
nerve crush
Neurite outgrowth
Axonal growth
Molteni et al., 2004
Manual Whisker
Stimulation
5 min/day
5 days/week
2 months
1 day Rat facial nerve transection ♀ Functional Recovery Angelov et al., 2007
Manual Muscle
Stimulation
5 min/day
5 days/week
2 months
1 day Rat hypoglossal transection ♀ Functional Recovery Guntinas-Lichius et al.,
2007
Manual Whisker
Stimulation
5 min/day
5 days/week
2 months
1 day Rat hypoglossal transection ♀ Functional Recovery Evgenieva et al., 2008
Manual Muscle
Stimulation
5 min/day
5 days/week
2 months
1 day Rat facial nerve transection ♀ Functional Recovery Bischoff et al., 2009
Manual Whisker
Stimulation
5 min/day
5 days/week
2 months
1 day BDNF+/− or trkB+/− rat facial
nerve transection ♀
Functional Recovery Sohnchen et al., 2010
Passive bicycle training 45 rpm 30
min/twice/day 4
weeks
5 days Rat sciatic nerve transection ♀ Functional Recovery
Axonal growth
Udina et al., 2011b
Skilled Motor Task 20 min/day 3
weeks
7 days Rat ulnar nerve crush ♂ Functional recovery Pagnussat et al., 2012
Exercise refers to what type of paradigm was used. Regimen specifies how long exercise lasted each day and how many days exercise was performed. Delay refers to how long after
injury before exercise was performed. Model specifies what type of injury and in what animal. Sex of animals is specified by ♀ or♂. If this is not listed, it was not specified. Result specifies
what outcome measure was analyzed. Denotes improvement in outcome measured, denotes worse outcome. No arrow denotes no effect.
Electrically stimulating Schwann cells increases their secretion
of NGF specifically, and not BDNF (Koppes et al., 2014). While
Schwann cell NGF is sufficient to promote axon growth, the study
of axon regeneration through nerve grafts made acellular by
repeated freezing and thawing has demonstrated that stimulation
of Schwann cells (and other cell types) is not required for the
efficacy of ES to enhance axon regeneration (English et al.,
2007; Koppes et al., 2014). Moreover, the use of optogenetics to
stimulate neurons selectively has shown that specific neuronal
activation is sufficient to enhance regeneration (Ward et al.,
2016). ES is also effective in promoting regeneration in nerves
that have been repaired months after injury, when Schwann cells
have stopped secreting neurotrophins and have started to die
off (Sulaiman and Gordon, 2000; Hoke et al., 2006; Brushart
et al., 2013; Huang et al., 2013; Elzinga et al., 2015). Thus,
while activity-dependent treatments may increase Schwann cell
neurotrophin secretion, this is not required for their enhancing
effects.
Unlike non-neuronal cells, neuronal neurotrophin secretion
is required for the efficacy of activity-dependent treatments.
Genetically deleting NT4/5 or BDNF from Schwann cells does
not alter the efficacy of ES or treadmill training in enhancing
axon growth, but deleting these neurotrophins from neurons
abolishes the effectiveness of these activity-dependent treatments
(English et al., 2007; Wilhelm et al., 2012). Both exercise and ES
have been shown to increase neuronal BDNF and its receptor,
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TABLE 5 | Effect of optogenetic stimulation on peripheral nerve regeneration.
Regimen Mouse Model Result References
1 h
20 Hz
5ms pulse
Thy1ChR2 Neonate DRG explant Neurite outgrowth Park et al., 2015
1 h
20 Hz
1ms pulse
Thy1ChR2 Sciatic nerve transection Axonal outgrowth Ward et al., 2016
1–2 h
10–20Hz (72 k
pulse total)
1ms pulse
Avil-Cre::ChR2-YFPf/f
Chat-ChR2-YFP
Sciatic nerve transection Axonal outgrowth Ward et al., 2018
Regimen specifies stimulation paradigm. Mouse specifies what transgenic mouse model was used. Result specifies what outcome measure was analyzed. Denotes improvement
in outcome measured, denotes worse outcome.
trkB (Al Majed et al., 2000a; Gomez-Pinilla et al., 2002; English
et al., 2007; Park and Höke, 2014; Park et al., 2015). Through co-
culturing light-sensitive DRG explants with wild type DRGs, Park
et al. demonstrated that the BDNF secreted in response to light
stimulation was sufficient to increase neurite outgrowth not only
from cells in a light-sensitive (ChR2-expressing) DRG, but also in
neighboring ganglia derived fromwild typemice. Protein analysis
of the media revealed increased BDNF and NGF secretion in
response to optical stimulation from the light-sensitive DRGs
only (Park et al., 2015).
There is a dose-dependence in activity-dependent treatments
for enhancing nerve regeneration. Whereas 1 h of 20Hz
stimulation has been shown to enhance DRG regeneration
after injury, an increase to just 3 h of ES decreased sensory
neuron regeneration, and was associated with a downregulation
in expression of the regeneration associated gene, GAP-43
(Geremia et al., 2007). In vitro, neurites from DRG explants
containing ChR2 had higher rates of growth with stimulation
paradigms resulting in 72k pulses of light (1 h 20Hz, 2 h
10Hz, 4 h 5Hz) than stimulation paradigms that resulted in
a higher number of pulses (20Hz for 1–3 days) or much
lower number of pulses (20Hz for 15min) (Park et al.,
2015). Three days of continuous depolarization through ES
or high concentrations of KCl results in complete failure of
dissociated DRG neurons to grow neurites in culture (Enes
et al., 2010). For motoneurons, high intensity exercise or
repeated bouts of ES result in decreased sprouting and fewer
synaptic contacts at neuromuscular junctions (Tam et al., 2001).
Application of 1 h of 20Hz ES every third day for 2 weeks
after sciatic nerve transection and repair did not enhance the
regeneration of motor axons in mice (Park et al., under review).
Interestingly, exogenous application of BDNF resulted in a dose-
dependent enhancement of axon regeneration as well (Boyd
and Gordon, 2002). Low to modest doses produced enhanced
axon regeneration, but higher doses inhibited regeneration.
Treatments with high doses of BDNF caused p75NTR activation,
which prevented DRG neurite outgrowth (Boyd and Gordon,
2002).
Neuronal Activity
The success of activity-dependent treatments in promoting
axon regeneration requires activation of the injured neurons.
Treating the neurons proximal to the stimulation site with
tetrodotoxin (TTX) to block their ability to conduct antidromic
action potentials abolishes the effect of ES, despite the continued
orthodromic firing of distal axons and muscle fibers (Al Majed
et al., 2000b). Similarly, inhibition of motoneuron activity during
treadmill training, using bioluminescent optogenetics (BL-OG),
abolishes the enhancing effect of exercise on motoneuron
regeneration (Jaiswal et al., 2017). Whether the increased
activation needed to promote axon regeneration requires action
potential generation is not entirely clear. Enhancement of
regeneration of axons of many more motoneurons than are
likely to be brought into full activity is found after treatments
with exercise at a slow treadmill speed (Gordon and English,
2016). Simply increasing the excitability of injured neurons
using chemogenetics could be sufficient to enhance regeneration
(Jaiswal et al., 2018).
Although Park et al. found that BDNF secretion from
neighbors can stimulate regeneration in neurons that were
not activated in vitro, optogenetic stimulation in vivo of only
motoneuron axons did not enhance DRG axon regeneration, nor
vice versa (Ward et al., 2018). When BDNF is knocked out in
only a subset of neurons, those specific neurons do not benefit
from exercise treatment (Wilhelm et al., 2012). Thus, it appears
neuronal BDNF is acting as an autocrine signal facilitating
enhanced regeneration (English et al., 2014; Gordon, 2016).
Androgens
The sex difference found in response to different exercise
regimens led to the hypothesis that androgen receptor signaling
was involved in activity-dependent treatments. The effect of
androgens in enhancing peripheral nerve regeneration had
already been thoroughly explored several years prior (Fargo et al.,
2009). All motoneurons contain androgen receptors, though
testosterone is not required for spontaneous regeneration—
treating animals of both sexes with the androgen receptor
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blocker flutamide does not inhibit regeneration, nor does
castration of males (Freeman et al., 1995; Thompson et al.,
2013). Application of exogenous androgens in males and females,
however, enhances axon regeneration in both cranial and spinal
nerve injuries (Kujawa et al., 1989, 1991; Jones, 1993; Freeman
et al., 1995; Tanzer and Jones, 1997; Brown et al., 1999).
This effect is androgen receptor-dependent, and blocking the
androgen receptor with flutamide prevents testosterone-induced
enhanced regeneration (Kujawa et al., 1995). In females, treating
mice with anastrazole, an aromatase inhibitor which blocks
the conversion of testosterone into estradiol, also dramatically
enhanced axon regeneration, without increasing serum androgen
levels (Thompson et al., 2013).
The sex difference in response to exercise regimens was
evidence that androgen receptor signaling and activity-
dependent treatments were linked. Slow, continuous treadmill
training resulted in an increase in serum testosterone levels
in males, though no similar increase was found for females
with interval training (Wood et al., 2012). Castrating males
prior to treadmill training abolishes its enhancing effect,
which cannot be rescued with interval training (Wood et al.,
2012). Treating both sexes with flutamide before appropriate
exercise regimens abolishes the effectiveness of this treatment
in enhancing peripheral nerve regeneration (Thompson et al.,
2013). Testosterone is also necessary for the beneficial effects
of ES—castrated rats treated with ES have poorer regeneration
compared to littermates who are treated with exogenous
testosterone (Hetzler et al., 2008; Sharma et al., 2009). As
with exercise, flutamide blocks the enhancing effects of ES in
both males and females (Thompson et al., 2013). Conversely,
combined exogenous androgen treatment with ES enhances
facial nerve regeneration in gonadally intact rats (Sharma et al.,
2010b).
Androgens regulate BDNF and its receptor, trkB, in
motoneurons (Osborne et al., 2007; Ottem et al., 2010; Sharma
et al., 2010a; Verhovshek et al., 2010). Exercise elicits an
upregulation of testosterone that is sustained and could result in
an increased duration of BDNF and trkB expression (Thompson
et al., 2013; English et al., 2014). ES elicits an early increase
in BDNF expression, whereas exogenous androgen application
results in a later and longer-duration increase in expression.
Combining the two treatments results in an additive upregulation
of BDNF and could explain the improved recovery over either
treatment alone (Sharma et al., 2010a).
SYNAPTIC REARRANGEMENTS
After peripheral nerve injury both excitatory and inhibitory
synaptic inputs onto injured motoneurons are withdrawn
(Blinzinger and Kreutzberg, 1968; Brannstrom and Kellerth,
1998; Linda et al., 2000; Oliveira et al., 2004). If motor axons
regenerate and reinnervate muscle targets, many of these inputs
are restored but, for those expressing the vesicular glutamate
transporter 1 (VGLUT1) and arising from muscle spindles, a
gradual withdrawal of their central axonal processes from the
ventral horn follows, resulting in a permanent loss of these
synaptic inputs (Alvarez et al., 2011; Rotterman et al., 2014). In
animals treated with exercise during the first few days following
sciatic nerve transection and repair, the extent of synaptic
contacts between these important sources of proprioceptive
feedback and motoneurons is not reduced (English et al., 2011;
Liu et al., 2014; Krakowiak et al., 2015). This robust connectivity
by VGLUT1+ inputs is retained at least 12 weeks later. No similar
effect is found if the onset of the exercise treatment is delayed
(Brandt et al., 2015). Application of 1 h of 20Hz ES had no effect
on synaptic coverage after nerve injury, but repeated applications
every third day for 2 weeks resulted in an effect similar to that
observed using exercise (Park et al., under review). It is not clear
whether this effect of these activity-dependent therapies is the
prevention of the original synaptic withdrawal, a stimulation of
new synapse formation to replace the withdrawn inputs, or some
combination of both. More studies are needed.
It is clear that BDNF plays a role in maintaining and
preserving synaptic inputs on motoneurons. Without exercise,
axotomizedmotoneurons lose approximately 35% of their overall
synaptic coverage (Krakowiak et al., 2015). This effect is BDNF-
dependent—knocking out BDNF in a subset of motoneurons
reduces synaptic coverage in those specific cells in intact animals,
and this synapse loss cannot be rescued with exercise (Krakowiak
et al., 2015). Wild-type motoneurons within an animal maintain
their synaptic contacts after nerve injury with exercise, but those
in which BDNF has been knocked out do not (Krakowiak et al.,
2015).
BDNF VAL66MET POLYMORPHISM
Given the relationship between activity-dependent treatments
and BDNF, any genetic mutations altering BDNF signaling
among the human population could affect the success of these
treatments. Such a mutation exists—a common single nucleotide
polymorphism in the BDNF gene. The G to Amutation at site 196
results in a Valine to Methionine substitution in the 66th codon
(Figure 1). This polymorphism was first described by Egan et al.
in 2003 and was quickly identified as incredibly common—the
met allele of the BDNF gene is present in 25% of the American
population and up to 50% of East Asian populations (Egan
et al., 2003; Shimizu et al., 2004). Carrying the met allele was
originally described as a risk factor for schizophrenia (Egan et al.,
2003). It has since been linked to numerous other disorders
and diseases, including Alzheimer’s disease, obsessive compulsive
disorder, anorexia nervosa, and bipolar disorder (Neves-Pereira
et al., 2002; Sklar et al., 2002; Egan et al., 2003; Hall et al.,
2003; Ribases et al., 2003; Notaras et al., 2015). Physiologically,
Met-carriers have been found to have decreased hippocampal
volume, and cells transfected with the Met allele have altered
activity-dependent secretion of BDNF (Egan et al., 2003).
Testing for deficient activity-dependent secretion of BDNF in
humans can be tricky. Generally, BDNF secretion is measured
through serum as an indirect measure of neuronal BDNF, and
exercise is a reliable method to increase serum BDNF levels
(Berchtold et al., 2005; Elfving et al., 2010; Klein et al., 2011;
Szuhany et al., 2015). Although one study has found that healthy
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adult Met-carriers did have increased serum BDNF after exercise
(Helm et al., 2017), others have found serum levels of BDNF did
not increase after high intensity exercise in elderly (Nascimento
et al., 2015), spinal cord injured (Leech and Hornby, 2017), or
healthy Met-carriers (Lemos et al., 2015). In mice expressing the
met allele, exercise results in deficient mRNA production as well
as decreased protein expression of BDNF (Ieraci et al., 2016).
These deficiencies in exercise-induced BDNF secretion mirror
the findings in cultured neurons expressing the Met allele, and
the use of cells transfected with the met allele in vitro as well as
the development of a transgenic mouse have allowed researchers
to elucidate the mechanism behind this deficient secretion (Egan
et al., 2003; Chen et al., 2004, 2006).
The valine to methionine substitution in this SNP occurs
in the prodomain of the BDNF protein (Egan et al., 2003).
Although it does not affect the ability of mBDNF to bind its
receptor, this substitution results in disorganized folding of the
prodomain, resulting in abnormal interactions with sortilin (see
above) (Chen et al., 2004; Anastasia et al., 2013). BDNFMet is thus
packaged inefficiently into calcium-sensitive secretory vesicles,
accounting for the deficient activity-dependent secretion that has
been reported (Chen et al., 2004). Being heterozygous for the
met allele does not protect from this deficient BDNF secretion—
BDNF forms homodimers, and in cells heterozygous for the
met allele, BDNFMet dimerizes with BDNFVal and prevents its
packaging into Ca2+-regulated secretory vesicles (Kolbeck et al.,
1994; Chen et al., 2004). Analysis of activity-induced BDNF
secretion from cultured hippocampal cells bears this out—those
cells heterozygous for the Met allele have deficient activity-
dependent secretion despite the presence of one copy of the
BDNFVal allele (Chen et al., 2006). Furthermore, once secreted,
BDNF availability may be affected by binding with the cleaved
prodomain. The prodomain binds BDNF with high affinity, and
the met allele results in enhanced BDNF binding and slower
dissociation once bound (Uegaki et al., 2017). This could limit
the availability of BDNF to bind its receptors.
Activity-dependent secretion of BDNF relies not only on
packaging into calcium-sensitive vesicles, but also on the spatial
targeting of mRNA into distal processes where BDNF can be
locally translated (Chiaruttini et al., 2008). This targeting is
achieved through binding of BDNF mRNA with translin, a
DNA/RNA binding protein involved in dendritic trafficking
of mRNAs (Li et al., 2008). The G to A mutation at site
196 disrupts translin binding of BDNF mRNA, and thus Met-
carriers have deficient trafficking of BDNF mRNA to distal
processes (Chiaruttini et al., 2009). Moreover, the transcripts
containing exon VI, which is upregulated by exercise, and exon
IV, which is calcium-sensitive, are found in reduced levels in the
hippocampus of mice homozygous for the met allele (Tao et al.,
1998; Baj et al., 2012; Mallei et al., 2015). These transcripts, along
with those containing exon II, are generally trafficked to distal
processes (Baj et al., 2011).
In addition to deficient activity-dependent BDNF secretion,
the met allele may result in increased p75NTR activation. Unlike
BDNFVal, when the prodomain is cleaved from BDNFMet, it is
bioactive and able to activate p75NTR with the help of SorCS2,
a member of the sortilin family of receptors (Deinhardt et al.,
2011; Anastasia et al., 2013). In vitro, application of exogenous
prodomain protein results in growth cone collapse and dendritic
spine disassembly (Anastasia et al., 2013; Giza et al., 2018).
Stimulating cells with high KCl concentration results in activity-
dependent secretion of both Val and Met prodomains, though
secretion is deficient in Met-carriers (Anastasia et al., 2013).
Although endogenous secretion of the Met prodomain has yet
to be linked to alterations in dendrites, decreased arborization
has been found in hippocampal and cortical neurons (Chen et al.,
2006; Liu et al., 2012).
The deficit in activity-dependent release of BDNF led to the
hypothesis that activity-dependent treatments to enhance axon
regeneration after peripheral nerve injury would be ineffective
in this population. Using a mouse model of this polymorphism
which recapitulates certain phenotypic aspects of the human
population such as decreased hippocampal volume and increased
anxiety-like behavior (Chen et al., 2006), we tested the efficacy
of treadmill training on motor axon regeneration 4 weeks after
complete sciatic nerve transection and repair in mice both
heterozygous and homozygous for the met allele of the Bdnf
gene (McGregor et al., under review). Exercise was completely
ineffective in enhancing axon regeneration in the Met-carriers.
However, peripheral axon regeneration in Met-carriers was
surprisingly enhanced without any treatment (McGregor et al.,
under review). One possibility for the failure of exercise
to enhance regeneration in Met-carriers is a ceiling effect—
exercise was not able to further enhance an already accelerated
regeneration. The question of why regeneration is accelerated
remains to be explored. The enhanced regeneration was found
both in vivo and in cultured DRG neurons, indicating that
enhanced axon outgrowth is a neuronal trait inMet-carriers. This
unanticipated result is some of the first good news regarding
what is a maligned SNP, although others have reported the met
allele may also be protective in stroke and traumatic brain injury
(Krueger et al., 2011; Rostami et al., 2011; Qin et al., 2014; Failla
et al., 2015). Thus, in human populations there may be striking
differences in response to peripheral nerve injury dependent on
individual gene expression. Enhanced regeneration associated
with the Val66Met polymorphism may explain the persistence of
the mutation within the human population.
CONCLUSION
The suboptimal regeneration of peripheral nerves presents a
challenge in medical care. Neurotrophins, particularly BDNF,
have been studied for their pro-growth properties, and
treatments that stimulate endogenous release of neurotrophins
have been successful in enhancing regeneration in animal
models. These treatments are currently being tested to enhance
peripheral nerve regeneration in patients with some success
(Gordon et al., 2010; Wong et al., 2015). The existence of
genetic polymorphisms in the bdnf gene, however, will affect the
outcome of these experiments, and preliminary investigations as
to the efficacy of activity-dependent treatments in individuals
with the met allele will hopefully spur the field toward
personalized medicine. Activity-dependent treatments can be a
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powerful tool for those responsive to them, and for the rest, new
therapies that do not rely on endogenous BDNF-signaling must
be developed.
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The remarkable plasticity of Schwann cells allows them to adopt the Remak (non-
myelin) and myelin phenotypes, which are specialized to meet the needs of small and
large diameter axons, and differ markedly from each other. It also enables Schwann
cells initially to mount a strikingly adaptive response to nerve injury and to promote
regeneration by converting to a repair-promoting phenotype. These repair cells activate
a sequence of supportive functions that engineer myelin clearance, prevent neuronal
death, and help axon growth and guidance. Eventually, this response runs out of steam,
however, because in the long run the phenotype of repair cells is unstable and their
survival is compromised. The re-programming of Remak and myelin cells to repair
cells, together with the injury-induced switch of peripheral neurons to a growth mode,
gives peripheral nerves their strong regenerative potential. But it remains a challenge
to harness this potential and devise effective treatments that maintain the initial repair
capacity of peripheral nerves for the extended periods typically required for nerve repair
in humans.
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INTRODUCTION: OVERVIEW OF SCHWANN CELLS AND NERVE
INJURY
Examination of the Schwann cells in uninjured nerves shows two surprisingly different cell types.
One of them is the rather inconspicuous Remak cell, or non-myelin Schwann cell. These cells
envelop all the small diameter axons, including many sensory axons and the all-important axons
of the autonomic nervous system. The axons lie in troughs along the cell surface, and in rodents
each cell generally ensheaths several axons, although in human nerves, one axon per Remak cell
is common. The larger axons, including some sensory axons and the axons of motor neurons, are
wrapped by myelin Schwann cells. They are 2–3 times longer that Remak cells and much bulkier,
containing the myelin sheath, which is formed by the Schwann cell membrane wrapping multiple
times around the axon and condensing to form a compact myelin cuff around the axon.
Both Remak and myelin cells are coated by a basal lamina, outside of which lies the connective
tissue, the endoneurium, which contains fibroblasts, blood vessels and a few macrophages and is
ultimately surrounded by a multi-layered cellular tube, the perineurium (Figure 1). This assembly
is termed a fascicle. Small nerves are uni-fascicular, while large nerves contain many fascicles bound
together by connective tissue, the epineurium.
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FIGURE 1 | Diagrammatic representation of uninjured and injured nerve. Each diagram shows one fascicle and its main cellular constituents. Red line: basal lamina
of Schwann cells (the basal lamina associated with perineurium and blood vessels is not shown), P, perineurium; R, Remak Schwann cell; M, myelin Schwann cell; F,
fibroblast; E the connective tissue of the endoneurium, Ma, macrophage; BB, Bungner band containing transverse profiles of several repair cells and surrounded by a
basal lamina.
While both Schwann cells are thought to provide axons with
metabolic and trophic support, only the myelin cells have the
key role of accelerating nerve impulse conduction. Remak and
myelin cells also express some common proteins, such as S100,
a classical Schwann cell marker, while at the same time each cell
possesses a characteristic molecular profile (reviewed in Jessen
and Mirsky, 2005, 2016; Glenn and Talbot, 2013; Brosius Lutz
and Barres, 2014; Monk et al., 2015). Thus, Remak cells express
several markers also found on developing Schwann cells, such
as neural cell adhesion molecule (NCAM), p75 neurotrophin
receptor (p75NTR) and glial fibrillary acidic protein (GFAP), and
L1 NCAM. The myelin cells on the other the hand express a
large range of molecules that relate to the synthesis, maintenance
or structure of the myelin sheath. This includes the major
pro-myelin transcription factor Egr2 (Krox20), high levels of the
enzymes that control cholesterol synthesis, structural proteins
such as myelin protein zero (MPZ) and myelin basic protein
(MBP), andmembrane associated proteins like myelin associated
glycoprotein (MAG), PMP22, and periaxin.
As different as Remak and myelin cells appear, these cells
nevertheless originate developmentally from a common cell, the
immature Schwann cell, present in rodent nerves in the perinatal
period (Figure 2). These cells, in turn, derive from a distinct
glial cell of embryonic nerves, the Schwann cell precursor.
The conversion of Schwann cell precursors to Schwann cells
is controlled by transcription factors such as AP2α, Zeb2,
and Notch, and extracellular signals including endothelin and
axon-associated neuregulin, which is essential for precursor
survival (reviewed in Jessen andMirsky, 2005; Jessen et al., 2015b;
Quintes and Brinkmann, 2017).
Schwann cell precursors unambiguously exhibit a glial
phenotype, expressing characteristic glial features, such as
ensheathing axons within nerves and expressing Schwann cell
associated mRNAs, such as those encoding for the major myelin
protein MPZ and desert hedgehog (Dhh). It is interesting,
however, that these cells also retain one notable feature of the
neural crest cells from which they originate, namely they have
a broad developmental potential. Thus, Schwann cell precursors
give rise to cells such as melanocytes, endoneurial fibroblasts
and neurons, in addition to Schwann cells, during embryonic
development (reviewed in Jessen et al., 2015b; Kastriti and
Adameyko, 2017).
One of the most interesting biological properties of Schwann
cells is their plasticity (reviewed in Boerboom et al., 2017;
Castelnovo et al., 2017; Jacob, 2017; Ma and Svaren, 2018).
The phenotype adopted by Schwann cells, such as the Remak
or myelin phenotypes described above, is strikingly dependent
on signals in the cellular environment. Thus, all the evidence
indicates that if a Remak cell was placed in contact with
large diameter axon it would adopt the myelin phenotype
and conversely, a myelin cell would convert to a Remak
cell if associated with small diameter axons. This phenotypic
instability may pre-dispose Schwann cells to demyelinating
disease, since myelin Schwann cells may regress from myelin
maintenance relatively easily in response to mutations that
disturb cellular homeostasis. After nerve damage, Schwann
cell plasticity and the ready response to environmental signals
initially helps to provide nerves with strong regenerative
potential, but at later times after injury, these features contribute
to regenerative failure, as repair supportive Schwann cells are
not sustained during the long times required for nerve repair in
humans.
After nerve injury, the Schwann cells distal to the damaged
area lose contact with axons as they degenerate. This represents
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FIGURE 2 | The main transitions in the Schwann cell lineage during development and after injury. Black uninterrupted arrows show normal development. Red
arrows show the Schwann cell injury response. Black stippled arrows show post-repair reformation of Remak and myelin cells (with permission from Jessen et al.,
2015b).
a radical change in the signaling environment, because key
signals for the control Schwann cell phenotype come from
axons. Subsequently, further change is provided by a cocktail of
bioactive factors secreted by macrophages, which invade injured
nerves in large numbers. In response to these perturbations,
Schwann cells show a remarkably fortunate response. This is
the conversion of Remak and myelin cells, within their original
basal lamina tubes, to a Schwann cell phenotype, the repair
Schwann cell, which is specialized to encourage regeneration
(reviewed in Jessen and Mirsky, 2016; Figure 2). These cells
execute a repair program, a partly overlapping sequence of
phenotypic changes involving myelin autophagy, expression of
cytokines that call in macrophages for later stages of myelin
clearance, activation of trophic factor expression and cellular
elongation and branching to form regeneration tracks, called
Bungner Bands. In this way, repair cells clear myelin, support
the survival of injured neurons, axon regeneration and target
innervation. These are the cells present in the distal stump of
injured nerves along which regenerating axons navigate after
injury, often for months or even years in humans due to the slow
rate of axon growth.
One of the main problems in human nerve repair is that
the phenotype of repair cells is not stable, but fades with time
as the cells fail to maintain expression of trophic factors that
promote axonal growth, likely due to gradual changes in the
signaling environment within the chronically denervated distal
stump (reviewed in Höke, 2006b; Sulaiman and Gordon, 2009).
Furthermore, the repair cell population is not stable, their
number eventually declining to very low levels. The reasons for
the deterioration of repair cells are poorly understood, although
the transcription factors STAT3 and c-Jun have been implicated
in this process.
Importantly, PNS neurons also respond to axonal damage
by activating an extensive gene program that facilitates axonal
regeneration, a response classically referred to as the cell body
response or the signaling to growth mode switch (Allodi et al.,
2012; Blesch et al., 2012; reviewed in Fu and Gordon, 1997;
Doron-Mandel et al., 2015).
Therefore, in response to damage, both neurons and Schwann
cells convert to cell states that are specialized to deal with
injury and promote healing. Comparable reprogramming of
differentiated cells in response to injury can also be seen
in other systems. This includes the conversion of fibroblasts
to myofibroblasts during wound healing, and of pigmented
epithelial cells to lens cells in the eye, the conversions of
supportive cells to hair cells in the ear, hepatocytes to biliary
epithelial cells in the liver, and of endocrine α to β cells in the
pancreatic isles. In all of these cases, differentiated cells change
identity in order to promote tissue homeostasis and repair.
This type of change has therefore been termed adaptive cellular
reprogramming (reviewed in Jessen et al., 2015a).
Eventually, axons that have successfully regenerated induce
ensheathing repair cells to adopt again the Remak and myelin
phenotypes, thereby restoring the nerve to its functional state.
The repair Schwann cells are therefore a transient population,
which exists only while they are needed.
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We will now discuss some of the issues aired above in more
detail.
THE SCHWANN CELL INJURY RESPONSE:
THE GENERATION OF REPAIR CELLS
Unfortunately, in humans most nerve injuries involve nerve
transection rather than the more easily repaired nerve crush.
After a nerve crush, the basal lamina around each axon/Schwann
cell unit remains intact and an axon stays within its basal lamina
tube as it grows across the injury site to reach the distal stump. It
therefore has a favorable possibility to reconnect with its original
target tissue and restore function.
In contrast, after cut, the connective tissue and basal lamina
tubes are disrupted. Regeneration units consisting of axons
accompanied by Schwann cells grow through a tissue bridge
that forms between the proximal and distal nerve stumps.
As a result of complex signaling between axons, Schwann
cells and macrophages, involving factors such as Sox2, ephrin-
B/EphB2 and TGFb, and guidance by fibroblasts and blood
vessels, axons regenerate across the bridge to meet the Schwann
cells that grow from the transected end of the distal stump
(Parrinello et al., 2010; Cattin et al., 2015; Clements et al.,
2017; reviewed in Cattin and Lloyd, 2016). Thus in cut nerves,
continuity between the proximal stump and the target is broken,
and axons are much less likely to find their way into their original
basal lamina tubes and their target tissues, compromising
proper restoration of function (Morris et al., 1972; Friede and
Bischhausen, 1980; Meller, 1987; Barrette et al., 2008). The
standard clinical treatment is to re-attach the proximal and distal
nerve stumps. Although this leaves only a microscopic gap to be
filled by a bridge, the problem of axons finding their original
basal lamina tubes remains (Witzel et al., 2005). This problem
is amplified when extensive injuries are repaired by the insertion
of a nerve graft or an artificial insert (Figure 3). The interesting
and intricate cellular interactions in the bridge region will not
be discussed here in detail (for review see Cattin and Lloyd,
2016).
It does not matter whether axons are interrupted by crush
or cut, in the distal stump the response of Schwann cells to
injury is similar. In both cases, it converts Remak and myelin
cells to repair supportive Schwann cells. The Schwann cell injury
response has two principal components and will be discussed in
terms of myelin Schwann cells only although similar principles
are likely to apply to the response of Remak cells. The reversal of
myelin differentiation represents one component. Genes coding
for Egr2 (Krox20), cholesterol-related enzymes and the myelin-
related proteins MPZ, MBP, MAG and periaxin are down-
regulated. Conversely, molecules that characterize developing
Schwann cells and adult Remak cells including, NCAM, p75NTR,
GFAP and L1 are up-regulated (reviewed in Chen et al., 2007;
Jessen and Mirsky, 2008; Martinez et al., 2015; Boerboom et al.,
2017).
The second important part of the injury response is the
appearance of a set of repair-supportive characteristics that are
not seen, or seen in a muted form, in Schwann cells in normal
mature nerves or in Schwann cells in developing nerves. This
repair component of the response includes a number of elements
(reviewed in Jessen and Mirsky, 2016).
1. Factors that promote the survival of injured neurons
and axonal elongation are up-regulated. These include
neurotrophic factors and surface molecules such as glial cell
FIGURE 3 | Main cell and tissue components of regenerating nerves. Repair cells in Bungner bands are shown in dark orange (e). Light blue shows the Schwann
cells of the tissue bridge, some of which migrate out from the distal stump (c), while others accompany regenerating axons forming regeneration units (a). Not shown
is the basal lamina that covers the Schwann cells in the proximal stump and the Bungner bands in the distal stump. The bridge Schwann cells receive important
signals from blood vessels (b), fibroblasts and macrophages (d). The position of an inserted regeneration conduit is also shown (although the cellular events within it
will depend on the nature of the conduit; with permission from Jessen and Arthur-Farraj, 2019).
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line-derived neurotrophic factor (GDNF), artemin, brain-
derived neurotrophic factor (BDNF), neurotrophin-3 (NT3),
nerve growth factor (NGF), vascular endothelial growth factor
(VEGF), erythropoietin, FGFs, pleiotrophin, N-cadherin and
p75NTR (Grothe et al., 2006; Fontana et al., 2012; Brushart
et al., 2013; reviewed in Boyd and Gordon, 2003; Chen et al.,
2007; Scheib and Höke, 2013; Wood and Mackinnon, 2015).
2. An innate immune response is activated. This involves the
upregulation of cytokines including tumor necrosis factor
α (TNFα), interleukin-1α (Il-1α), Il-1β, leukemia inhibitory
factor (LIF), monocyte chemotactic protein-1 (MCP-1) and
toll-like receptors by the Schwann cells in the distal stump
(reviewed in Martini et al., 2008; Rotshenker, 2011). This
allows repair Schwann cells to recruit macrophages and
other immune system cells such as neutrophils to the nerve,
promoting nerve regeneration in several ways. Cytokines
including Il-6 and LIF attract macrophages to the nerve
but also act directly on neurons to promote axon growth
(Hirota et al., 1996; Cafferty et al., 2001; reviewed in Bauer
et al., 2007). An additional sustained source of cytokines
are macrophages that invade nerves and ganglia. They also
promote vascularization of the nerve bridge between the
proximal and distal stumps (Barrette et al., 2008; Niemi et al.,
2013; Cattin et al., 2015). Macrophages also co-operate with
Schwann cells to degrade myelin debris (see further below;
reviewed in Hirata and Kawabuchi, 2002; Rotshenker, 2011).
3. Schwann cells proliferate and then undergo a striking about
three-fold elongation as they form the regeneration tracks,
Bungner bands, which are essential for guiding axons back
to their target areas (see further below). These structural
changes are a component of the tissue remodeling which
transforms the distal stump into a collection of regeneration
tracks (Gomez-Sanchez et al., 2017).
4. Repair cells activate mTOR-independent autophagy,
myelinophagy, to break down their myelin sheaths, which are
redundant after axonal degeneration (Gomez-Sanchez et al.,
2015; Suzuki et al., 2015; Jang et al., 2016; Brosius Lutz et al.,
2017).
THE PROPERTIES OF REPAIR CELLS
Repair Schwann Cells Show a Distinct
Molecular Profile
At least two genes, Olig 1, Shh, differentiate repair cells from
myelin and Remak cells, and also from immature Schwann
cells, and Schwann cell precursors in embryonic nerves. These
genes are highly up-regulated by c-Jun in Schwann cells of
injured nerves. These genes are distinctive markers of repair
Schwann cells because they are expressed de novo after injury
This applies also to GDNF, with the exception that this gene is
detected in embryonic Schwann cell precursors, although it is
down-regulated before birth (Lu et al., 2000; Zhou et al., 2000;
Piirsoo et al., 2010; Arthur-Farraj et al., 2012; Fontana et al., 2012;
Lin et al., 2015).
In addition, a gene expression screen found over a hundred
genes that were significantly up- or down-regulated in the
distal stump after damage, although they were not regulated
during development, since they were present at similar levels in
developing and adult uninjured nerves. The majority of these
genes were up-regulated by injury. This reveals a substantial
group of genes that are specifically activated in injured nerves,
and which are therefore candidate markers for repair cells (Bosse
et al., 2006).
Timing and the Repair Program
The different components of the repair program are not switched
on synchronously. Instead, each of them reaches peak expression
at different times after injury. For instance, protein levels of
cytokines such as Il-1β and TNFα, peak within 1 day of
injury, but are sharply lower at 3 days (Rotshenker, 2011),
autophagy is high at 5 days and reduced thereafter (Gomez-
Sanchez et al., 2015), GDNF protein levels peak at about
1 week after injury and BDNF is maximally expressed after
2–3 weeks (Eggers et al., 2010). The transcription factor c-Jun
which is an important regulator of the repair program (see
below), is activated within hours of injury, but c-Jun protein
levels continue to increase for at least 7–10 days and cellular
elongation continues for at least 4 weeks after injury (Gomez-
Sanchez et al., 2017). The repair program therefore represents
a temporal sequence of events that overlap and co-operate to
support repair.
The Elongation and Branching of Repair
Cells
One of the cardinal features of Schwann cells is their
extended morphology, a feature that is often associated with
the requirement to stretch out to cover the elongated axons.
However, Schwann cells which lose contact with degenerating
axons in the distal stump do not shorten. Rather, lineage tracing
studies have shown that loss of axonal contact triggers a striking
cellular elongation (Gomez-Sanchez et al., 2017). One week
after nerve transection without regeneration, Remak cells have
doubled in length, and 4 weeks after injury they are three-fold
longer than Remak cells in intact nerves. Similarly, myelin cells
have doubled in length by 4 weeks after injury. Loss of axonal
contact also induces the cells to branch. About 50% and 30% of
repair cells derived from Remak and myelin cells, respectively,
form branches, which are often long and lie parallel to the main
axis of the cell (Gomez-Sanchez et al., 2017; Figure 4).
This study also addressed two long-standing assumptions
about Schwann cells. First, that Remak and myelin cells
generate the cells found in the Bungner bands of injured
nerves, and second, that the Bungner band cells, in turn,
generate the myelin cells found in regenerated nerves. These
fundamental presumptions were confirmed directly using linage
tracing methods (Gomez-Sanchez et al., 2017). This allowed
repair cells from Remak cells and myelin cells to be studied
separately, and made it possible to identify the progeny of myelin
cell-derived repair cells among the cells that re-myelinate nerves
after regeneration. This revealed that re-myelination involves a
remarkable about seven-fold cell shortening, as the elongated
repair cells wrap axons to generate the typically short myelin
internodes of regenerated nerves.
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FIGURE 4 | Myelin, Remak and repair Schwann cells after genetic labeling in vivo. Shown in green are myelin and Remak cells of average length as they appear in
uninjured nerve. In red is an example of a long, branched repair cell (generated from a myelin cell), in 4 week cut nerve without reinnervation. All cells are shown to
scale. Shown also is a schematic diagram of a repair cell and the assembly of these cells to form a Bungner band enclosed by a basal lamina and containing a
regenerating axon (in blue). The electron micrograph shows a transverse section of a Bungner band (red image printed with permission from Gomez-Sanchez et al.,
2017). Scale bar: 1 µm.
Although Remak and myelin cells have sharply different
structure, they generate repair cells with broadly similar
morphology. The extremely elongated and branched structure
of these cells differentiates repair cells from other cells in
the Schwann cell lineage. This morphology also promotes
the generation of uninterrupted and robust regeneration
tracks by maximizing cell-cell overlap within each Bungner
band.
Myelin Clearance
Unlike the CNS, peripheral nerves are able to clear redundant
myelin after axonal degeneration, a feature that is widely believed
to facilitate regeneration because of the growth-inhibitory nature
of myelin (Kang and Lichtman, 2013; reviewed in Hirata and
Kawabuchi, 2002; Rotshenker, 2011). Nerves clear myelin by two
distinct mechanisms. First, Schwann cells switch from myelin
maintenance to actively breaking down their own myelin sheaths
through the mechanism of myelin autophagy (Gomez-Sanchez
et al., 2015; Suzuki et al., 2015; Jang et al., 2016; Brosius Lutz et al.,
2017). This process delivers myelin to Schwann cell lysosomes for
degradation, following internalization of myelin in the form of
myelin ovoids (Jung et al., 2011), and the formation of smaller
cytoplasmic myelin fragments. About 50% of total myelin is
thought to be broken down by Schwann cells (Perry et al., 1995).
Second, myelin debris is phagocytosed and degraded Schwann
cells and in particular by macrophages, which gradually invade
injured nerves, recruited by the repair cell cytokine expression
referred to above.
CONTROL OF REPAIR CELL GENERATION
Repair Schwann Cells Are Controlled by
Dedicated Signaling Mechanisms
A number of mechanisms take part in regulating the Schwann
cell injury response. Importantly, it has become clear that
this includes regulatory mechanisms that operate selectively
in repair cells, and have only a minor or undetectable
function in developing Schwann cells. This applies to the
transcription factors c-Jun and STAT3, which will be discussed in
subsequent sections. Regulation of histoneH3K27 trimethylation
represents another selective mechanism, which appears not
to be significantly involved in control of Schwann cell
development (Ma et al., 2016). In response to injury, however,
the activation of several injury-related genes is promoted by
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removal of the repressive histone mark H3K27 trimethylation
at their promoter regions, combined with the gain of the
active histone mark H3K4 methylation. At the same time,
the active histone mark H3K27 acetylation is lost from the
enhancers of myelin genes as their expression fades (Hung
et al., 2015; Ma et al., 2016). An important, selective role in
repair cells is also played by the tumor suppressor protein
Merlin. Schwann cell specific inactivation of Merlin has major
adverse effects on repair cell function, axonal regeneration
and re-myelination, but only minor effects on Schwann cell
development (Mindos et al., 2017). Together with the c-Jun and
STAT3, these histone methylation events described above, and
merlin, represent gene regulatory mechanisms, which selectively
control repair cells, and appear unimportant in developing
Schwann cells.
Other Signals That Control the Schwann
Cell Injury Response
Positive regulators of repair cell generation or function include
Notch (Woodhoo et al., 2009), Sox2 (Parrinello et al., 2010;
Roberts et al., 2017), gpr126 (Mogha et al., 2016), TGFb
(Morgan et al., 1994; Stewart et al., 1995; Cattin et al., 2015;
Clements et al., 2017) and ERK1/2, although its function is
complex, since it ERK1/2 activation is also required for myelin
synthesis (Harrisingh et al., 2004; Fischer et al., 2008; Newbern
et al., 2011; Napoli et al., 2012; Sheean et al., 2014; Cervellini
et al., 2018; reviewed in Monk et al., 2015; Jessen and Mirsky,
2016; Boerboom et al., 2017). The transcription factor Zeb2 is
required for normal re-myelination after injury, but appears
not to be important for the generation of repair cells (Quintes
et al., 2016; Wu et al., 2016). Toll-like receptors are involved
in up-regulation of cytokines, macrophage recruitment and
myelin clearance after injury, while the mTORC1 pathway
is also involved in myelin clearance and is needed for
effective expression of c-Jun and other repair cell genes
after injury (Boivin et al., 2007; Norrmén et al., 2018). The
significance of these proteins for axonal regeneration is not
clear.
Negative regulation of repair cells is exerted by histone
deacetylase 2 (HDAC2), which is activated after injury acts
to suppress c-Jun and delay the generation of repair cells.
Inhibition of HDAC2 therefore represents a potential route
to improve regeneration, because regeneration is accelerated
whenHDAC2 is inactivated, although re-myelination is impaired
(Brügger et al., 2017; Jacob, 2017).
Considerable attention has been paid to the potential role of
neuregulin in nerve injury. Schwann cells in transected nerves
elevate expression of ErbB2/3 receptors and neuregulin-1 I/ll
isoforms (Carroll et al., 1997; Stassart et al., 2013; Ronchi
et al., 2016). Surprisingly, however, neuregulin-1 is not involved
in injury-induced Schwann cell proliferation, and macrophage
recruitment, and myelin breakdown appears normal in nerves
without neuregulin (Atanasoski et al., 2006; Fricker et al.,
2013). Another unexpected finding is that even after removal of
neuregulin-1 from both Schwann cells and axons, re-myelination
of regenerated nerves after injury is eventually normal after
a substantial delay (Fricker et al., 2013; Stassart et al., 2013).
This contrasts with development, since neuregulin-1, expressed
by axons, is necessary for myelination by developing Schwann
cells (Birchmeier and Nave, 2008). In another deviation form
development, repair Schwann cell-derived neuregulin-1 has
a significant role in accelerating re-myelination after injury,
most likely working through an autocrine signaling loop,
while Schwann cell-derived neuregulin-1 is not important
for developmental myelination (Stassart et al., 2013). The
involvement of neuregulin-1 in the control of myelination
therefore differs between repair Schwann cells and developing
cells.
Inactivation of neuregulin-1 in axons and Schwann cells
results in slow axonal regeneration after injury. This suggests
that endogenous neuregulin signaling through ErbB2/3 receptors
in repair cells promotes the repair phenotype and enhances
the capacity of these cells to support axon growth, but direct
evidence for this mechanism of action is missing. Nevertheless,
pharmacologically enhancing neuregulin signalingmight serve as
a tool for promoting nerve repair, because enforced Schwann cell
ErbB2 expression, and exogenously applied neuregulin increase
axonal regeneration in vivo (Ronchi et al., 2013; Han et al., 2017;
reviewed in Gambarotta et al., 2013).
The Function of c-Jun in Repair Cells
The transcription factor c-Jun plays a crucial role in the Schwann
cell injury response (Jessen and Mirsky, 2016). c-Jun levels
are low in uninjured nerves, but are rapidly and strongly
elevated by injury (De Felipe and Hunt, 1994; Shy et al.,
1996). When this is prevented, by selective inactivation of
c-Jun in Schwann cells in transgenic mice (c-Jun cKO mice)
regeneration of axons and recovery of function after injury are
strikingly compromised. Uninjured nerves in these mice are
essentially normal. This indicates that c-Jun is not essential
for Schwann cell development, and that the role of this
transcription actor is restricted to controlling the response
of Schwann cells to nerve damage (Arthur-Farraj et al.,
2012).
The regeneration failure in c-Jun cKO mice is due to
the important function of c-Jun in injury-induced Schwann
cell reprogramming. c-Jun directly or indirectly affects the
expression levels of at least 172 genes of the ∼4,000 genes
that change expression in Schwann cells after injury. This gives
c-Jun significant control over both parts of the Schwann cell
injury response, de-differentiation of myelin cells and activation
of the repair program (Arthur-Farraj et al., 2012, 2017). c-Jun
helps de-differentiation, because it is needed for the normal
down-regulation of myelin genes after injury. Among these are
the genes encoding the transcription factor Egr2 (Krox20), a
master regulator of the myelin program, and the MPZ and
MBP genes. The negative gene regulation by c-Jun and its
cross-antagonistic relationship with Egr2 (Krox20) had been
studies before its importance for regeneration was revealed
and helped give rise to the idea that c-Jun, in combination
with a group of other transcriptional regulators, including
Notch, Sox2, Id2 and Pax3, functioned as negative regulators
of myelination (Kioussi et al., 1995; Parkinson et al., 2004,
2008; Le et al., 2005; Doddrell et al., 2012; Fazal et al.,
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2017; Florio et al., 2018; reviewed in Jessen and Mirsky, 2008).
Although these genes may be important for modifying the rate
or onset of myelination in developing nerves, a key role for c-
Jun-mediated gene down-regulation in vivo appears to be that of
helping to suppress myelin gene expression in adult nerves after
injury.
c-Jun also promotes the normal activation of the repair
program, which it controls in several important ways (Arthur-
Farraj et al., 2012; Fontana et al., 2012). First, in the absence
of Schwann cell c-Jun (c-Jun cKO mice), important trophic
factors and cell surface proteins that support survival and
axon growth fail to be normally upregulated. This includes
GDNF, artemin and BDNF, p75NTR and N-cadherin. Two
of these, GDNF and artemin, have been shown to be direct
c-Jun targets and have been implicated in sensory neuron
death after injury (Fontana et al., 2012). Normally some dorsal
root ganglion (DRG) sensory neurons and facial motoneurons
die after sciatic and facial nerve injury, respectively, and in
humans DRG neuron death is considered a major reason for
poor outcomes of nerve regeneration (Faroni et al., 2015).
Death of DRG neurons and facial motoneurons is greatly
increased in c-Jun cKO mice. This shows that a key function
for repair Schwann cells and c-Jun signaling is to support the
FIGURE 5 | The structure of regeneration tracks (Bungner Bands) is
controlled by Schwann cell c-Jun. Electron micrographs from the distal stump
of mouse sciatic nerve 4 weeks after transection (without regeneration).
(A) WT nerve showing classic regeneration tracks (Bands of Bungner; an
example is arrowed). (B) Distorted regeneration tracks in c-Jun cKO nerve,
containing irregular and flattened cellular profiles (with permission from
Arthur-Farraj et al., 2012). Scale bar: 1 µm.
survival of injured neurons. Second, the regeneration tracks
formed by denervated Schwann cells without c-Jun have a
disorganized structure (Figure 5). In culture, c-Jun is needed for
the typical narrow, bi/tripolar Schwann cell morphology, since
c-Jun-negative cells tend to be flat and sheet-forming. Similarly,
in vivo, the repair Schwann cells within the regeneration tracks
show grossly abnormal morphology when viewed in transverse
electron micrograph sections. c-Jun appears to be necessary for
the conversion of the complex and sheath-like structure of the
myelin cells to the narrow, rod-like and branched structure
of repair cells that is required for the formation of normal
regeneration tracks. Third, c-Jun promotes myelinophagy, and
c-Jun cKO nerves show a substantial delay in breakdown
of myelin (Arthur-Farraj et al., 2012; Gomez-Sanchez et al.,
2017).
Thus, c-Jun exerts a broad control over the Schwann cell
injury response, and thereby neuronal survival and regeneration.
It is therefore of interest that in two important situations where
repair cells fail, namely chronic denervation and aging, c-Jun
levels in these cells are reduced. This is discussed in ‘‘Nerve Injury
Activates Epithelial Mesenchymal Transition (EMT) Genes’’
section below.
NERVE INJURY ACTIVATES EPITHELIAL
MESENCHYMAL TRANSITION (EMT)
GENES
Recent gene screen studies suggest that the generation of repair
cells involves the activation of a process related to epithelial
mesenchymal transitions (EMTs; Arthur-Farraj et al., 2017;
Clements et al., 2017). RNA-Seq of distal nerve stumps 7 days
after injury show enrichment for EMT mRNAs and miRNAs.
This includes down-regulation of RNAs that are linked to
mesenchymal-epithelial transition (MET), and up-regulation of
RNAs associated with EMT. Enrichment for EMT genes was
also shown in more detailed experiments using FACs to sort
td-tomato labeled Schwann cells from injured nerves (Clements
et al., 2017). This study also showed that EMT activation
was strongest in the Schwann cells the tissue bridge, where
arguably tissue remodeling is more radical than in the distal
stump.
Typically, EMT-like processes involve also an increase in
stemness, namely the activation of genes associated with stem
cells (Fabregat et al., 2016; Liao and Yang, 2017). This is
also seen in injured nerves, where the generation of repair
cells is accompanied by activation of the Myc stemness and
Core pluripotencymodules and suppression of polycomb-related
factors (Clements et al., 2017).
In many tissues, the combined activation of EMT and
stemness is associated with increased cellular motility,
proliferation, morphological flexibility, tissue remodeling,
and the loosening up of differentiation states (Nieto et al.,
2016; Forte et al., 2017). These events are key features of the
response of many tissues to injury. Not surprisingly, therefore,
the activation of EMT and stemness programs have now been
established as a key physiological response to injury in various
tissues.
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The demonstration of EMT/stemness activation in Schwann
cells of injured nerves brings the nerve injury response in
line with injury responses in many other systems. It adds an
important new component to our understanding of the injury
response. In particular, the loosening of differentiation states
associated with increased stemness is consistent with the notion
that nerve injury triggers a shift in Schwann cell differentiation
state from myelin and Remak phenotypes to a Schwann cell state
specialized to promote repair.
WHY DOES REGENERATION FAIL?
In the light of the radical, adaptive injury response of neurons
and Schwann cells, which in many types of rodent experiments
results in effective nerve repair, why is it that the clinical
outcome after nerve injury in humans is generally poor? This
paradox of PNS repair can be explained by a number of factors,
including the hindrance to axon growth provided by the injury
site and the difficulty of getting large numbers of axons from
the proximal to the distal stump, misrouting of axons resulting
in re-innervation errors, and the presence of growth-inhibiting
extracellular matrix. Perhaps the most difficult problems arise
from the relatively slow growth of axons. Because of this, most
human nerve injuries involve chronic denervation of the more
distal parts of damaged nerves and of the target tissues such as
muscle. This results in target atrophy, while neurons gradually
die and surviving neurons may fail to sustain their capacity
to regenerate axons during the extended period required for
repair (Höke, 2006a; Sulaiman and Gordon, 2013; Patel et al.,
2018).
Here, we will consider another major issue in regeneration
failure. This is the fact that the nerve stump distal to transection
gradually loses the ability to support the growth of regenerating
axons during chronic denervation. This has been shown in
a number of studies, most of which represent cross-suturing,
typically involving the suturing of acutely transacted tibial nerve
to the distal stump of the common peroneal nerve, which
had be transected either acutely, the control condition, or at
different times up to 6 months previously. Other experiments for
addressing the same question have studied regeneration through
nerve grafts, where the graft is obtained from nerves that have
been denervated previously for various lengths of time. All of the
experiments agree that transected nerve stumps retain full or only
mildly reduced capacity for supporting regeneration for about
1 month (Li et al., 1997; Sulaiman and Gordon, 2000; Kou et al.,
2011; Jonsson et al., 2013). By 2 months, regeneration support
remains unchanged in some studies (Li et al., 1997), although
other reports show it reduced by about 40%–50% (Sulaiman
and Gordon, 2000; Kou et al., 2011). At 3 months regeneration
support is further diminished and reduced to very low levels by
6 months (Li et al., 1997; Sulaiman and Gordon, 2002; Gordon
et al., 2011; Jonsson et al., 2013; see however Rönkkö et al.,
2011).
While these experiments were carried out on rats, we find that
also inmice, the capacity of distal stumps to support regeneration
is reduced by about 50% after 2.5 months of chronic denervation
(Wagstaff et al., 2017).
IS THE FAILURE OF DISTAL STUMPS TO
SUPPORT GROWTH DUE TO LACK OF
SCHWANN CELLS?
The deterioration in the capacity of chronically denervated
stumps to support regeneration could result from two separate
factors: gradual reduction in Schwann cell numbers, or the
fading of the repair phenotype of cells still present in the nerve.
Both of these factors could in turn be influenced by signals
from macrophages that invade injured nerves and are initially
present in large numbers that decline with time. The question of
whether Schwann cell number is a key factor raises two additional
ones. First, what is known about Schwann cell numbers in
chronically transacted nerves? Second, are variations in Schwann
cell numbers within the range seen in cut nerves likely to affect
regeneration?
While it is long established that nerve injury triggers a
wave of Schwann cell proliferation, there is surprisingly little
quantitative information on Schwann cell numbers in cut nerves
after injury. Cell counts using electron microscopy show that
2 weeks after cut the number of Schwann cells in mouse sciatic
nerve has risen about 2.5-fold compared to uninjured nerves
and remains similar at 1 and 1.5 months (Wagstaff et al., 2017),
Using S100 to identify Schwann cells in the cut sciatic nerve of
rats show 3–4-fold increase at 1–2 weeks with little change at
1.5 months (Siironen et al., 1994). These workers also report a
sharp drop between 1.5 and 2 months, but since S100 is present
at reduced levels after injury, these figures might overestimate
the reduction in Schwann cell number (Siironen et al., 1994).
Another study also using S100 indicates that Schwann cell
numbers at 2.5 months remains 2–3-fold that in uncut nerves
(Salonen et al., 1988). Our data from mouse nerves show a drop
of about 30% between 2 weeks and 2.5 months (Wagstaff et al.,
2017).
A study employing a more indirect method involving
counting of the number of cells obtained by enzymatic
dissociation of nerves at different times after nerve cut without
innervation, concluded that the number of Schwann cells drops
by about 30% between 1 and 2 months with little change at
3 and 4 months (Li et al., 1998). The number of cells that can
be isolated from nerves after 6 months of chronic denervation is
only 10%–15% of that obtained at 4 weeks (Li et al., 1998; Jonsson
et al., 2013).
Although the data are limited and not always consistent, the
above suggests that 2–3 months after chronic denervation, a time
when growth support by the distal stump is significantly reduced,
the number of Schwann cells has dropped at most by about
30%–50% from the high cell number seen 1–4 weeks after injury.
This would mean that the number of cells at 2–3 months remains
substantially higher than the number in uninjured nerves.
Is it likely that this fall from peak cell numbers accounts for the
reduction in regenerative support during chronic denervation?
The answer to this question depends on the weight is put
on the reports discussed below that imply that regeneration
remains normal in nerves where injury-induced increase in
Schwann cell numbers is prevented, and cell numbers in the
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distal stump therefore remain similar to those in uninjured
nerves.
DOES NERVE REGENERATION DEPEND
ON SCHWANN CELL PROLIFERATION?
It is a common view that Schwann cell proliferation and
expansion in Schwann cell numbers in injured nerves is
required for regeneration (Hall and Gregson, 1977; Hall, 2005).
Recent genetic approaches to specifically inhibit Schwann cell
proliferation suggest, however, that this may not be the case.
Injury-induced Schwann cell proliferation depends on cyclin D1,
although this protein is not important for proliferation during
development. Nerves in D1−/− mice therefore develop normally,
but Schwann cell proliferation after injury is blocked. Perhaps
surprisingly, regeneration appears not to markedly affected in
these mice (Kim et al., 2000; Atanasoski et al., 2001; Yang et al.,
2008).
DETERIORATION OF REPAIR CELLS: AN
IMPORTANT REASON FOR
REGENERATION FAILURES
Since Schwann cell numbers after 2–3 months of chronic
denervation are likely to remain at least double that in uninjured
nerves, and in view of the experiments on cyclin1−/− mice
outlined above, it seems that lack of Schwann cells is unlikely
to be the major reason for the reduction in growth support
provided by 2–3 month chronically denervated stumps, although
at later times ongoing reduction in cell number will eventually
be significant. This suggests that the deterioration of repair cells
is a two-stage process involving, first, surviving cells gradually
down-regulating their repair phenotype, followed by death of
cells that have by that time lost most of their regeneration-
supportive properties. There is in fact ample evidence for
such fading of the repair cell phenotype, manifest in reduced
expression of neuron-supportive trophic factors during chronic
denervation, including GDNF, BDNF, NT3 and NGF (Eggers
et al., 2010; reviewed in Boyd and Gordon, 2003; Höke and
Brushart, 2010).
Thus, the fading of the repair phenotype, combined in the
long run with dwindling cell numbers, are likely to be the twin
reasons for reduced growth support provided by chronically
denervated stumps. It is therefore important to identify factors
that control the long-termmaintenance of repair cells, sustain the
expression of repair supportive genes and support cell survival.
SIGNALS THAT MAINTAIN REPAIR CELLS
While there are as yet surprisingly few studies on this important
topic, two transcription factors, STAT3 and c-Jun have recently
been shown to have a role in repair cell maintenance (Benito
et al., 2017; Wagstaff et al., 2017). Activation of Schwann
cell STAT3 is triggered by injury, and largely sustained in
long-term denervated repair cells (Sheu et al., 2000). Genetic
inactivation of STAT3 in these cells results in decreased autocrine
Schwann cell survival signaling and a striking loss of Schwann
cells from chronically denervated stumps. Loss of STAT3 also
reduces the expression of repair cell markers, including GDNF,
BDNF and Shh, during long-term denervation (Benito et al.,
2017). Inactivation of Schwann cell STAT3 does, however, not
significantly affect nerve development. The important role of
STAT3, therefore, is to acts as a brake on the deterioration of
repair cells in chronically denervated adult nerves.
Unlike STAT3, c-Jun levels in Schwann cells decline
significantly during long-term denervation, in tandem with
the fading of the repair phenotype, reduced cell numbers,
and reduced capacity to support regeneration. Significantly,
the ability of long-term denervated repair cells to support
regeneration can be restored to control levels by genetically
enhancing c-Jun expression in these cells to levels similar to
those in short-term denervated nerve stumps (Fazal et al.,
2017; Wagstaff et al., 2017). This raises the possibility that
the deterioration of chronically denervated repair cells is to
a significant extent caused by a failure to sustain high c-Jun
levels.
Aging, like chronic denervation, is accompanied by a marked
reduction in the rate of nerve regeneration (Verdú et al., 2000;
Painter, 2017). Using rodent models, this has been traced
primarily to age-related deterioration of repair Schwann cells,
since repair cells from older animals show reduced expression of
repair cell markers and reduced ability to support axon growth
(Painter et al., 2014). Many of the abnormally expressed genes
are c-Jun regulated, and c-Jun activation after injury is also
significantly reduced in older animals. These observations have
implicated dysregulation of Schwann cell c-Jun in the age-related
deterioration of nerve repair (Painter et al., 2014; Wagstaff et al.,
2017). A support for this suggestion comes from experiments
on transgenic animals in which c-Jun expression in injured old
nerves has been elevated to levels similar to those of injured
young nerves. This correction of Schwann cell c-Jun levels is
sufficient to correct the age-related regeneration deficit, and
accelerate the rate of axonal regeneration to that seen in young
animals (Wagstaff et al., 2017). Therefore, the inability of repair
Schwann cells in older animals to elevate c-Jun to high levels
may be a significant factor in the age-related failure of nerve
repair.
CONCLUSIONS
The key driver of nerve regeneration, apart from the neurons
themselves, are the denervated Schwann cells that make up
the regeneration tracks, Bungner bands, that occupy nerves
distal to the injury site. These repair Schwann cells are
adapted to meet the particular needs that arise in injured adult
nerves. They differ from other Schwann cells, having separate
transcriptional and epigenetic mechanisms, distinct morphology
and molecular profile, in addition to carrying out a set of
functions, comprising the repair program, which support nerve
regeneration.
The realization that these cells possess distinct properties and
cell-type specific control mechanisms is a useful step forward. It
will help to focus future work on learning how to manipulate
these particular cells, how to amplify their repair-supportive
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functions, and how prevent their deterioration in older age and
during the prolonged periods required for axonal regeneration in
human nerves.
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Axonal growth during normal development and axonal regeneration rely on the
action of many receptor signaling systems and complexes, most of them located in
specialized raft membrane microdomains with a precise lipid composition. Cholesterol
is a component of membrane rafts and the integrity of these structures depends on the
concentrations present of this compound. Here we explored the effect of cholesterol
depletion in both developing neurons and regenerating axons. First, we show that
cholesterol depletion in vitro in developing neurons from the central and peripheral
nervous systems increases the size of growth cones, the density of filopodium-like
structures and the number of neurite branching points. Next, we demonstrate that
cholesterol depletion enhances axonal regeneration after axotomy in vitro both in a
microfluidic system using dissociated hippocampal neurons and in a slice-coculture
organotypic model of axotomy and regeneration. Finally, using axotomy experiments in
the sciatic nerve, we also show that cholesterol depletion favors axonal regeneration
in vivo. Importantly, the enhanced regeneration observed in peripheral axons also
correlated with earlier electrophysiological responses, thereby indicating functional
recovery following the regeneration. Taken together, our results suggest that cholesterol
depletion per se is able to promote axonal growth in developing axons and to
increase axonal regeneration in vitro and in vivo both in the central and peripheral
nervous systems.
Keywords: regeneration, cholesterol, lipid rafts, axon growth, growth cone, filopodia
INTRODUCTION
Axonal guidance during the development of the nervous system is thought to be highly
regulated through interactions of transmembrane receptors with attractive, repulsive, and
trophic cues. Similar mechanisms regulate axonal regeneration after injury. The transected axon
undergoes morphological changes to form the growth cone, a highly dynamic structure that
senses the environment and leads the regenerative growth (Allodi et al., 2012). Membrane
receptors localized in the growth cone have an important role in axonal signaling (Guirland
et al., 2004; Kamiguchi, 2006). The regenerative shift of axotomized neurons is promoted
by injury-induced signals, which stimulate the transcription of various trophic factors,
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adhesion molecules, growth-associated proteins and structural
components needed for axonal regrowth and cell survival (Rishal
and Fainzilber, 2014).
Many intrinsic and extrinsic signals can promote or inhibit
axonal regeneration. Due to the importance of these signals
during axonal degeneration and regeneration after peripheral
nerve injury, microdomains in the membrane that cluster a range
of proteins and molecules related to cellular signaling may play a
key role in the regulation of these pathways. In particular, lipid
rafts have been described as cholesterol-enriched cell membrane
microdomains that compartmentalize lipids and protein to form
signaling platforms (Golub et al., 2004).
Cholesterol is a major component of the nervous system,
being essential for normal brain development. The brain is the
most cholesterol-rich organ, containing about 20% of the body’s
total cholesterol (Bjorkhem and Meaney, 2004). Under normal
physiological situations and because plasma lipoproteins do not
cross the intact blood-brain barrier, nearly all cholesterol in the
brain is synthesized in situ (Dietschy and Turley, 2001). Brain
cholesterol is an important structural component of cellular
membranes and myelin. It is also required for the synthesis of
steroid hormones and for the organization of lipid rafts, which
are involved in many aspects of brain function, such as growth
factor signaling, synapse and dendritic formation (Goritz et al.,
2005), and axon elongation and guidance (de Chaves et al., 1997).
Here we studied the effects of altered membrane integrity by
reducing the cholesterol content in the axons of three neuronal
systems, namely hippocampal and cerebellar external granular
layer (EGL) cells as a Central Nervous System (CNS) example,
and the dorsal root ganglion (DRG) neurons as a Peripheral
Nervous System (PNS) example. We show that depletion of
cholesterol leads to increased sizes of growth cones, filopodial
extensions and neurite length. Moreover, we also demonstrate
that cholesterol membrane and raft disruption increase the
regenerative capacity of axons after axotomy both in vitro and
in vivo and enhance muscle and sensory re-innervation of
distal targets. On the basis of our findings, we propose that
acute reduction of neuronal cholesterol emerges as a potential
therapeutic strategy to improve regenerative outcomes after
peripheral nerve lesion.
MATERIALS AND METHODS
Reagents and Antibodies
The following antibodies were used: anti-GFP (A11122,
Invitrogen); anti-IIIβ-tubulin (MMS-435P, Covance); anti-
growth associated protein 43 (GAP43) (AB5220, Millipore);
anti-myelin basic protein antibody (MBP) (ab7349, Abcam);
anti-neurofilament H (NF-H) (AB5539, Millipore); Donkey anti-
Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody
Alexa Fluor 488 (A-21202, Thermo Fisher); Donkey anti-Rabbit
IgG (H+L) Highly Cross-Adsorbed Secondary Antibody Alexa
Fluor 488 (A-21206, Thermo Fisher); Goat anti-Chicken IgY
(H+L) Alexa Fluor 488 (A-11039, Thermo Fisher), Biotinylated
Horse anti-rabbit IgG (BA-1000, Vector); Biotinylated Goat
anti-rat IgG (BA-9400, Vector), Streptavidin-Biotinylated HRP
Complex (RPN1051, GE Healthcare); and Streptavidin-Alexa
Fluor 594 (S32356, Thermo Fisher).
The following drugs and reagents were used: poly-D-Lysine
(P7280, Sigma); laminin (L2020, Sigma); Nystatin dihydrate
(N4014, Sigma); Cholesterol Oxidase Streptomyces sp. (ChOx)
(228250, Calbiochem); Methyl-β-cyclodextrin (MβCD) (C4555,
Sigma); DMSO (D5879, Sigma); phalloidin – TRITC (P1951,
Sigma); biocytin (B4261, Sigma); Cholera Toxin Subunit
B (Recombinant) Alexa Fluor 594 (CTxB-594) (C34777,
Life BioSciences).
Primary Cultures
Hippocampus
Primary cultures of mouse hippocampi were prepared from E16-
E17. Pregnant CD1mice were sacrificed by cervical dislocation,
and the fetuses were collected in a PBS-glucose 0.3% solution
and then decapitated. Hippocampi were isolated and trypsinized
for 6 min at 37◦C. Trypsin was then neutralized with FBS
and incubated with DNase for 10 min at 37◦C. Neurons
were then centrifuged at 800 rpm for 5 min, resuspended
and plated in pre-coated culture glasses with poly-D-lysine in
medium containing Neurobasal (w/o L-glutamine, w/Phenol
Red; GIBCO, 21103-049), 1% penicillin/streptomycin (GIBCO,
15140-122), 1% glutamine (GIBCO, 25030-024) and 2% B27
(GIBCO, 17504-044).
Cerebellum
Primary cultures of cerebellums were prepared from P4–P5
CD1 mice sacrificed by decapitation. Cerebellums were isolated,
mechanically disaggregated and trypsinized as previously
described. After centrifugation, neurons were resuspended in
2 mL of DMEM, and EGL were isolated by centrifugation
in a percol gradient. After a wash centrifugation, EGL
were plated in pre-coated culture glasses with poly-D-lysine
in medium containing DMEM (GIBCO, 41966-029), 1%
penicillin/streptomycin (GIBCO, 15140-122), 1% glutamine
(GIBCO, 25030-024), 4.5% D-(+)-Glucose (Sigma, G-8769), 5%
NHS (GIBCO, 26050-088), and 10% FBS (GIBCO, 16000-044)
for 24 h, and then NHS and FBS were replaced by 2% B27
(GIBCO, 17504-044) and 1% N2 (GIBCO, 17502-048).
Dorsal Root Ganglion (DRG)
Primary cultures of DRG neurons were prepared from E13–E14
mice. Pregnant CD1 mice were sacrificed by cervical dislocation,
and the fetuses were collected and decapitated. DRG neurons
were isolated and trypsinized as previously described. After
centrifugation, neurons were resuspended and plated in
pre-coated culture glasses with poly-D-lysine and laminin
in medium containing DMEM (GIBCO, 41966-029), 1%
penicillin/streptomycin (GIBCO, 15140-122), 1% glutamine
(GIBCO, 25030-024), 0.06% D-(+)-Glucose (Sigma, G-8769),
0.0045% NaHCO3 (GIBCO, 25080-060), 2% B27 (GIBCO,
17504-044) and 5 µg/ml NGF.
Organotypic entorhino-hippocampal slice cultures were
obtained from P0 actin-GFP and WT mice sacrificed by
decapitation. Horizontal sections 325 µm thick containing
both the entorhinal cortex (EC) and the hippocampus were
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obtained by cutting tissue pieces in a chopper (McIlwain Tissue
Chopper, Standard Table, 220V, Prod 10180-220). Slices were
laid on a porous Millicell CM plate culture insert (Millipore,
PICM03050) and incubated using the interface culture technique.
The medium comprised 35.5% Neurobasal, 25% MEM powder,
25% NHS (GIBCO, 26050-088), 12.5%HBSS (w/Mg, w/Phenol
Red, GIBCO, 24020-083), 0.5% D-(+)-glucose (Sigma, G-8769),
1% glutamine (GIBCO, 25030-024), 1% penicillin/streptomycin
(GIBCO, 15140-122), 1.1% sodium pyruvate (Sigma, P2256-
5G), 0.04% NaHCO3 (GIBCO, 25080-060), 2% B27 (GIBCO,
17504-044) and 1% N2 (GIBCO, 17502-048). The medium was
changed every 2 days. After 21 days in vitro (DIV), axotomy
was performed between the EC and the hippocampus with a
needle, and WT hippocampi were put with EC GFP. The cultures
were treated for 10 days with Nystatin or control medium
and fixed with 4% paraformaldehyde (PFA) for 1h. Cultures
were cut into 60 µm slices with a vibratome (Leica VT 1000
S) and cryopreserved at −20◦C until immunohistochemistry
was performed.
Drug Treatments in vitro
Growth Cone and Filopodium Experiments
Hippocampal and EGL primary cultures were treated after 3 DIV
and DRG after 1 DIV with 2.5 µg/mL Nystatin for 10 min,
0.5 mM MβCD for 10 min or 2U ChOx for 2 h. They were then
incubated for an additional 30 min in culture media (Neurobasal
or DMEM) and then fixed in 4% PFA.
Axon Extension and Branching Experiments in DRG
Neurons
After 2 h in culture, 2.5 µg/mL Nystatin and 2U ChOx were
added to the media for 24 h and neurons were then fixed. After
22 h in vitro, and therefore 2 h before neurons were fixed, 0.5 mM
MβCD was added to the media.
Axotomy Experiments
Axotomy in microfluidic chambers (AX50010TC, Millipore)
was performed with a pipette connected to a vacuum pump.
Complete axotomy was verified in the inverted microscope.
Immediately after axotomy, 2.5 µg/mL Nystatin was added and
maintained in the culture for 3 days. In organotypic cultures,
5 µg/mL Nystatin was added to the media just after axotomy and
maintained for 10 days, changing the media every 2 days.
Animals and Surgical Procedures
To study the effect of cholesterol depletion on healthy mice,
10 OF1 female mice (20–25 g) were divided in two groups
and treated with saline (vehicle) or MβCD 1000 mg/kg/week
intraperitoneal (i.p.) during 1 month. To study the effect of
lipid raft disruption on peripheral nerve regeneration, 13 female
mice (25–30 g) were injured on the sciatic nerve and allowed
to regenerate for 1 month while receiving saline (n = 6) or
1000 mg/kg/week MβCD (n = 7) i.p. treatment.
To perform the nerve injury, animals were anesthetized by
i.p. injection of ketamine (90 mg/kg; Imalgene 500, Rhône-
Merieux, Lyon, France) and xylazine (10 mg/kg; Rompun, Bayer,
Leverkusen, Germany). The right sciatic nerve was surgically
exposed at the midthigh and carefully freed from adherences
to surrounding tissues. Afterwards, it was cut at 45 mm from
the tip of the 3rd toe and immediately repaired using two
epineurial sutures (10–0), maintaining the fascicular alignment
of the sciatic branches. Finally, the wound was sutured in planes
and disinfected. Animals were left to recover on a hot pad after
being returned to their cages. The left paw was left uninjured
as a control.
All the animals had food and water ad libitum and were
kept at a standard temperature (22 ± 2◦C) and under 12:12-h
light-dark cycles (300 lux/0 lux). The experimental procedures
followed the recommendations of the European Communities
Council Directive 2010/63/EU for the care and use of laboratory
animals and were approved by the Committee for Ethics on
Experimental Animal and Human Research of the Universitat
Autònoma de Barcelona.
Electrophysiology Tests
To test possible effects of MβCD on intact animals,
electrophysiological tests were performed every 7 days after
beginning of the treatment and for 4 weeks. To monitor
peripheral nerve regeneration, electrophysiological tests were
performed at 14, 21, 25, 28, and 33 days post-injury (dpi).
Animals were anesthetized with pentobarbital (10 mg/kg) and
the sciatic nerve was stimulated using two needle electrodes
inserted percutaneously at the sciatic notch, applying single
rectangular pulses of 0.02 ms up to the voltage required to
obtain a maximal evoked response. The compound muscle action
potentials (CMAP, M wave) evoked by stimulation of motor
nerve fibers were recorded from the tibialis anterior (TA) and
plantar (PL) muscles with microneedle electrodes. All potentials
were amplified and displayed on a digital oscilloscope (Tektronix
450S; Tektronix, Beaverton, OR, United States) at the appropriate
settings for latency and amplitude measurements from the
baseline to the maximal negative peak. During the tests, the
animals were placed over a warmed flat coil controlled by a hot
water circulating pump to maintain body skin temperature.
Locomotion Evaluation
The DigiGait system (Mouse Specifics, Boston, MA,
United States) was used to assess locomotor performance
of healthy animals treated with MβCD or vehicle at weekly
intervals during treatment. The mice were forced to run over
the transparent belt of a motorized treadmill and recorded with
a high-speed video camera (80 frames/s) from below while
running at a constant treadmill velocity of 20 cm/s. A minimum
of 200 images were collected for each walking mouse containing
more than eight strides for each run and each video was analyzed
with the DigiGait software. The print length, and the toe spread
distance between toes 1–5 and toes 2–4 were measured, and the
sciatic functional index (SFI) between the right and the left paw
was calculated (Navarro, 2016).
Mechanical Algesimetry
The algesimetry tests for mechanical stimuli were performed
on both hindpaws every week along treatment in uninjured
animals. Sensibility to a non-noxious mechanical stimulus was
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measured by using an electronic Von Frey algesimeter (Bioseb,
Chaville, France). Mice were placed on a wire net platform in
plastic chambers 10 min before the experiment for habituation.
The hindpaw plantar surface was stimulated from the bottom
of the box by applying a 0.4 mm non-noxious pointed metal
probe to the central area of the paw, and then slowly increasing
the pressure until the mouse raised the paw, with a 35 g cut
off force to avoid skin damage. The mechanical nociceptive
threshold was taken as the mean of three measurements per
paw and the threshold was expressed as the force (in grams)
at which mice withdrew the paw in response to the stimulus
(Cobianchi et al., 2014).
Pinprick Test
Progression of nociceptive reinnervation of the hindpaw was
assessed at 14, 21, 25, 28, and 33 dpi by means of the pinprick test.
Awake animals were gently wrapped in a cloth with the injured
paw facing upward. The skin surface near C plantar pad and 4th
toe (more distal) were stimulated with a blunt needle with enough
intensity to indent the skin without damaging it (Cobianchi
et al., 2014). Each site was stimulated twice and responses were
recorded as positive only when clear pain reactions such as fast
withdrawal or vocalization were triggered. Positive responses
were taken as a sign of functional reinnervation of the skin.
Histology, Immunohistochemistry and
Immunocytochemistry
Neurons were fixed with a solution of 4% PFA in PBS for 10 min.
Subsequently, they were rinsed with PBS and permeabilized with
a solution of triton 0.1% X-100 in PBS for 10 min. Afterwards,
they were rinsed with PBS once more, and blocking solution
(NHS 10% in PBS) was added for 1 h at room temperature. After
blocking, the cells were incubated for 2 h with the respective
primary antibodies diluted in blocking solution. Unbound
primary antibodies were washed with PBS, and neurons were
incubated with the respective secondary antibodies in blocking
solution for 1 h at room temperature. For F-actin staining
after permeabilization, phalloidin diluted in PBS was added and
maintained for 30 min. Neurons were mounted using Mowiol.
Organotypic slices were rinsed with PBS with 0.5% Triton
three times, and were incubated for 2 h at room temperature with
blocking solution (10% NHS, 0.2M Glycine in PBS-Gelatin with
0.5%Triton). After blocking, the cells were incubated overnight
at 4◦C with the respective primary antibodies diluted in antibody
solution (5% NHS in PBS-Gelatin with 0.5%Triton). Unbound
primary antibodies were washed with PBS with 0.5% Triton, and
slices were incubated with the respective secondary antibodies in
antibody solution for 2 h at room temperature.
For the in vivo regeneration experiment, mice were
transcardially perfused with 4% PFA in PBS (0.1 M, pH
7.4) 1 month after beginning the treatment. Subsequently, the
sciatic nerve, spinal cord, L4 and L5 DRG neurons were removed,
postfixed for 24 h with PFA and cryopreserved in PB containing
30% of sucrose for immunohistochemistry analysis. Samples
were serially cut (15 µm) with a cryotome (Leica CM190) and
stored at−20◦C for further analysis.
For cholesterol depletion analysis, samples were defrosted for
30 min at room temperature and then rehydrated with PBS
for 5 min. DRG neurons were then incubated for 3 h at room
temperature with CTxB (1:200) in PBS. Slides were washed and
mounted using Mowiol.
For immunohistochemistry, samples were defrosted at room
temperature, blocked with PBS-specific animal serum, and
incubated overnight at 4◦C with the primary antibodies rabbit
anti- GAP43 (1:100), rat anti- MBP (1:200) and chicken anti-
NF-H (1:100). After washes, sections were incubated with the
respective biotinylated secondary antibody (1:200) for GAP43
and MBP and then for 1 h at room temperature with conjugated
Alexa Fluor streptavidin (1:200) or Alexa Fluor anti-chicken IgY.
Finally, sections were mounted with Mowiol containing DAPI for
nuclear staining.
Image Analysis
Images of primary cell cultures were taken in an epifluorescence
microscope (Eclipse Nikon E1000) with a 60× oil-immersion
objective. To take images from the in vitro axotomy experiments,
we used an inverted microscope (Olympus ScanR) with a
20× objective. For images of the organotypic cultures, we
used a confocal microscope (Leica TCS SP5) with a 20×
objective and a 20× objective with 2× zoom to quantify axon
regeneration. Images of the tibial nerve with MBP and NF-H
immunostaining were taken10 mm distally from the injury site
with an epifluorescence microscope (Eclipse Ni, Nikon) attached
to a digital camera (DS-Ri2, Nikon). Finally, we used a confocal
fluorescent microscope (Zeiss LSM 700) to acquire the images
from the SC and DRG tissue sections stained with GAP43, and
images were analyzed with ImageJ (Schneider et al., 2012). Briefly,
the area of the soma of at least 100 DRG neurons/animal and
10 motoneurons/animal were taken as ROI, and the integrated
density (mean gray value × area) was obtained. The mean value
obtained for each animal was used for comparison (Romeo-
Guitart et al., 2018).
Statistical Analysis
All in vitro experiments were done three times independently.
Data show means ± SEM. To analyze the statistics, we used
GraphPad software and applied ANOVA test for multiple
conditions or the Student’s t-test for two conditions. In vivo
results are presented as mean ± SEM and means were compared
with two-tailed, unpaired Student’s t-test, two-way ANOVA
followed by Tukey’s Multiple Comparison Test or Mantel–Cox
test. Differences were considered significant at p< 0.05.
RESULTS
Cholesterol Depletion Increases Growth
Cone Area and Number of Filopodia in
Hippocampal and EGL Cerebellar Axons
Growth cones play a key role during axonal growth and
guidance. First, we examined the effect of cholesterol depletion
on the morphological features of growth cones. To this end,
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we treated hippocampal and EGL neurons with two drugs that
efficiently reduce cholesterol in the cell membrane (Nystatin
and MβCD), and with ChOx, a cholesterol-depleting enzyme
(Figure 1) (Bolard, 1986; Cahuzac et al., 2006; Zidovetzki and
Levitan, 2007). Both neuron types were kept in culture for
3 DIV before being treated with the aforementioned drugs. In
hippocampal neurons, depletion of cholesterol driven by the
three drugs significantly increased the growth cone area identified
by phalloidin staining (Figures 1A,C). However, only Nystatin
increased this parameter in EGL neurons (Figures 1B,D).
Overall, our results show that cholesterol depletion increases the
growth cone area in hippocampal and EGL neurons in the CNS.
During the course of the experiments, we observed another
effect of cholesterol depletion, namely the development of
numerous filpodium-like extensions/branching points along
neurites. Filopodia, dynamic membranous structures driven
from the actin cytoskeleton, are necessary for axonal motility,
guidance, branching and regeneration. To determine the
importance of cholesterol in the formation of filopodium-
like structures, we again treated hippocampal and EGL
neurons with Nystatin, ChOx, and MβCD (Figure 2). The
filopodium-like structures were counted in discrete segments
of hippocampal and EGL axons (Figures 2A,B). Cholesterol
depletion induced by these drugs led to a significant increase
in the number of filopodium-like structures in both types of
neuron (Figures 2C,D).
These results indicate that a reduction in the cholesterol
content of the cell membrane of both types of neuron promoted
an increase in the number of filopodium-like structures
and branching. In contrast to the effect of these drugs on
growth cone area, these compounds enhanced the number of
filopodia/branches in hippocampal and EGL neurons.
Cholesterol Depletion Affects Growth
Cone Area, Number of Filopodia, and
Neurite Extension in DRG Neurons
To determine whether the effects of cholesterol depletion
observed in the CNS neurons can be extrapolated to the PNS, we
performed the same experiments using DRG neurons (Figure 3).
DRG neurons were isolated from mouse embryos at E13–14 and
treated after 1 DIV with cholesterol removal agents. Treatment
with Nystatin and ChOx led to an increase in growth cone
area in DRG neurons (Figures 3A,C), and the removal of
cholesterol with any of the three drugs enhanced the number of
filopodia (Figures 3B,D).
FIGURE 1 | Cholesterol depletion increases growth cone area in hippocampal neurons and EGL neurons. Examples of hippocampal (A) and EGL (B) growth cones
treated with control culture media, 2.5 µg/ml Nystatin, 2U ChOx, and 0.5 mM MβCD and stained with phalloidin. Growth cones areas from three independent
experiments were measured. Data represent means ± SEM (C,D). N = 150–250 growth cones in each condition (One-way ANOVA, Dunnett’s Multiple comparison
test ∗∗∗p < 0.0001). Scale bar 5 µm.
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FIGURE 2 | Cholesterol depletion increases filopodium-like structures in hippocampal neurons and EGL neurons. Examples of hippocampal (A) and EGL (B)
filopodium-like structures in axons treated with control culture media, 2.5 µg/ml Nystatin, 2U ChOx, and 0.5 mM MβCD and stained with phalloidin. The density of
filopodium-like structures was measured in discrete segments of axons in three independent experiments. Data represent means ± SEM (C,D). N = 150–250
neurons in each condition (One-way ANOVA, Dunnett’s Multiple comparison test ∗∗p < 0.01, ∗∗∗p < 0.0001). Scale bar 5 µm.
We also quantified the effect of cholesterol depletion on
neurite extension and branching (Figure 4). Treatments were
performed for 24 h in the case of Nystatin and ChOx and
for 2 h before fixation in the case of MβCD, as we observed
increased cell death with longer incubations with this drug. Only
the treatment with Nystatin increased the total length of DRG
neurites while ChOx and MβCD did not affect this parameter
(Figures 4A,B). We found that 24 h treatments with Nystatin and
ChOx led to a significant increase in the number of branching
points (Figures 4A,C).
These results suggest that pharmacological removal of
cholesterol from the cell membrane has similar effects on CNS
(hippocampal and cerebellar) and PNS (DRG) neurons. An acute
decrease in cholesterol levels per se increases growth cone area
and filopodia/branching point density in developing neurons.
Cholesterol Depletion Improves Axonal
Regeneration After Axotomy in vitro and
ex vivo
One of the hallmarks of CNS regeneration is the difficulty
to achieve the regrowth of damaged axons. This difficulty is
attributed mainly to the generation of an axon blocking “milieu.”
As we have shown that cholesterol depletion increases axonal
growth cone area and axonal extension, we next addressed, using
an in vitro and an ex vivo system, whether depletion of this lipid
enhances axonal regeneration.
First, E16 hippocampal neurons were seeded in a microfluidic
chamber (Figure 5) and neurons were axotomized. This chamber
allowed us to differentially treat the axons, on one side with
control medium and on the other with medium supplemented
with Nystatin applied immediately after axotomy (Figure 5D).
Axons treated with Nystatin showed a significant increase in
length when compared with those cultured in basal control
medium (Figures 5A–C).
These results suggest that the removal of cholesterol by
means of Nystatin enhances axon regeneration after axotomy
in vitro. We next used the ex vivo organotypic model of
axotomy and regeneration (del Rio and Soriano, 2010). Slice
co-cultures from P0 mouse hippocampi and the EC were
isolated and kept in culture for 21 days (Figure 6). Some
EC slices were obtained from actin-GFP transgenic mice. At
21 DIV, axotomy was performed sectioning the entorhino-
hippocampal connection (EHP) using a needle, and mixed
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FIGURE 3 | Cholesterol depletion affects growth cone area and the density of filopodia in DRG neurons. Examples of DRG growth cones (A) and filopodia (B)
incubated with control media, 2.5 µg/ml Nystatin, 2U ChOx, and 0.5 mM MβCD and stained with phalloidin. Growth cone areas and filopodia from three
independent experiments were measured. Data represent means ± SEM (C,D). N = 150–250 neurons in each condition (One-way ANOVA, Dunnett’s Multiple
comparison test ∗∗p < 0.01, ∗∗∗p < 0.0001). Scale bar 5 µm.
co-cultures were generated. The hippocampi from actin-GFP
co-cultures were removed and replaced by hippocampi from
WT mice organotypic cultures, thereby allowing the direct
visualization of regenerating GFP-positive EC-hippocampal
axons. Axotomized organotypic cocultures were treated with
Nystatin for 10 additional days (Figure 6A). In axotomized
co-cultures that were not treated with Nystatin, virtually
no regenerating axons (or very few) were found in the
SLM/ML layers, which are the layers of termination of the
EHP pathway (Figures 6B,D). In contrast, after Nystatin
treatment, we observed a 10-fold increase in the density
of regenerating EC axons present in the SLM/ML layers
(Figures 6C,D). Organotypic cultures treated with Nystatin
showed a normal morphology and distribution, and no evidence
of neuronal degeneration was appreciated (Figure 6C). In
another set of experiments, WT EC slice-cocultures were
generated and axotomized as described above (Figure 6A) and
regenerating EC axons were visualized by Biocytin injections
(del Rio and Soriano, 2010). Again, the number of regenerating
EHP axons was markedly increased by the incubation with
Nystatin. Together with the above results, the present findings
indicate that cholesterol depletion favors axonal regeneration
in vitro and ex vivo.
Treatment With MβCD Has No Effect on
Healthy Mice
The results of motor electrophysiological tests performed
showed that MβCD administration in vivo did not cause any
impairment in the mice. The M wave amplitude (Supplementary
Figures S1A,B) and latency (Supplementary Figures S1C,D)
of TA and PL muscles did not present significant differences
between MβCD treated and saline control groups. The walking
track test yielded no differences in the SFI between groups
(Supplementary Figure S1E). Finally, mechanical algesimetry
was performed to evaluate possible changes in nociception in
MβCD treated animals. Results showed no significant differences
between control and treated animals in pain threshold along time
(Supplementary Figure S1F).
Treatment With MβCD Alters the Integrity
of the Lipid Raft by Reducing the
Amount of Membrane Cholesterol
Our previous results suggest that cholesterol depletion is directly
involved in promoting axonal regeneration. However, we next
sought to determine the effect of acute reduction of cholesterol
levels in the in vivo model of peripheral nerve lesion and
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FIGURE 4 | Cholesterol depletion increases neurite elongation and branching in DRG neurons. Examples of DRG neurons incubated for long periods with control
media, 2.5 µg/ml Nystatin, 2U ChOx, and 0.5 mM MβCD (A) and immunolabeled with anti-βIII-tubulin. Total neurite extension and number of branching points in
each neuron were quantified in each condition in three independent experiments. Data represent means ± SEM (B,C). N = 30–60 neurons in each condition
(One-way ANOVA, Dunnett’s Multiple comparison test ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.0001). Arrows point cell body. Scale bar 100 µm.
regeneration. Cholesterol is a major component of lipid rafts,
which are specialized membrane microdomains that hold a
multitude of signaling receptors. It has recently been shown that
disruption of the raft by acute depletion of cholesterol promotes
regeneration and functional recovery after spinal cord injury
(Tassew et al., 2014). Thus, we first examined the integrity of
raft structures in DRG nerves after acute depletion of cholesterol
by treatment with MβCD. Contralateral DRG neurons of injured
mice treated with MβCD or saline were incubated with the CTxB.
This fraction of the toxin has a known affinity for ganglioside
GM1, a lipid raft-associated molecule (Schnaar et al., 2014) widely
used as a marker of the presence of cholesterol in the cellular
membrane and of lipid raft integrity. Fluorescent staining showed
clear CTxB labeling in the plasma membrane of DRG neurons
from animals that received vehicle for 1 month (Figure 7A) in
comparison with those treated with MβCD (Figure 7B).
Cholesterol Depletion Induced by MβCD
Increases GAP43 in Sensory Neurons
After Axotomy
To study the regenerative response in sensory (Figure 8A) and
motor (Figure 8B) neurons after nerve section, the expression
of the GAP43 was measured. GAP43 is expressed at high levels
during development and axonal regeneration, and it is considered
a crucial component of an effective regenerative response in the
nervous system, being used as a marker of regeneration in injured
axons. The results showed higher immunoreactivity for GAP43 in
DRG neurons in injured animals treated with MβCD compared
to those treated with vehicle (Figure 8C). This observation
indicates that cholesterol depletion after sciatic injury enhances
the neuronal regenerative program. No significant difference
was observed for motoneurons (Figure 8D). Moreover, myelin
staining of the regenerated nerve was conducted to assess
whether lipid raft disruption could affect axonal remyelination.
Qualitative assessment of both saline- and MβCD-treated
animals (Figure 8E) shows similar presence of myelin in nerve
fibers of both groups, thus indicating that lipid raft disruption did
not block remyelination after injury.
Cholesterol Depletion Induced by MβCD
Improves Muscle Reinnervation and
Sensory Responses in Mice
Electrophysiological tests performed to follow up nerve
regeneration after sciatic nerve section and repair showed a
progressive increase in the amplitude of the M wave of the
two muscles in both groups, thereby indicating progressive
reinnervation of the muscles by the regenerated axons. Although
no differences were seen for the proximal TA muscle, MβCD-
treated mice had significantly higher M wave amplitude of the
PL muscle than control animals at 33 days (Figures 9A,B),
indicative of greater reinnervation of the distal muscles. Values
of M wave latency did not show significant differences between
the two groups (Figures 9C,D).
No signs of autotomy, that could be indicative of neuropathic
pain, were found in any studied mice. Recovery of sensitivity
was studied by means of the pinprick test on areas of the paw
from proximal to distal region of the sciatic nerve innervation
territory (Cobianchi et al., 2014). In the C plantar pad, no
animals showed positive response at 21 days, and with time
more animals recovered sensory response without differences
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FIGURE 5 | Nystatin improves axon regeneration after axotomy in vitro. Examples of hippocampal axon regrowth at 24, 48, and 72 h after axotomy in control
condition (A) and in response to treatment with 2.5 µg/ml Nystatin (B). Axon lengths were measured in each condition. Data represent means ± SEM (C).
Schematic diagram of a microfluidic chamber (D). Cell bodies are in the central channel (white), axon growth through microfluidic channels (blue) to both sides (green
and red). After axotomy, control medium was applied on one side (red) and Nystatin on the other (green). N = 3 chambers (t-Test in each time point, ∗∗∗p < 0.0001).
Scale bar 50 µm.
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 February 2019 | Volume 13 | Article 40134
fncel-13-00040 February 9, 2019 Time: 17:8 # 10
Roselló-Busquets et al. Cholesterol and Axonal Regeneration
FIGURE 6 | Nystatin increases EC axon regeneration in organotypic cultures. (A) Schematic diagram that summarizes the experimental protocol. Slice co-cultures
from P0 actin-GFP and WT mice were isolated, as described in Section “Materials and Methods” and kept in culture 21 DIV. Axotomy of the EHP was performed,
and slices were treated for 10 DIV with control medium or 5 µg/ml Nystatin. (B) Representative examples of control hippocampal slices show virtually no regenerative
axons (upper panel) or very few regenerative axons (lower panel). (C) Examples of hippocampal slices treated with Nystatin show moderate axonal regeneration
(upper panel) or robust axonal regeneration (lower panel). Axons that cross a 250 µm line were counted in three random fields near the dentate gyrus in each slice.
Data represent means ± SEM (D). One dot corresponds to one slice (t-Test ∗p < 0.05). Scale bar 100 µm. ML, molecular layer; GL, granule cell layer; H, hilus.
between groups. However, in the 4th toe, which is the most
distal area, cholesterol-depleted mice showed positive response
earlier than injured controls, and at 33 dpi, 50% of the MβCD
group showed positive responses whilst only 12.5% of the vehicle-
treated animals did (Figures 9E,F).
DISCUSSION
Following axotomy, several metabolic changes occur in
injured neurons to reinnervate denervated targets and thus
ensure survival and regeneration. Moreover, a growth cone
is formed at the tip of growing axons, and this process
requires morphological and biochemical changes in the plasma
membrane, including membrane extension and remodeling. In
this context, cholesterol-rich lipid rafts, also called membrane
microdomains, play a key role as signaling platforms of both
growth-promoting and growth-inhibiting molecules. With
regard to the possible contribution of lipid rafts and cholesterol
to nerve regeneration, conflicting views can be found in the
literature. Some authors demonstrated that lipid rafts promote
axonal regeneration (Santuccione et al., 2005; Zhang et al., 2013)
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FIGURE 7 | MβCD disruption of lipid rafts in DRG neurons. (A,B) Representative images of the DRGs of animals treated with vehicle (A) and MβCD (B). Note the
absence of CTxB membrane staining in B after MβCD treatment, indicating lipid raft disruption. Scale bar: 100 µm.
while others claim that they have an inhibitory role (Vinson
et al., 2003; Hausott et al., 2011). These contradictions can be
explained by the fact that, in addition to a variety of proteins and
molecules that promote axonal regeneration, such as receptors
of neurotrophic factors, lipid rafts also contain proteins and
molecules that exert an inhibitory role, such as receptors of
myelin-associated proteins (Kappagantula et al., 2014). On the
other hand, there is also some discrepancy about the role of
lipid rafts in cell apoptosis. It is described that pro-apoptotic
receptors like Neogenin, FAS and its ligand, JNK, PKC, Src
kinases and a wide variety of lymphocyte-related receptors are
more functional when are localized in lipid rafts, inducing a line
of investigation in which lipid rafts are targets for chemotherapy
(George and Wu, 2012). However, receptors related with cell
survival, like Akt cascade, also depend on lipid rafts (George
and Wu, 2012). It has been shown that cholesterol depletion
with MβCD protects cerebellar neurons from apoptosis (Zhou
et al., 2012) and after spinal cord injury, lipid raft disruption
promotes cell survival due to a loss of function of Neogenin
(Tassew et al., 2014). In conclusion, some of these studies
were performed in vitro and sought to address the cellular
pathway or the signaling of a specific neurotrophin through
lipid rafts, and did not take into account all the trophic factors
and cell responses that occur in vivo, but instead focused on
single pathways.
In the present study, we show that cholesterol depletion in
juvenile cultured neurons increases the size of growth cones and
enhances neurite and axonal extension and the marked formation
of filopodium-like extensions in both central and peripheral
neurons. Although we did not address the underlying molecular
mechanisms, we believe that both the membrane fluidity induced
by cholesterol depletion and partial lipid raft disruption may
account for the effects observed, as extracellular matrix and
adhesion receptors are also grouped in lipid rafts (Leitinger
and Hogg, 2002; Decker and ffrench-Constant, 2004; Head
et al., 2014). In addition, the increased size of neurites suggests
that cholesterol depletion might be involved in the positive
regulation of the exocytotic machinery needed for neurite growth
(Ros et al., 2015).
Next, we addressed whether cholesterol depletion increases
the regrowth of axotomized neurons in two in vitro models:
dissociated hippocampal cultures and axotomized EC-
hippocampal slice cultures. In both cases, we found a marked
increase in the regenerative potential of lesioned axons,
again suggesting that cholesterol depletion not only increases
axonal length in developing axons but also axonal regrowth
and regeneration in vitro. In addition, the observation that
regenerated EC-hippocampal axons were correctly targeted to
the appropriate termination layers (SLM and ML) indicates
that cholesterol depletion does not alter the molecular
mechanisms involved in the guidance and targeting of these
axons to the hippocampus.
Membrane extension during axon growth after axotomy
requires the incorporation of new lipids to the tips of the
regenerating axons. Incorporated cholesterol in the axons of
peripheral neurons after axotomy comes from transported
cholesterol synthesized in the cell bodies of lesioned neurons
(de Chaves et al., 1997), and from recycled cholesterol from
cellular and myelin debris originated during the injury
(Goodrum, 1991; de Chaves et al., 1997). The existence of
multiple complementary mechanism to incorporate cholesterol
into the re-growing membranes suggest a redundancy in the
process of cholesterol reutilization. Our results in vitro and
in vivo suggest that acute and medium-term reduction of
cholesterol levels have positive effects for axon elongation and
regeneration after nerve injury. However, further studies are
required to evaluate long-term effects of systemic cholesterol
reduction. Secondary undesired effects associated with alteration
of membrane cholesterol levels should also have to be considered.
Previous reports have found that MβCD may alter crayfish
neuromuscular junction functioning in cold conditions (14◦C)
but not at 21◦C (Ormerod et al., 2012) and cholesterol depletion
in Caenorhabditis elegans results in decreased motility (Merris
et al., 2004). Moreover, reduction of membrane cholesterol
alters ion channel activity in sensory peripheral neurons (Saghy
et al., 2015), with direct consequences for their hypersensitivity
(Pristera et al., 2012) and the development of neuropathic
pain (Ferrari and Levine, 2015; Amsalem et al., 2018). As a
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FIGURE 8 | MβCD increases GAP43 expression in injured DRG neurons. (A,B) Detail of DRG (A, dashed line) and motoneurons (B, dashed line) analyzed for GAP43
expression. (C,D) Quantification of GAP43 positivity in DRG neurons (C) and motoneurons (D) from animals treated with vehicle or MβCD vs. Saline. (E) Detail of a
regenerated nerve stained for cell nuclei (blue), NF-H (green), and GAP43 (red) of saline- (top) and MβCD-treated (bottom) animals. Scale bar: 15 µm in (A,B); 50 µm
in (E). Student’s t-test, ∗∗p < 0.01.
consequence, electrophysiological tests, pain threshold tests
and locomotion studies were performed on healthy animals to
evaluate any possible effect derived from the systemic MβCD
administration and the consequent membrane cholesterol
depletion. Our results on healthy mice showed no significant
differences between treated and control animals with reported
values similar to those found in previous studies in the
literature (Verdu et al., 1996; Bruna et al., 2010; Ale et al.,
2016). Of particular interest, the algesimetry results showed no
indication of hyperalgesia in intact mice, and the absence of
autotomy in mice in the regeneration experiment also points
out that there was no increased pain sensitivity after lipid raft
disruption (Casals-Diaz et al., 2009). Therefore, although some
uncontrolled effect cannot be dismissed, 1 month of systemic
MβCD administration and lipid raft disruption did not alter
normal nervous system function in mice.
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FIGURE 9 | MβCD treatment accelerates motor and sensory functional recovery following sciatic nerve injury. (A–D) Electrophysiological results after nerve injury in
mice treated with vehicle or with MβCD. Results of CMAP amplitude (A,B) and latency (C,D) recorded in TA and PL at 14, 21, 25, 28, and 33 dpi. Data are shown as
the mean and SEM (bars). ∗p < 0.05 with two-way Anova and Bonferroni test. (E,F) Pinprick test results to analyze sensory reinnervation in the hindpaw pad C (E)
and 4th toe (F). Results show the percentage of animals with positive response in each area in the groups treated with vehicle or MβCD. p < 0.05 Mantel–Cox test
indicate differences in the proportion of mice with reinnervation.
We then studied the effect of cholesterol depletion on
peripheral nerve regeneration. To this end, we chose an in vivo
model of peripheral nerve injury to avoid focusing on a single
pathway or molecule, thus gaining a complete view of nerve
regeneration. Cholesterol depletion and lipid raft disruption
were achieved by means of treatment with MβCD (Zidovetzki
and Levitan, 2007), a cyclic oligosaccharide that has been
used as an antineoplastic (Grosse et al., 1998) and also as a
complexing agent in pharmacological applications (Upadhyay
et al., 2006). The latter use of MβCD is attributed to its
amphipathic properties, and molecules can be encapsulated
inside the cavity of cyclodextrins. Thus, MβCD may act not
only by extracting cholesterol from the plasma membrane and
disrupting lipid rafts but also by catalyzing neurotrophic factors
and favoring their uptake by neurons or glial cells that play a
role in peripheral nerve regeneration. This could explain the
increase in the number of GAP43-positive DRG neurons, an
observation that indicates that, after MβCD treatment, there
are more neurons able to regenerate or that have switched to a
regenerative state sooner.
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Our results indicate that lipid rafts are disrupted from the
cell membrane after MβCD treatment, as shown by the loss of
CTxB staining. CTxB has affinity for the GM1 ganglioside, a
member of the complex ganglioside family, which also includes
GD1 and GT1 (Schnaar et al., 2014), and it has been widely
used as a marker of lipid raft integrity (Kalka et al., 2001). It
has been reported that treatment with MβCD destabilizes the
link between the axon and myelin as a result of the reduction
of GD1 and GT1 in the membrane. These two gangliosides
act as a myelin-associated glycoprotein receptors (Vyas et al.,
2002) and, consequently, they mediate the inhibition of neurite
outgrowth. With lipid raft disruption by MβCD, gangliosides are
removed from the cell membrane and they cannot mediate the
inhibition of neurite outgrowth. This situation may confer the
axon with a greater capacity to regenerate. Thus, the increased
motor and sensory reinnervation we observed after axotomy and
treatment with MβCD is consistent with a reduction of GD1
and GT1 inhibition.
Moreover, other studies have reported that cholesterol
removal affects various modes of endocytosis (Rodrigues et al.,
2013). Endocytosis is a widely used mechanism for receptor
internalization from the cell membrane, and it has been
demonstrated that cholesterol and lipid rafts play key roles in
clathrin-independent endocytic (Lamaze et al., 2001) and in
clathrin-dependent endocytic mechanisms (Rodal et al., 1999).
Thus, with lipid raft alteration, endocytosis might be impaired,
thereby also remodeling the normal presence or removal of
different receptors at the cell surface. With cholesterol depletion
by MβCD, the endocytosis of neurotrophic factor receptors may
be inhibited (Hausott et al., 2011). As the improvement in motor
and sensory regeneration suggests, this inhibition would lead to
increased cell receptor availability at cell surface, thus facilitating
axon regeneration. On the other hand, MβCD treatment might
interfere with myelin as it has a high lipid and cholesterol content.
Indeed, deficient cholesterol biosynthesis in oligodendrocytes
delays myelination (Saher et al., 2005) and the maximal brain
cholesterol synthesis corresponds to the peak of myelination
process (Korade and Kenworthy, 2008). However, our results
indicate that MβCD treatment did not affect myelination of
the regenerated nerve fibers in the adult mice. Nevertheless,
a detailed histomorphometric quantification of the regenerated
axons might be needed for a quantitative evaluation of the degree
of remyelination after lipid raft disruption.
Finally, our results indicate that MβCD treatment accelerates
nerve regeneration after complete nerve lesion. The positive
effect was detected as faster and higher levels of reinnervation
of distal targets, such as plantar muscles, which are the most
discriminative for detecting differences in nerve regeneration
rate. Whether these results would be more pronounced after a
more severe nerve injury requires further attention.
The results of this study shed light on the role of lipid
rafts in peripheral nerve regeneration, although more research
is needed to elucidate the specific mechanisms affected by lipid
raft disruption. As this study was performed from a functional
perspective, a number of alterations may have been occurring.
On the one hand, we may have accelerated regeneration due
to an increase in myelin clearance and thus a decrease in
myelin-associated inhibitory agents. On the other, the beneficial
effect might be due to an alteration of membrane ganglioside ratio
or because lipid raft disruption promotes an environment that is
favorable for neuron regeneration.
In conclusion, we have found that lipid raft disruption
increases axonal growth in young neurons in vitro, enhances
axonal regeneration in two in vitro models, and promotes
peripheral nerve regeneration. Our results support the notion
that these membrane microdomains play an important role in
the signaling responsible for determining neural growth during
development, as well as for nerve degeneration and regeneration
after injury. This could be important because many pathways
and molecules are involved in the processes that occur after
nerve injury, and the environment plays a key role in the
success or failure of nerve regeneration and functional recovery.
However, caution should be taken before the translationability
of our results. Considering the slow rate of nerve regeneration,
in humans with considerable nerve length, target reinnervation
may need several months to year. The possible effects of
long-term lipid raft disruption treatment pointed above need
to be investigated in preclinical models before any potential
clinical application.
AUTHOR CONTRIBUTIONS
CR-B, RM-M, and MH-L designed, conducted, and analyzed
the in vitro experiments. NO, JV, and XN designed, conducted,
and analyzed the in vivo experiments. CR-B, RM-M, MH-L,
and NO wrote the first draft of the manuscript. MP performed
the organotypic experiments. AM did percoll gradients to
isolated EGL neurons. RM-M, JV, XN, and ES designed
the experiments, analyzed the data, and wrote the final
version manuscript.
FUNDING
Research in our laboratories was supported by grants from the
Spanish MINECO (SAF2016-76340R), CIBERNED, Spanish
MECD (FPU14/02156 and BES-2014-067857), TERCEL
(RD12/0019/0011) and ERDF funds. It was also supported
by the European Union FPT-ICT projects NEBIAS (contract
number FP7-611687), EPIONE (FP7-602547), and FP7-NMP
MERIDIAN 280778.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: https://www.frontiersin.org/articles/10.3389/fncel.2019.
00040/full#supplementary-material
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Physical rehabilitation is one of the cornerstones for the treatment of lesions of the
nervous system. After peripheral nerve injuries, activity dependent therapies promote
trophic support for the paralyzed muscles, enhance axonal growth and also modulate
the maladaptive plastic changes induced by the injury at the spinal level. We have
previously demonstrated that an intensive protocol of treadmill running (TR) in rats
reduces synaptic stripping on axotomized motoneurons, preserves their perineuronal
nets (PNN) and attenuates microglia reactivity. However, it is not clear through which
mechanisms exercise is exerting these effects. Here we aimed to evaluate if activation
of the locus coeruleus (LC), the noradrenergic center in the brain stem, plays a role
in these effects. Since LC is strongly activated during stressful situations, as during
intensive exercise, we selectively destroyed the LC by administering the neurotoxin
DPS-4 before injuring the sciatic nerve of adult rats. Animals without LC had increased
microglia reactivity around injured motoneurons. In these animals, an increasing intensity
protocol of TR was not able to prevent synaptic stripping on axotomized motoneurons
and the reduction in the thickness of their PNN. In contrast, TR was still able to attenuate
microglia reactivity in DSP-4 treated animals, thus indicating that the noradrenergic
projections are important for some but not all the effects that exercise induces on the
spinal cord after peripheral nerve injury. Moreover, animals subjected to treadmill training
showed delayed muscle reinnervation, more evident if treated with DSP-4. However, we
did not find differences in treated animals regarding the H/M amplitude ratio, which
increased during the first stages of regeneration in all injured groups.
Keywords: peripheral nerve injury, spinal circuitry, physical exercise, motoneuron, noradrenaline, locus coeruleus
INTRODUCTION
Peripheral nerve injury (PNI) results in a loss of motor, sensory and autonomic function in the
denervated territory. Although peripheral axons have the ability to regenerate, this regenerative
process is slow and functional recovery is often limited, mainly due to unspecific reinnervation
of the target organs but also to alterations at the central level. The disconnection between the
neurons and their target organs is accompanied by a disorganization of the central circuitry, in
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part due to the massive stripping of central synapses that
axotomized motoneurons suffer. The most affected ones are
the proprioceptive afferents from the muscle spindle that never
recover basal values (Alvarez et al., 2010).
There is extensive literature on the use of activity-dependent
therapies to improve axonal regeneration (van Meeteren et al.,
1997; Al-majed et al., 2000; Sabatier et al., 2008; Asensio-Pinilla
et al., 2009), and muscle reinnervation after sciatic nerve injury in
rats (Asensio-Pinilla et al., 2009; Udina et al., 2011a). In general,
when initiated during the denervation phase, moderate exercise
training results in accelerated functional recovery (Gutmann
and Jokoubek, 1963), whereas forced exercise or long-term
hyperactivity tend to have a detrimental effect (Herbison et al.,
1974; van Meeteren et al., 1997). Activity can also modulate the
plastic changes observed after PNI, as neuropathic pain (Nam
et al., 2001; Cobianchi et al., 2010) and hyperreflexia (Vivó et al.,
2008; Asensio-Pinilla et al., 2009; Udina et al., 2011a). Increased
activity, by reducing excitability of sensory neurons and synaptic
stripping of motoneurons, attenuates maladaptive plastic changes
in the spinal cord and central pathways (Mòdol et al., 2014;
Arbat-Plana et al., 2015).
Although it is well-known that exercise exerts positive effects
on the nervous system through modulation of brain derived
neurotrophic factor (BDNF) (Hutchinson et al., 2004; Molteni
et al., 2004; Gomez-Pinilla et al., 2012; Cobianchi et al., 2013),
in a recent work we observed that pharmacological activation
of TrkB, the specific receptor of BDNF, did not mimic all
the effects of exercise on axotomized spinal motoneurons
(Arbat-Plana et al., 2016). Moreover, we had previously shown
that the integrity of sensory inputs from the injured limb is
important for the maintenance of motoneuron perineuronal
nets (PNN) induced by treadmill exercise (Arbat-Plana et al.,
2015). PNN restrict plasticity and stabilize synapses (Kwok
et al., 2011), and thus exercise, by activating proprioceptive and
cutaneous receptors, facilitates preservation of central circuits
after PNI. However, besides peripheral activation of muscles
and sensory receptors, physical exercise is also activating a
complex central circuitry related with locomotion and stress.
Among it, the activation of noradrenergic neurons of the
locus coeruleus (LC) may be important. Whereas ascending
projections from this brain stem center, as part of the ascending
reticular formation system, regulates arousal and attention
(Berridge and Waterhouse, 2003), descending projections inhibit
nociceptive transmission (Millan, 2002; Pertovaara, 2006)
and modulate excitability of motoneurons (Heckman et al.,
2003) in the spinal cord. In addition, noradrenaline release
influences microglial function, by suppressing production of
pro-inflammatory cytokines and promoting anti-inflammatory
mediators (Heneka et al., 2010; Jardanhazi-Kurutz et al., 2011).
Interestingly, an intensive protocol of treadmill exercise is
able to attenuate the activation of microglia observed in the
spinal cord after PNI (Cobianchi et al., 2010). This anti-
inflammatory effect may be related to the increased activation
of the LC induced by physical activity. However, the role
of the LC in the activity-dependent-modulation of the spinal
changes observed after axotomy has not been addressed yet.
The LC can be chemically destroyed by using the neurotoxin
N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4), that
selectively damages noradrenergic projections originating from
the LC, inducing degeneration of noradrenergic terminals
(Dooley et al., 1987; Dudley et al., 1990; Prieto and Giralt,
2001; Scullion et al., 2009). Therefore, we evaluated the role of
the LC on the modulation of physical exercise on the plastic
changes that motoneurons suffer after axotomy by submitting to
TR control rats and rats that previously had suffered chemical
ablation of the LC.
MATERIALS AND METHODS
Experimental Design
Adult female Sprague Dawley rats (8 weeks old, 200–280 g)
were housed with free access to food and water at room
temperature of 22 ± 2◦C under a 12:12-h light–dark cycle.
All experimental procedures were approved by the ethics
committee of Universitat Autònoma de Barcelona and followed
the guidelines of the European Commission on Animal Care
(EU Directive 2010/63/EU). For all surgical interventions, rats
were anesthetized by intraperitoneal administration of ketamine
(90 mg/kg, 0.9 ml/kg; Imalgen 2000) supplemented with xylazine
(10 mg/kg, 0.5 ml/kg; Rompun 2%).
One group of animals was used as control group; these animals
were only axotomized and did not receive any treatment (AX).
Two groups of animals received DSP-4 before the surgery, as
described below. Animals of one of these groups were subjected
to exercise 3 days after the surgery (DSP-4+TR) whereas the
other ones were not trained (DSP-4). A fourth group was
subjected to the same protocol of exercise without receiving
pharmacological treatment (TR). Each group was divided in two
subgroups: one subgroup was euthanized 14 days after injury
(short-term) to evaluate motoneurons changes and the other was
euthanized 75 days after injury (long-term) in order to evaluate
functional recovery (Figure 1 and Table 1). Contralateral side was
used as control-intact side.
Retrograde Labeling
Retrograde tracing [True Blue Chloride (TB, Setareh Biotech) and
Fluorogold (FG, Fluorochrome)] were bilaterally applied 1 week
before intervention to identify motoneuron pools of both tibialis
anterior (TA) and gastrocnemius medialis (GM) muscles. A small
incision to the skin was made to expose the muscle, and then two
injections (2.5 µl/injection) were distributed within the muscle
with a glass pipette using a Picospritzer (Arbat-Plana et al., 2015).
The area of application was rinsed with saline to clean any
remnants of the tracer and the skin wound was sutured.
Surgical Procedure
Under anesthesia, the sciatic nerve was exposed at the mid-thigh
and cut by using micro scissors. The proximal and distal stumps
were rejoined with two epineural 10-0 sutures. Afterward, muscle
and skin were sutured in layers, iodine povidone was applied
to the wound, and the rats were allowed to recover in a warm
environment under close observation.
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FIGURE 1 | Diagram of the procedures performed in the study. Intramuscular injection of retrotracers was performed 1 week before the lesion to label motoneurons
of both tibialis anterior (TA) and gastrocnemius medialis (GM) muscles. Two days later, DSP-4 was administered in the groups where LC had to be destroyed.
Section and direct suture of the sciatic nerve was performed at point 0. Trained animals were exercised from 3 to 14 dpi. Animals were followed up for 14 days for
immunohistochemical analysis or for 75 days for long-term electrophysiological assessment.
Noradrenergic Depletion
DSP-4 (Sigma Aldrich) was dissolved in sterile NaCl 0.9% saline
and delivered as a single i.p. dose of 50 mg/kg according to
the work of Lyons et al. (1989) within 10 min of preparation.
DSP-4 was administrated 4 days before the injury to ensure LC
destruction at the beginning of the treadmill protocol. Control
animals received a single i.p. injection of saline solution. The
doses of DSP-4 used were devoid of adverse effects, and therefore
rats did not require special care during follow up.
Treadmill Training Protocol
To acclimatize the animals subject to training exercise in a motor-
driven rodent treadmill (Treadmill LE 8706, LETICA, Spain),
they were placed on the treadmill for 60 min twice a week prior
to surgery. During these training sessions, previous to surgery,
shock grid intensity was set at 0.4 mA to provide a mild negative
stimulus. The TR protocol was started 3 days after surgery and
was carried out during 2 weeks. TR consisted of one session of
TR 5 days/week with duration and intensity being progressively
increased; running started at a locomotion speed of 10 cm/s that
was increased 2 cm/s every 5 min, until a maximum speed of
30 cm/s for 60 min was reached during the final training session
(Cobianchi et al., 2013).
TABLE 1 | Description of the different experimental groups used in this study, the
type of follow-up and the number of animals used.
Group Follow-up Study
(1) Control group (AX) Short-term Changes around soma (n = 4)
Long-term EMG (n = 5)
(2) DSP-4
administration group
(DSP-4)
Short-term Changes around soma (n = 4)
Long-term EMG (n = 5)
(3) DSP-4 + Treadmill
running (DSP-4+TR)
Short-term Changes around soma (n = 4)
Long-term EMG (n = 5)
(4) Treadmill running
(TR)
Short-term Changes around soma (n = 4)
Long-term EMG (n = 5)
Immunohistochemical Analysis of Locus
Coeruleus and Spinal Cord
Fourteen days after sciatic nerve injury, deeply anesthetized
animals were transcardially perfused with 4% paraformaldehyde
in PBS. Brain and L3–L6 spinal cord segment were removed,
post-fixed for 4 h, cryoprotected in 30% sucrose, and stored
at 4◦C until use. To localize the LC in the brain, we used an
acrylic array of coronal brain matrix (Acrylic brain matrices
Alto, for small rat coronal, 175–300 gr). Both brain and spinal
cord samples were embedded in Tissue-Tek, serially cut (25 and
20 µm thickness, respectively) with a cryostat, and collected
onto gelatin-coated glass slides. All sections were first blocked
with 10% normal bovine serum for 1 h, followed by overnight
incubation at 4◦C with anti-tyrosine hydroxylase (1:500, Sigma)
for the brain sections or combinations of primary antibodies
for the spinal cord sections: rabbit anti Synaptophysin (1:200,
Covance), guinea pig anti VGlut1 (1:300, Millipore), guinea
pig anti VGat (1:200, Synaptic Systems), Lectin from Wisteria
Floribunda (1:100, Sigma), mouse anti GFAP (1:1000, Millipore),
rabbit anti Iba1 (1:500, Wako). After washes, immunoreactive
sites were revealed by species-specific secondary antibodies
conjugated to 488 Alexa Fluor (1:200, Invitrogen), 538 Alexa
Fluor (1:500, Invitrogen), Cy3 (1:200, Millipore), or Streptavidin
488 Alexa Fluor (1:200, Invitrogen). After 2 h incubation at room
temperature, the sections were thoroughly washed, mounted on
slides, and coverslipped with Fluoromount-G (SouthernBiotech).
Back-labeled motoneurons were localized and images captured
with a scanning confocal microscope (LSM 700 Axio Observer,
Carl Zeiss 40×/1,3 Oil DIC M27). On the brain sections, LC
was localized and images captured with an epifluorescence
microscope (Nikon eclipse Ni DS-Ri2, 40×).
Image analysis, processing and regression analysis from
motoneurons labeling quantification were performed by means
of in-house software implemented in MATLAB R2012b (The
Mathworks Inc., Natick, MA, United States). Firstly, back-labeled
motoneurons were automatically selected and delineated and a
constant threshold was used to segment and obtain an estimated
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average density for each labeling. As a control for the background,
the software checked for each analyzed neuron that the soma had
no labeling for the set threshold. Immunoreactivity was evaluated
in a perimeter of 5 µm thickness surrounding the motoneuron
soma (Arbat-Plana et al., 2015). Since some variability between
animals, samples and processing can occur, similar amount of
motoneurons from both sides were analyzed in each slide. For
each animal, 10 to 15 motoneurons of each pool and each
side were analyzed.
Electrophysiology Tests
For the long term follow-up, motor reinnervation and H
reflex were assessed by means of nerve conduction tests,
performed at 30, 45, 60, and 75 days after surgery, using
an electromyography apparatus (Synergy Medelec, Viasys
HealthCare). Electrophysiological evaluation was performed
under ketamine/xylazine anesthesia. During the test, the rat
body temperature was kept constant between 34 and 36◦C
by means of a thermostated flat coil. The sciatic nerve was
stimulated by two needle electrodes percutaneously inserted at
the sciatic notch, applying single rectangular pulses of 0.1 ms
duration up to the voltage required to obtain a maximal evoked
response. The compound muscle action potentials (CMAP)
were recorded from the TA, GM and plantar (PL) muscles
with microneedle electrodes. Onset latency and amplitude from
baseline to the maximal negative peak of the direct M wave and
the reflex H wave were measured. The maximal H/M amplitude
ratio was calculated for each muscle tested. The H wave (the
electrophysiological equivalent of the stretch reflex) suffers a rate
dependent depression (RDD) that is useful to corroborate that
the recorded wave is truly the H wave. It is important to note
that at early stages of regeneration, characterized by polyphasic
CMAPs in the reinnervated muscles, the H wave can be masked.
Thus, to ensure that the selected wave was the H wave, repeat
stimulation was applied at increasing frequencies (0.3, 1, 3, 5,
10, 15, 20, and 30 pps) and at the threshold intensity for the H
wave. The ratio between the amplitude of the last and the first
H wave recorded for the different protocols was calculated, in
order to evaluate the RDD. The different tests were performed
also in the contralateral non-injured side to obtain control values
for each animal.
Statistical Analysis
For the immunohistochemical analysis, quantitative variables
were normality assessed by Shapiro-Wilk test (Royston, 1993).
For variables with a normal distribution one-way ANOVA
and post hoc analysis by Bonferroni test were used to test
the significance of the difference between the lesion side and
the contralateral side. For non-normal variables such analysis
was performed by Kruskall-Wallis test. SPSS 20.0 (SPSS Inc.,
Chicago, IL, United States) was used for statistical analyses.
A nested design ANOVA test was used in order to determine
if the variability was due to differences between the different
motoneurons or between animals in each group. The H/M
ratio and RDD data were analyzed by two way ANOVA with
Bonferroni post hoc correction.
RESULTS
DSP-4 was administrated to destroy the LC and thus, to evaluate
the effects of this center on the spinal changes mediated by
TR during 14 days following PNI. Firstly, we explored the state
of LC after DSP-4 administration using Tyrosine Hydroxylase
antibody (TH), which is a useful marker for dopaminergic and
noradrenergic neurons. To localize the LC we used sections 9.16
to 10.04 mm caudal to Bregma, following the Rat Brain Atlas in
stereotaxic coordinates (Paxinos and Watson, 1998).
In control animals, a group of TH+ neurons organized in
a typical triangular shape was easily localized in each side of
the 4th ventricle (Figure 2A). In contrast, in DSP-4 treated
animals, few TH+ neurons were localized (Figure 2B). In some
animals, isolated brightly stained neurons were observed in
the region (Figure 2C).
Effects of DSP-4 Administration on
Central Changes After Axotomy
Synaptophysin (Syn) immunolabeling, a general marker
for synapses, showed that the number of synaptic coverage
of motoneurons was reduced after sciatic nerve injury,
whereas TR partially preserved that loss (77 ± 3 Syn/µm2
and 97 ± 3 Syn/µm2 in AX animals vs. 89 ± 2 Syn/µm2
and 104 ± 4 Syn/µm2 in trained animals, in TA and
GM, respectively, p < 0.01). No significant differences
were found between animals treated with DSP-4 (83 ± 3
Syn/µm2 in both TA and GM) compared to control
injured animals. DSP-4 administration combined with
TR induced a marked decrease of synapses labeling
on injured motoneurons compared to AX (63 ± 5
Syn/µm2 in TA and 71 ± 10 Syn/µm2 in GM, p < 0.05)
(Figures 3A, 4).
Excitatory synapses were analyzed using VGlut1, a specific
marker of proprioceptive afferents from the muscle spindle.
Axotomized TA and GM motoneurons had a density of about
40 ± 2 per µm2, less than half than in intact motoneurons. After
TR, the loss of excitatory synapses was also attenuated (60 ± 4
VGlut1/µm2 in both TA and GM, p < 0.01). Animals treated
with DSP-4 did not show significant differences compared to
injured control animals (42 ± 5 VGlu1/µm2). However, animals
treated with DSP-4 subjected to TR showed a significant decrease
of VGlut1 contacts on motoneurons in both TA and GM pools
compared to AX and TR animals (30± 3 VGlut1/µm2, p< 0.01)
(Figures 3B, 4).
The reduction of excitatory VGlut1 synapses suffered by
axotomized motoneurons was accompanied by an increase of
VGat labeled inhibitory synapses (67± 1 VGat/µm2 and 100± 3
VGat/µm2 in TA and GM, respectively). TR animals, showed
a lower increase in inhibitory synapses after axotomy (49 ± 2
VGat/µm2 and 85 ± 2 VGat/µm2 in TA and GM, p < 0.01)
than controls. In this case, no significant differences were found
between DSP-4 and DSP-4+TR animals compared to control
animals (Figures 3C, 4).
Wisteria floribunda immunoreactivity was used to analyze
PNN. Axotomized motoneurons had a reduction in the amount
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FIGURE 2 | Representative images from sections of the brain stem regions where LC is localized in animals non-treated (A) or treated with DSP-4 (B,C) and
immunostained against TH. The characteristic triangular shape of the LC nucleus (A) is lost 14 days after DSP-4 treatment. Hardly any TH+ neuron can be seen in
the region (arrow, B), being some isolated neurons highly stained (arrow, C).
FIGURE 3 | Quantitative analysis of synaptic stripping and excitatory/inhibitory synapses after axotomy in the different groups of animals. Evaluation of
Synaptophysin (A), VGlut1 (B), VGat (C), GFAP (D), and Iba1 (E) in TA (white bars) and GM (gray bars) 15 days after sciatic nerve cut and suture in sedentary or
trained animals, either treated with DSP-4 or untreated. Horizontal dotted lines indicate the average of motoneuron labeling in the non-injured side of both TA and
GM motoneurons. Immunoreactivity for GFAP and Iba1 is so low in intact motoneurons that the horizontal dotted lines are missing in D,E graphs. Synaptophysin,
Iba1 and GFAP values followed a normal distribution, whereas Vglut1 followed a non-normal one. Data are expressed as mean ± SEM, ∗p < 0.05, ∗∗p < 0.01, vs.
AX group.
of PNN (52 ± 5 PNN/µm2 in AX group compared to
150± 21 PNN/µm2 in intact rats) that was partially prevented
if animals were subjected to exercise (75± 4 PNN/µm2; p< 0.01
vs. AX group). We observed that PNN immunoreactivity in
injured motoneurons was lower in rats receiving DSP-4 (35 ± 1
PNN/µm2 and 42 ± 2 PNN/µm2 in TA and GM, respectively)
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FIGURE 4 | Quantitative analysis of perineuronal nets (PNN) 15 days after axotomy in animals subjected to treadmill or left untrained, either treated with DSP-4 or
untreated, in both experimental side (A) and contralateral side (B). Horizontal dotted lines indicate the mean of motoneuron labeling in the non-injured side of both
TA and GM motoneurons. PNN values followed a non-normal distribution. Data are expressed as mean ± SEM, ∗p < 0.05, ∗∗p < 0.01, vs. AX group.
than in only injured animals (p < 0.01). DSP-4+TR animals
had also a low density of PNN surrounding motoneurons
(35 ± 5 PNN/µm2 in both TA and GM). Interestingly, in DSP-
4 group, GM motoneurons at the contralateral side showed a
reduced PNN density (172 ± 8 PNN/µm2) compared to those
of AX animals (182 ± 6 PNN/µm2), whereas this reduction
was not observed in PNN from TA motoneurons (145 ± 18
PNN/µm2 in DSP-4 group and 139± 2 PNN/µm2 in AX group)
(Figures 4, 5).
Astroglial reactivity, estimated by measuring the density
of GFAP immunolabeling surrounding motoneurons, was
significantly increased in animals subjected to TR (261 ± 1
and 263 ± 1 GFAP/µm2 in TA and GM, respectively)
compared to the control injured group (5 ± 1 and 6 ± 1
GFAP/µm2, respectively, p < 0.001). Astroglial reactivity was
also increased in both groups of animals treated with DSP-
4 (around 271 ± 3 GFAP/µm2 for both muscles) similarly
to TR only animals. Thus, administration of DSP-4 did not
affect the modulation of astroglial reactivity induced by exercise
(Figures 3, 5).
Iba1 immunostaining around axotomized motoneurons was
used to evaluate microglial reactivity. Fourteen days after
nerve injury, there was a marked increase of microglia
labeling in control rats (76 ± 4 and 84 ± 5 Iba1/µm2 in
TA and GM, respectively). DSP-4 administration significantly
increased microglial reactivity (316 ± 4 and 324 ± 5
Iba1/µm2 in TA and GM, respectively, Figure 3) that also
presented a phagocytic phenotype (Figure 5). Exercise drastically
reduced microglia reactivity around injured motoneurons
(49 ± 1 and 51 ± 1 Iba1/µm2 in TA and GM, respectively),
and similar low activation of microglia was observed in
animals treated with DSP-4 and also subjected to exercise
(51 ± 1 Iba1/µm2 for both muscles), thus indicating that
the modulation of microglia by exercise was not affected
with the loss of LC.
Muscle Reinnervation
Electrophysiological studies were performed to evaluate motor
reinnervation during 75 days after sciatic nerve injury. The M
wave values of the muscles at the contralateral side were similar in
all animals. At the injured side, all the groups showed an increase
in the amplitude of the M wave of the muscles tested along time,
but with different progression.
The groups of animals subjected to TR had lower M wave
amplitude of the GM muscle at 45 and 60 days than the untreated
group. However, at the end of follow up, the TR group achieved
similar levels of reinnervation than the control, whereas the
DSP-4+TR group remained with lower levels of reinnervation
in both GM and TA muscles (Figures 6A,B). GM from DSP-4
group followed a similar progression of reinnervation than GM
from control group. In contrast, at the end of follow-up, TA
reinnervation in DSP-4 group was significantly higher than in AX
group. Reinnervation of the PL muscles started in AX and DSP-4
groups at 45 dpi, and at 60 dpi in TR group. In contrast, in the
DSP-4+TR group, we did not record M waves in the PL muscles
at the end of follow up (data not shown), further indicating that
motor regeneration was hampered by the combination of both
treatments (Figures 6A,B).
Regarding the recovery of the H wave, there was an increase
of the maximal H/M ratio after sciatic nerve injury, indicative
of hyperreflexia, that followed a similar course to attain close to
normal values at 75 days, without significant differences between
groups (Figures 6C,D). In the injured side, the RDD rate was
increased at all time points but again no differences between
groups were observed.
DISCUSSION
The results of this study corroborate that a high intensity
protocol of TR applied during 2 weeks after sciatic nerve
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FIGURE 5 | Evaluation of excitatory and inhibitory synapses, PNN, astroglia, and microglia reactivity surrounding axotomized motoneurons. All immunostainings
were evaluated in confocal images of spinal cord regions containing back-labeled motoneurons (blue) of TA and GM muscles 15 days after nerve cut repaired with
direct suture in the different groups of animals.
injury was able to attenuate synaptic stripping and PNN loss
around axotomized motoneurons, as we had shown previously
(Arbat-Plana et al., 2015). In this work we aimed to analyze
if the noradrenergic neurons of the LC play a role in these
effects. Since a previous work pointed different responses
to exercise in male and female mice (Liu et al., 2015),
and we had previously evaluated the effects of two protocol
of TR in female rats, here we used the more successful
intensity of exercise to prevent central changes after PNI in
female rats only.
The LC is strongly activated in stressful situations and
besides its key role in arousal (Berridge and Waterhouse, 2003),
it also plays an important role in modulating excitability of
spinal motoneurons (Heckman et al., 2003) and nociceptive
transmission (Millan, 2002; Pertovaara, 2006). It has recently
demonstrated that contrasting modulation of pain-related
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FIGURE 6 | Plots of the amplitude of the CMAPs (A,B) and of the H/M ratio (ratio between the amplitude of the H reflex wave and the amplitude of the direct M
wave after electrical stimulation of the nerve) (C,D) from the electrophysiological tests performed in the different experimental groups. Results recorded in GM (A,C)
and TA (B,D) muscles at 30, 45, 60, and 75 dpi. Horizontal dotted lines indicate the average of CMAP or H/M ratio in the non-injured side of both TA and GM
muscles. Data are expressed as mean ± SEM, ∗p < 0.05, ∗∗p < 0.01, ∗AX vs. DSP-4+TR; #AX vs. TR; &AX vs. DSP-4.
behaviors is mediated with distinct noradrenergic neuronal
populations, being the spinal-projections from the LC the ones
related with analgesia (Hirschberg et al., 2017). Therefore, we
disrupted the LC by administration of DSP-4 before performing
a sciatic nerve injury in rats. DSP-4 is a neurotoxin that
quite specifically destroys noradrenergic neurons of the LC,
whereas respects similar neurons of other brain stem regions
(Ross and Stenfors, 2015).
Destruction of LC did not affect synaptic stripping on
axotomized spinal motoneurons. In contrast, when these animals
were subjected to TR, the preventing effects of exercise on
synaptic stripping were lost. In fact, they even showed more
marked synaptic stripping and larger loss of VGlut1 synaptic
contacts than injured control rats. Loss of noradrenergic
projections from the brain stem also blocked the ability of
TR exercise to revert the reduction in PNN. These results
support the hypothesis that the increasing intensity TR protocol
promotes activation of the LC, which play a role on the
maintenance of synapses in axotomized motoneurons. As stated
before, ascending projections from the LC influence arousal and
attention (Berridge and Waterhouse, 2003) and optimize also
task-performance (Aston-jones and Cohen, 2005). Therefore,
loss of these ascending projections could indirectly affect
spinal motoneurons. However, since descending neurons project
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directly onto the spinal cord, its logical to assume that are
the descending neurons the ones mediating most of the effects
we observed on DSP-4 treated animals. In fact, the LC is an
important source of descending noradrenergic projections to the
spinal cord (Grzanna and Fritschy, 1991), and thus its destruction
would reduce the noradrenergic inputs that spinal motoneurons
receive. Nevertheless, other brainstem noradrenergic nuclei, like
A5 and A7, also send projections to the spinal cord. Since DSP-
4 is a specific neurotoxin for LC neurons (Ross and Stenfors,
2015), we did not completely abolish all the NA projections that
motoneurons receive and, therefore, stronger effects could be
expected if all the spinal sources of NA had been ablated.
It is important to take into account that descending
noradrenergic projections have a modulatory effect on the
excitability of motoneurons, facilitating their activation when
receiving other synaptic inputs (Heckman et al., 2008).
Noradrenaline acts by facilitating persistent inward currents
(PICs) in the dendrites (Hultborn et al., 2004; Perrier and
Delgado-Lezama, 2005; Heckman et al., 2008, 2003). When
activated, PICs amplify ionotropic synaptic inputs and are
essential for normal repetitive firing (Lee and Heckman, 1999;
Heckman et al., 2003), and thus for the production and
facilitation of movement. Therefore, the loss of noradrenergic
projections can reduce the effects of other synaptic inputs on
motoneurons and limit the effects of increased activity induced
by exercise. It is interesting to note that loss of noradrenergic
projections also had effects on PNN of uninjured motoneurons,
suggesting a widespread effect. After injury, animals that are
not forced to run probably decrease their motor activity and
thus, the loss of descendent noradrenergic projections does not
potentiate the effects observed after the injury in motoneurons.
In contrast, animals forced to run in a treadmill strongly
activate these projections. It seems that in these situation,
the lack of noradrenergic modulatory inputs in axotomized
motoneurons is detrimental on the maintenance of the synaptic
arbor and the PNN.
As we have already shown (Arbat-Plana et al., 2015), TR also
affects the contralateral side, increasing the thickness of PNN
around intact motoneurons, but it is unlikely that this increase
has any relevant physiological effect in a context where plasticity
is not triggered. In contrast, after a PNI, that lead to changes
in the spinal circuitry, preservation of PNN could attenuate
maladaptive plasticity and disorganization of the synaptic arbor
of axotomized motoneurons, facilitating functional recovery.
Besides its ability to increase activity of the injured circuits
and to preserve synapses and PNN in spinal motoneurons, TR
exercise also modulates the inflammatory response observed in
the spinal cord after PNI. Interestingly, noradrenaline has anti-
inflammatory effects in the periphery (Kohm and Sanders, 1999;
Sanders and Straub, 2002). Loss of the LC increased microglia
reactivity around axotomized motoneurons in DSP-4 treated
animals compared to controls. In contrast, animals forced to run
in the treadmill downregulated microglia reactivity (Cobianchi
et al., 2013). However, this anti-inflammatory effect of exercise
at the spinal level seems independent of the LC noradrenergic
system, since similar attenuation of microglia reactivity was
observed in exercised animals after its depletion. Of course, NA
from other sources could compensate the loss of noradrenergic
inputs from LC and thus, modulate this inflammatory response.
Recent works have shown that the inflammatory response
is important to switch the peripheral sensory neurons from
a neurotransmitter state to a pro-regenerative state (Liberto
et al., 2004; Frey et al., 2008; Niemi et al., 2013). Similarly,
reactive microglia might influence the regenerative program in
axotomized motoneurons. Since noradrenaline is a known anti-
inflammatory (Heneka et al., 2010), its reduction in the spinal
cord due to LC ablation, by increasing microglia reactivity around
motoneurons might facilitate faster axonal regeneration and
thus, explain the increased motor reinnervation observed in the
DSP-4 group. On the contrary, TR exercise by itself attenuated
the inflammatory response and delayed muscle reinnervation,
as suggested by the lower amplitude of CMAPs observed in
exercised animals during the first 8 weeks. Indeed, the effects of
exercise on regeneration and muscle reinnervation are variable,
depending upon intensity and duration of the protocol, and the
period during which it is applied after the injury (Udina et al.,
2011b; Gordon and English, 2015). It has been hypothesized that
moderate exercise training enhances functional sensorimotor
recovery, whereas forced intense exercise, such as the increasing
intensity TR protocol applied here, may have a detrimental effect.
In our study we also observed that at later stages, several weeks
after stopping TR training, reinnervation improved. However,
in exercised animals treated with DSP-4 this late increase of
reinnervation was not observed, indicating that LC noradrenergic
pathways are somehow mediating the effects of exercise on
nerve regeneration.
It is interesting to note that that low intensity TR protocols,
although being more effective promoting nerve regeneration
and muscle reinnervation (Udina et al., 2011a), have limited
effects on the preservation of synapses and PNN on axotomized
motoneurons (Arbat-Plana et al., 2015), thus indicating that the
protocol that facilitates regeneration differs from the one that
favors maintenance of spinal circuitry.
Since the lack of recovery of the functional stretch reflex can
be due to the permanent loss of proprioceptive afferent/VGlut1
synapses onto injured motoneurons even when they reinnervate
the muscle (Alvarez et al., 2010; Rotterman et al., 2014) we also
evaluated the state of the stretch reflex circuit by means of its
electrophysiological equivalent, the H wave. The H/M amplitude
ratio has been extensively used in the literature to measure spinal
excitability. When the spinal reflex response is facilitated, the
H/M ratio increases (Burke et al., 1999). At early stages of muscle
reinnervation there is an electrophysiological hyperexcitability
and the H/M ratio increases; as muscle reinnervation is
consolidated, it returns to normal values (Valero-Cabré and
Navarro, 2001). In our study we observed the same changes along
time, without differences between experimental groups. However,
it is argued that the electrophysiological recovery of the H reflex
after PNI does not guarantee the functionality of the stretch reflex
(Cope et al., 1994; Haftel et al., 2005; Bullinger et al., 2011).
In fact, we previously found that a low intensity protocol of
TR (Vivó et al., 2008; Asensio-Pinilla et al., 2009; Udina et al.,
2011a) attenuated such hyperexcitability by means of a decreased
H/M ratio. However, this protocol was less effective preserving
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proprioceptive synapses on axotomized motoneurons than
the high intensity TR protocol used here (Arbat-Plana
et al., 2015). Therefore, evaluation of the functionality of
stretch reflex is needed in order to fully understand the
functional relevance of proprioceptive synaptic preservation by
exercise after PNI.
In conclusion, LC seems to play a complex role on
the effects of exercise on injured motoneurons. This center
mediates the ability of physical exercise to activate motoneurons,
and contribute to the maintenance of the normal synaptic
inputs but does not participate in the anti-inflammatory
effect of TR at the spinal level. Other sources of NA or
either other monoamines like serotonin (Lopez-Alvarez et al.,
2018) can also contribute to the effects of TR on the spinal
cord. Interestingly, the sole elimination of LC in injured
animals not subjected to exercise markedly increased microglia
reactivity and improved early muscle reinnervation. In contrast,
TR exercise, by reducing microglia reactivity, would delay
motor regeneration and muscle reinnervation. However, this
reduced microglia reactivity mediates other positive effects,
such as attenuation of synaptic stripping and neuropathic
pain (Cobianchi et al., 2010; López-Álvarez et al., 2015).
Therefore, it seems that there is a delicate equilibrium between
modulation of maladaptive plasticity and enhancement of
regeneration. At this stage of research, exercise of moderate
intensity seems more adequate than intensive protocols that
can interfere with axonal regeneration. Use of combined
protocols could also compensate the limitations of single
therapeutic approaches.
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The Complex Work of Proteases
and Secretases in Wallerian
Degeneration: Beyond Neuregulin-1
Marta Pellegatta* and Carla Taveggia*
Division of Neuroscience and INSPE at IRCCS San Raffaele Scientific Institute, Milan, Italy
After damage, axons in the peripheral nervous system (PNS) regenerate and regrow
following a process termed Wallerian degeneration, but the regenerative process is
often incomplete and usually the system does not reach full recovery. Key steps to the
creation of a permissive environment for axonal regrowth are the trans-differentiation
of Schwann cells and the remodeling of the extracellular matrix (ECM). In this review
article, we will discuss how proteases and secretases promote effective regeneration
and remyelination. We will detail how they control neuregulin-1 (NRG-1) activity at the
post-translational level, as the concerted action of alpha, beta and gamma secretases
cooperates to balance activating and inhibitory signals necessary for physiological
myelination and remyelination. In addition, we will discuss the role of other proteases
in nerve repair, among which A Disintegrin And Metalloproteinases (ADAMs) and
gamma-secretases substrates. Moreover, we will present how matrix metalloproteinases
(MMPs) and proteases of the blood coagulation cascade participate in forming newly
synthetized myelin and in regulating axonal regeneration. Overall, we will highlight how
a deeper comprehension of secretases and proteases mechanism of action in Wallerian
degeneration might be useful to develop new therapies with the potential of readily and
efficiently improve the regenerative process.
Keywords: wallerian degeneration, remyelination, secretases, matrix metalloproteinases, fibrinolysis
PERIPHERAL NERVE REGENERATION
In the peripheral nervous system (PNS), nerves can be damaged following various events such
as traumatic injuries, metabolic alterations and genetic peripheral neuropathies. All these events
significantly impact the quality of life of both patients and caregivers. Regardless of the nature of the
triggering cause, after injury both Schwann cells and neurons are compromised as their reciprocal
interdependence determines that damaging one cell type will eventually influence the other. Unlike
the central nervous system, the PNS possesses the intrinsic capability to regenerate, as axons can
regrow over long distances to reach their final target and Schwann cells are able to remyelinate
them. Nonetheless, the regenerative process often remains incomplete, due to the inability of the
repair machinery to maintain an extended growth promoting response (Gaudet et al., 2011).
After traumatic injury, PNS axons can regrow and remyelinate following a process termed
Wallerian degeneration. The cascade of events leading to the axon regrow and the re-establishment
of a functional myelinated axo-glia unit has been originally described by August Waller
as the result of nerve axotomy (Waller and Owen, 1850), and might partially differ from
those observed after crush injury (Stoll et al., 2002; Gaudet et al., 2011; Rotshenker, 2011).
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In this review article, we will report the role of molecules
and modifiers of the extracellular matrix (ECM) in the process
of regeneration and remyelination. Since these molecules
have been investigated in both models of crush injury and
axotomy we will generally refer to their role in peripheral
nerve injury.
During early Wallerian degeneration, axons degenerate and
Schwann cells adopt a specific response to injury: the repair
program (Gerdts et al., 2016). Specifically, denervated Schwann
cells lose their myelin sheath and downregulate the expression
of myelin-associated genes, among which Egr2/Krox20, MPZ,
MBP, MAG and periaxin. In addition, they start to proliferate
and upregulate molecules characteristic of their immature stage
such as L1, NCAM, p75NTR and GFAP (Jessen and Mirsky,
2008). However, after injury, Schwann cells do not simply
revert their phenotype to an earlier developmental stage, but
undergo a proper ‘‘trans-differentiation’’ phase in which they
acquire unique characteristics, becoming true ‘‘repair cells’’
(Arthur-Farraj et al., 2012; Jessen et al., 2015). In particular,
they upregulate neurotrophic factors supporting axon survival
and elongation, a necessary step towards regeneration (Fontana
et al., 2012; Brushart et al., 2013). In addition, they specifically
activate a massive myelin-breakdown and play an early pivotal
role in removing myelin debris, which represents a barrier
to the regrowth of axons distal to the injury site (Brown
et al., 1994; Perry et al., 1995; Hirata and Kawabuchi, 2002;
Gomez-Sanchez et al., 2015; Jang et al., 2016). During the first
week after injury, repair Schwann cells also produce cytokines
that induce macrophages’ activation and recruitment from the
bloodstream (Bolin et al., 1995; Kurek et al., 1996; Shamash
et al., 2002; Tofaris et al., 2002; Roberts et al., 2017). In the
following stages, indeed, macrophages assume a primary role in
debris removal and growth factors production, supporting axons
regeneration and Schwann cells migration through the distal
nerve stump (Gaudet et al., 2011; Gerdts et al., 2016). Within
this complex pro-regenerative environment, repair Schwann
cells adopt an elongated bipolar morphology and align to
form regenerative tracks from the injury site to the nerve
target, called ‘‘Bungner bands’’ (Gomez-Sanchez et al., 2017).
These structures generate along the basal lamina that previously
surrounded the Schwann cell-axon unit in intact nerves and
support injured axons regrowth through the distal stump to reach
their final target.
Axo-glial communication is essential for nerve repair: not
only Schwann cells create a permissive environment for axons
regrowth, but also axon-derived signals promote differentiation
of repair cells (Fawcett and Keynes, 1990; Stassart et al., 2018).
The re-establishment of the axo-glial unit during later phases of
the regenerative process allows Schwann cells to re-differentiate
and remyelinate the newly generated axon and to re-establish
rapid saltatory conduction of the nerve impulse. Nonetheless,
remyelinated axons have shorter internodes and thinner myelin
sheaths as compared to uninjured nerves (Fancy et al., 2011;
Stassart et al., 2018).
Given the inefficiency in the regenerative process, there is
an evident need to envisage more effective therapeutic strategies
allowing complete recovery. Recent advances in biomaterial
and biomedical engineering have provided new strategies to
improve regenerative capabilities in injured nerves with synthetic
conduits (Tajdaran et al., 2018). These scaffolds support the
reconstruction of long nerve gaps, as they allow the application
of exogenous agents with neurotrophic properties. Although not
pertinent to this review, nerve-scaffolding techniques represent a
strategic line of research in nerve regeneration.
Finally, axonal loss and repeated attempts of nerve
regeneration are key features also of several peripheral
neuropathies, like Charcot Marie Tooth hereditary neuropathies
(Stassart et al., 2018). Thus, the development of more adequate
treatments to promote nerve repair could similarly benefit these
pathologies for which there is no effective therapy.
NEUREGULIN-1
Neuregulins are transmembrane proteins belonging to the
family of epidermal growth factor (EGF)-like growth factors
(Falls, 2003). They signal by binding to the tyrosine kinase
receptors of the ErbB family expressed on Schwann cells
(Yarden and Sliwkowski, 2001), thereby activating different
intracellular signal transduction pathways in glial cells
(Yang et al., 2004; Gu et al., 2005). Neuregulin-1 (NRG-1)
is the most important gene among the members of this
family and it is also the best characterized. The Nrg1 gene
encodes for several isoforms, all containing an EGF-like
domain, which is required to activate the ErbB receptors.
All NRG1 isoforms differ mainly for the composition of
their N-terminal end, on the base of which they have been
classified into six different groups (Garratt et al., 2000;
Buonanno and Fischbach, 2001; Mei and Nave, 2014).
Distinct NRG1 isoforms use specific promoters to drive
their expression in a tight spatio-temporal regulated pattern.
Indeed, they are implicated in different cellular function, like
migration, proliferation, morphogenesis and control of cell size
(Buonanno and Fischbach, 2001; Esper et al., 2006; Britsch, 2007;
Mei and Nave, 2014).
Among the various types of Neuregulins, we will focus
on NRG1 type I and type III, which are the main isoforms
thus far investigated in PNS development and regeneration.
NRG1 type I is a single-pass membrane protein and presents
an Immunoglobulin-like domain at the N-terminus, while
NRG1 type III, in addition to the transmembrane domain,
possesses a cysteine-rich domain in the N-terminal portion
that further anchors the protein to the plasma membrane
(Ho et al., 1995).
In the PNS, NRG1 type III is essentially expressed on
axonal membranes (Figure 1). During nerve formation,
NRG1 type III is required for Schwann cells proliferation and
differentiation (Nave and Salzer, 2006). Indeed, in mutant
mice lacking NRG1 type III expression, Schwann cells are
absent, and this causes a severe cell death of dorsal root ganglia
(DRG) and motor neurons (Wolpowitz et al., 2000). During
development, NRG1 type III forces Schwann cells to choose
between myelination and non-myelination (Taveggia et al.,
2005). Of note, axonal levels of NRG1 type III also determine
the thickness of the myelin sheath: mice overexpressing
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FIGURE 1 | This model depicts molecules and secretases mainly involved in axonal regeneration after injury and their cellular localization.
axonal NRG1 type III are hypermyelinated, whereas mice
haploinsufficient for NRG1 type III are hypomyelinated
(Michailov et al., 2004; Taveggia et al., 2005). Binding of
NRG1 to their cognate ErbB2/ErbB3 receptors, activates
multiple signal transduction pathways in Schwann cells,
including PI3K-AKT1, calcineurin and MAPK signaling
pathways (Taveggia et al., 2005, 2010; Kao et al., 2009;
Pereira et al., 2012). Of note, NRG1 type III activity
is regulated by the extracellular cleavage of secretases
(Willem, 2016). While the beta secretase β-site amyloid
precursor protein-cleaving enzyme 1 (BACE1) activates
NRG1 type III, enhancing myelination (Hu et al., 2006;
Willem et al., 2006), cleavage of NRG1 type III by the
α-secretase ADAM17 inhibits myelination (La Marca et al.,
2011; Bolino et al., 2016). Accordingly, transgenic mice
lacking BACE1 are hypomyelinated (Hu et al., 2006; Willem
et al., 2006) and mice depleted of neuronal ADAM17 are
hypermyelinated, with a phenotype that remarkably resembles
NRG1 type III overexpressing mice (Michailov et al., 2004;
La Marca et al., 2011).
Following traumatic nerve injury, the expression of several
components of the NRG1 signaling machinery is dys-regulated
(Birchmeier and Bennett, 2016; Morano et al., 2018). For
example, ErbB2/ErbB3 receptors expression is increased after
damage and their activation status is enhanced (Cohen et al.,
1992; Carroll et al., 1997; Kwon et al., 1997; Guertin et al.,
2005), although the effective role of ErbB receptors in peripheral
nerve injury is partly controversial (Atanasoski et al., 2006).
Moreover, neuronal NRG1 type III expression decreases as soon
as the Schwann cells-axon unit is destroyed but it is subsequently
re-expressed during late phases of nerve regeneration, when
axons re-innervate their target (Bermingham-Mcdonogh et al.,
1997; Stassart et al., 2013).
Axonal NRG1 plays an important role in peripheral nerve
repair, which, under many aspects, is different from that
accomplished during nerve development (Birchmeier and
Bennett, 2016). After an injury insult, axonal NRG1 is a driving
force for regeneration and it controls the expression of genes
involved in peripheral nerve injury (El Soury et al., 2018).
Its juxtacrine interactions with Schwann cells, in fact, prompt
both remyelination and normal re-innervation of neuromuscular
junctions (Fricker et al., 2011). Accordingly, remyelination in
mice lacking NRG1 expression in a subset of motor and sensory
neurons is severely impaired (Fricker et al., 2011). Unexpectedly,
these defects are transient, and axons in mutant nerves are
efficiently remyelinated during late nerve regeneration (Fricker
et al., 2013). NRG1 therefore is an important factor in regulating
nerve repair following injury but, unlike development, it does not
control the myelinating fate of axons.
While the above-mentioned studies suggest that axonal
NRG1 is dispensable for long term remyelination, it has also
been reported that neuronal overexpression of NRG1 type I
and type III isoforms facilitates nerve repair and improves
remyelination after injury (Stassart et al., 2013). Although these
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 March 2019 | Volume 13 | Article 93156
Pellegatta and Taveggia Proteases and Secretases in Nerve Injury
findings seem contradictory, it is possible that gain and loss of
function approaches are targeting different mechanisms. Lack
of NRG1 after injury might in fact be compensated with time
by other molecules, whereas its overexpression could promote
Schwann cells re-differentiation and favor nerve regeneration
through a distinct process.
Unlike NRG1 type III, NRG1 type I expression is potently
induced in Schwann cells early after nerve damage, and
although dispensable for developmental myelination, it is critical
for remyelination (Figure 1; Loeb et al., 1999; Falls, 2003;
Stassart et al., 2013). Indeed, mutant mice specifically lacking
NRG1 type I expression in Schwann cells poorly remyelinate
after injury, suggesting that Schwann cells require autocrine
NRG1 type I signaling to support re-differentiation and repair
(Stassart et al., 2013).
Interestingly, administration of exogenous NRG1 type III
and NRG1 type I promotes neurite outgrowth and nerve
regeneration (Mahanthappa et al., 1996; Cai et al., 2004).
Moreover, modulation of NRG1 activity in animal models of
CMT1A (Fledrich et al., 2014), CMT1B (Scapin et al., 2018)
and Congenital HypomyelinatingNeuropathy (Belin et al., 2018),
can ameliorate the peripheral hypomyelination observed in these
diseases, prevent axonal loss and promote nerve functional
recovery, the latter all features observed also after nerve injury.
Nonetheless, it has also been recently reported that NRG1 is
already highly expressed in nerves of CMT1A pre-clinical
models, thus indicating that delivery of exogenous NRG1 should
be carefully evaluated (Fornasari et al., 2018),
Collectively these studies suggest that after damage, Schwann
cells might have developed new strategies to accomplish many
of their cellular functions. Thus, a better understanding of the
molecular mechanism underlying their extraordinary plasticity
remains crucial towards the development of powerful therapies
leading to complete regeneration.
BACE1
The beta secretase BACE1 is an aspartyl protease mostly involved
in processing type I transmembrane proteins, which results in the
generation of a cleaved, membrane-bound portion of the target
molecule and in the release of a soluble fragment. BACE1 has
been well characterized in the pathogenesis of Alzheimer’s
disease, since it is one of the main enzymes responsible for
the processing of the amyloid precursor protein and for the
generation of amyloid beta plaques, a pathological hallmark of
the disease (Sinha and Lieberburg, 1999; Vassar et al., 1999; Yan
et al., 1999; Cai et al., 2001; Luo et al., 2001; Roberds et al., 2001).
Besides the amyloid precursor protein, BACE1 cleaves a
variety of substrates (Hemming et al., 2009). Among them, in
the nervous system, there are voltage-gated sodium channels
(Wong et al., 2005; Kim et al., 2007, 2011; Gersbacher et al.,
2010), the potassium channel proteins KCNE1 and KCNE2 (Hitt
et al., 2012; Sachse et al., 2013), the adhesion molecules L1 and
close homolog of L1 (CHL1; Hitt et al., 2012; Kuhn et al., 2012;
Zhou et al., 2012), contactin-2 (Kuhn et al., 2012) and Seizure-
related gene 6 protein (Sez 6; Kuhn et al., 2012). Processing of
these substrates by BACE1 perturbs several brain functions, as
these proteins are involved in different tasks. Indeed, BACE1 is
crucial to generate axonal connections (Hitt et al., 2012), regulate
axonal guidance (Kuhn et al., 2012; Zhou et al., 2012) and
modulate neurite outgrowth and neural connectivity (Kuhn
et al., 2012). Surprisingly, despite being implicated in processing
many substrates, constitutive ablation of BACE1 in mice results
in viable and fertile animals, with only moderate behavioral
abnormalities (Cai et al., 2001; Luo et al., 2001; Roberds et al.,
2001; Laird et al., 2005; Savonenko et al., 2008).
In the PNS, BACE1 is mainly expressed in motor neurons
and in DRG sensory neurons (Willem et al., 2006) and its
expression is highly similar to that of NRG1 type III. Nonetheless,
BACE1 is present at very low levels also in Schwann cells in
normal nerves and at higher levels in damaged nerves (Hu
et al., 2015; Figure 1). Constitutive deletion of BACE1 results
in severe myelination defects during development (Hu et al.,
2006; Willem et al., 2006; Velanac et al., 2012). Interestingly,
NRG1 cleavage is impaired in BACE1 null mice (Hu et al.,
2006; Willem et al., 2006), and the hypomyelinating phenotype
resembles that observed in NRG1 type III haploinsufficient mice
(Michailov et al., 2004; Taveggia et al., 2005). Accordingly, in
peripheral nerves, BACE1 directly cleaves axonal NRG1 type
III, generating a membrane-tethered portion of the molecule
that exposes the EGF-like domain allowing the activation of
the ErbB2/ErbB3 receptors complex on Schwann cells, thereby
promoting myelination (Hu et al., 2008; Velanac et al., 2012).
BACE1 is also implicated in peripheral nerve injury;
specifically, in the absence of BACE1 remyelination is impaired.
Accordingly, injured nerves of BACE1 null mice have thinner
myelin sheath and increased number of un-myelinated axons
(Hu et al., 2008). These defects have been ascribed to
aberrant processing of axonal NRG1 type III, which impairs
PI3K/AKT1 signaling pathway activity (Hu et al., 2008). More
recently, also the contribution of glial BACE1, i.e., expressed
in Schwann cells, has been investigated in nerve remyelination
(Hu et al., 2015). Nerve graft experiments suggest that both
axonal and Schwann cell-derived BACE1 activity are decisive
for remyelination (Hu et al., 2015). Interestingly, since both
BACE1 and NRG1 type I are induced in Schwann cells after
injury (Hu et al., 2008, 2015; Stassart et al., 2013), it is likely
that glial BACE1 contributes to nerve repair by promoting
NRG1 type I cleavage (Hu et al., 2015), though this has never
been formally demonstrated.
Other studies reported an opposite role for BACE1 in PNS
remyelination. By analyzing early regenerative events, Farah
et al. (2011) observed that BACE1 knockout mice present
enhanced myelin and axonal debris clearance, an increased
number of regenerated fibers and precocious re-innervation
of neuromuscular junctions. These phenomena are likely due
to neuronal BACE1, as overexpression of BACE1 in neurons
determines a marked decrease in peripheral axons regeneration
capacity (Tallon et al., 2017). These data suggest that neuronal
BACE1 could act as a negative regulator of axonal regeneration
in early events following injury, contradicting previous studies.
To reconcile these conflicting results and to better clarify
the role of BACE1 in nerve regeneration and remyelination,
further studies in conditional knockout mice allowing ablation
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in defined temporal windows are necessary. Moreover, since
BACE1 processes many substrates, which are expressed in
different cell types and at specific stages of the repair process,
the study of its cell autonomous role could help in defining
the effector(s) through which BACE1 regulates specific stages of
axonal regeneration and remyelination.
Since BACE1 has a prominent role in the generation of
amyloid beta plaques during AD pathogenesis, a lot of effort
has been devoted in developing small molecules that could
inhibit the enzyme’s activity (Coimbra et al., 2018), however
only one study has tested their efficacy in a model of nerve
crush injury. A 7 days treatment with a BACE1 inhibitor starting
immediately after damage increases regeneration and enhances
myelin debris clearance (Farah et al., 2011), supporting the
hypothesis that BACE1 inhibits early axonal regeneration (Farah
et al., 2011; Tallon et al., 2017). Although the possibility of using
BACE1 inhibitors to boost axonal regeneration is potentially
promising, it is essential to better define their application, given
the contradictory role of BACE1 after injury (Hu et al., 2008,
2015). Thus, further studies are required to exactly determine the
efficacy of BACE1 inhibitor(s) in the resolution of PNS injury.
Particularly relevant would be to define the exact time frame in
which to administer these compounds to promote axonal growth
without altering remyelination.
A DISINTEGRIN AND
METALLOPROTEINASES
ADisintegrin AndMetalloproteinases (ADAMs) are membrane-
anchored metalloproteinases involved in the proteolytic
processing of several transmembrane proteins and in the
consequent regulation of the cleaved substrates’ activity
(Schlöndorff and Blobel, 1999). ADAM proteases have both
proteolytic and disintegrin characteristics (Schlöndorff and
Blobel, 1999). They present a conserved structure composed by
distinct domains (Schlöndorff and Blobel, 1999; Primakoff and
Myles, 2000) and have been implicated in the release of several
molecules among which EGF receptor ligands, tumor necrosis
factor family members, neuregulins and other transmembrane
proteins (Black and White, 1998; Blobel, 2000). ADAM proteins
participate in many biological functions such as cell migration,
cell membrane fusion and cytokines and growth factors
shedding. Moreover, members of this family cooperate in muscle
development, fertilization, neurogenesis, angiogenesis and cell
fate determination (Schlöndorff and Blobel, 1999; Primakoff and
Myles, 2000; Horiuchi et al., 2003; Seals and Courtneidge, 2003).
Pathologies like inflammation-related disorders and cancer
also implicate ADAM proteins (Seals and Courtneidge, 2003;
Blobel, 2005).
It is thus not surprising that ADAM secretases have a
role also in PNS myelination. In particular, the α-secretase
ADAM17 possesses an intrinsic proteolytic activity, which
inhibits NRG1 type III and the process of myelination during
development. Thus, only a fine balance between activating and
inhibitory signals coming from the activity of BACE1 and
ADAM17 could physiologically regulate the correct formation of
the myelin sheath (La Marca et al., 2011).
Not only ADAM17, but also ADAM10 and ADAM19, play
important roles in PNS functioning (Figure 1). In particular,
ADAM10 is highly expressed in Schwann-cells DRG neuronal
co-cultures during myelination and its chemical inhibition
impairs axonal outgrowth in vitro (Jangouk et al., 2009).
Nonetheless, in vivo studies have shown that ADAM10 is
dispensable for developmental myelination. In fact, both
overexpression of a dominant negative form of the protein
(Freese et al., 2009) as well as its conditional inactivation
in a transgenic model (Meyer zu Horste et al., 2015) do
not alter myelination. Interestingly, ADAM10 promotes axonal
sprouting, as its deficiency in motor neurons impairs the extent
of axons growth in vitro (Meyer zu Horste et al., 2015).
Moreover, this secretase is critical for axonal outgrowth during
peripheral nerve regeneration as deletion of ADAM10 in motor
neurons reduces the axonal density of small caliber fibers
after crush injury. Thus, ADAM10 seems mainly implicated
in the specific control of post-traumatic outgrowth of axons
(Meyer zu Horste et al., 2015).
ADAM19 is highly expressed in developing PNS, and its
expression pattern resembles that of NRG1 (Kurisaki et al.,
1998; Shirakabe et al., 2001); both proteins are co-expressed in
DRG and in motor neurons (Marchionni et al., 1993; Shirakabe
et al., 2001). Of note, ADAM19 can cleave membrane-anchored
NRG1 proteins in cultured neurons (Kurisaki et al., 1998;
Shirakabe et al., 2001;Wakatsuki et al., 2004). In vivo studies have
shown that while ADAM19 is dispensable for PNS development,
remyelination after nerve injury is impaired in its absence
(Wakatsuki et al., 2009). Further, after injury, ADAM19 regulates
the re-differentiation of Schwann cells from a pro-myelinating
stage to a fully myelinating one by activating the AKT pathway
(Wakatsuki et al., 2009).
Although ADAM10 and ADAM19 participate in the
progression of nerve regeneration, nerve repair is eventually
achieved in both mutants. It is thus possible that compensatory
mechanisms intervene to favor remyelination, likely carried out
by other secretases. Since ADAM17 is fundamental in nerve
development and NRG1 processing, it would be important to
assess the role of this secretase during nerve regeneration.
GAMMA SECRETASES
Gamma secretases (γ-secretases) are a multi-subunit
protease complex responsible for the intramembrane
cleavage of transmembrane proteins, mostly known for
the generation of the β-amyloid peptide in Alzheimer’s
disease (De Strooper et al., 1998; Wolfe et al., 1999).
Beside the amyloid precursor protein, γ-secretases process
several type I transmembrane proteins, among which the
adhesion molecules N-cadherin and E-cadherin (Struhl and
Adachi, 2000; Golde and Eckman, 2003), the neurotrophin
receptor p75 (p75NTR; Jung et al., 2003), the β2 subunit of
voltage-gated sodium channel (Kim et al., 2005), the protein
receptor Notch (De Strooper et al., 1999) and Neuregulins
(Dejaegere et al., 2008; Trimarco et al., 2014). Although
no direct functional role of the γ-secretase complex has
been described in peripheral nerve regeneration, some of
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its substrates are relevant for such process, in particular
Notch and p75NTR.
Notch activity is regulated by a classical regulated
intramembrane proteolysis (RIP) mechanism (Figure 1).
After binding to its substrates, Notch is first cleaved in its
extracellular domain (Pan and Rubin, 1997; Brou et al.,
2000; Hartmann et al., 2002; van Tetering et al., 2009); this
cleavage induces a subsequent process in the transmembrane
domain, which is mediated by the γ-secretase complex (De
Strooper et al., 1999; Struhl and Greenwald, 1999). Notch
intracellular domain then translocates in the cell nucleus,
where it regulates the transcription of genes important for
cell development and differentiation (Kopan and Goate, 2000;
Kopan and Ilagan, 2004; Louvi and Artavanis-Tsakonas, 2006).
In peripheral nerves, Notch negatively regulates developmental
myelination (Woodhoo et al., 2009). After injury, Notch is
rapidly upregulated in peripheral nerves and, in a mouse model
in which Notch is conditionally ablated in Schwann cells,
the rate of Schwann cells dedifferentiation after axotomy is
reduced (Woodhoo et al., 2009). This impairment relies on
Notch intracellular domain, as a similar defect is found also in
mice deficient in Schwann cells RBPJ (Recombination signal
Binding Protein for Immunoglobulin Kappa J region), the
key transcriptional mediator of canonical Notch intracellular
signaling (Woodhoo et al., 2009).
p75NTR regulates a variety of cellular function in the
nervous system, from programmed cell death, axonal growth
and degeneration, to cell proliferation, myelination and synaptic
plasticity (Kraemer et al., 2014; Meeker and Williams, 2015).
This wide range of biological effects is due to the multiplicity
of ligands and co-receptors which partner with p75NTR to
regulate its signaling. In particular, p75NTR promotes cells
survival through association with TRK receptors (Hempstead
et al., 1991; Meeker and Williams, 2015; Pathak et al., 2018),
inhibits axonal regeneration by interacting with Nogo receptor
and Lingo (Wang et al., 2002; Wong et al., 2002; Mi et al., 2004)
and induces apoptosis via high affinity binding with Sortilin
(Friedman, 2000; Beattie et al., 2002; Nykjaer et al., 2004).
Similarly to Notch, also p75NTR is regulated by RIP: upon ligand
binding, the extracellular domain of the receptor is first cleaved
by ADAM17 (Weskamp et al., 2004) and then processed by
the γ-secretase complex, thereby releasing a small intracellular
domain (Zampieri et al., 2005). p75NTR is highly expressed
in Schwann cells and neurons during development, and its
expression levels decline with age (Cosgaya et al., 2002). Both
nerve crush injury and axotomy induce a strong upregulation of
p75NTR in neurons and Schwann cells in distal nerve segments
(Ernfors et al., 1989; Koliatsos et al., 1991; Saika et al., 1991;
Syroid et al., 2000; Petratos et al., 2003; Figure 1). The role
of p75NTR after injury is complex and partially contradictory
(for a comprehensive review see Meeker and Williams, 2015),
nonetheless, grafting of Schwann cells deficient for p75NTR
impairs motor neuron survival after injury (Tomita et al., 2007).
Moreover, remyelination is hampered in mice lacking p75NTR
and nerve repair is delayed (Song et al., 2006; Chen et al., 2016).
Thus, p75NTR likely has a pivotal role in supporting neuronal
survival, nerve regeneration and remyelination after injury.
In addition to the above-described roles, p75NTR also
regulates fibrinolysis. Upon nerve injury, fibrin accumulates in
the nerves to promote axon degeneration and Schwann cells
dedifferentiation. However, to achieve efficient regeneration,
fibrin has to be degraded in a process called fibrinolysis
(Akassoglou et al., 2002). In injured nerves, accumulation of
p75NTR in Schwann cells inhibits fibrinolysis thus maintaining
Schwann cells in a un-differentiated state (Akassoglou et al.,
2002; Sachs et al., 2007). During nerve regeneration, fibrin is
degraded, p75NTR is downregulated and Schwann cells can
re-differentiate to initiate remyelination (Akassoglou et al., 2000;
Sachs et al., 2007; Figure 2). Thus, the biological role of
p75NTR in axonal regeneration and remyelination is complex
and probably depends on the relative contribution of its function
as a regulator of cell death/survival and as an inhibitor of
fibrin degradation.
Of note, the γ-secretase complex processes also axonal
NRG1 type III (Bao et al., 2003, 2004). As already described,
the extracellular processing of NRG1 type III prompts a
forward signaling to initiate myelination (Hu et al., 2006;
Willem et al., 2006; La Marca et al., 2011). The γ-secretase
intracellular cleavage of axonal NRG1 type III, instead,
generates a NRG1-ICD intracellular fragment, which activates
the transcription of the lipocalin-type prostaglandin-D synthase
(L-Pgds) gene (Trimarco et al., 2014). L-PGDS further induces a
pro-myelinating pathway in Schwann cells controlling formation
and maintenance of the myelin sheath (Trimarco et al., 2014).
Given the importance of NRG1 in nerve regeneration, additional
studies to clarify the contribution of NRG1-ICD and L-PGDS
after injury could contribute to the understanding of the
processes involved in nerve repair.
MATRIX METALLOPROTEINASES
The matrix metalloproteinases (MMPs) are a family of
zinc-dependent enzymes, which can degrade all components of
the ECM (McCawley and Matrisian, 2001). At least 24 members,
including collagenases, gelatinases, matrilysins, stromelysins and
membrane-type MMPs belong to the MMPs family (Nagase
et al., 2006). Proteolytic MMPs activity is necessary to regulate
expression levels and function of ECM components and cell
surface signaling receptors (Page-McCaw et al., 2007).
Among the various MMPs, MMP-2 and MMP-9 have
been implicated in nerve development, and after injury (Platt
et al., 2003). During development, MMP-2 and MMP-9 process
dystroglycan to facilitate the formation of the dystroglycan
receptor complex, a laminin receptor required for the correct
formation of apposition and Cajal bands along myelinated fibers
(Court et al., 2011).
Upon axotomy, MMP-9 mRNA levels are rapidly upregulated
starting few hours after injury and peak at day 3 (La Fleur
et al., 1996; Siebert et al., 2001; Hughes et al., 2002; Platt
et al., 2003) while its activity increases already 12 h after
axotomy, peaks around day 2 and returns to basal levels
after 4 days (Siebert et al., 2001). In a model of crush nerve
injury, MMP-9 localizes in myelinating Schwann cells,
immune cells and endothelial cells (La Fleur et al., 1996;
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FIGURE 2 | After injury, fibrin deposits inside the nerve while Schwann cells
undergo de-differentiation and upregulate p75NTR. During active phases of
regeneration p75NTR expression is diminished in remyelinating Schwann
cells, and the induction of the plasminogen and of the tissue plasminogen
activator (tPA)/plasmin cascade leads to fibrin degradation thus promoting
remyelination. Modified with permission from Akassoglou et al. (2002).
Shubayev and Myers, 2000; Hughes et al., 2002; Figure 1).
During nerve regeneration, MMP-9 negatively controls Schwan
cells proliferation (Chattopadhyay et al., 2007). Accordingly,
nerves of mice lacking MMP-9 have increased numbers of
post-mitotic Schwann cells, together with shorter internodes
and nodal abnormalities (Kim et al., 2012). In vivo studies in
mutants lacking MMP-9 indicate that MMP-9 activity during
axonal degeneration is crucial to promote myelin sheath collapse
and to prompt the blood-nerve-barrier breakdown allowing the
influx of immune cells into the nerve (Shubayev and Myers,
2000; Chattopadhyay et al., 2007; Kobayashi et al., 2008). More
recent studies have implicated also MMP-9, together with
MMP-7, in regulating claudin proteins expression at the tight
junction in nerves after crush injury, suggesting that high levels
of MMPs might alter nerve physical barriers (Wang et al., 2018).
Further, MMP-9 stimulates the rearrangement of the basal
lamina (La Fleur et al., 1996; Hartung and Kieseier, 2000; Platt
et al., 2003; Shubayev et al., 2006; Chattopadhyay et al., 2007;
Kobayashi et al., 2008).
Interestingly, together with MMP-9, also its endogenous
inhibitor TIMP-1 is upregulated in nerves early after injury (Kim
et al., 2012); thus, it has been proposed that a fine balance
between MMP-9 and TIMP-1 activity might regulate Schwann
cells mitogenesis and maturation and control the molecular and
structural assembly of myelin domains in remyelinated fibers to
prompt a correct nerve repair (Kim et al., 2012). Thus, during
early phases of axonal degeneration, a physiological inhibition of
MMP-9 activity might be precisely coupled with its activation to
coordinate an effective nerve repair.
PLASMINOGEN ACTIVATORS AND
RELATED PROTEASES
The plasminogen activators (PAs), namely tissue PA (tPA)
and urokinase PA (uPA), are key enzymes of the blood
coagulation cascade implicated in several biological processes,
including vascular and tissue remodeling, tumor development
and progression (Mekkawy et al., 2014) and nervous system
pathophysiology (Deryugina and Quigley, 2012; Thiebaut
et al., 2018). These secreted proteases cleave the proenzyme
plasminogen to turn it into its active form, plasmin (Collen,
1999; Rijken and Lijnen, 2009). Plasmin is a serine protease
involved in processing a vast spectrum of molecules (Liotta
et al., 1981), but its main substrate is fibrin (Bugge et al.,
1996). Plasmin, in fact, degrades fibrin clots allowing scar
resolution (Weisel and Litvinov, 2017). In addition, plasmin
can activate other proteins, like MMPs (Keski-Oja et al.,
1992; Murphy and Docherty, 1992; Zou et al., 2006) and
growth factors (Saksela and Rifkin, 1990; Brauer and Yee,
1993; Munger et al., 1997). In the PNS, PAs activity is
elevated during axonal outgrowth. PAs are secreted by primary
neurons and Schwann cells in culture (Krystosek and Seeds,
1981, 1984) and their activity is localized in growth cones
(Krystosek and Seeds, 1984). Moreover, the PA system is
induced in vivo in embryonic DRG and motor neurons
during axonal outgrowth (Seeds et al., 1992; Sumi et al.,
1992). Interestingly, the PA system is potently induced also
after peripheral nerve injury in mice (Siconolfi and Seeds,
2001a,b). Regeneration of peripheral nerves relies on the
ability of axons to regrow in a very complex environment
at the injury site, made of a structurally altered ECM,
myelin and axon debris, surrounding tissues and infiltrating
inflammatory cells. These adverse conditions represent an
obstacle for axonal growth, thus regenerating neurites secrete
PAs to dissolve cell-cell and cell-matrix adhesion. Accordingly,
tPA and uPA mRNAs are promptly upregulated early after
peripheral nerve injury in Schwann cells and neurons and their
activity increases at the injury site up to 7 days post-crush
(Akassoglou et al., 2000; Siconolfi and Seeds, 2001a; Figure 2).
Moreover, recovery in knockout mice deficient for tPA, uPA
and Plasminogen is significantly delayed after nerve injury,
indicating that they are necessary for timely regeneration
of peripheral nerves and the re-establishment of peripheral
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sensitivity (Siconolfi and Seeds, 2001b). Plasmin is therefore
protective for nerve injury (Akassoglou et al., 2000) and
this effect is linked to the proteolytic activity plasmin exerts
on fibrin (Figure 2). Accordingly, the vast axonal damage
observed in tPA and plasminogen knockout nerves correlates
with excessive accumulation of fibrin. Interestingly, genetic and
pharmacological depletion of fibrinogen, the fibrin molecular
precursor, enhances regeneration in these mutants (Akassoglou
et al., 2000). Thus, fibrin deposition exacerbates axonal injury
and the physiological induction of the tPA/plasmin cascade after
injury prompts fibrin removal and stimulates repair (Figure 2).
Of note, the important role of this cascade has been described
also in humans, as there is a direct correlation between the
extent of fibrinolytic activity and the degree of regeneration
in patients with peripheral neuropathies (Previtali et al., 2008;
Rivellini et al., 2012).
In addition to the PA system, thrombin, another key
enzyme of the blood coagulation system, and its inhibitor
Nexin-1, are potently induced after sciatic nerve injury. In
the blood coagulation cascade, thrombin converts fibrinogen
into fibrin, its insoluble derivative (Weisel and Litvinov, 2017).
Nexin-1, instead, a member of the large serpin superfamily,
directly inhibits thrombin proteolytic activity (Cavanaugh et al.,
1990; Gurwitz and Cunningham, 1990). In injured sciatic
nerves, thrombin levels are elevated immediately after damage
and reach their peak 1 day post-injury, declining after one
week (Smirnova et al., 1996; Gera et al., 2016). On the
contrary, upregulation of Nexin-1 in injured nerves occurs 6–9
days after thrombin induction (Meier et al., 1989; Smirnova
et al., 1996) and is required to neutralize excessive thrombin
proteolytic activity.
Collectively, these studies indicate that the proteases of the
blood coagulation system and their regulators are essential to
stimulate recovery in injured PNS and a precise balance between
activation and inhibition of their proteolytic activity is required
to correctly modulate nerve repair.
CONCLUDING REMARKS
In the present review article, we presented a selected range of
molecules and pathways involved in injured PNS.We specifically
focused on extra cellular matrix and tissue modifiers and on
growth factors’ processing. Several studies have demonstrated
how crucial is the role of these enzymes in tissue remodeling
in response to damage. Nonetheless, despite the extensive
studies conducted thus far, additional work is required to
better define both the cell autonomy and the time frame in
which these molecules and pathways are mostly active. We thus
think that clarifying these aspects could be beneficial to define
new therapeutic strategies that, together with the development
of conduit devices, could efficiently improve the regenerative
process and prompt full functional recovery.
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Ascorbic acid (AA) is an essential micronutrient that has been safely used in the
clinic for many years. The present study indicates that AA has an unexpected
function in facilitating nerve regeneration. Using a mouse model of sciatic nerve
crush injury, we found that AA can significantly accelerate axonal regrowth in the
early stage [3 days post-injury (dpi)], a finding that was revealed by immunostaining
and Western blotting for antibodies against GAP-43 and SCG10. On day 28 post-
injury, histomorphometric assessments demonstrated that AA treatment increased the
density, size, and remyelination of regenerated axons in the injured nerve and alleviated
myoatrophy in the gastrocnemius. Moreover, the results from various behavioral tests
and electrophysiological assays revealed that nerve injury-derived functional defects in
motor and sensory behavior as well as in nerve conduction were significantly attenuated
by treatment with AA. The potential mechanisms of AA in nerve regeneration were further
explored by investigating the effects of AA on three types of cells involved in this process
[neurons, Schwann cells (SCs) and macrophages] through a series of experiments.
Overall, the data illustrated that AA treatment in cultured dorsal root ganglionic neurons
resulted in increased neurite growth and lower expression of RhoA, which is an
important inhibitory factor in neural regeneration. In SCs, proliferation, phagocytosis,
and neurotrophin expression were all enhanced by AA. Meanwhile, AA treatment also
improved proliferation, migration, phagocytosis, and anti-inflammatory polarization in
macrophages. In conclusion, this study demonstrated that treatment with AA can
promote the morphological and functional recovery of injured peripheral nerves and that
this effect is potentially due to AA’s bioeffects on neurons, SCs and macrophages, three
of most important types of cells involved in nerve injury and regeneration.
Keywords: ascorbic acid, nerve regeneration, peripheral nerve injury, neuron, Schwann cell, macrophage
INTRODUCTION
Although the peripheral nervous system (PNS) has an intrinsic ability to repair and regenerate,
this capability is limited, and spontaneous neural regeneration is notably slow. Functional
recovery from peripheral nerve injury (PNI) is generally far from satisfactory. Due to the
slow rate of axonal regeneration, irreversible damage to the structure and function of target
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organs may occur before regenerated axons reinnervate these
targets, which could have a profound and permanent impact
on patients (Grinsell and Keating, 2014; Faroni et al., 2015). To
alleviate the suffering of PNI patients, research on approaches
to accelerate peripheral nerve regeneration is encouraged. In
the present study, the effect of ascorbic acid (AA) on neural
regeneration after PNI was assessed.
AA, or vitamin C, is a dietary essential micronutrient that
plays key roles in many important biological processes (Granger
and Eck, 2018). AA is not only considered an important daily
nutrient for maintaining health but also has long been used
safely in the clinic to protect against many diseases. Moreover,
recent studies indicate that AA has many unexpected newly
discovered biological functions. For example, AA can be used
to promote stem cell reprogramming (Wang et al., 2011;
Cimmino et al., 2018). It is essential for the development and
physiological functions of nervous tissue (May, 2012; Granger
and Eck, 2018) and has therapeutic effects in neurodegenerative
diseases (Kocot et al., 2017; Moretti et al., 2017). Clinical
studies and animal experiments have demonstrated that AA
administration can improve functional recovery from spinal
cord injury (Lamid, 1983; Robert et al., 2012; Yan et al.,
2014; Guo et al., 2018). Existing data on PNI indicate that
AA has antinociceptive effects on PNI animals, which may
be achieved mainly through interactions with N-Methyl-D-
aspartate (NMDA) receptors or through ROS activity (Lu et al.,
2011; Saffarpour and Nasirinezhad, 2017). However, evidence
regarding whether AA has an effect on the morphological and
functional recovery of injured nerves is lacking. To address this
issue, we developed a sciatic nerve crush injury mouse model
of PNI to test the potential role of AA in peripheral nerve
regeneration. Its potential mechanism was studied in neurons,
Schwann cells (SCs) and macrophages, which are the most
important cell types involved in nerve injury and regeneration.
MATERIALS AND METHODS
Ethics Statement
All procedures involving animals, including surgery,
electrophysiological tests, behavior tests and tissue collection,
were carried out with the approval of the Southern Medical
University Animal Care and Use Committee in accordance
with the guidelines for the ethical treatments of animals. All
efforts were made to minimize the number of animals used and
their suffering.
Sciatic Nerve Injury Model Preparation and
Drug Administration
C57BL/6mice (n = 16 per group, female, 6–8 weeks old, weighing
18–20 g, provided by the Animal Center of the Southern Medical
University) were used for the sciatic nerve crush injury model
as described in our previous report (Qian et al., 2018). Briefly,
the mice were anesthetized with an intraperitoneal injection
of 12 mg/ml tribromoethanol (180 mg/kg body weight). The
sciatic nerve in the left leg was bluntly exposed after performing
a lateral skin incision along the length of the femur. Then,
wound closure without manipulation of the nerve was performed
(sham-surgery group), or the mice were subjected to a calibrated
sciatic crush injury 0.5 cm distal to the sciatic notch. The
nerves were crushed with a fine, smooth, straight hemeostat
(tip width: 1 mm) for 2 min, and the crush site was marked
with a 9–0 nylon suture as previously reported (Sheu et al.,
2012). The mice that underwent nerve injury were randomly
divided into the AA and saline groups. AA (purchased from
Baiyunshan Pharmaceuticals Company, Guangzhou, China) was
prepared in a suspension with saline at a concentration of
13.33 mg/ml. Immediately after surgery, the animals in the AA
group received an intragastric administration (i.a.) of the AA
solution (400 mg/kg) followed by daily i.a. of AA (200 mg/kg).
The mice in the saline group received the same volume of saline
as the volume of AA suspension administered to the AA group.
The drug administration method strictly followed published
protocols (Yagi et al., 2015; Liu et al., 2016). A solution of
AA or saline was intragastrically administered via a customized
probe through which the solution could be pushed forward into
the stomach. All animals received routine postoperative care
and were housed under standard laboratory conditions with a
12 h/12 h light-dark cycle and free access to food and water.
At 3 days post-injury (dpi), six mice per group were sacrificed,
and axonal regeneration in the injured nerve was detected
by immunohistochemistry and Western blotting for antibodies
against growth-associated protein 43 (GAP43) and superior
cervical ganglion 10 (SCG10). At 28 dpi, 10 mice per group
were subjected to behavioral tests and an electrophysiological
assessment. Then, the sciatic nerves and gastrocnemius muscles
were collected, and immunohistochemistry, eletromicroscopy,
and hemeatoxylin staining were performed as described in the
following sections.
Behavioral Tests
The motor and sensory functional recovery of the injured
hindlimb of mice receiving sciatic nerve crush injury was
detected at 28 dpi by gait analysis, rotarod, and the hot plate
test, which are widely used in sciatic nerve crush injury models
(Jungnickel et al., 2010; Gallaher and Steward, 2018). Eachmouse
was allowed at least a 2-h break between testing sessions. All
behavior tests were formally performed 28 dpi, but the mice were
trained for 2 days before the final tests.
Gait Analysis
Motor function of the experimental mice was quantified using
a gait analysis system (Mouse Specifics Inc., Quincy, MA, USA,
DigiGait; Glajch et al., 2012). The mice were trained to walk
on a motorized transparent treadmill belt, and their footprints
were captured with a video camera set beneath the belt. Then,
the sciatic functional index (SFI) was calculated with software
following the protocol of the system (Jungnickel et al., 2010;
Wang et al., 2018).
Rotarod Assay
Motor performance was also measured using a rotarod device
(TSE Systems; Singh et al., 2017). Briefly, the mice were
pretrained for 2 days on an automated 6-lane rotarod unit that
could be set at a fixed or accelerating speed. During the training
protocol, the mice were placed on the rod as it rotated at a
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speed of 5 rotations per minute (RPM) for 60 s. During the
testing phase, the mice were placed on the rod as it accelerated
from 0 RPM to 40 RPM over a period of 20 s. The length of
time that each mouse stayed on the rotating rod was measured
and recorded.
Hot Plate Test
The recovery of sensory function of the injured nerve was
assessed by a hind paw thermal withdrawal test using a hot-plate
instrument (Muromachi Kikai, Tokyo, Japan) as previously
described (Gallaher and Steward, 2018; Ibrahim et al., 2018).
Before performing the test, each mouse was habituated twice to
the hot plate set to room temperature. Then, each mouse was
placed on the hot plate set to a temperature of 55 ± 0.5◦C. The
withdrawal latency, manifested by the time (in seconds) until
hind paw licking or jumping, was recorded.
Electrophysiological Assessment
Two hours after the final behavioral analyses, each mouse
was anesthetized by an intraperitoneal injection of 12 mg/ml
tribromoethanol (180 mg/kg body weight) and subjected
to electrophysiological tests following a previously described
protocol (Wang et al., 2014). Briefly, the sciatic nerve was
re-exposed, a pair of stimulating electrodes (13 mm long,
0.5 mm in diameter) was inserted 3 mm proximal to the
crushed site to stimulate the sciatic nerve, and a pair of needle
electrodes (13 mm long, 0.5 mm in diameter) was inserted
subcutaneously into the middle of the intrinsic foot muscle to
record the compound muscle action potential (CMAP) with a set
of electrophysiological recorders (Axon Digidata 1550 Digitizer,
Molecular Devices). The amplitude and latency of each test were
analyzed to determine the nerve conduction strength and nerve
conduction speed, respectively.
Tissue Collection
Neural regeneration after nerve injury was detected at two
time points. At 3 dpi, six mice per group were sacrificed
by decapitation. Then, tissue was collected for Western
blotting (n = 3 per group) or, following perfusion, for
immunohistochemistry (n = 3 per group). At 28 dpi, immediately
after the electrophysiological recordings were completed, the
mice (n = 10 per group) were intracardially perfused with 0.1 M
phosphate-buffered saline (PBS) for 10 min, followed by 4%
paraformaldehyde (PFA, in 0.1 M PBS) for 30 min; then, the
sciatic nerves and gastrocnemius muscles were harvested for
further investigation.
Western Blotting
Three mice per group were decapitated at 3 dpi, and a
1-cm piece of the sciatic nerve was dissected from the
injury site, frozen in liquid nitrogen for 30 s, minced and
homogenized in RIPA lysis buffer (Sigma, St. Louis, MO,
USA) containing 1% protease inhibitor cocktail (Cell Signaling).
The cultured SCs and macrophages were also homogenized
in RIPA lysis buffer (Sigma, St. Louis, MO, USA) containing
1% protease inhibitor cocktail (Cell Signaling). The proteins
were separated on 10% sodium dodecyl sulfate-polyacrylamide
gels and transferred to polyvinylidene difluoride membranes
(Bio-Rad, Hercules, CA, USA). After blocking with 5% bovine
serum albumin (BSA) in Tris-buffered solution containing
0.5% Tween-20 for 2 h, the blots were probed overnight at
4◦C with the following primary antibodies: rabbit anti-GAP43
(1:2,000; ab16053, Abcam), rabbit anti-SCG10 (1:1,000; NBP1-
49461, Novusbio), rabbit anti-iNOS (1:1,000; ab178945, Abcam),
rabbit anti-CD163 (1:1,000; ab213612, Abcam), rabbit anti-NGF
(1:1,000; ab6199, Abcam), rabbit anti-NT-3 (1:500; sc-547,
Santa Cruz), rabbit anti-GDNF (1:500; ab119473, Abcam),
rabbit anti-BDNF (1:500; ab6201, Abcam), rabbit anti-laminin
(1:500; ab7463, Abcam), rabbit anti-β-actin (1:1,000; ab008,
Multisciences). After incubation with an HRP-conjugated
secondary antibody (Molecular Probes) for 2 h at room
temperature, the immunoreactive proteins were visualized
by an enhanced chemiluminescence reaction, and the band
density was calculated using Image-Pro Plus 6.0 software
(Media Cybernetics).
Immunohistochemistry
The nerves dissected from the perfused animals (3 dpi, n = 3;
28 dpi, n = 6 per group) were post-fixed in 4% PFA for 24 h,
cryoprotected in 30% sucrose overnight at 4◦C, and then
sectioned on a cryostat (Leica) at a thickness of 10 µm. The
sciatic nerve samples collected at 3 dpi were longitudinally cut
1.5 cm distal to the injury site. The nerves collected at 28 dpi
were transversely cut in the range of 5–6 mm distal to the
injury site. All sections were mounted onto poly-lysine-coated
glass slides and stored at −20◦C for immunohistochemistry.
Briefly, the sections were penetrated with 0.5% Triton X-100
(Sigma, St. Louis, MO, USA) for 30 min and incubated with
blocking buffer [5% fish gelatine (Sigma, St. Louis, MO, USA)
containing 0.3% Triton X-100] at room temperature for 1 h,
followed by incubation with primary antibodies diluted in
blocking buffer overnight at 4◦C, incubation with Alexa Fluor
488 and/or 568 fluorescent-conjugated secondary antibodies
(Molecular Probes) for 2 h at room temperature, and incubation
with DAPI (1:5,000; Sigma, St. Louis, MO, USA) for 2 min
to counterstain the nuclei. After immunohistochemistry, the
sections were mounted using anti-fading mounting medium
(Vector), and images were captured under a fluorescence
microscope (Leica). The following primary antibodies were
used for immunostaining of the longitudinal sections: rabbit
anti-GAP43 (1:400; ab16053, Abcam), rabbit anti-SCG10
(1:500; NBP1-49461, Novusbio), rat anti-mouse f4/80 (1:400;
CL89170AP, Cedarlane), rabbit anti-iNOS (1:1,000; ab178945,
Abcam) and rabbit anti-CD163 (1:1,000; ab213612, Abcam).
In addition, mouse anti-MBP (1:200; NE1018, Calbiochem)
and rabbit anti-NF (1:800; N4142, Sigma, St. Louis, MO,
USA) primary antibodies were used for double staining of
the transverse sections. The number of S100-positive cells,
f4/80-positive cells, iNOS-positive cells or CD163-positive cells
in the longitudinal sections of each sciatic nerve was counted in a
250µm× 250µmarea 1mmdistal to the crush site. The number
of NF-positive axons in the cross-sections of each sciatic nerve
was counted with Photoshop 5.0 software (Adobe, USA) by
an investigator blinded to the experimental groups
(Schreiber et al., 2015).
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Transmission Electron Microscopy
Partial sciatic nerves dissected at 28 dpi (n = 4 per group) were
subjected to transmission electron microscopy (TEM). Briefly,
2-mm long segments from an area 5 mm distal to the injury
site were post-fixed with 2.5% glutaraldehyde plus 2% PFA
for 24 h followed by 1% OsO4 for 2 h at 4◦C, dehydrated
stepwise in increasing concentrations of acetone and embedded
in Spurr’s resin (Sigma, St. Louis, MO, USA) for ultrathin
transverse sectioning (70 nm). After staining with 2% uranyl
acetate and lead citrate, ultrathin sections were observed under a
transmission electron microscope (H-7500, Hitachi). Six images
of each sample were randomly captured at a magnification of
3,500. Then, the diameter of each axon or whole nerve fiber
and the area of each axon were measured with Image-Pro Plus
6.0 software (Media Cybernetics). Based on the collected data, the
G-ratio and axon area distribution were calculated to reflect the
myelin thickness and axon size, respectively. Briefly, the G-ratio
was determined as the ratio of the axon diameter to the fiber
diameter (Wen et al., 2017). The axon area distribution was
determined by Penna’s protocol (Penna et al., 2011) with minor
revisions. Briefly, after the area of each axon was measured by
Image-Pro Plus 6.0 software, the collected data were grouped
in 5-µm2 increments (i.e., 0–5 µm2, 5–10 µm2, 10–15 µm2,
etc.). Then, the percentage of the number of axons in each group
compared with the total number of axons was determined as the
axon area distribution (%).
Histomorphometry of the Gastrocnemius
Muscle
Since the level of myoatrophy in target muscles is known to
be an important index of nerve injury and regeneration, we
performed histomorphometry of the gastrocnemius muscle at
28 dpi. Briefly, the midbellies of the gastrocnemius muscles from
the perfused mice were trimmed and post-fixed with 4% PFA
for 24 h at 4◦C. Subsequently, the muscles were embedded with
Tissue OCT-Freeze Medium and transversally cut into 10-µm
sections. The sections were stained with 0.5% hemeatoxylin to
show the outline of the myofibers, and the areas of the myofibers
were calculated as described in our previous publications (Wang
et al., 2014; Pan et al., 2017). Briefly, six random non-overlapping
fields from five sections from each animal were captured, and the
image analysis was performed using Image-Pro Plus 6.0 software
to quantify the areas of the myofibers.
Primary Cell Culture
DRG Neuron Cultures
Based on the protocol described previously (Chang et al., 2016),
the dorsal root ganglia (DRG) from neonatal 1-day-old SD rats
were rapidly dissected and digested with 0.125% trypsin (Sigma,
St. Louis, MO, USA) at 37◦C for 30 min. The separated cells
were cultured in Dulbecco’s modified Eagle’s medium/Ham’s
F-12 (DMEM/F-12) with 1% fetal bovine serum (FBS; Corning)
and plated onto the Poly-L-lysine (PLL, Sigma-Aldrich, St. Louis,
MO, USA)-treated coverslips in culture dishes. Medium for half
of the cultures was supplemented with AA (200 µM, Sigma,
St. Louis, MO, USA). After being cultured for 24 h, the cells were
fixed with 4% PFA. Immunocytochemistry for a mouse anti-Tuj1
antibody (1:400; T8660, Sigma, St. Louis, MO, USA) or a mouse
anti-RhoA antibody (1:200; sc-418, Santa Cruz) was performed
following routine protocols.
Primary Schwann Cell Cultures
As described in our previous publication (Wen et al., 2017), SCs
were isolated from the spinal nerves of SD rats at postnatal day 3.
The collected nerves were dissociated with 0.25% trypsin-EDTA
(Gibco) at 37◦C for 30 min, and single cells suspended in
DMEM/F12 (Corning) containing 10% FBS (Corning) were
plated onto PLL-coated Petri dishes. After overnight incubation,
the cultures were treated with cytosine arabinoside (10 µM,
Sigma-Aldrich, St. Louis, MO, USA) for 48 h to eliminate
fibroblasts. Then, the cells were routinely cultured with SC
medium [DMEM/F12 containing 3% FBS, 3 µM forskolin
(Sigma-Aldrich, St. Louis, MO, USA), 10 ng/ml heregulin
(PeproTech) and 100 mg/ml penicillin-streptomycin (Gibco)] to
expand the cells.
Primary Macrophage Cultures
Resident peritoneal macrophages were isolated from adult SD
rats. Immediately after the rat was anesthetized by overdose
with 80 mg/kg pentobarbital sodium, 10 ml of sterile Hank’s
Balanced Salt Solution (HBSS, Gibco) was gently injected into
the caudal half of the peritoneal cavity, and then the HBSS
containing the resident peritoneal cells was slowly withdrawn.
The cells were resuspended in DMEM culture medium (Gibco)
with 10% FBS and plated onto dishes at a density of 2 × 106
cells/ml. The medium was replaced twice every 2 h to remove the
non-adherent cells. Thereafter, the adhered macrophages were
cultured using a routine cell culture protocol (Yuan et al., 2017).
Cell Proliferation Assays
The proliferating capability of SCs and macrophages was
measured by a WST-1 assay and a bromodeoxyuridine
(BrdU) assay.
First, a WST-1 Cell Proliferation Assay Kit II (Abcam) was
utilized to detect cell proliferation based on the manufacturer’s
instructions and previous literature (Wu et al., 2017). Briefly,
primary SCs or macrophages were seeded in 96-well plates at a
density of 1 × 104 cells/well in 100 µl of medium (SC medium
for SCs and DMEM/F12 with 10% FBS for macrophages) with or
without 200 µMAA. Following 36 h of routine incubation, WST
working solution was added to the culture medium (10 µl/well)
and maintained for another 3 h. Then, the absorbance was
recorded at 450 nmwith aMicroplate Reader (Bio-Rad, Hercules,
CA, USA). All experiments were performed in triplicate, and
three independent experiments were performed.
For the BrdU assay, 1 × 105 SCs or macrophages in 1 ml
of medium (SC medium for SCs and DMEM/F12 with 10%
FBS for macrophages) with or without 200 µM AA were plated
onto PLL-coated coverslips in 24-well plates. Twenty-four hours
later, BrdU (10 µM, Sigma, St. Louis, MO, USA) was added
to the medium, and the cells were further incubated for 36 h.
Then, the cells were fixed with 4% PFA for 1 h, denatured
with 2 N HCl at 37◦C for 30 min and neutralized with 0.1 M
borate buffer (pH = 8.5) for 15 min. Immunocytochemistry
was performed as follows: after blocking with 1% BSA for
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1 h, the cells were penetrated with 1% Triton X-100 for 1 h,
incubated with a mouse anti-BrdU primary antibody (1:200;
NA61, Sigma, St. Louis, MO, USA) followed by an Alexa
Fluor 568-conjugated secondary antibody (Molecular Probe) and
incubated with DAPI (1:5,000, Sigma, St. Louis, MO, USA) for
5 min to counterstain the nuclei of the cells. Five images of
each coverslip (the center and four quadrants) were captured
using a fluorescence microscope (Leica), and the percentage of
cells that were positive for BrdU was quantified. All experiments
were performed in triplicate, and three independent experiments
were performed.
Migration Assay
The migration of the SCs and macrophages was assessed by a
Transwell assay using 6.5-mm Transwell chambers (8-µm pores,
Corning Costar) as described previously (Wen et al., 2017).
After the chambers were pretreated with 10 µg/ml laminin
solution or culture medium, 1 × 105 SCs or macrophages in
100 µl of DMEM/F12 containing 1% FBS were seeded into
the upper chamber, and the lower chamber was filled with
600 µl DMEM/F12 containing 10% FBS without cells. The SCs
and macrophages were allowed to migrate for 4 h and 24 h,
respectively, and then fixed with 4% PFA for 20 min. After
careful removal of the cells on the upper surface with a cotton
swab, the cells adhered to the lower surface of the Transwell
membrane were stained with 0.1% crystal violet (Beyotime) for
30 min. Then, five images of each membrane (the center and four
quadrants) were captured under an inverted microscope (Leica)
for quantification.
Phagocytic Capability Assay
Phagocytosis in SCs and macrophages was assessed by the
ingestion of lumispheres. Briefly, 0.1 mg/ml fluorescent
lumispheres (1-µm diameter, BaseLine Chromtech, China)
were added into the culture medium of SCs or macrophages
for 6 h or 3 h, respectively. To accurately count the number
of intracellular lumispheres, the lumisphere-treated cells were
collected by trypsinization and then re-cultured on PLL-coated
slides for 3 h after being rinsed three times with HBSS to
remove the attached lumispheres from the cell surface. Finally,
the cells were fixed with 4% PFA and stained with CNPase
(1:400; BS3461, Bioword Technology, Inc., St. Louis Park, MN,
USA) or ED1 (1:200; MAC341GA, AbD Serotec) to identify
the outlines of the SCs and macrophages. With a fluorescence
microscope (Leica), the number of lumispheres ingested by each
cell was counted.
Statistical Analysis
Statistical analyses were performed using SPSS statistical software
20.0 (IBM). All values are presented as the mean ± the
standard error of the mean (SEM). In experiments with two
groups, independent samples t-tests were used to analyze
values between the two groups. In experiments with more
than two groups, one-way analysis of variance (ANOVA) was
used. A p-value <0.05 was considered statistically significant.
For all graphs, ∗indicates P < 0.05 and N.D. indicates no
significant difference.
RESULTS
AA Accelerates Axonal Regeneration in the
Early Stage of Nerve Injury
GAP43 is a widely used marker of axonal regeneration
after nerve injury (Ma et al., 2011). SCG10, which is
expressed in adult sensory neurons, is an efficient and
selective marker for regenerating sensory axons in the
early stage of axonal regeneration (Shin et al., 2014). Both
are barely detectable in intact adult nerves but are highly
expressed in regenerating axons (Figures 1A–C,F–H).
Figures 1B,C,F,G show that the GAP43- or SCG10-
positive axons extending from the crush site to the distal
trunk were significantly longer in the AA group than
those in the saline group. This finding was verified by the
quantification of Western blot analysis (Figures 1D,E or 1I,J).
Significant differences among the groups were revealed by
statistical analysis.
AA Increases the Number of Regenerated
Axons and the Level of Remyelination in
the Injured Nerve
As shown in Figure 2, many NF-positive axons were present
in the distal portion of the injured nerves at 28 dpi, and
most of these axons were wrapped with MBP-positive myelin.
Compared those in the saline group (Figure 2B), the number
of axons (Figure 2D) and the ratio of MBP/NF (Figure 2E)
were dramatically increased in the nerves of the AA group
(Figure 2C). However, the number of axons and the thickness
of the myelin sheaths in the nerves of the AA group did not
reach the levels observed in the nerves of the sham control
group (Figure 2A).
To accurately quantify the size of the regenerated axons
and the myelin, parts of the nerves (n = 4 per group) were
examined by TEM (Figures 2F–H). Statistically, the G-ratio (the
diameter of the axon/the diameter of the whole nerve fiber), a
widely used myelin thickness index (Tateshita et al., 2018), in
the AA group was significantly lower than that in the saline
group (Figure 2I), indicating that AA administration enhanced
myelination and increased the thickness of the myelin sheaths.
However, the G-ratio in the nerves of the AA group did not
reach the level observed in the nerves of the sham group. In
addition, the axonal area observed in the AA group was greater
than that observed in the saline group (Figure 2J). The axonal
area distribution (Figure 2K) reveals that the predominance
of axons in the saline group had an area in the range of
0–15 µm2. Almost no axons in this group had an area greater
than 15 µm2. Most axons in the AA groups had an area in
the range of 0–15 µm2, but the percentage of axons with
an area between 10 and 15 µm2 was notably higher in the
AA group compared with that in the saline group (20.1% vs.
6.7%). Moreover, some axon areas (5.2%) in the AA group
reached the range of 15–20 µm2. Overall, these data indicate
that AA treatment not only increased the number and size
of the regenerated axons but also enhanced the thickness of
the myelin.
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FIGURE 1 | GAP43 and SCG10 immunostaining and Western blotting show that ascorbic acid (AA) accelerates the regrowth of injured axons in the early stage
after sciatic nerve crush injury. (A–C) Representative samples of GAP43-immunostained longitudinal sciatic nerve sections at 3 dpi from the sham group (A), saline
group (B), and AA group (C). Asterisks represent the lesion site. (D,E) Western blots and schematic diagrams of the statistical analysis showing the protein level of
GAP43 in the distal trunk of the injured sciatic nerves (n = 3, ∗P < 0.05). (F,G) Representative samples of SCG10-immunostained longitudinal sciatic nerve sections
from the sham group (F), saline group (G), and AA group (H). Asterisks represent the lesion site. (I,J) Western blots and schematic diagrams of the statistical
analysis showing the protein level of SCG10 in the distal trunk of the injured sciatic nerves (n = 3 for each test, ∗P < 0.05).
AA Attenuates Myoatrophy of the
Gastrocnemius Muscle
The gastrocnemius muscle is one of the main target muscles
of the sciatic nerve and is widely used to reflect functional
recovery in injured sciatic nerves. Compared to those in the
sham group, the myofibers in the groups that underwent
sciatic nerve injury (the saline group and the AA group)
were notably smaller, which suggests dramatic myoatrophy.
Nevertheless, the level of myoatrophy in the AA group was
much less than that in the saline group (Figures 3A–C). This
difference can be quantified by measurements and statistical
analyses (Figure 3D).
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FIGURE 2 | NF (Neurofilament, red) and MBP (Myelin Basic Protein, green) double immunohistochemistry and transmission electron microscopy (TEM) illustrating
that AA enhances axonal regeneration and remyelination in the distal portion of the injured sciatic nerve at 28 dpi. Representative samples from (A1–A3) the sham
group, (B1–B3) saline group, and (C1–C3) AA group. (D) The number of NF-positive axons in the cross-sections of the nerves (n = 6, ∗P < 0.05). (E) The MBP/NF
ratio of myelinated axons from each group (n = 6, ∗P < 0.05). (F–H) Representative TEM images showing the axons and their myelin sheaths. (I–K) Quantification of
the G-ratio (I), the axonal area (J), and the axonal area distribution (K; n = 4, ∗P < 0.05).
AA Enhances Motor and Sensory Function
Recovery
The SFI is among themost widely used parameters for measuring
reflexive motor function after sciatic nerve injury. Compared
to that in the sham group, the SFI value was significantly
decreased in the PNI groups. However, this lower SFI was
dramatically reversed by AA treatment (Figure 4A). Motor
coordination and balance were also measured by a rotarod
test. The mice in the AA group remained on the rotating
rod for a much longer duration than the mice in the saline
group but for a shorter duration than the mice in the sham
group (Figure 4B).
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FIGURE 3 | Histomorphometry of gastrocnemius muscles showing that AA alleviates myoatrophy in the target muscle. (A–C) Representative images of
hemeatoxylin-stained transverse sections of gastrocnemius muscles from each group collected at 28 dpi. (D) Quantification of the myofiber area for each group
(n = 10, ∗P < 0.05).
Furthermore, sensory functional recovery was assessed with
the hot plate test, in which longer latency reflexes suggest a
sluggish sensory function in the tested foot. As expected, sciatic
nerve injury caused the latency to significantly increase in the
saline group compared to that in the sham group, but AA
treatment shortened the latency (Figure 4C).
AA Facilitates Nerve Conduction Function
Recovery
The amplitude and latency of the CMAP were measured by
electrophysiology. A shorter latency corresponds to quicker
nerve conduction, which may result from a higher level of
nerve myelination. A higher amplitude indicates a greater
number of regenerated axons and a higher level of reinnervation
of the measured muscles (Park et al., 2018). Quantification
analysis of the CMAP images (Figures 4D–F) revealed that
the latency in the sham group < AA group < saline
group (Figure 4G) and that the amplitude in the sham
group > AA group > saline group (Figure 4H). The
differences among the groups were all statistically significant.
Overall, the data from the above experiments indicate that
PNI impairs nerve conduction, while the oral administration
of AA significantly accelerates functional recovery, including
the recovery of motor and sensory behavior and nerve
conduction electrophysiology.
AA Promotes Neurite Outgrowth and
Alleviates RhoA Expression in Cultured
DRG Neurons
When the isolated DRG neurons were cultured in medium
with a low concentration of serum (1% FBS), there were few
neurites extending from the soma, and those that were present
were short in length, as illustrated by Tuj1 immunostaining
(Figure 5A). AA treatment dramatically increased the number
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FIGURE 4 | AA enhances functional recovery after sciatic nerve injury at 28 dpi. (A) Gait analysis results indicating the sciatic functional index (SFI). (B) Rotarod
assay results showing the amount of time the mice remained on the rotating rod. (C) Hot plate test results showing withdrawal latency from a hot plate.
(D–F) Respective compound muscle action potential (CMAP) images of the three groups. (G,H) Quantification of latencies and amplitudes of the CMAPs (n = 10,
∗P < 0.05; N.D. indicates no significant difference).
and length of the neurites (Figures 5B–D). Moreover,
immunostaining showed that RhoA immunoreactivity was
concentrated in the neuronal soma and that the immune
intensity was much higher in the control group than in the
AA group (Figures 5E–G).
AA Promotes Proliferation, Phagocytosis
and Neurotrophic Factor Secretion in SCs
In the present study, two methods were used to assess the
capability for cell proliferation in vitro. Using a BrdU assay, we
found that the ratio of BrdU-positive cells in the AA-treated
SCs was significantly higher than that in SCs from the control
group (Figures 6A–C). The OD value determined by the
WST-1 test in the AA group was also statistically higher
than that in the control group (Figure 6D). The above data
indicate that AA can increase the proliferation of SCs. To
confirm the results obtained from the in vitro experiments,
S100 and Ki67 double immunohistochemistry was performed
on the longitudinal sections of the sciatic nerves collected at
3 dpi (Figures 7A–H). Quantitative analysis illustrated that
both the number of S100-positive cells (Figure 7I) and the
ratio of ki67/S100 (Figure 7J) in the AA group were higher
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FIGURE 5 | AA promotes neurite outgrowth and alleviates RhoA expression in cultured dorsal root ganglia (DRG) neurons. (A,B) Representative images of cultured
neurons immunostained for Tuj1 to show the neurites. (C,D) Comparison of neurite length and number between two groups is shown (n = 3, ∗P < 0.05).
(E–G) Immunofluorescence and quantification analysis illustrated that the immunointensity of RhoA was significantly decreased in the AA group (n = 3, ∗P < 0.05).
than those in the saline group. However, the Transwell test
indicated that the migration ability of the SCs was not affected
by AA, as the number of migrated cells was not different
between the AA group and the control group (Figures 6E–G).
Since the lumispheres are considered foreign materials to the
co-cultured cells, it is expected that some of them would
be ingested by SCs (Figures 6H–M); thus, the number of
lumispheres in each cell reflects the cell’s phagocytic capability.
Quantitative analysis illustrated that there were more ingested
lumispheres in the AA-treated SCs than in SCs from the control
group (Figure 6N). Finally, Western blotting indicated that
the protein levels of NGF, NT-3, GDNF, BDNF, and laminin
expressed by the SCs were all significantly increased by AA
treatment (Figures 6O,P).
AA Increases the Proliferation, Migration,
Phagocytic Capability and M2 Subtype
Polarization of Macrophages
As described in the ‘‘Materials and Methods’’ section, the
proliferation, migration and phagocytic capability of the cultured
macrophages were detected using the same assays as those used
in the SCs. Statistical data of the BrdU assay (Figures 8A–C)
and the WST-1 test (Figure 8D) showed that the BrdU
positive ratio and the WST-1 OD value were significantly
higher in the AA group compared to those in the control
group, which indicated that AA increases the proliferation of
macrophages. Double immunohistochemistry with f4/80 and
ki67 antibodies of the sciatic nerve longitudinal sections
(Figures 9A–H) illustrated that both the number of f4/80-
positive cells (Figure 9I) and the ratio of ki67/f4/80 (Figure 9J)
in the AA group were higher than those in the saline
group. Subsequently, the migration and phagocytic capability
of the macrophages were detected by a Transwell assay and
lumisphere ingestion test in the cultured cells. The number of
macrophages on the lower surface of the Transwell membrane
was almost double that in the AA group (Figures 8E–G).
This upregulation effect was also found in the phagocytic
capability assay (Figures 8H–M). The number of lumispheres
ingested by the macrophages was almost doubled by treatment
with AA (Figure 8N).
Finally, macrophage polarization was assessed by
immunocytochemistry with specific markers of a
pro-inflammatory subtype (M1, iNOS) or an anti-inflammatory
subtype (M2, CD163), both in vitro (Figures 8O–V) and
in vivo (Figures 10A–L). Quantitative results illustrated that the
number of iNOS-positive M1 macrophages (Figures 8R, 10M)
decreased dramatically, while the number of CD163-positive
M2 macrophages (Figures 8V, 10N) increased significantly in
the AA group. The Western blot results (Figures 10O–Q) were
consistent with the immunostaining data.
DISCUSSION
PNI is a common disease worldwide. Epidemiologic studies
have indicated that PNI is involved in up to 2.8% of trauma
cases (Noble et al., 1998). PNI has a marked impact on patient
quality of life because the injury causes partial or complete
loss of function in the target organs of the lesioned nerve. In
contrast to the central nervous system (CNS), where damaged
axons are usually unable to regenerate, axons in the PNS are
capable of regeneration in cases where the injured nerve is
properly surgically repaired (Gey et al., 2016; Wang et al.,
2017). Nevertheless, the regeneration rate of peripheral nerves is
slow, and functional recovery is generally far from satisfactory
(Modrak et al., 2017). Thus, the effort to identify effective and
safe drugs that can accelerate the neural regeneration rate has
gained broad awareness.
To the best of our knowledge, this report is the first to provide
solid evidence demonstrating that the oral administration of
AA has significant efficacy in facilitating peripheral nerve
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FIGURE 6 | AA promotes proliferation, phagocytosis and neurotrophic factor secretion in Schwann cells (SCs) but does not affect the migration of SCs in vitro.
(A,B) Representative images of BrdU immunofluorescence staining from each group. The total cells were labeled with DAPI (blue). (C,D) Quantitative analysis of the
BrdU and WST assays (n = 3, ∗P < 0.05). (E,F) Representative images showing migrated SCs (arrows) from each group (arrowheads indicate the micropores on the
membrane). (G) Statistics showing there was no significant difference between the two groups (n = 3, N.D. indicates no significant difference). (H–M) Images
showing the ingested lumispheres (green) within the cells. The SCs were identified with CNPase immunocytochemistry (red). (N) Quantitative analysis of the number
of lumispheres per cell (n = 3, ∗P < 0.05). (O) Western blots and (P) their quantification indicate the expression level of neurotrophic factors (n = 3, ∗P < 0.05).
regeneration. Previously, some studies have reported using
vitamins to treat peripheral nerve injuries, but these studies
mainly focused on nerve injury-derived neuropathic pain, and
the reported effects were mainly the results of interactions
between the vitamins and pain-related receptors in the spinal
cord (Teixeira et al., 2002; Lu et al., 2011). In addition, many
studies have demonstrated that AA plays a role in myelin
formation, mainly myelination studies of SC/neuron coculture
systems in vitro (Podratz et al., 2001; LaMarca et al., 2011; Hyung
et al., 2015), and observations of peripheral nerve demyelination
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FIGURE 7 | AA promotes the proliferation of SCs in vivo. (A–H) Representative images of S100 (red) and ki67 (green) double immunostaining showing proliferating
SCs (arrows) in each group. (I) Quantitative analysis of the number of S100-positive cells (n = 3, ∗P < 0.05). (J) The ratio of ki67/S100 in each group (n = 3,
∗P < 0.05).
in Charcot-Marie-Tooth disease (Passage et al., 2004; Gess et al.,
2013). However, no data revealing the role of AA in axonal
regeneration and remyelination after PNI are available.
The present data showed that at 3 dpi, GAP43- or SCG10-
positive regenerating axons in lesioned nerves treated with
AA were significantly longer than those in nerves from the
control group, which indicates that AA can accelerate early
axonal regeneration. In addition, axons in the distal stump
and their myelin sheaths must be disintegrated after nerve
injury. Subsequently, the axons regrow from the proximal
end, extend to the distal trunk and become remyelinated
by SCs. Thus, the axons and myelin sheaths detected in
the distal portion of an injured nerve are the result of
nerve regeneration. As shown in Figure 2, the number of
NF-positive axons in the AA group was greater than that
in the saline group and even greater than that in the sham
group. Following nerve injury, a single proximal axon generates
several lateral buds and then regenerates toward the distal
trunk during nerve repair. These lateral buds noticeably
outnumber the original axons in the nerve. This phenomenon
is known as ‘‘multiple amplification’’ (Jiang et al., 2007; Deng
et al., 2017). The present assessments by NF/MBP double
immunostaining and TEM demonstrate that AA may increase
the number and size of the regenerated axons and the
myelin thickness.
It is well known that PNI-derived denervation leads to
myoatrophy in the targetmuscles. Once regenerating axons reach
and reinnervate the target muscles, myoatrophy can be reversed
(Pak et al., 2016). Here, we performed histomorphometry
on the gastrocnemius muscle and found larger myofibers in
the AA-treated animals compared with those in the saline-
treated control animals. This result combined with the behavior,
electrophysiology andmorphology results, leads us to believe that
supplementation with AA is an efficient approach for facilitating
nerve regeneration in PNI.
The most disastrous consequences of PNI are the loss of
motor and sensory functions in the area innervated by the
injured nerve. Here, we utilized three widely used behavior tests
to evaluate functional nerve regeneration. The data shown in
Figure 4 demonstrate that all nerve injury-derived functional
defects identified by comparing the saline group with the
sham group were significantly alleviated in the AA group,
which indicated that supplementation with AA can significantly
improve both motor and sensory functional recovery. Then,
the behavior profiles were confirmed by an electrophysiological
assessment that showed that the AA treatment shortened the
latency and increased the amplitude of CMAP in the injured
sciatic nerves. CMAP is commonly used to measure nerve
conduction properties. A shortened latency can reflect quicker
nerve conduction, which is mainly related to the level and
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FIGURE 8 | AA promotes the proliferation, migration, phagocytic capability, and M2 polarization of macrophages but inhibits M1 polarization in vitro. (A,B) Images
of immunofluorescence staining for BrdU (red). Cell nuclei were labeled with DAPI (blue). (C,D) Statistical analysis of the quantifications of the BrdU and WST assays
(n = 3, ∗P < 0.05). (E–G) Images and quantification showing migrated macrophages in the two groups (n = 3, ∗P < 0.05). (H–M) Representative images of
lumispheres ingested by macrophages (ED1 positive). (N) Quantitative analysis of the number of lumispheres per macrophage (n = 3, ∗P < 0.05).
(O–U) Representative images and quantitative analysis illustrate that, compared with that in the control group, the number of M1-type macrophages in the AA group
was reduced (R), while the number of M2 macrophages in the AA-treated group was increased (V; n = 4, ∗P < 0.05).
quality of myelin surrounding the nerve fibers. In addition,
an increased amplitude suggests that a greater number of
regenerated axons are present at the assessed time point (Wang
et al., 2015; Salehi et al., 2018). Overall, the data derived from this
electrophysiological assessment illustrate that nerve conduction
capability is improved by treatment with AA.
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FIGURE 9 | AA promotes the proliferation of macrophages in vivo. (A–H) Representative images of f4/80 (red) and ki67 (green) double immunohistochemistry
showing proliferating macrophages (arrow) in each group. (I) Quantitative analysis of the number of f4/80-positive cells (n = 3, ∗P < 0.05). (J) The ratio of
ki67/f4/80 in each group (n = 3, ∗P < 0.05).
FIGURE 10 | AA inhibits the M1 polarization of macrophages but promotes M2 polarization in vivo. (A–F) Representative images of f4/80 (red) and iNOS (green)
double immunohistochemistry in each group. (G–L) Representative images of f4/80 (red) and CD163 (green) double immunohistochemistry in each group. (M) The
ratio of iNOS/f4/80 in each group (n = 3, ∗P < 0.05). (N) The ratio of CD163/f4/80 in each group (n = 3, ∗P < 0.05). (O–Q) Western blots and schematic diagrams of
the statistical analysis showing the protein levels of iNOS and CD163 in the distal trunk of the injured sciatic nerves (n = 3, ∗P < 0.05).
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Subsequently, three types of cells, including neurons, SCs
and macrophages, which are involved in nerve injury and
repair, were investigated to explore the potential role of AA
in nerve regeneration. First, we isolated neurons from the
DRG after axon removal, and the neurons were cultured in
medium with a low concentration of FBS (1%) to mimic an
unhealthy microenvironment. In these cultures, we found that
AA significantly increased the number and length of regenerated
neurites and decreased the expression of RhoA. RhoA is a
crucial inhibiting factor for neuronal regeneration and is highly
expressed in injured neurons (Devaux et al., 2017; Hu et al.,
2017). Therefore, the downregulation of RhoA expression is
beneficial to neurite outgrowth.
In addition to neuronal intrinsic capacity, environmental
factors such as SC activation can contribute to axonal
regeneration and remyelination. Adequate proliferation to
produce a sufficient cell population and the migration of cells
to the correct site are important processes in peripheral nerve
regeneration even before the cells contribute to regeneration
(Zhang et al., 2017). The present in vitro data from the BrdU
assay and the WST-1 assay and the in vivo data from the double
immunohistochemistry for S100 and ki67 demonstrated that
AA can promote SC proliferation but has no statistical effect
on SC migration. SCs are reported to participate in myelin
phagocytosis in the early stage of Wallerian degeneration, prior
to the recruitment of macrophages (Lutz et al., 2017). Using a
lumisphere test, we found that many more lumispheres were
ingested by AA-treated SCs than by naïve cells. These results
indicate that AA can enhance the phagocytic capability of SCs
and favor nerve regeneration by accelerating the elimination
of debris from the injured nerve. Another important function
of SCs is the secretion of neurotrophins and extracellular
molecules (ECMs) to support and induce axonal regeneration.
Herein, we detected the expression levels of laminin, a
well-accepted component of the ECM that is essential for
neuroregeneration, and NGF, NT-3, GDNF and BDNF, which
are neurotrophins produced by SCs. Consistently, these proteins
were all significantly upregulated by AA treatment. Overall, our
data suggest that AA may affect the behavior of SCs and thereby
enhance nerve regeneration.
Macrophage recruitment to the injured nerve is considered
a key prerequisite for nerve regeneration by eliminating
broken myelin and axonal debris. Our in vitro data also
demonstrate that AA promotes the phagocytic and migration
capabilities of macrophages. Furthermore, the present in vitro
and in vivo data indicate that AA may significantly improve
the proliferation and M2 polarization while decreasing the
pro-inflammatory subtype (M1) polarization of macrophages.
The anti-inflammatory subtype (M2) of macrophages is well
accepted and has the capability to facilitate axonal regeneration
by secreting axonal regeneration-related factors, including ECM
proteins, growth factors, cytokines and chemokines (Gaudet
et al., 2011; Nadeau et al., 2011). In this view, our data
are reasonable. However, post-injury inflammatory signals
are also regarded as having a positive influence on axonal
oxidative signaling for promoting axonal regeneration (Hervera
et al., 2018). As inflammatory signals are mainly released
by M1 macrophages, the present data cannot thoroughly
explain the potential effect of the decreased number of
M1 macrophages induced by treatment with AA in nerve
regeneration. We hypothesize that an appropriate ratio of M1 vs.
M2 macrophages may be important for nerve regeneration, and
this hypothesis should be systematically studied in the future.
In summary, the present experiments suggest that AA may
have an effect on neurons, SCs and macrophages to facilitate
nerve regeneration.
CONCLUSION
The current study is the first to provide experimental evidence
demonstrating that supplementation with AA can sufficiently
promote nerve regeneration in a model of moderate nerve injury
and that this effect is related to the effect of AA on neurons,
SCs and macrophages, which are key cells involved in nerve
injury and repair. Given that AA is an essential nutrient in our
diet and that it has been widely used as a dietary supplement
and clinical drug (Chin and Ima-Nirwana, 2018; Granger and
Eck, 2018), supplementation with AA may be a safe, affordable,
convenient, and efficient strategy for accelerating peripheral
nerve regeneration.
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Developments in tissue engineering yield biomaterials with different supporting
strategies to promote nerve regeneration. One promising material is the naturally
occurring chitin derivate chitosan. Chitosan has become increasingly important in
various tissue engineering approaches for peripheral nerve reconstruction, as it has
demonstrated its potential to interact with regeneration associated cells and the
neural microenvironment, leading to improved axonal regeneration and less neuroma
formation. Moreover, the physiological properties of its polysaccharide structure
provide safe biodegradation behavior in the absence of negative side effects or toxic
metabolites. Beneficial interactions with Schwann cells (SC), inducing differentiation of
mesenchymal stromal cells to SC-like cells or creating supportive conditions during
axonal recovery are only a small part of the effects of chitosan. As a result, an
extensive body of literature addresses a variety of experimental strategies for the different
types of nerve lesions. The different concepts include chitosan nanofibers, hydrogels,
hollow nerve tubes, nerve conduits with an inner chitosan layer as well as hybrid
architectures containing collagen or polyglycolic acid nerve conduits. Furthermore,
various cell seeding concepts have been introduced in the preclinical setting. First
translational concepts with hollow tubes following nerve surgery already transferred the
promising experimental approach into clinical practice. However, conclusive analyses of
the available data and the proposed impact on the recovery process following nerve
surgery are currently lacking. This review aims to give an overview on the physiologic
properties of chitosan, to evaluate its effect on peripheral nerve regeneration and discuss
the future translation into clinical practice.
Keywords: microsurgery, peripheral nerve injuries, nerve surgery, nerve regeneration, nerve reconstruction,
chitosan, nerve growth factors
Abbreviations: BMSC, bone marrow mesenchymal stromal cells; CCL2, chemokine ligand 2; DOA, degree of acetylation;
EGR2, early growth response protein 2; FGF-2, fibroblast growth factor-2; GDNF, glial cell line-derived growth factor; NCAM,
neural cell adhesion molecule; NGF, nerve growth factor; PDGF, platelet-derived growth factor (PDGF); PGA, poly glycolic
acid; PLA, polylactic acid; PLGA, poly(lactic-co-glycolic acid); PNI, peripheral nerve injury; SC, Schwann cells.
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INTRODUCTION
Approximately 2.8% of all hospitalized trauma patients suffer
from traumatic peripheral nerve injury (Noble et al., 1998). The
related severe functional impairment, as well as the consequent
socio-economic impact, led to continuous research efforts in
this field (Nicholson and Verma, 2004). If a direct tension free
approximation of the nerve stumps is possible, to this day,
the epineural nerve suture represents the first line therapy.
Alternatively, if tension free coaptation is not achievable, the
autologous nerve transplantation (ANT) is the current gold
standard (Deumens et al., 2010). However, given the limited
availability of donor nerves and the associated donor site
morbidity, new approaches are needed to support in peripheral
nerve surgery. Ideally, nerve conduits could provide guidance
for the regenerating axons toward the distal nerve stump in
the absence of negative side effects like an extended foreign
body reaction or an undirected axonal regeneration. Tissue
engineering utilized a considerable diversity of materials, but
basic techniques like the ANT, firstly described in the 1970’s,
are still up to date (Davis and Perret, 1946; Tarlov et al.,
1946). Various materials have been tested for bridging peripheral
nerve defects reaching from non-resorbable materials like silicon
(Lundborg, 2004) to fully biodegradable materials such as
Collagen or PGA (Inada et al., 2007; Bozkurt et al., 2012; Boecker
et al., 2015). Today, it is a common consent that the material
used to support the peripheral nerve regeneration should ideally
base on a fully degradable matrix without negatively influencing
the regeneration during biodegradation process (Schmidt and
Leach, 2003). However, despite substantial developments in tissue
engineering, there is still no material or bio-mimicking concept,
which revealed superior results in peripheral nerve regeneration
compared to the ANT as the current gold standard for bridging
peripheral nerve defects (Deumens et al., 2010).
Besides the already established materials, Chitosan is a
promising relatively novel material in the field of peripheral
nerve regeneration. As it is based on the shell of arthropods
it is universally available at low costs and provides a fully
bioresorbable structure in the absence of toxic metabolites,
potentially interfering the regeneration process (Freier et al.,
2005b). Moreover, its specific physical and chemical properties
enable to simulate the physiological multilayer architecture of
peripheral nerves in artificial tissue engineered nerve conduits.
This provides a wide field of potential applications in peripheral
nerve surgery such as gap bridging, nerve suture protection or
even neuroma prevention.
Previous preclinical and clinical studies investigated these
conditions and demonstrated chitosan to support the axonal
regeneration (Haastert-Talini et al., 2013; Stenberg et al.,
2016), reduce extensive scarring, improve functional recovery
(Neubrech et al., 2018) and prevent neuroma formation following
peripheral nerve injury (Marcol et al., 2011). These promising
preclinical and early clinical experiences in diverse nerve
injury models along with its physiologic features emphasize the
future potential of chitosan-based matrices in reconstructive
nerve surgery. This work aims to systematically review the
current tissue engineering strategies and the current process of
clinical implementation.
PROPERTIES OF CHITOSAN AND ITS
IMPACT ON PERIPHERAL NERVE
REGENERATION
The basic component of Chitosan is Chitin, a long-chain polymer
of N-acetylglucosamine which is harvested by the exoskeletons of
arthropods. After cellulose, Chitin is the second most abundant
polysaccharide in nature and is aimed to be mainly used in its
deacetylated modification (Chitosan) in the field of peripheral
nerve surgery (Crompton et al., 2007). Chitin and chitosan can
be classified into the family of the glycosaminoglycans, related
to groups of chondroit sulfates, hyaluronic acid, and heparins.
However, glycosaminoglycans may be the only polysaccharides
with bioactive capabilities (Struszczyk, 2002). Chitin consists of a
linear homopolymer of N-acetyl-D-glucosamine units with β-(1-
4)-linkages. After partial deacetylation, chitin becomes chitosan
(see Figure 1). Thus it can be can be easily obtained at very low
production costs for commercial purposes by alkaline hydrolysis
of chitin (Freier et al., 2005b). Depending on the processing of
the chitosan, the degree of acetylation (DOA) can be varied and
thus influences the molar mass as well as solvent characteristics
(Chatelet et al., 2001).
Moreover, the DOA has also been shown to be a relevant
factor, influencing survival, proliferation and cell activity of
regeneration supporting cells like SC (Carvalho et al., 2017). But,
the exact adjustments of chitosan matrices remain challenging,
because the mechanical stiffness, the biodegradation time, the
geometric architecture as well as the sterilization method
potentially influence the axonal regeneration process and thus
need to be taken into account throughout the manufacturing
process (Stößel et al., 2018).
In tissue engineered nerve conduits, the biodegradation and
physiologic replacement processes start immediately and thus
present the central mechanisms of action which influence nerve
recovery. In contrast to acid-based materials, like polyglycolic
acid (PGA) or polylactide derivates, which undergo a ph
decrease during biodegradation or signs of inflammatory
foreign body reaction (Meek and Coert, 2008), metabolites of
chitosan demonstrated neuroprotective effects during peripheral
nerve regeneration.
Here, a degradation product of Chitosan, the
Chitooligosaccharide (COS), has been found to promote
cell proliferation and prevent apoptosis especially for SC, as the
FIGURE 1 | Chemical structure of Chitin and Chitosan. The chemical
structure of Chitin based on a linear homopolymer of N-acetyl-D-glucosamine
units (A). After partial deacetylation chitin becomes chitosan mainly used in
peripheral nerve surgery (B).
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vital cell for a sufficient axonal regeneration (Zhou et al., 2008;
Huang et al., 2015). Furthermore, Wang et al. (2016) attributed
these stimulating effects of COS to an accelerated cell cycle
leading to increased SC proliferation.
Moreover, COS stimulate the CCL2 expression by down-
regulating the miR-327 of the SC, resulting in enhanced
macrophage migration to the injury site (Zhao et al., 2017).
In line with this, Bin et al. analyzed the anti-apoptotic effects
of carboxymethylated chitosan (CMC) on SC by decreasing
caspase-3, -9 and Bax activities and increasing Bcl-2 activities
in CMC treated SC. To prevent the SC against oxidative stress,
COS led to a reduced activity of malondialdehyde as well as
to increased activity of superoxide dismutase activities (SOD)
(He et al., 2014). Further in vivo experiments demonstrated a
significantly improved peripheral nerve regeneration following
daily intravenous injection COS for 6 weeks in an axonotmesis
rabbit animal model. Interestingly, the number of regenerated
myelinated nerve fibers, the myelin sheath thickness, as well
as the compound muscle action potential (CMAP) as the
parameter for electrophysiological recovery, has been shown
to be significantly superior in COS treated animals. Thus,
Gong et al. (2009) sum up, that COS not only accelerate the
peripheral nerve regeneration but also can be seen as a
neuroprotective agent after PNI.
Furthermore, the beneficial effect on neural disorders by
suppression of the β-amyloid formation and supporting the
anti-neuroinflammatory activity underlines the tremendous
potential of COS, and consequently of chitosan, in the field of
neuropathologies (Pangestuti and Kim, 2010; Hao et al., 2017).
Focusing on the tissue engineered designs, in most
publications, Chitosan is the main component for a new
tissue-engineered nerve conduit to bridge peripheral nerve
defects. Interestingly, there are some alternative geometric
structures of chitosan to promote axonal regeneration or even
prevent neuroma formation.
Xu et al. (2017) have recently published another concept
in the tissue engineering of chitosan by presenting a
chitosan-based hydrogel in combination with a poly 3,4-
ethylenedioxythiophene. Supported cell adhesion, vitality, and
proliferation of PC-12 cells underline the potential of chitosan
hydrogel for further neural tissue engineering. Interestingly
tissue engineered concepts based on chitosan focused not only
on the treatment of PNI but also for neuroma prevention. Marcol
et al. (2011) applied, mircrocrystallic chitosan to the proximal
nerve stump after PNI and showed less autotomy behavior
and minor axonal sprouting as a key ability for neuroma
prevention in the future.
MECHANICAL PROPERTIES AND
TOPOGRAPHIC STRATEGIES IN TISSUE
ENGINEERING OF CHITOSAN
Mechanical Properties and Challenges
In a medical application, chitosan has already a long history
due to its biocompatibility and to its non-toxic, biodegradable
properties (Freier et al., 2005b).
Not only in the field of peripheral nerve surgery chitosan
plays a crucial role, but also for wound healing or as a
drug delivery system. Referring to the peripheral nerve, low
mechanical strength has been a tremendous challenge in the early
phase after implantation of chitosan and its derivates. Matrices
of chitosan showed decreased stability under physiological
conditions (Madihally and Matthew, 1999; Itoh et al., 2003) and
therefore make it not suitable for the translational application.
Modifications have been made to improve mechanical stability
by designing an internal architecture by puncturing the
chitosan while molding procedures with needles (Wang et al.,
2006). Alternatively, Ao et al. (2006) developed a new uni-
directional temperature gradient leading to a chitosan scaffolds
incorporated with longitudinal microfibers. Unfortunately, the
scaffold presents an appropriate mechanical strength under
in vitro conditions but fail to show stability under physiological
in vivo circumstances. To improve the mechanical strength of
chitosan, further adjustments like additional cross-linking by
supplementation of chitin (Yang et al., 2004) or formaldehyde
(Desai and Park, 2005) have been published. The mechanical
stability of the chitosan is also affected by the degree of acetylation
(DOA). Higher DOA has been reported to improve the stability
of chitosan and lead to a superior keratinocytes cell adhesion
(Chatelet et al., 2001). Referring to the neural cell lineage,
acetylation rates of 0.5 and 11% showed more and longer neurites
of regeneration of dorsal chick root ganglions neurons compared
to other concentration. However, cell viability of 0.5% was
approximately eight times higher compared to a DOA of 11%.
Thus, surface modifications of chitosan films referring to the cell
viability and cell adhesion can clearly be modified by the DOA
(Freier et al., 2005a) and needs to be addressed in the future tissue
engineering for chitosan materials. In line with this, supporting
cells, like SC, also benefit from a low DOA by presenting a better
cell spreading and proliferation (Wenling et al., 2005).
However, for translation applications, the mechanical strength
of the material to prevent the collapse of the material is essential
as well as the ability for an inner lining of regenerating axons.
Exemplary, Wang et al. present a chitosan two-layer approach
with an oriented inner layer of nanofibers and a random outer
layer with superior stability compared to random fiber mesh
tubes (Wang et al., 2008a,b).
Forms of Chitosan and Topographic
Concepts
Several forms and techniques of chitosan have been published in
literature reaching from hydrogels (Zheng et al., 2010; Rickett
et al., 2011; Nawrotek et al., 2016b; Du et al., 2017), films
(Pavinatto et al., 2010; Xiao et al., 2013; Meyer et al., 2016b),
microspheres (Zeng et al., 2014) or tubes (Itoh et al., 2003;
Wang et al., 2006; Shapira et al., 2016) in the field of
peripheral nerve surgery.
Hydrogels
Hydrogels are a frequently applied form in the field of tissue
engineering because of the similarity to the extracellular matrix,
and the modest way of processing.
Freier et al. (2005b) presented, after the hydrolyzation of
chitin, a hydrogel-based chitosan tube with superior mechanical
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strength, measured by the transverse compressive test. Chitosan
Hydrogel has also been used as an alternative to the fibrin
glue or even to the epineural suture after peripheral nerve
lesion (Rickett et al., 2011). Further in vitro studies combine
chitosan hydrogels with hydroxyapatite as a source for calcium
ions to modify mechanical and biological properties. Cytotoxic
and pro-inflammatory tests could mark the biocompatibility of
this hydrogel solution independently of the tested composition
(Nawrotek et al., 2016a).
Interestingly, in vivo studies with a chitosan/glycerol-beta-
phosphate disodium salt hydrogel presented an impaired
peripheral nerve regeneration for 10 mm sciatic nerve defect
compared to chitosan tubes filled with SC suspension or culture
medium (Zheng et al., 2010). Hydrogels as an inner filling in
combination with chitosan tubes tested under in vivo conditions
led to further enhanced peripheral nerve regeneration.
As drug delivery system, chitosan hydrogels have also been
explored by a continuous delivery of methylprednisolone.
Functional recovery of the rat’s facial (Chao et al., 2015) and
sciatic nerve (Mehrshad et al., 2017) was accelerated for animals
with a supplementary methylprednisolone delivery.
Hydrogels of other components, like Hyaluronic hydrogels
(Meyer et al., 2016b) fibrin nanofiber hydrogels (Du et al.,
2017) or simvastatin/Pluronic F-127 hydrogels (Guo et al., 2018)
have been frequently combined with chitosan tubes. Axonal
regeneration and motor functional recovery was improved by
applying these hydrogels as inner filling for chitosan tubes.
Films
In the field of peripheral nerve surgery, chitosan films are applied
directly for enhancing peripheral nerve regeneration but also
as an inner architecture for nerve guides to bridge peripheral
nerve defects. Mechanical stability and biocompatibility were
proven for neural cells and peripheral nerves tissue engineering
(Pavinatto et al., 2010).
Meyer et al. (2016a) combined a chitosan nerve tube with
a supporting inner layer of a chitosan film over 15 mm long
distance defects of a rat’s sciatic nerve lesion and presented
superior axonal regeneration as well functional recovery
compared to hollow non-modified chitosan tubes.
Chitosan films have been modified with several other
components by crosslinking or incorporation. Proanthocyanidin
was crosslinked to chitosan films with gelatine and showed
improved mechanical properties, a decreased biodegradation
rate, superior cell adhesion as well as improved proliferation
compared to non-crosslinked gelatin or chitosan alone (Kim
et al., 2005). Similar results have been found by the crosslinking
of chitosan and hyaluronic in a polyelectrolyte multilayer
film (Schneider et al., 2007). Incorporation of polyethylene
oxid with chitosan revealed a superior water permeability
and a ratio-depended antibacterial effects as well as improved
mechanical strength compared to non-modified chitosan films
(Zivanovic et al., 2007).
Microspheres
Chitosan can also be manufactured as microspheres or
microparticles mainly used for drug delivery. Chitosan
microspheres loaded with NGF has been incorporated to
collagen-chitosan scaffolds for a rat’s sciatic nerve and led
to promising results in functional outcome in combination
with microchannels as inner lining (Zeng et al., 2014) as
well as combined with a chitosan nerve guide conduit for
reconstruction of facial nerve injuries (Liu et al., 2013). Further
developments in tissue engineering enable an additional
loading of cores-shell poly(lactide-co-glycolide)-chitosan
microparticles as drug delivery system for continuous release of
NGF (Zhang et al., 2017).
Tubes and Inner Architecture
Different strategies of the treatment of peripheral nerve injuries
based on chitosan have been explored in the literature, reaching
from chitosan filament mesh tubes to chitosan-based nerve
conduits. Exemplary, chitosan tubes were described by Suzuki
et al. (2003) coupled with synthetized laminin under in vivo
conditions to bridge a 15 mm sciatic nerve lesion. Despite
the modification with the laminin peptides YIGSR and IKVAV,
no superior results compared to the ANT have been shown
(Suzuki et al., 2003). Further developments of tissue engineering
led to chitosan tubes with a triangular inner surface and an
additional coating with hydroxyapatite as well as laminin and
laminin-1 peptides. Histological findings presented the beneficial
effects of a triangular inner architecture for peripheral nerve
regeneration. However, despite histological regeneration is like
the ANT, delayed functional recovery was shown after 12 weeks
of regeneration (Itoh et al., 2003). Addressing the essential need
for inner guidance to bridge long distance peripheral nerve
defects, porous chitosan tubular scaffold with chitosan fiber-
based yarns with interconnected micropores were created (Wang
et al., 2006). Wang et al. (2008a) also published alternative
strategies for an inner lining by combining chitosan film tube as
an outer layer with a nano/microfiber mesh as inner guidance.
Different degrees of deacetylation were tested and compared to
an ANT. Histological finding presents a better cell migration
and attachment as well as neurite outgrowth for scaffolds with
deacetylation rate of 93% compared to scaffolds with 78%
(Wang et al., 2008a).
Furthermore, an additional mobilization with polarized
β-tricalcium phosphate particles led to superior results
in histological findings compared to non-polarized mesh
tubes and similar results to the ANT (Wang et al., 2010).
Silva et al. (2014) followed another approach presenting
nanostructured hollow tubes with an additional crosslinking
of genipin. Biological performance of this modified hollow
tubes was assessed focussing on cell adhesion, viability,
and proliferation (Silva et al., 2014). Recently, chitosan flat
membranes crosslinked with dibasic sodium phosphate alone
and combined with γ-glycidoxypropyltrimethoxysilan showed
increased water stability and stiffness under in vitro conditions.
For a 1 cm median nerve gap, chitosan conduits associated
with γ-glycidoxypropyltrimethoxysilan promoted nerve fiber
regeneration and functional recovery similar to the autograft
(Fregnan et al., 2016).
Chitosan can also be combined with autologous materials by
utilizing a chitosan tube with fresh skeletal muscle fibers as an
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inner layer to bridge nerve defects in the rat’s median nerve.
Interestingly, Neuregulin-1 is upregulated for chitosan tubes with
internal muscle fibers but not for hollow tubes and may be crucial
to further improve axonal nerve regeneration over long nerve
lesions (Ronchi et al., 2018).
Biochemical Properties and Surface
Modifications
Cell affinity for the neural cell lineage plays a crucial role to
support neural regeneration. Therefore, chitosan is loaded
with laminin or poly-lysine and led mainly to superior
neurite outgrowth compared to the non-blended alternative
(Haipeng et al., 2000). Cheng et al. (2004) applied PC12 cell
culture to test cell affinity in poly-L-lysine different blended
chitosan nerve tubes. Interestingly, the hydrophobicity
of the poly-L-lysine in combination with the increased
surface charge might be the reason for the increased cell
attachment, growth, and differentiation (Cheng et al., 2004).
Furthermore, increased concentration of poly-D-lysine not
influence cell survival but can inhibit neurite outgrowth
(Crompton et al., 2007).
Compositions of chitosan and gelatin have also been tested
referring to the cell affinity and the potential to neurite
outgrowth. Despite a decreased cell viability, chitosan blended
with gelatine was able to show superior neurite outgrowth and in
the first days of cell culture compared to PLL containing materials
(Martín-López et al., 2012).
Alternative surface modification to promote peripheral nerve
regeneration, are the YIGSR (Tyr-Ile-Gly-Ser-Arg) and IKVAV
(Ile-Lys-Val-Ala-Val) sequences, which are known to modify
receptor specific neural cell adhesion as well as to support
neurite outgrowth. Itoh et al. (2005) were able to bond the
YIGSR (Tyr-Ile-Gly-Ser-Arg) and IKVAV (Ile-Lys-Val-Ala-Val)
peptides to molecular aligned chitosan. The peptides A3G75 and
A3G83 of the laminin alpha chain LG4 modules promote neurite
outgrowth. Conjugated peptides of the LG4 and LG5 modules
to chitosan membranes presented improved cell attachment and
neurite outgrowth for PC12 cells (Kato et al., 2002). A2G94
peptide is expressed by the Laminin alpha2 chain and led
to a promoted alpha6beta1-mediated cell attachment as well
as neurite outgrowth after conjugation in a chitosan tube
(Urushibata et al., 2010).
Furthermore, Laminin-modified chitosan membranes
significantly enhance SCs attachment and affinity for the
guided peripheral nerve regeneration. Percentage of laminin
incorporation is significantly higher by using the oxygen
plasma technique compared to conventional chemical methods
(Huang et al., 2007). Laminin has also been used to bond
an additional glycin spacer to nano/microfiber mesh surface
of the chitosan tube. SC affinity has been further improved
by these surface modification (Huang et al., 2007). The
combination of negatively charged heparin and positively
charged γ-aminopropyltriethoxysilane (APTE) on porous
chitosan scaffolds led to superior SC proliferation, attachment,
and biological activity after seeding was shown under in vitro
conditions (Li et al., 2015).
EXPERIMENTAL CHITOSAN-BASED
HYBRID STRATEGIES TO PROMOTE
PERIPHERAL NERVE REGENERATION
UNDER EXPERIMENTAL CONDITIONS
The recent literature describes a variety of different types
of hybrid strategies which aim to combine the advantages
of chitosan with specific characteristics of other materials
(see Table 1). The following section presents such chitosan
hybrid strategies and discusses their potential role in
reconstructive nerve surgery.
Collagen
Advantages of an adjustable biodegradation time as well as the
relief of non-toxic components during biodegradation, make
collagen a precious and well-investigated material supporting
peripheral nerve healing (Deumens et al., 2010). Considering the
accepted biomimicking concept for the treatment of peripheral
nerve lesions, Nawrotek et al. (2016c) developed an epineurium-
mimicking chitosan conduit by a chemical composition of
collagen, chitosan, and hyaluronic acid. Testing on mHippoE-18
mouse hippocampal cells, cell stimulation without cytotoxicity
has been shown. As an alternative geometric design, one
of the first chitosan-collagen films presented by Wei et al.
(2003) showed promising results in a functional recovery for
bridging peripheral nerve lesion of 5–10 mm. Progress in tissue
engineering further expanded the biomimicking approach for
peripheral nerve reconstruction; thus Xiao combined a hybrid
nerve guide based on collagen-chitosan and added an Arg-
Gly-Asp (RGD) sequence, which is a well-known pattern and
mostly used for supporting cell-adhesion abilities in tissue
engineering. This led to superior results in histological and
functional recovery compared to nerve conduits lacking an
additional RGD sequence (Xiao et al., 2013). Recently, a
collagen/chitosan nerve scaffold was introduced by Peng et al.
(2018) fabricated by an “unidirectional freezing process” followed
by further freeze-drying (Ding et al., 2010). On the basis
of a collagen and chitosan suspension, this new scaffold was
applied for bridging a peripheral nerve defect of 30 mm
of the beagle’s sciatic nerve. Based on the results of the
electrophysiological assessment, retrograde tracing as well as
histological evaluation, this collagen-chitosan nerve scaffold
presented results equivalent to the ANT. If further experimental
research confirms these identical recovery results via artificial
conduits, such strategies will next be investigated in future clinical
trials (Peng et al., 2018).
Polyglycolic Acid (PGA)
Polyglycolic acid has been widely used in the field of bridging
peripheral nerve defects. Focusing on the reconstruction of
extended- distance peripheral nerve defects PGA conduits
filled with laminin-soaked collagen scaffolds or PGA-collagen
fibers were found to promote axonal regeneration over a
nerve lesion of up to 80 mm (Toba et al., 2002). Thus, it
is reasonable to combine the beneficial effects of PGA with
the potential of chitosan to further optimize the regeneration
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supporting conduit features. Therefore, Wang et al. (2005)
developed a dual-component artificial nerve graft with an
outer microporous conduit of chitosan and an inner layer
of filaments PGA. In a beagle dog animal model with
sciatic nerve lesion of 30 mm and a recovery interval of
6 months, the chitosan/PGA group showed a similar distribution
pattern of myelinated fiber diameter compared to the ANT
(Wang et al., 2005).
Polylactic Acid (PLA) and
Poly(Lactic-Co-glycolic Acid) (PLGA)
The combination of chitosan and polylactide (CH-PLA) fibers
presented a higher tensile strength and a lower tendency for
swelling compared to chitosan fibers alone. The combination of
a chitosan-based outer layer with an inner lining by (CH-PLA)
fibers led to a guided axonal regeneration and thereby to the
possibility to bridged long-distance peripheral nerve defects.
Furthermore, the CH-PLA fibers have been tested as a
continuous release system of attached growth factors such as
NGF and thereby induced a continuous outgrowth of PC12
cells as receptors for epidermal growth factor (EGF) both
known to promote peripheral nerve regeneration (Huff and
Guroff, 1979). Thus, CH-PLA fibers can be manufactured
for gradient delivering not only for NGF but also other
relevant growth factors by loading them into the alginate
layers. Wu et al. emphasized the vast potential of these CH-
PLA fibers, especially for a guided axonal regeneration for
long-gap nerve repair (Wu et al., 2017). In line with this,
Shen and colleagues bridged a peripheral nerve lesion of
25 mm of the canine tibial nerve in a dog animal model.
Histological results illustrated that the PLGA/chitosan conduits
were capable of providing peripheral nerve regeneration after
12 weeks. Results similar to the ANT can be reached by
combining the PLGA/chitosan conduit with an additional
coating of the ciliary neurotrophic factor (Shen et al., 2010).
Moreover, the average maximum nerve fiber diameter and
motor function have been improved by introducing dorsal root
ganglion-derived SC to poly-(lactic-co-glycolic acid)/chitosan
nerve scaffold for 10 mm sciatic nerve lesion in the rat (Zhao
et al., 2014). However, materials based on PLA and PLGA
suffer under a pH-decrease of the microenvironment during
degradation and leading to an impaired of axonal regeneration
(Deumens et al., 2010).
Polyethylene Glycol
Another promising hybrid approach is to combine chitosan-
based nanofiber conduits with an additional filling of
polyethylene glycol solution. In a 10 mm nerve defect of
the rat’s sciatic nerve, the superior functional outcome has been
shown for animals treated with a substitute of the polyethylene
solution. In contrast, functional recovery compared to the
ANT showed clear inferior results for the experimental groups
(Mokarizadeh et al., 2016). Furthermore, challenges of the
chitosan in tissue engineering referring to the disadvantage
in the processing of three-dimensional tubular forms without
heating processing methods like extrusion or casting (Ao
et al., 2006), were addressed by Nawrotek and colleagues by
developing a tubular chitosan-carbon nanotube through the
electrodeposition method. This conduit provided an excellent
cell-adhesion, cell-proliferation, and cell-viability as well
as structural stability for 28 days under in vivo conditions
(Nawrotek et al., 2016c).
To sum up, hybrid concepts with chitosan have been well
explored in literature, mostly for bridging peripheral nerve
defects and led to promising results in peripheral nerve
regeneration. Interestingly, the hybrid approach mainly revealed
superior results of axonal recovery compared to concepts with
chitosan alone. However, an exact differentiation of the effects
of chitosan and the added material in a hybrid approach is not
possible. Furthermore, hybrids concepts present the possibility
of a tailored biodegradation as well as the embedding of growth
factors or additional cell seeding related to the needs of peripheral
nerve regeneration.
ADDITIONAL CELL SEEDING
COMBINED WITH CHITOSAN-BASED
TREATMENT STRATEGIES
Nerve regeneration through chitosan-based nerve tubes can be
promoted by conduit enrichment via supportive molecules like
laminin or growth factors as well as additional cell seeding
(see Table 2).
Additional Cell-Seeding With Schwann
Cells (SC)
The proliferative effect of chitosan on SC and inhibiting effect
on the fibroblast growth has already been shown by Kuang et al.
(1998). Thereby, chitosan has the potential to support the axonal
regeneration by increasing the number of SC and may prevent
scar tissue formation after peripheral nerve lesion (Kuang et al.,
1998). Further investigations regarding biocompatibility among
SC chitosan scaffolds or fibers were conducted by Yuan et al.
(2004), leading to the conclusion that chitosan has an excellent
neuroglial cell affinity with the ability to be an excellent cell carrier
system after implantation. Chitosan membranes or fibers showed
almost no cell toxicity for SC considering the results in the MTT
Assay (Yuan et al., 2004).
As mentioned above, the DOA of the chitosan is crucial for
the solvent characteristics and molar mass. Carvalho has shown
that acetylation of 5% results in higher cell proliferation and
phenotypic expression of SC-like cells compared to chitosan
membranes with acetylation rates of 1% or 2% (Carvalho
et al., 2017). The combination of SC with a chitosan nerve
conduit substituted with self-fibroin filamentous fillers showed
superior regeneration results compared to non-seeded chitosan
conduits regarding the histological and functional outcome
(Zhu et al., 2017).
Additional Cell-Seeding With Bone
Marrow Stromal Cells (BMSC)
Bone marrow stromal cells seeded nerve conduits, in general,
have shown to be a successful concept for bridging peripheral
nerve defects and promoting axonal regeneration (Mimura et al.,
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2004; Keilhoff et al., 2006; Boecker et al., 2015). Consequently,
strategies to enhance peripheral nerve regeneration by BMSC
seeded chitosan-based nerve guides has also been described.
Hsu et al. (2013) published a two-component nerve tube with an
inner layer based on laminin-modified chitosan and a silicon-
based outer layer with a supplementary seeding of BMSC.
As the control group, non-seeded laminin modified-chitosan
scaffolds and empty silicone tubes have been utilized. After
a regeneration period of 16 weeks and following histological
investigations, hyperplasia tissue enriched with eosinophils and
macrophages has been found. In this context, the importance
of the inflammation after PNI, induced by these cells, was
emphasized by the author (Hsu et al., 2013). In line with
this, a chitosan-coated poly-3-hydroxybutyrate nerve conduit
has been seeded with BMSC to bridge a 10 mm sciatic
nerve lesion and led to superior results in functional recovery
compared to non-seeded control group. However, the ANT
showed still the best results of functional recovery (Ozer et al.,
2018). Similar results have been assessed through Moattari
et al. (2018) by exhibiting significant superior effects in
which group? in the electromyography, nerve fiber density
and myelinated axon diameter (Moattari et al., 2018). For
bridging long distance peripheral nerve injuries of 50 mm
or even 60 mm, in a dog sciatic nerve, chitosan/poly(lactic-
co-glycolic acid) (PLGA)-based neural scaffolds have been
combined with BMSC and evaluated by electrophysiology,
retrograde tracing, and histology after recovery of 6 or
12 months. The results led to a nearly similar degree
of functional regeneration compared to the ANT (Ding
et al., 2010; Xue et al., 2012). Interestingly, Yao et al.
(2016) was able to show, that Bone Marrow Mononuclear
Cells joined with a chitosan/silk fibroin scaffold survived at
least 2 weeks under in vivo conditions associated with an
improved axonal guidance. Nearly similar results for functional
recovery was accomplished compared to the ANT in the
CatWalk gait analysis after 12 weeks of recovery (Yao et al.,
2016). However, SC harvested during nerve surgery need
long cultivation times to reach sufficient cell numbers for
reimplantation and are associated with a loss of function related
to donor’s nerve.
Alternatively, BMSC can be harvested through bone marrow
biopsy and revealed cell plasticity that can be adapted to the
conditions of peripheral nerve regeneration (Keilhoff et al.,
2006). However, the operation procedure is associated with
surgical risks, like infection, bleeding, etc. Furthermore, the
stability of differentiation has to be taken into account,
BMSC have the ability to differentiate to SC-like cells under
in vitro conditions but also have the capacity to re-differentiate
to stem cell under the absence of the required factors,
which is associated with a higher malignity degeneration rate
(Gore et al., 2011).
Most current concepts of additional cell-seeding in peripheral
nerve surgery remain as a proof principle because of the potential
donor site morbidities, long lasting cultivation times before
implantation and instability of cell differentiation (Boecker
et al., 2015). Thereby, translational concepts with additional cell
seeding based on chitosan are strongly restricted.
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CHITOSAN-BASED DELIVERY SYSTEMS
FOR GROWTH FACTORS
In tissue engineered delivery systems the release kinetics of
growth factors play a crucial role for axonal regeneration.
Recently, a variety of different concepts have been published
using chitosan as a delivery system for growth factors while
peripheral nerve regeneration (see Table 2).
Nerve Growth Factor (NGF)
Pfister et al. (2008) were able to show a continuous delivery
of bioactive NGF in low nanogram doses for 15 days.
A nerve conduits of polyelectrolyte alginate/chitosan was
coated with layers of poly(lactide-co-glycolide) (PLGA) to
control the delivery of embedded NGF (Pfister et al., 2008).
Moreover, the relevance of continuous delivery of NGF by
using chitosan as carrying material and its synergetic effects
have been marked by Chao et al. (2016). The combination
of vein conduits filled with a chitosan-β-glycerophosphate-
NGF hydrogel presented superior histological, functional and
electrophysiological recovery compared to non-filled vein
conduits (Chao et al., 2016). This underlines the capacity of
chitosan to be an excellent delivering system for growth factors
related to the peripheral nerve regeneration.
Furthermore, chitosan nerve conduits with a supplementary
immobilization of NGF via genipin cross-linking, were compared
to the ANT for a 10 mm-long sciatic nerve gap with 24 weeks
recovery time. The crosslinked nerve conduit was superior
compared to a non-crosslinked control but not to the ANT
and led to inferior results in the electrophysiology and axon
density compared to the gold standard. Thus, the real potential
of additional NGF-application is hard to evaluate in this study
design (Wang et al., 2012). The indication of chitosan tubes
is not only limited to the treatment of PNI but can also be
extended for nerve compression syndromes. Zhang et al. (2017)
developed a chitosan-sericin scaffold for a continuous delivering
of NGF. After application, a better functional recovery, as well
as superior histological results has been demonstrated, probably
caused by the beneficial effects of degradation products and the
corresponding inducement of mRNA levels of GDNF, EGR2,
NCAM as well as down-regulation levels of inflammatory genes
(Zhang et al., 2017).
Glial Cell Line-Derived Growth Factor
(GDNF)
The beneficial effects of GDNF on the peripheral nerve
regeneration, like the support of motoneuron regeneration,
acceleration of axonal regeneration and the prevention of muscle
atrophy are known in the literature (Chen et al., 2001; Jubran and
Widenfalk, 2003). Further developments in tissue engineering
led to chitosan conduits enriched with laminin and GDNF.
Non-prepared laminin-loaded chitosan tubes were compared to
laminin-loaded chitosan tubes with supplementation of GDNF
and used to bridge a nerve lesion of 10 mm. An additional GDNF
blending explicated a significant superior sensory recovery
compared to unblended chitosan tubes (Patel et al., 2007).
Fibroblast Growth Factor-2 (FGF-2)
Fibroblast growth factor-2 is one of the 22-member of the
fibroblast growth factor family. In association with heparin or
heparin sulfate proteoglycan, a variety of different effects has
been reported including potent effects on angiogenesis and
cell differentiation in the central nervous system. Chitosan-
nanoparticles have been utilized as drug delivery systems
for FGF-2. The chitosan scaffolds with incorporated FGF-2
microspheres reviewed superior results in cell survival and
growth of neural stem cells compared to non-incorporated
chitosan scaffolds under in vitro conditions (Woodbury and
Ikezu, 2014). In line with this, chitosan scaffolds cross-linked
with heparin and FGF-2 were assessed for cytocompatibility,
attachment, and survival of neural stem cells (Skop et al.,
2013). Alternatively, FGF-2 concentration can be increased by
overpressing SC seeded in a chitosan hydrogel as an inner filling
for a chitosan tube. Neural and Vascular (NVR) gel as inner filling
has the obstacle to impair axonal outgrowth in a rat’s sciatic nerve
model. However, this challenge could be overcome by consistent
delivery of FGF-2 of overexpressing SC and led to a significant
extent in neurite outgrowth compared to free FGF-2 delivery or
non-modified Neonatal Rat SC (Meyer et al., 2016b).
Platelet-Derived Growth Factor (PDGF)
Platelet-derived growth factor (PDGF) has been shown to
support the migration of bone marrow stromal cells. Chitosan
scaffolds have been loaded with chitosan-encapsulated PDGF
microspheres and investigated for the biocompatibility of
neural progenitor cells. Directional migration and growth of
these cells were shown for scaffolds with additional PDGF
incorporation. Chitosan microspheres underline their potential
as a drug delivery system by releasing 52% of the PDGF in
4 weeks under in vitro conditions without a burst release
(Chen et al., 2018). The beneficial effect of PDGF on neural
stem progenitor cells by promoting the cell survival and
cell differentiation to oligodendrocytes is described in the
literature (Delayed transplantation of adult neural precursor cells
promotes remyelination and functional neurological recovery
after spinal cord injury; Endogenous and exogenous CNS
derived stem/progenitor cell approaches for neurotrauma). In
combination with chitosan channels and a continuous release
of PDGF osmotic pump, neural stem progenitor cells have been
significantly enhanced in cell survival under in vivo conditions
(Guo et al., 2012).
TRANSLATIONAL CONCEPTS OF
CHITOSAN-BASED NERVE TUBES
Yet, the application of chitosan-based nerve conduits beneath
experimental research as translational concepts has not been
explored sophisticatedly. Only a few studies have already
implemented chitosan tubes in clinical practice and evaluated the
functional outcome after application.
In first clinical treatments, the combination of a chitosan-PGA
nerve conduit was utilized to bridge a long-distance defect of
35 mm of the median nerve distal to the bicep’s aponeurosis.
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During a 3-year follow-up period sensory and motor function
recovered satisfactorily to M4 and S3+ levels in testing. However,
this case report need to be amended by further clinical studies to
prove the clinical value of this nerve conduit (Fan et al., 2008).
Similar results have been found by Gu et al. (2011) after bridging
a 30 mm nerve defect of the median nerve with the same nerve
conduit 2 years later. In June 2014, the first unaccompanied
chitosan-based nerve conduit, named Reaxon R©has been launched
by Medovent GmbH (Mainz, Germany). Reaxon R©was developed
in accordance with the international standard DIN EN ISO
13485 and can be manufactured in different sizes depending
on the diameter of the nerve. Nerve defects with a size up
to 26 mm can be bridged in the clinical setting (Neubrech
et al., 2016b). Furthermore, Reaxon R©cannot only be used as
tubulization-technique for bridging the peripheral nerve defects
but also as a protector for the nerve coaptation after a tension-free
epineural suture (Neubrech et al., 2016a).
Thus, besides several studies investigated beneficial effects
of chitosan and its derivates in preclinical in vitro and in vivo
models, the functional outcome after traumatic sensory nerve
lesions can significantly be enhanced by a supplementary
use of Reaxon R©as protection for the epineural suture in
daily clinical routine (see Figure 2). In a double-blinded,
randomized, prospective clinical trial, after a 6-months
follow-up, a 6.3 mm two-point-discrimination has been
found for patients treated with the additional chitosan-based
conduit compared to the control group with two-point
discrimination of 8 mm. This significant enhancement of
the tactile gnosis is a relevant parameter for functional
recovery of the hand (Neubrech et al., 2018). The capability
of Reaxon R©has been further investigated by Ronchi et al. by
combining the chitosan tube with skeletal muscle fibers of
the pectoralis muscle to bridge a 10 mm nerve lesion of the
median nerve. Biomolecular analysis has shown an increased
production and release of Neuregulin, as a key factor for
SC survival and vitality. However, functional recovery and
morphometric analyses presented no significant differences
compared to hollow chitosan tubes. The author considered,
beneficial effects of an inner lining by an additional muscle
application is more indicated for nerve lesion of an extended
distance than for a nerve lesion size of 10 mm in humans
(Ronchi et al., 2018).
In the future, the possible clinical application of Chitosan in
the field of peripheral nerve surgery is vast and can be used
for bridging peripheral nerve lesion, protecting the epineural
coaptation or even for neuroma prevention.
Referring to the findings of Marcol et al. (2011), new
developments in material science led to chitosan-based nerve
caps, which may have the capacity to limit neuroma formation
by combining a mechanical obstacle with an additional material-
related biochemical barrier for unguided axonal sprouting. Based
on the material properties, recent material science concepts, such
as chitosan gel, film or microcrystals, for an easier application of
the material is also possible.
FIGURE 2 | Translational Concepts in daily clinical practice. Chitosan nerve tube protects the epineural nerve coaptation (A). Magnification of the chitosan-based
nerve tube for covering the epineural suture of the third proper palmar digital (B). Protection of the epineural nerve coaptation by a chitosan-based nerve tube in a
model (C). (A,B) has been taken during clinical routine care.
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In conclusion, the capability of chitosan as a sophisticated
partner in the peripheral nerve regeneration has been explored
in several in vitro and in vivo experimental approaches. Not only
the cell biocompatibility of chitosan on neural cells was shown
but also beneficial effects on the differentiation and proliferation
on SC as well as BMSC. Moreover, COS, as the metabolite
of chitosan during biodegradation, is a neuroprotective agent
during peripheral nerve regeneration and a direct stimulator
for SC. Under in vivo conditions, chitosan was able to bridge
peripheral nerve defects up to 60 mm in combination with
a chitosan/poly(lactic-co-glycolic acid) (PLGA)-based neural
scaffold combined with BMSC. First human trials in 2011
presented sensory recovery after chitosan tube implantation for
a median nerve lesion. Recently, the first chitosan-based nerve
guide was launched for clinical application and led to superior
sensory recovery by using it as a biochemical protector for the site
of the epineural nerve coaptation. However, given the only few
human clinical trials investigating chitosan conduits, the effect on
the outcome following all kinds of nerve surgery (decompression,
defect reconstruction, and neuroma prevention) and thereby its
potential value have to be evaluated. However, considering the
first results of clinical trials and previous in vitro and in vivo
experiments, chitosan has an immense potential to be a valuable
partner for the peripheral nerve surgeon in the future.
CONCLUSION
The relevance and application of chitosan in the field of
peripheral nerve surgery are tremendous and can principally be
separated between the support axonal regeneration by giving
mechanical guidance and stability (as chitosan tube, inner
filling or epineural suture protector) or being used as drug
delivery system.
Chitosan has good biocompatibility of the peripheral
nervous system, and mechanical properties make custom-
made biodegradation possible. To overcome mechanical
instability in a variety of different approaches in tissue
engineering reaching from chitosan microspheres to chitosan
hydrogel have been explored. Especially hybrid-models based
on chitosan can be tailored to the demands of nerve
recovery and showed promising results on all levels of
peripheral nerve regeneration. In translational concepts,
chitosan has been generally proven to support functional
recovery, however, the clinical evidence is limited to a small
number of studies yet. Future investigations should focus
on the clinical outcome after application of chitosan as a
drug delivery system or mechanical guidance/protection after
peripheral nerve injury.
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Injuries and diseases of the peripheral nervous system (PNS) are common but frequently
irreversible. It is often but mistakenly assumed that peripheral neuron regeneration
is robust without a need to be improved or supported. However, axonal lesions,
especially those involving proximal nerves rarely recover fully and injuries generally are
complicated by slow and incomplete regeneration. Strategies to enhance the intrinsic
growth properties of reluctant adult neurons offer an alternative approach to consider
during regeneration. Since axons rarely regrow without an intimately partnered Schwann
cell (SC), approaches to enhance SC plasticity carry along benefits to their axon
partners. Direct targeting of molecules that inhibit growth cone plasticity can inform
important regenerative strategies. A newer approach, a focus of our laboratory, exploits
tumor suppressor molecules that normally dampen unconstrained growth. However
several are also prominently expressed in stable adult neurons. During regeneration
their ongoing expression “brakes” growth, whereas their inhibition and knockdown may
enhance regrowth. Examples have included phosphatase and tensin homolog deleted
on chromosome ten (PTEN), a tumor suppressor that inhibits PI3K/pAkt signaling,
Rb1, the protein involved in retinoblastoma development, and adenomatous polyposis
coli (APC), a tumor suppressor that inhibits β-Catenin transcriptional signaling and its
translocation to the nucleus. The identification of several new targets to manipulate
the plasticity of regenerating adult peripheral neurons is exciting. How they fit with
canonical regeneration strategies and their feasibility require additional work. Newer
forms of nonviral siRNA delivery may be approaches for molecular manipulation to
improve regeneration.
Keywords: peripheral nerve, RhoA, Netrin/Unc5H, PTEN, RB1, BRCA1, APC/β-catenin
INTRODUCTION
Favorable outgrowth of peripheral nervous system (PNS) axons after injury is often considered in
comparison with that of the central nervous system (CNS) where severe barriers, even for limited
outgrowth occur. In the clinical context, however, there is striking evidence for its inadequacy.
Functional recovery from trauma or disease to the PNS is slow, incomplete and complicated by
neuropathic pain. Long target distances, gaps from nerve transection and delayed regrowth into
distal nerve territories add substantial and additional barriers to regrowth (Zochodne, 2012).
Patients with severe, nominally reversible peripheral nerve disorders such as Guillain-Barre
syndrome or vasculitis have prolonged, if not permanent deficits. Similarly, large proximal nerve
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lesions such as those at the brachial plexus or high sciatic nerve
rarely recover completely. There are both intrinsic and extrinsic
factors that act as barriers to the successful regrowth of neurons.
Following acute axonal injury to peripheral nerves, a series
of active molecular events that degrade the distal axon
develop. ‘‘Wallerian’’ degeneration refers to these degenerative
events in distal nerve stumps strictly after transection
whereas ‘‘axonal degeneration (AxD)’’ (or ‘‘Wallerian-like
degeneration’’), is a broader term that encompasses all forms
of irreversible axon injury. While AxD is initiated immediately
after axon injury, a series of morphological changes soon
follow. There is fragmentation of axons, dissolution of
their neurofilament scaffolds, proliferation and activation
of Schwann cells (SCs), recruitment of inflammatory cells
including macrophages, and dissolution then clearance
of the myelin sheath and axon debris (Waller, 1850; Ide,
1996; Burnett and Zager, 2004; Chen et al., 2007; Zochodne,
2008; Figure 1). Following axonal degeneration, proliferating
SCs organize themselves into bands of Bungner. These are
tubular collections of both SC and basement membrane that
serve as both guideposts and channels for newly sprouting
axons. These peripheral events accompany changes in
neuron perikarya and associated satellite glial cells. For
example perineuronal satellite cells which surround nerve
cell bodies in sensory and autonomic ganglia, begin to
proliferate within a 2–3 days after peripheral axon injury
accompanied by local proliferation of resident macrophages,
both constituting a population of dorsal root ganglia (DRG)
recycling cells (DRCCs) (Wong and Mattox, 1991; Sulaiman
and Gordon, 2000; McKay Hart et al., 2002; Zochodne, 2008;
Krishnan et al., 2018a).
At most steps during regeneration, there is unexpected
axon hesitation. For example, axon regrowth from proximal
nerve stumps after transection is delayed, slow and staggered.
‘‘Pioneer’’ axons, which resemble those of development are
the first to emerge, but almost always follow leading SCs and
their processes (Chen et al., 2005; McDonald et al., 2006).
Navigation of axons across gaps that form between the proximal
and distal stump is challenging and it is estimated that only
one in 10 axons traverse it (Witzel et al., 2005). Distal nerve
stumps over time also become inhospitable to hosting regrowing
axons. This is contributed to by loss or atrophy of SCs, declines
in their elaboration of SC-derived growth factors and declines
in the local vascular supply (Sulaiman and Gordon, 2000;
Hoke et al., 2001, 2002).
Here, we discuss why peripheral neurons do not grow as
robustly as assumed. We begin with a discussion of growth
factors that support the PNS, but shift our emphasis to
intrinsic controls of growth within neurons and the potential to
manipulate novel molecular pathways to enhance growth after
injury (Table 1).
EXTRINSIC SUPPORT OF REGENERATION
THROUGH GROWTH FACTORS
The discovery over the past 50 years that extrinsic molecules can
influence the behavior of neurons, either during development
or during adulthood was a remarkable advance. The prototypic
growth factor was nerve growth factor (NGF) discovered in
mouse submaxillary glands and snake venom that supported
robust outgrowth of branches from sympathetic neurons. For
its discovery, the Nobel prize in Medicine and Physiology was
awarded toDrs Levi-Montalcini and Cohen in 1986. NGFwas the
first of a family of extrinsic growth factors termed neurotrophins.
Several of these are discussed below (Table 1). Beyond this family,
an expanded repertoire of growth factors is now available for
improving the outcome of peripheral nerve trunk injury but their
practical application remains problematic. Each axon subtype
has a limited receptor deployment available to a given growth
factor, requiring cocktails to support all classes of fibers in a nerve
trunk. There also remain issues with access, timing of such
delivery, where to administer them and their overall stability
(Kemp et al., 2007).
Neurotrophin Family Members
Nerve Growth Factor
NGF supports the survival and subsequent differentiation
of sensory and sympathetic neurons of the PNS (Levi-
Montalcini, 1950, 1987). In the CNS, NGF plays a role in the
neurodevelopment and ongoing maintenance of basal forebrain
cholinergic neurons (Dreyfus, 1989), septo-hippocampal
pathways, hippocampal neurons and cortical neurons (Zhang
et al., 1993; Culmsee et al., 1999a,b; Kume et al., 2000). NGF
mediates its trophic effect by binding to specific receptors,
tropomyosin-receptor kinase A (TrkA) and p75 neurotrophin
receptor (p75NTR) (Hempstead et al., 1991; Chao, 2003; Huang
and Reichardt, 2003). When p75NTR is activated in the absence
of Trk ligation, however, it promotes apoptosis of neurons. In
the presence of Trks, p75NTR enhances neurotrophin responses
(Kaplan and Miller, 1997). After sciatic nerve injury, NGF
receptor expression increased in motor neurons at spinal levels
L4-L6 where it reached a maximum level between 1 and 7 days,
and normalized to baseline by day 30 (Rende et al., 1992a;
DiStefano and Curtis, 1994). NGF is also increased in injured
distal nerve stumps (Richardson and Ebendal, 1982; Heumann
et al., 1987) and it probably protects adult rat DRG neurons
from retrograde cell atrophy and death following axotomy
injury (Rich et al., 1987). NGF treatment to pre-injured sensory
neurons in vitro, derived from young (3 months) and old (26
months) mice supports neurite outgrowth (Horie et al., 1991).
Similarly, delayed administration of NGF to the sciatic nerve
3 weeks after transection restores high-affinity NGF receptor
density and partially restores neuronal volume (Verge et al.,
1989). Topical application of NGF (1 µg) into a nerve crush
site increases motor nerve conduction velocity (MNCV), and
numbers of regenerating myelinated fibers (RMFs) in rat sciatic
nerves (Chen and Wang, 1995). Similar benefits accrue when
NGF is given by silicone chamber to injured nerves (Derby
et al., 1993; Santos et al., 2017) although gradients are difficult to
establish (Kemp et al., 2007).
Brain Derived Neurotrophic Factor
Perhaps the best characterized andmost promising neurotrophin
family member is brain derived neurotrophic factor (BDNF).
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FIGURE 1 | A schematic representation of Wallerian degeneration and regeneration after peripheral nervous system (PNS) injury. In the peripheral nerve following
and acute transection axonal injury, Wallerian degeneration, which takes place during few days after injury, is characterized by proliferation and activation of Schwann
cells (SCs), recruitment of inflammatory cells including macrophages and dissolution and clearance of the myelin sheath and debris. Proliferating SCs respond by
organizing themselves providing a pathway for newly sprouting axons during regeneration and later remyelination associated with reinnervation of the distal target
tissue (Duraikannu, original illustration).
BDNF has essential roles in neuronal survival, growth and
differentiation during development, and synaptic plasticity in
adult peripheral neurons (Thoenen, 1995; Huang and Reichardt,
2001). As such, BDNF has been a potential candidate to
promote nerve regeneration. After injury, the BDNF mRNA
expression is increased in DRG, SCs and muscle fibers (Zhang
et al., 2000; Fukuoka et al., 2001; Kobayashi et al., 2008).
Enhanced BDNF protein expression has also been identified
in DRG neurons after spinal dorsal horn injury (Fukuoka
et al., 2001; Miletic and Miletic, 2002; Geng et al., 2010).
More importantly, BDNF and its receptor TrkB (affinity
tyrosine kinase receptor B) are robustly expressed in both
DRG sensory, and spinal motor neurons (Foster et al., 1994;
Hammarberg et al., 2000) after sciatic nerve injury. Specifically,
BDNF was expressed prominently in both small and medium
size DRG neurons following nerve injury (Cho et al., 1998;
Kashiba and Senba, 1999). Sensory-neuron derived BDNF is
also transported in the anterograde direction, appearing at the
injured nerve site. The levels of BDNF decline over weeks
following the injury (Zhou and Rush, 1996; Tonra et al.,
1998). Furthermore, BDNF and TrkB receptors are expressed
in different muscles to coordinate muscle innervation and the
functional differentiation of neuromuscular junctions (Chevrel
et al., 2006). In contrast, following nerve injury deprivation
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TABLE 1 | A selected listing of approaches discussed in this review that promote
axonal regeneration.
Neurotrophic factors
Nerve growth factor (NGF)
Brain derived neurotrophic factor (BDNF)
Neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5)
Ciliary neurotrophic factor (CNTF)
Leukemia inhibitory factor (LIF)
Oncostatin M (OSM)
Glial cell line-derived neurotrophic factor (GDNF)
Hepatocyte growth factor (HGF)
Cardiotrophin-1 (CT-1)
Neurturin (NRTN)
Artemin (ARTN)
Persephin (PSP)
Bone morphogenetic proteins (BMPs)
Epidermal growth factor (EGF)
Fibroblast growth factor (FGF)
Osteopontin (OPN)
Insulin
Electrical stimulation
Developmental molecules in regeneration
Unc5H inhibition
Growth cone manipulation
Inhibition of RHOA-ROK
Influence of tumor suppressor pathways during regeneration
Phosphatase and tensin homolog (PTEN)
Retinoblastoma 1 (Rb1)
APC-β-catentin pathway
of endogenous BDNF showed attenuated axon outgrowth, and
reduced myelinated axon repopulation and regeneration (Song
et al., 2008). Treatment with exogenous BDNF to peripheral
nerves is transganglionically transported within the spinal cord
(Curtis et al., 1998) and as expected, increased recovery after
spinal cord injury (Song et al., 2008). In addition, single
intrathecal injections of BDNF effectively produce long-lasting
thermal hyperalgesia and tactile allodynia in normal mice and
may play an important role in chronic pain syndromes (Yajima
et al., 2002; Nijs et al., 2015; Sikandar et al., 2018). Delivery
of BDNF to the hindpaw or sciatic nerve improves locomotion
recovery after contusion injury (Song et al., 2008). Therefore,
given these data, there is a reason to believe that BDNF may
offer therapeutic benefits for peripheral nerve regeneration.
Neurotrophins-3 and 4/5
Neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5),
additional members of neurotrophin family, support nervous
system development, survival, differentiation, and repair
(Yamamoto et al., 1996). In the CNS, NT-3 prevents
degeneration of noradrenergic (Arenas and Persson, 1994)
and dopaminergic neurons (Hyman et al., 1994). NT-3 with or
without BDNF improves axonal regeneration after spinal cord
injury (Schnell et al., 1994; Xu et al., 1995; Ramer et al., 2001;
Liu et al., 2016; Keefe et al., 2017). NT-4/5 stimulates axonal
branching from regenerating retinal ganglion cells (RGCs; Sawai
et al., 1996). In the PNS, NT-3 promotes neurite outgrowth
and survival in peripheral sensory, motor and sympathetic
neurons (Rosenthal et al., 1990; Henderson et al., 1993). NT-3
binds to the TrkC receptor (Katoh-Semba et al., 1996) mainly
in large sensory neurons (Zhou and Rush, 1993). NT-4 at the
site of sciatic nerve injury increases axon numbers, axonal
diameter, myelin thickness and sciatic function index (Yin
et al., 2001). NT-4/5 prevents the cell death of embryonic rat
spinal motor neurons in vitro (Henderson et al., 1993). NT-3
and NT-5 stimulate functional reinnervation of skeletal muscle
(Braun et al., 1996).
Other Extrinsic Growth Factors
Ciliary Neurotrophic Factor
Ciliary neurotrophic factor (CNTF) is derived from
parasympathetic cholinergic neurons and is highly expressed
in embryonic chick eye (Helfand et al., 1976; Adler et al., 1979;
Barbin et al., 1984), adult rat peripheral nerve axons, SCs and
spinal nerve roots (Williams et al., 1984; Manthorpe et al.,
1986; Millaruelo et al., 1986; Rende et al., 1992b). In the CNS,
CNTF is expressed in the optic nerve, mainly in astrocytes
(Stöckli et al., 1991). Intravitreal injection of recombinant CNTF
increased RGC survival and axon regeneration (Müller et al.,
2009). In nerve, CNTF expression appears to be downregulated
in the distal stump after injury site but recovered within SCs
during regeneration (Williams et al., 1984; Sendtner et al., 1992).
CNTF was detected in both small and large subpopulation
neurons and regenerating neurites in vitro (Sango et al., 2007).
Exogenous CNTF prevents degeneration of motor neurons after
facial nerve lesions in neonatal rats (Sendtner et al., 1990). In
addition, injured nerve sites exposed to recombinant human
CNTF had greater numbers of regrowing axons in the distal
stumps after injury (Sahenk et al., 1994). Topical application
of CNTF to injured sciatic nerves resulted in higher MNCV
indicating larger, more mature axons and higher compound
muscle action potential amplitudes of the anterior tibial
muscle (Zhang et al., 2004b). Likewise, CNTF null (-/-) mutant
mice have reductions in axon diameter, had myelin sheath
disruption, and demonstrated loss of axon-SC cell architecture
at nodes of Ranvier (Gatzinsky et al., 2003). Exposure to CNTF
enhanced neurite outgrowth of dissociated adult sensory neurons
in vitro (Saleh et al., 2013). Finally, CNTF treatment improved
sensory nerve regeneration after crush injury in diabetic rats
(Mizisin et al., 2004).
Leukemia Inhibitory Factor
Leukemia inhibitory factor (LIF) supports the neurodevelopment
of sensory neurons from the neural crest (Murphy et al., 1991).
In the mouse DRG (embryos), LIF supports the survival of NGF
non-responsive neurons and regulates sensory development
in vivo (Murphy et al., 1993). LIF supports the survival of sensory
neurons after sciatic nerve injury in rat pup. Interestingly,
sciatic nerve injury induced LIF expression in the distal and
proximal stumps and in denervated muscle fibers (Curtis et al.,
1994; Kurek et al., 1996). Injured sciatic nerves treated with
a silicone cuff containing LIF increased the recovery of muscle
contraction, conduction velocity, myelinated fiber number and
diameter (Tham et al., 1997). LIF deleted nerve segments were
less supportive of axonal outgrowth (Ekström et al., 2000)
and LIF knockdown mouse had impaired muscle regeneration
(Kurek et al., 1997). In the CNS, deletion of LIF expression
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was associated with impaired axon sprouting of cultured RGC
neurons in vitro and delayed recovery after optic nerve injury
in vivo (Ogai et al., 2014).
Oncostatin M
Oncostatin M (OSM), a neuroprotective cytokine of the
interleukin-6 family (Taga and Kishimoto, 1997; Heinrich et al.,
1998; Senaldi et al., 1999) attenuates neuronal neuron death
(Weiss et al., 2006). OSM induces signals through glycoprotein
130 (gp130) and the OSM-specific β subunit receptor complex
(Mosley et al., 1996). In the PNS, OSMR beta was expressed
in small caliber non-peptidergic neurons of the dorsal root
and trigeminal ganglia (Tamura et al., 2003; Morikawa et al.,
2004; Morikawa, 2005). OSM mRNA expression in the nerve
increased rapidly up to 14 days following injury (Ito et al., 2000).
Interestingly, subcutaneous injection of OSM into the hind paw
ofC57BL6J wild typemice was associated with a reduction of paw
withdrawal latencies to heat stimulation (Langeslag et al., 2011),
indicating support for axon repair (Ito et al., 2000).
Glial Cell Line-Derived Neurotrophic Factor
Glial cell line-derived neurotrophic factor (GDNF), belongs to
the transforming growth factor-β (TGF-β) superfamily (Tomac
et al., 1995), and enhances the survival and morphological
differentiation of midbrain dopaminergic neurons (Lin et al.,
1993). Recombinant GDNF promotes the survival of motor
neurons (Chen et al., 2000), sympathetic neurons and enhanced
neurite outgrowth in embryonic chick sympathetic neurons
(Trupp et al., 1995). Local application of GDNF to the injured
neonatal facial nerve prevented retrograde motor neuron loss
and atrophy (Yan et al., 1995). After injury, GDNF and its
receptor, GFRα-1, mRNA levels increased in sciatic nerve (Trupp
et al., 1995) distal stumps. Interestingly, GFRα-1 was also
increased in the DRG ipsilateral to the nerve injury (Hoke et al.,
2000). GDNF mRNA and protein expression was upregulated
in SCs 48 h after injury and declined to basal levels by
6 months of denervation. GFRα-1 and GFRα-2 mRNAs were
increased only after GDNF upregulation and remained elevated
as late as 6 months (Hoke et al., 2002). Pre-conditioning injury
of cultured DRG neurons in vitro treated with exogenous
GDNF increased neurite outgrowth (Mills et al., 2007). In
addition, GDNF induced neurite outgrowth and upregulation
of galectin-1 (GAL-1) through the RET/PI3K pathway in DRG
sensory neurons in vitro (Takaku et al., 2013). GDNF also
induced directional turning of adult neuron growth cones but
only did so in the company of hepatocyte growth factor (HGF) or
a phosphatase and tensin homolog (PTEN) inhibitor (Guo et al.,
2014). GDNF also influences SC function (Zhang et al., 2009).
In contrast, lentiviral vector-mediated GDNF overexpression
for 16 weeks increased GDNF expression at regenerating sites
but impaired long-distance nerve regeneration (Eggers et al.,
2008; Tannemaat et al., 2008; Ortmann and Hellenbrand,
2018). Finally, GDNF may offer analgesia in animal models of
neuropathic pain (Boucher et al., 2000).
Hepatocyte Growth Factor
HGF, was initially identified as a mitogen for hepatocytes
(Nakamura et al., 1984, 1989). HGF interacts with c-Met receptor
tyrosine kinase (Bottaro et al., 1991). In normal DRG, c-Met
receptor was expressed in small and medium-size neurons and
to a lesser extent in large-size neurons. However, following
sciatic nerve ligation (SNL) c-Met expression increased after
injury (Zheng et al., 2010). Mutations in the HGF receptor (Met
tyrosine kinase), show abnormal limb innervation correlated
with reductions of muscle fibers of mouse embryos (Maina et al.,
1997). In normal DRG, HGF is expressed mainly in medium
and large diameter neurons. Following SNL, HGF expression
decreased in L4-L5 DRG neurons (Zheng et al., 2010). HGF
in combination with BDNF and NT3, had no impact on DRG
sensory neurite outgrowth in vitro. In contrast, HGF cooperated
with NGF to enhance axonal outgrowth (Maina et al., 1997).
Similarly, HGF also cooperates with CNTF positive neurons
in supporting the survival and growth of parasympathetic
and proprioceptive neurons (Davey et al., 2000). Repeated
intramuscular injection of human HGF gene to a crush injured
rat showed increased expression of HGF protein andmRNA level
in DRGs associated with improvements in function and structure
of the crushed nerve (Kato et al., 2005; Boldyreva et al., 2018;
Ko et al., 2018).
Cardiotrophin-1
Cardiotrophin-1 (CT-1) supports the survival of developing
motor neurons in vivo and in vitro (Pennica et al., 1996;
Oppenheim et al., 2001). CT-1 signals by activating the leukemia
inhibitory factor, gp130 (LIFRβ/gp130) and the CT-1 α receptor
subunit (CT-1Rα) receptor complex (Pennica et al., 1995;
Robledo et al., 1997). CT-1 protects animals from progressive
motor neuronopathy (PMN), a condition in which mice suffer
from motor neuronal degeneration of facial motoneurons and
phrenic nerve myelinated axons (Bordet et al., 1999). CT-1
also prevents deterioration in wobbler mice motor neuron
disease (MND): paw position, walking pattern abnormalities,
intramuscular axonal sprouting and large myelinated motor
axons (Mitsumoto et al., 2001), indicating CT-1 may have
therapeutic benefits in patients with MND.
Neurturin
Neurturin (NRTN) supports embryonic and adult rat midbrain
dopaminergic neurons (Horger et al., 1998; Reyes-Corona et al.,
2017). NRTN signaling activates Ret tyrosine kinase together
with a glycosylphosphatidylinositol (GPI)-linked coreceptor
(either GFRα1 or GFRβ2) (Kotzbauer et al., 1996; Golden et al.,
1999). NTN−/− mice had loss of GFRα2-expressing neurons
from DRG and trigeminal sensory ganglia (Heuckeroth et al.,
1999). Neuturin and activated GFRα2 receptor are important for
parasympathetic innervation of mucosae (Wanigasekara et al.,
2004). NRTN has been shown to upregulate B1 (bradykinin)
receptors expressed in isolated nociceptive neurons in mice,
indicating a possible influence on pain and inflammation
pathways (Vellani et al., 2004).
Artemin
Artemin (ARTN) supports the dopaminergic neurons in the
rat embryonic ventral midbrain (Baloh et al., 1998b). ARTN
operates through GDNF family receptor GFRα3, together with
RET tyrosine kinase receptor (Baloh et al., 1998b). After optic
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nerve injury, ARTN receptor GFRα3 mRNA and protein levels
increased within the first week. ARTN and its receptor (GFRα3),
offered neuroprotection of injured RGCs through the PI3K-AKT
signaling pathway and enhanced optic nerve regeneration in rats
(Omodaka et al., 2014). In the PNS, ARTN is expressed in both
immature and mature myelinating SCs. After injury, ARTN was
highly expressed in the distal nerve segment, indicating that it
influences both developing and regenerating peripheral neurons
(Baloh et al., 1998b; Ikeda-Miyagawa et al., 2015). In neonatal rat
neuron cultures in vitro, ARTN supported the survival of sensory
neurons derived from the DRG and the trigeminal ganglion (TG)
and visceral sensory neurons of the nodose ganglion (NG; Baloh
et al., 1998b). In vivo, ARTN is expressed in both large and small
sensory neurons before and after injury (Baloh et al., 1998b;
Wang et al., 2014). Treatment of injured peripheral nerves with
ARTN enhanced motor, sensory axon regeneration including
functional recovery (Jeong et al., 2008; Wang et al., 2008, 2014;
Widenfalk et al., 2009; Zhou et al., 2009; Wong L. E. et al., 2015).
Persephin
Persephin (PSP) supports midbrain dopaminergic neuron
survival (Milbrandt et al., 1998) in a manner similar to
other neurotrophic factors like GDNF and NRN (Baloh
et al., 1998a; Milbrandt et al., 1998; Leitner et al., 1999).
However, PSP binds efficiently only to GFRα-4 receptors
(Enokido et al., 1998). Recent work has suggested that PSP
has a neuroprotective effect in animal models of Parkinson’s
disease (Yin et al., 2015). In the PNS, PSP supports the survival
of motor neurons but not autonomic neurons in the superior
cervical ganglion (SCG), sensory neurons, or enteric neurons
(Milbrandt et al., 1998).
Bone Morphogenetic Proteins
Bone morphogenetic proteins (BMPs) belong to the TGF-β
superfamily. BMPs signal using serine/threonine kinasetype I
and type II receptors (Ebendal et al., 1998). BMP-2 is expressed
in normal sciatic nerve. After injury, BMP-2 was localized at
both distal and proximal stumps (Tsujii et al., 2009). BMP-2
improved regeneration of facial nerves and acted as a potential
neurotrophic factor (Wang et al., 2007). In contrast, treatment
of E10 (mouse embryos) trigeminal neurons with BMP4 in vitro
resulted in neuronal death, indicating responsiveness of the
neurons to BMP4 (Guha et al., 2004). However, BMP-4 promotes
the survival of motor neurons and protects neurons from
glutamate-induced toxicity (Chou et al., 2013). Treatment with
BMP-7 improved recovery in spinal cord injured rats (Chen
et al., 2018). In double-ligated sciatic nerves, BMP4 protein was
expressed at both the proximal and distal portion of motor axons,
indicating BMP-4 proteins were anterogradely and retrogradely
transported (Chou et al., 2013). During Wallerian degeneration,
BMP-7 expression was increased within proximal and distal
injured nerve stumps (Tsujii et al., 2009).
Epidermal Growth Factor
Epidermal growth factor (EGF) promotes the proliferation of
fibroblast and epithelial cells (Carpenter and Cohen, 1979;
Plata-Salamán, 1991; Wong and Guillaud, 2004). EGF-induced
neurotrophic action is mediated by activation of EGF receptor
(EGFr) and plays a vital role during the development of mouse
and rat brain (Yamada et al., 1997; Wong and Guillaud, 2004;
Yang et al., 2018). In the adult normal human DRG, Epidermal
growth factor receptor (EGFR) is strongly expressed in the
small, intermediate size neurons, satellite glial cells and SCs
(Huerta et al., 1996). In the sciatic nerve, EGFr mRNA and
protein are expressed mainly in both SCs and fibroblasts in
rats. After transection injury, EGFr mRNA and protein levels
increased in both proximal and distal nerve stumps (Toma et al.,
1992). During development, EGF limited the neurite branching
in DRG (Explant and dissociated) neurons in vitro (Maklad
et al., 2009). Interestingly, ablation of EGFr was associated with
disorganized sensory innervation in dorsal skin, indicating that
EGFr is required for proper cutaneous innervations of the skin
(Maklad et al., 2009).
Fibroblast Growth Factor (FGF)
Basic fibroblast growth factor (bFGF or FGF2), is a potent growth
factor for mesoderm derived cells and acts as a neurotrophic
factor to various neural cells. It has been found to enhance
hippocampal, cerebral cortical, granule, ciliary ganglion and
spinal cord neuron survival. bFGF also promotes neurite
extension (Gospodarowicz, 1979; Gospodarowicz et al., 1984;
Morrison et al., 1986; Walicke et al., 1986; Unsicker et al.,
1987; Hatten et al., 1988; Fujimoto et al., 1997). FGF mainly
mediates its trophic action by binding to membrane-bound
receptors (FGF receptors) that possess tyrosine kinase activity
to generate downstream signal transduction (Imamura et al.,
1988; Walicke et al., 1989; Ornitz and Itoh, 2015). In the PNS,
both acidic and basic fibroblast factors (aFGF, bFGF) mRNA
levels were expressed in small and medium-size DRG neurons
(Ji et al., 1995; Acosta et al., 2001). After 3 days of sciatic nerve
injury, aFGF(FGF1) mRNA levels increase in DRG neurons but
bFGF mRNA levels were upregulated in most DRG neurons
but declined after 1 week (Ji et al., 1995). In addition, FGF
2 and 7 were also increased in lumbar DRG neurons but FGF
13 levels decreased after injury (Li et al., 2002). In the sciatic
nerve, FGF 2 and FGF receptor (FGFR1-3) mRNA expression
increased after injury (Grothe et al., 2001). Local treatment
with bFGF after injury increased the number of regenerating
axons. FGF receptor expression increased in the proximal and
distal segments (Fujimoto et al., 1997; Archer et al., 1999;
Grothe and Nikkhah, 2001; Namaka et al., 2001). Interestingly,
FGF-2 overexpression generated SC proliferation, doubled the
number of regenerating axons and enhanced remyelination after
sciatic crush in mice (Jungnickel et al., 2006). Treatment with
recombinant human FGF-2 (rhFGF-2) to a mental nerve crush
injured rats had improved regeneration and sensory functional
recovery (Lee et al., 2017).
Osteopontin
Osteopontin (OPN) is a secreted phosphoprotein that interacts
with receptor αvβ3 integrin (Liaw et al., 1995). OPN plays an
important role in rat brain development (Shin et al., 1999;
Lee et al., 2001). Furthermore, OPN expression was increased
in pyramidal neurons in Alzheimer’s disease (AD) brain in
comparison to age-matched controls (Wung et al., 2007). In
the PNS, OPN is expressed mainly in the larger sized DRG
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and TG neurons (Ichikawa et al., 2000). After injury, OPN was
expressed in the degenerating distal nerve stump during the first
day but was downregulated at day 14. Later stage after axotomy,
SC-OPN was re-expressed in regenerating crushed nerves but
not in permanently transected nerves (Jander et al., 2002;
Wright et al., 2014).
Insulin
Insulin acts as a growth factor that supports the survival and
synaptic plasticity of neurons (Fernyhough et al., 1993; Toth
et al., 2006; Hoybergs and Meert, 2007; McNay et al., 2010;
Singh et al., 2012b). Insulin receptor (IR) mRNA is regulated
during postnatal peripheral nerve development (Shettar and
Muttagi, 2012). In dissociated neurons in vitro, insulin signaling
regulates neurite outgrowth (Fernyhough et al., 1989, 1993;
Govind et al., 2001; Choi et al., 2005; Singh et al., 2012b).
Neurons may also have the capacity to synthesize insulin
(Devaskar et al., 1994; Rulifson et al., 2002). In adult DRG
neurons, IR mRNA and protein levels were higher in small
caliber neurons and sciatic nerves (Sugimoto et al., 2000,
2002). Similarly, insulin receptor subunit β (IRβ) expression was
increased in sensory neurons after sciatic nerve crush injury
(Xu et al., 2004) and has been identified in dermal fibers of
mouse foot pads (Guo et al., 2011). In injured sciatic nerves,
systemic insulin administration enhanced reinnervation of foot
interosseous endplates associated with enhanced functional
recovery (Xu et al., 2004). Intrathecal insulin increased calcitonin
gene related peptide (CGRP) expression in DRG neurons,
enhanced functional recovery of sensation and increased axon
regrowth rate identified by the pinch test following sural nerve
crush (Toth et al., 2006). In diabetic rats, near sciatic nerve
insulin treatment enhanced local motor conduction velocities
but also increased the percentage of small (≤9.0 µm diameter)
myelinated fibers within nerves exposed to it (Singhal et al.,
1997). Local sub-hypoglycemic insulin has had additional
impacts in diabetic models including reversal of axon atrophy
after intrathecal injection, enhanced epidermal axon regrowth
following local injection and improvements in neuropathy from
intranasal injection (Brussee et al., 2004; Guo et al., 2011;
De la Hoz et al., 2017).
ELECTRICAL STIMULATION AND AXON
REGENERATION
One of the most robust empiric approaches, now with evidence
of efficacy in humans, has been post-injury exogenous electrical
stimulation. In work pioneered by Brushart, Gordon, Verge,
Chan and others (Brushart et al., 2002; Geremia et al., 2007;
Gordon et al., 2008, 2010; McLean et al., 2014; Wong J. N.
et al., 2015), brief post-injury electrical stimulation enhanced
the regrowth of motor and sensory axons (Al-Majed et al.,
2000a; Gordon et al., 2007). While its full capabilities and
exact mechanisms are not fully characterized, they include
a retrograde ramp-up of regeneration-associated genes and the
action of BDNF.
Work by Gordon et al. established that post-injury
stimulation at 20 Hz for 1 h offered an impressive impact
on regeneration. Interestingly this is a very specific outcome
limited to a well-circumscribed paradigm but not effective
with other tested forms of Electrical stimulation (ES). For this
review, most of the citations here refer to this specific approach.
ES increased the speed and accuracy of axonal regeneration
and re-innervation (Al-Majed et al., 2000b; Brushart et al.,
2002; English et al., 2007) and benefitted both sensory and
motor re-innervation (Al-Majed et al., 2000b; Brushart et al.,
2002; Geremia et al., 2007; Gordon et al., 2009; Singh et al.,
2012a). In adult DRG neurons in vitro plated over stimulating
microelectrodes, ES accelerated early neurite outgrowth (Singh
et al., 2012a). Brief electrical stimulation then applied in vivo to
the proximal injured site in mice enhanced regrowth of axons
across transection sites (Singh et al., 2012a). ES accelerated
the return of reflex foot withdrawal and contractile force in
re-innervated leg muscles (Nix and Hopf, 1983; Pockett and
Gavin, 1985). ES also increased the numbers of regenerated
axon density and diameter after 8 weeks of surgery (Haastert
et al., 2011), enhanced myelination and angiogenesis (Lu
et al., 2008; Deng et al., 2018). In post-surgical patients that
had sustained complete digital nerve transection there were
greater improvements in sensory re-innervation following ES
(Wong J. N. et al., 2015).
ES facilitates myelination through impacts on SC polarization
and BDNF (Wan et al., 2010). Along these lines, delayed brief
ES increased expression of myelin basic protein (MBP) and
promoted re-organization of the node of Ranvier coinciding
with the early reappearance of re-myelinated axons (McLean
et al., 2014). ES also accelerated the removal of myelin debris
and promotedmore vigorous clearance of activatedmacrophages
from the demyelination zone (McLean et al., 2014).
In sensory neurons, enhanced BDNF immunoreactivity
expression was identified after ES (Alrashdan et al., 2010). Al-
Majed et al. (2000a) demonstrated that 7 days after femoral nerve
transection and stimulation the mRNA expression of BDNF and
its receptor TrkB level had a two-fold rise within rat femoral
motor neurons. In additional work, ES promoted the release of
NGF from cultured SCs through calcium influx (Huang et al.,
2010). ES is associated with rises in neuronal calcium content
(Singh et al., 2012b) a change that might correlate with additional
mechanisms of the ES response such as rises in regeneration
related molecules including tubulin, Sonic hedgehog (Shh) and
GAP43 mRNA (Singh et al., 2015).
RESURRECTION OF DEVELOPMENTAL
MOLECULES IN REGENERATION
An important regeneration theme is the redeployment of
developmental related molecules for new roles during regrowth.
The netrin-Deleted in Colorectal Cancer (DCC)-Unc5H
interactions are an important example.
Netrins belong to an evolutionarily conserved and
developmentally important family of laminin-related proteins
(Sun et al., 2011). Netrin-1 receptors include two main
families: DCC, comprising DCC and neogenin, and the
uncoordinated gene 5 (UNC-5) proteins (Keino-Masu et al.,
1996; Ackerman et al., 1997; Leonardo et al., 1997). Ligation of
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DCC and UNC4H2 receptors by extracellular netrin-1 inhibited
apoptosis. DCC and UNC5H2 are also called ‘‘dependence
receptors’’ that trigger either survival or apoptotic signals
depending on whether netrin-1 is respectively present or absent
(Mehlen and Mazelin, 2003; Mehlen and Tauszig-Delamasure,
2014). Netrin-1 up-regulation is important for neuronal
navigation (Jiang et al., 2003; Cirulli and Yebra, 2007; Mehlen
et al., 2011). Netrin-1 and DCC have specifically been linked to
neural crest cell migration (Jiang et al., 2003).
Netrin-1 and its receptor proteins are involved in axonal
guidance in C. elegans (Serafini et al., 1994; Leonardo et al.,
1997) and act as a cue that is bifunctional and attracts or repels
different axons. It attracts commissural axons using the DCC
receptor and repels others through Unc5 receptors (Kennedy
et al., 1994; Moore et al., 2007; Briançon-Marjollet et al., 2008).
Moreover, its repulsive guidance may specifically be involved in
DRG sensory axon fate during development (Watanabe et al.,
2006; Masuda et al., 2008). In the CNS, netrin-1 is also expressed
by oligodendrocytes and inhibits regeneration of adult CNS
neurons that express Unc5H2 (Manitt et al., 2009). Netrin-1 may
also have direct impacts on axon growth and branching (Dun and
Parkinson, 2017; Boyer and Gupton, 2018). For example, netrin
guides RGC axons as they navigate the visual pathway (Deiner
and Sretavan, 1999) but also targets arborization of mature RGC
axons. This involves DCC-dependent increases in presynaptic
differentiation and dynamic branching (Manitt et al., 2009).
In the PNS, netrin-1 receptors are expressed in sensory
and motor neurons, SCs and axons both intact or after injury
(Park et al., 2007). DCC receptors and Unc5H2 receptor
are expressed in glial cells, particularly in proximal nerve
stumps following peripheral nerve injury (Webber et al.,
2011). Knockdown of DCC locally, using an siRNA approach
directed at the proximal stump of a transected nerve trunk
impaired SC activation and outgrowing migration, and was
associated with secondarily attenuated regeneration. In contrast,
similar local knockdown of Unc5H2 receptors enhanced SC
outgrowth and follow on axon regeneration. The overall findings
indicated that the netrin-DCC receptor interaction is redeployed
from development for use during adult axon regeneration.
There were, however, differences between development and
adult regeneration. In the former, the specific attractive
netrin-DCC and repulsive netrin-UnC5H interactions are
among growing neurons. In the adult, this machinery is
subsumed by reactive SCs but with the same direction of
impact. Since axon-SC interactions are intimate and essential
for overall nerve regrowth, knockdown of the Unc5H2 ‘‘brake’’
ultimately benefitted axon regrowth, following along outgrowing
SCs. Interestingly, injury itself upregulated DCC receptors
and down-regulated Unc5H2 receptors providing facilitation
for regrowth. Similarly, knockdown of DCC upregulated its
reciprocal Unc5H2 receptor. Taken together, not only was
there acquisition of attractive and repellant developmental
neuronal molecules by SCs in the adult, their relationship
also remained reciprocal. Exogenous netrin-1 peptides added
to neurons in vitro or sciatic nerves in vivo did not impact
regeneration, likely indicating sufficient endogenous levels to
activate these receptors (Webber et al., 2011). However, higher
concentrations of exogenous netrin-1 in adult DRG explants
and dissociated DRG culture may inhibit neurite outgrowth
(Park et al., 2007).
GROWTH CONE GTPases: RhoA AND Rac1
Local growth cone molecules may be the final arbiters over
whether extension or advancement of axons occurs or whether
they retract and withdraw. Among these molecules, a prominent
role for the Rho family GTPases exists. RhoA GTPase and its
downstream effector Rho-kinase (ROCK) signal an inhibitory
pathway involved in cellular growth, differentiation, migration
and survival (Mueller et al., 2005). RhoA is activated by
GTP binding. RhoA/ROCK activation is involved in growth
cone collapse and reduced axonal outgrowth in CNS neurons
(Lehmann et al., 1999). Moreover, RhoA/ROCK activation has
been detected in both spinal cord and optic nerve injury
(Lehmann et al., 1999; Fu et al., 2016). After spinal cord injury,
expression of RhoA was increased in neurons, astrocytes and
oligodendrocytes (Dubreuil et al., 2003), indicating an important
role in the inhibition of CNS regeneration (Hu and Selzer,
2017). Thus, the ROCK inhibitor, Y27632 administered after
spinal cord injury was associated with new axon sprouts in the
gray matter distal to injury and improved functional recovery
(Chan et al., 2005).
RhoA/ROCK impacts PNS axon regeneration. In the PNS,
RhoA and ROCK1 mRNA and proteins are expressed in the
dorsal root ganglion (DRG) neurons, axons and SCs of the
sciatic nerve and upregulated after injury (Terashima et al.,
2001; Cheng et al., 2008). Moreover activated RhoA GTPase
was upregulated in proximal stumps of transected nerve trunks
(Cheng et al., 2008). RhoA protein was also increased in motor
neurons after mouse sciatic nerve injury (Hiraga et al., 2006;
Joshi et al., 2015). Pharmacological inhibition of RhoA-ROCK,
using the small molecule inhibitor HA1077 promoted neurite
and axonal outgrowth of DRG neurons in vitro. Furthermore,
when the ROCK inhibitor was applied to the tip of the
sciatic nerve injury site, the number of outgrowing axons
and associated SCs was enhanced (Cheng et al., 2008). RhoA
GTPase also is involved in growth cone behaviour of PNS
neurons. Specifically, application of a ROCK inhibitor induced
growth in sensory neuron growth cones (Guo et al., 2014).
Hiraga et al. (2006), noted that the ROCK inhibitor (fasudil)
increased amplitudes of distally evoked compoundmuscle action
potentials after axonal injury. Along with these physiological
benefits, the agent increased numbers and caliber of regenerating
axons indicating a role in promoting axon maturation through
ROCK inhibition.
A ROLE FOR TUMOR SUPPRESSORS IN
NEURONS: PTEN IS AN INTRINSIC
BLOCKER OF AXON REGROWTH
PTEN is a tumor suppressor that converts phosphatidylinositol
(3,4,5)-triphosphate (PIP3) into phosphatidylinositol (4,5)-
biphosphate (PIP2). On inactivation of PTEN, PIP3 accumulates,
thereby phosphorylation activating Akt whereas pAkt
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subsequently inhibits GSK3β, itself an inhibitor of axon
growth. Knockdown of PTEN and activating the PIP3/Akt
pathway is closely linked to proliferation, cell survival, increased
cell size and epithelial polarity. Mutations in PTEN are
found in malignant glial brain tumors (Ali et al., 1999;
Broderick et al., 2004). Loss of heterozygosity of PTEN is
observed in human malignancies especially endometrial
and ovarian cancer, late-stage metastatic tumors and others
(Li and Sun, 1997). Inactivation of a single PTEN allele
increases cell proliferation and cell survival and reduces
apoptosis (Di Cristofano et al., 1999; Podsypanina et al.,
1999). Accordingly, PTEN has many roles in the nervous
system during development and adulthood (Kath et al., 2018).
Recent studies have demonstrated that neurotrophin-related
growth and differentiation is specifically inhibited by PTEN
overexpression (Musatov et al., 2004). Conditional deletion of
PTEN in the developing hippocampus and cortex is associated
with neuronal hypertrophy and behavioral alterations that
model human autism (Kwon et al., 2006). On the other hand,
PI3K activation regulates neuronal differentiation, survival
migration, extension and guidance (Brunet et al., 2001;
Rodgers and Theibert, 2002; Arimura and Kaibuchi, 2005;
Chang et al., 2006).
PI3K/Akt signals are expressed and activated during
axon regeneration. For example, knockdown of PTEN by
siRNA increased neuronal polarity and axonal outgrowth
in hippocampal neurons in vitro (Jiang et al., 2005). PTEN
deleted mice had increased RGC survival and extended
robust long-distance axon regeneration after 14 days of optic
nerve injury. Inactivation of PTEN leads to activation of
PI3K, pAkt and mammalian target of rapamycin (mTOR)
signaling in CNS neurons. Studies from several models
(C. elegans to mammalian neurons) have identified a role for
PI3K in asymmetric signaling and its impact on orienting
polarized outgrowth during axonogenesis (Yoshimura
et al., 2005; Adler et al., 2006). PTEN knockdown through
enhanced mTOR activity increased RGC survival and axon
regeneration whereas rapamycin blocked mTOR activity
and attenuated regeneration. Further, axotomy in RGCs
markedly reduced pS6 levels possibly accounting for the
limited CNS regeneration after crush injury (Park et al., 2008).
S6 ribosomal kinase 1 is targeted by the mTOR pathway, and
its phosphorylation is indicative of mTOR activity (Kim et al.,
2016). Similarly, PTEN deleted mice had improved repair
of the corticospinal tract (CST) of spinal cord injury mice
(Geoffroy et al., 2016). Inhibition of PTEN improves outcome
in experimental spinal cord injuries, with lesser motorneuron
death, greater tissue sparing and smaller cavity formation
(Walker et al., 2012).
PTEN knockdown is associated with substantial benefits
following peripheral nerve injury. PTEN is expressed widely in
sensory and motor neurons but there is intense expression
among small caliber IB4 nonpeptidergic DRG neurons.
Paradoxically its levels rise after nerve injury. PTEN is also
expressed in SC and in regrowing injured axons (Christie
et al., 2010). Local inhibition using either the pharmacological
inhibitor BpV(pic) or siRNA knockdown enhances axon
FIGURE 2 | Signaling of the phosphatase and tensin homolog deleted on
chromosome ten (PTEN)/PI3K/Akt pathway. PTEN converts
phosphatidylinositol (3,4,5)-triphosphate (PIP3) into phosphatidylinositol
(4,5)-bisphosphate (PIP2), thus inhibiting Akt activation and peripheral nerve
regeneration. Activation of PI3K and Akt signals through deletion of PTEN
[BPV (pic) or siRNA] increases regeneration of axons in injury. These impacts
appear to be independent of mammalian target of rapamycin (mTOR) but
require the activity of PI3K and Akt (Duraikannu, original illustration).
outgrowth as evaluated in both in vitro and in vivo analysis
(Figure 2; Christie et al., 2010). PTEN knockdown using siRNA
was accomplished without a viral vector. In the PNS these
impacts appear to be independent of mTOR but require the
activity of PI3K and Akt.
PTEN may influence distal regenerative events within
growing axons through central rather than peripheral
modulation of cellular machinery. For example, local exposure of
adult growth cones to gradients of the PTEN inhibitor, BpV (pic)
did not have significant impacts on growth cone turning, unless
combined with a local growth factor. However, when inhibitory
gradients were instead directed at the perikarya of in vitro adult
sensory neurons, there was a striking rise of distal outgrowth in
distal branches growing in directions unrelated to the inhibitory
gradient. These data suggest that PTEN modulation is a central
deterministic signal that instructs distal growth cone behavior
(Christie et al., 2010).
In a mouse spinal muscular atrophy (SMA) model,
knockdown of PTEN rescued defects in axon length, growth cone
structure and overall survival (Ning et al., 2010). In a chronic
diabetic neuropathy model, with documented regenerative
failure, PTEN levels in motor and sensory neurons were
upregulated (Singh et al., 2014). In keeping with this finding,
PTEN knockdown rescued the regenerative deficit.
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A FURTHER TUMOR SUPPRESSOR AND
ITS IMPACT ON ADULT NEURONS:
RETINOBLASTOMA 1
The retinoblastoma tumor suppressor Retinoblastoma 1 (Rb1)
operates at the core of the cell cycle pathway. Its mutations
are associated with childhood retinoblastoma tumors. Rb1 is
linked to neuronal fate, regulating proliferation and migration
of neuronal progenitors during brain development (Slack et al.,
1998; Ferguson et al., 2002, 2005; McClellan et al., 2007;
Andrusiak et al., 2010). In the canonical pathway, Rb1 regulates
cell cycle progression by binding and signaling through the
E2F family of transcription factors. The operational status of
Rb1 protein depends on its phosphorylation status, in turn
mediated by the cyclin/cyclin-dependent kinase (CDK) complex
(Giacinti and Giordano, 2006).
Deletion of Rb1 is a frequent and early molecular hallmark
of cancer. Specifically, individuals with germ-line Rb1 mutations
are at risk of developing trilateral retinoblastoma, a pediatric
intracranial neuroblastic tumor (Jakobiec et al., 1977; Marcus
et al., 1998). Rb null mice die as embryos by E15 from
hematopoietic and neurological abnormalities linked to the
failure of cells to permanently withdraw from the cell cycle
(Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992).
Conditional deletion of Rb1 in the embryonic retina display
ectopic division and apoptosis of developing retinal transition
cells (MacPherson et al., 2004; Zhang et al., 2004a). Rb1 functions
within RGC axons, such that its absence is associated with
retinal and midline pathfinding errors, leading to aberrant tectal
innervation. In sensory ganglia, extensive loss of sensory neurons
and expression of TrkA, B neurotrophin receptors was associated
with Rb1 deletion during development (Lee et al., 1992).
Rb deletion induces cell cycle re-entry in several systems
(Sage, 2012), including mouse embryonic fibroblasts (MEFs;
Sage et al., 2003), mammalian muscle cells (Zacksenhaus et al.,
1996; Pajcini et al., 2010) and adult cortical neurons (Andrusiak
et al., 2012). In contrast, loss of Rb is capable of driving
mutated SC growth through a signaling pathway distinct from
PI3-AKT-mTOR and using an E2F-independent mechanism
(Collins et al., 2012).
As discussed, previous studies indicate that the PI3K/Akt
signaling pathway influences axon outgrowth and neuronal
plasticity and that these roles overlap with protection and
survival. In postmitotic adult injured neurons, Rb1may influence
the downstream PI3K-Akt pathway on growth, a pattern
resembling the impact of PTEN (Christie et al., 2014).
Following sciatic nerve injury, Rb was robustly expressed in
neurofilament labeled DRG neurons and axons, despite its role
as an inhibitor of sensory neuron growth after injury. Like
PTEN, the Rb1 protein paradoxically rises following injury and
may also operate downstream of Raf-MEK and the PI3K-Akt
pathway. In vitro knockdown of Rb using siRNA increased
neurite outgrowth and length in dissociated adult sensory
neurons (Christie et al., 2014). As in the PTEN knockdown
studies and subsequent adenomatous polyposis coli (APC) work
described below, the approach used nonviral methods to achieve
knockdown. In addition, silencing of Rb protein enhanced
neurite branching in both uninjured and injured DRG neurons.
These actions were abrogated with concurrent knockdown of the
Rb1 effector, E2F1. E2F1 operates as a divergent transcription
factor and stimulates transcription and neuronal plasticity. In
adult neurons, knockdown of Rb1 was not associated with cell
death with no impact on the expression of activated caspase-3
or DNA damage markers (phosphohistone H2A.X). In vivo
local knockdown at a nerve crush site enhanced regeneration
of axons and promoted functional recovery in injured mice
(Christie et al., 2014).
BRCA1 PROTECTS REGENERATING
NEURONS
Breast cancer susceptibility protein 1 (BRCA1), a tumor
suppressor, plays a critical role in DNA repair and CNS
development (Miki et al., 1994). BRCA1 is expressed in
proliferating embryonic and adult neural stem cells (Korhonen
et al., 2003). Deleting BRCA1 in the CNS, results in various
abnormalities in brain development and overall brain volume
is severely reduced, apparent in the neocortex, cerebellum,
and olfactory bulbs (Gowen et al., 1996; Pulvers and Huttner,
2009; Pao et al., 2014). BRCA1 is also involved in rat RGC
neuron survival and DNA repair after exposure to ionizing
radiation in vitro (Wang et al., 2018). In spinal cord injury,
BRCA1 is highly expressed in spinal microglia (Noristani et al.,
2017). In the PNS, BRCA1 is expressed in DRG, sciatic nerve
and SCs in adult rat and after injury, is expressed at high
levels in both proximal and distal nerve. BRCA1 expression
was identified in injured SCs, neuronal satellite cells and
axons and it translocated to neuronal nuclei. Interestingly,
BRCA1 supported the regenerative phenotype in neurons such
that its knockdown was associated with a decrease in neurite
outgrowth and reduced branch length of injured sensory neurons
in vitro (Krishnan et al., 2018b). In SCs BRCA1 depletion
impaired SC proliferation. BRCA1 modulates oxidative stress
in injured sensory neurons and SCs (Krishnan et al., 2018b).
It appears critical in modulating DNA repair by preserving
DNA integrity in neurons, particularly after injury through its
nuclear enrichment. The role of BRCA1 in sensory neurons
has taught us that DNA repair may be an intrinsic element
of their acquisition of a regenerative phenotype. In addition
to BRCA1, adult peripheral neurons constitutively express
additional DNA repair molecules, such as 53BP1, important for
their ongoing wellbeing.
APC AND ITS β-CATENIN PARTNER
The parallel but thus far largely unconnected impact of two
critical tumor suppressor pathways, PTEN and Rb1, on post-
mitotic adult sensory neurons was remarkable. BRCA1 appears
to have a different operational mandate in neurons. Given all
of these findings, however, we hypothesized that exploitation of
a range of tumor-related pathways might be a general property
of regenerating adult neurons. Along these lines, we chose to
study yet an additional tumor suppressor pathway, APC and
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FIGURE 3 | Adenomatous polyposis coli (APC) and β-Catenin in sensory neurons. (A,B) APC and β-Catenin co-localize in the dorsal root ganglia (DRG) and sciatic
nerve. (A) APC is expressed in β-catenin positive DRG neurons. Importantly, APC is prominently co-localized with β-Catenin in a subset of small (white arrow) and
medium size (yellow arrow) uninjured DRG neurons. (B) Longitudinal section of uninjured sciatic nerve. APC (red, white arrow) and β-catenin (green, white arrow)
showing colocalization. (C) Z stacks confocal picture demonstrate the nuclear localization of β-catenin in cultured DRG neurons with APC knockdown when
compared to those exposed to scrambled control siRNA in vitro. Scale bar = 50 µm. (D) Silencing APC by siRNA increased neurite outgrowth in cultured DRG
neurons when compared to scrambled siRNA in both sham sciatic injury and sciatic axotomy pre-conditioning injury. Scale bar = 50 µm (Duraikannu,
original illustration).
its β-catenin pathway, important culprits in the development of
colorectal tumors.
Wnt/β-catenin signaling plays a significant role in
neurodevelopment and neuronal plasticity (Tawk et al., 2011).
TheWnt/β-catenin pathway contributes toward oligodendrocyte
and SC myelination; the expression of myelin genes, SC
migration, and their proliferation in the PNS (Tawk et al., 2011).
In Wnt signaling, β-catenin is an important multifunctional
transcriptional protein, binding to APC and GSK3β. A
remarkable feature of β-catenin protein is that it promotes
cell proliferation and resistance to apoptosis (Clevers, 2006;
Shelton et al., 2006). APC is a binding partner to β-catenin
that results in a destruction complex involving proteasomal
degradation and transcriptional inhibition (Kimelman and Xu,
2006). Through this interaction, APC is involved in proliferation,
apoptosis, cell adhesion, and migration (Hanson and Miller,
2005). APC activities also play a vital role in both the developing
as well as adult nervous system (Bhat et al., 1994). APC is
expressed in neurites of neuroblastoma cells and cortical
neurons (Morrison et al., 1997a,b). Loss of APC enhances
β-catenin accumulation in the nucleus with its transcriptional
partner T cell factor/lymphoid enhancer factor (TCF/LEF).
β-catenin expression influences neural proliferation and
neuronal differentiation (Patapoutian and Reichardt, 2000) and
it is involved in hippocampal neurogenesis (Peng et al., 2009).
Furthermore, β-catenin phosphorylation at residue Y654 and
Y142 and its nuclear localization increases axon growth and
branching in hippocampal neurons through TCF4/β dependent
transcription (David et al., 2008). In post-mitotic neurons,
it is involved in dendritogenesis, synaptogenesis and synaptic
formation (Peng et al., 2009). Both Wnt and β-catenin combined
regulate synaptic plasticity and axonal growth. In CNS neurons,
N and C-terminal domains of β-catenin are involved in
cell-cell adhesion and promotion of axonal branching (Elul
et al., 2003). Increased expression of β-catenin and Wnt
were observed after spinal transection in adult zebrafish and
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FIGURE 4 | Schematic of the β-catenin-lymphoid enhancer-binding factor/T cell factor (LEF/TCF) signal pathway that regulates peripheral neuron regeneration by
APC knockdown. There is normally interaction of APC with AXIN and GSK3 that phosphorylates β-catenin to be rapidly degraded by the ubiquitin proteasome. In the
absence or knockdown of APC signal with an altered AXIN-GSK3β complex, β-catenin accumulates and forms a complex with LEF/TCF in the nucleus, which
initiates transcription of downstream target genes, in turn to promote regeneration (Duraikannu, original illustration).
correlated with axonal regeneration and improved functional
recovery (Strand et al., 2016). With spinal cord lesions,
Wnt/β-catenin signaling also regulates collagen type XII alpha
1 chain (col12a1) transcription and synthesis of Collagen XII
by non-neuronal cells such as fibroblasts for the extracellular
matrix (ECM). These actions promoted axon regeneration and
functional recovery (Wehner et al., 2017). Knockdown of β-
catenin showed a delay in axonal sorting whereas gain-of-
function of β-catenin mutations resulted in accelerated sorting
(Grigoryan et al., 2013).
In adult DRG sensory neurons, β-catenin was expressed
widely among all sensory neurons including neuronal nuclei,
and cytoplasm and was also identified in perineurial satellite
cells. Axonal injury results in reduced β-catenin expression in
neuronal nuclei, satellite cells and sciatic nerves. In contrast,
its binding partner APC was reciprocally increased following
axotomy injury. Notably, after injury, expression of APC was
prominent within slower growing small nonpeptidergic IB4DRG
neurons and SCs, in a remarkable similarity to PTEN expression.
Furthermore, the intensity of APC expression increased in
motor neurons and regenerating axons. The rises of APC,
considering its role to inactivate transcriptional-related targets,
indicated that it might act as a regenerative ‘‘brake’’ on neurons.
Indeed, both the APC and β-catenin partners are combinatorially
expressed in DRG neurons and their axon branches (Figure 3).
Overexpression of APC interacts with β-catenin to enhance
proteasomal degradation and attenuate transcription. In sensory
neurons, knockdown of APC increased β-catenin nuclear
accumulation, was associated with upregulation TCF and
lymphoid enhancing binding factor (LEF) transcription factors
(Figure 4). In addition, knockdown of APC in adult DRG
neurons increased neurite outgrowth of both uninjured and
preconditioned neurons (Duraikannu et al., 2018). Narciso
et al. (2009), showed that β-catenin expression increased in
Galectin-3 knockout mice associated with enhanced neuronal
survival and axon regeneration after traumatic nerve lesions.
Furthermore, interactions between β-catenin and TCF3 were
required for SC myelination in vivo (Tawk et al., 2011).
Inhibition of β-catenin and TCF activity impaired neurite
outgrowth in DRG neurons in vitro (Duraikannu et al., 2018).
In vivo, local knockdown of APC following nerve trunk crush
injury using siRNA increased the repopulation of myelinated
axons and was associated with improved indices of functional
recovery. In keeping with the reciprocal actions of these partners,
knockdown of APC led axons and SCs to express higher levels
of β-catenin in vivo. Moreover, β-catenin appears to be required
for SC proliferation in vitro, a critical partnering step in nerve
regeneration (Narciso et al., 2009).
Overall, manipulation of the APC-β-catentin pathway has
provided yet another example of how plasticity molecules are
expressed in apparently stable and hard-wired neural systems.
However, after injury, they play a role in supporting the plasticity
essential for regeneration. In the case of APC, knockdown of
its inhibitory impact releases β-catenin transcriptional activation
required to support repair and outgrowth. Like PTEN and Rb1,
APC is a new and important tumor suppressor in neurons that
normally suppresses their growth. Whether this approach offers
synergy with other tumor suppressor pathways is unclear at
this time.
CONCLUSIONS
The primary goal of many endpoints in the clinical treatment of
nerve injury and neuropathies is to identify improved functional
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recovery. Here, we identify how that may be accomplished
through the actions of neuronal growth factors but more recently
bymanipulating the intrinsic growth properties of adult neurons.
These approaches operate downstream of growth factors, that
have the potential for off-target actions and that have impacts
limited to specific subtypes of neurons. Exogenous ES activates
neuronal regenerative progress through a ‘‘brute force’’ reset
of intrinsic neuron properties that recapitulates their injury
response. By doing so, the approach exploits the known property
of previously injured neurons to ramp up their regenerative
machinery, the ‘‘preconditioning’’ response. Resurrection of
developmental pathways to enhance regeneration in adults
likely has more room for investigation. Recognition that the
array of receptors and expression patterns of neurons differs
between development and adulthood is essential toward further
understanding of their potential role. Re-appropriation of
pathways used by neurons in development by glial cells, as
described with netrin-DCC-Unc5h, is an important example
of this.
Here, we focusmost of this review on novel intrinsic pathways
that have remarkable impacts on regrowth, downstream from
growth factor receptors. That all three pathways described
here influence the development of neoplasms should not be
seen as a disincentive for further consideration. It is unlikely
that anatomically restricted administration and temporary
use of knockdown during regeneration would replicate the
complex and multistage prolonged processes required for
oncogenesis. In the case of BRCA1, ongoing DNA repair
during neuron reprogramming toward a regenerative state
may be essential. Further work is required over how the
growth pathways presented here, and very likely additional
neuron growth pathways interact. It is not known whether they
operate synergistically with a downstream common impact on
PI3K-pAkt signaling, an unequivocal and critical pathway that
supports regrowth. It is also yet to be determined whether
manipulation of intrinsic growth pathways might be coupled
with added growth factors. Finally, the use of nonviral siRNA
delivery has been an important part of regenerative studies using
in vivo models. The elimination of viral delivery constructs will
prove to be a major advantage to its use in humans and builds on
the recognition that there is considerable extracellular trafficking
capability in using siRNA. We have, for example, shown that
siRNAs are routinely taken up by distal axons and retrogradely
transported to their perikarya to knockdown ‘‘central’’ cellular
gene expression. Improved approaches to enhance the stability
of applied siRNAs and their access to penetrate the blood-brain
barrier will be very welcomed.
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To improve the outcome after autologous nerve grafting in the clinic, it is important
to understand the limiting variables such as distinct phenotypes of motor and
sensory Schwann cells. This study investigated the properties of phenotypically
different autografts in a 6 mm femoral nerve defect model in the rat, where the
respective femoral branches distally of the inguinal bifurcation served as homotopic,
or heterotopic autografts. Axonal regeneration and target reinnervation was analyzed
by gait analysis, electrophysiology, and wet muscle mass analysis. We evaluated
regeneration-associated gene expression between 5 days and 10 weeks after repair,
in the autografts as well as the proximal, and distal segments of the femoral nerve
using qRT-PCR. Furthermore we investigated expression patterns of phenotypically pure
ventral and dorsal roots. We identified highly significant differences in gene expression of
a variety of regeneration-associated genes along the central – peripheral axis in healthy
femoral nerves. Phenotypically mismatched grafting resulted in altered spatiotemporal
expression of neurotrophic factor BDNF, GDNF receptor GFRα1, cell adhesion
molecules Cadm3, Cadm4, L1CAM, and proliferation associated Ki67. Although
significantly higher quadriceps muscle mass following homotopic nerve grafting was
measured, we did not observe differences in gait analysis, and electrophysiological
parameters between treatment paradigms. Our study provides evidence for phenotypic
commitment of autologous nerve grafts after injury and gives a conclusive overview
of temporal expression of several important regeneration-associated genes after repair
with sensory or motor graft.
Keywords: femoral nerve, Schwann cell, phenotype, gene expression, neurotrophic factor, cell adhesion
molecule, peripheral nerve regeneration
INTRODUCTION
Injuries to the upper extremities are amongst the most common work-, sports- and traffic related
injuries. These injuries may result in peripheral nerve damages with loss of nerve continuity
and subsequent loss of motor and sensory function. They require long rehabilitation phases and
have a major impact on the quality of life of the patient. The clinical gold standard to bridge a
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nerve injury with segmental loss is the autologous nerve
transplant. In clinical cases, a sensory nerve is harvested and
used as a transplant to bridge the defect in order to restore
essential motor functions. However, functional outcome after
nerve grafting is very often not satisfactory, especially after
nerve injury with profound tissue loss (Meek et al., 2005; Secer
et al., 2008; Yang et al., 2011). A reason could be the presence
of phenotypically mismatched Schwann cells in the purely
sensory nerve grafts. Several groups have provided evidence
that there are phenotypical differences between Schwann cells
from sensory and motor nerves regarding the expression of
neurotrophic factors and their receptors (Höke et al., 2006;
Chu et al., 2008; He et al., 2012b; Jesuraj et al., 2012, 2014).
Furthermore, sensory and motor branches of the femoral
nerve differ in architecture, thereby influencing regeneration
of axons after injury (Moradzadeh et al., 2008). The majority
of publications investigating the effect of sensory nerve grafts
suggests a negative impact of sensory phenotype on motor
axon regeneration when compared to a motor graft (Sulaiman
et al., 2002; Brenner et al., 2006; Abdullah et al., 2013).
However, a comprehensive study investigating the effect of
phenotypically different grafting including functional outcome,
gene expression patterns and histology has not been published
yet. We hypothesized that there are differences in the gene
expression patterns in sensory Schwann cells when compared
to Schwann cells derived from motor nerves and that this
phenotypical commitment has an effect on the regenerative
capacity of axons. First, we investigated the baseline gene
expression levels along the central-peripheral axis in uninjured
femoral nerves with emphasis on phenotypical differences.
Second, we determined the influence of a phenotypically different
environment on the regenerative capacity of motor and sensory
axons, thereby establishing a characteristic expression profile
along the phenotypical mixed, motor (carrying afferent and
efferent fibers from/to the muscle) and purely sensory nerves.
For this study we used a preclinical in vivo model, which reflects
the clinical situations (i.e., the use of autologous sensory nerve
graft to support axonal regeneration and restore motor function).
Therefore we performed homotopic as well as heterotopic
nerve autografting in a femoral nerve defect model. Taken
together, this study evaluated the spatiotemporal expression
of key regeneration-associated genes and their influence on
functional reinnervation. We aim to add insight into regenerative
processes in phenotypically mismatched environments to allow
future development of strategies to improve functional outcome
after nerve grafting surgeries.
MATERIALS AND METHODS
Experimental Model
To analyze the spatiotemporal gene expression changes during
nerve regeneration the establishment of an appropriate animal
model was mandatory for this study. We adapted the rat femoral
nerve model, described earlier to the present study, as it bifurcates
into a mixed motor, and a purely sensory branch at the inguinal
region (Brushart, 1990; Jesuraj et al., 2012; He et al., 2016).
A power analysis was performed using StatMate 2.0 (GraphPad)
in order to evaluate appropriate sample size and power. A total of
99 male Sprague Dawley rats (Charles River, Sulzfeld, Germany)
weighing 300–350 g were randomly assigned to treatment groups.
Group sizes were as follows: gene expression analysis (n = 8–10),
histological evaluation (n = 3–5), and retrograde labeling (n = 2–
3). Animals were subdivided in 4 different observation time
groups: 5 days, 2 weeks, 6 and 10 weeks (Figure 1E and Table 1).
Animals were kept pairwise in appropriate cages according
to internal standard operating procedures, including food (Sniff,
Soest, Germany), and water ad libitum. Animals were allowed to
accustomize for 7 days prior to any experimental handling.
Surgical Procedure
All procedures were performed under aseptical conditions
according to Austrian law and the guide for the care and use of
laboratory animals, and were approved by the City Government
of Vienna (Animal use permit: MA58 149539/2012/5). Under
general anesthesia (110 mg/kg Ketamin, 12 mg/kg Xylazin;
inhalation of 1–2 Vol% Isofluran-Oxygen mix) and analgesia
(1× daily 1.25 mg/kg Butorphanol s.c. and 1× daily 0.15 mg/kg
Meloxicam for 4 days starting on the day of surgery) a
longitudinal 3–4 cm groin incision was applied in order to
expose the right femoral neurovascular bundle. Blunt exploration
was performed until the bifurcation of the femoral nerve was
exposed. The exposed motor and sensory branches were sharply
transected distal to the bifurcation resulting in a 6 mm gap and
a 6 mm graft of each branch, respectively (Figure 1B). Elastic
retraction of nerves was negligble and tension-free suturing
was carried out. According to the assigned treatment group
the gaps were repaired with either a homotopic graft (motor
graft in motor branch and sensory graft in sensory branch)
(Figure 1C) or a heterotopic graft (motor graft in sensory
branch and sensory graft in motor branch) (Figure 1D) using
2 epineural sutures per coaptation site (Ethilon 11-0; Ethicon,
Somerville, NJ, United States). Postoperative analgesia was given
once a day for 4 days.
Catwalk Automated Gait Analysis
Functional analysis was performed with the CatWalk XT
(Version 10.6) automated gait analysis system (Noldus
Information System, Wageningen, Netherlands). (Pena and
Baron, 1988; Hamers et al., 2001; Vrinten and Hamers, 2003;
Koopmans et al., 2007; Bozkurt et al., 2008, 2011, 2012; Hausner
et al., 2012; Huang et al., 2012; Li et al., 2014; Kappos et al., 2017).
Animals were pre-trained to use the CatWalk daily, for
1 week prior to surgery. Data was collected according to the
recommendations made in the literature (Deumens et al., 2014).
Parameters assessed were print area, swing time, and duty cycle.
Data was obtained from 37 animals in total, which were
subdivided into the following groups:
Homotopic nerve graft (n = 19, observed 6 weeks: n = 9,
observed 10 weeks: n = 10).
Heterotopic nerve graft (n = 18, observed 6 weeks: n = 10,
observed 10 weeks: n = 8).
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FIGURE 1 | Overview of surgical procedure and experimental timeline. (A) Femoral nerve at the bifurcation into motor and sensory branch. (B) Transection sites on
both branches resulting in a 6 mm gap and 6 mm graft. (C) Homotopic (excised motor segment is turned by 180◦ and used to bridge the motor defect, the excised
cutaneous segment is used to bridge the cutaneous defect). (D) Heterotopic autologous nerve transplantation in both branches of the femoral nerve with
intra-operative result after repair. (E) timetable of follow up and analyses.
We collected 3 runs per trial at baseline and from then every
week, ending data collection either 6 weeks (n = 19) or 10 weeks
(n = 18) after surgery.
Since strong emphasis has been placed on crossing time or
crossing speed as crucial factors to control for proper analysis of
data we collected 3 runs per trial, within the exact same velocity
ranges as defined by Koopmans et al. (2007). Additionally,
only those runs were recorded which contained at least 3
step cycles per paw.
Each of the three parameters (Print Area, Swing Time and
Duty Cycle) was assessed for both hind paws and for each one a
ratio was calculated by dividing the right side’s value (transection)
by the left side’s (control). This ratio (Print Area ratio, Swing
Time ratio, Duty Cycle ratio) was then compared to the ratio
at baseline for each postoperative time point and the result
given in percent.
Electrophysiology and Quadriceps
Muscle Mass
In order to evaluate successful reinnervation of the quadriceps
muscle, compound muscle action potential (CMAP), and peak
amplitude of voltage signal was measured at the end of the
observation time at 2, 6, and 10 weeks. The femoral nerve was
explored and for stimulation of the motor branch a bipolar
stimulation electrode was placed proximal to the bifurcation
using a micro manipulator. Two needle electrodes were placed
into the quadriceps muscle approximately 10 mm apart for
recording, whereas the grounding electrode was placed in the
surrounding tissue. A Neuromax EMG device (Natus, WI,
United States) was used for stimulation and recording. The
contralateral healthy femoral nerve and quadriceps muscle served
as an internal control. Core temperature of the animal was
measured rectally and used for normalization.
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TABLE 1 | Nerve segments used for qRT-PCR.
Excised nerve samples for qRT-PCR analysis
Healthy contralateral Injured ipsilateral
Dorsal roots (DR) L2 and L3
Ventral roots (VR) L2 and L3
Femoral nerve proximal of bifurcation Femoral nerve proximal of bifurcation
Cutaneous branch of femoral nerve Graft in cutaneous branch
Cutaneous branch distal of graft
Motor branch of femoral nerve Graft in motor branch
Motor branch distal of graft
Baseline expression was evaluated using the contralateral, healthy nerves. Effect of
injury and graft phenotype was evaluated by comparing the nerve segments from
the injured side to their contralateral counter part in the same animal.
(Muscle) Mass Evaluation
At all endpoints quadriceps muscles were excised bilaterally and
weighed to evaluate atrophy and regeneration. Muscle weight was
set in to relation of total weight of the animal.
(Immuno)-Histological Evaluation
For immunohistological evaluation, femoral nerves were
harvested 5 days and 2 weeks after surgery and fixated in 4%
buffered formaldehyde (VWR, Radnor, PA, United States)
overnight. Subsequently, nerves were washed (distilled water)
and transferred into 30% sucrose in phosphate buffered saline
(PBS). 25 µm thick longitudinal sections were cut using a
cryostat and mounted on gelatine-coated glass slides.
In order to evaluate axonal reinnervation, sections were
blocked with 5% skim milk and subsequently stained with anti-
Neurofilament (rabbit monoclonal; Abcam, United Kingdom)
overnight at 4◦C. After washing with PBS, sections were
incubated with secondary antibody (anti-rabbit Alexa Fluor
488 Life Technologies, MA, United States) mounted for
microscopical evaluation using glycerol.
Cresyl violet staining was performed as follows: cryosections
were rinsed in distilled water and stained with 1% w/v Cresyl
Violet solution pH 4 (Sigma-Aldrich) for 5–10 min. Samples were
mounted with DPX mounting media (Sigma-Aldrich).
Quantitative Real Time Reverse
Transcription Polymerase Chain
Reaction (qRT-PCR)
For gene expression analysis, nerve fragments were harvested
from all observation time groups 5 days, 2, 6, and 10 weeks
(n = 8–10), according to Table 1. Samples were immediately snap
frozen in liquid N2 and stored on −80◦C. RNA was isolated
using peqGOLD TriFast according to manufacturer’s instructions
(VWR, United States) and used for subsequent cDNA synthesis
(EasyScriptTM RTase, ABM, CAN). Analysis of mRNA levels were
performed by qRT-PCR using 18 ng cDNA, primer according to
Table 2, and KAPA SYBR (KAPA SYBR, Peqlab/PerfeCTa SYBR,
VWR, United States) on a Bio-Rad CFX 96 cycler (Bio-Rad, CA,
United States) (for detailled protocol see Supplementary Data).
We focused our investigation on three groups of targets:
First, neurotrophins and their receptors, as they play crucial
roles in regeneration and maintenance of the peripheral nervous
system. Second, cell adhesion molecules, with special emphasis
on Schwann cell – axon interactions. Third, a group of genes,
which give us information about the cell status, again with
emphasis on Schwann cells.
We tested several reference genes including beta-actin
(ß-Actin) and ankyrin repeat domain-containing protein
27 (Ankrd27) (Gambarotta et al., 2014) in a subset of
samples, however, we did not detect a significant influence
of central-peripheral axis and phenotype as well as injury on the
expression levels between HPRT and others (Supplementary
Figure 1). Data were normalized to Hypoxanthine-
guanine phosphoribosyltransferase (HPRT) mRNA level in
the same sample.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6.0
(GraphPad Software Inc., San Diego, CA, United States).
The data was tested for normal distribution using the
Kolmogorov–Smirnov test. Data was statistically analyzed
using either Student’s t-test (two groups to compare),
multiple t-tests using Holm-Sidak correction for multiple
comparison or one-way ANOVA, and Tukey’s multiple
comparison post hoc test. To compare various experimental
groups among different time points, two-way ANOVA
with Tukey’s multiple comparison post hoc tests was
used. Results are expressed as means with standard error
of the mean (SEM). P-value of <0.05 was considered as
statistically significant.
RESULTS
Functional Reinnervation Is Comparable
After Homotopic and Heterotopic
Autografting
Gait Analysis Is a Feasible but Limited Functional
Testing Method in Femoral Nerve Defect Models
Several gait parameters showed overall significant changes after
autografting surgery. Mean hind paw print area was reduced
to 33.6 ± 8.75 and 35.6 ± 9.83% (homotopic vs. heterotopic
group) with no significant differences found between the two
setup paradigms 1 week after injury. At the same time point
duty cycle was reduced to 64.77 ± 10.6 and 69.09 ± 6.8%
(homotopic vs. heterotopic groups) compared to the contralateral
side. Swing time extended to 234.59 ± 55.6% (homotopic) and
225.96 ± 36% (heterotopic). Restoration of all three parameters
to pre-injury levels was observed between postoperative weeks
7 and 10 with no significant differences between homotopic
and heterotopic grafting (Figure 2). Furthermore, counting
of retrograde labeled motoneurons innervating the femoral
motor branch indicated similar numbers of reinnervating
motoraxons (Supplementary Figure 2 and see Supplementary
Data for methods).
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TABLE 2 | Primer sequence, annealing- and melting temperature, and detected transcript variants.
Target name Primer sequence Annealing temp. (exp) Melting temp. (exp) Transcript variants
BDNF
NM_012513.4
s: TGA G AGA C G CAC AGG A
as: AGA GGT A GTG TAG G GGA C
59.0◦C 77.5◦C 1-10 X1
GDNF
NM_019139.1
s: G TAG G GCT C G TGA C
as: CCA GGG TCA GAT ACA TCC AC
60.0◦C 82.0◦C X1–X4
L1CAM (He et al., 2012a)
NM_017345.1
s: GCCTCAGCCTCTATGTG
as: GCCAGTGCCATTAGTCTTC
60.0◦C 80.0◦C X1–X4
HPRT
NM_012583.2
s: AGT CCC AGC GTC GTG ATT AG
as: TGG CCT CCC ATC TCC TTC AT
63.5◦C 78.0◦C HPRT, HPRT1
Fibronectin (Yoshida et al., 2002)
NM_019143.2
s: GTGGCTGCCTTCCTTCTC
as: GTGGGTTGCACCTTCT
58.0◦C 80.0◦C X1–X10
Ankrd27 (Gambarotta et al., 2014)
NM_001271264.1
s: CCCAGGATCCGAGAGGTGCTGTC
as: CAGAGCCATATGGACTTCAGGGGG
62.0◦C 79.0◦C X1, X6
GFAP (Tanga et al., 2004)
NM_017009.2
s: TGG CCA CCA GTA ACA TGC
as: CAGTTGGCGGCGATAGTCAT
62.0◦C 83.0◦C GFAP
TrkB (Kondo et al., 2010)
NM_012731.2
s: CACACACAGGGCTCCTTA
as: AGTGGTGGTCTGAGGTTGG
63.0◦C 80.0◦C X1–X5
Itgα5
NM_001108118.1
s: GTTTACACATGCCCTCTCAC
as: GATTCCCTTTACAGCTCCA
59.0◦C 80.0◦C Itgα5
Itgß1
NM_017022.2
s: A CAG T C AGA ACA GTC C
as: AGG ATC G T CTC ACA ATG G
56.0◦C 81.0◦C X1
MKi-67
NM_001271366.1
s: ACT GTA T T ATT GCC TGT GCT
as: CCC ACC A CAT TTA C TGC T
60.0◦C 78.0◦C X1
GFRα1
NM_012959.1
s: CTG TCT TTC TGA TAG TGA TTT CGG
as: GTG A CTG CTT CTC C GG
56.0◦C 83.5◦C X1,X2
Cadm3
NM_001047103.1
s: CTCTCTGTCCGACCCT
as: TTTGTGCCGGATCATAGTG
60.0◦C 80.5◦C X1
Cadm4
NM_001047107.1
s: CAG TAT GAT GGG TCT ATA GTC GT
as: GGA GCC ACT G ACA GTG AG
64.0◦C 85.5◦C Cadm4
LIFR
NM_031048.1
s: CATCTACTGGGCCTTTACC
as: TCTCTGCTTTGTGTTGTGGA
59.0◦C 78.5◦C X1–X3
p75
NM_012610.2
s: CTG T GCG G AGA TCC CT
as: G ATG GAG C TAG ACA GGA
60,0◦C 85,0◦C X1,X2
HSP70
NM_212546.4, NM_031971.2,
NM_212504.1
s: GGTGCTGATCCAGGTGTACGAGG
as: GATGTCGGGTCACCTCGATCTGG
55.0◦C 85.0◦C Hspa1a, Hspa1b, Hspa1l
ß-Actin (Kondo et al., 2010)
NM_031144.3
s: CCTGTATGCCTCTGGTCGTA
as: CCATCTCTTGCTCGGTCT
55.0◦C 85.5◦C Actb
Homotopic Grafting Results in Increased Wet Muscle
Mass but Not in Improved Electrophysiological
Parameters
In order to further evaluate axonal regeneration through the
phenotypically different autografts and reinnervation of the
quadriceps muscle, we performed electrophysiological testing
at 2, 6 and 10 weeks after homotopic or heterotopic femoral
nerve autografting. Evoked CMAP and peak amplitude increased
steadily over time indicating functional regeneration of motor
axons and reinnervation of the denervated quadriceps muscle. As
peak amplitude correlates well with the number of regenerated
large (Aαß) myelinated fibers (Navarro, 2016), this demonstrates
functional regeneration in both grafting groups over the time
course of 10 weeks. However, both repair groups did not show
full recovery of electrophysiological parameters (Figures 3A,B)
during the observation period. Wet muscle mass of the
quadriceps muscle evaluated 5 days, 2, 6 and 10 weeks after
repair, demonstrated strong atrophy after femoral nerve defect in
both autografting paradigms. Atrophy remained prominent until
6 weeks postoperatively. This was followed by increase in muscle
mass on week 10. Interestingly, homotopic autografting of the
femoral motor branch resulted in significantly higher quadriceps
muscle mass recovery than heterotopic grafting (Figure 3C).
Staggered Regeneration of Axons
Occurs Independently of Pathway
Modality and Graft Phenotype
To evaluate overall integrity of the grafts and axonal regeneration
of the femoral motor and cutaneous branches, cresyl violet as
well as neurofilament (NF) stainings were performed 5 days
and 2 weeks after nerve repair. Representative images of
macroscopical evaluation as well as cresyl violet staining showed
intact suture sites in all excised samples (Figure 4). NF staining
revealed the axonal regeneration front to be staggered at
the proximal coaptation sites at 5 days. However, 2 weeks
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FIGURE 2 | Weekly Catwalk automated gait analysis after homotopic or heterotopic autografting: All three parameters showed injury-dependent changes and
recovered over the observation period of 10 weeks ad integrum. No significant differences between treatment groups were observed. Data is depicted as
means ± SEM, at least 3 comparable runs/animal/timepoint, n ≥ 19 (until 6 weeks), n ≥ 8 weeks 7–10, One-way analysis of variances (ANOVA) with repeated
measurements to test for significant differences over time, and non-paired t-tests to test significance between groups.
FIGURE 3 | Electrophysiological evaluation and quantification of quadriceps muscle mass. (A) Peak amplitude of voltage signal as well as (B) evoked compound
nerve action potential (CNAP) steadily increased over the observation period of 10 weeks. Homotopic grafting reached comparable outcome as heterotopic grafting.
(C) Atrophy of the denervated quadriceps muscle is prominent until 6 weeks postoperatively. Functional reinnervation results in gain of muscle mass 10 weeks after
injury. Homotopic grafting results in significantly higher muscle mass than heterotopic grafting. Mean, n = 5 (5 days), 8 (10 weeks heterotopic), 9 (6 weeks), 10
(2 weeks, 10 weeks homotopic), Multiple t-tests using Holm-Sidak correction for multiple comparison, (∗∗∗p < 0.001).
postoperatively, regenerated axons were visible in the distal parts
of the motor and cutaneous branches regardless of homotopic or
heterotopic grafting.
Quantification of Baseline Gene
Expression Analysis in Healthy Nerves
Quantitative reverse transcription PCR was used to evaluate
expression profiles of 15 target genes over the motor and
cutaneous central-peripheral axis of the femoral nerve. L2 and
L3 dorsal (DR) and ventral roots (VR), the motor and cutaneous
branches and a 10 mm piece of the proximal part of the healthy,
contralateral femoral nerve were excised. Targets constitute of
two well-described neurotrophic factors (BDNF and GDNF) and
three of their receptors (Low affinity neurotrophic receptor –
p75, Tropomyosin kinase receptor B – TrkB and GDNF receptor
α1 – GFRα1), additionally we included the receptor of leukemia
inhibitory factor (LIFR) as LIF is a known autocrine survival
factor for Schwann cells (Ito et al., 1998; Dowsing et al.,
1999). Furthermore, cell adhesion molecules, involved in axonal
pathfinding (Fibronectin and its receptor integrin α5ß1) and
in (re-)myelination processes (Cadm3, Cadm4, and L1CAM)
were investigated. Finally Schwann cell specific glial fibrillary
acidic protein (GFAP), proliferation associated protein Ki-67 and
stress-responsive heat shock protein 70 (HSP70) were chosen to
provide a more general overview of cell-status in the analyzed
nerve samples. Comparison of expression levels of three different
reference genes: HPRT, ß-Actin, and Ankrd27, was performed
on a subset of samples. Expression levels of all three reference
genes were proven to be unaffected by phenotypical and central-
peripheral origin of nerve samples (Supplementary Figure 1). All
subsequent data were normalized to HPRT.
Nerve Phenotype and Central-Peripheral Axis Do Not
Affect Neurotrophic Factor Expression Whereas Their
Receptors Are Strongly Affected
Due to their potent effect on regeneration we evaluated the
baseline mRNA levels of neurotrophic factors and their receptors
(Figure 5). Brain derived neurotrophic factor (BDNF) as well
as glial cell line-derived neurotrophic factor (GDNF) showed
similar expression levels in dorsal, ventral roots as well as
the peripheral mixed (proximal), motor, and cutaneous nerves.
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FIGURE 4 | Representative examples of histological evaluation after homotopic/heterotopic nerve grafting. The proximal and distal coaptation sites in the motor as
well as the cutaneous nerve can be seen in the macroscopic picture taken directly after excision. Suture sites are indicated in the cresyl violet overview (left panel).
Axonal regeneration was visualized by Neurofilament 200 staining (right panel). Axonal regeneration front is staggered at the proximal coaptation site at 5 days
(highlighted by asterisks). Two weeks after repair, axonal regeneration has surpassed the distal coaptation site in both grafting modalities.
However, expression of the BDNF receptor tyrosine receptor
kinase B (TrkB) was strongly increased in the cutaneous branch,
when compared to other parts of the femoral nerve. The low-
affinity neurotrophic factor receptor p75, as well as the GDNF
receptor GFRα1, displayed central-peripheral commitment as
both receptors showed significantly higher expression in the
central L2, and L3 roots regardless of their phenotype. In
contrast, LIFR demonstrated reduced expression in central parts
of the femoral nerve.
Central-Peripheral Axis Strongly Affects Expression
Levels of Cell Adhesion-Associated Genes
Fibronectin and its neuronal integrin receptor α5ß1 play
crucial roles in Schwann cell migration after peripheral nerve
injury (de Luca et al., 2014). Also Cadm4, Cadm3, and the
L1 cell adhesion molecule (L1CAM) are prominent factors
in cell migration, axon pathfinding, and (re)-myelination
processes. Therefore we evaluated differences in baseline
expression of these factors along the different parts of the
femoral nerve (Figure 6). All excised peripheral samples of
the femoral nerve (proximal, cutaneous, and motor branch)
showed higher expression of Fibronectin and Integrin α5
than the dorsal and ventral roots. However, expression levels
of Integrin ß1, Cadm4, and Cadm3 were reduced in these
samples when compared to the dorsal and ventral roots.
L1CAM expression displayed a strong phenotypical/central
discrepancy as the motor branch of the femoral nerve
expressed significantly lower levels of L1CAM mRNA than the
central roots and the proximal as well as cutaneous parts of
the femoral nerve.
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FIGURE 5 | Comparison of baseline mRNA expression of neurotrophic factors and their receptors relative to HPRT in Schwann cells of the femoral nerve
constituents. In contrast to BDNF and GDNF, expression levels of neurotrophic factor receptors display significant discrepancies along the central-peripheral axis.
motor, femoral nerve motor branch; cutaneous, femoral nerve cutaneous branch; proximal, mixed femoral nerve segment proximal to bifurcation; VR, ventral
root; DR, dorsal root. Data are presented as mean ± SEM, n ≥ 57, One-way analysis of variances (ANOVA) with Tukey’s multiple comparison. (∗p < 0.05,
∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).
FIGURE 6 | Quantification of baseline expression of cell adhesion molecules along the central-peripheral axis in healthy nerves. A strong spatial influence on
expression of cell adhesion molecules was measured. Additionally the L1CAM mRNA levels in the femoral motor branch were significantly lower than in the central,
proximal and cutaneous nerve segments. motor, femoral nerve motor branch; cutaneous, femoral nerve cutaneous branch; proximal, mixed femoral nerve segment
proximal to bifurctaion; VR, ventral root; DR, dorsal root. Data are presented as mean ± SEM, n ≥ 57, One-way analysis of variances (ANOVA) with Tukey’s multiple
comparison. (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).
Cell Proliferation and Survival – Associated Genes
Are Differentially Expressed Along the
Central-Peripheral Axis
Cell proliferation-associated Ki-67 as well as stress responsive
heat shock protein 70 (HSP70) show expression patterns similar
to Cadm3 and Cadm4 as well as Integrin ß1, GFRα1, and p75
as they exhibit higher mRNA levels in ventral and dorsal roots.
Levels of Schwann cell specific cytoskeleton constituent, GFAP
mRNA were highest in the L2 and L3 dorsal roots, and lowest in
the motor branch of the femoral nerve (Figure 7).
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FIGURE 7 | The central-peripheral axis in healthy nerves strongly influences the expression of GFAP, Ki-67, and HSP70 along the healthy femoral nerve. motor,
femoral nerve motor branch; cutaneous, femoral nerve cutaneous branch; proximal, mixed femoral nerve segment proximal to bifurctaion; VR, ventral
root; DR, dorsal root. Data are presented as mean ± SEM, n ≥ 57, One-way analysis of variances (ANOVA) with Tukey’s multiple comparison. (∗∗p < 0.01,
∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).
Spatiotemporal Expression Patterns
After Homotopic and Heterotopic
Autografting
We used qRT-PCR to evaluate the expression patterns of 15
regeneration-associated genes in a femoral nerve defect model.
Target mRNAs were chosen upon literature research and include
several mRNAs investigated in previous studies (see Table 2).
Besides the investigation of expression of neurotrophic factors
and their receptors we decided to include several cell adhesion
molecules as well as proliferation and damage response –
associated proteins. We evaluated gene expression patterns
5 days, 2, 6, and 10 weeks after nerve repair. The expression of
these targets is first compared to the reference gene HPRT and
then set into relation to the healthy contralateral corresponding
femoral nerve part. We hypothesize that this broad spectrum of
targets provides an intelligible overview of the cellular responses
after nerve injury and repair with an either phenotypically
matched or mismatched autologous nerve graft.
Expression Levels of BDNF and GDNF as Well as
Their Receptors Are Strongly Affected by Injury and
Axonal Regeneration
As neurotrophic factors and their signaling play crucial roles in
axonal path finding and regeneration, Schwann cell proliferation
as well as (re-) myelination, we investigated mRNA levels over
time. The neurotrophic factors BDNF and GDNF were highly
up regulated in the grafts, bridging the motor and cutaneous
defects as well as the distal compartments of the respective
branches (Figure 8). Two weeks after repair, expression of
both factors reached a peak followed by normalization of
mRNA levels at 6 and 10 weeks. Grafting of a purely sensory
autologous transplant resulted in a significantly higher BDNF
expression 2 weeks postoperatively in the graft bridging the
motor defect as well as the distal motor branch, when
compared to homotopic grafting. The phenotypical mismatch
of a motor graft to bridge the defect of the cutaneous
nerve did however, not influence BDNF expression. The
phenotypically mixed femoral nerve fragment proximal to the
injury displayed no up regulation of either neurotrophic factor
at any timepoint.
Accordingly to previous studies (Boyd and Gordon, 2003a),
we observed significant up regulation of the low affinity
neurotrophic receptor p75 as soon as 5 days after nerve injury.
Here a strong trend indicates higher expression in sensory
derived graft in the motor defect than the phenotypically matched
motor graft. We observed up regulation of p75 mRNA with
peak expression at 2 weeks followed by normalization of p75
mRNA levels at later timepoints in all nerve samples distal to
the injury. In contrast, the high affinity BDNF receptor TrkB is
strongly down regulated after injury in motor as well as cutaneous
pathways. Analogous to the preferential expression of BDNF
in cutaneous nerves, the expression of TrkB is increased after
heterotopic grafting in the motor branch on week 10.
The spatiotemporal expression pattern of GFRα1 closely
resembles the GDNF expression pattern, with a peak expression
at 2 weeks. However, in the denervated cutaneous branch the
motor phenotype graft demonstrated significantly lower GFRα1
expression at 5 days than the phenotypically matched cutaneous
graft. Similar to the neurotrophic factors and p75, the mRNA
levels of GFRα1 reduced to contralateral, healthy levels over the
time course of 6–10 weeks.
We were able to show a reduced expression of LIFR, 5 days,
and 2 weeks after femoral nerve defect repair, with a steady
increase to contralateral expression levels at 6 and 10 weeks. It
is noteworthy, that at 10 weeks the motor derived graft in the
cutaneous graft displayed higher levels of LIFR than the sensory
derived autograft.
Expression of Fibronectin and Its Receptor Integrin
α5ß1 Was Not Influenced by Autologous Nerve
Grafting in Contrast to Cell Adhesion Molecules
Cadm3, Cadm4, and L1CAM
We investigated the expression levels of Fibronectin mRNA as
well as the spatiotemporal expression of integrins α5 and ß1,
which form one of the major Fibronectin receptors. We did not
observe any significant differences in either of the three mRNAs
at any timepoint investigated. The levels in the injured nerves
were similar to the contralateral side (Figure 9).
Schwann cell specific cell adhesion molecule Cadm4, as well
as its heterophilic axonal counterpart Cadm3 were strongly
down regulated 5 days after nerve grafting surgery in the
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FIGURE 8 | Normalized mRNA levels of neurotrophic factors and receptors after homotopic or heterotopic autografting relative to contralateral side. Data are
presented as mean ± SEM, Two-way ANOVA with Tukey’s multiple comparison test. (∗p < 0.05, ∗∗p < 0.01).
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FIGURE 9 | Normalized mRNA levels of cell adhesion molecules after homotopic and heterotopic autografting relative to contralateral side. Data are presented as
mean ± SEM, Two-way ANOVA with Tukey’s multiple comparison test. (∗p < 0.05, ∗∗p < 0.01).
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repaired branches of the femoral nerve. This was followed
by an up regulation of Cadm4 in the cutaneous and motor
branch at 2 weeks. In contrast to Cadm4, Cadm3 mRNA levels
stayed reduced for at least 2 weeks with a slow increase to
contralateral levels at 10 weeks. Phenotypically mismatched
grafting resulted in higher Cadm3 expression at 10 weeks
in the respective grafts in the motor and the cutaneous
femoral nerve.
Five days after nerve repair, both femoral nerve branches
demonstrated reduced expression of L1CAM, whereas at 2 weeks,
the mRNA levels normalized in all investigated nerve samples
except for the grafts in the motor branch. Here an increase in
expression was observed as well as higher expression of L1CAM
in the grafted nerve segments at 10 weeks after heterotopic
grafting compared to homotopic grafting.
Influence of Homotopic or Heterotopic Grafting on
Expression of GFAP, Ki-67, and HSP70
In contrast to previously published data, we were not able
to detect significant up regulation of GFAP in neither the
motor nor the cutaneous branch after injury, except for a late
increase in GFAP mRNA levels in the respective heterotopic
grafts at 10 weeks (Figure 10). However, significantly enhanced
expression of the proliferation-associated gene Ki-67 was
observed at 5 days. The sensory graft demonstrated highest
Ki-67 expression levels in both the cutaneous as well as the
motor branch, indicating enhanced proliferation of Schwann
cells of a sensory phenotype. Finally the chaperone HSP70
displayed a slight increase in expression over the time course
of 10 weeks after injury, although no significant changes
were determined.
DISCUSSION
Experimental Model
We chose the femoral nerve model for our investigations, as it
has been used to investigate phenotypical differences between
motor and cutaneous pathways before (Brushart, 1990; Höke
et al., 2006; Kawamura et al., 2010; Jesuraj et al., 2012; Brushart
FIGURE 10 | Normalized mRNA levels of GFAP, Ki-67, and HSP70 after homotopic and heterotopic autografting relative to contralateral side. Data are presented as
mean ± SEM, Two-way ANOVA with Tukey’s multiple comparison test. (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001).
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et al., 2013; Gordon and Borschel, 2017). Motor and cutaneous
femoral branches are similar in size, fiber width and nerve
cross sectional area (Brenner et al., 2006). Previous studies
used ventral root isografts as phenotypically pure motor nerve
grafts (Höke et al., 2006) or femoral nerve isografts from other
animals (Moradzadeh et al., 2008; Kawamura et al., 2010).
However, we adapted the model by performing homotopic
and heterotopic autografting techniques for the repair of the
motor and cutaneous branch (Figure 1). We used the femoral
motor branch in contrast to the purely motor ventral root, as
this more closely reflects the situation in other experimental
autologous nerve transplantation models (i.e., the sciatic nerve
defect model). Although a mixed nerve, a previous study by
Marquardt and Sakiyama-Elbert proved motor phenotypical
commitment of Schwann cells derived from the motor branch
of the femoral nerve (Marquardt and Sakiyama-Elbert, 2015),
deeming it a suitable graft for our purposes. Furthermore we
performed autografting instead of isografting to represent clinical
cases more accurately. Brushart et al. investigated the mRNA
expression patterns of a variety of growth factors in cutaneous
and motor nerves with differing denervation times ranging from
5 to 30 days (Brushart et al., 2013). Accordingly, we aimed
to investigate the spatiotemporal gene expression pattern in
denervated cutaneous and motor pathways, repaired with either
phenotypically matched, or mismatched grafts.
Functional Evaluation
So far, functional regeneration after injury to the femoral nerve
was performed using single-frame motion analysis (SFMA)
(Irintchev et al., 2005; Ahlborn et al., 2007). We identified
three parameters directly correlating to de- and reinnervation
of femoral nerve using gait analysis: Print area, swing time
and duty cycle. Knee extension and bending are impaired after
defect to the femoral nerve, as the quadriceps muscle is solely
innervated by the femoral motor branch (Irintchev et al., 2005).
The resulting abnormal bending of the knee joint results in
abnormal plantar flexion and lifting of the heel, which decreases
print area of the paw. The dynamic parameters swing time and
duty cycle were also affected significantly by denervation of the
quadriceps muscle, which is in accordance with findings after
sciatic nerve injury in rats (Bozkurt et al., 2008), probably due to
injury to the cutaneous branch of the femoral nerve (Puigdellívol-
Sánchez et al., 2000; Kambiz et al., 2014). To the best of our
knowledge this is the first study using catwalk automated gait
analysis to evaluate regeneration in a femoral nerve defect model.
Homotopic and heterotopic grafting resulted in comparable
outcome regarding all three parameters. However, we consider
the possibility that this evaluation method is lacking sensitivity
due to the superior regenerative capacity of rodents combined
with the short defect (6 mm) as well as the proximity to the
target muscle and the provision of activated Schwann cells in both
treatment paradigms.
Similarly, it was not possible to observe significant differences
between the treatment groups in electrophysiological evaluations
of the femoral motor branch. A general increase in CMAP and
peak amplitude over time was determined. However, a large
dispersion of values was apparent. The short defect of 6 mm in
combination with high variability in the chosen functional tests is
very likely hindering detection of differences between treatment
groups. Previous studies claimed no difference after isografting
of a femoral nerve defect with either a sensory or motor graft
regarding histomorphometrical evaluations (Kawamura et al.,
2010). Extended atrophy of the quadriceps muscle was measured
until 6 weeks after injury, followed by an increase of muscle
mass at 10 weeks in both treatment groups. Increase in muscle
mass is only possible after successful reinnervation and reversal
of atrophic processes of the quadriceps muscle. Interestingly,
we measured significantly larger quadriceps muscle mass gain
at 10 weeks after homotopic grafting than after heterotopic
grafting (Figure 3C). This could indicate a superior capability
of a phenotypically matched motor graft to regenerate motor
axons when compared to a sensory graft, in accordance with
data by Brenner et al. (2006) indicating inferior motor axonal
regeneration through sensory grafts than size-matched motor
grafts. As a growing body of literature has shown in numerous
in vitro as well as in vivo studies, these effects could be
explained by the phenotypical commitment of Schwann cells
(Nichols et al., 2004; Höke et al., 2006; Moradzadeh et al., 2008;
Jesuraj et al., 2012).
Axonal Regeneration
In order to correlate functional regeneration and spatiotemporal
gene expression patterns, we performed immunohistological
evaluations of the repaired femoral nerves. NF staining revealed
that 5 days after injury the main axonal regeneration front is
still at the proximal coaptation site (Figure 4). Amongst other
factors, the presence of a proximal suture site and ongoing
clearance of residual myelin debris by macrophages hinder
axonal reinnervation of the grafts in motor as well as cutaneous
branches at this early timepoint (Fex Svennigsen and Dahlin,
2013). When confronted with a suture site, axons show staggered
regeneration as a result of misalignment of Schwann cells in
the fragmented extracellular matrix and asynchronous outgrowth
of axons (Witzel et al., 2005). At 2 weeks we observed axonal
reinnervation of all distal nerve stumps in both treatment groups,
proving the capacity of phenotypically different Schwann cells
to support axonal regeneration. Interestingly, Kawamura et al.
(2010) observed no reinnervation of the distal branches 5 weeks
after isografting of 10 mm nerve grafts in the same model,
indicating a far slower regeneration of axons through isografts.
Schwann Cell Phenotype and the
Central-Peripheral Axis
Schwann cells are the glial cells of the peripheral nervous system
and their phenotype is mainly associated with their functions
as myelinating or non-myelinating cells, ensheathing Remak
cells (Jessen and Mirsky, 2002). Schwann cells provide metabolic
support for axons and are essential for axonal integrity (Nave,
2010; Harty and Monk, 2017). Over the last two decades, studies
additionally revealed phenotypes of motor and sensory Schwann
cells with distinct expression profiles for a variety of growth
factors (Höke et al., 2006; He et al., 2012b; Jesuraj et al., 2012).
We combined the expression profile data of more than 56 animals
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to investigate phenotypical commitment in healthy, contralateral
nerves further. We focused on three sets of mRNAs: neurotrophic
factors and their receptors, cell adhesion molecules and cell
status-defining mRNAs, giving us insight into a broad spectrum
of cellular responses.
Neurotrophic factors and their receptors play essential roles
during development of the peripheral nervous system in axonal
guidance, myelination and neuronal survival (Zhang et al., 2000;
Wiese et al., 2001). The effects of neurotrophic factors and
their receptors have been investigated intensively in vitro as
well as in vivo. However, data on their baseline expression
in healthy peripheral nerves is scarce. In contrast to Brushart
et al. ( 2013) we did not observe significantly higher expression
of neurotrophic factors BDNF or GDNF in L2 and L3 dorsal
and ventral roots when compared to the peripheral motor,
cutaneous or proximal segments of the healthy femoral nerve.
The reason could be the use of HPRT instead of glycerinaldehyde-
3-phosphat dehydrogenase (GAPDH) as a reference gene in the
present study, as GAPDH is more highly expressed, resulting
in generally very low relative expression levels in the studies
by Höke et al. (2006), (Brushart et al., 2013). Furthermore
higher variances were observed in the present study, as no
pooling of samples was performed prior to qRT-PCR. In addition,
we used a BDNF primer set, detecting all splicing variants of
BDNF as expression of different splicing variants of BDNF
is highly tissue dependent (Aid et al., 2007). Also, regarding
BDNF expression our results are in line with data from Jesuraj
et al. (2012), indicating no preferential expression along the
central-peripheral axis nor in healthy phenotypically different
Schwann cells. In stark contrast to neurotrophin expression
levels, all investigated neurotrophin receptors showed large
differences in expression along the central-peripheral axis in
the healthy nerve.
We determined significantly increased TrkB expression in the
cutaneous femoral branch and a very low relative expression of
TrkB in ventral roots L2 and L3. This may indicate increased
dependency of distal sensory Schwann cells on BDNF signaling
including PI3K and the ras/ERK pathway (Boyd and Gordon,
2003b) or enhanced signaling of BDNF via the TrkB receptor
rather than via p75. The low affinity neurotrophic factor p75 as
well GFRα1 on the other hand were more highly expressed in
dorsal and ventral roots, which could explain the responsiveness
of motoneurons and their axons to introduced BDNF, and GDNF
after ventral root avulsion (Pajenda et al., 2014). Additionally, a
low expression is known in motoneurons and sensory neurons
in adulthood (Ernfors et al., 1989; Wyatt et al., 1990). As p75
expression is correlating with proliferation (Provenzano et al.,
2011), it was not surprising that Ki67 expression is also higher
in central parts of the femoral nerve. However, the reason
underlying the higher mitotic activity of dorsal and ventral
root cells compared to peripheral segments remains target of
further studies.
Schwann cells have the intrinsic capacity to produce not
only LIF but also LIFR resulting in strong autocrine survival
signaling. The lower expression of LIFR in central segments of
the femoral nerve could be explained by the reduced relative
numbers of non-neuronal cells in ventral and dorsal roots. This
may also be the reason for our observation of lower expression
of Fibronectin and integrin subunit α5 in ventral and dorsal
roots. A close coregulation of Integrin α5 with Fibronectin can
be expected, as the only binding partner for integrin α5 is
Fibronectin. The interactions of neural crest cells and peripheral
neurons with Fibronectin are mediated by integrins containing
the ß1 subunit (Bronner-Fraser, 1985; Thiery and Duband,
1986; Plantman, 2013), which has numerous heterodimeric
partners including vimentin, laminin, and L1CAM. Therefore
an increased expression in proximity to neuronal cell bodies is
not surprising. Dorsal root ganglions as well as motoneurons
express especially high levels of integrin ß1 as reviewed by
Plantman (Plantman, 2013). Furthermore, He et al. (2012b)
demonstrated, that integrin ß1 is more highly expressed in
sensory nerves, which is in line with our observation, that
dorsal roots express significantly higher levels of ß1 than ventral
roots. The same holds true for the cutaneous femoral branch
exhibits higher expression than the motor branch. Another
class of cell adhesion molecules, also known as nectin-like
molecules are Cadm4 and Cadm3. Cadm4 is mainly expressed
in Schwann cells and builds strong heterophilic interactions
with Cadm3, which is expressed by axons (Maurel et al.,
2007). In the healthy nerve both molecules are clustered at
the periaxonal membrane and at the internodes and Schmidt-
Lanterman incisures of myelinated axons (Maurel et al., 2007;
Perlin and Talbot, 2007; Spiegel et al., 2007). Cadm4 and Cadm3
are essential for myelination, therefore the increased central
expression observed in this study can be explained by the
high numbers of myelinated axons in L2 and L3 ventral roots
(Biscoe et al., 1982) and the substantial expression in dorsal root
ganglions (Chen et al., 2016).
The neuronal cell adhesion molecule L1CAM is part of the Ig
superfamily of cell adhesion molecules and displays homophilic
as well as heterophilic (i.e., NCAM) interactions. We detected less
pronounced expression levels of L1CAM in the motor femoral
branch in healthy nerves than in the cutaneous branch. This
is in accordance with other studies, where sensory Schwann
cells exhibit higher levels of L1CAM than motor Schwann
cells in vitro (He et al., 2012a) and in vivo (Jesuraj et al.,
2012). However, this phenomenon is restricted to the peripheral
nerve segments, as we observed similar expression levels of
L1CAM in purely motor ventral roots, and dorsal roots. GFAP
is known to be mainly expressed in non-myelinating or repair
Schwann cells, explaining the low expression in femoral motor
nerve branch. The higher expression in ventral and dorsal
roots could be due to a higher proportion of undifferentiated,
proliferating Schwann cells in these segments, as we also detected
enhanced expression of proliferation-associated Ki67 and stress
responsive HSP70 levels in ventral and dorsal roots. Additionally
the significantly higher expression of GFAP in dorsal roots is
expected, as they contain a high number of non-myelinating
Schwann cells. HSP70 is one of the earliest up regulated
proteins after nerve injury in zebrafish (Nagashima et al., 2011).
This might occur because ventral and dorsal roots are more
prone to experience stress-inducing traction and compression
even in healthy animals, as they do not possess a protective
connective tissue layer.
Frontiers in Cellular Neuroscience | www.frontiersin.org 14 May 2019 | Volume 13 | Article 182234
fncel-13-00182 May 7, 2019 Time: 16:51 # 15
Hercher et al. Gene Expression in Regenerating Nerves
Spatiotemporal Expression Patterns
After Homotopic and Heterotopic
Grafting
Brain derived neurotrophic factor is a potent survival factor
for motoneurons after proximal axotomy (Kishino et al., 1997;
Pajenda et al., 2014). Furthermore, its expression is necessary
for remyelination (Zhang et al., 2000) and as a guidance
molecule for axonal regeneration (Boyd and Gordon, 2003a).
In our study, grafting of a purely sensory autologous transplant
resulted in a significantly higher BDNF expression 2 weeks
postoperatively in the graft bridging the motor defect as well
as the distal motor branch, when compared to homotopic
grafting. This indicates not only that Schwann cells of a
sensory phenotype express higher levels of BDNF when they
encounter motor axons, but also influence expression levels
in the distal motor branch. Sensory Schwann cells enhance
expression of BDNF, probably to overcome their reduced
capacity to support motor axonal regeneration. Sensory axons
are less susceptible to phenotypical mismatch than motor axons,
therefore no compensation in the cutaneous graft was observed
(Marquardt and Sakiyama-Elbert, 2015). BDNF signals via two
receptors, TrkB and p75.
Denervation of motor and sensory branches of the femoral
nerve resulted in a marked decrease of TrkB, which is
consistent with data provided by Funakoshi et al. (1993).
Over the time course of 6–10 weeks normalization of TrkB
expression was observed, which allows normal remyelination
of regenerated axons (Cosgaya et al., 2002). We observed up
regulation of p75 mRNA with peak expression at 2 weeks
followed by normalization of p75 mRNA levels at later
timepoints in all nerve samples distal to the injury. This is
consistent with data from previous work which indicate a
role in pre-myelination (Cosgaya et al., 2002). Although the
general up regulation of p75 after injury is well described
(Boyd and Gordon, 2003b; Cragnolini and Friedman, 2008;
Jessen and Mirsky, 2016), the exact spatiotemporal expression
pattern in phenotypically different, injured nerves has not
been described earlier. Timeline of expression levels closely
resembles the BDNF mRNA expression pattern indicating
co-regulation of BDNF and its low affinity receptor p75.
Binding of BDNF to p75 results in activation of the Ras/ERK
pathway and activation of c-Jun, which in turn activates BDNF
as well as GDNF transcription (Arthur-Farraj et al., 2012;
Jessen and Mirsky, 2016).
GDNF is produced by myelinating and non-myelinating
Schwann cells (Xu et al., 2013) and in our setup, exhibited
a close resemblance in expression pattern to its high affinity
receptor GFRα1, with a peak expression at 2 weeks. GDNF
signaling may occur in a ret-dependent and ret-independent
way. Both signaling modalities promote cell survival and, as
Schwann cells are the main producers of GDNF, it is thought
that the elevated levels of GDNF in the denervated parts of
the femoral nerve branches induce strong pro-survival cues via
GFRα1 in an autocrine way. Interestingly, homotopic grafting
in the cutaneous branch resulted in a delayed up regulation of
GFRα1 mRNA.
Leukemia inhibitory factor receptor (LIFR) mRNA is known
to be reduced after crush and transection injury, however, the
expression pattern after autologous nerve grafting as well as
the influence of phenotypically mismatched Schwann cells has
not been investigated. As LIF expression is up regulated after
peripheral nerve injury (Banner and Patterson, 1994), observed
down regulation of LIFR for at least 2 weeks may prevent non-
neuronal cells from undesired consumption of LIF (Ito et al.,
1998). In contrast to previously published data we did not observe
a significant increase in mRNA levels of neither Fibronectin nor
its heterodimeric integrin receptor α5ß1. A possible explanation
could be post-transcriptional regulation of these molecules.
Cell adhesion molecules Cadm4, which is mainly expressed
on Schwann cells as well as its heterophilic axonal counterpart
Cadm3, were strongly down regulated 5 days after nerve
grafting surgery in the repaired branches of the femoral nerve
(Figure 9). In contrast to Zelano et al. (2009) we did not observe
Cadm4 up regulation 5 days after injury, which might originate
from the different animal model used, as they investigated
a sciatic nerve defect without repair. However, we observed
up regulation of Cadm4 in the cutaneous and motor branch
at 2 weeks, the time point at which axonal reinnervation of
the nerve grafts and even the distal segments is taking place.
This is in line with the role Cadm4 plays in remyelination
processes. It is required for myelination and its expression is
increased by axonal contact (Perlin and Talbot, 2007; Spiegel
et al., 2007). More precisely, Cadm4 induces clustering of
Cadm3 on axons to enable efficient heterophilic interaction
between regrown axons and resident Schwann cells. This also
explains the spatiotemporal expression of Cadm3, which is
reaching normal levels between 6 and 10 weeks after injury.
The significantly higher expression of Cadm3 in sensory-
derived grafts in both branches indicates ongoing reorganization
processes of myelination in phenotypically mismatched grafts.
As uninjured Schwann cells also express Cadm3 another
explanation could be the re-established expression of Cadm3
by Schwann cells at this late timepoint after injury (Zelano
et al., 2009). Finally, Cadm3 has been shown to inhibit
myelination via activation of PI3 Kinase/Akt signaling. This may
result in less myelination of regenerated axons in these grafts
(Chen et al., 2016).
The neuronal cell adhesion molecule L1CAM plays a role
in early myelination and its expression coincides with a
decrease in proliferation (Guseva et al., 2009; Lutz et al.,
2016). L1CAM signaling results in activation of the ERK
pathway and induces axonal growth (Maness and Schachner,
2007). The restoration of L1CAM expression 2 weeks after
injury and the observed axonal regeneration at this timepoint
confirms this observation. In accordance with Qian-ru et al we
measured higher L1CAM mRNA levels in the grafts bridging
the motor defect than in the cutaneous defect. An increase
in L1CAM to induce axonal growth in the motor branch is
to be expected, considering that the baseline expression of
L1CAM in motor nerves is lower than in cutaneous nerves
(Jesuraj et al., 2012; He et al., 2016). We did not observe
significant influences of phenotypical mismatch at early stages
after nerve grafting.
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Furthermore we discovered a decrease of GFAP mRNA in the
denervated motor branch 5 days after injury, which indicates
regulation of GFAP expression on the protein level, as other
groups provided evidence for enhanced levels of GFAP after
nerve defect (Triolo, 2006; Wang et al., 2010). Heterotopic
grafting however, resulted in increased levels of GFAP in the
respective grafts at late stages of regeneration, indicating higher
numbers of non-myelinating Schwann cells in phenotypically
mismatched grafts (Yang and Wang, 2015). Proliferation of
denervated Schwann cells is a hallmark of the repair phenotype
(Jessen and Mirsky, 2016). We observed slightly increased
expression of Ki67 in sensory derived grafts, providing further
evidence for a higher proliferative capacity of cutaneous Schwann
cells (Jesuraj et al., 2014).
We summarized spatiotemporal expression patterns in a
comprehensive overview of all investigated genes in motor as well
as sensory grafts in Figure 11.
CONCLUSION
Sensory nerve autografts are the clinical gold standard to bridge
peripheral nerve defects. However, functional outcome after
autologous nerve transplantation is often unsatisfying (Meek
et al., 2005; Secer et al., 2008; Yang et al., 2011). In this study we
investigated the effect of phenotypical commitment of peripheral
motor and sensory nerve grafts on axonal regeneration in a
rat femoral nerve defect model. Furthermore, we examined the
influence of motor and sensory phenotype on the expression level
of several regeneration-associated genes in healthy and injured
femoral nerves. We uncovered highly significant differences
in gene expression along the central-peripheral axis and
between motor and sensory constituents of the healthy femoral
nerve. A significant influence of phenotypical mismatch on
the spatiotemporal expression of several investigated mRNAs
in regenerating motor and cutaneous nerves was evident.
Overall, we observed similar but not identical spatiotemporal
expression of a variety of regeneration-associated genes in
motor (mixed) and cutaneous grafts. Furthermore, we elucidated
that phenotypical mismatched grafting can influence expression
patterns of distal nerve segments, thereby potentially influencing
axonal regeneration, and target reinnervation. This study shows
that in a small 6 mm femoral nerve defect the graft phenotype
has only a minor influence on functional regeneration. Success of
axonal regeneration after nerve defect repair is highly dependent
on a tightly regulated spatiotemporal profile of genes. The
differences observed in our study might prove to be crucial in
large nerve defects, where mismatched Schwann cell phenotype
may interfere with correct path finding of motor and sensory
nerves to their respective end organs. However, the effect of
phenotypically mismatched long grafts on axonal regeneration
and functional recovery -especially after delayed repair- remains
to be elucidated.
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Guides With Increased Bendability
Support Recovery of Skilled Forelimb
Reaching Similar to Autologous
Nerve Grafts in the Rat 10 mm
Median Nerve Injury and
Repair Model
Nina Dietzmeyer1,2†, Maria Förthmann1,2†, Julia Leonhard1, Olaf Helmecke3,
Christina Brandenberger4, Thomas Freier3 and Kirsten Haastert-Talini1,2*
1 Institute of Neuroanatomy and Cell Biology, Hannover Medical School, Hanover, Germany, 2 Center for Systems
Neuroscience (ZSN) Hannover, Hanover, Germany, 3 Medovent GmbH, Mainz, Germany, 4 Institute of Functional and Applied
Anatomy, Hannover Medical School, Hanover, Germany
Tension-free surgical reconstruction of transected digital nerves in humans is regularly
performed using autologous nerve grafts (ANGs) or bioartificial nerve grafts. Nerve
grafts with increased bendability are needed to protect regenerating nerves in highly
mobile extremity parts. We have recently demonstrated increased bendability and
regeneration supporting properties of chitosan nerve guides with a corrugated outer
wall (corrCNGs) in the common rat sciatic nerve model (model of low mobility). Here,
we further modified the hollow corrCNGs into two-chambered nerve guides by inserting
a perforated longitudinal chitosan-film (corrCNG[F]s) and comprehensively monitored
functional recovery in the advanced rat median nerve model. In 16 adult female Lewis
rats, we bilaterally reconstructed 10 mm median nerve gaps with either ANGs, standard
chitosan nerve guides (CNGs), CNGs (CNG[F]s), or corrCNG[F]s (n = 8, per group).
Over 16 weeks, functional recovery of each forelimb was separately surveyed using
the grasping test (reflex-based motor task), the staircase test (skilled forelimb reaching
task), and non-invasive electrophysiological recordings from the thenar muscles. Finally,
regenerated tissue harvested from the distal part of the nerve grafts was paraffin-
embedded and cross-sections were analyzed regarding the number of Neurofilament
200-immunopositive axons and the area of newly formed blood vessels. Nerve tissue
harvested distal to the grafts was epon-embedded and semi-thin cross-sections
underwent morphometrical analyses (e.g., number of myelinated axons, axon and fiber
diameters, and myelin thicknesses). Functional recovery was fastest and most complete
in the ANG group (100% recovery rate regarding all parameters), but corrCNG[F]s
accelerated the recovery of all functions evaluated in comparison to the other nerve
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guides investigated. Furthermore, corrCNG[F]s supported recovery of reflex-based
grasping (87.5%) and skilled forelimb reaching (100%) to eventually significantly higher
rates than the other nerve guides (grasping test: CNGs: 75%, CNG[F]s: 62.5%;
staircase test: CNGs: 66.7%, CNG[F]s: 83.3%). Histological and nerve morphometrical
evaluations, in accordance to the functional results, demonstrated best outcome in
the ANG group and highest myelin thicknesses in the corrCNG[F] group compared to
the CNG and CNG[F] groups. We thus clearly demonstrate that corrCNG[F]s represent
promising innovative nerve grafts for nerve repair in mobile body parts such as digits.
Keywords: bendable nerve guides, chitosan, rat median nerve, functional recovery, nerve histomorphometry
INTRODUCTION
Traumatic injuries of peripheral nerves represent a frequent
reason for morbidity and life-long physical restrictions.
Worldwide, about 2.8% of all trauma patients suffer from
peripheral nerve injuries (Noble et al., 1998). In many cases,
these injuries lead to life-long dependency on aid and substantial
reduction of quality of life (Noble et al., 1998). Around the
world, more than 1 million people are affected per year (Asplund
et al., 2009). Recovery of peripheral nerve injuries often remains
incomplete and progresses slowly. Additionally, only less than
50% of the patients regain good to excellent motor functions
(Grinsell and Keating, 2014). In clinical routine, peripheral
nerve injuries most often affect the upper limbs (Kouyoumdjian,
2006; Deumens et al., 2010) and in 6.4% of all hand injuries, the
joint-crossing digital nerves are affected (Renner et al., 2004).
When nerve ends cannot be surgically reconnected by tension-
free end-to-end-suture, insertion of autologous nerve grafts
(ANGs) still represents the gold standard therapy. However, the
usage of ANGs comes along with several downsides such as donor
side morbidity, limited availability of donor tissue, and prolonged
surgery time followed by increased surgery costs (Hallgren et al.,
2013; Faroni et al., 2015).
To circumvent these downsides, we have previously
contributed to the development of bioartificial nerve guidance
conduits made out of chitosan (Haastert-Talini et al., 2013).
In 2015, these nerve guides have been made available for the
reconstruction of peripheral nerve gaps in human patients
with a maximum distance of 2.6 cm (Reaxon
R©
Nerve Guides;
Medovent GmbH, Germany). In animal studies, the suitability of
those chitosan nerve guides (CNGs) to support peripheral nerve
regeneration across limited and critical gap lengths have been
proven not only for acute (Haastert-Talini et al., 2013; Gonzalez-
Perez et al., 2015; Shapira et al., 2015; Meyer et al., 2016b), but
also for delayed (Stenberg et al., 2017) repair of rat sciatic nerves.
The rat sciatic nerve injury and repair model is most commonly
used to evaluate new developments for peripheral nerve guidance
and regeneration support (Angius et al., 2012; Geuna, 2015).
When using this model, however, nerve reconstruction is usually
performed in an extremity region with minimized mobility, e.g.,
along the femur bone. In order to address the need for nerve
grafts with increased flexibility/bendability in connection with
preserved collapse stability for nerve reconstruction in highly
mobile regions such as digital joints, we recently modified the
original standard CNGs into CNGs with a wavy wall structure
at the outside, the so-called corrugated chitosan nerve guide
(corrCNG). These corrCNGs have demonstrated similar support
as standard hollow CNGs with regard to axonal and functional
peripheral nerve regeneration in 15 mm rat sciatic nerve gaps,
both after acute and delayed repair (Stößel et al., 2018b).
We have previously shown that longitudinal insertion of a
perforated chitosan film into hollow CNGs and applying such
two-chambered nerve guides (CNG[F]s) for 15 mm rat sciatic
nerve gap reconstruction could significantly increase recovery
of motor function. However, ANG implantation still resulted
in best recovery rates (Meyer et al., 2016a). To further increase
the regeneration support given by corrCNGs, we also enhanced
them into two-chambered nerve guides by inserting a perforated
longitudinal chitosan film (corrCNG[F]) in the current study.
Using the recently advanced rat median nerve injury
and repair model (Stößel et al., 2017), we here investigated
the regeneration supporting properties of corrCNG[F]s in
comparison to ANGs, CNGs, and CNG[F]s after reconstruction
of 10 mm nerve gaps. While implantation of ANGs still
showed fast and most complete functional recovery, we clearly
demonstrate that corrCNG[F]s accelerated and for some skilled-
forelimb reaching also significantly increased the recovery of
all functions evaluated in comparison to the other bioartificial
nerve guides investigated. Results from immunohistological and
histomorphometrical evaluation of the distal graft and nerve
distal to it underline the superiority of corrCNG[F]s compared
to the other artificial nerve guidance channels tested here.
MATERIALS AND METHODS
Experimental Design
In this study, we bilaterally reconstructed 10 mm median
nerve gaps of 16 female Lewis rats with either gold standard
ANGs (control group; n = 8), standard hollow CNGs (n = 8),
two-chambered chitosan-film enhanced chitosan nerve grafts
(CNG[F]s; n = 8), or two-chambered corrugated chitosan-film
enhanced CNGs (corrCNG[F]s; n = 8). This procedure resulted
in a 50% reduction of animal numbers for the study, because
two reconstruction conditions could be studied in one animal.
During 16 weeks of investigation, functional recovery of each paw
was separately surveyed using the grasping test (every second
week), the staircase test and non-invasive electrophysiological
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recordings from the thenar muscles (every fourth week).
Evaluation was finalized by histomorphometrical analyses of the
regenerated nerve tissue within the grafts and distal to it at
16 weeks post-surgery.
Manufacturing of Classic, Corrugated,
and Corrugated Chitosan-Film Enhanced
Chitosan Nerve Guides
Medical grade chitosan derived from Pandalus borealis shrimp
shells was processed by Chitinor AS (Norway). All types of CNGs
were manufactured by Medovent GmbH (Germany) under ISO
13485 regulations using a patented extrusion process with either
standard tubular molds or molds with a corrugated design. All
nerve guides were prepared in a length of 14 mm, an inner
diameter of 1.6 mm, and a final degree of acetylation (DA)
of ∼5%. A DA of ∼5% has previously been proven to be
most supportive for peripheral nerve regeneration in the rat
sciatic nerve model (Haastert-Talini et al., 2013). Chitosan-films
for CNG[F]s and for corrCNG[F]s were manually produced
as described earlier (Meyer et al., 2016a). Briefly, rectangular
pieces (length 10 mm, width: 5 mm) of chitosan-films were
perforated (along the midline of the longer axis, diameter
of perforation: 0.3 mm, distance in between: 2 mm) and
subsequently Z-shape-folded (opposite kinked edges, width of
outer edges: 1.7 mm) before they were inserted into the lumen
of hollow standard CNGs or corrCNGs leading to 2 mm spaces
on each side of the tubes.
Sterilization of all types of CNGs was performed by beta
irradiation (11 kGy, 10 MeV) by BGS Beta-Gamma-Service
GmbH & Co. KG (Wiehl, Germany) (Stößel et al., 2018a). All
CNGs used for median nerve repair were rinsed in 0.9% sodium
chloride solution (NaCl 0.9%, B. Braun Melsungen GmbH,
Germany) for at least 20 min prior to implantation.
Animals and Surgical Procedure
This study was carried out in accordance with the principles
of the Basel Declaration and recommendations of Directive
2010/63/EU: TierSchG 13.07.2013, BGBl I Nr. 36 12.07.2013,
p. 2182 + TierSchVersV. The protocol was approved by the
animal care committee of Lower-Saxony, Germany (approval
code: 33.12-42502-04-15/1761; approval date: April 10, 2015).
Sixteen young adult female Lewis rats (LEW/OrlRj, mean body
weight at the day of surgery: 217.8 ± 1.73 g) were obtained
from Janvier Labs SAS [Genest Saint Isle (Le), France] at an age
of 13 weeks and housed in groups of four under standardized
housing conditions (22.2◦C; humidity 55.5%; light/dark cycle
14 h/10 h). Food and water was provided ad libitum except
during staircase test phases, when animals were fed restrictively
with 12 g food per animal and day. As earlier described (Stößel
et al., 2017) body weight was controlled every other day (tolerable
weight loss up to 15%). A time interval of 72 h was kept between
the end of restrictive feeding and eventual anesthesia. Female
rats were used because they are generally smaller than male
rats (weight difference 100–150 g) and in order to guarantee
only minimal size increase during the 16 weeks observation
time. Weight increase in Lewis rats follows a flatter curve
in female than in male individuals and is already reaching
the plateau at an age of 12 weeks in female animals when
male rats are still growing. The use of female animals in this
study therefore ensured easy handling for the grasping test,
when animals were grasped around their trunk with one hand
pending to be quickly held only on their tail during the test
procedure. The flatter growth curve of female rats further
ensured that while already being optimally sized at training
onset for the staircase test (not able to turn around or grab
pellets with the contralateral paw), tentative weight gain was
limited during the observation period. Thus, the staircase test
apparatuses did not become too narrow for the still slightly
growing young adult animals.
Animals were habituated to the functional testing procedures
(grasping test and staircase test) 3 weeks prior to surgery and pre-
surgically healthy baseline reference values of all animals were
recorded as described in the related sections below.
All surgeries (performed on rats with an age of 19 weeks)
and electrodiagnostic recordings were performed under
deep anesthesia (intraperitoneal injection of chloral hydrate,
370 mg/kg, Sigma-Aldrich Chemie GmbH, Germany) and
aseptic conditions. To minimize the decrease of body
temperature animals were placed on a heating pad and
rectal body temperature was measured before and after surgery
in order to ensure that it did not fall below 36.5◦C. After surgery
the animals were blanketed with several layers of tissue paper
in order to avoid further cooling. Sufficient analgesia during
surgery/electrodiagnostic evaluation and the two following
days was induced by subcutaneous injection of Butorphanol
(0.5 mg/kg, Turbogesic R©; Pfizer GmbH, Germany).
For nerve transection surgery, a 1 cm incision was performed
parallel to the humerus in the axillary region to approach the
median nerve. In addition to general anesthesia (see above),
drops of bupivacaine (0.25%, Carbostesin R©; AstraZeneca GmbH,
Germany) and lidocaine (2%, Xylocain R©; AstraZeneca GmbH,
Germany) were locally applied on the prospective transection
sites of the exposed nerve some minutes before nerve transection
in order to ensure sufficient analgesia.
In case of ANG repair, the median nerve was first transected
at the distal location (proximal to the point where the median
nerve is crossed by the brachial artery), followed by the second
transection 10 mm proximal to this point. The nerve piece
was then reversed and rotated 180◦ before suturing it between
the two nerve ends. Each end was sutured by two epineural
9–0 stitches. In CNG, CNG[F], and corrCNG[F] groups, the
second transection was performed 7 mm proximal to the distal
transection with removal of the nerve piece and its further
procession for histomorphometrical analyses (healthy control).
After application of either nerve guide, both nerve ends were
introduced into the nerve graft and sutured with one epineural
9–0 stich generating an overlap of 2 mm at each nerve end and a
10 mm median nerve gap.
Wound closure was performed by using first three to four
resorbable sutures on the muscle layers (3–0 Polysorb, UL-215,
Syneture, United States) followed by three to four non-resorbable
mattress sutures (4–0 EthilonTM II, EH7791H, Ethicon, United
Kingdom) for skin suture.
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Grasping Test – Evaluation of
Reflexed-Based Paw-Usage Ability
To evaluate the recovery of finger flexion progressing to
restoration of grip force, reflex-based movement (Tupper and
Wallace, 1980) was assessed every second week from the fourth
week post-surgery onward.
Briefly, the paw-usage ability was video recorded and grip
force was measured as described previously (Stößel et al., 2017).
During testing the animals were carefully grasped around
their trunk to support them while bringing them close to the
test apparatus. For the concrete test procedure the hand around
the trunk was removed and the animals were held only by
their tail root (1–1.5 cm from the fur) for 5–15 s. Test periods
>5 s were only needed when finger flexion was not possible
and the experimenter had to take some more time for deciding
to end the trial.
For scoring, three categories of grasping behavior were set:
Category 1 – no finger flexion while touching the grasping bar;
Category 2 – ability to grasp the bar (closing digits around it) but
not able to hold it while being slowly withdrawn; and Category
3 – ability to grasp and pull the bar with a detectable force (gross
motor skills). Since the scoring was performed in accordance to
our previous open access report we kindly refer the reader to it
for an illustration (Stößel et al., 2017).
Staircase Test – Evaluation of Skilled
Forelimb Reaching Ability
Prior to surgery (for the recording of healthy baseline reference
values) and at pre-defined time points after surgery, the animals
were (re-)habituated to the testing procedure and restrictively fed
for 7 consecutive days. Therefore, food was restricted to 12 g per
animal and day and body weight was controlled every other day.
The tolerable weight loss was up to 15%.
On the next 3 days (for pre-surgery values) or on the last
3 days (for post-surgical values), the mean maximum number
of pellets retrieved per animal/paw was determined for each
individual paw (Stößel et al., 2017). Therefore, the rats sat within
the staircase apparatuses on the plinth in the middle not being
able to turn around and only reaching the left/right stairs with
the respective paw. Each of the stairs is composed of seven steps,
and was equipped with three sugar pellets each (AIN-76A Rodent
Tablet 45 mg IRR, Lot number: 12SEP17RTD1, TestDietTM,
United States). After a 15 min testing period, remaining sugar
pellets on the stairs and also sugar pellets on the ground
(representing failed attempts) were summed up. Post-surgically,
the test was performed at 4, 8, 12, and 16 weeks.
Forelimbs were classified as successfully participating as soon
as more than three pellets were retrieved, because over time and
with further slightly increasing body size, the animals could reach
three pellets on the first step with their tongue and mouth.
Non-invasive Electrodiagnostic
Recordings – Evaluation of Thenar
Muscle Reinnervation
Healthy baseline reference values of non-invasive electrodiag-
nostic measurements were recorded from the anesthetized
animals, right before surgery. Post-surgical recordings were
performed every fourth week.
Under deep anesthesia (body temperature was controlled and
approximately 36.6 ± 0.3◦C), animals were placed in supine
position and single stimulating electric impulses (100 µs, 1 Hz)
were induced by transcutaneous monopolar needle electrodes.
Stimulation intensity was constantly increased up to 30%
supramaximal level. The reconstructed median nerve was either
stimulated proximal to the injury site in the axillary region or
distal to the graft at the elbow. Evocable compound muscle
action potentials (CMAPs) were recorded transcutaneously from
the thenar muscles (Stößel et al., 2017). Despite possible co-
stimulation of the ulnar nerve in the axillary region, CMAP
recordings from the thenar muscles only result from the median
nerve stimulation, because of the anatomical situation and
trajectory of the median nerve (Stößel et al., 2017).
Semi-automatical evaluation of the amplitudes caused by the
evocable CMAPs (manual setting of baseline to negative peak of
M-wave) was performed by using a Dantec
R©
Keypoint
R©
Focus
device (Natus Europe GmbH, Germany). If no evocable CMAP
or CMAPs with no clear negative M-wave peak could be detected,
a zero value was included into the statistical analysis.
Nerve Immunohistochemistry in the
Distal Nerve Grafts – Quantification
of Axonal Profiles
At 16 weeks post-surgery, all animals were sacrificed in deep
anesthesia in carbon dioxide atmosphere followed by cervical
dislocation. The regenerated nerve tissue was removed from the
lumen of the nerve guides, together with the central chitosan-
film, in case of chitosan-film enhanced nerve guides. The
tissue was fixed overnight [4% paraformaldehyde in phosphate-
buffered saline (PBS, Dulbecco, Biochrom GmbH, Germany),
4◦C, Sigma-Aldrich Chemie GmbH, Germany] before paraffin-
embedding was performed.
From the distal portion of ANG grafts or at 3.7 mm proximal
to the distal suture of tissue harvested from the nerve guides,
series of 80 blind-coded cross-sections (7 µm) were prepared.
Selected sections were Hematoxylin and Eosin (HE) stained
in order to generate an overview of the composition of the
regenerated tissue and to quantify median blood vessel areas
(see the section “Quantification of median blood vessel area
in the distal nerve grafts”). Consecutive sections were stained
for neurofilament 200 (NF200) (Meyer et al., 2016a; Stenberg
et al., 2017). For anti-NF200 staining, sections were incubated
in blocking solution [3% milk powder (Bio Magermilch Pulver,
Heirler Cenovis GmbH, Germany), 0.5% Triton-X 100 (Roche
Diagnostics GmbH, Germany) in PBS] prior to incubation with
primary rabbit anti-NF200 antibody (against phosphorylated
NFeH, N4142, 1:500, Sigma-Aldrich GmbH, Germany, 4◦C
overnight) followed by incubation with Alexa-488-conjugated
secondary goat anti-rabbit antibody (A11034, 1:1000, Invitrogen
AG, Germany, 1 h at room temperature). The antibodies
were diluted in blocking solution and the incubation steps
separated by three-times washing in PBS. After nuclear counter
staining with 4′, 6-diamidin-2-phenylindol (DAPI, 1:2000 in PBS,
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Sigma-Aldrich GmbH), sections were mounted using Mowiol
(Calbiochem GmbH, Germany).
Representative photomicrographs of NF200-stained as well as
HE-stained sections were created as multiple image alignments
(MIA) using a BX51 microscope (Olympus GmbH, Germany).
Neurofilament 200-immunopositive axonal profiles were
quantified with the help of ImageJ version 1.48 (National
Institutes of Health, United States). Therefore, areas containing
NF200-immunopositive axons were used to determine the
regions of interest (ROI), which were needed to quantify the
particle number later. By using a threshold strategy, NF200-
photomicrographs were converted to binary images. Threshold
pixel values reached from minimum 71 to maximum 172.
This allowed distinguishing between individual nerve fibers.
Afterwards NF200-immunopositive axonal profiles within the
ROI were detected by using the particle analysis function of
ImageJ. To avoid the detection of background noises, only
particles with a size bigger than 0.001 Pixel2 were counted.
Quantification of Median Blood Vessel
Area in the Distal Nerve Grafts
Virtual slides of HE-stained sections were created with the help
of macroscopic tissue slide scanner (Axio Scan.Z1, Carl Zeiss
Microscopy GmbH, Germany). Tissue sections were scanned
at 40× magnification. Cross sectional areas (µm2) of blood
vessels within complete sections were quantified with the help
of ZEN Imaging Software version 2.5, blue edition (Carl Zeiss
Microscopy GmbH, Germany). Therefore, blood vessels within
HE-photomicrographs were identified and their inner border,
meaning the endothelial layer adjacent to the lumen, was
contoured by using the Graphics tool and its area was quantified.
Only blood vessels with visible erythrocytes within their lumen
or, if no erythrocytes could be detected, with an intact endothelial
layer were included into the evaluation.
Nerve Histomorphometry Distal
to the Nerve Grafts
Segments of the nerve, which were harvested directly distal to
the nerve grafts, were fixed in Karnovsky solution, flushed in
sucrose–sodium cacodylate buffer. Post-fixation was performed
in 1% osmium tetroxide for 1.5 h before myelin sheaths were
stained with 1% potassium dichromate and hematoxylin (Korte
et al., 2011). Afterwards the samples were embedded into Epon
and semi-thin cross-sections (1 µm) were prepared. To enhance
the myelin staining a toluidine blue staining was performed.
Finally, sections were mounted by using Mowiol.
Histomorphometrical evaluation was performed as described
before (Stößel et al., 2017). Two sections of each reconstructed
median nerve (n = 8 per group) were randomly selected and
were evaluated at light microscopic level (BX50 microscope
Olympus GmbH, Germany; 100× magnification) equipped with
a prior controller (MBF Bioscience, United States). Total fiber
numbers were determined using a two-dimensional procedure
(optical fractionator; grid size: 150 × 150 µm2; counting frame
size 30 × 30 µm2) by means of Stereo Investigator version
11.04 (MBF Bioscience). Therefore, systematic random sampling
(Geuna, 2000) was applied to pick 12–16 sampling fields,
depending on the size of the cross sectional area. In each of
these sampling fields a two-dimensional dissector procedure was
performed. Here, only the “tops” of fibers, meaning the first part
of the fiber’s border that touched the edge of the counting frame,
were counted to overcome the “edge effect” (Geuna, 2000).
In four photomicrographs (100× magnification) of each
section, which were randomly selected, assessment of axon and
fiber diameters and myelin thicknesses (G-ratio plug-in1, ImageJ
version 1.48, National Institutes of Health, United States) was
performed in, with an examination of 10 axons per picture,
80 axons per specimen, and 640 axons per group. Axon and
fiber diameter were calculated based on the assumption of
a circular shape.
Statistical Analysis
Statistical analyses were applied to the data obtained in this study
by using GraphPad Prism version 6.07 (GraphPad Software,
United States). To detect significant differences, we resorted to
two-way ANOVA followed by Tukey’s multiple comparisons and
Kruskal–Wallis test followed by Dunn’s multiple comparisons.
For statistical analysis of the qualitative outcome of the functional
evaluation, we calculated the proportion of animals per group
displaying evocable CMAPs or successful participation in either
the grasping or the staircase test as percentages (0–100%) and
compared them pair-wise with the Chi-square test. The p-value
was set to p < 0.05 as significance level. All results are displayed
as mean± SEM or median± range as indicated.
RESULTS
Overall Qualitative Assessment of
Functional Recovery
For full clarity, it needs to be stressed again that in this study
10 mm median nerve gaps were bilaterally reconstructed in 16
female Lewis rats and that the numbers given for specimen
analyzed per group consequently refer to median nerves repaired
with the respective approach (n = 8 for each group) instead of the
number of animals studied.
Table 1 summarizes the qualitative results from the functional
evaluation performed. For each evaluated parameter a more
detailed description of the obtained results follows.
Forelimbs were evaluated as successfully participating in the
grasping test when displaying recovery of function of category
3 (ability to grasp and pull the bar with detectable force,
see also Figure 1). Forelimbs were evaluated as successfully
participating in the staircase test when they retrieved more than
three pellets, because the three pellets initially placed on the first
step could be reached with their tongue and mouth. With regard
to electrodiagnostic measurements forelimbs were evaluated as
successful, when evocable CMAPs, recorded from the thenar
muscle, were detected.
As depicted in Table 1, the electrodiagnostic measurements
showed similar results for the ANG and corrCNG[F] group as
1http://gratio.efil.de/
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TABLE 1 | Summary of functional recovery based on successful participation in the grasping and the staircase test and on evocable CMAPs recorded from the thenar
muscle upon electric stimulation of the reconstructed median nerve.
4 Weeks post-surgery 8 Weeks post-surgery 12 Weeks post-surgery 16 Weeks post-surgery Total best
Forelimbs/ Forelimbs/ Forelimbs/ Forelimbs/ Forelimbs/
group [%] group [%] group [%] group [%] group [%]
Grasping testa ANG 0/8 0.0 8/8 100.0• 6/8 75.0#, 6/8 75.0#, 8/8 100.0•
CNG 0/8 0.0 1/8 12.5,∗ 3/8 37.5 3/8 37.5 6/8 75.0
CNG[F] 0/8 0.0 0/8 0.0 4/8 50.0 3/8 37.5 5/8 62.5
corrCNG[F] 0/8 0.0 0/8 0.0 6/8 75.0#, 5/8 62.5#, 7/8 87.5
Staircase testb ANG 1/6 16.7• 6/6 100.0• 6/6 100.0#, 6/6 100.0#, 6/6 100.0#,
CNG 0/6 0.0 1/6 16.7 4/6 66.7 4/6 66.7 4/6 66.7
CNG[F] 0/6 0.0 1/6 16.7 3/6 50.0 5/6 83.3# 5/6 83.3#
corrCNG[F] 0/6 0.0 1/6 16.7 6/6 100.0#, 6/6 100.0#, 6/6 100.0#,
Electro-diagnostic
recordingsc
ANG 8/8 100.0,∗ 8/8 100.0#, 8/8 100.0 8/8 100.0 8/8 100.0
CNG 8/8 100.0,∗ 7/8 87.5 8/8 100.0 8/8 100.0 8/8 100.0
CNG[F] 5/8 62.5 7/8 87.5 8/8 100.0 8/8 100.0 8/8 100.0
corrCNG[F] 6/8 75.0 8/8 100.0#, 8/8 100.0 8/8 100.0 8/8 100.0
The process of recovery started with evocable CMAPs upon electrodiagnostic measurements, followed by participation in the staircase test and at latest participation in
the grasping test was detected. At the end of the study, all animals showed recordable CMAPs. Full recovery of gross motor function (grasping test) in 100% of the tested
forelimbs was only achieved by the ANG group, while full recovery of fine motor skills (staircase test) in all tested forelimbs was present in the ANG and corrCNG[F] groups.
ANG, autologous nerve graft; CNG, chitosan nerve guide; CNG[F], chitosan-film enhanced chitosan nerve guide; corrCNG[F], corrugated chitosan-film enhanced chitosan
nerve guide. Values are given as total numbers (forelimbs successfully participating per group) as well as percentages (%). aForelimbs were evaluated as successfully
participating when displaying recovery of function of Category 3 (ability to grasp and pull the bar with a detectable force). bForelimbs were evaluated as successfully
participating, when they retrieved more than three pellets because three pellets on the first step could be reached with their tongue and mouth. cForelimbs were evaluated
as successfully, when evocable CMAPs recorded from the thenar muscle were detected. Statistical differences were calculated with the Chi-square test between single
group pairs at the same time point (•p < 0.05 ANG vs. all nerve guide groups, #p < 0.05 vs. CNG, p < 0.05 vs. CNG[F], ∗p < 0.05 vs. corrCNG[F]).
FIGURE 1 | Percentage of the individual paw usage abilities based on video-recorded reflex-based grasping test performed every 2 weeks over 16 weeks
post-surgery. Pulling the bar with a force is the most complete ability to be recovered (Category 3). This recovery of gross motor function is achieved by all forelimbs
of the ANG group (A). Among the artificial nerve guides corrCNG[F]s (D) led to the highest recovery rate. No statistical evaluation was applied. Values are given as
percentages in relation to all evaluated forelimbs per group. (A) ANG, autologous nerve graft; (B) CNG, chitosan nerve guide; (C) CNG[F], chitosan-film enhanced
chitosan nerve guide; (D) corrCNG[F], corrugated chitosan-film enhanced chitosan nerve guide: n = 8.
early as 8 weeks post-surgery, while performance in the other
groups was still significantly inferior (p < 0.05, Chi-square test).
At 12 weeks post-surgery ANG and corrCNG[F] reconstructed
forelimb groups showed the same level of performance in the
grasping and the staircase test which was again significantly
superior to the performance of the other groups evaluated
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(p < 0.05, Chi-square test). The total best performance could
be ranked number 1 for ANG reconstructed forelimbs (100%
in all three tests applied), number 2 for corrCNG[F] (100%
in electrodiagnostic testing and skilled fore-limb reaching
test, 87.5% in reflexed-based motor task), and number 3
for CNG and CNG[F].
Grasping Test – Evaluation of
Reflex-Based Paw-Usage Ability
The reflex-based grasping test (Figure 1) was categorized as
described above [Category 1 – no finger flexion while touching
the grasping bar; Category 2 – ability to grasp the bar (closing
digits around the bar) but not to hold it while being slowly
withdrawn; Category 3 – ability to grasp and pull the bar with
a detectable force (gross motor skills)].
Generally, recovery of gross motor function was fastest in the
ANG group achieving 100% recovery 8 weeks post-surgery. At
4 weeks post-surgery, no ANG-treated forelimb showed finger
flexion while 2 weeks later all animals were able to grab the
bar. At this time point, three out of eight forelimbs in the ANG
group were able to apply a certain force to the grasping frame.
At 8 weeks post-surgery, all ANG group forelimbs regained
their gross motor function. Finger flexion (Category 2) was
possible in week 8 by 37.5% (3/8) of forelimbs of the CNG and
corrCNG[F] groups, while the first 12.5% (2/8) of forelimbs of the
CNG[F] group showed finger flexion at 10 weeks post-surgery.
At 12 weeks after surgical intervention, 37.5% of forelimbs in
the CNG group, 50% (4/8) in the CNG[F], and 75% (6/8) of
the forelimbs that received median nerve reconstruction with
corrCNG[F] had recovered the ability to encompass the grasping
bar, to close the digits around it and to pull is with some
force (Category 3).
Over time, the animals showed less motivation to participate
in this test, which induced little fluctuations in the performances
from 8 weeks post-surgery onward. Therefore, the total
best performance of each animal was considered additionally
(Figure 1, see also Table 1).
Looking at the total best performances, none of the nerve
guide groups achieved recovery of gross motor skills in all
forelimbs in contrast to the ANG group. The ability to grasp and
pull the bar with a recordable force (Category 3) recovered in 75%
of the CNG group, whereby the residual 25% remained without
finger flexion (Category 1). 62.5% of the CNG[F]-reconstructed
forelimbs regained gross motor function. 25% of this group had
the ability for finger flexion (Category 2), while one reconstructed
forelimb (12.5%) remained without finger flexion (Category 1).
Among the artificial nerve guide groups regeneration was most
complete in the corrCNG[F] group (87.5%, Category 3). The
residual 12.5% were able to flex their fingers (Category 2).
Staircase Test – Evaluation of Skilled
Forelimb Reaching Ability
Healthy baseline reference values for each individual paw, which
were calculated as mean maximum number of pellets retrieved
in the last 3 days of training, display that animals were able to
retrieve a median of 7.84 pellets per paw at the end of the training
period (data not shown). Eight forelimbs of five animals (left and
right forelimbs of three animals, left forelimbs of two animals)
had to be excluded from evaluation, since these animals only
achieved a median of 0.84 retrieved pellets pre-surgically and
their participation in the test did not improve post-surgically due
to lack of motivation. This resulted in a number of n = 6 animals
per group evaluated in the staircase test.
To exclude individual paw preference and behavioral
influences, post-surgical outcomes are presented as percentages
from healthy individual reference values, which were calculated
as 100% (Figure 2).
At 4 weeks post-surgery two ANG-reconstructed forelimbs
participated in the test, but only one of the two ANG-treated
forelimbs participated successfully (retrieving more than three
pellets, see also Table 1). At 8 weeks post-surgery one forelimb of
each nerve guide group performed successfully (see also Table 1),
whereby three additional forelimbs in the corrCNG[F] group
started to participate. At this time point, all ANG-reconstructed
forelimbs participated successfully (retrieving more than three
pellets, individual success rates reached from 84.3 to 399.4%,
median success rate: 105.5% of the maximum pellets retrieved
in healthy state). At 12 weeks post-surgery, four forelimbs of
the CNG group and three forelimbs of the CNG[F] group
participated successfully and two additional animals of the
CNG[F] group evidently started to participate. At the same
time, all forelimbs of the corrCNG[F] group (median individual
success rate: 128.1%) showed successful participation. While the
number of paws that successfully participated in the staircase
test did not further increase in the CNG group (4/6 forelimbs),
one animal of the CNG[F] group was not able to reliably regain
fine motor skills until 16 weeks after surgery. After 16 weeks of
observation the median maximum number of pellets retrieved
vs. healthy state exceeded the 100% healthy baseline in the ANG,
CNG, and corrCNG[F] groups (ANG: 131.35; CNG: 118.25;
corrCNG[F]: 132.10). Animals of the CNG group reached a
median maximum number of 98.00% of healthy values. Despite
the pre-surgical performance of the animals had reached a
plateau after the 7 days training period, the finding, that healthy
baseline reference values were far exceeded in part, can be
attributed to the fact, that the process of learning was still ongoing
during the observation period and not completed pre-surgically
(Stößel et al., 2017). Also it cannot be excluded that the lesion and
use of the temporarily impaired limb did recapitulate the learning
process toward a better performance after recovery.
Non-invasive Electrodiagnostic
Recordings – Evaluation of
Thenar Muscle Reinnervation
Compound muscle action potential amplitude areas resulting
from stimulation distal to the graft were recorded in order to
estimate the number of axons participating in thenar muscle
reinnervation (Figure 3). Healthy baseline reference values for
each paw were determined right before surgery (healthy mean:
4.595± 0.267 ms ∗ mV).
At 4 weeks, most reconstructed forelimbs of all groups
showed evocable signals (ANG: 8/8, CNG: 8/8, CNG[F]: 5/8,
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FIGURE 2 | Quantitative results of the staircase test showing recovery of skilled forelimb reaching revealed by individual success rates in pellet retrieval over
16 weeks post-surgery. The success rates of ANG-reconstructed forelimbs significantly increased 16 weeks after reconstruction when compared to the 4-week time
point. CorrCNG[F]-reconstructed forelimbs recovered to the same extend as forelimbs of the ANG group, while not all forelimbs of the CNG and CNG[F] groups
achieved pre-surgical performance levels. Two-way ANOVA showed an effect of the parameters 4 vs. 16 weeks post-surgery [F (3,80) = 12.9, p < 0.0001] and
groups [F (3,80) = 5.59, p = 0.0016] but there was no interaction. Tukey’s multiple comparisons were applied to detect significant differences (∗p < 0.05 vs. 4 weeks
post-surgery within the same group). Values are displayed as median ± range and displayed as percentages in relation to pre-surgical healthy nerve mean values
shown as baseline at 100%. ANG, autologous nerve graft; CNG, chitosan nerve guide; CNG[F], chitosan-film enhanced chitosan nerve guide; corrCNG[F],
corrugated chitosan-film enhanced chitosan nerve guide: n = 6).
FIGURE 3 | Evocable CMAPs amplitude areas as evaluated during electrodiagnostic recordings from the thenar muscle over 16 weeks observation period.
ANG-reconstructed forelimbs showed significant improvement after 12 weeks post-surgery and significantly higher amplitudes compared to the nerve guide groups.
Among the artificial nerve guide groups, no significant increase could be detected after the 16-week observation period. CNG-reconstructed forelimbs, however,
revealed a significantly lower amplitude area in comparison to ANGs. The continuous horizontal line displays the pre-surgically recorded healthy nerve mean value
(n = 32 forelimbs). Two-way ANOVA showed an effect of the parameters 12 vs. 4 and 8, as well as 16 vs. 4 and 8 weeks post-surgery [F (3, 112) = 19.35,
p < 0.0001], groups [F (3,112) = 18.54, p < 0.0001), and the interaction between both parameters [F (9,12) = 3.534, p = 0.0007]. Tukey’s multiple comparisons were
applied to detect significant differences (∗∗∗p < 0.001 vs. 4 weeks post-surgery within the same group; #p < 0.05, ###p < 0.001 vs. 8 weeks post-surgery within the
same group; $$p < 0.01, $$$p < 0.001 vs. ANG). Values are given as median ± range (n = 8). ANG, autologous nerve graft; CNG, chitosan nerve guide; CNG[F],
chitosan-film enhanced chitosan nerve guide; corrCNG[F], corrugated chitosan-film enhanced chitosan nerve guide.
corrCNG[F]: 6/8, see also Table 1). There were no significant
differences in the CMAP amplitude areas when comparing all
groups (two-way ANOVA). While CMAP amplitude area in the
ANG group was highest (1.085 ms ∗ mV) it was smallest in the
CNG[F] group (0.561 ms ∗ mV). In comparison to the 4-week
time point, medians only slightly increased within the next
4 weeks in all groups (ANG: 1.595 ms ∗ mV, CNG: 1.208 ms ∗ mV,
CNG[F]: 0.826 ms ∗ mV, corrCNG[F]: 1.111 ms ∗ mV). At that
time point, stimulation in only one forelimb each in the CNG
as well as in the CNG[F] group did not result in a recordable
CMAP. In the ANG group, CMAP amplitude areas significantly
increased at 12 weeks post-surgery (3.931 ms ∗ mV) when
compared to 4 and 8 weeks post-surgery (p < 0.001, two-
way ANOVA). At this time point, ANG reconstructed forelimbs
delivered significantly higher CAMP amplitude areas than the
artificial nerve guide groups (CNG: 1.601 ms ∗ mV, CNG[F]:
1.328 ms ∗ mV, corrCNG[F]:1.123 ms ∗ mV) with none of the
forelimbs remaining unresponsive to stimulation (p < 0.001,
two-way ANOVA). Sixteen weeks after surgical intervention,
CMAP amplitude areas of the CNG[F] and the corrCNG[F]
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FIGURE 4 | Representative pictures of the macroscopic appearance of the
sutured grafts right before explantation (A, B, E, F) and of the explanted
regenerated tissue at 16 weeks post-surgery (C, D, G, H). For treatment of
10 mm median nerve gaps either ANGs (A, C), hollow standard CNGs (B, D),
CNG[F]s (E, G), or corrCNG[F]s (F, H) were inserted and sutured at the
corresponding nerve end (p = proximal, d = distal). In ANG- and
CNG-reconstructed forelimbs one nerve strand was formed. On the other
hand, CNG[F]s and corrCNG[F]s led to two thinner nerve strands, generally
divided from each other by the z-folded chitosan-film. Perforations within the
chitosan-films allowed for growth of macroscopically visible, eventually blood
supplied, connections between the two nerve strands (indicated by ∗).
group further increased while CNG reconstructed forelimbs
still performed significantly less compared to the ANG group
(p < 0.01, two-way ANOVA).
Macroscopic Evaluation of the
Regenerated Tissue Upon Explantation
To generate an overview of tissue regeneration between
the proximal and the distal nerve end, ANGs as well as
regrown tissue inside the diverse nerve guides were first
surveyed macroscopically at 16 weeks post-surgery (Figure 4).
Reconstruction of the nerves with ANGs and corrCNG[F]s
resulted in full-distance regenerated tissue in all animals of
the group. Two reconstructed median nerves of the CNG
group revealed no connections between the nerve ends and
in one graft only a very thin connection was detectable,
which was too thin for paraffin embedding. For the latter
sample the nerve distal to the graft was, however, processed
for nerve morphometry (see the section “Quantification of
blood vessel area in the distal chitosan nerve grafts”). Also,
implantation of CNG[F]s led to one forelimb without any
regenerated tissue.
While reconstruction with ANGs and CNGs, respectively, led
to one thick connection between the proximal and distal nerve
ends, reconstruction with either type of CNG[F]s or corrCNG[F]
resulted in the formation of two thinner tissue cables, one on
each side of the film, connecting the two nerve ends. At the
level of chitosan-film perforations, tissue which grew through
the perforations could be detected. These tissue bridges formed
a connection between the two regenerated tissue cables.
Nerve Immunohistochemistry in the
Distal Nerve Grafts – Quantification
of Axon Profiles
For histological evaluation of the regenerated tissue within the
nerve grafts, not all samples could be used. This was related
to very thin or even missing connections between the proximal
and distal nerve ends, so that no tissue could be processed
for immunocytochemistry. Therefore, regenerated tissue from
n = 8 ANG- and corrCNG[F]-treated forelimbs, n = 5 CNG-
treated forelimbs, and n = 7 CNG[F]-treated forelimbs were
incorporated into the evaluation. Cross-sections were prepared
at the distal end of the ANG grafts and at 3.7 mm proximal
to the distal suture site within the nerve grafts. These cross-
sections were stained for HE to demonstrate the composition of
the regenerated tissue (Figures 5B,D,F) and to analyze the area of
blood vessel within the regenerated tissue inside the nerve guides
(see the section “Nerve immunohistochemistry in the distal nerve
grafts – quantification of axon profiles”).
Hematoxylin and Eosin-stained cross-sections show single
strands of regenerated tissue in the ANG and CNG (Figure 5B)
groups, while two strands, one at each side of the chitosan-
film, were formed in the CNG[F] (Figure 5D) and corrCNG[F]
(Figure 5E) groups. HE stained sections eventually also
illustrated, that film-perforations contained regrown tissue as
well (Figure 5F, indicated by arrow). Consecutive sections
of those, that underwent HE staining, were stained for
NF200 and counter-stained with DAPI. This enabled the
immunodetection of regenerated axonal profiles in the distal
nerve grafts. Representative photomicrographs (Figures 5A,C,E)
show the presence of NF200-immunopositive axons within the
regenerated tissue strands. In chitosan-film enhanced nerve
guides, axonal profiles were detectable at both sides of the
chitosan-film (Figures 5C,D, indicated by ∗), but eventually also
in tissue bridges connecting the two nerve strands (Figure 5C,
indicated by #). As ANGs and CNGs led to regeneration of
thicker tissue cables, we further investigated if this was associated
with a higher number of regrown axons within the distal
graft in comparison to CNG[F]s and corrCNG[F]s. Therefore,
quantification of NF200-immunopositive axonal profiles was
performed (Figure 6). Median nerve reconstruction with ANGs
revealed the highest number of NF200-immunopositive axonal
profiles (3981 ± 393.9). Numbers of NF200-immunopositive
axonal profiles were smaller in the distal CNGs (2139.1± 165.5),
CNG[F]s (1993.4 ± 185.4), and corrCNG[F]s (2285.2 ± 425.2),
but no significant differences could be detected between all
groups (Kruskal–Wallis test). Among the bioartificial nerve
guide groups, the highest number of NF200-immunopositive
axonal profiles was detected in distal nerve graft samples from
corrCNG[F] reconstructed forelimbs.
Quantification of Blood Vessel Area in
the Distal Chitosan Nerve Grafts
In previous studies we have postulated that introducing the
chitosan-films into the CNGs may increase the vascularization
of the regenerated tissue (Stenberg et al., 2017; Stößel et al.,
2018b). To analyze this in some more detail, we quantified the
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FIGURE 5 | Representative photomicrographs of consecutive cross-sections through the regenerated tissue within the distal nerve graft at 16 weeks post-surgery.
Immunohistological staining (A, C, E) against NF200 (green) and DAPI nuclear counter staining (blue) display immunodetection of all regenerated axonal profiles.
(Continued)
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FIGURE 5 | Continued
HE staining (B, D, F) displays an overview of the composition of the regenerated tissue. Thicker and single-strand tissue connections between proximal and distal
nerve ends were found in the ANG and CNG groups. Axonal staining proofed that on each side of the chitosan-film the regenerated tissue contained NF200-positive
axons. Arrow is indicating the tissue bridge, which was formed inside the chitosan-film perforation and connected the two nerve cables (chitosan-film indicated by ∗,
NF200-positive axonal profiles within the tissue bridge indicated by #). CNG, standard chitosan nerve guide; CNG[F], chitosan-film enhanced CNG; corrCNG[F],
corrugated chitosan-film enhanced chitosan nerve guide.
mean area of clearly identifiable blood vessels in the HE sections
obtained from the CNG groups (n = 5 CNG, n = 7 CNG[F],
and n = 8 corrCNG[F]). As depicted in Figure 7, the evaluation
of the mean blood vessel area did not reveal any significant
differences between the experimental groups (Kruskal–Wallis
test). The data point out, however, that larger mean blood vessel
FIGURE 6 | Quantification of NF200-immunopositive axonal profiles at
midgraft-level at 16 weeks post-surgery. ANG reconstructions revealed the
highest numbers of NF200-positive axonal profiles among all tested implants.
CorrCNG[F]s showed slightly increased numbers of immunopositive axonal
profiles, when compared to the other artificial nerve guides tested.
Kruskal–Wallis test [H(3, N = 28) = 7.74, p = 0.0517] followed by Dunn’s
multiple comparisons were applied. No significant differences were detected.
Values are given as mean ± SEM. ANG, autologous nerve graft; corrCNG[F],
corrugated chitosan-film enhanced chitosan nerve guide: n = 8; CNG,
chitosan nerve guide: n = 5; CNG[F], chitosan-film enhanced chitosan nerve
guide: n = 7.
FIGURE 7 | Quantitative results of the mean blood vessel area within the
distal nerve graft at 16 weeks post-surgery. No significant differences could be
detected among the experimental groups. Kruskal–Wallis test [H(2,
N = 20) = 0.929, p = 0.6456) followed by Dunn’s multiple comparisons were
applied to detect significant differences. Values are given as median ± range.
CNG, chitosan nerve guide: n = 5; CNG[F], chitosan-film enhanced chitosan
nerve guide: n = 7; corrCNG[F], corrugated chitosan-film enhanced chitosan
nerve guide: n = 8.
areas (e.g., >100 µm2) have a higher probability to be formed
when CNGs contain a chitosan-film.
Nerve Histomorphometry Distal
to the Nerve Grafts
For stereological and morphometrical assessment of regenerated
myelinated axons, semi-thin cross-sections were prepared from
distal nerve segments of reconstructed median nerves at 16 weeks
post-surgery (Figure 8). Two samples of the CNG group with no
evident regrown tissue detected during macroscopic inspection
(see the section “Non-invasive electrodiagnostic recordings –
evaluation of thenar muscle reinnervation”) were excluded from
evaluation (n = 6). In the CNG[F] group also one sample was
excluded due to lack of regeneration (n = 7).
Regarding the numbers of myelinated fibers (Figure 9A),
axon diameters (Figure 9B), fiber diameters (Figure 9C), and
myelin thicknesses (Figure 9D), samples resulting from ANG
reconstructed forelimbs were superior over all bioartificial nerve
guide groups tested. While no significant differences could
be detected when comparing numbers of myelinated fibers
of ANGs with CNGs and corrCNG[F]s, CNG[F]s revealed
significantly lower numbers of myelinated fibers (p < 0.05,
Kruskal–Wallis test). When looking at the axon diameters and
fiber diameters, CNG(F)s and corrCNG[F]s showed significantly
smaller diameters in both parameters when compared to the
ANG group (p< 0.05 for axon diameter of CNG[F], corrCNG[F],
and fiber diameter of corrCNG[F], p < 0.01 for fiber diameter of
CNG[F], Kruskal–Wallis test). However, only CNG[F]s showed
significantly thinner myelin sheaths when compared to ANGs
(p < 0.01, Kruskal–Wallis test), whereas reconstruction with
corrCNG[F]s revealed the thickest myelin sheaths among the
nerve guide groups. Major variations or significant differences
in g-ratio values (data not shown), however, were not detected
among all groups (ANG: 0.67± 0.01; CNG: 0.68± 0.03; CNG[F]
0.68± 0.02; corrCNG[F] 0.66± 0.01).
DISCUSSION
In connection with peripheral nerve injuries the application of
ANGs still represents the gold standard (Daly et al., 2012). As
this method goes along with various downsides (Siemionow
et al., 2010; Hallgren et al., 2013; Kuffler, 2014), researchers
still try to substitute or replace the use of ANGs by alternative
bioartificial nerve guide-based treatment strategies (Gu et al.,
2014; Faroni et al., 2015).
For studying the properties of novel bioartificial nerve grafts,
nerve transection models are commonly used. Complete nerve
transection injuries are characterized by structural changes,
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FIGURE 8 | Representative pictures of toluidine blue-stained semi-thin cross-sections of distal nerve segments at 16 weeks post-surgery. Images show healthy
nerve segments (A) serving as control compared to distal nerve segments of reconstructed median nerves (B–F). (B) Example of no axonal regeneration from the
CNG[F] group. Examples of regenerated nerve samples from the ANG group (C), CNG group (D), CNG[F] group (E), and corrCNG[F] group (F). White scale bars
display 10 µm.
including axonal and myelin breakdown (Deumens et al.,
2010). As such the model has distinct differences to other
peripheral nerve injury models, e.g., loose ligation models of
the rat sciatic nerve. Nerve ligation models are studied in
the context of the development of neuropathic pain in which
early events at the lesion sites are characterized by edema and
inflammatory infiltration (e.g., Pacini et al., 2010; Di Cesare
Mannelli et al., 2016). One leading event after nerve transection
injury, besides axonal and myelin breakdown, is also recruitment
of macrophages that help in myelin clearance during Wallerian
degeneration over 3–6 weeks after the injury (Gaudet et al.,
2011; Faroni et al., 2015; Jessen and Mirsky, 2016). Since
morphological changes after median nerve transection injury
have been described elsewhere before (e.g., Ronchi et al., 2016),
we were not focusing on these events in the current study.
Here, besides thorough functional analyses, we focused on
end-point histological analysis of the regenerated nerve tissue
after 16 weeks post-surgery. At this late time point, edema or
continued inflammatory infiltrations would only be expected in
case of immune responses against the artificial nerve grafts or
their degradation products. This was, however, never detected in
other studies evaluating chitosan-based nerve guides before (e.g.,
Haastert-Talini et al., 2013; Stößel et al., 2018a,b). We further
did not study effects of any complementary treatment to protect
peripheral nerve arrangement and to prevent development of
neuropathic pain, like, e.g., daily oral administration of rosemary
extracts (Pacini et al., 2010; Di Cesare Mannelli et al., 2016),
because the rat median nerve transection and repair model has
not been reported before to induce neuropathic pain.
In this study we compared ANGs and three different types of
chitosan-based nerve guide grafts with regard to their support for
peripheral nerve regeneration after acute repair of 10 mm median
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FIGURE 9 | Quantitative results of the nerve morphometrical analyses of distal nerve segments of reconstructed median nerves at 16 weeks post-surgery. Bar
graphs are representing the total numbers of myelinated fibers (A), axon diameters (B), fiber diameters (C), and myelin thicknesses (D). Samples from
ANG-reconstructed forelimbs were superior to the artificial nerve guides concerning all tested parameters. Only single events of statistically significant differences
could be detected. CNG[F]s and corrCNG[F]s led to significantly lower axon diameters when compared to the ANG group. Additionally, CNG[F]s led to significantly
thinner nerve fibers and myelin sheaths when compared to samples from ANG-reconstructed forelimbs. Horizontal continuous lines display healthy nerve mean
values (n = 6). Kruskal–Wallis test [(A) H(3, N = 29) = 10.19; (B) H(3, N = 29) = 11.24; (C) H(3, N = 29) = 15.03; (D) H(3, N = 29) = 12.34] with Dunn’s multiple
comparisons were applied to detect significant differences (∗p < 0.05, ∗∗p < 0.01 vs. ANG at the same time point). Values are given as mean ± SEM. ANG,
autologous nerve graft; corrCNG[F], corrugated chitosan-film enhanced chitosan nerve guide: n = 8; CNG, chitosan nerve guide: n = 6; CNG[F], chitosan-film
enhanced chitosan nerve guide: n = 7.
nerve defects. The nerve guides evaluated consisted of standard
hollow CNGs (Haastert-Talini et al., 2013), CNG[F]s ( Meyer
et al., 2016a), or corrCNG[F]s. The corrugated structure of the
outer wall of hollow CNGs is thought to make them most suitable
for bridging peripheral nerve gaps in highly mobile locations
(Stößel et al., 2018b). Highly mobile locations are for example
human digits, in which digital nerves, originating from the
median nerve, are even traveling across joints. Previous studies
have demonstrated that by inserting a z-folded chitosan-film
and creating a two-chambered chitosan nerve guide (CNG[F]),
the support of functional recovery after immediate and delayed
critical defect length rat sciatic nerve repair could even be
increased in comparison to standard CNGs (Meyer et al., 2016a;
Stenberg et al., 2017). Consequently, in this current study, we
have evaluated corrCNG[F]s for their regeneration supporting
properties in the rat median nerve model. We suppose the rat
median nerve model to be more translational than the classic rat
sciatic nerve model (Stößel et al., 2018b) with regard to the repair
of human digital nerve injuries, which are displaying the majority
of clinically relevant peripheral nerve injuries (McAllister et al.,
1996; Renner et al., 2004).
Clinically most important for patients suffering from
peripheral nerve injury is the recovery of fine and gross motor
function (Fugleholm et al., 2000; Valero-Cabre et al., 2001),
which can still not be guaranteed even after nerve reconstruction
with the use of ANGs (Deumens et al., 2010; Isaacs, 2010). The
median nerve model used in the current study allows to define
rather precisely the onset of different level motor functional
recovery and to evaluate the final recovery level of the different
motor functions (Stößel et al., 2017). For a good comparison
of results and like in many other studies in the field and in
accordance to our previous work (Stößel et al., 2017) we used
female young adult rats (15 weeks at beginning of adaptation to
test conditions) in the current study.
Our results demonstrate that median nerve reconstruction in
the rat with corrCNG[F]s achieved functional results comparable
to the results obtained after reconstruction with ANGs. Even
though the functional recovery was fastest and most complete
(100% recovery rate) in the ANG group already 8 weeks post-
surgery, corrCNG[F]s significantly accelerated the recovery of
fine and gross motor functions when compared to CNGs and
CNG[F]s. Final recovery levels for skilled forelimb reaching
ability were even significantly superior in the corrCNG[F] group
when compared to the two other nerve guide groups evaluated.
While this overall conclusion could easily be drawn from the
results presented, this discussion will focus on a more detailed
analysis of the evaluation methods used and the particular
results they provided.
The reflex-based grasping test, which is used to analyze the
recovery of gross motor function (Tupper and Wallace, 1980),
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was performed every second week in the current study. This
is the simplest test in our test battery and certainly the less
stress-full for the animals, because it does not require any
specific preparation and is performed with the awaken animal.
Therefore, in our preceding study (Stößel et al., 2017), the
grasping test was performed weekly and was found to thereby
discover rather precisely the onset of reflex-based gross motor
functional recovery. But the weekly testing procedure also
resulted in a reduced motivation of the animals to participate
in the test (Stößel et al., 2017). This observation has also been
described before (Bertelli and Mira, 1995), and therefore, to keep
motivation to participate, we decided to perform the test only
every second week in the current study. Still we were facing
minor undulation in the recovery rate of gross motor function
(ANG group between 8 and 10 weeks post-surgery; and either
nerve guide groups between 14 and 16 weeks post-surgery), but
were also able to detect differences in the recovery time and
recovery rates among the groups. The grasping test confirmed
that ANG reconstruction was most supportive for recovery of
gross motor function, since exclusively the ANG group showed
a 100% recovery rate in this test. Comparing the total best
results among the nerve guide groups, use of corrCNG[F]s for
reconstruction led to the highest percentage of forelimbs (87.5%)
being able to apply a certain force to the bar (Category 3), which
is the most complete ability to be recovered (Stößel et al., 2017).
Notably, superiority of the corrCNG[F] grafts over the other
nerve guides is also indicated by the observation, that none of the
corrCNG[F] reconstructed forelimbs remained without ability
of finger flexion (Category 2) in contrast to the CNG group
(two animals without finger flexion) and the CNG[F] group (one
animal without finger flexion).
The staircase test was performed for comprehensive
evaluation of recovery of fine motor skills (Montoya et al.,
1991). The test requires a preparatory period of restrictive
feeding and can therefore only be applied on a monthly basis.
The power of this test is again highly affected by the motivation
of the animals to participate (Nikkhah et al., 1998; Galtrey and
Fawcett, 2007). While in our previous study only 1 out of 16
animals demonstrated un-willingness to participate already
during the pre-surgical habituation and training period (Stößel
et al., 2017), in the current study, three animals were not at
all sufficiently participating and two additional animals were
only participating with their right forelimb. This situation was
reducing the power of the test since it reduced the evaluated
group size from initially eight to only six animals. Lewis rats
had been described before to probably display less motivation
to participate, but to also provide a potentially reduced learning
ability (Nikkhah et al., 1998; Galtrey and Fawcett, 2007). On
the other hand, some of the remaining animals in all evaluated
groups achieved success rates highly above their pre-surgical
values during the recovery period. Thus, this displays an ongoing
process of learning after pre-surgical training and during the
post-surgical observation period (Stößel et al., 2017). Although
there is certainly more to consider when applying the staircase
test paradigm for median nerve injury and repair studies,
we again found it useful in depicting another type of motor
functional recovery than the grasping test and in elucidating
differences among our evaluated groups. Complete recovery of
fine motor skills (100% recovery rate) was achieved in the ANG
as well as by the corrCNG[F] group, while not all forelimbs of
the CNG and CNG[F] groups achieved pre-surgical performance
levels and some of them did not recover skilled forelimb reaching
abilities at all.
When assembling the overall motor abilities recovered as
assessed by us in the advanced rat median nerve model, one could
even detect some striking results in single animals that need a
more reflected view on the underlying axonal regeneration. One
of the ANG-reconstructed forelimbs successfully participated
in the staircase test already 4 weeks post-surgery (retrieving
more than three pellets), while demonstrating no finger flexion
in the grasping test at the same time. The same phenomenon
also occurred in one animal of the CNG[F] group at 8 weeks
post-surgery. Looking at these results one should assume that
axons were correctly directed to the target muscles, since fine
motor skills require accurate reinnervation (Galtrey and Fawcett,
2007). Furthermore, successful pellet retrieval requires the ability
for finger flexion, resulting in the assumption that the absence
of finger flexion in the grasping test may be again explained
by a lack of motivation of the animals (Nikkhah et al., 1998;
Galtrey and Fawcett, 2007). This observation can obviously not
be related to the nerve graft applied for reconstruction and has
therefore negatively biased the results from the grasping test. One
should also consider that even a certain number of misdirected
axons would lead to the ability for reflexed-based gross motor
grasping function, because for this the amount of reinnervating
axons is more important than the accuracy of reinnervation
(Galtrey and Fawcett, 2007).
The previous considerations lead over to the discussion of
the electrodiagnostic measurements applied in the current study.
Similar to the staircase test, these measurements were performed
on a monthly basis, because we have been experiencing low
tolerability of repetitive anesthesia in a previous study (Korte
et al., 2011). Also, the obtainable data by recording and
analyzing evocable CMAP amplitude areas are providing a
quantitative estimation on the degree of motor reinnervation, but
no indication on its consequences on forelimb usage abilities.
In our previous study we demonstrated that electrodiagnostic
recordings from the thenar muscles are a valuable tool to
elucidate the early onset of motor axon regeneration, which is
somehow predictive for the time period needed until motor
skills will also start to return (Stößel et al., 2017). We had
a similar observation in the current study. At 4 weeks post-
surgery, evoked CMAPs were recordable in 100% of ANG and
CNG reconstructed forelimbs when still no finger flexion was
detected with the grasping test and only one ANG-forelimb and
none CNG-forelimb successfully participated in the staircase test.
The same findings could be detected in the two other groups
where the majority of the reconstructed nerves (CNG[F]: 62.5%;
corrCNG[F]: 75.0%) transmitted evocable CMAPs to the thenar
muscles, but none of the forelimbs achieved Category 2 (ability
for finger flexion) in the grasping test or successfully participated
in the staircase test. Occurrence of 100% of reconstructed
forelimbs showing evocable thenar muscle CMAPs revealed a
timeline among the groups with the ANG-group and CNG-group
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being the first (4 weeks post-surgery), the corrCNG[F] group the
second (8 weeks post-surgery), and the CNG[F] group followed
12 weeks post-surgery.
Electrodiagnostic recordings provide a twofold estimation
of functional recovery. First, the pure evidence of muscle
reinnervation as detected by recording of evoked CMAPs, and
second, the estimation of the quality of reinnervation as it can
be retrieved from analyzing the CMAP amplitude area. The
CMAP amplitude area correlates with the number of functioning
axons (Cuddon, 2002). Although, in the current study, the CNG
group showed the earliest onset of motor reinnervation among
the bioartificial nerve guide groups, the CMAP amplitude area
was still significantly smaller after 16 weeks post-surgery when
compared to the ANG group, which achieved the overall highest
median amplitude area among all nerve grafts tested. At this
time point median CMAP amplitude areas were not anymore
significantly different to the ANG values in the CNG[F] and
corrCNG[F] groups.
Extrapolating these results now to usage abilities and evidently
recovered motor skills is, however, also not fully possible.
Although the median CMAP amplitude area recorded in the
CNG[F]s ranged slightly above that one recorded from the
corrCNG[F] reconstructed forelimbs, motor skills returned to
a higher rate in the second group. This indicates again that
CMAP amplitude recovery is not necessarily accompanied by
precise regeneration of all motor axons (Archibald et al., 1991;
Fugleholm et al., 2000; Valero-Cabre et al., 2001; Navarro and
Udina, 2009; Pfister et al., 2011). Additionally, it demonstrates
that also stimulation of finally misdirected axons contributes to
the value of CMAP amplitude areas and these axons do not
compulsorily lead to regeneration of especially fine motor skills
(Galtrey and Fawcett, 2007).
Those electrodiagnostic measurements, as performed in our
current study, should only be one tool to evaluate functional
recovery of the rat median nerve, as must also be concluded from
the macroscopic inspection of the nerve grafts upon explantation
and the subsequent histomorphometrical analysis. The latter
is also irreplaceable for a comprehensive evaluation of nerve
repair approaches.
Upon explantation of the nerve grafts, we could macrosco-
pically detect visible tissue connections between the proximal
and the distal nerve end in all ANG and corrCNG[F] grafts,
while surprisingly two nerve guides from the CNG group and
one from the CNG[F] group did not contain sufficient amount
of tissue. Although during establishment of the advanced median
nerve model we did not find evidences that false positive
recordings could occur from electrodiagnostic measurements
(Stößel et al., 2017), we need to reconsider this possibility. In the
current study, all forelimbs of the CNG and the CNG[F] group
presented with evocable CMAPs in electrodiagnostic evaluation.
Analysis of CMAP amplitude areas could again be judged to
be of major value, since we at least detected that the false
positive CMAPs displayed an area below the group median and
histomorphometric analysis of distal nerve segments did not
detect regrown axons.
Histomorphometrical analysis finally serves not only to
reveal more quantitative data indicative also for the quality of
axonal regeneration, but could also provide insight into tissue
compositions related to good functional recovery.
As observed in previous studies (Meyer et al., 2016a; Stenberg
et al., 2017), tissue regeneration through CNG[F]s results in
growth of two nerve strands separated by the chitosan-film. As
we have shown previously and here again, these nerve strands
are eventually connected via tissue bridges that have formed
within the perforations in the film. In the current study we
were even able to detect NF200-immunopositive axons inside
these tissue bridges.
Quantification of the number of NF200-immunopositive
axonal profiles within the distal grafts revealed no significant
differences within the groups, although the highest mean value
was detected in the ANG group and the corrCNG[F] group
showed slightly higher values than the two other nerve guide
groups. These findings already correlate to our results from
the motor skills analyses. We have previously postulated that
chitosan-film enhanced nerve guides would attract a higher
degree of neovascularization and that this may directly correlate
to better functional outcome (Meyer et al., 2016a; Stenberg
et al., 2017). Early revascularization is an important factor for
successful regeneration as it is supposed to prevent apoptosis
of Schwann cells, fibrosis, and failure of regeneration (Penkert
et al., 1988). In addition, blood-derived macrophages are known
to support peripheral nerve regeneration by producing growth
factors and adhesion molecules (Fansa et al., 2001; Haastert-Talini
et al., 2013; Mokarram et al., 2017; Stenberg et al., 2017). In the
current study we determined the median blood vessel area in the
distal nerve guides in order to elucidate potential differences in
neovascularization among the different nerve guide types. And
indeed, although not significant again, in the corrCNG[F] group,
with the best functional outcome among the nerve guide groups,
we found in 50% of the samples mean blood vessel areas above the
group mean, while in the CNG[F] group and CNG group these
are only 43 and 40%, respectively.
It is noteworthy that immunohistological evaluation of
the number of NF200-immunopositive axonal profiles in the
distal grafts resulted in reduced numbers of detected axons
in comparison to the histomorphometrical analysis performed
distal to the grafts. Among all investigated groups, more
regenerated and myelinated nerve fibers were detected in the
nerve specimen distal to the grafts than within the grafts. This
could be found to be in contradiction to the assumption that not
all nerve fibers that sprout proximally should reach their distal
target and that the number of detectable axons will therefore
get smaller at more distal locations. One should, however,
consider that immunohistological staining and quantification in
fluorescence microscopy may miss a certain amount especially
of small regenerated axons, due to thresholds that have to be set
manually. Therefore, a more reliable axon count will always result
from nerve morphometrical analysis.
Nerve morphometry finally performed in specimen harvested
distal to the grafts revealed that less axons regenerated in the
nerve guide groups than in the ANG group, with CNG[F]
samples showing significantly less axons. As shown before (Sinis
et al., 2005; Haastert-Talini et al., 2013; Ronchi et al., 2017; Stößel
et al., 2017), ANG reconstruction results in higher numbers of
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myelinated fibers in comparison to the artificial nerve guides and
even compared to the healthy nerve. Healthy nerve values for
numbers of myelinated fibers were exceeded by the ANG, CNG,
and corrCNG[F] group, a phenomenon that has been described
before in different models (Meyer et al., 2016a; Stenberg et al.,
2017; Stößel et al., 2017). Probably the second most indicative
nerve morphometrical parameter for functional recovery, which
has been analyzed in the current study, is the myelin thickness.
The myelin thickness determines the nerve conduction velocity
(Valero-Cabre and Navarro, 2002; Korte et al., 2011) and could
therefore have a direct impact on fine motor reaching skills.
Axons from CNG[F] group samples displayed significantly
thinner myelin sheaths than those from the ANG group, while
the other nerve guide groups showed no significant differences.
Samples from the corrCNG[F] group displayed slightly thicker
myelin sheaths of their axons among the bioartificial nerve graft
groups. These findings underline that corrCNG[F] supported
functional regeneration of the reconstructed median nerve to a
higher extend than the other CNGs evaluated.
In conclusion, we demonstrated that the use of corrCNG[F]s
represents a promising approach for reconstruction of small
nerves in a mobile extremity location. The results of the
current study are translational for the repair of digital nerves
in humans since different nerve guides were comprehensively
tested against the gold standard ANG and the clinically approved
classic hollow CNG.
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Peripheral Nerve Injury (PNI) is common following blunt or penetrating trauma with an
estimated prevalence of 2% among the trauma population. The resulting economic
and societal impacts are significant. Nerve regeneration is a key biological process in
those recovering from neural trauma. Real Time-quantitative Polymerase Chain Reaction
(RT-qPCR) and RNA sequencing (RNA seq) are investigative methods that are often
deployed by researchers to characterize the cellular and molecular mechanisms that
underpin this process. However, the ethical and practical challenges associated with
studying human nerve injury have meant that studies of nerve injury have largely been
limited to rodent models of renervation. In some circumstances it is possible to liberate
human nerve tissue for study, for example during reconstructive nerve repair. This
complex surgical environment affords numerous challenges for optimizing the yield
of RNA in sufficient quantity and quality for downstream RT-qPCR and/or RNA seq
applications. This study characterized the effect of: (1) Time delays between surgical
liberation and cryopreservation and (2) contact with antiseptic surgical reagents, on the
quantity and quality of RNA isolated from human and rodent nerve samples. It was found
that time delays of greater than 3 min between surgical liberation and cryopreservation
of human nerve samples significantly decreased RNA concentrations to be sub-optimal
for downstream RT-qPCR/RNA seq applications (<5 ng/µl). Minimizing the exposure of
human nerve samples to antiseptic surgical reagents significantly increased yield of RNA
isolated from samples. The detrimental effect of antiseptic reagents on RNA yield was
further confirmed in a rodent model where RNA yield was 8.3-fold lower compared to
non-exposed samples. In summary, this study has shown that changes to the surgical
tissue collection protocol can have significant effects on the yield of RNA isolated
from nerve samples. This will enable the optimisation of protocols in future studies,
facilitating characterisation of the cellular and molecular mechanisms that underpin the
regenerative capacity of the human peripheral nervous system.
Keywords: peripheral nerve regeneration/repair, RNA isolation and purification, RT-qPCR, RNA seq, surgery,
cellular and molecular biology, human tissue, surgical antisepsis
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INTRODUCTION
Peripheral nerve injury (PNI) is a common outcome following
blunt or penetrating trauma with an estimated prevalence
of 2% among the trauma population (Brattain, 2013). The
resulting economic and societal ramifications are significant
(Taylor et al., 2008). Nerve regeneration is a key biological
process in those recovering from neural trauma. The cellular and
molecular mechanisms that underpin this process have been well
characterized in rodent models of PNI and have been central
to therapeutic advancements made in this field of regenerative
neuroscience (Kaplan et al., 2015; Jessen and Mirsky, 2016).
Investigative methods such as RNA seq (RNA sequencing) and/or
Real Time-quantitative Polymerase Chain Reaction (RT-qPCR)
are often deployed in studies to characterize these mechanisms
(Bosse et al., 2001; Jiang et al., 2014; Clements et al., 2017;
Yi et al., 2017). However, the ethical and practical challenges
associated with studying human nerve injury have meant that
studies of nerve injury have largely been limited to rodent
models of damage and renervation. For example, it is challenging
to liberate human nerve samples without worsening patient
morbidity. Moreover, traumatic nerve injuries represent a highly
heterogeneous cohort and a standardized model in which human
nerve regeneration can be studied is awaited.
In some circumstances it is possible to liberate human nerve
tissue for study, for example during reconstructive nerve repair.
Samples that can be extracted are often finite and are exposed
to the complex surgical environment, which includes chemical
and physical environmental factors, time pressures and other
priorities which are not present when sampling animal tissues
in a laboratory setting. This affords numerous challenges when
optimizing protocols for the extraction of RNA with sufficient
quantity and quality for quantitative analysis, therefore this study
is dedicated to exploring these challenges.
The extraction of RNA in sufficient quantity and quality is
a critical step toward obtaining valid RT-qPCR/RNA seq results
(Atz et al., 2007; Popova et al., 2008; Abasolo et al., 2011).
A minimum concentration of 5 ng/µl is often used for the
synthesis of single stranded complementary DNA (cDNA) (Fox
et al., 2012; França et al., 2012) and in the quantitative and
qualitative assessments of RNA yields; a critical step toward
valid RT-qPCR and/or RNA seq results (Bastard et al., 2002;
Fleige and Pfaffl, 2006; Wilkes et al., 2010). The quality of RNA
can be determined using quantitative and qualitative assays;
260/280 ratios and electropherograms respectively (Mee et al.,
2011; Yockteng et al., 2013; Samadani et al., 2015; Walker et al.,
2016). When optimizing RNA extraction protocols to attain
yields sufficient for RT-qPCR assays, it is necessary to consider the
tissue that is being processed; a review of the literature highlights
differentials in the yield of RNA isolated from different tissues
(Ruettger et al., 2010; Walker et al., 2016; Grinstein et al., 2018).
Based on experiences within our research unit and others,
there appears to be a differential between the RNA extraction
ratio [mean total RNA (µg) divided by initial tissue sample
mass (mg)] of healthy and denervated nerve liberated from rats.
Typical values range from 0.09 µg/mg for healthy sciatic nerve to
0.27 µg/mg for denervated sciatic nerve (Yamamoto et al., 2012;
Weng et al., 2018). This differential is perhaps attributable to the
presence of higher numbers of proliferating cells in denervated
tissue. Moreover, the degradation of connective tissue during
Wallerian degeneration is likely to make denervated tissue more
amenable to complete lysis. In comparing peripheral nerve to
other tissues, the reported RNA extraction ratios are considerably
lower than those reported for RNA isolated from other tissues
such as liver, kidney and spleen which have mean extraction
ratios of 1.56 µg/mg, 0.50 µg/mg, and 0.41 µg/mg respectively
(Yamamoto et al., 2012). The lower RNA yields reported from
nerve samples are at least partially attributable to the fact that
nerves are invested by fibrous connective tissue particularly in
the epineurium (Thomas, 1963). The biomechanical properties
of this tissue are antagonistic to total cellular disruption and lysis
of nerve tissue which is an imperative step in RNA isolation
(Bastard et al., 2002; Guan and Yang, 2008). This is an indication
for the application of specialist RNA extraction kits which include
a broad spectrum serine protease such as Proteinase K to facilitate
optimal digestion of tissue and lysis of cells (Yockteng et al., 2013;
Peeters et al., 2016; Amini et al., 2017).
Accepting that the concentration of RNA that can be isolated
from peripheral nerve tissue is likely to be lower than other
tissues, it is pertinent to optimize surgical protocols in order
to conserve whatever RNA is available. One variable that has
been shown to be predictive of the quality and quantity of
RNA extracted from samples is the time interval between sample
liberation and cryopreservation (Borgan et al., 2011; Hatzis et al.,
2011; Caboux et al., 2013); a variable that is difficult to control
in the surgical environment due to intra-operative priorities and
handling limitations. It has been shown that delays of hours
between sample liberation and cryopreservation impairs RNA
isolated from cancerous samples (Borgan et al., 2011; Hatzis et al.,
2011; Caboux et al., 2013). However, corresponding time frames
using human nerve samples have not been reported.
While a number of past studies of other surgically liberated
tissues for qPCR analysis have been optimized by manipulating
variables such as time delays and RNA extraction protocols
(Berglund et al., 2007; Borgan et al., 2011; Hatzis et al., 2011;
Caboux et al., 2013), the exploration of other peri-operative
variables that could impact on RNA yields, such as the chemical
environment, have not been reported. The liberal application
of antiseptic compounds in a surgical setting may influence
RNA yields although this has not been reported previously.
The most common constituents of these reagents globally are
chlorhexidine and iodine (Hirsch et al., 2010). Despite in vitro
experimental evidence demonstrating chlorhexidine and iodine
based surgical antiseptic reagents can be cytotoxic to human
SH-SY5Y neuroblastoma cells and rat RSC96 Schwann cell
populations (Doan et al., 2012), their effects on RNA yield and
quality have not been well characterized.
Protocols that detail how human nerve samples should be
handled to optimize RNA yields for subsequent RT-qPCR and
RNA seq analysis are not documented. This study aimed to
explore the time course of RNA degradation in nerve tissue
in order to establish an ideal time frame for the liberation of
human nerve samples and cryopreservation (snap-freezing in
liquid nitrogen). Additionally, this study aimed to investigate for
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the first time the effect of exposure of human nerve samples to
surgical antiseptic reagents.
MATERIALS AND METHODS
Optimizing the Human Surgical
Environment for RNA Isolation
A total of 12 denervated human nerve samples were harvested
from 12 different patients who underwent reconstructive surgery
at the Peripheral Nerve Injury Unit, Royal National Orthopaedic
Hospital after informed consent for the therapeutic procedure
and for tissue donation (Table 1). Informed consent was
obtained using the guidelines detailed in the UK Human
Tissue Act (Human Tissue Act, 2004). Ethical approval for
this project was provided by the UCL Biobank Research
Committee (REC 15.15).
In all cases the site of operation was prepared with
chlorhexidine or iodine based antiseptic reagents in concordance
with standard surgical protocol (Digison, 2007). The
demographic of the study subjects and details of the nerve
samples harvested are documented in Table 1.
Samples harvested were often heterogeneous in size,
morphology and innervation, so they were dissected into sections
measuring 0.5 ± 0.2 cm in the longitudinal orientation. The
dimensions of the samples were chosen to allow comparisons
with other RT-qPCR studies of rodent nerve samples which
used similar dimensions (Jiang et al., 2014). Additionally,
samples were characterized as denervated using intra-operative
neurophysiological monitoring to record compound nerve
action potentials (CNAPs) (Slimp, 2000; Herrera-Perez et al.,
2015). The nerve was assumed to be denervated if a CNAP was
absent and no muscle twitch was observed. Innervated samples
were harvested from sites external to the site of injury (sural,
intercostal and supraclavicular nerve samples) for the purpose of
surgical nerve repair.
Nerve samples were stratified into 3 experimental groups
(shown in Table 1):
Group 1: Samples whereby the time between sample
liberation and cryopreservation was less than 3 min.
Group 2: Samples where the time interval between surgical
liberation of the nerve sample and cryopreservation
was greater than 3 min ranging up to 20 min.
Since RNA yields from nerve samples remained
lower than that reported in rodent studies following
optimisation of handling times, the exploration of
other peri-operative variables was necessitated. This
informed the development of a third experimental
group to explore the effect of minimizing the
exposure of nerve samples to antiseptic reagents.
Group 3: Samples liberated and cryopreserved within 3 min
but utilizing a “clean change” of surgical gloves and
surgical equipment for harvest and handling of the
sample to minimize exposure to antiseptic reagents.
This group included healthy nerve samples in
addition to denervated nerves.
Isolating the Effects of Antiseptic
Reagents on RNA Yield Using a Rodent
Model of Peripheral Nerve Liberation
Standard international operating protocols dictate that iodine
and/or chlorhexidine based antiseptic reagents should be used
to prepare the site of surgical incision as detailed by the World
Health Organization (WHO Surgical Site Infection Prevention
Guidelines, 2016). In order to investigate the effects of these
reagents on RNA, a rodent model of surgical nerve liberation
was utilized in an environment that was otherwise absent of
antiseptic reagents. All animal use was performed according to
the UK Animal Scientific Procedures Act 1986 / the European
Communities Council Directives (86/609/EEC) and approved by
the UCL Animal Welfare and Ethics Review Board. A total of 9
Sprague Dawley rats (6 female and 3 male) were culled using CO2
inhalation and had their sciatic nerves excised. The nerves were
then sharply dissected into 0.5 cm sections (to reflect the size of
samples harvested from human patients). The sections were then
randomized into 2 groups:
Control group: Samples were processed before any
of the experimental samples to minimize the risk of
contamination of the experimental environment.
Experimental group: 100 µl of one of the following
commonly used surgical antiseptic reagents were applied
by pipette: 10% iodine/water, 10% iodine/EtOH (Ethanol)
or 2% chlorhexidine gluconate. Within 30 s of the
nerve samples being excised, the nerve sample and
antiseptic reagent was allowed to stand for 30 s and then
immediately snap-frozen.
RNA Extraction Protocol
All materials used in this process of RNA isolation were treated
with RNase Zap (Invitrogen). Rodent and human nerves were
placed into a 5 ml tube and snap frozen in liquid nitrogen.
The time between tissue isolation and freezing was monitored
as well as the interaction of samples with antiseptic surgical
reagents. RNA was isolated from all nerve samples using the
Qiagen RNeasy R© Fibrous Tissue Mini Kit. The total volume of
eluted RNA for each sample was 40 µl.
The quantity of RNA was determined using a TecanTM
Infinite 200 PRO multimode reader. Quality of RNA was
measured using a NanoDropTM spectrophotometer to ascertain
260/280 ratios for each sample. Samples were also analyzed
using Bio-rad ExperionTM RNA analysis kits to assess Ribosomal
Integrity Number (RIN), and obtain electropherogram data
and automated agarose gel readings from samples using the
ExperionTM Automated Electrophoresis System.
RESULTS
Optimisation of the Surgical Environment
for RNA Extraction
The effect of time between tissue extraction and freezing
on the yield of RNA isolated from human nerve samples
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TABLE 1 | Demographic of patients and samples included in this study.
Mechanism of injury Intra-operative
findings
Details of surgery Nerve assessed Denervated/
Innervated
Approximate time
delay between
surgical liberation
and cryopreservation
(min)
Experimental group 1
Motorbike accident Axonotmesis of the
tibial nerve
Below the knee
amputation
Tibial Denervated 3
Motorbike accident Right C5/6 Avulsion Oberlin’s nerve transfer Biceps branch of
musculocutaneous
Denervated 3
Fall on to sharp cast iron
railing
Axonotmesis of
superficial peroneal
nerve
Excision of nerve Superficial common
peroneal nerve
Denervated 3
Motorbike accident Left C6-T1 root
avulsion
Somsak’s nerve
transfer
Medial head of triceps
branch of the radial
nerve
Denervated 3
Experimental group 2
Iatrogenic nerve injury
secondary to humeral
fracture repair
Neurotmesis of the
axillary nerve
Somsak’s nerve
transfer
Axillary Denervated 5
Car v Tree Right C4 - T1 avulsion Intercostal nerve
transfer to
musculocutaneous
nerve
Biceps branch of
musculocutaneous
Denervated 10
Motorbike accident Right C5/6 Avulsion Oberlin’s nerve transfer Biceps branch of
musculocutaneous
Denervated 15
Car v Lorry Axonotmesis of the
accessory nerve
Fascicle of C7 transfer
to accessory nerve
Fascicle of C7 to
pectoralis muscles to
accessory nerve
Denervated 15
Motorbike accident C5/6/7 Avulsion Double Oberlin’s nerve
transfer
Biceps branch of
musculocutaneous
Denervated 20
Experimental group 3
Iatrogenic nerve injury
secondary to left neck
lymph node biopsy
Neurotmesis of the
spinal accessory nerve
Supraclavicular nerve
transfer to spinal
accessory
Supraclavicular and
Spinal accessory
Supraclavicular
(innervated)
and Spinal
accessory
(denervated)
3
Trampoline accident Neurotmesis of the
ulnar nerve
Sural nerve autograft to
ulnar
Ulnar and Sural Ulnar
(denervated),
Sural
(innervated)
3
Moped v Lampost C5-8 Avulsion Intercostal nerve
transfer to triceps
division of radial nerve
Radial and Intercostal Intercostal
(innervated),
Radial
(denervated)
3
was investigated (Group 1 and Group 2). Figure 1
demonstrates that the optimal yield of RNA isolated from
samples cryopreserved within 3 min of surgical liberation
(Group 1) is approximately 3.6-fold higher than that from
samples frozen after more than 3 min (Group 2) (p < 0.01).
Importantly, the latter group had an RNA yield approximately
equivalent to the minimum threshold value required for
acceptable analysis and cDNA synthesis (Bastard et al., 2002;
Fleige and Pfaffl, 2006; Wilkes et al., 2010; Fox et al., 2012;
França et al., 2012).
The quality of RNA extracted from these nerve samples
was concurrently determined quantitatively using 260/280
absorbance ratios (Figure 2) and semi-quantitatively by
analyzing the ratio of ribosomal RNA bands in agarose gels and
changes in electropherogram morphology (Figure 2). Nucleic
acids have an absorbance maxima at 260 nm. The ratio of this to
the absorbance at 280 nm is used to determine the purity of DNA
and RNA. A ratio of 1.8–2.2 is predictive of high quality RNA
(Desjardins and Conklin, 2010). The distribution of 260/280
ratios assessed for samples cryopreserved within 3 min (Group 1)
is shown in Figure 2, all of which fall within the optimal range
(1.8–2.2). In addition, two distinct ribosomal RNA bands at 28S
and 18S with a ratio of around 2.0 can be seen in the agarose gels
(Figure 2) indicating high quality RNA isolated from samples
processed within 3 min. Figure 2 demonstrates how this ratio is
lost in samples exposed to time delays of up to 20 min (Group 2
samples). An electropherogram was also assessed to illustrate the
overall size of the ribosomal peaks and to further characterize the
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FIGURE 1 | The effect of time between tissue liberation and cryopreservation
on RNA yield in human nerve tissue in a surgical environment utilizing
standard antiseptic protocols. The duration between nerve tissue removal and
freezing was monitored and samples were grouped according to whether the
delay was more than (n = 5) or less than 3 min (n = 4). There was a statistically
significant difference between each group (p < 0 01 two tailed t-test). The
dotted black line represents the minimum concentration of RNA often cited
(Bastard et al., 2002; Fleige and Pfaffl, 2006; Wilkes et al., 2010; Fox et al.,
2012; França et al., 2012) required for downstream RT-qPCR/RNA seq Data
is presented as a mean ± 1 Standard Deviation (SD).
differential in RNA quality between samples processed within
3 min and those exposed to time delays (Figure 2).
Using the data from the electropherogram reports, a RIN
ranging from 1 to 10 (with 10 being predictive of high quality
RNA) was assigned to each sample. RIN is generated using
an algorithm that selects features from the electropherograms
and constructs regression models based on Bayesian learning
techniques. This assessment has been validated in a number of
studies and has been shown to be highly predictive of RNA
quality (Mueller et al., 2004; Imbeaud et al., 2005; Schroeder et al.,
2006). It was found that all samples with 260/280 ratios between
1.8 and 2.2 (considered optimal) had RIN of between 7 and 10
Moreover, samples that did not have a ratio of between 1.8 and
2.2 had a RIN lower than 7. This provides further evidence that
this RNA is of high quality and suitable for RT-qPCR and/or
RNA seq analysis.
Since RNA yields from human denervated tissue remained
lower than that reported from rodent studies (Yamamoto
et al., 2012; Weng et al., 2018), this necessitated further
exploration of peri-operative variables. Specifically, the effect
of surgical antiseptics on RNA yield. Figure 3 suggests that
samples liberated using the “clean change” surgical protocol
(Group 3) yielded RNA in concentrations 2.8 times higher
than those extracted under standard conditions (p < 0.01)
(Groups 1 and 2). In comparing denervated tissue to healthy
nerve samples, the concentration of RNA isolated from healthy
nerve samples was significantly lower than that from denervated
tissue (p < 0.05) (Figure 3). Assessments of RNA quality
(260/280 absorbance ratios, ratio of ribosomal RNA bands in
agarose gels and changes in electropherogram morphology)
suggested that the RNA was of high quality (Figure 2) similar
to the quality of RNA from nerve samples cryopreserved within
3 min (Figure 2).
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FIGURE 2 | The effect of time delays and surgical antiseptic reagents on the
quality of RNA isolated from human nerve tissue. (A) A scatter plot to
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FIGURE 2 | Continued
demonstrate the distribution of 260/280 ratios yielded from RNA isolated from
denervated human nerve samples surgically liberated and cryopreserved
within 3 min (experimental Group 1) compared to those that were not
cryopreserved within this timeframe (experimental Group 2). The two dotted
black lines represent the range of 260/280 ratios that is predictive of high
quality RNA (1.8–2.2). (B) Electropherograms (left) and agarose gels (right)
digitally produced by the ExperonTMAutomated Electrophoresis System to
assess quality of RNA isolated from denervated human nerve samples. The
electropherogram is displayed with fluorescence on the y-axis and time of the
fragment on the x-axis. The upper electropherogram/agrose gel represents a
denervated sample cryopreserved within 3 min (Group 1) and the lower
electropherogram/agrose gel represents a denervated sample that was
exposed to a time delay of 20 min (Group 2). (C) A scatter plot to represent
the 260/280 ratios yielded from healthy and denervate samples liberated
under a “clean change” surgical protocol (Group 3). (D) Electropherogram
(left) and agarose gels (right) to assess the quality of RNA isolated from healthy
and denervated samples liberated under a “clean change” surgical protocol.
The upper electropherogram/agarose gel represents a denervated sample
(Group 3) and the lower electropherogram/agarose gel represents sural nerve
(Group 3). All samples that yielded 260/280 ratios of between 1.8 and 2.2
were assessed to have Ribosomal Integrity Numbers (RIN) of between 7 and
10 (predictive of high quality RNA).
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FIGURE 3 | Even when the time delay is minimized/equivalent between
samples there is still a large differential In RNA yield due to exposure to
surgical antiseptics. Denervated samples were liberated under a standard
(n = 4) and “clean change” (n = 3) surgical protocol. Samples liberated in a
surgical environment where the “clean change” surgical protocol was
implemented yielded RNA concentrations significantly higher than those
liberated under standard conditions (p < 0.01, two tailed t-test). Healthy nerve
samples were also liberated under a “clean change” protocol (n = 3) which
yielded significantly lower concentrations of RNA compared to denervated
samples < p < 0.001 two tailed t-test). The dotted black line represents the
minimum concentration of RNA often required for downstream RT-qPCR/RNA
seq. Data are means ± 1 SD.
Using nerve tissue freshly harvested from rats under carefully
controlled environmental conditions enabled the effects of
antiseptic reagents to be studied in isolation. A significant
decrease in the yield of RNA (approximately 8.3 fold lower in
exposed nerves compared to the untreated group) (p< 0.01) was
detected following exposure of rodent nerve samples to each of
the different antiseptic reagents (Figure 4).
DISCUSSION
In order to establish a protocol for the reliable extraction of RNA
from human nerve samples, this study set out to characterize
peri-operative variables predictive of RNA yield. The effect on
FIGURE 4 | RNA yield from rodent nerves is reduced following exposure to
surgical antiseptic reagents There was a statistically significant difference
between the untreated (n = 8) and each of the treated groups (2%
Chlorhexidine gluconate (n = 6), 10% lodine/EtOH (n = 6). 10%
lodine/H2O < n = 6) as assessed by a one way ANOVA and Dunnett’s test
(p < 0.0l between each treatment group and the untreated group). Data are
means ± 1 SD. The black dotted line at 5 ng/ul represents the minimum
concentration of RNA required for downstream RT-qPCR and RNA
seq applications.
RNA yield of time delays between liberation of the nerve sample
and snap freezing was investigated and results suggested that
nerve samples should be snap frozen within 3 min to preserve
RNA quantity and quality. This time interval is considerably
shorter than that cited in other studies that have extracted RNA
from surgical specimens which have shown that time delays
of several hours between surgical liberation of a sample and
cryopreservation is detrimental to RNA quantity and quality
(Mee et al., 2011; Samadani et al., 2015; Patel et al., 2017).
Studies of surgically harvested tissue have largely been limited
to the study of non-fibrous cancerous tissues such as breast and
prostate (Mee et al., 2011; Samadani et al., 2015; Patel et al., 2017).
These studies achieved optimal yields of RNA (sufficient for RT-
qPCR and RNA seq analysis) largely through the optimisaiton
of RNA extraction protocols alone. This is perhaps attributable
to the fact that the cancerous tissues explored in these studies
have higher cellular densities than nerve tissue and thus more
RNA that can be isolated, perhaps diminishing the impact of
time delays and/or exposure of samples to antiseptic reagents
on the quantity and quality of isolated RNA. Another major
difference between nerve samples and other organs is that the
nerve trunk contains bundles of axons, together with Schwann
cells, fibroblasts, endothelial cells, perineurial cells and other
associated cells, but the cell bodies of the neurons are not
present since they are located within the CNS or adjacent ganglia.
Therefore the RNA which is obtained from excised nerve samples
will be predominantly derived from Schwann cells and other
non-neuronal cells rather than neurons.
Even when delay was minimized, RNA yields from human
nerves in this study remained lower than those reported in
rodent studies of denervated nerve tissue (Yamamoto et al.,
2012; Weng et al., 2018). Therefore the exploration of other
peri-operative variables such as the interaction of samples with
antiseptic surgical reagents such as chlorhexidine and iodine
was necessitated. This study showed for the first time that
exposure of nerves to surgical antiseptic reagents had detrimental
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effects on the quantity of RNA that was isolated from the samples.
Chlorhexidine and povidone-iodine based antiseptic reagents
are cytotoxic to prokaryotic and eukaryotic cells. Chlorhexidine
works by binding to the cell membrane causing it to rupture.
On the other hand, povidone-iodine has a broader spectrum of
antimicrobial activity. It works by crossing the cell membrane
and destroying microbial proteins as well as DNA. It follows that
these reagents may have acute cytotoxic effects within the nerve
samples thus impairing RNA yield.
It was evident that healthy nerve samples yielded significantly
lower quantities of RNA than that from denervated tissue, which
concurs with rodent studies (Yamamoto et al., 2012; Weng et al.,
2018) even when the exposure of nerve samples to antiseptic
reagents was minimized and the time delay was limited to 3 min.
The differential observed in both species is likely to be due to
the biological mechanisms that underpin nerve regeneration.
Evidence from rodent and human models of nerve injury have
shown that Wallerian degeneration starts soon after nerve injury,
involving a complex cascade of events including degradation
of the fibrous connective tissue (Rotshenker, 2011). This may
make denervated tissue more amenable to lysis and cellular
disruption leading to higher yields of RNA compared with
intact healthy nerve tissue. Furthermore, Wallerian degeneration
involves proliferation of Schwann cells as well as infiltration and
proliferation of other non-neuronal cells (such as macrophages
and other immune system cells) (Rotshenker, 2011), potentially
contributing to increased RNA content in denervated nerve
tissue. This finding highlights the pertinence of considering the
innervation status of nerve tissue in order to optimize RNA yield.
In order to isolate and further investigate the effects of
exposure to antiseptic reagents, this study used a rodent model
of peripheral nerve liberation which showed that these antiseptic
reagents reduced RNA yields significantly. Chlorhexidine and
iodine based reagents can be found in abundance in operating
theaters around the world where they are often deployed
for preoperative skin preparation. This finding, together with
experimental evidence that has shown iodine and chlorhexidine
based reagents to have cytotoxic effects on in vitro populations
of human neuronal cells and rodent Schwann cells (Doan et al.,
2012), necessitates further work to characterize the effect of
these reagents on the regenerative capacity of the peripheral
nervous system. This could potentially inform the modification
and development of surgical tissue handling protocols more
generally, beyond just the focus here on obtaining nerve tissue
RNA for research.
In addition to influencing RNA extraction, iodine and
chlorhexidine based reagents may have downstream effects on
qPCR assays. These reagents have been shown to inactivate the
Human Immunodeficiency Virus through a mechanism thought
to be at least partially attributable to the ability of these reagents
to manipulate the viral DNA reverse transcriptase (Harbison and
Hammer, 1989; Sattar and Springthorpe, 1991). This enzyme is
analogous to the RNA to cDNA reverse transcriptase step used
in RT-qPCR and RNA seq assays, providing an additional reason
to avoid the contamination of samples intended for downstream
qPCR and RNA seq assays.
In summary, this study reports new experimental evidence
from human and animal studies that reveals the effects of
time delays and surgical antiseptics on the RNA yield obtained
from nerve tissue. This information can help to inform the
development of improved methodology, specifically limiting time
delay between sample liberation and cryopreservation to less than
3 min whilst utilizing a “clean change” surgical protocol to reduce
antiseptic exposure. These findings provide new information
about the response of fresh nerve tissue following isolation,
including differences between healthy and denervated samples.
This understanding will enable more effective use to be made of
valuable human nerve tissue samples, addressing the knowledge
gaps that currently exist in studying cellular and molecular
mechanisms that underpin human nerve regeneration.
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Schwann cell reprogramming and differentiation are crucial prerequisites for neuronal
regeneration and re-myelination to occur following injury to peripheral nerves. The
neurotrophin receptor p75NTR has been identified as a positive modulator for Schwann
cell myelination during development and implicated in promoting nerve regeneration
after injury. However, most studies base this conclusion on results obtained from
complete p75NTR knockout mouse models and cannot dissect the specific role of
p75NTR expressed by Schwann cells. In this present study, a conditional knockout
model selectively deleting p75NTR expression in Schwann cells was generated, where
p75NTR expression is replaced with that of an mCherry reporter. Silencing of Schwann
cell p75NTR expression was confirmed in the sciatic nerve in vivo and in vitro, without
altering axonal expression of p75NTR. No difference in sciatic nerve myelination during
development or following sciatic nerve crush injury was observed, as determined by
quantification of both myelinated and unmyelinated nerve fiber densities, myelinated
axonal diameter and myelin thickness. However, the absence of Schwann cell p75NTR
reduced motor nerve conduction velocity after crush injury. Our data indicate that the
absence of Schwann cell p75NTR expression in vivo is not critical for axonal regrowth or
remyelination following sciatic nerve crush injury, but does play a key role in functional
recovery. Overall, this represents the first step in redefining the role of p75NTR in the
peripheral nervous system, suggesting that the Schwann cell-axon unit functions as a
syncytium, with the previous published involvement of p75NTR in remyelination most
likely depending on axonal/neuronal p75NTR and/or mutual glial-axonal interactions.
Keywords: Schwann cells, p75NTR, myelination, regeneration, nerve injury
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INTRODUCTION
Schwann cells are axon-ensheathing glial cells of the peripheral
nervous system (PNS) and are essential in maintaining normal
nerve function as well as facilitating nerve repair following
injury. Two subtypes of Schwann cells exist in the adult
PNS, either myelinating or non-myelinating. The myelinating
Schwann cells form a multi-layered myelin sheath around a
segment of a single large-caliber axon, spirally wrapping its
plasma membrane around the axon. In contrast, non-myelinating
Schwann cells surround and segregate groups of several small-
diameter nociceptive axons, in a structure called Remak bundles.
The development of the PNS into these organized structures
has been extensively studied and the identification of essential
molecules and signaling pathways established (Jessen and Mirsky,
2005; Richner et al., 2014; Gonçalves et al., 2017). An important
group in this context is the family of neurotrophins consisting
of nerve growth factor (NGF), brain derived neurotrophic factor
(BDNF), neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5),
which binds to two structurally unrelated receptors: the p75
neurotrophin receptor (p75NTR) and the tropomyosin receptor
kinases (TrkA, -B, and -C). It is generally well accepted that
binding of neurotrophins to the Trk receptors mediate survival
and differentiation, but the specific functions of p75NTR in the
PNS remains elusive. The controversy may partly be attributed
to the fact that p75NTR is expressed by both neuronal and
glial cell types and furthermore may have very different and
even contradictory roles depending on cell type and temporal
expression pattern, including survival signaling, cytoskeletal
organization as well as the induction of cell death (Chao,
2003; Reichardt, 2006; Meeker and Williams, 2015), providing
substantial cellular and molecular diversity of this receptor.
Damage to adult peripheral nerves causes axonal degene-
ration, myelin degradation and Schwann cell dedifferentiation
distal to the injury site in the process of Wallerian degeneration.
Interestingly, such injury also induces mechanisms at the cellular
level resembling those active during development, including
increased neurotrophin synthesis in neurons and Schwann cells
which, which is important for guiding and supporting axonal
regeneration (Richner et al., 2014). It is well established that
p75NTR is expressed by Schwann cells during development and
following peripheral nerve injury (Taniuchi et al., 1986; Johnson
et al., 1988), where a high expression level is maintained until
contact between the (re)growing axons and Schwann cells have
been established and (re)myelination initiated (Johnson et al.,
1988). In line with this, studies using complete p75NTR knockout
(KO) mouse models have found that the lack of p75NTR results
in reduced PNS myelination (Cosgaya et al., 2002). However, the
mechanism by which p75NTR affects nerve regeneration following
injury is unclear. p75NTR has been reported to inhibit motor
axonal regeneration (Boyd and Gordon, 2001), be indispensable
for motor axonal regrowth (Gschwendtner et al., 2003), to be
important for regeneration and remyelination of motor neurons
(Tomita et al., 2007), and important for both the number
and regrowth of axons in a mixed nerve (Song et al., 2006,
2009). A central tool for the majority of previous studies
investigating the role of p75NTR in the PNS has been the
complete p75NTR KO mouse models, the exon III deletion (Lee
et al., 1992) and the subsequent exon IV model (von Schack
et al., 2001). These KO models demonstrate a dramatic PNS
phenotype, with an approximately 40–50% reduction in DRG
neurons and myelinated axon numbers as well as impaired
levels of myelination (Cosgaya et al., 2002). Importantly, these
models exhibit loss of p75NTR in Schwann cells, DRG- and
motor neurons and the use of such models cannot therefore
clarify whether the observed phenotypes result from loss of
p75NTR in the Schwann cells, a neuronal subpopulation or
both. To complicate matters further, it has subsequently been
determined that both models are not complete KOs but retain
the expression of an alternative active splice variant (exon III
model) or results in a pro-apoptotic fragment (exon IV model)
(von Schack et al., 2001; Murray et al., 2003; Paul et al., 2004).
In this study, to dissect the role of p75NTR signaling in Schwann
cells in the process of nerve regeneration and remyelination
following nerve crush injury, we have developed a conditional
KO model selectively deleting p75NTR expression in Schwann
cells. Our results show that p75NTR deletion in Schwann cells
does not affect the structure of the uninjured myelinated or
unmyelinated fibers. In response to injury, although axonal
regeneration and remyelination appeared unaffected in Schwann
cell p75NTR deficient animals, these mice nonetheless exhibited
reduced recovery of motor nerve conduction velocity.
MATERIALS AND METHODS
Mouse Model Generation
To generate mice with conditional deletion of p75NTR in
Schwann cells, p75fl/fl mice (Boskovic et al., 2014) were crossed
to transgenic mice containing the myelin protein zero promoter
driving expression of Cre recombinase (Mpz-cre) (sourced from
the Jackson Laboratory strain #017927) (Feltri et al., 1999). Upon
recombination, the p75NTR genomic DNA flanked by the loxP
sites is inverted and, in p75in/in cells, expression of p75NTR
is replaced by expression of mCherry (Boskovic et al., 2014).
The resulting knockout mice were termed p75in/in Mpz-cre
(referred to as SC-p75NTR-KO throughout this manuscript). All
mice were on a C57BL/6 background and housed in specific
pathogen-free conditions at the Melbourne Brain Centre Animal
Facility (The Royal Melbourne Hospital, Australia). Animal
breeding procedures were approved by The Florey Institute for
Neuroscience and Mental Health Animal Ethics Committee and
followed the Australian Code of Practice for the Care and Use of
Animals for Scientific Purposes.
Mouse Surgery
For the mouse model of injury, 8–10-week-old female SC-
p75NTR-KO and p75NTRfl/fl Cre- (control littermates) were used.
By this age, the PNS is already mature and injury effects will
not be misinterpreted by the developmental process. Anesthesia
was induced with isoflurane and a subcutaneous injection of
buprenorphine and ampicillin administered prior to surgery, to
minimize pain and post-surgical distress. The thigh and legs
were shaved, eyes protected from drying and the sciatic nerve
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exposed at the mid-thigh level by separating the biceps femoris
and the gluteus superficialis. After carefully clearing surrounding
connective tissue, the left sciatic nerve was crushed with a
non−serrated clamp, twice for 15 s. A sham operation was
performed similarly at the contralateral side, where the sciatic
nerve was exposed and the skin closed immediately after. In both
situations, the musculature was prepared with minimum tissue
damage to guarantee the ideal conditions for functional recovery.
Mice were cared for in a pathogen-free environment, in a
12 h light/dark cycle and with water and food ad libitum. One
group of animals was euthanized at post-injured day 15 (n = 4
littermates, n = 6 SC-p75NTR-KO) while the other group was
sacrificed 29 days after injury (n = 8 littermates, n = 6 SC-p75NTR-
KO). Animals were handled according to the European Union
Council Directive and National rules.
Sensorimotor Analysis
Sensorimotor behavior was analyzed before (0) and 1, 5, 7, 14,
and 28 days after injury.
Mechanical allodynia was assessed with the application of
a set of calibrated Von Frey filaments (Touch-Test
R©
Sensory
Evaluators, North Coast Medical, CA, United States) into the
midplantar side of the hind paw until the filament was just bent
(bending forces from 0.2 to 2 g). Mice were placed in a Plexiglas
cage with mesh flooring and allowed to acclimate for 1 h. The
stimulus was repeated five times with each filament and a positive
response in three out of five repetitive stimulations stated as the
pain threshold. The withdrawal threshold is expressed in grams.
The Hargreaves test was used to measure paw withdrawal
latency to a noxious thermal stimulus using a Heat Flow I.R,
Radiometer (Hargreaves Apparatus, Cat. #37370, Ugo Basile,
Gemonio, Italy). The radiant heat source was kept at 50%
(190 mW/cm2) in all tested animals that were let to acclimatize
for 1 h before the procedure. Hind paws were tested alternately
with 5 min between consecutive tests, and five measurements
were obtained for each side, that were averaged for a final result.
A cut-off of 20 s was established to avoid potential burn injury.
Walking tract analysis was performed to access locomotor
functional recovery. Briefly, the mice hind feet were pressed
onto a non-toxic ink pad and animals were then allowed to
walk through a dark corridor over an A3 white printer paper.
The obtained footprints were then measured to calculate the
sciatic functional index (SFI) using the empirical equation
adapted for mice by Inserra et al. (1998): SFI = 118.9 × [(ETS-
CTS)/CTS] − 51.2 × [(EPL-CPL)/CPL] − 7.5, where ETS
represents operated experimental toe spread (distance between
the first and fifth toes), CTS stands for control toe spread, EPL
for operated experimental print length and CPL for control print
length (Inserra et al., 1998). Footmarks made at the beginning of
the trial were excluded and three analyzable walks were evaluated
from each run, for individual step parameter calculation. The
pre-injured SFI values (time point = 0) were used as control
for comparison. The SFI scores that we processed ranged from
0 to −130, with 0 representing normal or completely recovered
nerve function and −100 or more, a non-functional nerve;
thus, mice that dragged their toes were arbitrarily assigned a
value of−100.
Nerve Conduction Velocities
Motor (sciatic) and sensory (sural) nerve conduction velocities
(NCV) were performed in naïve mice and 29 days injured
ones, according to (Oh et al., 2010) using a Viking Quest
apparatus (Natus Neurology Incorporated, United States).
Briefly, for sural nerve, recording electrodes were placed in
the dorsal part of the foot, with supramaximal stimulation
at the ankle. Sural sensory NCV (m/s) was calculated by
dividing the distance between the recording and stimulating
electrodes (mm) by the onset latency (ms) of the sensory nerve
action potential after supramaximal antidromic stimulation.
Sciatic-tibial motor NCV was recorded by placing electrodes
dorsally in the foot and orthodromically stimulating first at
the ankle, then at the sciatic notch. The distance between
the two sites of stimulation (mm) was then divided by the
difference between the two onset latencies (ankle distance
and notch distance, ms) to calculate the final sciatic-tibial
motor NCV (m/s).
Immunohistochemistry and Microscopy
Naïve P11 mice were perfused transcardially with 4%
paraformaldehyde (PFA), sciatic nerves isolated, frozen and
10 µm cryosections collected. For tissue imaging, frozen
sections were incubated with primary antibodies directed against
p75NTR (G323A, Promega), βIII-tubulin (G7121, Promega)
and contactin-associated protein 1 (Caspr, a kind gift from
Professor Elior Peles, Weizmann Institute of Science, Israel),
diluted in blocking buffer containing 10% FBS and 0.3% Triton
X100 in PBS. Incubation with proper fluorophore-conjugated
secondary antibodies (Invitrogen) was followed. PBS was then
used to wash the sections that were finally mounted in DAKO
mounting medium containing DAPI. Three animals per group
were evaluated, and images captured by confocal microscopy
(LSM 780, Carl Zeiss, Germany).
Western Blot Analysis
Sciatic nerves from adult control littermates (n = 6) and SC-
p75NTR-KO (n = 6) mice were dissociated in lysis buffer
(2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 140 mM
NaCl and 1% Triton X-100, pH 7.8, with protease inhibitors
from Roche) and centrifuged at 10.000 × g for 10 min at
4◦C. Total protein concentration was determined using the
Bicinchoninic Acid kit from Sigma. Protein lysates were run
on 12% SDS-PAGE (20 µg/lane) and electro-blotted for 1.5 h
onto polyvinylidenedifluoride (PVDF) filters (Amersham) in
192 mM glycine, 25 mM Tris–HCl, pH 8.0. Membranes were
then blocked and incubated overnight at 4◦C with the primary
antibodies: rabbit anti-p75NTR (1:500, Promega, Cat. #G323A)
and mouse anti-β-actin (1:5000, Sigma, Cat. #A5441). Following
a washing step, membranes were incubated with horseradish
peroxidase (HRP)-conjugated secondary antibodies (1:1000,
swine anti-rabbit, Dako, Cat. # P0217; rabbit anti-mouse, Dako
# P0260) and blots visualized with the Amersham ECL plus
western blotting detection reagents (GE Healthcare) and Fuji
film LAS1000. Densitometry was performed with QuantityOne
software (Bio-Rad).
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Morphological and Morphometric
Analysis
Nerve samples were processed for morphological and morpho-
metrical analysis of myelinated and unmyelinated nerve fibers.
Fixation of nerve samples was carried out using 2.5% purified
glutaraldehyde and 0.5% sucrose in 0.1M Sorensen phosphate
buffer for 2–4 h. Samples were subsequently post-fixed in
2% osmium tetroxide for 2 h at 4◦C and dehydrated in a
sequence of ethanol from 30 to 100%. After being cleared
in propylene oxide, samples were embedded in Glauerts’
embedding mixture of resins containing equal parts of Araldite
M and Araldite Harter, HY 964 (Merck, Darmstad, Germany),
including 0.5% of the plasticizer dibutyl phthalate and
1–2% of the accelerator 964, DY 064 (Merck). For high-
resolution light microscopy, semi-thin transverse sections
(2.5 µm) were cut in a Leica Ultracut UCT ultramicrotome
(Leica Microsystems, Wetzlar, Germany) and stained with
Toluidine blue. Stereology was performed in a DM4000B
microscope equipped with a DFC320 digital camera and an
IM50 image manager system (Leica Microsystems, Wetzlar,
Germany). Systematic random sampling and D-dissector
were adopted using a protocol previously described (Geuna
et al., 2000, 2004). Total number of myelinated fibers,
axon and fiber size, myelin thickness and g-ratio were
then determined.
For electron microscopy, ultrathin sections (70 nm thickness)
were cut by using an ultramicrotome Leica EM UC7 (Leica,
Wien, Austria). Sections were collected onto formvar-coated slot
grids and counterstained with uranyl acetate and lead citrate.
A 100 kV transmission electron microscope (EM JEM 1230, JEOL
Ltd., Tokyo, Japan) was used for qualitative and quantitative
examination of the samples. For C-fiber counting, we started at
one corner of the fascicle and acquired images of every third
microscopic field with 15,000× magnification until 35 images
were photographed. C-fibers in the images were counted and
their density calculated.
Schwann Cell Cultures Derived From
Sciatic Nerves of Adult Mice
Schwann cell cultures from adult mouse sciatic nerves were
prepared as described by Wang and colleagues (Wang et al.,
2013), with some alterations to the protocol. In brief, n = 16
littermates and n = 16 SC-p75NTR-KO mice were sacrificed
by cervical dislocation prior to sciatic nerve dissection into
L-15 medium. The dissected nerves were rinsed in PBS and
incubated in Schwann cell culture medium [SCCM; DMEM
supplemented with 10% FBS, 2 µM forskolin (Sigma, Cat.
#F6886), 10 ng/mL human heregulin-β1 (R&D Systems, Cat.
#396-HB) and 50 ng/mL b-FGF (PeproTech, Cat. #100-18B)]
for 1 week at 37◦C and 5% CO2. The media was changed every
2 days. Nerves were then cut into approximately 2 mm and
digested for 40 min with a mixture of 0.2% collagenase NB4
Standard Grade (Nordmark Biochemicals, Cat. #S1745402) and
0.2% dispase (Sigma, Cat. #D4693) at 37◦C and subsequently
triturated and plated onto poly-L-lysine coated 60 mm dishes
and incubated for 2 days in SCCM. The mixed cultures where
then trypsinized and plated on coverslips at a density of 100,000
cells/coverslip and cultured for additional 2 days before fixation
in 4% PFA for further processing.
Immunocytochemistry and Microscopy
of Schwann Cell Cultures
The fixed Schwann cell cultures were permeabilized with PBS
containing 0.1% Triton-X 100 for three times 10 min and
subsequently incubated in PBS containing 5% donkey serum
and 1% BSA to block unspecific binding of the antibodies. The
cells were incubated with rabbit anti-p75NTR [1:1500, (Huber
and Chao, 1995), Cat. #9651] diluted in PBS containing 1%
BSA overnight at 4◦C. The samples were incubated 1 h at room
temperature the following day before three times 10 min wash
in PBS and 4 h incubation with AlexaFlour488 donkey anti-
rabbit IgG (H+L) (1:300, Life Technologies, #A21206) diluted
in PBS containing 1% BSA. After three times 10 min washing,
Hoechst 33258 was used for nuclear staining (1:10.000, Sigma).
Sections were then mounted with Dako Fluorescent mounting
medium and sealed with nail polish. Images were acquired
with a ZEISS Axio Imager 2 microscope (Carl Zeiss, Germany)
equipped with a Hamamatsu digital camera (ORCA-flash4.0
digital camera, model C11440-22CU, Hamamatsu Photonics
Deutchland GmbH, Germany) and subsequent image analysis
performed with ImageJ.
Statistical Analysis
Statistical comparison of data was accomplished using the
Student t-test or One/Two-way ANOVA followed by Bonferroni
post-test, with Graph Pad Prism software. Quantitative data is
reported as mean ± SEM. Statistical significance was established
for p∗ < 0.05, p∗∗ < 0.01, p∗∗∗ < 0.001.
RESULTS
Targeted Disruption of p75NTR
in Schwann Cells
To generate an in vivo model appropriate for investigating the
involvement of Schwann cell-expressed p75NTR in peripheral
myelination, we developed mice with selective deletion of
p75NTR in Schwann cells. For this purpose, mice harboring
loxP recognition sites in the Ngfr gene (Boskovic et al., 2014)
were crossed with transgenic mice in which Cre recombinase
is expressed under the control of the Myelin Protein Zero
(P0) promoter (Feltri et al., 1999), to finally produce SC-
p75NTR-KO mice. The P0 promoter becomes active in Schwann
cell precursors at embryonic day 13.5–14.5, which includes
cells that develop into both myelinating and non-myelinating
Schwann cells but excludes other glial cells and dorsal root
ganglion neurons (Feltri et al., 1999, 2002). Therefore, upon
introduction of Cre recombinase (as heterozygote Cre+/−),
the Ngfr genomic DNA flanked by loxP sites is inverted and
expression of p75NTR in Schwann cells is replaced with that of
mCherry, while Cre-negative (Cre−/−) littermate controls have
unchanged p75NTR expression (Figure 1A). Immunofluorescent
Frontiers in Cellular Neuroscience | www.frontiersin.org 4 May 2019 | Volume 13 | Article 235269
fncel-13-00235 May 27, 2019 Time: 14:38 # 5
Gonçalves et al. Schwann Cell p75NTR in Peripheral Regeneration
FIGURE 1 | Continued
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FIGURE 1 | P75NTR inactivation in Schwann cells. (A) Double-label immunofluorescence microscopy of p75NTR (green) and βIII-tubulin (pink) in P11 sciatic nerve of
SC-p75NTR-KO and WT littermates. mCherry emitting fluorescence was identified in channel 568. Nuclei are labeled with Hoechst (blue). The overlap of tubulin and
p75NTR reflects axonal p75NTR (white). Note that in the WT, there is a noticeable amount of p75NTR staining that does not overlap with tubulin (green color in the
merge), possibly due to p75NTR expression in Schwann cells. Images represent n = 4 mice/group; scale bar 25 µm. (B) Fluorescence images of cells that were
primary cultured from adult mice sciatic nerves, fixed and stained with an antibody against p75NTR (green). mCherry 568 fluorescence was observed in Schwann
cells from SC-p75NTR-KO but not WT littermates. In the merge panel, it is clear that p75NTR was only present in Schwann cells and not fibroblasts from the WT
nerves (cells with bigger nuclei displayed with Hoechst, blue), being completely absent in the SC-p75NTR-KO. Scale bar 10 µm; n = 16 mice/group. (C) P75NTR was
determined by immunoblot analysis in extracts of sciatic nerves isolated from adult mice. Quantification of p75NTR ratios by densitometry against levels of β-actin.
Data represent the mean ± SEM for six mice/genotype (∗∗∗p < 0.001 compared with littermate controls). (D) Immunofluorescence microscopy of Caspr (green) in
naïve P11 sciatic nerves. Note similar intensity and distribution of immunoreactivity throughout the tissue in both genotypes. Nuclei are identified with DAPI (blue) and
mCherry visualized in the red channel in SC-p75NTR-KO mice. Scale bar, 50 µm; n = 4 mice/group.
staining of sciatic nerves demonstrated a significant amount of
p75NTR immunostaining in axons of both SC-p75NTR-KO or
littermate controls (Figure 1A), confirming that SC-p75NTR-KO
mice continuously express p75NTR in peripheral neurons/axons.
To further substantiate that the inversion strategy resulted in
loss of p75NTR protein in Schwann cells, we prepared Schwann
cell primary cultures from adult mice. Our results clearly
confirmed that SC-p75NTR-KO derived Schwann cells presented
red mCherry fluorescent signal and no p75NTR immunostaining,
with contrary observations in Schwann cells isolated from
the littermate controls (Figure 1B). Western blot analysis
of lysates isolated from whole sciatic nerves demonstrated
an approximately 30% reduction of p75NTR expression in
SC-p75NTR-KO nerves relative to littermate control nerves
(Figure 1C), revealing that the majority of p75NTR protein in
adult mouse sciatic nerves is expressed by other cell types,
primarily neurons (axons). We did not detect any evidence of
altered Mendelian ratios of the SC-p75NTR-KO mice relative
to littermate controls, and deviation in size or weight was
not found between adult mice of different genotypes (data
not shown). Finally, there were no indication of any overt
neurological abnormalities in the SC-p75NTR-KO mice, and
Caspr immunostaining in developing nerve (at P11) did not
reveal any differences between paranodal junctions in myelinated
fibers between genotypes (Figure 1D).
SC-p75NTR-KO Mice Exhibit Mild
Behavioral Defects After Nerve Injury
To investigate the sensorimotor phenotype of SC-p75NTR-
KO mice, we initially evaluated sensory profiles by von
Frey filaments (mechanical sensitivity) and Hargreaves test
(thermal/heat sensitivity), as well as motor recovery by walking
tract analysis. Tests were performed as pre-injury baseline (time
point = 0) and at 1, 7, 14, 21, and 28 days following sciatic
crush injury. Baseline levels were equivalent between sham-
operated SC-p75NTR-KO and littermate controls for both Von
Frey and Hargreaves tests (Figures 2A,B). As expected, both
genotypes demonstrated reduced sensitivity from day 1 post-
injury, confirming destruction of sensory axons by the crush
procedure. Mechanical sensitivity increased over the following
period for both genotypes, likely reflecting axonal regeneration
and accompanying reinnervation of target tissues. The recovery
profile was largely identical for the two genotypes, reaching
baseline levels at day 14 and with a non-significant tendency
of increased sensitivity in the injured paw. For the SC-p75NTR-
KO we observed a small but significant transient decrease in
mechanical threshold at day 21 (relative to the contralateral
uninjured paw), however, this effect was absent at day 28
(Figure 2A). Hargreaves test demonstrated a pattern largely
identical to that of the von Frey test; 1-day after injury, both SC-
p75NTR-KO mice and littermate controls experienced reduced
sensitivity to heat-induced noxious stimulus that recovered to
baseline levels by day 7. We again observed a transient reduction
in sensitivity 21 days following nerve crush in the SC-p75NTR-
KO mice, which was absent by day 28 (Figure 2B). Recovery of
motor function was determined by assessing the SFI at the same
time points as for the sensory tests. No differences were found
at day 0 or any other time point after sciatic nerve crush injury
among the two mice groups (Figure 2C).
Electrophysiological properties of the sciatic nerves were
evaluated by measurements of sensory and motor nerve
conduction velocity (SNCV and MNCV, respectively) at 29 days
post nerve damage, as a terminal endpoint. Nerves from naïve
SC-p75NTR-KO mice and littermate controls displayed identical
SNCV (Figure 2D) and MNCV (Figure 2E). As expected, SNCV
and MNCV were significantly reduced following the injury.
However, although we did not detect any difference in post-injury
SNCV between SC-p75NTR-KO mice and littermate controls,
SC-p75NTR-KO mice exhibited a further 36% reduction of post-
injury MNCV relative to littermate controls (Figure 2F), pointing
toward ion leakage or/and structural defects in the largest
myelinated axons.
Conditional Deletion of p75NTR in
Schwann Cells Has No Impact on
Peripheral Myelination or Axon
Regeneration Following Nerve Injury
The observation of decreased MNCV in the injured SC-p75NTR-
KO mouse model could be due to variation in Schwann
cell remyelination of the damaged axons since appropriate
re-myelination after peripheral nerve injury has previously
been attributed to p75NTR (Song et al., 2006; Tomita et al.,
2007). We therefore evaluated nerve fiber morphology in semi-
thin cross-sections of sciatic nerves using light microscopy.
Representative images of sciatic nerves from SC-p75NTR-KO
and littermate controls, 15 and 29 days after injury, together
with respective non-lesioned nerves (contralateral sham) are
illustrated in Figure 3A.
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FIGURE 2 | Sensorimotor phenotypic analysis before and after sciatic nerve crush injury. (A) Mechanical nociceptive functional recovery evaluated using the Von
Frey filaments before and 1, 7, 14, 21, and 28 days after nerve injury. Significant difference noticed between contralateral sham and injured paw at 1- and 21-days
post-lesion in the SC-p75NTR-KO group, as consequence of nerve injury (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (B) Nociception evaluated with the Hargreaves test
at baseline (time = 0), 1, 7, 14, 21, and 28 days after nerve crush injury; (∗p < 0.05, ∗∗p < 0.01). (C) Locomotor function recovery assessed by walking tract analysis
and calculation of SFI at pre-treatment (time = 0), 1, 7, 14, 21, and 28 days after nerve crush injury. Nerve conduction velocity analysis of sural (sensory) (D) and
sciatic (motor) (E) nerves in naïve SC-p75NTR-KO and control littermates (n = 6 mice per genotype). (F) Nerve conduction velocity measurements in both genotypes
29 days after injury (∗∗∗p < 0.001; n = 6 SC-p75NTR-KO and n = 8 littermates).
Naïve sciatic nerves from SC-p75NTR-KO mice appeared
normal, with axons of various diameters present in proportions
that appeared similar to those observed in littermate controls and
with similar total numbers of myelinated axons (Figures 3A,B).
Features of myelinated axonal degeneration consistent with
axonal loss were observed in both SC-p75NTR-KO and littermate
controls after injury, with a similar decrease in axon number
(Figure 3B) in mice of both genotypes, however, only statistically
Frontiers in Cellular Neuroscience | www.frontiersin.org 7 May 2019 | Volume 13 | Article 2352 2
fncel-13-00235 May 27, 2019 Time: 14:38 # 8
Gonçalves et al. Schwann Cell p75NTR in Peripheral Regeneration
FIGURE 3 | Continued
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FIGURE 3 | Ablation of p75NTR in Schwann cells has no impact on re-myelination after nerve injury. (A) Representative light microscopy images of toluidine-blue
stained semithin transverse sections of sham contralateral and distal stumps from crush injured nerves, 15- and 29-days post-lesion. Scale bar 20 µm. (B–G)
Histograms obtained from the morphometrical analysis of the myelinated fibers. (B) Total number of myelinated fibers, (C) axon diameter, (D) fiber diameter, (E)
myelin thickness, and (F) g-ratio. Scatter plots showing g-ratio of individual myelinated axons as a function of axon diameter in contralateral shams (G) or injured
nerves at time points of 15 (H) and 29 days post lesion (I). Numbers for quantifications were as follows: n = 11 sham, n = 6 at 15 days, and n = 6 at 29 days for
SC-p75NTR-KO; n = 9 sham, n = 3 at 15 days, and n = 6 at 29 days for littermates.
different in the SC-p75NTR-KO mice. Mean of axonal diameter
(Figure 3C), fiber diameter (Figure 3D) or myelin thickness
(Figure 3E) were unchanged between genotypes both before
and following crush injury, but with an injury effect over time,
compared with the respective shams, as expected. Quantification
of acquired light microscopy images (with about 100 fibers
analyzed per animal) revealed no differences in averaged g-ratios
(Figure 3F) or in g-ratios of individual fibers vs. axon diameters,
as illustrated by scatter plots of sham and injured nerves, 15 or
29 days after damage (Figures 3G–I).
Proceeding with ultrastructural EM analysis of sciatic nerve
transverse sections, we found that the uninjured contralateral
nerve of both SC-p75NTR-KO and control mice was dominated
by large and medium-sized myelinated axons. Unmyelinated
axons (C-fibers) occurred in large groups embedded in Schwann
cells, forming Remak bundles (Figure 4A, left panel). The
endoneurium contained several blood vessels, fibroblasts, and
a few mast cells and macrophages. No variance in C-fiber
density was observed between the two mice cohorts (Figure 4B).
Pathology was evident in the injured ipsilateral side of mice of
both genotypes 15 days after crush, with most large myelinated
axons being absent and several medium-sized remyelinated
axons present in the endoneurium (Figure 4C). At days
15 and 29 post injury we observed myelin debris, multi-
vesicular bodies (MVB) and osmophilic and osmophobic fat
droplets in the perineurium, endoneurium, Schwann cells,
macrophages, fibroblasts and pericytes in all injured nerves.
Segmental demyelination of the internodal length and paranode
(Figure 4D) was a prominent feature of injured nerves from
both WT and SC-p75NTR-KO mice. Unmyelinated axons were
very sparse and predominantly appeared solitary rather than in
high numbers in Remak bundles in the Schwann cell cytoplasm
(Figure 4A, right panel). No obvious morphological differences
were found between control littermates and SC-p75NTR-KO
mice; however, although not statistically significant, the mean
C-fiber density in SC-p75NTR-KO mice tended to be slightly
decreased compared to that of littermate controls, 29 days after
injury (Figure 4B). This result suggests that lack of p75NTR
expression in Schwann cells can possibly alter their molecular
signaling profile, affecting glial-axon communication and slowing
down the C-fiber regenerative process.
DISCUSSION
In this study, to elucidate the in vivo function of p75NTR
in Schwann cells during re-myelination and regeneration after
peripheral nerve injury, we generated a new mouse model
for the conditional deletion of p75NTR in Schwann cells.
Through functional testing, morphological and morphometrical
analyses of SC-p75NTR-KO mice, we found that ablation of
p75NTR in Schwann cells correlated with a reduced motor nerve
conduction velocity but had no impact regarding remyelination
or axonal growth after sciatic nerve crush injury.
p75NTR is widely expressed in the nervous system during
development and has even been considered as a neural crest
marker (Wislet et al., 2018). Although p75NTR, also called NGF
receptor, has no intrinsic catalytic activity, it interacts and
modulates the function of TrkA, TrkB, and TrkC, providing
substantial cellular and molecular diversity for regulation of
neuron survival, neurogenesis, immune responses and processes
that support neural function (McGregor and English, 2019). In
Schwann cells, p75NTR is expressed by the immature type during
development and remains being expressed by the mature non-
myelinating Schwann cells in the adult. In contrast, myelinating
Schwann cells are not immunoreactive for p75NTR (Jessen and
Mirsky, 2005). Because p75NTR is highly down-regulated as the
nervous system matures, a powerful tool to induce expression
of this receptor is the dedifferentiation of Schwann cells by
induced nerve injury. Several reports demonstrated dramatic
upregulation of p75NTR in response to injury or disease, in both
the PNS and CNS (Meeker and Williams, 2015). However, these
previous studies focusing on the roles of p75NTR in development
and nerve regeneration have utilized the complete p75NTR KO
mouse model, resulting in loss of p75NTR in both Schwann cells
as well as in a DRG neuron subpopulation (Lee et al., 1992; von
Schack et al., 2001).
Two complete p75NTR KO models have been developed,
both of which demonstrate a dramatic PNS phenotype with
approximately 50% reduction in neuron/myelinated axon
number as well as reduced myelination of the remaining axons.
The first model was constructed by deleting exon III of the
Ngfr gene (Lee et al., 1992), however, it later turned out that
this model produces an alternatively spliced isoform of p75NTR
(s-p75NTR), producing a protein that lacks the portion of the
extracellular domain responsible for neurotrophin binding but
with its intracellular death-signaling moiety intact (Murray et al.,
2003). Complicating the picture, it appears that the genetic
background of the mouse also impacts on the phenotype as
expression of the s-p75NTR splice variant demonstrated a strain
dependent expression level (Naumann et al., 2002). This finding
triggered the development of another KO model, the exon
IV KO model (p75NTRExonIV) which does not express the
s-p75NTR variant. The p75NTRExonIV mice display a more
severe phenotype than the previous p75NTRexonIII mutants,
including a larger reduction in the number of DRG neurons
and Schwann cells, vascular system defects, and approximately
40% of p75NTRExonIV mice do not survive beyond the perinatal
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FIGURE 4 | Trend toward decreased C-fiber density in injured nerves from mice lacking Schwann cell p75NTR expression. (A) Representative images of ultrathin
transverse sciatic nerve sections from sham contralateral nerves (left panel) and 29 days post injury distal stumps (right panel) of the two experimental groups.
Arrowheads identify C-fibers. Scale bar 2 µm. (B) Density of C-fibers expressed as number of unmyelinated axons per square millimeter (n/mm2) Numbers for
quantifications were as follows: n = 12 sham, n = 6 at 15 days, and n = 4 at 29 days for SC-p75NTR-KO; n = 9 sham, n = 3 at 15 days, and n = 4 at 29 days for
littermates. (C) Electron micrographs showing re-myelinated fibers (asterisk) in both SC-p75NTR-KO and control WT littermates, 15 days after sciatic nerve crush
injury. (D) Representative pictures of segmental demyelination observed in both strains after sciatic nerve injury, both at internodal and paranodal regions.
Scale bar 5 µm.
period (von Schack et al., 2001). It was, however, soon determined
that the p75NTRExonIV model express a p75NTR gene product
encoding a truncated protein with an apparent molecular weight
of 26 kDa (Paul et al., 2004). The utilization of mouse models
with a general targeting profile (including both neurons and
Schwann cells) combined with the incomplete nature of the
p75NTR deletions and the difficulties in delineating the impact of
the genetic background, all complicates a rigorous interpretation
of previous findings on the role of p75NTR in specific PNS
cell subpopulations.
In the present study, the conditional deletion of p75NTR
in Schwann cells is driven by the P0 promotor, expressed in
Schwann cell precursors early in development (around E14),
thus silencing p75NTR expression in both myelinating and
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non-myelinating Schwann cells types (Feltri et al., 1999). Several
studies support a key role for p75NTR in the myelination
process (Chan et al., 2001; Cosgaya et al., 2002; Tolwani
et al., 2004). Surprisingly, our present results demonstrate
that depleting the myelinating Schwann cell subpopulation of
p75NTR during the myelination process does not compromise
myelin sheet formation nor motor function in the adult
naïve SC-p75NTR-KO mice.
Boskovic et al. (2014) have not detected any splice variant
at the transcriptional or protein levels when developing the
p75in/in mouse line used in our study. The fact that we see
no neuronal phenotype (reduction in axon number) supports
that the model is “clean” from the splice variants found in
the p75NTRExonIII and p75NTRExonIV models (which display
dramatic PNS phenotypes). Besides neurons and Schwann cells,
other cells types have been reported to express p75NTR such as
macrophages (Wong et al., 2010), endothelial cells (Tanaka et al.,
2004), white fatty tissue (Peeraully et al., 2004), and fibroblasts
(Palazzo et al., 2011). Whether such cell types in the sciatic nerve
also express p75NTR remains to be determined but this (along
with continued axonal expression) may explain the remaining
expression of p75NTR in the sciatic nerve upon deletion of
Schwann cell p75NTR. Our in vitro cultures of mouse Schwann
cells reveal that these cells are indeed devoid of p75NTR (and
positive for mCherry, confirming Cre-activity in these cells).
Due to the pleiotropic roles of p75NTR, it is not surprising
that its role in regeneration following nerve injury has been
controversial. While Song et al. observed reduced regeneration
in the p75NTR KO model, work from Scott and Ramer reported
that p75NTR expressed by Schwann cells is actually deleterious for
nerve regeneration. The mechanism suggested was that increased
Schwann cell p75NTR expression might sequester endogenous
neurotrophins and thus reduce their availability for axonal Trk
signaling (Scott and Ramer, 2009); a notion supported by the
enhanced regeneration of injured peripheral motor axons in
mice lacking the neurotrophin-binding domain of p75NTR (Boyd
and Gordon, 2001). In contrast with this observation, another
study using transplantation of p75NTR-deficient Schwann cells
to injured nerves from nude mice found that a lack of glial
p75NTR had a negative impact in the regeneration of motor
neurons (Tomita et al., 2007). This model is closer to ours in
terms of Schwann cell selectivity, however, the fact that they used
nude mice may complicate comparisons since other mechanisms
might have been activated by the inhibited immune system,
which consequently altered the Schwann cell-axon signaling
profile. Nevertheless, like in our study, no difference in the total
number of myelinated fibers and fiber density was observed, but
a significant decrease in motor nerve conduction velocity was
detected (Tomita et al., 2007). Myelin affects nerve conduction
velocity and in contrast with our observations, p75NTR null
Schwann cell-grafted mice displayed a significant decrease in
myelin thickness (Tomita et al., 2007), which could explain
the altered motor nerve conduction profile. Yet, this is not
always the case; for example, in mouse models of diabetic
neuropathy, decreased nerve conduction velocity is often not
accompanied by demyelination or fiber loss (Hinder et al., 2017).
The reason why this happens is not really understood, but
several factors are known to alter nerve conduction velocity
in addition to motor axon loss or decreased myelin thickness,
such as length of nodal gap (Arancibia-Cárcamo et al., 2017),
nodal axonal hydropic swelling (Kolaric et al., 2013), distribution
of sodium channels, defects in the Na+/K+ ATPase (Freeman
et al., 2016), impaired Schwann cell exocytosis (Chen et al.,
2012), mitochondrial fiber deficiency (Viader et al., 2011; Bala
et al., 2018) or reduced endoneurial nutritive blood flow (Coppey
et al., 2001). We speculate that in our model, the segmental
demyelination of the internodal length and paranode in the SC-
p75NTR-KO injured nerves leads to leakage of ions from the axons
culminating with slower motor nerve conduction velocities,
throughout a mechanism that still needs further clarification
but that might involve alterations in axonal sodium channels,
molecular signaling or composition, and differential regulation
of myelin production and repair (Taveggia et al., 2010). Thus, it
is fair to speculate that p75NTR might have a role in internode
length and/or nodal composition after injury. In line with this,
the regulation of neuronal form and function by Schwann cells
has been found to be mediated by different forms of intercellular
communication (Orellana et al., 2012; Samara et al., 2013), and
recent findings suggest the occurrence of lateral molecular cargo
transfer to axons mediated by exosomes secreted from Schwann
cells (Lopez-Verrilli and Court, 2012). This mechanism has
been poorly explored to date, but recent papers have described
Schwann cell secreted exosomes being incorporated into axons
and increasing neurite sprouting (Court et al., 2008; Lopez-
Verrilli et al., 2013). These findings open a new dimension to the
degree of intercellular interactions and the idea of a functional
nerve syncytium. Deletion of p75NTR in Schwann cells had no
apparent effect on basic sciatic nerve structure (developmental
effects) including the number or density of myelinated and
unmyelinated axons, myelination (g-ratio), nor on regeneration
upon crush injury. This is somewhat surprising, considering
the observations that p75NTR is highly expressed in Schwann
cells during development and the regenerative process. It is now
accepted that neurons can synthesize proteins locally in axons
and dendrites, and that this localized translation is required for
neuronal homeostasis (Jung et al., 2012). Perhaps neurons/axons
develop compensatory mechanisms to balance and counteract the
absence of p75NTR Schwann cell expression, altering e.g., vesicle
cargo and the glial-axon communication process?
A mouse line carrying a conditional knockout allele
for p75NTR (p75NTRExonIV–VI) was previously generated to
investigate its functions in DRG neurons in vivo (Bogenmann
et al., 2011). The allele was designed such that a complete and
conditional knockout could be achieved without the molecular
complexities observed in mice with either the p75NTRExonIII
(von Schack et al., 2001) or the p75NTRExonIV allele (Paul
et al., 2004). While otherwise normal in size (contrasting the
ExonIV model), p75NTRExonIV–VI mice displayed an abnormal
hind limb “clenching” phenotype similar to that seen in
p75NTRExonIII and p75NTRExonIV mice, suggesting that this
common neuropathic phenotype was at least in part due to
the impaired function of p75NTR specifically in neural crest
cells. In addition, there were far fewer small (unmyelinated and
lightly myelinated) diameter axon bundles in the mutant nerves
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(Bogenmann et al., 2011). Another study using stereological
counting demonstrated that p75NTRExonIII mice display a
52% loss of DRG neurons, with the loss of small nociceptors
being larger than the loss of large proprioceptors (57 vs. 39%,
respectively), and these data were supported by similar results
obtained by nerve fiber counts of unmyelinated vs. myelinated
axons (Gjerstad et al., 2002). This could either reflect that
p75NTR expression occurs predominantly in small nociceptors
or that it is most important for non-myelinating Schwann cells
to support axon survival, homeostasis and growth. The fact
that non-myelinating Schwann cells express p75NTR in adult
mice in contrast to the myelinating type also fits well within
this observation. Recently, one study indicated that neuron-
specific deletion of p75NTR at E12.5 was insufficient to impact
on neuronal survival during embryogenesis whereas 20% of DRG
neurons were lost in adult mice, suggesting that neuronal p75NTR
functions only postnatally in sensory neuron diversification
(Chen et al., 2017). In our Schwann cell conditional p75NTR
KO mouse model, we found a trend for reduced preservation of
unmyelinated fibers in the sciatic nerve 29 days after injury. The
crush injury model is a model of axonotmesis, in which axons
are disrupted but the connective tissue and the Schwann cell
basal lamina remains intact. When this crush model is applied in
rodents, axonal regeneration is remarkably efficient and function
is restored in 3–4 weeks (Jessen et al., 2015). Thus, it would
be predictable that potential early or late differences regarding
remyelination and axon regeneration would be detected by
evaluation of nerve morphology and morphometry at both 15-
and 29-days post-crush injury. Nevertheless, whether different
outcomes could have been found at even earlier time points after
nerve injury remains to be investigated.
In summary, the influence that p75NTR exerts upon the
regenerative and remyelinative processes in the PNS remain
controversial, with conflicting findings in DRG- and motor
neurons (Tomita et al., 2007; Scott and Ramer, 2009) and a lack
of clarity around Schwann cell and neuronal influences. Through
utilization of a Schwann cell specific p75NTR knockout strategy,
we demonstrate that Schwann cell expression of p75NTR is not
important for either sciatic nerve regeneration and remyelination
following crush injury, but does exert important influences upon
recovery of motor nerve function.
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The successful introduction of innovative treatment strategies into clinical practise
strongly depends on the availability of effective experimental models and their reliable
pre-clinical assessment. Considering pre-clinical research for peripheral nerve repair and
reconstruction, the far most used nerve regeneration model in the last decades is the
sciatic nerve injury and repair model. More recently, the use of the median nerve injury
and repair model has gained increasing attention due to some significant advantages
it provides compared to sciatic nerve injury. Outstanding advantages are the availability
of reliable behavioural tests for assessing posttraumatic voluntary motor recovery and a
much lower impact on the animal wellbeing. In this article, the potential application of
the median nerve injury and repair model in pre-clinical research is reviewed. In addition,
we provide a synthetic overview of a variety of methods that can be applied in this
model for nerve regeneration assessment. This article is aimed at helping researchers
in adequately adopting this in vivo model for pre-clinical evaluation of peripheral nerve
reconstruction as well as for interpreting the results in a translational perspective.
Keywords: median nerve, injury, animal experimental model, repair, regeneration, translational research
INTRODUCTION
Peripheral nerve injuries are commonly caused by motor vehicle, domestic, work or sport accidents
or during surgeries (iatrogenic nerve injuries) (Jones et al., 2016). Nerve injuries can lead to
motor and sensory deficits that may result in disabilities permanently compromising the patients’
quality of life.
The general ability of peripheral nerves to regenerate has been recognised more than a century
ago, but until today functional recovery outcome after severe nerve injury and reconstructive
surgery is often still poor in many patients. Nowadays, the “gold standard” reconstructive technique
for bridging a nerve gap is autologous nerve grafting. This technique, however, is accompanied
by important drawbacks such as the donor site morbidity, the need of additional surgery and
the limited availability of graft material for extended repair (Konofaos and Ver Halen, 2013;
Faroni et al., 2015).
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Over the past decades, substantial effort has been made to
identify new strategies to improve peripheral nerve regeneration
after grafting and to substitute the autologous nerve graft.
Advancements in biomedical methods, the tissue-engineered
technology, gene therapy approaches, nanotechnology, biology,
and microsurgical skills have opened new research fields in
the nerve reconstruction area. Indeed, there is an exponential
increase in the number of publications dealing with experimental
nerve regeneration research over the years: a literature search
with the PubMed search string (“Nerve-Regeneration”[Mesh]
OR nerve-regenerat∗ OR nerve-repair∗) AND (rat∗ OR mouse
OR mice OR rabbit∗ OR sheep), delivered 26 results in 1970
and 479 in 2018.
In the context of pre-clinical peripheral nerve regeneration
research, the choice of the experimental animal model is
of fundamental importance. When a researcher moves on
to test a novel attempt in vivo, the animal model should
be chosen according to the study aims [e.g., for studying
the involvement of a specific molecule in the biological
process of nerve regeneration, the most appropriate choice
will most likely be different to the model chosen for
evaluating the effectiveness of a nerve conduit for long
gap (>50 mm) repair]. Obviously, the pros and cons
of the different available options must also be taken into
careful consideration.
The choice of the appropriate experimental nerve
injury model is usually guided by several factors. For
nerve repair studies, in particular, the size (diameter and
length) of the model nerve is certainly one of the main
aspects considered. Indeed, most nerve repair studies are
conducted on the sciatic nerve especially because of its
big dimension that facilitates experimental microsurgery
(Varejao et al., 2004; Bozkurt et al., 2011; Sinis et al.,
2011a). The sciatic nerve is the biggest nerve in the body
and the choice among mouse, rat, rabbit, dog, or sheep
already provides variability in nerve gap lengths to be applied
(Angius et al., 2012).
Different downsides resulting from experimental injury to
the sciatic nerve have, however, led to increasing interest in
the median nerve as alternative model nerve (Bertelli et al.,
2004). At first, injury to the sciatic nerve results in a paralysis
of the hind limb and, often, in automutilation behaviour, such
as biting and self-amputation of denervated toes and paw areas
by the subjected animal. Longer lasting paralysis (>4 weeks
in the rat) often leads to joint contractures and stiffness.
Automutilation behaviour and joint contractures reduce the
reliability of functional tests, such as estimation of the sciatic
function index or, in severe cases, will lead to exclusion of the
respective animal from a study for ethical and animal welfare
reasons. Furthermore, possibilities for evaluation functional
recovery of motor skills after sciatic nerve lesion in the awaken
animal are rather limited or need considerable efforts to be
realised (Navarro, 2016).
In the recent years employment of the median nerve injury
and repair model in the experimental research has increased
(Papalia et al., 2003b; Ronchi et al., 2009) because of several
advantages. Transection injury of the rodent median nerve,
results in only partial impairment of the upper limb function
(Bertelli et al., 1995). Incidence of automutilation is significantly
lower in comparison to the sciatic nerve model, ulcerations
are fewer and no joint contractures can be seen. This milder
phenotype results from the fact that after median nerve injury,
the ulnar and radial nerves still preserve sensitivity and motor
function in the forearm (Sinis et al., 2006). An additional
advantage of the rodent median nerve injury and repair model
is that positively evaluated attempts are more likely to be
translated into clinical practise, since surgical interventions
for the repair of a damaged human nerve are very often
performed at the upper limb level. In addition, the hand
functions require a fine finger movement that is quite similar
between rodents and humans (Whishaw et al., 1992). From
this perspective, the possibility to apply specific and precise
functional tests for motor recovery evaluation following median
nerve reconstruction is a further pro of this model in pre-
clinical research.
This review provides an overview on the use of the median
nerve injury and repair experimental model in pre-clinical
research. The different animal species (not only mouse and
rat but also larger animals such as rabbit, sheep, and monkey)
are taken into account as are the different options these
species provide with regard to comprehensive analysis of the
regeneration outcome.
THE PRE-CLINICAL MEDIAN NERVE
INJURY AND REPAIR MODEL IN
DIFFERENT ANIMAL SPECIES
The use of the median nerve injury and repair model as pre-
clinical model has progressively increased in the last years, but
the sciatic nerve injury and repair model is still more often
employed [in PubMed a research on (median-nerv∗) AND
(regenerat∗ OR repair) yielded 1002 papers, while (sciatic-nerv∗)
yielded 6612 papers].
Information from our literature search is presented
in Tables 1–5. The tables summarise peripheral nerve
regeneration studies after median nerve injury and repair
in the different animal models. In addition to the specific
reference, the tables list animal strain and sex, type
of injury/gap, follow up periods and type of analyses
conducted. We took our best efforts to include all articles
available until end of 2018; nevertheless, inadvertently, we
could have missed some papers and apologise in advance
with their authors.
In the following paragraph specificities of the different models
listed in the tables will be reviewed in more detail.
Mouse Model
Since most of the available transgenic animal models are mice,
they are often used for studying the role of specific genes in the
peripheral nerve regeneration process. For this purpose, genes of
interest are knocked-out, mutated or over-expressed. Moreover,
mice – especially wild type strains – are economical in their
keeping, simple to handle and to care for and can therefore
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References Strain Sex Type of injury/gap Follow up Analysis
Jager et al., 2014 – F Crush injury (n = 5); Contralateral nerves
used as control (uninjured) nerves
25 days Functional analysis (grasping test), histological
analysis, TEM, morphometry
Park and Hoke, 2014 C57Bl/6J M Nerve repair (microsurgical 10/0 suture)
without Exercise (n = 8); Nerve repair
(microsurgical 10/0 suture) with
Exercise (n = 8); Control group (n = 8)
6 weeks Functional test, Electrophysiology,
morphometry, Immunohistochemistry, ELISA
assay (serum sample)
Speck et al., 2014 Swiss mice M Crush injury (n = 12); Control group
(n = 12)
21 days Functional test (IBB – Irvine, Beatties, and
Bresnahan – Forelimb Scale), Histology
Jaminet et al., 2013b CD1 and
C57BL/6
M Immediate microsurgical repair using
12/0 sutures (n = 48 WT); Immediate
microsurgical repair using 12/0 sutures
(n = 8 WT); Control (n = 8 WT)
Immediate microsurgical repair using
12/0 sutures (n = 8 heterozygous
Netrin-1(+/−); Control (n = 8
heterozygous Netrin-1(+/−)
0, 7, 14, 21, and
50 days
Real-time PCR, Western Blot, TEM,
morphometry, functional analysis (grasping test)
Jaminet et al., 2013a C57BL/6 – Immediate microsurgical repair using
12/0 sutures (n = 24 WT); Immediate
microsurgical repair using 12/0 sutures
(n = 12 WT); Control (n = 12 WT)
Immediate microsurgical repair using
12/0 sutures (n = 12 UNC5b+/−
heterozygous); Control (n = 12
UNC5b+/− heterozygous)
0, 7, 14, 21, and
50 days
Western Blot, TEM, morphometry, functional
analysis (grasping test)
Ronchi et al., 2013 BALB/c M Crush injury (n = 16 BALB-neuT); Crush
injury (n = 16 WT); Contralateral nerves
used as control (uninjured) nerves
2 and 28 days Functional analysis, immunohistochemistry,
histology, stereological analyses, TEM, western
blot, real-time PCR
Oliveira et al., 2010 C57/Black6 – Nerve lesion followed by tubulization
[polycaprolactone (PCL) conduits] with
DMEM (n = 10), 3-mm gap; Nerve
lesion followed by tubulization (PCL
conduits) with MSC in DMEM (n = 11),
3-mm gap Control (n = 10)
4, 8, and 12 weeks SEM, TEM, histomorphometry analysis,
immunohistochemistry, functional analysis
Ronchi et al., 2010 FVB M Crush injury (5 animals); Microsurgical
12/0 suture (end-to-end neurorrhaphy)
(n = 6) and controls (n = 6) from Tos
et al. (2008)
25 days Functional analysis, histology, stereological
analyses
Tos et al., 2008 FVB M Microsurgical 12/0 suture (end-to-end
neurorrhaphy) (n = 6); Controls (n = 6)
75 days Functional, histology, stereological analyses,
TEM
be studied in large groups. Mice nerves can be subjected to
different types of injury and repair and analysed with all kinds
of functional, morphological and biomolecular assays. The most
simple crush injury can be easily used and standardised. On
the other hand, peripheral nerves in mice are rather small and
experimental in vivo work employing more complex surgeries on
them, such as end-to-end repair, requires advanced microsurgical
skills. These skills are provided by many clinical researchers
from disciplines routinely performing nerve surgeries but are less
prevalent in the basic researcher community. Furthermore, when
it comes to studies evaluating new developments for bio-artificial
nerve guides, the much smaller diameter of mouse peripheral
nerves is not fitting the larger one of nerve guides that are
primarily commonly designed to fit human digital nerves.
Rat Model
Among rodents, rats are the most commonly used in vivo
model in peripheral nerve regeneration research. This relates
mainly to the dimension of their nerves. Surgery on rat
peripheral nerves requires less microsurgical skills than needed
for mouse models and rat limbs and nerves are long enough
to allow 1.5–2 cm gap repair to be studied at least in the
sciatic nerve. Moreover, rats can be investigated in large groups
because their keeping is economical, and they are mostly
simple to handle and to care for. Transgenic rat models are,
however, less available than mouse transgenic models and also
the availability of rat specific antibodies for molecular and
histological examination is rather limited. But due to their
prevalent employment, functional tests for evaluating motor
or sensory recovery in rats are more standardised (Navarro,
2016) and comparable among different research groups. Rat
nerves can be subjected to different types of injury and repair
and analysed in most comprehensive functional, morphological
and biomolecular assays (Ronchi et al., 2009; Navarro, 2016;
Ronchi et al., 2016). Different rat strains can be utilised, for
which varying willingness to enrol in specific functional tests is
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TABLE 2 | Rat model.
References Strain Sex Type of injury/gap Follow up Analysis
Casal et al., 2018 Wistar F Control (n = 17) Excision (n = 17) 10 mm autograft
(n = 19); Conventional flap (n = 19); Arterialised
venous nerve flap (n = 15); Prefabricate nerve flap
(n = 8)
100 days Grasping test; nociception evaluation;
running velocity; walking track analysis,
retrograde labelling, infra-red
thermography, electroneuromyography,
immunohistochemistry
Chen et al., 2018 Sprague-
Dawley
M Control (n = 6); Nerve constriction with four loose
ligatures for 1 (n = 6), 2 (n = 4), 3 (n = 4), and
4 weeks (n = 4); Median nerve transection (n = 5),
1 week intraplantar administration of saline, M871
(a GalR2 antagonist), or AR-M1896 (a GalR2
agonist)
1, 2, 3, and
4 weeks
Immunocytochemistry, von Frey
filaments test
Gao et al., 2018 Sprague-
Dawley
F Entire contralateral C7 root was transected and
transferred to the median nerve (n = 18); Only the
posterior division of the contralateral C7 root was
transected and transferred to the median nerve
(n = 18); The entire contralateral C7 root was
transected but only the posterior division was
transferred to the median nerve (n = 18)
8, 12, and
16 weeks
Electrophysiological examination,
Muscle tetanic contraction force test,
Muscle fibre cross-sectional area,
histological and morphometrical
analysis
Gluck et al., 2018 Sprague-
Dawley
F Control (n = 10); Low strain injury (strain of 14%
elongation) (n = 5/time point); High strain injury
(strain of 20% elongation) (n = 5/time point)
0, 1, 3, 8, and
12 weeks
Second Harmonic Generation (SHG)
microscopy, histology, and
Immunohistochemistry
Marchesini et al., 2018 Wistar M Autograft – 1.5 cm gap (n = 6) 1.5 cm median
nerve gap repaired with amnion muscle combined
graft (AMCG) conduits (n = 8)
90 days Grasping test, histological and
morphometrical analysis
Marcioli et al., 2018 Wistar M Neural compression without treatment (n = 6);
Neural compression and treated with neural
mobilisation for 1 min (n = 6); then 6 sessions on
alternate days of mobilisation; Neural compression
and treated with neural mobilisation for 3 min
(n = 6); then 6 sessions on alternate days of
mobilisation
14 days Histology and morphometric analysis,
PCR
Muratori et al., 2018 Wistar F Control (n = 6); Crush injury (n = 3/time point + 3
for histology); End-to-end repair (n = 3/time point);
Degenerating nerve (n = 3/time point)
1, 3, 7, 15, and
30 days
Real time PCR, western blot,
immunohistochemistry
Ronchi et al., 2018 Wistar F Nerve repaired with chitosan conduit (10 mm long)
(n = 5 for each time point); Nerve repaired with
chitosan conduit (10 mm long) filled with fresh
muscle fibres (n = 5 for each time point); Autograft
(n = 5 for each time point)
1, 7, 14, and
28 days and
12 weeks
Grasping test, histological analysis,
morphometrical analysis,
Meyers et al., 2017 Sprague-
Dawley
F End-to-end repair of the median nerve distal to the
elbow (n = 6); End-to-end repair of the median and
ulnar nerves proximal to the elbow (n = 6); Repair of
the median and ulnar nerves with a 7-mm
polyurethane tube (gap 5 mm) proximal to the
elbow (n = 9)
Up to 13 weeks Evaluation of volitional forelimb strength
Ronchi et al., 2017 Wistar F Immediate, 3 and 6 months delayed nerve repair
with a cross suture between the degenerated
median nerve distal stump and the freshly
axotomised ulnar proximal stump (n = 7/group);
Controls: healthy nerve (n = 5); 9-month
degenerated nerve (n = 5); 3-month regenerated
end-to-end–repaired median nerves (n = 5)
6 months Grasping test, histological analysis,
morphometrical analysis, gene
expression analysis, protein analysis
Stossel et al., 2017 Lewis F 7 mm-long nerve repaired with muscle-in vein graft
(n = 8); Control: autologous nerve graft (n = 8)
1, 2, and 3 months Electrophysiology, grasping test,
staircase test, histological analysis,
morphometrical analysis
Coradini et al., 2015 Wistar M Healthy nerve in obese rat model (8 rats); Crush
nerve injury in obese rat model (8 rats); Crush nerve
injury and physical exercise (swimming) in obese rat
model (8 rats); Controls: healthy nerve (8 rats);
crush nerve injury (8 rats); crush nerve injury plus
physical exercise (8 rats)
3, 7, 14, and
21 days
Nociception threshold, histological
analysis, protein analysis
(Continued)
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Fregnan et al., 2016 Wistar F 10 mm-nerve gap repaired with two different
types of chitosan membrane based conduit
(n = 4/group); Control: autograft (n = 4)
3 months Grasping test, histological analysis,
morphometrical analysis
Huang and Tsai, 2016 Sprague–
Dawley
M Control (n = 12); Median nerve compression
with four loose ligatures (n = 12/time point) with
delivery of the JNK inhibitor at different doses
[20 (n = 6), 40 (n = 6), or 80 nmol (n = 6), or
with vehicle (n = 6)]; Animals were given vehicle
(n = 18) or DHA at doses of 100 (n = 18), 250
(n = 18), or 500 nmol/kg (n = 18)
5 h, 1, 3, 5, 7, 14,
and 21 days
Immunohistochemistry,
double-immunofluorescence labelling and
Western blotting, Enzyme-linked
immunosorbent assay, Behavioural testing
Papalia et al., 2016 Wistar F 10 mm-nerve gap repaired with end-to-side
neurorrhaphy with or without epineurial window,
using ulnar nerve fixed by applying
cyanoacrylate solution (n = 7/group); Control:
healthy nerve (n = 5)
9 months Grasping test, histological analysis,
morphometrical analysis
Ronchi et al., 2016 Wistar F Crush nerve injury (n = 15); Nerve transection
and immediately repair with end-to-end
technique (n = 15); Nerve transection followed
by no repair (n = 15); Control: healthy nerve
(n = 7)
1, 3, 7, 14, and
28 days
Histological analysis, gene expression analysis,
protein analysis
Shaikh et al., 2016 Long Evans F Nerve transection and nerve wrapping with a
strip of Rose Bengal chitosan adhesive followed
by laser irradiation (n = 10); Nerve transection
repaired with end-to-end neurorrhaphy (n = 10);
Control: nerve wrapping with a strip of Rose
Bengal chitosan adhesive followed by laser
irradiation (n = 10)
3 months Cold and warm plate test, withdrawal threshold
tests
Gambarotta et al., 2015 Wistar F Transected nerve repaired with 10 mm-long
muscle-in-vein graft with muscle fibres
expressing AAV2-LacZ or AAV2-ecto-ErbB4
(n = 5/group); Control: 10 mm-long nerve graft
(n = 5)
3 months Grasping test, histological analysis,
morphometrical analysis
Beck-Broichsitter et al.,
2014b
Wistar F Nerve transection repaired with direct
coaptation plus pulsed magnetic therapy
(n = 12); Controls: nerve transection repaired
with direct coaptation (n = 12)
3 months Grasping test, histological analysis,
morphometrical analysis
Beck-Broichsitter et al.,
2014a
Wistar F 6 weeks delayed nerve repair with autograft
(n=); Nerve injury with sensory protection and
6 weeks delayed repair with autograft (n = 10)
15 weeks Grasping test, muscle weight, histological
analysis, morphometrical analysis
Li et al., 2014 Sprague-
Dawley
– Acute group (immediately after injury, n = 18)
and subacute (2 weeks after injury, n = 18)
group, each divided in three subgroups: Nerve
transected without repair; Nerve transected and
repaired immediately; Healthy control
Immediately and
2 weeks after injury
fMRI/fcMRI
Manoli et al., 2014 Wistar F Direct suture (n = 3); Direct suture plus
vein-graft wrapping (n = 4); Direct suture plus
vein-graft wrapping filled with Perineurin vehicle
(n = 2); Direct suture plus vein-graft wrapping
filled with Perineurin (n = 6); Direct suture (n = 5)
FloSeal application to the nerve stumps and
direct suture (n = 6); Electrocoagulation of the
nerve stumps and direct suture (n = 5)
12 weeks Electrophysiological and histomorphological
analysis
Oliveira et al., 2014 Wistar M Nerve transection (4 mm gap) repaired with
polycaprolactone conduit, with an injection of
cell medium alone (n = 3) or containing bone
marrow-derived mesenchymal stem cell (n = 3);
Control: healthy nerve (n = 4)
10 weeks Histological analysis, morphometrical analysis,
electrophysiological cortical mapping of the
somatosensory representation
Ronchi et al., 2014 Wistar F Control (n = 5); Crush injury (n = 5); Autograft
(n = 5)
12 weeks Histological and morphometrical analysis (at
light and electron microscopy)
(Continued)
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Ghizoni et al., 2013 Sprague-
Dawley
F 40 mm nerve gap repaired with autograft
(contralateral median nerve) and nandrolone
treatment (n = 20) 40 mm nerve gap repaired with
autograft (contralateral median nerve) (n = 20);
Control: non-grafted animals (n = 20)
6 months Electrophysiology, grasping test,
muscle weight, nociceptive sensation
recovery
Ho et al., 2013 Sprague-
Dawley
Nerve repaired with silicone rubber tubes (gap
5 mm) and subjected to acupuncture and
electroacupuncture at two different intensities
(n = 7/group); Control: nerve repaired with silicone
rubber tubes (gap 5 mm); no stimulation
5 weeks Electrophysiology, Histology, Grasping
test
Marcioli et al., 2013 Wistar M Nerve compression and treatment with neural
mobilisation for 1 or 3 min (n = 6/group); Control:
nerve compression without mobilisation (n = 6)
3, 5, 7, 11, and
13 days, 2 weeks
Nociception evaluation, histological
Analysis, morphometrical analysis
Moimas et al., 2013 Wistar F Transected nerve repaired using 10 mm-long
muscle-in-vein graft with muscular fibres expressing
AAV2-LacZ or AAV2-VEGF (n = 7/group). Control:
healthy nerve (n = 5)
3 months Grasping test, histological analysis and
morphometrical analysis of both nerve
and muscle, muscle immunochemistry
Papalia et al., 2013 Wistar F 10 mm-long defect repaired with adipose
tissue-in-vein conduit (n = 5) or muscle-in-vein
conduit (n = 5); Control: autologous nerve graft
(n = 5)
6 months Grasping test, histological analysis,
morphometrical analysis
Lanza et al., 2012 Wistar F Nerve transection immediately repaired with
end-to-side neurorrhaphy (n = 10); 2 mm-long
nerve segment exported and not repaired (n = 10)
6 and 12 days Histological analysis, gene expression
analysis
Muratori et al., 2012 Wistar F Crush injury (n = 5); Control: healthy nerve (n = 5) 8 and 24 weeks Histological analysis, morphometrical
analysis
Moges et al., 2011 Sprague
Dawley
F 7 mm-long nerve gap repaired with autograft (sural
nerve) with/without light therapy (n = 12/group).
Control: sham operated group without injury and
repair; Control: sham operated group (n = 12)
4 months Grasping test, muscle action potential
measurements, histological analysis,
morphometrical analysis
Nabian et al., 2011 Wistar M Right sciatic nerve and both median nerves (1 week
later) were excised (n = 10); Both median nerves
were excised, and the sciatic nerves were left intact
(n = 10); Control: no surgical intervention (n = 10)
17 days Sciatic functional index
Sinis et al., 2011b Wistar F Floseal application to nerve stumps before nerve
repair with end-to-end neurorrhaphy (n = 12);
Electrocoagulation of nerve stumps before
end-to-end neurorrhaphy (n = 12); Control: nerve
repaired with end-to-end neurorrhaphy (n = 12)
3 months Grasping test, muscle weight,
histological analysis, morphometrical
analysis
Chiono et al., 2009 Wistar F Repair of a 1.5 cm gap with PCL guides (2 cm
long); Cross chest median/median nerve (5 cm PCL
guides; 4.5 cm gap)
6 and 8 months,
respectively
Grasping test, histological and
immunohistochemical analysis
Nicolino et al., 2009 Wistar F 10 mm-long nerve gap repaired with muscle-in-vein
graft (n = 16); Nerve transection with no repair
(n = 16)
5, 15, and 30 days Histological analysis, expression
analysis in muscle
Ronchi et al., 2009 Wistar F Crush injury (n = 14); Control (no injury) (n = 6) Grasping test, histology,
morphometrical analysis, TEM
Sinis et al., 2009 Wistar F Nerve repaired with end-to-end neurorrhaphy, with
a wrapping by external jugular vein segment, filled
with iron chelator DFO; Control: nerve repaired with
end-to-end neurorrhaphy, with a wrapping by
empty external jugular vein segment
3 months Grasping test, muscle weight,
histological analysis, morphometrical
analysis, immunochemistry
Werdin et al., 2009 Wistar F Control group (n = 9); End-to-end nerve repair
(n = 18) 2-cm autograft (n = 27)
12 weeks Electrophysiological analysis
Audisio et al., 2008 Wistar F Nerve transection and repair with end-to-end
neurorrhaphy (n = 10); Nerve transection and repair
with end-to-side neurorrhaphy (distal stump
sutured to the ulnar nerve) (n = 10); Control: healthy
nerve (n = 10)
1, 2, and 3 weeks Gene expression analysis
(Continued)
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Ozalp and Masquelet,
2008
Wistar
albino
M 5-mm gap repaired with silicon tube; after 5 weeks,
the implant was removed and a nerve graft was
anastomosed inside the neo-formed biological
membrane (n = 10) 5-mm gap repaired with
autograft (n = 10)
12 weeks Grasping test
Geuna et al., 2007a Wistar F Median nerve repaired with muscle-vein-combined
conduit (n = 3/time point)
0 (2 h after
preparation), 5, 15,
and 30 days
IHC, Electron Microscopy, PCR
Geuna et al., 2007b Wistar F End-to-side neurorrhaphy on the intact ulnar with a
perineurial window; Tubulization by
muscle-vein-combined guides Y-shaped
muscle-vein-combined guides to repair both
median and ulnar nerves
5 and 30 days Grasping test, histological analysis
(light, confocal and electron
microscopy), PCR, muscle weight
Lee et al., 2007 Wistar F Controls (n = 4); End-to-end (median-to-median)
(n = 4); End-to end (ulnar-to-ulnar) (n = 4); Median
and ulnar nerve repaired with a 14-mm Y-shaped
muscle-in-vein conduit (n = 4)
10 months Grasping test, histological and
morphometrical analysis
Papalia et al., 2007 Wistar F Median nerve repaired with end-to-side
neurorrhaphy after epineurotomy on the radial nerve
(n = 10)
30 weeks Grasping test, histological,
morphometrical and
electrophysiological analysis
Sinis et al., 2007 Lewis F Control (n = 22); Autologous nerve graft (n = 22);
Empty TMC/CL conduit (n = 16); TMC/CL conduit
and SC (n = 22)
9 months Grasping test, electrophysiological and
histological analysis; muscle weight
Tos et al., 2007 Wistar F 10-mm-long nerve defect repaired with
muscle-in-vein conduit (15 mm long) using fresh
muscle (n = 12); 10-mm-long nerve defected
repaired with muscle-in-vein conduit (15 mm long)
using freeze-thawed muscle (n = 12)
5 days, 1 month Histological analysis, morphometrical
analysis, gene expression analysis
Sinis et al., 2006 Lewis Cross-chest (a gap of 40 mm was repaired with the
two ulnar nerves) (n = 12); Control (healthy) (n = 12)
12 months Grasping test, histological and
morphological analysis
Bontioti et al., 2005 Wistar F End-to-side neurorraphy median/ulnar nerves to the
musculocutaneous nerve (n = 11); End-to-side
neurorraphy radial nerve to the musculocutaneous
nerve (n = 11)
7 days and
6 months
Pawprints test, retrograde labelling,
histological and morphometrical
analysis, tetanic muscle force and
muscle weight
Sinis et al., 2005 Lewis F Nerve defect of 2 cm repaired with resorbable
hollow nerve conduit (n = 16); Nerve defect of 2 cm
repaired with nerve conduit containing Schwann
cells suspended in matrigel (n = 16); Nerve defect
of 2 cm repaired with autograft (n = 22); Control:
healthy nerve (n = 22)
9 months Electrophysiology, grasping test,
histological analysis, muscle weight
Gigo-Benato et al.,
2004
Wistar F Complete nerve transection (15 mm gap) repaired
with end-to-side neurorrhaphy on the ulnar nerve
plus laser therapy (laser used: continuous, pulsed
and a combination of the two) (n = 4/group). Nerve
transection repaired with end-to-side neurorrhaphy
on the ulnar nerve (n = 4); Controls: nerve
transaction without repair (n = 4), healthy nerve
(n = 5)
4 months Grasping test, muscle weight,
histological analysis, morphometrical
analysis
Tos et al., 2004 Wistar F Controls (n = 5); Median and ulnar nerve repaired
with a 14-mm Y-shaped muscle-in-vein conduit
(n = 5)
8 months Grasping test, histological and
morphometrical analysis
Papalia et al., 2003a Wistar F 10 mm-long nerve defect repaired with end-to-side
neurorrhaphy, through an epineurial window on the
ulnar nerve (n = 20)
7 months Grasping test, electrophysiology,
muscle weight, histological analysis,
morphometrical analysis
Papalia et al., 2003b Wistar F End-to-side neurorrhaphy (n = 6) 16 weeks Grasping test
Accioli De Vaconcellos
et al., 1999
Sprague-
Dawley
F Control group (n = 8); Fresh autograft 20 mm long
(n = 12); Frozen acellular autograft 20 mm long
(n = 12); Fresh xenograft 20 mm long (n = 12);
Frozen acellular xenograft 20 mm long (n = 12)
3, 6, 9, and
12 months
Grasping test, Retrograde labelling of
neurons, Histological and
histochemistry studies
(Continued)
Frontiers in Cellular Neuroscience | www.frontiersin.org 7 June 2019 | Volume 13 | Article 288286
fncel-13-00288 June 27, 2019 Time: 15:15 # 8
Ronchi et al. Median Nerve Injury and Repair Model
TABLE 2 | Continued
References Strain Sex Type of injury/gap Follow up Analysis
Bertelli and Mira, 1995 Sprague-
Dawley
F Median and ulnar nerve bilateral dissection (n = 15);
Left median nerve crush (n = 10); Left median nerve
crush and right median nerve transection (n = 10);
Left median nerve transection (n = 10); Left median
and ulnar nerve transection (n = 10)
14 days, 3, 4, and
5 weeks
Grasping test, muscle weight
reported (Nikkhah et al., 1998; Galtrey and Fawcett, 2007), but so
no comparative studies investigating differences in their ability to
regenerate have been published.
When using rodents (mice and rats) as animal models for
peripheral nerve regeneration, researchers must finally be aware
of the following immanent differences to mankind: (1) gaps that
can be produced are shorter than those commonly found in
human nerve lesions; (2) axonal regeneration rate is faster than
in humans; (3) recovery is often complete, while in humans it is
often incomplete (Kaplan et al., 2015).
Rabbit Model
In peripheral nerve regeneration research, rabbits offer the
possibility to study regeneration across gap lengths of up to
6 cm. Rabbits are, however, expensive to purchase and maintain,
and difficult to care for. Rabbits are more delicate and less
resilient than rats and mice, and their occurrence as pet animals
probably creates ethical problems for animal care takers and
researchers. Also, there are almost no valid functional assays
that can be applied in rabbit models, besides electrodiagnostic
evaluation. Finally, very few specific antibodies are available
to be used on rabbit tissue samples, so that conclusions on
the regeneration outcome can mainly only be based on nerve
morphometry studies.
Sheep Model
The sheep as an animal model is useful when nerve regeneration
across very long gaps should be evaluated. An ethical advantage of
this animal is provided by the fact that a median nerve transection
injury does not result in serious impairment of the limb usage
ability and functional read-outs have been described in the recent
years. To establish the model and to provide adequate housing
conditions is, however, a considerable challenge, and research in
this model will often only be realised through collaborative work.
Monkey Model
Although non-human primates could be useful to test safety and
efficacy of synthetic nerve conduits – because of the similarity
of non-human primates with human beings – their use is
considerably limited for ethical reasons. Monkeys are considered
as animal models mainly to study neuronal plasticity occurring
in the brain following peripheral nerve injury and repair. Again,
studies in this model will mainly be subject of collaborative work
and not appropriate for early stage pre-clinical research.
Other Animals
Other large animals can be used as models to study median nerve
injury and regeneration, such as pigs (Ochoa and Marotte, 1973;
Marotte, 1974), dogs (Lee et al., 1999), and cats (Murray et al.,
1997), but their use is limited for three main reasons: (1) animal
care for large species is considerably expensive; (2) for some
species the possibilities for functional testing are limited or
require complex training, therefore, nerve regeneration may only
be assessed with nerve morphometry; (3) dogs and cats are
domestic animals, and their use in research is more restricted for
ethical reasons.
METHODOLOGICAL
CONSIDERATIONS – APPROACHES FOR
THE TREATMENT OF NERVE INJURIES
The following criteria should be considered for selecting the most
suitable animal model for pre-clinical research on peripheral
nerve regeneration: (1) costs to purchase and house the animals;
(2) ease of handling, such as tolerance to captivity; (3) tolerance
for surgery and eventual repetitive anaesthesia, as well as
resistance to infection; (4) compliance with national policies and
with ethical principles; (5) inter-animal uniformity, life span of
the species, biological information and available tools; (6) overall
experimental plan (Angius et al., 2012). With regard to the latter,
especially when several time-points are to be analysed, rodents
represent the best choice. On the contrary, rodent life span is
short, therefore for long experiments (>1–1.5 years), it becomes
necessary to use lager animals as model organism.
In the last years, several approaches have been developed and
tested in pre-clinical animal models to improve peripheral nerve
regeneration. All these approaches can be applied on different
nerves and are not median-nerve specific. In this paragraph we
will present an overview of different techniques, including the
use of different conduits to guide regenerating axons, the use
of stem cell transplantation, the application of physical therapies
and optogenetics, all of which have been demonstrating variable
positive effects on nerve regeneration irrespectively of the model
they were investigated in.
Nerve Guidance Conduits
The major disadvantage of the autologous nerve graft technique
is the remarkable sensitivity loss (mainly sural nerve grafts are
harvested for this) and the limited availability of donor tissue
(Ray and Mackinnon, 2010). Reconstruction of a nerve with
artificial or non-artificial nerve conduit grafts is particularly
indicated in case of extensive nerve tissue loss. Nerve guidance
conduits made of several materials, artificial or of natural origin,
are available; most common and FDA approved for clinical use
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TABLE 3 | Rabbit model.
References Strain Sex Type of injury/gap Follow up Analysis
Sun et al., 2012 New Zealand
rabbits
M/F In situ anastomosis of the median nerves was
made in parallel to the surrounding elbow veins,
the transplanted epineurium and the adventitia
were sutured with nerve anastomosis line
(n = 30). Gap: 3 cm In situ anastomosis (control
group); (n = 30). Gap: 3 cm
1, 2, 4, 8, and
12 weeks
Electrophysiological testing,
and histopathology
observation, TEM
Yin et al., 2011 New Zealand
rabbits
– Groups 2 and 3: Proximal median/ulnar nerve
segment was served as father nerve to repair
the distal nerve stump (Dor–Dor) (n = 6/group)
Group 4: Serving as a donor nerve, the proximal
1/2 median nerve was fixed to the distal stumps
of 1/2 median and ulnar nerve simultaneously,
using biodegradable chitin conduits with a gap
of 1 mm. (1/2 Dor − 1/2 Dor + Rec) (n = 6)
Group 1: Control group (n = 6)
4 months Electrophysiology, histology
and morphometry
Kim et al., 2011 New Zealand
rabbits
M The ulnar nerve was transected and the distal
end sutured to the median nerve 3 cm above
the elbow (n = 30); The ulnar nerve was
transected and the distal end sutured to the
median 3 cm below the elbow joint (n = 30)
1, 2, 3, 4, 5, and
6 weeks
Morphometric analysis and
immunohistochemistry.
Wang et al., 2009 New Zealand
rabbits
– Proximal nerve segment as donor nerve (n = 6)
Intermediate nerve segment as donor nerve
(n = 6); Distal nerve segment as donor nerve
(n = 6); Right side nerves as control
3 months Electrophysiology, histology
and stereology; muscle
weights
Zhang et al., 2006 New Zealand
rabbits
– End-to-side nerve coaptation performed
immediately (n = 12); End-to-side nerve
coaptation performed after nerve degeneration
(n = 12); Control (n = 12)
3 and 6 months Electrophysiology,
Histomorphometry, Muscle
weight
Baoguo et al., 2004 Japanese white
rabbits
– Study 1: the median nerve was elongated for
10 days (n = 6), for 15 days (n = 7) and for
20 days (n = 6). Study 2: Right arm: the
proximal segment of an injured median nerve
was elongated for 10 days (n = 10) and for
15 days (n = 10). Left arm: a 10- for 15-mm
segment of the median nerve was removed,
and a 10- for 15-mm segment, respectively, of
the tibial nerve was grafted in its place.
4 months Electrophysiology,
Histomorphometry
Ruch et al., 2004 New Zealand
rabbits
M Group 1: nerve repaired with a tension-free
medial antebrachial cutaneous graft (n = 11);
Group 2: end-to-end repair without distraction
(n = 13); Group 3: end-to-end repair with
gradual distraction) (n = 12)
3 and 6 months Electrophysiology,
Histomorphometry, Muscle
weight
Gui et al., 1997 – – The injured median nerve regenerated through
degenerative latissimus dorsi muscle; The
injured median nerve regenerated through the
brachial triceps muscle
7, 14, 28, 45, 60,
and 180 days
Histology
Shibata et al., 1991 – – Median nerve immediately repaired with the
contralateral ulnar nerve graft (gap: 3-cm);
Median nerve repaired with the contralateral
ulnar nerve graft (gap: 3-cm) after resection of
scar and coaptation at the distal site done
10 weeks later.
24 and 62 weeks Electrophysiology,
Histomorphometry, Muscle
weight
Kawai et al., 1990 – – Nerve repaired with vascularised median nerve
graft; Nerve repaired with non-vascularised
median nerve graft. Length of the grafts: 2, 4,
or 6 cm.
8 and 24 weeks Histomorphometry
de la Monte et al., 1988 – – n = 34 total; Axonal regeneration across
allografts (fresh or predegenerated) or autograft
in cyclosporin A-treated/non-treated animals
– Histology
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TABLE 4 | Sheep model.
References Strain Sex Type of injury/gap Follow up Analysis
Kettle et al., 2013 – – Median-to-ulnar nerve end-to-side
neurorrhaphy (n = 12); Conventional method of
nerve repair (n = 18); Control (n = 8)
12 months Electrophysiology and
histology; Physiology of the
muscle
Forden et al., 2011 Suffolk ewes – Defect of 5 cm repaired with 7 cm of radial
sensory nerve (n = 12); Control (n = 1)
6 and 9 months Electrophysiology,
histology,
immunohistochemistry, and
morphometric analyses
Jeans L.A. et al., 2007 – – Microsurgical epineurial repair using 10/0
polyamide (n = 12); CRG-wrap and 6/0
polyglactin (n = 12); CRG-wrap and fibrin glue
(n = 12)
7 months Measure of transcutaneous
stimulated jitter (TSJ),
maximum conduction
velocity (CVmax), wet
muscle mass and
morphometric
measurements.
Jeans L. et al., 2007 – – Epineurial suture repair using 9/0 polyamide;
CRG-wrap secured by Tisseel glue; CRG-wrap
secured by polycaprolactone glue; Wrap
secured by suturing (6/0 polyamide)
7 months Electromyography, nerve
conduction studies, wet
muscle mass
measurements, and
morphometry
Kelleher et al., 2006a – – Entubulation within a biodegradable glass tube
(CRG tubes) (n = 6); Gap: 4/5 cm; Small
magnets were applied to the sides of the
biodegradable glass tube before the median
nerve was repaired (n = 6); Gap: 4/5 cm Control
(n = 6);
10 months Morphometry
electrophysiology and
isometric tension
assessment
Kelleher et al., 2006b – – Median nerve repaired using an epineurial
suture technique. CNTF was supplied into the
CSF at the level of C6 by an implanted osmotic
pump (n = 5). Median nerve repaired using an
epineurial suture technique. Physiological saline
was placed in the osmotic pump (n = 5);
Control (n = 5);
6 months Electrophysiological,
morphometric and
isometric tension
experiments; muscle mass.
Matsuyama et al., 2000 – – Autograft (right side) and allograft (left side);
immunosuppression with Cyclosporine A; 5-cm
gap repaired with two cables of the radial
sensory nerve (8-cm) (n = 4); Autograft (right
side) and allograft (left side); (control n = 4)
between 35 and
47 days
Histology, Morphometry
Fullarton et al., 1998 Scottish
black-faced
sheep
F Nerve immediately repaired with freeze-thawed
muscle autografts (n = 5); gap 3 cm; Nerve
repaired 30 days after injury with freeze-thawed
muscle autografts (n = 5); gap 3 cm.
6 months Electrophysiology and
morphometry. Blood flow
Glasby et al., 1998 Scottish,
black-faced
sheep
F Nerve immediately repaired with freeze-thawed
muscle autografts (n = 5); gap 3 cm; Nerve
repaired 4 weeks after injury with freeze-thawed
muscle autografts (n = 5); gap 3 cm.
6 months Electrophysiology and
morphometry. Blood flow
Lawson and Glasby,
1998
Scottish,
black-faced
sheep
F Nerve repaired with fascicular cable graft
(n = 5); Nerve repaired with freeze-thawed
muscle grafts (n = 5)
6 months Nerve blood flow, nerve
conduction velocity and
morphological indices
Glasby et al., 1998 Scottish,
black-faced
sheep
F Nerve immediately repaired with freeze-thawed
muscle autografts (n = 6); gap 3 cm; Nerve
repaired 30 days after injury with freeze-thawed
muscle autografts (n = 6); gap 3 cm.
6 months Electrophysiology and
morphometry. Blood flow
Strasberg et al., 1996 – – Fresh nerve autograft (n = 5); Fresh nerve
allograft (n = 5); Cold-preserved nerve (n = 5);
Cold-preserved nerve allograft (n = 5)
6 and 10 months Histological, morphometric,
and electrophysiologic
analyses.
Lawson and Glasby,
1995
Scottish,
black-faced
sheep
F Nerve immediately repaired with freeze-thawed
muscle autografts (n = 5); gap 3 cm; Nerve
repaired 30 days after injury with freeze-thawed
muscle autografts (n = 5); gap 3 cm.
6 months Electrophysiology and
morphometry. Blood flow
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TABLE 5 | Monkey model.
References Strain Sex Type of injury/gap Follow up Analysis
Pace et al., 2014 Macaca
fascicularis
monkeys
F Nerve repaired with bovine collagen I nerve
conduit (NeuraGen) filled with keratin hydrogel
(n = 8) (gap: 1 cm); Nerve repaired with bovine
collagen I nerve conduit (NeuraGen) filled with
sterile saline (n = 6) (gap: 1 cm)
12 months Electrophysiology, nerve
histology and morphometry,
muscle histology and
morphometry, antibody titer
Hu et al., 2013 Rhesus
monkeys
– Nerve defect (50 mm) repaired with: Autograft
(n = 3); Chitosan/PLGA scaffold, followed by
injection of autologous MSCs (n = 3);
Chitosan/PLGA scaffold alone (n = 3); Nerve
defect left untreated (control) (n = 3)
12 months Locomotive activity
observation,
electrophysiological
assessments, FG
retrograde tracing tests,
histological and
morphometric analyses,
blood test and
histopathological
examination
Hara et al., 2012 Macaca
fascicularis
– 20-mm-long-segment was resected and
repaired with: Lengthening of both nerve
stumps (n = 3); Autograft with the sural nerve
(n = 3);
16 weeks Electrophysiological,
histological, and functional
recovery
Zhang et al., 2009 Rhesus
monkeys
M Right sides: small gap (2 mm) repaired with
chitin conduit (length 10 mm); Left sides:
traditional epineurium suture (n = 8)
6 months Histology
Krarup et al., 2002 Macaca
fascicularis
M Nerve gap distances of 5, 20, or 50 mm were
repaired with nerve grafts or collagen-based
nerve guide tubes (total of 46 median nerve
lesion). Control: direct repair
3–4 years Electrophysiology
Florence et al., 2001 Macaca radiata – Median nerve was cut and sutured prenatally
(n = 1); sensory enrichment of the nerve-injured
hand; Median nerve was cut and sutured after
birth (n = 5); 4 animals received sensory
enrichment of the nerve-injured hand
3.5 months Electrophysiological
mapping studies (3b
somatosensory cortex)
Florence et al., 1996 Macaque
monkeys
(immature)
– Median nerve was cut and sutured prenatally
(n = 2); Median nerve was cut and sutured after
birth (n = 2)
10–18 months of
age
Retrograde labelling to
study the dorsal horn and
cuneate nucleus;
Electrophysiological
mapping studies (3b
somatosensory cortex)
Archibald et al., 1995 Macaca
fascicularis
– Autograft (gap 5 mm) in one side; In the
contralateral wrist, the 5 mm nerve gap was
bridged with a collagen nerve guide (n = 4);
Direct suture (positive controls) (n = 4); Nerve
gaps of mm bridged by polylactate nerve
guides (n = 1). After 630–679 d the nerve guide
was removed and the resulting gap of 15 mm
was bridged by a collagen nerve guide.
Average of 1,342 d
after surgery
Electrophysiology, motor
conduction studies,
sensory conduction
studies, responses evoked
by tactile stimulation,
morphometric analyses.
Florence et al., 1994 Macaque
monkeys
– Median nerve was cut and sutured (n = 3) 7–13 months Retrograde labelling to
study the dorsal horn and
cuneate nucleus;
Electrophysiology to study
the 3b of somatosensory
cortex
Tountas et al., 1993 – – Median nerve repaired by microsurgical suture
or tubulization with a non-woven,
bioabsorbable, polyglycolic acid device (n
tot = 30)
6 and 12 months Electrophysiology and
histology
Archibald et al., 1991 Macaca
fascicularis
M Nerve transected and repaired with: 4 mm
nerve autograft (n = 3); Collagen-based nerve
guide conduit (gap 4 mm) (n = 3)
760 days Electrophysiology
(Continued)
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TABLE 5 | Continued
References Strain Sex Type of injury/gap Follow up Analysis
Badalamente et al.,
1989
Capuchin
monkeys
(C. apella)
- Epineural repair (nerve stumps and thenar
muscles were first bathed/injected with
leupeptin) (n = 5); Epineural repair (nerve
stumps were bathed with saline solution) (n = 5)
6 and 8 weeks, 3,
6 months
Electrophysiology, histology
Wall et al., 1986 Aotus
trivirgatus
– Nerves reconnected with 10/0 epineural
sutures (n = 5)
From 76 to
322 days
Neurophysiological
recording (cortical areas 3b
and 1)
Grabb, 1968 Rhesus
monkeys
F Nerves were cut and sutured primarily (4 h after
nerve injury, n = 30), or secondarily (about
3 weeks after injury, n = 30).
9 months Electromyographic
examination
are conduits made of collagen, chitosan, or poly (DL-lactide-
ε-caprolactone) (Kornfeld et al., 2018). All devices currently on
the market and FDA-approved have proven good support for
the promotion of peripheral nerve regeneration in pre-clinical
models. Good clinical results, however, are obtained only for
lesions with a substance loss inferior to 3 cm in length, while
severe and enlarged injuries remain a critical condition (Kaplan
et al., 2015). For this reason, research in the field of novel nerve
conduit functionalisation strategies is still highly vivid.
Application of Stem Cells and Their
Secretome
In regenerative medicine and tissue engineering, the use of Stem
Cells and their secretome is fast expanding with the aim to
develop innovative therapeutic strategies for the treatment of
peripheral nerve injuries (Caplan, 2015; Caseiro et al., 2016;
Busuttil et al., 2017; Sayad-Fathi et al., 2019). In particular,
Mesenchymal Stem Cells (MSCs) present relevant key features:
they can be easily expanded, they can differentiate into different
cell types, they are immune-privileged and immune-modulatory,
they show preferential homing to injured sites (Frausin et al.,
2015; Sullivan et al., 2016; Jiang et al., 2017). Moreover, the
MSC secretome contains trophic mediators (Meirelles Lda et al.,
2009; Fu et al., 2017), modulating the function of several
tissues, including the skeletal muscle (Pereira et al., 2014)
and the peripheral nervous system (Lopatina et al., 2011;
Gartner et al., 2012, 2014).
The most widely source of MSCs for therapeutic purposes
is the bone marrow; as good alternative other sources are: the
umbilical cord blood, the stromal tissue of the umbilical cord, the
dental pulp, the adipose tissue (Jin et al., 2013).
Transgenic Models to Promote
Peripheral Nerve Regeneration
To study the biology of peripheral nerve regeneration, different
transgenic models can be used (Magill et al., 2008). Most of
the available transgenic animals are mice and they represent
a powerful tool to study the influence of over-expression or
depletion or mutation of a specific gene in a specific cell type,
using inducible systems, but it must be kept in mind that mice
are difficult subjects for microsurgical models due to the small
size of their nerves, as discussed above.
To investigate the function of specific genes in nerve
regeneration discriminating between motor and sensitive
neurons, transgenic mice over-expressing the gene of interest
in postnatal motoneurons or dorsal root ganglion neurons
can be obtained using Thy1 or NSE (neuron specific enolase)
promoters (Michailov et al., 2004; Gomez-Sanchez et al., 2009;
Velanac et al., 2012).
To obtain tissue specific expression or depletion of specific
proteins, the inducible cre-lox system can be applied:
transgenic mice driving motor neuron specific expression
of cre recombinase with the promoter of Mnx1 (motor neuron
and pancreas homeobox 1) gene can be used to specifically
in/activate the expression of floxed genes in motor neurons,
while specific in/activation in Schwann cells can be obtained
using the promoter of Mpz (myelin protein zero) gene
(La Marca et al., 2011).
Transgenic animals can also be developed as advanced
experimental models to study genetic diseases giving rise to
peripheral neuropathies (Hoke, 2012; Juneja et al., 2018), and
they can be studied to investigate their ability to regenerate
injured peripheral nerves.
Finally, the expression of neurotrophic factors or other
potentially therapeutic proteins in Schwann cells or in neurons
can be obtained through the use of different viral vectors
(Tannemaat et al., 2008).
Physical Therapies
The efficacy of brief Electric Stimulation (ES) of the proximal
stump of an injured nerve in promoting nerve regeneration in
animal models has been verified in several independent studies
reviewed by Gordon (2016) and Gordon and English (2016).
In particular, a 14 days period of ES was chosen (Al-Majed
et al., 2000) to accelerate the regenerative process and the
effect was dramatic: preferential motor reinnervation of motor
pathways was evident at 21 days rather than at 42 days, and,
importantly, all of the motoneurons had regenerated into the
motor nerve branch.
Another interesting study was aiming at evaluating the value
of electromagnetic stimulation for the neural regenerative process
of the rat median nerve after transection and end-to-end repair
(Beck-Broichsitter et al., 2014b). From the 1st day after surgery a
pulsed magnetic therapy was daily applied in the experimental
group. Magnetic stimulation was positively influencing the
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functional regeneration in terms of grasping force and reduced
muscular atrophy.
Optogenetics
Axonal regeneration and functional recovery are enhanced
by activity-related therapies, such as exercise and electrical
stimulation (Gordon, 2016). Unlike electrical stimulation,
optogenetics allows to selectively activate or inactivate specific
neurons: for example, selective expression of the light-sensitive
cation channel channelrhodopsin-2 (ChR2), that is maximally
activated by blue light, can be used to depolarise neurons, thereby
driving action potentials. Conversely, selective expression of the
light-sensitive inward chloride pump halorhodopsin (Halo), that
is maximally activated by amber light, can be used to obtain
neuron hyperpolarisation, thereby inhibiting action potentials
(Montgomery et al., 2016). Optically induced neuronal activity
has been shown to be sufficient to promote functional motor
axon regeneration in vivo (Ward et al., 2016). Moreover,
through the selective expression of opsins in sensory neurons
or motoneurons, it was possible to investigate the effect of
system-specific neuronal activation on axonal regeneration,
thus demonstrating that acute activation is sufficient to
enhance regeneration of both motor and sensory axons
(Ward et al., 2018).
Until now, in the peripheral nervous system, optogenetics
has been applied mainly to sciatic nerves in transgenic mice
expressing different opsins, but given its therapeutic potential
it will be certainly applied also to median nerves and in
other animal models, by injection of optogenetic constructs to
transduce opsin expression in peripheral nerves in the future.
Immunomodulation
The early inflammatory reactions undergoing in the course
of Wallerian Degeneration of the distal nerve, comprise
the activation of the complement system, arachidonic acid
metabolites, and inflammatory mediators involved in myelin
fragmentation and activation of repair Schwann cells. Fine-
tuned upregulation of the cytokine/chemokine network by repair
Schwann cells activates resident and hematogenous macrophages
to complete the clearance of axonal and myelin debris and
stimulate regrowth of axonal sprouts (Yona and Jung, 2010;
Cortez-Retamozo et al., 2012; Dubovy et al., 2013; Jessen and
Mirsky, 2016). An innovative approach in the field of peripheral
nerve regeneration is exploiting the endogenous capacity of the
body to repair itself through immune cells. In very promising
studies, starting from the known different pro-inflammatory and
pro-regenerative macrophage phenotypes, they were modulated
through their response to different IFN-γ or IL-4 cytokines
and studied in their ability to influence nerve regeneration in
a critically sized, 15 mm rat sciatic nerve gap. The results of
this research have shown that the administration of IL-4 at the
injury site increased the pro-regenerative effect and therefore
that the regenerative outcomes appeared to be influenced
not only by the macrophage presence, but by their specific
phenotype at the site of injury (Mokarram et al., 2012). A similar
approach was conducted later by the same authors, through
early stage administration of fractalkine, a chemokine able to
control the phenotype in monocyte recruitment and to increase
the regenerative potential. The pharmaceutical approach was
evaluated from a morphological and functional point of view
(Mokarram et al., 2017).
METHODOLOGICAL
CONSIDERATIONS – TECHNIQUES TO
INVESTIGATE PERIPHERAL NERVE
REGENERATION
A number of different techniques have been developed to
investigate the degree and the accuracy of nerve regeneration.
While functional tests must be nerve-specific, all other methods
can be applied to all types of peripheral nerves. In this paragraph
we describe in detail different functional tests that are used
to study the functional recovery of the median nerve and, in
addition, we present an overview of other methods used for
the investigation of nerve regeneration, including morphological
and morphometrical analysis, gene expression analysis and
fluorescent transgenic animal models.
Functional Evaluation
Several functional tests are available for rodents, both rats and
mice (Galtrey and Fawcett, 2007). Some have been designated
ad hoc to evaluate functional recovery following median nerve
repair (e.g., grasping test), others have been adapted from tests
normally used following other lesion types (injuries to the spinal
cord or sciatic nerves).
The tests described below refer to the rat, but most of them are
adaptable also to mice.
• The grasping test is a simple method to assess the flexor
function, first introduced by Bertelli and Mira (1995).
The modified method (Papalia et al., 2003a) consists in
presenting a small tower with only three bars forming
a triangle on its top instead of a grid for grasping.
With this modification the tendency to walk on the
grid is avoided and the presence of a band put just
below the three bars avoids that the rat employs the
wrist flexion to hold the bars. This device is connected
to a precision dynamometer. The animal is hold by its
tail and allowed to grasp the grid. Then, the animal is
pulled upward until it loses its grip. The balance records
the maximum weight that the animal managed to hold
before losing the grip.
• The staircase test is a functional test which assesses
skilled forepaw reaching and grasping (Montoya et al.,
1991). Two/three food pellets are placed on each step
of two staircases located one on either side of a central
platform. Both stairs are composed of seven steps. The
animal is placed in a box and can only reach the pellets
from the left staircase with its left paw and those from the
right staircase with its right paw. The rat can grasp, lift,
and retrieve food pellets from the steps of the staircase.
The number of pellets completely removed from the
staircase box provides a quantifiable measure of the
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distance and efficiency of fine motor reaching skills.
Rats need to be pre-trained in the staircase test before
surgery, put on restrictive diet before testing and need
to be accomodated again to the test conditions for some
days before the following evaluation. Therefore, this test
is more complex to be applied than the grasping test
described above.
• The walking track analysis is used to evaluate forelimb
motor recovery (Ozmen et al., 2002; Galtrey and
Fawcett, 2007). The rat forepaw is dipped in an ink
solution and the animal is allowed to walk down
the track upon a strip of white or graph paper. The
prints by the ink are left to dry and then analysed.
Different parameters can be analysed (longest length
and widest width of the paw impression, widest width
between the second and third fingers, distance between
homologous points of sequential paw impressions on a
given side, perpendicular distance between the central
portion of the paw impression and the direction of
movement). Moreover, walking track analysis can be
performed by 2D digital video motion analysis, which
allows also to quantify the movement of the wrist and
the metacarpophalangeal joint (Wang et al., 2008).
• The Von Frey filament test is used to evaluate mechanical
allodynia (Galtrey and Fawcett, 2007). The animal is
placed in a box on a wire mesh floor. Von Frey filaments
of different bending forces are used to examine the
mechanical threshold of the rat forepaws. The test
starts with the smallest bending force and continues in
increasing order. Each filament is inserted through the
mesh and applied in the medial surface of the forepaw.
To perform the test, the rat must be stationary and
standing on the four paws. The first filament in the series
that evoked withdrawal three times is regarded as the
paw withdrawal threshold.
• The Irvine, Beattie, and Bresnahan (IBB) scale test
(Irvine et al., 2014) is used for the assessment of fine
control of the forelimb and digit movements. Spherical-
and donut-shaped pieces of cereal are given to the rat.
The forelimb behaviour (joint position, object support,
wrist and digit movement, and grasping method) used
while eating both cereal shapes is analysed. An IBB score
is assigned using the 10-point (0–9) ordinal scale for
each shape, and the highest score reflects the greatest
amount of forelimb recovery.
• The ladder rung walking test is used to assess forelimb
strength, stepping, placing, and co-ordination during
skilled locomotion (Metz and Whishaw, 2002; Galtrey
and Fawcett, 2007). The apparatus consists of two side
walls with rungs inserted into the walls to create a ladder.
The ladder is elevated and can also be inclined. The
animal is conditioned to run on the ladder on several
training sessions. Performance is scored (successful
steps/total steps).
• The Randall-Selitto test is used to assess the nociceptive
withdrawal threshold (Galtrey and Fawcett, 2007).
The test consists in the application of an increasing
mechanical force with the tip of an algesimeter on
the medial portion of the forepaw until a withdrawal
response results.
• For the cold sensory test an ice probe is made by freezing
water in a 1.5-ml tube (Lindsey et al., 2000; Galtrey and
Fawcett, 2007). When the rat is drinking from the water
bottle, the ice probe is applied to the glabrous skin of
the forepaw. The withdrawal latency is measured. At
least 1 min between trials is needed to allow the skin
to return to body temperature and prevent sensitisation.
If the rat does not withdraw the paw after 10 s, the
probe is removed.
• The cold and hot plate test is used to assess temperature
sensation. The rat is placed in a Plexiglas chamber
where the metal base temperature is 25◦C. For cold
plate testing, the temperature is rapidly lowered and
the animal behaviour is observed for signs of pain-
like behaviour (avoiding contact with the cold plate,
suspension of the affected forelimb, licking of the
paw, lack of grooming and exploration vocalisation,
or freezing behaviour). Once pain-like behaviour is
observed, the temperature is increased to a higher
temperature. For hot plate testing, the temperature is
raised and the behaviour is assessed as described above
(Shaikh et al., 2016).
• The CatWalk automated quantitative gait analysis is
a computer-assisted method that can simultaneously
measure dynamic as well as static gait parameters,
including duration of different phases of the step cycle
and pressure applied during locomotion (Bozkurt et al.,
2008). The animal is placed in the CatWalk walkway,
which is comprised of a glass plate with two Plexiglas
walls, a high-speed colour camera, and recording and
analysis software. The animal walks voluntarily from
one side of the glass plate to the other. Its footprints
are captured. The intensity of the signal depends on the
degree of paw floor contact and increases with pressure
applied. The more pressure is exerted, the larger the
total area of skin–floor contact and thus the brighter
the pixel. An appropriate software visualises the prints
and calculates statistics related to print dimensions and
the time and distance relationships between footfalls
(Chen et al., 2012a,b).
• Electrophysiology is often used in rat, while in the mouse
model it is less used probably for the small size. The
maximum amplitude and latency of evoked compound
muscle action potentials recorded from the thenar
muscles are usually evaluated (Werdin et al., 2009).
In conclusion, the list provided above clearly demonstrates
that a large variety of tests can be used to evaluate the functional
recovery after median nerve transection and repair in rodents.
From a translational point of view, tests should be selected
in way to model as closely as possible the course of functional
recovery as it is observed in human patients. Recently, the
combination of electrodiagnostic evaluation, with the commonly
used grasping test (reflex-based gross motor function) and the
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staircase test (skilled forelimb reaching) has been described to
produce results with high translatability (Stossel et al., 2017).
A final comment needs to be put on the fact that different rat
strains have been described to demonstrate different motivation
degrees to participate in more complex tasks, like, e.g., the
staircase test. Especially, Lewis rats have been described to be
less motivated and also to eventually be less capable of learning
how to perform more complex motor tasks (Nikkhah et al., 1998;
Galtrey and Fawcett, 2007).
In the other animals, the functional recovery is assessed mainly
by electrophysiology. Indeed, while in rats and mice the fingers do
a fine movement quite similar to humans and their functionality
can be assessed by different suitable and specific tests, the other
animals can do gross movements only.
Morphology and Morphometry
(Stereology)
Regardless of the animal model used, nerve regeneration
assessment must necessarily have an accurate morphological and
morphometrical evaluation (Geuna and Herrera-Rincon, 2015).
Among the techniques that allow this type of analysis, immuno-
histochemistry offers the possibility to specifically identify the
different structures of the regenerating nerve, such as Schwann
cells, motor or sensory axons, blood vessels, and other cell
types, including macrophages, fibroblast-like cells, perineurial
cells, endothelial cells (Carriel et al., 2014b). Moreover,
immunofluorescence or immunohistochemical techniques allow
to accurately quantify the fraction area and the intensity
of the expression of specific proteins which are correlated
with regenerative processes. For example, the expression of
markers such as Neurofilament in neurons or S-100 in
Schwann cells are indicative of an excellent regenerative process,
when these levels reach the values of the control nerves
(Carriel et al., 2014a).
To quantify the number of sensitive and motor neurons which
were able to regenerate axons across a nerve gap, the retrograde-
labelling technique can be applied. A dye will be applied into the
distal nerve and taken up by regenerated axons and retrogradely
transported into the neuronal soma of sensory neurons in the
dorsal root ganglia or motor-neurons in the ventral horn of the
spinal cord (Hayashi et al., 2007; Kemp et al., 2017).
Together with functional assessment, quantitative estimation
of regenerated nerve fibres is a key investigation tool in
nerve regeneration research (Kanaya et al., 1996; Geuna et al.,
2004). The toluidine blue staining of resin-embedded semithin
sections allows to clearly identify most of the myelinated
axons and their myelin organisation thanks to the post-
fixation with OsO4 (Raimondo et al., 2009). Usually, morpho-
quantitative analysis is performed on one randomly selected
toluidine blue semi-thin transverse nerve section. The total
cross-sectional area of the nerve is measured. Then, an
adequate number of fields of interest (according to the size
of the nerve) is randomly selected following a systematic
random protocol and analysed (Raimondo et al., 2009).
The parameters used as nerve regeneration indicators are
myelinated fibre number and density, fibre and axon diameter,
myelin thickness and g-ratio (axon-diameter/fibre-diameter)
(Geuna, 2000, 2005).
In order to compare results obtained by different research
groups, different potential sources of bias should be considered.
First of all, the strain, the gender and the age of experimental
animals, that can affect the quantification outcome.
The second aspect that can influence the results of a
stereological analysis is the level at which it is conducted and,
obviously, the different investigation time points. The analysed
parameters can vary significantly depending on the distance from
the lesion point, especially in the early time points after injury,
considering that a nerve can grow approximately 1 mm/day
(Santos et al., 2007). Therefore, only quantitative data taken at the
same location along the nerves can actually be compared (e.g.,
5 mm distal to the lesion site). Obviously, also the time point
analysed gives different results and should always be considered
(with the same lesion type, a 3-month regenerated nerve will
be different from a 6-month regenerated nerve). Finally, it must
possibly be considered to analyse all branches of a nerve. The
portion of the median nerve that is usually injured and repaired
in experimental studies goes from the axillary region to the
elbow. In this tract, the median nerve is unifascicular, but for
more distal investigation sites the anatomy of the nerve needs to
be considered. The median nerve gives off three palmar digital
branches more distally, at the level of the carpal bones, that
in turn bifurcate between the 1st, 2nd, and 3rd digit (Barton
et al., 2016). Other nerves (i.e., the sciatic nerve) release branches
in the tract that is commonly investigated. Therefore, if the
morphological/morphometrical analysis requires the nerve cross
section (for example to estimate the total number of nerve fibres),
all branches must be analysed.
The third aspect is represented by the chosen method for
measuring the selected size parameters (computerised or manual
analysis). It is important to note how computers can certainly
make quantitative morphology easier and faster (Williams and
Rakic, 1988; Dolapchieva et al., 2000), but a comparison of the
performance of automated cell detection revealed that a manual
approach is still the most appropriate method for stereological
counting (Schmitz et al., 2014).
Gene Expression Analysis
Injured median nerve gene expression analysis can be carried
out both at mRNA and protein level. To reduce the number of
animals and comply with the 3R’ Principle (Replace, Reduce, and
Refine) (Tannenbaum and Bennett, 2015) a good strategy is to
extract from the same nerve sample both total RNA and proteins,
using commercially available kits.
The first point that should be considered when analysing
a nerve sample is that protein extraction involves all nerve
components, neuronal axons and peripheral cells (Schwann
cells, fibroblasts, macrophages, and so on). RNA extraction
mostly encloses peripheral cells, because neuronal RNA is mainly
localised in the cell bodies of sensory neurons (in the dorsal root
ganglia) or motor neurons (in the ventral horn of the spinal cord),
with only few mRNAs locally translated in the axon after nerve
injury (Terenzio et al., 2018).
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The second point that should be carefully considered is the
portion of the injured nerve to be analysed and the time window
for the analysis. Indeed, in the 1st days after injury, regenerating
axons start to colonise the proximal portion of the repaired
nerve, while in the distal portion axons are still undergoing
Wallerian degeneration (Girouard et al., 2018). In the following
days, regeneration occurs also in the distal stump. Therefore,
gene expression analysis will give information about regeneration
or Wallerian degeneration taking place according to the region
and the time point analysed: for gene expression analysis, like
previously discussed for morphology and morphometry, the
region and the time point analysed must be the same for all
samples and for comparison with other studies.
For mRNA analysis, quantitative real time PCR can be
carried under paying attention to the housekeeping genes
used for normalisation: indeed, it is really important to
normalise data to genes whose expression is not affected by
nerve injury (Vandesompele et al., 2002). To this aim, stable
housekeeping genes suitable for gene expression analysis were
identified (Gambarotta et al., 2014; Wang et al., 2017). To avoid
amplification of contaminant genomic DNA, a good strategy
is to design primers on different exons, possibly separated by
introns larger than 1,000 bp, or straddling two contiguous exons.
For protein analysis, western blots can be carried out using
the stain-free technology, which is a good strategy, because
protein expression is normalised to the total protein content,
bypassing the problem of the choice of suitable housekeeping
genes (Gurtler et al., 2013).
Transgenic Models to Evaluate
Peripheral Nerve Regeneration
A transgenic model that can be used for evaluating and
monitoring peripheral nerve regeneration in mice and rats
is Thy1-GFP, in which Thy1 promoter drives neuron specific
expression of GFP, allowing imaging of nerve regeneration
following nerve injuries (Porrero et al., 2010; Moore et al., 2012;
Kemp et al., 2013).
CONCLUSION
In this review we emphasised the use of the median nerve
as pre-clinical experimental model to study nerve regeneration
in vivo. Accordingly, in the last years the median nerve model
is increasingly used due to different reasons, including a better
animal well-being, and availability of different functional tests
which, specifically in rodents, allow testing the digital fine
movement, making the results obtained with this model more
translatable into the clinic.
With regard to the animal choice, the rat definitely represents
the easiest and more translatable model, especially for studies
evaluating regeneration across short nerve gaps, while for
large nerve gaps the use of other, larger, animals would be
recommended. In case large animal facilities are not available, an
alternative and very interesting approach might be the cross-chest
median nerve transfer in the rat animal model (Sinis et al., 2006).
Indeed, this method would allow the use of rodents, which are less
expensive and easier to handle compared to large animals, but at
the same time would allow studying nerve regeneration across
long gaps (up to 40 mm).
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